<rdf:RDF
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:j.0="http://purl.org/dc/terms/"
    xmlns:data="http://utpl.edu.ec/lod/publicCOVID/data/"
    xmlns:dbc="http://dbpedia.org/resource/Category:"
    xmlns:schema="http://schema.org/"
    xmlns:myOnto="http://utpl.edu.ec/lod/publicCOVID/myOnto/"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:fabio="http://purl.org/spar/fabio/"
    xmlns:rdfs="https://www.w3.org/2000/01/rdf-schema/"
    xmlns:j.1="http://xmlns.com/foaf/0.1/">
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081582402">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Nelson C.W.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Nature">
        <j.1:name>Nature</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:volume>579</myOnto:volume>
    <j.0:publisher>Nature Research</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>COVID-19: time for WHO to reconsider its stance towards Taiwan</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081582402</j.0:identifier>
    <schema:keywords>binding protein; virus vaccine; COVID-19; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; decision making; epidemic; global health; health care system; human; Letter; priority journal; SARS coronavirus; severe acute respiratory syndrome coronavirus 2; Taiwan; World Health Organization; Coronavirus infection; health care delivery; politics; virus pneumonia; World Health Organization; Coronavirus Infections; Delivery of Health Care; Humans; Pneumonia, Viral; Politics; Taiwan; World Health Organization</schema:keywords>
    <j.0:identifier>10.1038/d41586-020-00693-2</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>7798</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081582402&amp;doi=10.1038%2fd41586-020-00693-2&amp;partnerID=40&amp;md5=7372e40e60894312d6e5bd3617558416&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078826093">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Recent advances in the detection of respiratory virus infection in humans</j.0:title>
    <j.0:identifier>2-s2.0-85078826093</j.0:identifier>
    <schema:keywords>DNA; quantum dot; Coronavirinae; diagnostic procedure; DNA microarray; enzyme linked immunosorbent assay; high throughput sequencing; human; Human adenovirus C; Human respiratory syncytial virus; Human rhinovirus; immunoassay; immunofluorescence test; Influenza virus; intermethod comparison; lateral flow immunoassay; limit of detection; limit of quantitation; molecular diagnosis; multiplex polymerase chain reaction; multiplex real time polymerase chain reaction; nonhuman; Qiagen ResPlex II V2.0; real time polymerase chain reaction; real time reverse transcription polymerase chain reaction; reproducibility; reverse transcription loop mediated isothermal amplification; Review; semi-nested polymerase chain reaction; sensitivity and specificity; viral respiratory tract infection; virus detection; virus isolation; Coronavirus infection; growth, development and aging; human adenovirus infection; immunological procedures; influenza; isolation and purification; nucleic acid amplification; picornavirus infection; respiratory syncytial virus infection; respiratory tract infection; Rhinovirus; virus; Adenovirus Infections, Human; Coronavirus Infections; Humans; Immunoassay; Immunologic Tests; Influenza, Human; Multiplex Polymerase Chain Reaction; Nucleic Acid Amplification Techniques; Picornaviridae Infections; Real-Time Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Rhinovirus; Viruses</schema:keywords>
    <dc:creator>Zhang N., Wang L., Deng X., Liang R., Su M., He C., Hu L., Su Y., Ren J., Yu F., Du L., Jiang S.</dc:creator>
    <myOnto:issue>4</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology">
        <j.1:name>Journal of Medical Virology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:type>Review</j.0:type>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:citeyBy>10</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1002/jmv.25674</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078826093&amp;doi=10.1002%2fjmv.25674&amp;partnerID=40&amp;md5=af264f7a2267556f98f8d69ac75c9e88&gt;</schema:url>
    <rdfs:comment>Respiratory tract viral infection caused by viruses or bacteria is one of the most common diseases in human worldwide, while those caused by emerging viruses, such as the novel coronavirus, 2019-nCoV that caused the pneumonia outbreak in Wuhan, China most recently, have posed great threats to global public health. Identification of the causative viral pathogens of respiratory tract viral infections is important to select an appropriate treatment, save people's lives, stop the epidemics, and avoid unnecessary use of antibiotics. Conventional diagnostic tests, such as the assays for rapid detection of antiviral antibodies or viral antigens, are widely used in many clinical laboratories. With the development of modern technologies, new diagnostic strategies, including multiplex nucleic acid amplification and microarray-based assays, are emerging. This review summarizes currently available and novel emerging diagnostic methods for the detection of common respiratory viruses, such as influenza virus, human respiratory syncytial virus, coronavirus, human adenovirus, and human rhinovirus. Multiplex assays for simultaneous detection of multiple respiratory viruses are also described. It is anticipated that such data will assist researchers and clinicians to develop appropriate diagnostic strategies for timely and effective detection of respiratory virus infections. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081281123">
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081281123</j.0:identifier>
    <j.0:title>Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China</j.0:title>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <dc:creator>Rello J., Tejada S., Userovici C., Arvaniti K., Pugin J., Waterer G.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.accpm.2020.03.001</j.0:identifier>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Anaesthesia_Critical_Care_and_Pain_Medicine">
        <j.1:name>Anaesthesia Critical Care and Pain Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081281123&amp;doi=10.1016%2fj.accpm.2020.03.001&amp;partnerID=40&amp;md5=86e8a35a78b9aa025dabd5d915937e40&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081970526">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Visual_Journal_of_Emergency_Medicine">
        <j.1:name>Visual Journal of Emergency Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>COVID-19 Personal Protective Equipment (PPE) for the emergency physician</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>19</myOnto:volume>
    <j.0:identifier>10.1016/j.visj.2020.100740</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081970526</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <dc:creator>Holland M., Zaloga D.J., Friderici C.S.</dc:creator>
    <j.0:publisher>Elsevier Inc</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081970526&amp;doi=10.1016%2fj.visj.2020.100740&amp;partnerID=40&amp;md5=e5b56f87329141eafec2e7bc74e40504&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079334104">
    <j.0:identifier>2-s2.0-85079334104</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079334104&amp;doi=10.1038%2fd41586-020-00354-4&amp;partnerID=40&amp;md5=163f00f7b800074499bd9c225269307a&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:identifier>10.1038/d41586-020-00354-4</j.0:identifier>
    <myOnto:issue>7794</myOnto:issue>
    <myOnto:volume>578</myOnto:volume>
    <dc:creator>Bhadelia N.</dc:creator>
    <schema:keywords>2019 novel coronavirus; body fluid; Coronavirinae; Coronavirus infection; coughing; decontamination; disease transmission; Ebola hemorrhagic fever; hand washing; health care facility; health care personnel; health care policy; health care quality; human; infection control; infection risk; influenza A (H1N1); intensive care; measles; nonhuman; Note; pandemic; patient care; personnel shortage; priority journal; sample size; severe acute respiratory syndrome; sneezing; travel; tuberculosis; virus particle; Coronavirus infection; influenza; Influenza A virus (H1N1); New York; tertiary care center; Coronavirus; Coronavirus; Coronavirus Infections; Health Personnel; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; New York City; Tertiary Care Centers</schema:keywords>
    <dc:language>English</dc:language>
    <rdfs:comment>Use techniques honed during the SARS, H1N1 and Ebola epidemics to separate sick and well, keep workers safe and prepare for the next outbreak, says Nahid Bhadelia [Figure not available: see fulltext.] © 2020, Nature.</rdfs:comment>
    <j.0:title>Coronavirus: hospitals must learn from past pandemics</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081254713">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081254713&amp;doi=10.1016%2fj.janxdis.2020.102211&amp;partnerID=40&amp;md5=2ad79e140377c3f67cab9965d372d174&gt;</schema:url>
    <j.0:title>How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Anxiety_Disorders">
        <j.1:name>Journal of Anxiety Disorders</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081254713</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <schema:keywords>antivirus agent; virus vaccine; 2009 H1N1 influenza; anxiety; authority; coronavirus disease 2019; Coronavirus infection; coughing; decision making; Editorial; environmental exposure; epidemic; fever; health behavior; health belief; health care personnel; health promotion; human; infection risk; knowledge; medical care; medical information; morbidity; mortality; myalgia; pandemic; public health service; social behavior; vaccination</schema:keywords>
    <myOnto:volume>71</myOnto:volume>
    <dc:creator>Asmundson G.J.G., Taylor S.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.janxdis.2020.102211</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081609193">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081609193</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; disease predisposition; epidemic; female; human; patient care planning; practice guideline; pregnancy; pregnancy complication; virology; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Disease Susceptibility; Female; Humans; Patient Care Planning; Pneumonia, Viral; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious</schema:keywords>
    <j.0:title>Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?</j.0:title>
    <j.0:identifier>10.1111/aogs.13836</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Liang H., Acharya G.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081609193&amp;doi=10.1111%2faogs.13836&amp;partnerID=40&amp;md5=abeab7d5d08dc9eb9d902d790a9d32e4&gt;</schema:url>
    <j.0:publisher>Wiley-Blackwell</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Acta_Obstetricia_et_Gynecologica_Scandinavica">
        <j.1:name>Acta Obstetricia et Gynecologica Scandinavica</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081531253">
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m943</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)">
        <j.1:name>BMJ (Clinical research ed.)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85081531253</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081531253&amp;doi=10.1136%2fbmj.m943&amp;partnerID=40&amp;md5=19de616de840aa96138ff76ff234ce0d&gt;</schema:url>
    <j.0:title>Covid-19: UK records first death, as world's cases exceed 100?000</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080972037">
    <myOnto:issue>3</myOnto:issue>
    <schema:keywords>COVID-19; China; Coronavirus infection; human; Iceland; pandemic; uncertainty; virus pneumonia; China; Coronavirus Infections; Humans; Iceland; Pandemics; Pneumonia, Viral; Uncertainty</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>Icelandic</dc:language>
    <myOnto:volume>106</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Laeknabladid">
        <j.1:name>Laeknabladid</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Briem H.</dc:creator>
    <j.0:title>COVID-19. The only certainty is the uncertainty</j.0:title>
    <j.0:identifier>2-s2.0-85080972037</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.17992/lbl.2020.03.469</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080972037&amp;doi=10.17992%2flbl.2020.03.469&amp;partnerID=40&amp;md5=abf5fac507f9f776c7dec9ad30a3d496&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078687659">
    <myOnto:issue>7792</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <dc:creator>Callaway E., Cyranoski D.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078687659&amp;doi=10.1038%2fd41586-020-00166-6&amp;partnerID=40&amp;md5=f74708082b7663f1aebd486d1605f0c0&gt;</schema:url>
    <j.0:identifier>10.1038/d41586-020-00166-6</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:identifier>2-s2.0-85078687659</j.0:identifier>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <myOnto:volume>577</myOnto:volume>
    <schema:keywords>anti human immunodeficiency virus agent; antivirus agent; COVID-19; virus vaccine; animal; asymptomatic infection; basic reproduction number; China; Coronavirinae; Coronavirus infection; Europe; genetics; human; isolation and purification; mortality; organization and management; pathogenicity; procedures; quarantine; severe acute respiratory syndrome; United States; virology; virus pneumonia; World Health Organization; zoonosis; Animals; Anti-HIV Agents; Antiviral Agents; Asymptomatic Infections; Basic Reproduction Number; China; Coronavirus; Coronavirus Infections; Europe; Humans; Pneumonia, Viral; Quarantine; Severe Acute Respiratory Syndrome; United States; Viral Vaccines; World Health Organization; Zoonoses</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>China coronavirus: Six questions scientists are asking</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081669458">
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:creator>Dyer O.</dc:creator>
    <j.0:identifier>2-s2.0-85081669458</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:title>Covid-19: China's president Xi visits Wuhan amid confidence that virus is under control</j.0:title>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1136/bmj.m995</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081669458&amp;doi=10.1136%2fbmj.m995&amp;partnerID=40&amp;md5=1e25685bbdcf5961b3214d1e8deadcba&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081924823">
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV [Recomendaciones prácticas para el manejo perioperatorio del paciente con sospecha o infección grave por coronavirus SARS-CoV-2]</j.0:title>
    <dc:language>English; Spanish</dc:language>
    <dc:date>2020</dc:date>
    <rdfs:comment>In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications. © 2020 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier Doyma</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081924823</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081924823&amp;doi=10.1016%2fj.redar.2020.03.003&amp;partnerID=40&amp;md5=6de68ff6d6405369f1438237811e4021&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Revista_Espanola_de_Anestesiologia_y_Reanimacion">
        <j.1:name>Revista Espanola de Anestesiologia y Reanimacion</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Montero Feijoo A., Maseda E., Adalia Bartolomé R., Aguilar G., González de Castro R., Gómez-Herreras J.I., García Palenciano C., Pereira J., Ramasco Rueda F., Samso E., Suárez de la Rica A., Tamayo Medel G., Varela Durán M., en nombre del Grupo de Trabajo de Infeccion Perioperatoria de la Sociedad Espanola de Anestesiologia y Reanimacion (GTIPO-SEDAR)</dc:creator>
    <j.0:identifier>10.1016/j.redar.2020.03.003</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081722616">
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <rdfs:comment>The emergence and spread of 2019 novel coronavirus–infected pneumonia (COVID-19) from Wuhan, China, it has spread globally. We extracted the data on 14 patients with laboratory-confirmed COVID-19 from Jinhua Municipal Central hospital through 27 January 2020. We found that compared to pharyngeal swab specimens, nucleic acid detection of COVID-19 in fecal specimens was equally accurate. And we found that patients with a positive stool test did not experience gastrointestinal symptoms and had nothing to do with the severity of the lung infection. These results may help to understand the clinical diagnosis and the changes in clinical parameters of COVID-19. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:title>Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1002/jmv.25742</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>2-s2.0-85081722616</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Zhang J., Wang S., Xue Y.</dc:creator>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081722616&amp;doi=10.1002%2fjmv.25742&amp;partnerID=40&amp;md5=29fbd3f47b97933531731a2cf450b403&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078832422">
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85078832422</j.0:identifier>
    <j.0:title>Response to the emerging novel coronavirus outbreak</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1136/bmj.m406</j.0:identifier>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ">
        <j.1:name>The BMJ</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>368</myOnto:volume>
    <schema:keywords>2019 novel coronavirus; China; Coronavirinae; Coronavirus infection; disease surveillance; Editorial; epidemic; human; infection control; international cooperation; pandemic; politics; priority journal; quarantine; racism</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078832422&amp;doi=10.1136%2fbmj.m406&amp;partnerID=40&amp;md5=cbc28bee08eefd7430cc858b4774ef1e&gt;</schema:url>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:creator>Kickbusch I., Leung G.</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082198183">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Hare S.S., Rodrigues J.C.L., Jacob J., Edey A., Devaraj A., Johnstone A., McStay R., Nair A., Robinson G.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082198183&amp;doi=10.1016%2fj.crad.2020.03.005&amp;partnerID=40&amp;md5=1aa943f66426b17dee8f95de3807f608&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082198183</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_Radiology">
        <j.1:name>Clinical Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:identifier>10.1016/j.crad.2020.03.005</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>A UK-wide British Society of Thoracic Imaging COVID-19 imaging repository and database: design, rationale and implications for education and research</j.0:title>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081945655">
    <dc:creator>Lum L.H.W., Tambyah P.A.</dc:creator>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081945655&amp;doi=10.11622%2fsmedj.2020018&amp;partnerID=40&amp;md5=0298f02c381ccfb8cac20f89d4a01cc7&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081945655</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>COVID-19; Coronavirus infection; economics; fear; global health; health care delivery; human; industry; international cooperation; medical research; organization and management; public relations; science; Singapore; travel; virus pneumonia; Biomedical Research; Coronavirus Infections; Delivery of Health Care; Fear; Global Health; Humans; Industry; Internationality; Interprofessional Relations; Pneumonia, Viral; Science; Singapore; Travel</schema:keywords>
    <j.0:identifier>10.11622/smedj.2020018</j.0:identifier>
    <myOnto:issue>2</myOnto:issue>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>61</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Singapore_medical_journal">
        <j.1:name>Singapore medical journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Outbreak of COVID-19 - an urgent need for good science to silence our fears?</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079084303">
    <j.0:identifier>2-s2.0-85079084303</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; adult; complication; Coronavirus infection; diagnostic imaging; epidemic; female; health care policy; human; lung; male; middle aged; migration; patient isolation; quarantine; South Korea; virus pneumonia; young adult; Adult; Coronavirus Infections; Disease Outbreaks; Emigration and Immigration; Female; Health Policy; Humans; Lung; Male; Middle Aged; Patient Isolation; Pneumonia, Viral; Quarantine; Republic of Korea; Young Adult</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079084303&amp;doi=10.3346%2fjkms.2020.35.e62&amp;partnerID=40&amp;md5=77f62b4a2d43037ee4737a21b1a48586&gt;</schema:url>
    <myOnto:volume>35</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Yoo J.-H., Hong S.-T.</dc:creator>
    <j.0:title>The outbreak cases with the novel coronavirus suggest upgraded quarantine and isolation in Korea</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>5</myOnto:issue>
    <j.0:identifier>10.3346/jkms.2020.35.e62</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science">
        <j.1:name>Journal of Korean Medical Science</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081743468">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081743468</j.0:identifier>
    <dc:creator>Peng Y., Zhou Y.-H.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1002/jmv.25753</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:title>Is novel coronavirus disease (COVID-19) transmitted through conjunctiva?</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081743468&amp;doi=10.1002%2fjmv.25753&amp;partnerID=40&amp;md5=b02c13984c0348000307148cd9e40572&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080054477">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/One_Health">
        <j.1:name>One Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:volume>9</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>10.1016/j.onehlt.2020.100123</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Marty A.M., Jones M.K.</dc:creator>
    <schema:keywords>2019 novel coronavirus; China; Coronavirus infection; Editorial; epidemic; genetic analysis; human; nonhuman; One Health; patient isolation; public health; viral genetics; virus transmission</schema:keywords>
    <j.0:title>The novel Coronavirus (SARS-CoV-2) is a one health issue</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080054477</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080054477&amp;doi=10.1016%2fj.onehlt.2020.100123&amp;partnerID=40&amp;md5=ee7b24a40e5a60b50cae7e9e6580d24e&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082137078">
    <dc:language>English</dc:language>
    <j.0:title>The impact of covid-19 epidemic declaration on psychological consequences: A study on active weibo users</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082137078&amp;doi=10.3390%2fijerph17062032&amp;partnerID=40&amp;md5=4a1f75d6c389c549a7258eb86a840593&gt;</schema:url>
    <myOnto:volume>17</myOnto:volume>
    <dc:date>2020</dc:date>
    <schema:keywords>Coronavirus</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Environmental_Research_and_Public_Health">
        <j.1:name>International Journal of Environmental Research and Public Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85082137078</j.0:identifier>
    <dc:creator>Li S., Wang Y., Xue J., Zhao N., Zhu T.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.3390/ijerph17062032</j.0:identifier>
    <myOnto:issue>6</myOnto:issue>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>COVID-19 (Corona Virus Disease 2019) has significantly resulted in a large number of psychological consequences. The aim of this study is to explore the impacts of COVID-19 on people’s mental health, to assist policy makers to develop actionable policies, and help clinical practitioners (e.g., social workers, psychiatrists, and psychologists) provide timely services to affected populations. We sample and analyze the Weibo posts from 17,865 active Weibo users using the approach of Online Ecological Recognition (OER) based on several machine-learning predictive models. We calculated word frequency, scores of emotional indicators (e.g., anxiety, depression, indignation, and Oxford happiness) and cognitive indicators (e.g., social risk judgment and life satisfaction) from the collected data. The sentiment analysis and the paired sample t-test were performed to examine the differences in the same group before and after the declaration of COVID-19 on 20 January, 2020. The results showed that negative emotions (e.g., anxiety, depression and indignation) and sensitivity to social risks increased, while the scores of positive emotions (e.g., Oxford happiness) and life satisfaction decreased. People were concerned more about their health and family, while less about leisure and friends. The results contribute to the knowledge gaps of short-term individual changes in psychological conditions after the outbreak. It may provide references for policy makers to plan and fight against COVID-19 effectively by improving stability of popular feelings and urgently prepare clinical practitioners to deliver corresponding therapy foundations for the risk groups and affected people. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081169126">
    <j.0:identifier>2-s2.0-85081169126</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Gostic K.M., Gomez A.C.R., Mummah R.O., Kucharski A.J., Lloyd-Smith J.O.</dc:creator>
    <j.0:identifier>10.7554/eLife.55570</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:volume>9</myOnto:volume>
    <j.0:title>Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19</j.0:title>
    <rdfs:comment>Traveller screening is being used to limit further spread of COVID-19 following its recent emergence, and symptom screening has become a ubiquitous tool in the global response. Previously, we developed a mathematical model to understand factors governing the effectiveness of traveller screening to prevent spread of emerging pathogens (Gostic et al., 2015). Here, we estimate the impact of different screening programs given current knowledge of key COVID-19 life history and epidemiological parameters. Even under best-case assumptions, we estimate that screening will miss more than half of infected people. Breaking down the factors leading to screening successes and failures, we find that most cases missed by screening are fundamentally undetectable, because they have not yet developed symptoms and are unaware they were exposed. Our work underscores the need for measures to limit transmission by travellers who become ill after being missed by a screening program. These findings can support evidence-based policy to combat the spread of COVID-19, and prospective planning to mitigate future emerging pathogens. © 2020, eLife Sciences Publications Ltd. All rights reserved.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/eLife">
        <j.1:name>eLife</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <schema:keywords>article; human; infectious agent; life history; nonhuman; risk assessment; travel; asymptomatic infection; Betacoronavirus; Coronavirus infection; epidemic; infection control; isolation and purification; mass screening; procedures; risk assessment; travel; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Asymptomatic Infections; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Infection Control; Mass Screening; Pneumonia, Viral; Risk Assessment; Travel</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:publisher>eLife Sciences Publications Ltd</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081169126&amp;doi=10.7554%2feLife.55570&amp;partnerID=40&amp;md5=407f9ba4d7bf69558522bdfe6fdc93c6&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081989362">
    <j.0:type>Article</j.0:type>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1136/bmj.m1072</j.0:identifier>
    <j.0:title>Covid-19: junior doctor calls on colleagues to gather supplies for staff working long hours</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081989362&amp;doi=10.1136%2fbmj.m1072&amp;partnerID=40&amp;md5=87ad98598ba7463baec71d600a2adeb3&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081989362</j.0:identifier>
    <dc:creator>Rimmer A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078933824">
    <j.0:identifier>10.1056/NEJMp2000929</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078933824&amp;doi=10.1056%2fNEJMp2000929&amp;partnerID=40&amp;md5=ed48ca4a59a68d08a1fa9a4c36b54b6a&gt;</schema:url>
    <schema:keywords>China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease severity; disease transmission; health care; health care facility; health center; human; Influenza A virus; Influenza A virus (H1N1); Japan; Middle East respiratory syndrome coronavirus; Nepal; nonhuman; pandemic; pathogenicity; patient monitoring; priority journal; public health; Review; SARS coronavirus; severe acute respiratory syndrome coronavirus 2; Singapore; South Korea; Taiwan; Thailand; United States; Viet Nam; Betacoronavirus; communicable disease control; Coronavirus infection; disease notification; epidemic; health survey; mortality; pathogenicity; virology; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Communicable Disease Control; Coronavirus Infections; Disease Notification; Disease Outbreaks; Humans; Mortality; Pneumonia, Viral; Population Surveillance</schema:keywords>
    <j.0:type>Review</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:title>A novel coronavirus emerging in China - Key questions for impact assessment</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine">
        <j.1:name>New England Journal of Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>26</myOnto:citeyBy>
    <dc:creator>Munster V.J., Koopmans M., van Doremalen N., van Riel D., de Wit E.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85078933824</j.0:identifier>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <myOnto:volume>382</myOnto:volume>
    <myOnto:issue>8</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082050136">
    <j.0:publisher>Springer</j.0:publisher>
    <dc:date>2020</dc:date>
    <dc:creator>Arabi Y.M., Murthy S., Webb S.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>the original version of this article unfortunately contained a mistake. there was an error in table one: in the last row, second column the part “still being defined to” should be crossed out. the correct table 1 can be found below. we apologize for the mistake. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:identifier>10.1007/s00134-020-06009-2</j.0:identifier>
    <schema:keywords>erratum</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine">
        <j.1:name>Intensive Care Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Correction to: COVID-19: a novel coronavirus and a novel challenge for critical care (Intensive Care Medicine, (2020), 10.1007/s00134-020-05955-1)</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082050136</j.0:identifier>
    <j.0:type>Erratum</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082050136&amp;doi=10.1007%2fs00134-020-06009-2&amp;partnerID=40&amp;md5=f02bb7605ae65d5fe889a677672507db&gt;</schema:url>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082011122">
    <j.0:identifier>10.1016/j.rce.2020.03.001</j.0:identifier>
    <j.0:publisher>Elsevier Doyma</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082011122</j.0:identifier>
    <dc:language>English; Spanish</dc:language>
    <j.0:type>Review</j.0:type>
    <j.0:title>COVID-19, a worldwide public health emergency [COVID-19, una emergencia de salud pública mundial]</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Palacios Cruz M., Santos E., Velázquez Cervantes M.A., León Juárez M.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Revista_Clinica_Espanola">
        <j.1:name>Revista Clinica Espanola</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082011122&amp;doi=10.1016%2fj.rce.2020.03.001&amp;partnerID=40&amp;md5=b66c125bd7ec3d850415e785dc64b4e3&gt;</schema:url>
    <rdfs:comment>A new coronavirus outbreak emerged on the 31st of December 2019 in Wuhan, China, causing commotion among the medical community and the rest of the world. This new species of coronavirus has been termed 2019-nCoV and has caused a considerable number of cases of infection and deaths in China and, to a growing degree, beyond China, becoming a worldwide public health emergency. 2019-nCoV has high homology to other pathogenic coronaviruses, such as those originating from bat-related zoonosis (SARS-CoV), which caused approximately 646 deaths in China at the start of the decade. The mortality rate for 2019-nCoV is not as high (approximately 2-3%), but its rapid propagation has resulted in the activation of protocols to stop its spread. This pathogen has the potential to become a pandemic. It is therefore vital to follow the personal care recommendations issued by the World Health Organisation. © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081585939">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:title>Passengers' destinations from China: Low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Epidemiology_and_Infection">
        <j.1:name>Epidemiology and Infection</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081585939</j.0:identifier>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <j.0:identifier>10.1017/S0950268820000424</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081585939&amp;doi=10.1017%2fS0950268820000424&amp;partnerID=40&amp;md5=395fb8493adaccd0b3b0df7a2f904a8c&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Haider N., Yavlinsky A., Simons D., Osman A.Y., Ntoumi F., Zumla A., Kock R.</dc:creator>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Africa; airport; aviation; Betacoronavirus; China; communicable disease; Coronavirus infection; emporiatrics; epidemic; health survey; human; risk assessment; South America; virus pneumonia; Africa; Air Travel; Airports; Betacoronavirus; China; Communicable Diseases, Imported; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; Population Surveillance; Risk Assessment; South America; Travel Medicine</schema:keywords>
    <rdfs:comment>Novel Coronavirus (2019-nCoV [SARS-COV-2]) was detected in humans during the last week of December 2019 at Wuhan city in China, and caused 24 554 cases in 27 countries and territories as of 5 February 2020. The objective of this study was to estimate the risk of transmission of 2019-nCoV through human passenger air flight from four major cities of China (Wuhan, Beijing, Shanghai and Guangzhou) to the passengers' destination countries. We extracted the weekly simulated passengers' end destination data for the period of 1-31 January 2020 from FLIRT, an online air travel dataset that uses information from 800 airlines to show the direct flight and passengers' end destination. We estimated a risk index of 2019-nCoV transmission based on the number of travellers to destination countries, weighted by the number of confirmed cases of the departed city reported by the World Health Organization (WHO). We ranked each country based on the risk index in four quantiles (4th quantile being the highest risk and 1st quantile being the lowest risk). During the period, 388 287 passengers were destined for 1297 airports in 168 countries or territories across the world. The risk index of 2019-nCoV among the countries had a very high correlation with the WHO-reported confirmed cases (0.97). According to our risk score classification, of the countries that reported at least one Coronavirus-infected pneumonia (COVID-19) case as of 5 February 2020, 24 countries were in the 4th quantile of the risk index, two in the 3rd quantile, one in the 2nd quantile and none in the 1st quantile. Outside China, countries with a higher risk of 2019-nCoV transmission are Thailand, Cambodia, Malaysia, Canada and the USA, all of which reported at least one case. In pan-Europe, UK, France, Russia, Germany and Italy; in North America, USA and Canada; in Oceania, Australia had high risk, all of them reported at least one case. In Africa and South America, the risk of transmission is very low with Ethiopia, South Africa, Egypt, Mauritius and Brazil showing a similar risk of transmission compared to the risk of any of the countries where at least one case is detected. The risk of transmission on 31 January 2020 was very high in neighbouring Asian countries, followed by Europe (UK, France, Russia and Germany), Oceania (Australia) and North America (USA and Canada). Increased public health response including early case recognition, isolation of identified case, contract tracing and targeted airport screening, public awareness and vigilance of health workers will help mitigate the force of further spread to naïve countries. © 2020 The Author(s).</rdfs:comment>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079834019">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079834019&amp;doi=10.12809%2fhkmj208375&amp;partnerID=40&amp;md5=46d36a13e364405801d21c00a604c0ba&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079834019</j.0:identifier>
    <j.0:identifier>10.12809/hkmj208375</j.0:identifier>
    <myOnto:volume>26</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Hong Kong Academy of Medicine Press</j.0:publisher>
    <j.0:title>Severe acute respiratory symptoms and suspected sars again 2020</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; Adenoviridae; avian influenza; coronavirus disease 2019; disease surveillance; epidemic; fever; health care personnel; Hong Kong; human; influenza A; Letter; measles; Middle East respiratory syndrome; nonhuman; pandemic; pneumonia; public health; respiratory tract disease; SARS coronavirus; severe acute respiratory syndrome</schema:keywords>
    <dc:creator>Hon K.L., Leung K.K.Y.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Hong_Kong_Medical_Journal">
        <j.1:name>Hong Kong Medical Journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082180786">
    <dc:creator>Hsih W.-H., Cheng M.-Y., Ho M.-W., Chou C.-H., Lin P.-C., Chi C.-Y., Liao W.-C., Chen C.-Y., Leong L.-Y., Tien N., Lai H.-C., Lai Y.-C., Lu M.-C.</dc:creator>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082180786&amp;doi=10.1016%2fj.jmii.2020.03.008&amp;partnerID=40&amp;md5=26ba4b57ea4411be3b75c4cf85700f81&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.jmii.2020.03.008</j.0:identifier>
    <schema:keywords></schema:keywords>
    <rdfs:comment>Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CO-V-2), was first reported in Wuhan, Hubei province, China has now rapidly spread over 50 countries. For the prevention and control of infection, Taiwan Centers for Disease Control initiated testing of SARS-CoV-2 on January 24th 2020 for persons suspected with this disease. Until February 28th, 43 flu-like symptomatic patients were screened in China Medical University Hospital. Methods: Two patients were confirmed positive for SARS-CoV-2 infection by rRT-PCR as COVID-19 patients A and B. Causative pathogens for included patients were detected using FilmArray™ Respiratory Panel. We retrospectively analyzed the clinical presentations, laboratory data, radiologic findings, and travel and exposure contact histories, of the COVID-19 patients in comparison to those with other respiratory infections. Results: Through contact with Taiwan No. 19 case patient on 27th January, COVID-19 patients A and B were infected. Both patients had no identified comorbidities and developed mild illness with temporal fever, persistent cough, and lung interstitial infiltrates. Owing to the persistence of positive SARS-CoV-2 in respiratory specimen, the two COVID-19 patients are still in the isolation rooms despite recovery until 10th of March. The results of FilmArrayTM Respiratory Panel revealed 22 of the 41 non-COVID-19 patients were infected by particular pathogens. In general, seasonal respiratory pathogens are more prevalent than SARS-CoV-2 in symptomatic patients in non- COVID-19 endemic area during the flu season. Since all patients shared similar clinical and laboratory findings, expanded surveillance of detailed exposure history for suspected patients and application of rapid detection tools are highly recommended. © 2020</rdfs:comment>
    <j.0:identifier>2-s2.0-85082180786</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection">
        <j.1:name>Journal of Microbiology, Immunology and Infection</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan</j.0:title>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082061557">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Cucinotta D., Vanelli M.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Acta_Biomedica">
        <j.1:name>Acta Biomedica</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>1</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>Mattioli 1885</j.0:publisher>
    <j.0:identifier>2-s2.0-85082061557</j.0:identifier>
    <j.0:identifier>10.23750/abm.v91i1.9397</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082061557&amp;doi=10.23750%2fabm.v91i1.9397&amp;partnerID=40&amp;md5=1e77c68a340a36822d4c5167ca04da4a&gt;</schema:url>
    <j.0:title>WHO declares COVID-19 a pandemic</j.0:title>
    <myOnto:volume>91</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; human; pandemic; virology; virus pneumonia; World Health Organization; Betacoronavirus; China; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; World Health Organization</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081398077">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081398077&amp;doi=10.1080%2f22221751.2020.1738279&amp;partnerID=40&amp;md5=3d04f73430da9e388a6f0240f80c7eb3&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081398077</j.0:identifier>
    <schema:keywords>gene expression system; laboratory; nonhuman; Note; priority journal; SARS coronavirus; virus gene; Betacoronavirus; Coronavirus infection; epidemic; genetic engineering; genetic recombination; genetics; human; isolation and purification; nucleotide sequence; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Base Sequence; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Genetic Engineering; Humans; Pneumonia, Viral; Recombination, Genetic</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections">
        <j.1:name>Emerging Microbes and Infections</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1080/22221751.2020.1738279</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Hao P., Zhong W., Song S., Fan S., Li X.</dc:creator>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <myOnto:volume>9</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081893352">
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:title>Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081893352&amp;doi=10.1080%2f22221751.2020.1739565&amp;partnerID=40&amp;md5=51aa7e1c01618a80eeefd59c4c6c1c2e&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081893352</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <myOnto:issue>1</myOnto:issue>
    <schema:keywords>coronavirus spike glycoprotein; dipeptidyl peptidase IV; DPP4 protein, human; polysaccharide; protein binding; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; chemistry; genetics; human; metabolism; molecular model; protein quaternary structure; Betacoronavirus; Dipeptidyl Peptidase 4; Humans; Models, Molecular; Polysaccharides; Protein Binding; Protein Structure, Quaternary; Spike Glycoprotein, Coronavirus</schema:keywords>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1080/22221751.2020.1739565</j.0:identifier>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>9</myOnto:volume>
    <dc:creator>Vankadari N., Wilce J.A.</dc:creator>
    <rdfs:comment>The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity. Here we report our modelled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free) and open (ligand-bound) conformation, which is involved in host cell adhesion. We also predict the unique N- and O-linked glycosylation sites of spike glycoprotein that distinguish it from the SARS and underlines shielding and camouflage of COVID-19 from the host the defence system. Furthermore, our study also highlights the key finding that the S1 domain of COVID-19 spike glycoprotein potentially interacts with the human CD26, a key immunoregulatory factor for hijacking and virulence. These findings accentuate the unique features of COVID-19 and assist in the development of new therapeutics. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080036716">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <dc:creator>Huang W.-H., Teng L.-C., Yeh T.-K., Chen Y.-J., Lo W.-J., Wu M.-J., Chin C.-S., Tsan Y.-T., Lin T.-C., Chai J.-W., Lin C.-F., Tseng C.-H., Liu C.-W., Wu C.-M., Chen P.-Y., Shi Z.-Y., Liu P.-Y.</dc:creator>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:title>2019 novel coronavirus disease (COVID-19) in Taiwan: Reports of two cases from Wuhan, China</j.0:title>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jmii.2020.02.009</j.0:identifier>
    <rdfs:comment>We reported two cases with community-acquired pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who returned from Wuhan, China in January, 2020. The reported cases highlight non-specific clinical presentations of 2019 novel coronavirus disease (COVID-19) as well as the importance of rapid laboratory-based diagnosis. © 2020</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080036716&amp;doi=10.1016%2fj.jmii.2020.02.009&amp;partnerID=40&amp;md5=19c0da7c5c9bd23785c914f03deeb38a&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080036716</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080881381">
    <myOnto:issue>5</myOnto:issue>
    <j.0:title>Potential interventions for novel coronavirus in China: A systematic review</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>An outbreak of a novel coronavirus (COVID-19 or 2019-CoV) infection has posed significant threats to international health and the economy. In the absence of treatment for this virus, there is an urgent need to find alternative methods to control the spread of disease. Here, we have conducted an online search for all treatment options related to coronavirus infections as well as some RNA-virus infection and we have found that general treatments, coronavirus-specific treatments, and antiviral treatments should be useful in fighting COVID-19. We suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's RNA-virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers. In addition, convalescent plasma should be given to COVID-19 patients if it is available. In conclusion, we suggest that all the potential interventions be implemented to control the emerging COVID-19 if the infection is uncontrollable. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:creator>Zhang L., Liu Y.</dc:creator>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>10.1002/jmv.25707</j.0:identifier>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:identifier>2-s2.0-85080881381</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080881381&amp;doi=10.1002%2fjmv.25707&amp;partnerID=40&amp;md5=a111fa8995ffd319e060ae9cd8adb19e&gt;</schema:url>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:volume>92</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:keywords>alpha tocopherol; antivirus agent; ascorbic acid; chloroquine; cinanserin; cyclosporine; diarylheptanoid derivative; dipeptidyl carboxypeptidase inhibitor; emodin; flavonoid; immunoglobulin; interferon; iron; lopinavir plus ritonavir; monoclonal antibody; nelfinavir; nicotianamine; omega 3 fatty acid; polyunsaturated fatty acid; promazine; proteinase inhibitor; remdesivir; retinol; ribavirin; selenium; thymopentin; thymosin alpha1; unclassified drug; unindexed drug; vitamin B group; zinc; COVID-19; immunologic factor; severe acute respiratory syndrome coronavirus 2; trace element; virus vaccine; vitamin; antiviral therapy; China; Chinese medicine; coronavirus disease 2019; coronavirus disease 2019; diet therapy; human; infection control; nonhuman; Review; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; systematic review; virus infection; Betacoronavirus; China; Coronavirus infection; nutritional status; passive immunization; pathogenicity; plasma; virus pneumonia; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; Humans; Immunization, Passive; Immunologic Factors; Nutritional Status; Plasma; Pneumonia, Viral; Trace Elements; Viral Vaccines; Vitamins</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079436157">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:issue>5</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:creator>Li X., Wang W., Zhao X., Zai J., Zhao Q., Li Y., Chaillon A.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079436157&amp;doi=10.1002%2fjmv.25701&amp;partnerID=40&amp;md5=9f1c831073549154cfa94bd643ba9f8f&gt;</schema:url>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:title>Transmission dynamics and evolutionary history of 2019-nCoV</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>article; China; clinical article; evolutionary rate; genetic variability; human; nonhuman; public health; Thailand; virus genome; virus strain; Bayes theorem; Betacoronavirus; biological model; Coronavirus infection; epidemic; genetics; mutation rate; phylogeny; statistical model; United States; virus genome; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Bayes Theorem; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Genome, Viral; Humans; Likelihood Functions; Models, Genetic; Mutation Rate; Phylogeny; Pneumonia, Viral; Thailand; United States</schema:keywords>
    <j.0:identifier>10.1002/jmv.25701</j.0:identifier>
    <rdfs:comment>To investigate the time origin, genetic diversity, and transmission dynamics of the recent 2019-nCoV outbreak in China and beyond, a total of 32 genomes of virus strains sampled from China, Thailand, and the USA with sampling dates between 24 December 2019 and 23 January 2020 were analyzed. Phylogenetic, transmission network, and likelihood-mapping analyses of the genome sequences were performed. On the basis of the likelihood-mapping analysis, the increasing tree-like signals (from 0% to 8.2%, 18.2%, and 25.4%) over time may be indicative of increasing genetic diversity of 2019-nCoV in human hosts. We identified three phylogenetic clusters using the Bayesian inference framework and three transmission clusters using transmission network analysis, with only one cluster identified by both methods using the above genome sequences of 2019-nCoV strains. The estimated mean evolutionary rate for 2019-nCoV ranged from 1.7926 × 10?3 to 1.8266 × 10?3 substitutions per site per year. On the basis of our study, undertaking epidemiological investigations and genomic data surveillance could positively impact public health in terms of guiding prevention efforts to reduce 2019-nCOV transmission in real-time. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079436157</j.0:identifier>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078741591">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet">
        <j.1:name>The Lancet</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy>94</myOnto:citeyBy>
    <j.0:identifier>10.1016/S0140-6736(20)30251-8</j.0:identifier>
    <j.0:title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</j.0:title>
    <myOnto:issue>10224</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:creator>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., Zhou H., Hu Z., Zhou W., Zhao L., Chen J., Meng Y., Wang J., Lin Y., Yuan J., Xie Z., Ma J., Liu W.J., Wang D., Xu W., Holmes E.C., Gao G.F., Wu G., Chen W., Shi W., Tan W.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>angiotensin converting enzyme 2; complementary DNA; COVID-19; severe acute respiratory syndrome coronavirus 2; virus DNA; virus receptor; 2019 novel coronavirus; Article; Betacoronavirus; bronchoalveolar lavage fluid; China; clinical article; controlled study; epidemiological data; genomics; high throughput sequencing; hospital patient; human; human cell; nonhuman; phylogeny; priority journal; receptor binding; Sanger sequencing; SARS coronavirus; sequence homology; virus genome; virus isolation; virus pneumonia; virus transmission; Betacoronavirus; Coronavirus infection; disease carrier; genetics; genomics; metabolism; procedures; sequence alignment; virology; virus genome; virus pneumonia; Betacoronavirus; Bronchoalveolar Lavage Fluid; China; Coronavirus Infections; Disease Reservoirs; DNA, Viral; Genome, Viral; Genomics; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; Pneumonia, Viral; Receptors, Virus; Sequence Alignment</schema:keywords>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078741591&amp;doi=10.1016%2fS0140-6736%2820%2930251-8&amp;partnerID=40&amp;md5=d171d93b32431ee2172079e77d395488&gt;</schema:url>
    <rdfs:comment>Background: In late December, 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV). As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed. Methods: We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan. Complete and partial 2019-nCoV genome sequences were obtained from these individuals. Viral contigs were connected using Sanger sequencing to obtain the full-length genomes, with the terminal regions determined by rapid amplification of cDNA ends. Phylogenetic analysis of these 2019-nCoV genomes and those of other coronaviruses was used to determine the evolutionary history of the virus and help infer its likely origin. Homology modelling was done to explore the likely receptor-binding properties of the virus. Findings: The ten genome sequences of 2019-nCoV obtained from the nine patients were extremely similar, exhibiting more than 99·98% sequence identity. Notably, 2019-nCoV was closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV. Notably, homology modelling revealed that 2019-nCoV had a similar receptor-binding domain structure to that of SARS-CoV, despite amino acid variation at some key residues. Interpretation: 2019-nCoV is sufficiently divergent from SARS-CoV to be considered a new human-infecting betacoronavirus. Although our phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans. Importantly, structural analysis suggests that 2019-nCoV might be able to bind to the angiotensin-converting enzyme 2 receptor in humans. The future evolution, adaptation, and spread of this virus warrant urgent investigation. Funding: National Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, Chinese Academy of Sciences, Shandong First Medical University. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85078741591</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081737846">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1002/asi.24357</j.0:identifier>
    <dc:creator>Xie B., He D., Mercer T., Wang Y., Wu D., Fleischmann K.R., Zhang Y., Yoder L.H., Stephens K.K., Mackert M., Lee M.K.</dc:creator>
    <j.0:title>Global health crises are also information crises: A call to action</j.0:title>
    <rdfs:comment>In this opinion paper, we argue that global health crises are also information crises. Using as an example the coronavirus disease 2019 (COVID-19) epidemic, we (a) examine challenges associated with what we term “global information crises”; (b) recommend changes needed for the field of information science to play a leading role in such crises; and (c) propose actionable items for short- and long-term research, education, and practice in information science. © 2020 Association for Information Science and Technology</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081737846&amp;doi=10.1002%2fasi.24357&amp;partnerID=40&amp;md5=143b7fdd515d2db5179736513e8b12a8&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:identifier>2-s2.0-85081737846</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <schema:keywords>Coronaviruses; Global health; Global informations</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_Association_for_Information_Science_and_Technology">
        <j.1:name>Journal of the Association for Information Science and Technology</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082084785">
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Cheng V.C.C., Wong S.-C., Chen J.H.K., Yip C.C.Y., Chuang V.W.M., Tsang O.T.Y., Sridhar S., Chan J.F.W., Ho P.-L., Yuen K.-Y.</dc:creator>
    <rdfs:comment>Background:To describe the infection control preparedness for Coronavirus Disease (COVID-19) due to SARS-CoV-2 [previously known as 2019-novel coronavirus] in the first 42 days after announcement of a cluster of pneumonia in China, on 31 December 2019 (day 1) in Hong Kong.Methods:A bundle approach of active and enhanced laboratory surveillance, early airborne infection isolation, rapid molecular diagnostic testing, and contact tracing for healthcare workers (HCWs) with unprotected exposure in the hospitals was implemented. Epidemiological characteristics of confirmed cases, environmental and air samples were collected and analyzed.Results:From day 1 to day 42, forty-two (3.3%) of 1275 patients fulfilling active (n=29) and enhanced laboratory surveillance (n=13) confirmed to have SARS-CoV-2 infection. The number of locally acquired case significantly increased from 1 (7.7%) of 13 [day 22 to day 32] to 27 (93.1%) of 29 confirmed case [day 33 to day 42] (p&amp;lt;0.001). Twenty-eight patients (66.6%) came from 8 family clusters. Eleven (2.7%) of 413 HCWs caring these confirmed cases were found to have unprotected exposure requiring quarantine for 14 days. None of them was infected and nosocomial transmission of SARS-CoV-2 was not observed. Environmental surveillance performed in a patient with viral load of 3.3x106 copies/ml (pooled nasopharyngeal/ throat swab) and 5.9x106 copies/ml (saliva) respectively. SARS-CoV-2 revealed in 1 (7.7%) of 13 environmental samples, but not in 8 air samples collected at a distance of 10 cm from patient's chin with or without wearing a surgical mask.Conclusion:Appropriate hospital infection control measures could prevent nosocomial transmission of SARS-CoV-2. © 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082084785&amp;doi=10.1017%2fice.2020.58&amp;partnerID=40&amp;md5=5a8421e3e69e27dc73dd31e66eb2383a&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1017/ice.2020.58</j.0:identifier>
    <j.0:identifier>2-s2.0-85082084785</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology">
        <j.1:name>Infection Control and Hospital Epidemiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <j.0:title>Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078468661">
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Coronavirus infection; epidemic; human; Note; priority journal; virus transmission</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <j.0:title>Offline: 2019-nCoV outbreak—early lessons</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Horton R.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85078468661</j.0:identifier>
    <myOnto:issue>10221</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078468661&amp;doi=10.1016%2fS0140-6736%2820%2930212-9&amp;partnerID=40&amp;md5=32ab029b08b0e7737b7f666d5cf2c9c9&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S0140-6736(20)30212-9</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081904554">
    <j.0:identifier>10.1136/bmj.m1038</j.0:identifier>
    <dc:creator>Rimmer A.</dc:creator>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>2-s2.0-85081904554</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:title>Covid-19: GPs call for appraisals and CQC inspections to be suspended</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081904554&amp;doi=10.1136%2fbmj.m1038&amp;partnerID=40&amp;md5=e76a3a73dffd8ae641cf15d270087f6e&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080879659">
    <j.0:identifier>2-s2.0-85080879659</j.0:identifier>
    <dc:creator>Gao J., Tian Z., Yang X.</dc:creator>
    <j.0:title>Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.5582/bst.2020.01047</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080879659&amp;doi=10.5582%2fbst.2020.01047&amp;partnerID=40&amp;md5=0bbbee7d4553c3346ebe6ad5870599d3&gt;</schema:url>
    <myOnto:volume>14</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Bioscience_trends">
        <j.1:name>Bioscience trends</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <schema:keywords>chloroquine; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; clinical trial (topic); Coronavirus infection; drug repositioning; human; multicenter study (topic); virus pneumonia; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; Drug Repositioning; Humans; Multicenter Studies as Topic; Pneumonia, Viral</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081665911">
    <j.0:publisher>International Journal of Ophthalmology (c/o Editorial Office)</j.0:publisher>
    <dc:creator>Zhang M.-Z.</dc:creator>
    <j.0:identifier>10.3980/j.issn.1672-5123.2020.3.01</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:title>New coronavirus pneumonia COVID-19 and ocular surface transmission [?????????????????]</j.0:title>
    <j.0:identifier>2-s2.0-85081665911</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Eye_Science">
        <j.1:name>International Eye Science</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081665911&amp;doi=10.3980%2fj.issn.1672-5123.2020.3.01&amp;partnerID=40&amp;md5=c6935e34b3a6b195dc8f3af6ecd06556&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <dc:language>Chinese</dc:language>
    <myOnto:volume>20</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Since the end of 2019, the novel coronavirus pneumonia (COVID-19) has rapidly spread in Wuhan City, Hubei Province of China. This has aroused great concern of the Chinese government and the international community. There have been unconfirmed threads of COVID-19 patients with conjunctivitis as the first symptom. Therefore, the issue that whether and how the novel coronavirus strain SARS-CoV-2 infection is transmitted through the ocular surface has become a new concern. In the absence of clinical and experimental evidence of COVID-19 in ocular infection, we have conducted a retrospective literature analysis of viral pathogens that simultaneously trigger ocular lesions during the onset of epidemic diseases. The purpose of this paper is to provide some reference and suggestions for appropriately understanding of ocular protection in the prevention and control of the COVID-19. Copyright 2020 by the IJO Press.</rdfs:comment>
    <schema:keywords>Article; Coronavirinae; Coronavirus infection; eye; human; infection control; infection prevention; nonhuman; virus pneumonia; virus transmission</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082186000">
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85082186000</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Global_Health">
        <j.1:name>The Lancet Global Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1016/S2214-109X(20)30101-7</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082186000&amp;doi=10.1016%2fS2214-109X%2820%2930101-7&amp;partnerID=40&amp;md5=99213a1debc0f019951bb8f72c6172a1&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:title>Can Nigeria contain the COVID-19 outbreak using lessons from recent epidemics?</j.0:title>
    <dc:creator>Ebenso B., Otu A.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081967440">
    <j.0:title>Internationally lost COVID-19 cases</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081967440</j.0:identifier>
    <j.0:identifier>10.1016/j.jmii.2020.03.013</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <dc:creator>Lau H., Khosrawipour V., Kocbach P., Mikolajczyk A., Ichii H., Schubert J., Bania J., Khosrawipour T.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081967440&amp;doi=10.1016%2fj.jmii.2020.03.013&amp;partnerID=40&amp;md5=adda80e4c302dd46bd8f40930aee55ca&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>Background: With its epicenter in Wuhan, China, the COVID-19 outbreak was declared a pandemic by the World Health Organization (WHO). While many countries have implemented flight restrictions to China, an increasing number of cases with or without travel background to China are confirmed daily. These developments support concerns on possible unidentified and unreported international COVID-19 cases, which could lead to new local disease epicenters. Methods: We have analyzed all available data on the development of international COVID-19 cases from January 20th, 2020 until February 18th, 2020. COVID-19 cases with and without travel history to China were divided into cohorts according to the Healthcare Access and Quality Index (HAQ-Index) of each country. Chi-square and Post-hoc testing were performed. Results: While COVID-19 cases with travel history to China seem to peak for each HAQ-cohort, the number of non-travel related COVID-19 cases seem to continuously increase in the HAQ-cohort of countries with higher medical standards. Further analyses demonstrate a significantly lower proportion of reported COVID-19 cases without travel history to China in countries with lower HAQ (HAQ I vs. HAQ II, posthoc p &lt; 0.01). Conclusions: Our data indicate that countries with lower HAQ-index may either underreport COVID-19 cases or are unable to adequately detect them. Although our data may be incomplete and must be interpreted with caution, inconsistencies in reporting COVID-19 cases is a serious problem which might sabotage efforts to contain the virus. © 2020</rdfs:comment>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079896211">
    <myOnto:issue>2</myOnto:issue>
    <j.0:title>Novel coronavirus 2019, an emerging public health emergency</j.0:title>
    <myOnto:volume>67</myOnto:volume>
    <j.0:identifier>10.1111/tbed.13509</j.0:identifier>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:identifier>2-s2.0-85079896211</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079896211&amp;doi=10.1111%2ftbed.13509&amp;partnerID=40&amp;md5=716fcacb7ed49bf4498e0e7a989eeb54&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Transboundary_and_Emerging_Diseases">
        <j.1:name>Transboundary and Emerging Diseases</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>2019 novel coronavirus; Alphacoronavirus; Betacoronavirus; China; climate change; coronavirus disease 2019; disease transmission; dyspnea; Editorial; fever; Gammacoronavirus; geographic distribution; headache; human; lung lesion; Middle East respiratory syndrome; public health; severe acute respiratory syndrome; thorax radiography; urbanization; virus isolation; World Health Organization; zoonosis</schema:keywords>
    <dc:language>English</dc:language>
    <dc:creator>Ward M.P., Li X., Tian K.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081734247">
    <dc:date>2020</dc:date>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081734247&amp;doi=10.1002%2fjmv.25740&amp;partnerID=40&amp;md5=0474a10f9e8be7310a8545a516b34ea5&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Coronavirus disease (COVID-19) and neonate: What neonatologist need to know</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>2-s2.0-85081734247</j.0:identifier>
    <schema:keywords></schema:keywords>
    <rdfs:comment>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25740</j.0:identifier>
    <dc:creator>Lu Q., Shi Y.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081405799">
    <j.0:identifier>2-s2.0-85081405799</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081405799&amp;doi=10.1038%2fs41569-020-0360-5&amp;partnerID=40&amp;md5=49c3d3397d90b2e71856f3d5425ad4dc&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:title>COVID-19 and the cardiovascular system</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1038/s41569-020-0360-5</j.0:identifier>
    <dc:creator>Zheng Y.-Y., Ma Y.-T., Zhang J.-Y., Xie X.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Reviews_Cardiology">
        <j.1:name>Nature Reviews Cardiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Nature Research</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082015088">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Covid-19: medical schools are urged to fast-track final year students</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:creator>Iacobucci G.</dc:creator>
    <j.0:identifier>2-s2.0-85082015088</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1136/bmj.m1064</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082015088&amp;doi=10.1136%2fbmj.m1064&amp;partnerID=40&amp;md5=dd7eae3c8644b47d4e5f9f84eb8a10f3&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082088375">
    <j.0:identifier>2-s2.0-85082088375</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082088375&amp;doi=10.1136%2fbmj.m1090&amp;partnerID=40&amp;md5=c9402a714324916ecb16a0069974238d&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>368</myOnto:volume>
    <dc:creator>Tanne J.H., Hayasaki E., Zastrow M., Pulla P., Smith P., Rada A.G.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1136/bmj.m1090</j.0:identifier>
    <j.0:title>Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081207857">
    <j.0:identifier>2-s2.0-85081207857</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081207857&amp;doi=10.1016%2fj.jaad.2020.02.030&amp;partnerID=40&amp;md5=94cd273e182a4d8588b11519742c1d16&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Chen Y., Pradhan S., Xue S.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>4</myOnto:issue>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>82</myOnto:volume>
    <j.0:publisher>Mosby Inc.</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_American_Academy_of_Dermatology">
        <j.1:name>Journal of the American Academy of Dermatology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1016/j.jaad.2020.02.030</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079789188">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Australia; Betacoronavirus; Coronavirus infection; human; virus pneumonia; Australia; Betacoronavirus; Coronavirus Infections; Humans; Pneumonia, Viral</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079789188</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.33321/cdi.2020.44.15</j.0:identifier>
    <myOnto:volume>44</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)">
        <j.1:name>Communicable diseases intelligence (2018)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>COVID-19 National Incident Room Surveillance Team</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>COVID-19, Australia: Epidemiology Report 3 (Reporting week ending 19:00 AEDT 15 February 2020)</j.0:title>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079789188&amp;doi=10.33321%2fcdi.2020.44.15&amp;partnerID=40&amp;md5=ac2b04d90007549287e5bc1623d36646&gt;</schema:url>
    <rdfs:comment>This is the third epidemiological report for coronavirus disease 2019 (COVID-19), previously known as novel coronavirus (2019-nCoV), from the virus now known as SARS-CoV-2, reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 15 February 2020. It includes data on the COVID-19 Australian cases, the international situation and current information on the severity, transmission and spread. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082184155">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082184155&amp;doi=10.1016%2fj.jgg.2020.01.003&amp;partnerID=40&amp;md5=4bc0646c7ff3907217aea6559929bdb5&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Genetics_and_Genomics">
        <j.1:name>Journal of Genetics and Genomics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Qiu T., Mao T., Wang Y., Zhou M., Qiu J., Wang J., Xu J., Cao Z.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85082184155</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Institute of Genetics and Developmental Biology</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jgg.2020.01.003</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081529817">
    <dc:language>English</dc:language>
    <j.0:identifier>10.26355/eurrev_202002_20378</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Kannan S., Shaik Syed Ali P., Sheeza A., Hemalatha K.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081529817&amp;doi=10.26355%2feurrev_202002_20378&amp;partnerID=40&amp;md5=347e5679478f7d5d7713291f39f7b06f&gt;</schema:url>
    <myOnto:volume>24</myOnto:volume>
    <myOnto:issue>4</myOnto:issue>
    <j.0:title>COVID-19 (Novel Coronavirus 2019) - recent trends</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_Review_for_Medical_and_Pharmacological_Sciences">
        <j.1:name>European Review for Medical and Pharmacological Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Verduci Editore s.r.l</j.0:publisher>
    <rdfs:comment>The World Health Organization (WHO) has issued a warning that, although the 2019 novel coronavirus (COVID-19) from Wuhan City (China), is not pandemic, it should be contained to prevent the global spread. The COVID-19 virus was known earlier as 2019-nCoV. As of 12 February 2020, WHO reported 45,171 cases and 1115 deaths related to COVID-19. COVID-19 is similar to Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) virus in its pathogenicity, clinical spectrum, and epidemiology. Comparison of the genome sequences of COVID-19, SARS-CoV, and Middle East Respiratory Syndrome coronavirus (MERS-CoV) showed that COVID-19 has a better sequence identity with SARS-CoV compared to MERS CoV. However, the amino acid sequence of COVID-19 differs from other coronaviruses specifically in the regions of 1ab polyprotein and surface glycoprotein or S-protein. Although several animals have been speculated to be a reservoir for COVID-19, no animal reservoir has been already confirmed. COVID-19 causes COVID-19 disease that has similar symptoms as SARSCoV. Studies suggest that the human receptor for COVID-19 may be angiotensin-converting enzyme 2 (ACE2) receptor similar to that of SARSCoV. The nucleocapsid (N) protein of COVID-19 has nearly 90% amino acid sequence identity with SARS-CoV. The N protein antibodies of SARS-CoV may cross react with COVID-19 but may not provide cross-immunity. In a similar fashion to SARS-CoV, the N protein of COVID-19 may play an important role in suppressing the RNA interference (RNAi) to overcome the host defense. This mini-review aims at investigating the most recent trend of COVID-19. © 2020 Verduci Editore s.r.l. All rights reserved.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081529817</j.0:identifier>
    <schema:keywords>nucleocapsid protein; viral protein; COVID-19; nucleocapsid protein; severe acute respiratory syndrome coronavirus 2; Article; coronavirus disease 2019; Coronavirus infection; host resistance; human; incidence; laboratory diagnosis; nonhuman; RNA interference; sustained virologic response; trend study; virus genome; World Health Organization; animal; Betacoronavirus; chemistry; genetics; metabolism; virus activation; virus pneumonia; Animals; Betacoronavirus; Coronavirus Infections; Genome, Viral; Humans; Nucleocapsid Proteins; Pneumonia, Viral; Virus Activation; World Health Organization</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081127132">
    <dc:creator>Liu Y., Eggo R.M., Kucharski A.J.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081127132</j.0:identifier>
    <schema:keywords>China; epidemic; high risk patient; human; infection rate; infection risk; infection sensitivity; Letter; nonhuman; priority journal; risk assessment; SARS coronavirus; secondary attack rate; Severe acute respiratory syndrome coronavirus 2; social interaction; virus transmission</schema:keywords>
    <myOnto:issue>10227</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081127132&amp;doi=10.1016%2fS0140-6736%2820%2930462-1&amp;partnerID=40&amp;md5=c80e30c41649bbdd662632bf39f0b955&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <j.0:title>Secondary attack rate and superspreading events for SARS-CoV-2</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30462-1</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079688117">
    <j.0:identifier>2-s2.0-85079688117</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Poland G.A.</dc:creator>
    <myOnto:volume>38</myOnto:volume>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079688117&amp;doi=10.1016%2fj.vaccine.2020.02.039&amp;partnerID=40&amp;md5=e28aade65f4a9d746be4ab299454943e&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue>10</myOnto:issue>
    <schema:keywords>antivirus agent; virus vaccine; 2019 novel coronavirus; China; Coronavirinae; Coronavirus infection; disease surveillance; disease transmission; drug development; drug efficacy; Editorial; epidemic; food handling; hand washing; health care cost; human; immunoimmaturity; immunopathology; immunosensecence; infection control; infection prevention; Middle East respiratory syndrome coronavirus; mortality rate; nonhuman; priority journal; public health service; SARS coronavirus; upper respiratory tract infection</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Vaccine">
        <j.1:name>Vaccine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1016/j.vaccine.2020.02.039</j.0:identifier>
    <j.0:title>Another coronavirus, another epidemic, another warning</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080839534">
    <j.0:identifier>2-s2.0-85080839534</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Kruse R.L.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080839534&amp;doi=10.12688%2ff1000research.22211.2&amp;partnerID=40&amp;md5=8cdac4341a520b514b00b25795694ae0&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.12688/f1000research.22211.2</j.0:identifier>
    <myOnto:volume>9</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <j.0:title>Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China</j.0:title>
    <dc:date>2020</dc:date>
    <schema:keywords>angiotensin converting enzyme 2; COVID-19; dipeptidyl carboxypeptidase; monoclonal antibody; neutralizing antibody; oligonucleotide; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; compassionate use; Coronavirus infection; drug effect; drug repositioning; epidemic; epidemiology; human; virus pneumonia; Antibodies, Monoclonal; Antibodies, Neutralizing; Betacoronavirus; China; Compassionate Use Trials; Coronavirus Infections; Disease Outbreaks; Drug Repositioning; Humans; Oligonucleotides; Peptidyl-Dipeptidase A; Pneumonia, Viral</schema:keywords>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>A novel coronavirus (2019-nCoV) originating in Wuhan, China presents a potential respiratory viral pandemic to the world population. Current efforts are focused on containment and quarantine of infected individuals. Ultimately, the outbreak could be controlled with a protective vaccine to prevent 2019-nCoV infection. While vaccine research should be pursued intensely, there exists today no therapy to treat 2019-nCoV upon infection, despite an urgent need to find options to help these patients and preclude potential death. Herein, I review the potential options to treat 2019-nCoV in patients, with an emphasis on the necessity for speed and timeliness in developing new and effective therapies in this outbreak. I consider the options of drug repurposing, developing neutralizing monoclonal antibody therapy, and an oligonucleotide strategy targeting the viral RNA genome, emphasizing the promise and pitfalls of these approaches. Finally, I advocate for the fastest strategy to develop a treatment now, which could be resistant to any mutations the virus may have in the future. The proposal is a biologic that blocks 2019-nCoV entry using a soluble version of the viral receptor, angiotensin-converting enzyme 2 (ACE2), fused to an immunoglobulin Fc domain, providing a neutralizing antibody with maximal breath to avoid any viral escape, while also helping to recruit the immune system to build lasting immunity. The sequence of the ACE2-Fc protein is provided to investigators, allowing its possible use in recombinant protein expression systems to start producing drug today to treat patients under compassionate use, while formal clinical trials are later undertaken. Such a treatment could help infected patients before a protective vaccine is developed and widely available in the coming months to year(s). Copyright: © 2020 Kruse RL.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/F1000Research">
        <j.1:name>F1000Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080141713">
    <rdfs:comment>On Feb 26, 2020, we were informed by the authors of this Correspondence1 that the account described therein was not a first-hand account, as the authors had claimed, and that they wished to withdraw the piece. We have therefore taken the decision to retract this Correspondence. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>The Editors of The Lancet Global Health</dc:creator>
    <j.0:type>Erratum</j.0:type>
    <j.0:title>Retraction—Chinese medical staff request international medical assistance in fighting against COVID-19 (The Lancet Global Health, (S2214109X20300656), (10.1016/S2214-109X(20)30065-6))</j.0:title>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080141713</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080141713&amp;doi=10.1016%2fS2214-109X%2820%2930076-0&amp;partnerID=40&amp;md5=511531ee7634bd63005fd0dc0e08347f&gt;</schema:url>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Global_Health"/>
    <j.0:identifier>10.1016/S2214-109X(20)30076-0</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081690253">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081690253&amp;partnerID=40&amp;md5=9fbc81e06e4c420adb1ac8cf762bbffa&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Indian_Drugs">
        <j.1:name>Indian Drugs</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Indian Drug Manufacturers' Association</j.0:publisher>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Challenging Covid-19?</j.0:title>
    <j.0:identifier></j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:volume>57</myOnto:volume>
    <j.0:identifier>2-s2.0-85081690253</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>Coronavirinae; Coronavirus infection; Editorial; epidemic; human; nonhuman; pathogenesis</schema:keywords>
    <dc:creator>Rao N.N.</dc:creator>
    <j.0:type>Editorial</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082054160">
    <dc:creator>Sivertsen ØS.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082054160</j.0:identifier>
    <myOnto:volume>140</myOnto:volume>
    <dc:language>Norwegian</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Covid-19: Vi som tror vi ikke kan hjelpe</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.4045/tidsskr.20.0217</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Tidsskrift_for_den_Norske_laegeforening_:_tidsskrift_for_praktisk_medicin,_ny_raekke">
        <j.1:name>Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082054160&amp;doi=10.4045%2ftidsskr.20.0217&amp;partnerID=40&amp;md5=864b83978eec8978f18820eff2938de6&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081896533">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081896533&amp;doi=10.1136%2fbmj.m959&amp;partnerID=40&amp;md5=8be8e3db99888a3e367d32cf932132b1&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081896533</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m959</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Covid-19: out-of-hours providers are drafted in to manage non-urgent patients in community</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082085547">
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S2213-2600(20)30116-8</j.0:identifier>
    <dc:creator>Fang L., Karakiulakis G., Roth M.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082085547</j.0:identifier>
    <j.0:title>Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine">
        <j.1:name>The Lancet Respiratory Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082085547&amp;doi=10.1016%2fS2213-2600%2820%2930116-8&amp;partnerID=40&amp;md5=95eacc8217986e495038ed8a4b9e690b&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082198910">
    <schema:keywords>erratum</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082198910</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <j.0:type>Erratum</j.0:type>
    <j.0:identifier>10.1016/S2213-2600(20)30085-0</j.0:identifier>
    <rdfs:comment>Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; published online Feb 17. https://doi.org/10.1016/S2213-2600(20)30076-X—In this Case Report “by obtaining biopsy samples at autopsy” has been replace with “by postmortem biopsies” in paragraph 1, “microvascular” has been replaced with “microvesicular” in two incidences in paragraph 5, and “(B) Frequency of Th17 (CD4+ CCR6+CCR4+) subset” has been changed to “(B) Frequency of Th17 (CD4+ CCR6+) subset” on page 3 of the appendix. These corrections have been made to the online version as of Feb 25, 2020, and will be made to the printed version. © 2020 Elsevier Ltd</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082198910&amp;doi=10.1016%2fS2213-2600%2820%2930085-0&amp;partnerID=40&amp;md5=c617db880a14f157e72d7d0f646c1e7d&gt;</schema:url>
    <j.0:title>Correction to Pathological findings of COVID-19 associated with acute respiratory distress syndrome (The Lancet Respiratory Medicine, (S221326002030076X), (10.1016/S2213-2600(20)30076-X))</j.0:title>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082114353">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082114353&amp;doi=10.1111%2f1471-0528.16192&amp;partnerID=40&amp;md5=9be1e1b44e254f7aadaf9559f209cc67&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85082114353</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/BJOG:_An_International_Journal_of_Obstetrics_and_Gynaecology">
        <j.1:name>BJOG: An International Journal of Obstetrics and Gynaecology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Chua M.S.Q., Lee J.C.S., Sulaiman S., Tan H.K.</dc:creator>
    <j.0:title>From the frontline of COVID-19 – How prepared are we as obstetricians: a commentary</j.0:title>
    <j.0:identifier>10.1111/1471-0528.16192</j.0:identifier>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081074554">
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <schema:keywords>coronavirus disease 2019; Editorial; health care planning; human; infection control; isolation; pandemic; priority journal; severe acute respiratory syndrome; Coronavirus infection; health care planning; national health service; pandemic; United Kingdom; virus pneumonia; COVID-19; Coronavirus Infections; Health Planning; Humans; Pandemics; Pneumonia, Viral; State Medicine; United Kingdom</schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:volume>368</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081074554</j.0:identifier>
    <j.0:identifier>10.1136/bmj.m810</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Watkins J.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081074554&amp;doi=10.1136%2fbmj.m810&amp;partnerID=40&amp;md5=0016b83fa5fb73047f2233525d0a00dd&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Preventing a covid-19 pandemic</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081206852">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association">
        <j.1:name>JAMA - Journal of the American Medical Association</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:creator>Adalja A.A., Toner E., Inglesby T.V.</dc:creator>
    <j.0:identifier>10.1001/jama.2020.3413</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081206852&amp;doi=10.1001%2fjama.2020.3413&amp;partnerID=40&amp;md5=6846aafc1e006550d2e7e54707ba3183&gt;</schema:url>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:title>Priorities for the US Health Community Responding to COVID-19</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081206852</j.0:identifier>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081958351">
    <j.0:identifier>10.1111/aos.14412</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Qing H., Li Z., Yang Z., Shi M., Huang Z., Song J., Song Z.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081958351&amp;doi=10.1111%2faos.14412&amp;partnerID=40&amp;md5=ac99d11db602481a1873073b44cea449&gt;</schema:url>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Acta_Ophthalmologica">
        <j.1:name>Acta Ophthalmologica</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <j.0:title>The possibility of COVID-19 transmission from eye to nose</j.0:title>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081958351</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082143183">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_travel_medicine">
        <j.1:name>Journal of travel medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>27</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082143183&amp;doi=10.1093%2fjtm%2ftaaa022&amp;partnerID=40&amp;md5=c5c67e15513661be4eddf9b41b736b67&gt;</schema:url>
    <dc:creator>Zhao S., Zhuang Z., Cao P., Ran J., Gao D., Lou Y., Yang L., Cai Y., Wang W., He D., Wang M.H.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1093/jtm/taaa022</j.0:identifier>
    <j.0:title>Quantifying the association between domestic travel and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan, China in 2020: a correlational analysis</j.0:title>
    <j.0:identifier>2-s2.0-85082143183</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; cluster analysis; Coronavirus infection; disease transmission; human; pathogenicity; physiology; travel; virus pneumonia; Betacoronavirus; China; Cluster Analysis; Coronavirus Infections; Correlation of Data; Disease Transmission, Infectious; Humans; Pneumonia, Viral; Travel</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079790330">
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1016/S2213-2600(20)30076-X</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <dc:creator>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.-S.</dc:creator>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079790330</j.0:identifier>
    <j.0:title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</j.0:title>
    <myOnto:citeyBy>12</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079790330&amp;doi=10.1016%2fS2213-2600%2820%2930076-X&amp;partnerID=40&amp;md5=a1ab14d785a4c95284158e515bc8fdbb&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081961963">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1136/bmj.m1053</j.0:identifier>
    <j.0:title>Budgeting for covid-19: Changing the narrative and narrating the change</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>budget; coronavirus disease 2019; Coronavirus infection; funding; health care cost; health economics; herd immunity; human; migrant; national health service; pandemic; politics; priority journal; public policy; Short Survey; tax; United Kingdom</schema:keywords>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081961963&amp;doi=10.1136%2fbmj.m1053&amp;partnerID=40&amp;md5=7809b4144aadb252b09b380a6938b55d&gt;</schema:url>
    <j.0:type>Short Survey</j.0:type>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081961963</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:creator>Cowper A.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079082102">
    <dc:creator>Jin Y.-H., Cai L., Cheng Z.-S., Cheng H., Deng T., Fan Y.-P., Fang C., Huang D., Huang L.-Q., Huang Q., Han Y., Hu B., Hu F., Li B.-H., Li Y.-R., Liang K., Lin L.-K., Luo L.-S., Ma J., Ma L.-L., Peng Z.-Y., Pan Y.-B., Pan Z.-Y., Ren X.-Q., Sun H.-M., Wang Y., Wang Y.-Y., Weng H., Wei C.-J., Wu D.-F., Xia J., Xiong Y., Xu H.-B., Yao X.-M., Yuan Y.-F., Ye T.-S., Zhang X.-C., Zhang Y.-W., Zhang Y.-G., Zhang H.-M., Zhao Y., Zhao M.-J., Zi H., Zeng X.-T., Wang Y.-Y., Wang X.-H.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Military_Medical_Research">
        <j.1:name>Military Medical Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85079082102</j.0:identifier>
    <myOnto:citeyBy>7</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079082102&amp;doi=10.1186%2fs40779-020-0233-6&amp;partnerID=40&amp;md5=52396be752e138a934b55b7edfc0be6d&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Review</j.0:type>
    <j.0:title>A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)</j.0:title>
    <myOnto:volume>7</myOnto:volume>
    <rdfs:comment>In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named "2019 novel coronavirus (2019-nCoV)" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world's attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV. © 2020 The Author(s).</rdfs:comment>
    <schema:keywords>antivirus agent; antiinfective agent; COVID-19; herbaceous agent; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; antiviral therapy; case finding; Chinese medicine; clinical feature; computer assisted tomography; Coronavirinae; coronavirus disease 2019; Coronavirus infection; differential diagnosis; epidemic; evidence based practice; hematological procedure; hospital infection; host; human; incubation time; infection control; infection prevention; mass screening; molecular epidemiology; nonhuman; physical examination; practice guideline; priority journal; prognosis; Review; thorax radiography; travel; virus carrier; virus detection; virus pathogenesis; virus pneumonia; virus transmission; Betacoronavirus; Coronavirus infection; cross infection; diagnostic imaging; evidence based medicine; fluid therapy; infection control; isolation and purification; lung; mass screening; nursing care; pathogenicity; practice guideline; protective equipment; virus pneumonia; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cross Infection; Diagnosis, Differential; Drugs, Chinese Herbal; Evidence-Based Medicine; Fluid Therapy; Humans; Infection Control; Lung; Mass Screening; Molecular Epidemiology; Nursing Care; Personal Protective Equipment; Pneumonia, Viral</schema:keywords>
    <j.0:identifier>10.1186/s40779-020-0233-6</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>1</myOnto:issue>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081653269">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081653269&amp;doi=10.1136%2fbmj.m993&amp;partnerID=40&amp;md5=3f0ac9c64bcce0537377b5530f6a5f44&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Tanne J.H.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081653269</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1136/bmj.m993</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <myOnto:volume>368</myOnto:volume>
    <j.0:title>Covid-19: Trump proposes tax cuts and improved health insurance, but millions are not covered</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081951781">
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1177/0022034520914246</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Dental_Research">
        <j.1:name>Journal of Dental Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine</j.0:title>
    <rdfs:comment>The epidemic of coronavirus disease 2019 (COVID-19), originating in Wuhan, China, has become a major public health challenge for not only China but also countries around the world. The World Health Organization announced that the outbreaks of the novel coronavirus have constituted a public health emergency of international concern. As of February 26, 2020, COVID-19 has been recognized in 34 countries, with a total of 80,239 laboratory-confirmed cases and 2,700 deaths. Infection control measures are necessary to prevent the virus from further spreading and to help control the epidemic situation. Due to the characteristics of dental settings, the risk of cross infection can be high between patients and dental practitioners. For dental practices and hospitals in areas that are (potentially) affected with COVID-19, strict and effective infection control protocols are urgently needed. This article, based on our experience and relevant guidelines and research, introduces essential knowledge about COVID-19 and nosocomial infection in dental settings and provides recommended management protocols for dental practitioners and students in (potentially) affected areas. © International &amp; American Associations for Dental Research 2020.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081951781&amp;doi=10.1177%2f0022034520914246&amp;partnerID=40&amp;md5=9b8e942752f5eec4f1681b003cbef73f&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>SAGE Publications Inc.</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081951781</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:creator>Meng L., Hua F., Bian Z.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081695984">
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081695984&amp;doi=10.1016%2fS2352-4642%2820%2930072-9&amp;partnerID=40&amp;md5=35b939c4037dc6d26a10350807df4be1&gt;</schema:url>
    <schema:keywords>antivirus agent; nitric oxide; remdesivir; surfactant; artificial ventilation; coronavirus disease 2019; drug efficacy; drug safety; extracorporeal oxygenation; high risk patient; human; Letter; neonatal intensive care unit; neonatal respiratory distress syndrome; newborn care; newborn screening; nucleic acid analysis; patient monitoring; pulmonary hypertension; respiratory failure; SARS coronavirus; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Child_and_Adolescent_Health">
        <j.1:name>The Lancet Child and Adolescent Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Wang J., Shi Y.</dc:creator>
    <j.0:title>Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/S2352-4642(20)30072-9</j.0:identifier>
    <j.0:identifier>2-s2.0-85081695984</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>4</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue>4</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079820712">
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:title>Rules on isolation rooms for suspected covid-19 cases in GP surgeries to be relaxed</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079820712</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Kmietowicz Z.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m707</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079820712&amp;doi=10.1136%2fbmj.m707&amp;partnerID=40&amp;md5=0836b0b62982dceb2b6246046c2512f9&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>368</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078736778">
    <j.0:type>Note</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:citeyBy>37</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>nucleic acid; 2019 novel coronavirus; bat; blood; China; civet (animal); common cold; Coronavirinae; disease carrier; electron microscopy; epidemic; human; idiopathic disease; law; lung fluid; market; nonhuman; Note; nucleotide sequence; quarantine; rural area; throat culture; Torovirus; virus culture; virus detection; virus identification; virus isolation; virus pneumonia; virus shedding</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Lu H., Stratton C.W., Tang Y.-W.</dc:creator>
    <j.0:identifier>2-s2.0-85078736778</j.0:identifier>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>92</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078736778&amp;doi=10.1002%2fjmv.25678&amp;partnerID=40&amp;md5=a7fe6da72f1082a0f7473b7a2f95b2a1&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:title>Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle</j.0:title>
    <j.0:identifier>10.1002/jmv.25678</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079272171">
    <myOnto:volume>9</myOnto:volume>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079272171&amp;doi=10.1016%2fj.hlpt.2020.02.001&amp;partnerID=40&amp;md5=74cb845a1d5a4a88848c5ca49e13ceec&gt;</schema:url>
    <dc:creator>Singer D.R.J.</dc:creator>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Health_Policy_and_Technology">
        <j.1:name>Health Policy and Technology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>2019 novel coronavirus; China; Coronavirinae; Coronavirus infection; Ebola hemorrhagic fever; Editorial; human; Middle East respiratory syndrome; pandemic; priority journal; severe acute respiratory syndrome; Zika fever</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>10.1016/j.hlpt.2020.02.001</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>A new pandemic out of China: the Wuhan 2019-nCoV coronavirus syndrome</j.0:title>
    <j.0:identifier>2-s2.0-85079272171</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079170254">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:volume>33</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease">
        <j.1:name>Travel Medicine and Infectious Disease</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079170254&amp;doi=10.1016%2fj.tmaid.2020.101578&amp;partnerID=40&amp;md5=1e8d9b9ce3106701ea885949c5a21ce3&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <j.0:identifier>10.1016/j.tmaid.2020.101578</j.0:identifier>
    <j.0:title>Going global – Travel and the 2019 novel coronavirus</j.0:title>
    <schema:keywords>antivirus agent; interferon beta serine; lopinavir; lopinavir plus ritonavir; oseltamivir; remdesivir; ritonavir; virus vaccine; COVID-19; severe acute respiratory syndrome coronavirus 2; antiviral therapy; Asia; bronchus epithelium; China; Coronavirinae; Coronavirus infection; Editorial; emporiatrics; epidemic; Europe; home care; human; infection risk; international health regulation; interpersonal communication; Middle East respiratory syndrome coronavirus; monotherapy; novel coronavirus 2019; priority journal; public health; risk assessment; SARS coronavirus; severe acute respiratory syndrome; South and Central America; travel; United Kingdom; United States; virus strain; virus transmission; World Health Organization; Betacoronavirus; Coronavirus infection; epidemic; global health; infection control; pathogenicity; practice guideline; virus pneumonia; Betacoronavirus; Communication; Coronavirus Infections; Disease Outbreaks; Europe; Global Health; Guidelines as Topic; Humans; Infection Control; Latin America; Pneumonia, Viral; Travel; Travel Medicine; United Kingdom; United States</schema:keywords>
    <dc:creator>Rodríguez-Morales A.J., MacGregor K., Kanagarajah S., Patel D., Schlagenhauf P.</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85079170254</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079288295">
    <myOnto:citeyBy>29</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079288295&amp;doi=10.1016%2fS0140-6736%2820%2930360-3&amp;partnerID=40&amp;md5=05e8ca00a84dad2b6f329a8ac73aec66&gt;</schema:url>
    <rdfs:comment>Background: Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. Limited data are available for pregnant women with COVID-19 pneumonia. This study aimed to evaluate the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission potential of COVID-19 infection. Methods: Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for nine pregnant women with laboratory-confirmed COVID-19 pneumonia (ie, with maternal throat swab samples that were positive for severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan 20 to Jan 31, 2020. Evidence of intrauterine vertical transmission was assessed by testing for the presence of SARS-CoV-2 in amniotic fluid, cord blood, and neonatal throat swab samples. Breastmilk samples were also collected and tested from patients after the first lactation. Findings: All nine patients had a caesarean section in their third trimester. Seven patients presented with a fever. Other symptoms, including cough (in four of nine patients), myalgia (in three), sore throat (in two), and malaise (in two), were also observed. Fetal distress was monitored in two cases. Five of nine patients had lymphopenia (&lt;1·0 × 10? cells per L). Three patients had increased aminotransferase concentrations. None of the patients developed severe COVID-19 pneumonia or died, as of Feb 4, 2020. Nine livebirths were recorded. No neonatal asphyxia was observed in newborn babies. All nine livebirths had a 1-min Apgar score of 8–9 and a 5-min Apgar score of 9–10. Amniotic fluid, cord blood, neonatal throat swab, and breastmilk samples from six patients were tested for SARS-CoV-2, and all samples tested negative for the virus. Interpretation: The clinical characteristics of COVID-19 pneumonia in pregnant women were similar to those reported for non-pregnant adult patients who developed COVID-19 pneumonia. Findings from this small group of cases suggest that there is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy. Funding: Hubei Science and Technology Plan, Wuhan University Medical Development Plan. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079288295</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:title>Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records</j.0:title>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:keywords>alanine aminotransferase; aspartate aminotransferase; C reactive protein; COVID-19; severe acute respiratory syndrome coronavirus 2; abnormal laboratory result; adult; alanine aminotransferase blood level; amnion fluid analysis; Apgar score; Article; aspartate aminotransferase blood level; breast milk; cesarean section; China; clinical article; clinical feature; computer assisted tomography; Coronavirinae; coronavirus disease 2019; Coronavirus infection; coughing; diarrhea; female; fetus distress; fever; human; human cell; intrauterine infection; lactation; leukocyte count; live birth; lymphocytopenia; malaise; medical record review; myalgia; pregnancy; pregnant woman; priority journal; retrospective study; rigor; Severe acute respiratory syndrome coronavirus 2; sore throat; thorax pain; throat culture; umbilical cord blood; vertical transmission; virus pneumonia; Betacoronavirus; case report; complication; Coronavirus infection; coughing; dyspepsia; fever; isolation and purification; myalgia; newborn; pathogenicity; pharyngitis; pregnancy complication; pregnancy outcome; third trimester pregnancy; Betacoronavirus; Cesarean Section; Coronavirus Infections; Cough; Dyspepsia; Female; Fever; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Myalgia; Pharyngitis; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Third; Retrospective Studies</schema:keywords>
    <dc:creator>Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q., Liao J., Yang H., Hou W., Zhang Y.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>10.1016/S0140-6736(20)30360-3</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>10226</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081669039">
    <j.0:identifier>2-s2.0-85081669039</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Niud Y., Xu F.</dc:creator>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:volume>8</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081669039&amp;doi=10.1016%2fS2214-109X%2820%2930085-1&amp;partnerID=40&amp;md5=b80a7ebaec639ae363a2b4e650cfe296&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Global_Health"/>
    <j.0:identifier>10.1016/S2214-109X(20)30085-1</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>China; community transmission; coronavirus disease 2019; Coronavirus infection; disease surveillance; disease transmission; early diagnosis; epidemic; health care personnel; hospital infection; human; incidence; medical education; nonhuman; Note; novel coronavirus 2019; practice guideline; priority journal; quarantine; SARS coronavirus; social isolation; treatment response; virus detection; virus isolation; virus transmission</schema:keywords>
    <j.0:title>Deciphering the power of isolation in controlling COVID-19 outbreaks</j.0:title>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079501279">
    <j.0:identifier>2-s2.0-85079501279</j.0:identifier>
    <dc:creator>Shen K.-L., Yang Y.-H.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/World_Journal_of_Pediatrics">
        <j.1:name>World Journal of Pediatrics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Institute of Pediatrics of Zhejiang University</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1007/s12519-020-00344-6</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079501279&amp;doi=10.1007%2fs12519-020-00344-6&amp;partnerID=40&amp;md5=b8ec15e51d80682a1d31b793b8d2fe57&gt;</schema:url>
    <j.0:title>Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080975858">
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85080975858</j.0:identifier>
    <j.0:identifier>10.1002/jmv.25698</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080975858&amp;doi=10.1002%2fjmv.25698&amp;partnerID=40&amp;md5=0fdd2ca574e7fa6ca16b73e6dbbcb641&gt;</schema:url>
    <rdfs:comment>The 2019 novel coronavirus (2019-nCoV) outbreak has caused a large number of deaths with thousands of confirmed cases worldwide, especially in East Asia. This study took an immunoinformatics approach to identify significant cytotoxic T lymphocyte (CTL) and B cell epitopes in the 2019-nCoV surface glycoprotein. Also, interactions between identified CTL epitopes and their corresponding major histocompatibility complex (MHC) class I supertype representatives prevalent in China were studied by molecular dynamics simulations. We identified five CTL epitopes, three sequential B cell epitopes and five discontinuous B cell epitopes in the viral surface glycoprotein. Also, during simulations, the CTL epitopes were observed to be binding MHC class I peptide-binding grooves via multiple contacts, with continuous hydrogen bonds and salt bridge anchors, indicating their potential in generating immune responses. Some of these identified epitopes can be potential candidates for the development of 2019-nCoV vaccines. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Baruah V., Bose S.</dc:creator>
    <schema:keywords>COVID-19; epitope; HLA antigen class 1; severe acute respiratory syndrome coronavirus 2; virus envelope protein; Betacoronavirus; biology; China; Coronavirus infection; human; immunology; molecular dynamics; protein tertiary structure; virus pneumonia; Betacoronavirus; China; Computational Biology; Coronavirus Infections; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Histocompatibility Antigens Class I; Humans; Molecular Dynamics Simulation; Pneumonia, Viral; Protein Structure, Tertiary; Viral Envelope Proteins</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081043436">
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; disease transmission; human; prevention and control; public health; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disease Transmission, Infectious; Humans; Pneumonia, Viral; Public Health</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Bulletin_of_the_World_Health_Organization">
        <j.1:name>Bulletin of the World Health Organization</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Public health round-up</j.0:title>
    <j.0:identifier>2-s2.0-85081043436</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <dc:creator>[No author name available]</dc:creator>
    <myOnto:issue>3</myOnto:issue>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>98</myOnto:volume>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081043436&amp;doi=10.2471%2fBLT.20.010320&amp;partnerID=40&amp;md5=007a44dea152e42dde29f8d39b3da685&gt;</schema:url>
    <j.0:identifier>10.2471/BLT.20.010320</j.0:identifier>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082146253">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>24</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:title>Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?</j.0:title>
    <j.0:identifier>10.26355/eurrev_202003_20551</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85082146253</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_review_for_medical_and_pharmacological_sciences">
        <j.1:name>European review for medical and pharmacological sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082146253&amp;doi=10.26355%2feurrev_202003_20551&amp;partnerID=40&amp;md5=33c108c03e850df0c457671b381b25f2&gt;</schema:url>
    <dc:date>2020</dc:date>
    <dc:creator>Ceccarelli M., Berretta M., Venanzi Rullo E., Nunnari G., Cacopardo B.</dc:creator>
    <myOnto:issue>5</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082031190">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adolescent; adult; aged; Australia; Betacoronavirus; child; complication; Coronavirus infection; female; health survey; hospitalization; human; infant; isolation and purification; male; middle aged; pathogenicity; preschool child; travel; very elderly; virus pneumonia; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Australia; Betacoronavirus; Child; Child, Preschool; Coronavirus Infections; Female; Hospitalization; Humans; Infant; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Travel; Young Adult</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>44</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>This is the seventh epidemiological report for coronavirus disease 2019 (COVID-19), reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 14 March 2020. It includes data on COVID-19 cases diagnosed in Australia, the international situation and a review of current evidence. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082031190&amp;doi=10.33321%2fcdi.2020.44.23&amp;partnerID=40&amp;md5=875d17c00cb897a360d482130ad5146d&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082031190</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)"/>
    <j.0:title>COVID-19, Australia: Epidemiology Report 7 (Reporting week ending 19:00 AEDT 14 March 2020)</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.33321/cdi.2020.44.23</j.0:identifier>
    <dc:creator>COVID-19 National Incident Room Surveillance Team</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082129059">
    <j.0:identifier>2-s2.0-85082129059</j.0:identifier>
    <j.0:identifier></j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>The COVID-19 outbreak continues to evolve with the number of cases increasing in Malaysia, placing a significant burden on general practitioners (GPs) to assess and manage suspected cases. GPs must be well equipped with knowledge to set up their clinics, use Personal Protective Equipment (PPE) appropriately, adopt standard protocols on triaging and referrals, as well as educate patients about PPE. The correct use of PPE will help GPs balance between personal safety and appropriate levels of public concern. © 2020, Academy of Family Physicians of Malaysia. All rights reserved.</rdfs:comment>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Ambigapathy S., Rajahram G.S., Shamsudin U.K., Khoo E.M., Cheah W.K., Peariasamy K.M., Goh P.P., Khor S.K.</dc:creator>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Academy of Family Physicians of Malaysia</j.0:publisher>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:volume>15</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082129059&amp;partnerID=40&amp;md5=f3583311e14660ea9aaf4f42debd438c&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Malaysian_Family_Physician">
        <j.1:name>Malaysian Family Physician</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>How should front-line general practitioners use personal protective equipment (PPE)?</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079880333">
    <j.0:title>Chloroquine for the 2019 novel coronavirus SARS-CoV-2</j.0:title>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>chloroquine; hydroxychloroquine; remdesivir; teicoplanin; chloroquine; severe acute respiratory syndrome coronavirus 2; antiviral activity; China; Coronavirus disease 2019; coronavirus disease 2019; Coronavirus infection; drug efficacy; drug repositioning; drug safety; EC50; Editorial; in vitro study; nonhuman; phagolysosome; priority journal; SARS coronavirus; severe acute respiratory syndrome; severe acute respiratory syndrome 2; severe acute respiratory syndrome coronavirus 2; virus inhibition; virus isolation; virus replication; animal; bat; Betacoronavirus; Coronavirinae; epidemic; pneumonia; Animals; Betacoronavirus; Chiroptera; Chloroquine; Coronavirus; Disease Outbreaks; Pneumonia; SARS Virus</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079880333&amp;doi=10.1016%2fj.ijantimicag.2020.105923&amp;partnerID=40&amp;md5=006b04747f6da9984216a6e4819a4461&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079880333</j.0:identifier>
    <j.0:identifier>10.1016/j.ijantimicag.2020.105923</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Colson P., Rolain J.-M., Raoult D.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>55</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Antimicrobial_Agents">
        <j.1:name>International Journal of Antimicrobial Agents</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081148400">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081148400&amp;doi=10.4103%2f1995-7645.277815&amp;partnerID=40&amp;md5=daf7a2113862693ee63dff1c80a609b4&gt;</schema:url>
    <dc:creator>Yasri S., Wiwanitkit V.</dc:creator>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081148400</j.0:identifier>
    <j.0:identifier>10.4103/1995-7645.277815</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Wolters Kluwer Medknow Publications</j.0:publisher>
    <j.0:title>Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>13</myOnto:volume>
    <schema:keywords>lopinavir plus ritonavir; proteinase; virus enzyme; 2019 novel coronavirus; antiviral therapy; calculation; comparative study; Coronavirinae; Coronavirus infection; enzyme activity; human; Human immunodeficiency virus infection; Letter; mathematical model; molecular weight; nonhuman; prediction; priority journal</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Pacific_Journal_of_Tropical_Medicine">
        <j.1:name>Asian Pacific Journal of Tropical Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081092802">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Eastern_Mediterranean_Health_Journal">
        <j.1:name>Eastern Mediterranean Health Journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>oseltamivir; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; acute respiratory tract disease; bat; coronavirus disease 2019; coughing; disease surveillance; disease transmission; Editorial; fever; geographic distribution; health care personnel; human; Middle East respiratory syndrome; public health; public health service; sea food; severe acute respiratory syndrome; Southern Europe; virus detection; animal; Betacoronavirus; Coronavirus infection; epidemic; infection control; pandemic; procedures; public health service; Southern Europe; virus pneumonia; World Health Organization; Animals; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Infection Control; Mediterranean Region; Pandemics; Pneumonia, Viral; Public Health Practice; World Health Organization</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081092802</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.26719/2020.26.2.136</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081092802&amp;doi=10.26719%2f2020.26.2.136&amp;partnerID=40&amp;md5=18c52216cea17307b9bf89f31296b378&gt;</schema:url>
    <myOnto:volume>26</myOnto:volume>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Coronavirus disease 2019 outbreak: Preparedness and readiness of countries in the eastern mediterranean region</j.0:title>
    <j.0:publisher>World Health Organization</j.0:publisher>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <dc:creator>Al-Mandhari A., Samhouri D., Abubakar A., Brennan R.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079515414">
    <myOnto:issue>1</myOnto:issue>
    <j.0:title>Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody</j.0:title>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079515414&amp;doi=10.1080%2f22221751.2020.1729069&amp;partnerID=40&amp;md5=8b21752fa2518ce267adba5ee3790c3b&gt;</schema:url>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:volume>9</myOnto:volume>
    <dc:creator>Tian X., Li C., Huang A., Xia S., Lu S., Shi Z., Lu L., Jiang S., Yang Z., Wu Y., Ying T.</dc:creator>
    <schema:keywords>angiotensin converting enzyme 2; arginine; asparagine; epitope; human monoclonal antibody; lysine; m396 antibody; monoclonal antibody CR3022; neutralizing antibody; unclassified drug; valine; virus antibody; virus glycoprotein; virus spike protein; virus vaccine; coronavirus spike glycoprotein; COVID-19; monoclonal antibody; severe acute respiratory syndrome coronavirus 2; virus antibody; 2019 novel coronavirus; amino acid sequence; antibody specificity; binding affinity; binding competition; carboxy terminal sequence; competitive binding assay; controlled study; Coronavirinae; cross reaction; drug binding site; drug potency; drug receptor binding; enzyme linked immunosorbent assay; human; hydrogen bond; interferometry; Letter; nonhuman; phylogeny; priority journal; protein conformation; protein purification; SARS coronavirus; Betacoronavirus; Coronavirus infection; cross reaction; immunology; protein tertiary structure; SARS coronavirus; virus pneumonia; Amino Acid Sequence; Antibodies, Monoclonal; Antibodies, Viral; Betacoronavirus; Coronavirus Infections; Cross Reactions; Humans; Pneumonia, Viral; Protein Structure, Tertiary; SARS Virus; Spike Glycoprotein, Coronavirus</schema:keywords>
    <myOnto:citeyBy>10</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079515414</j.0:identifier>
    <j.0:identifier>10.1080/22221751.2020.1729069</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor-binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-SARS CoV antibodies with 2019-nCoV spike protein, which could have important implications for rapid development of vaccines and therapeutic antibodies against 2019-nCoV. Here, we report for the first time that a SARS-CoV-specific human monoclonal antibody, CR3022, could bind potently with 2019-nCoV RBD (KD of 6.3 nM). The epitope of CR3022 does not overlap with the ACE2 binding site within 2019-nCoV RBD. These results suggest that CR3022 may have the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections. Interestingly, some of the most potent SARS-CoV-specific neutralizing antibodies (e.g. m396, CR3014) that target the ACE2 binding site of SARS-CoV failed to bind 2019-nCoV spike protein, implying that the difference in the RBD of SARS-CoV and 2019-nCoV has a critical impact for the cross-reactivity of neutralizing antibodies, and that it is still necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079900882">
    <j.0:title>Unveiling the Origin and Transmission of 2019-nCoV</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Short Survey</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079900882&amp;doi=10.1016%2fj.tim.2020.02.001&amp;partnerID=40&amp;md5=a2602372c957e36b9fef7177497afc26&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Trends_in_Microbiology">
        <j.1:name>Trends in Microbiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:volume>28</myOnto:volume>
    <j.0:identifier>2-s2.0-85079900882</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:identifier>10.1016/j.tim.2020.02.001</j.0:identifier>
    <schema:keywords>China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; eating habit; epidemic; epidemiological monitoring; feeding behavior; gene mutation; genetic recombination; genetic variability; genome analysis; high risk population; human; illness trajectory; infection control; infection prevention; infection risk; nonhuman; prevalence; priority journal; public health problem; risk reduction; severe acute respiratory syndrome coronavirus 2; Short Survey; virus detection; virus gene; virus transmission; virus virulence; animal; bat; Betacoronavirus; Coronavirus infection; genetics; livestock; Melia azedarach; Middle East respiratory syndrome coronavirus; pathogenicity; public health; SARS coronavirus; virus pneumonia; zoonosis; coronavirus spike glycoprotein; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; Chiroptera; Coronavirus Infections; Disease Outbreaks; Humans; Livestock; Melia azedarach; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; Public Health; SARS Virus; Spike Glycoprotein, Coronavirus; Zoonoses</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>A novel coronavirus has caused thousands of human infections in China since December 2019, raising a global public health concern. Recent studies (Huang et al., Chan et al., and Zhou et al.) have provided timely insights into its origin and ability to spread among humans, informing infection prevention and control practices. © 2020 Elsevier Ltd</rdfs:comment>
    <myOnto:issue>4</myOnto:issue>
    <dc:creator>Xu Y.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081379683">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>BACKGROUND Coronavirus disease 2019 (COVID-19), formerly known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 2019 novel coronavirus (2019-nCoV), was first identified in December 2019 in Wuhan City, China. Structural equation modeling (SEM) is a multivariate analysis method to determine the structural relationship between measured variables. This observational study aimed to use SEM to determine the effects of social support on sleep quality and function of medical staff who treated patients with COVID-19 in January and February 2020 in Wuhan, China. MATERIAL AND METHODS A one-month cross-sectional observational study included 180 medical staff who treated patients with COVID-19 infection. Levels of anxiety, self-efficacy, stress, sleep quality, and social support were measured using the and the Self-Rating Anxiety Scale (SAS), the General Self-Efficacy Scale (GSES), the Stanford Acute Stress Reaction (SASR) questionnaire, the Pittsburgh Sleep Quality Index (PSQI), and the Social Support Rate Scale (SSRS), respectively. Pearson's correlation analysis and SEM identified the interactions between these factors. RESULTS Levels of social support for medical staff were significantly associated with self-efficacy and sleep quality and negatively associated with the degree of anxiety and stress. Levels of anxiety were significantly associated with the levels of stress, which negatively impacted self-efficacy and sleep quality. Anxiety, stress, and self-efficacy were mediating variables associated with social support and sleep quality. CONCLUSIONS SEM showed that medical staff in China who were treating patients with COVID-19 infection during January and February 2020 had levels of anxiety, stress, and self-efficacy that were dependent on sleep quality and social support.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081379683&amp;doi=10.12659%2fMSM.923549&amp;partnerID=40&amp;md5=655f329518c27669dbdad297c549ab6d&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Medical_science_monitor_:_international_medical_journal_of_experimental_and_clinical_research">
        <j.1:name>Medical science monitor : international medical journal of experimental and clinical research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <dc:creator>Xiao H., Zhang Y., Kong D., Li S., Yang N.</dc:creator>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; anxiety; Betacoronavirus; China; Coronavirus infection; cross-sectional study; female; human; male; medical staff; mental stress; questionnaire; self concept; sleep; social support; virus pneumonia; Adult; Anxiety; Betacoronavirus; China; Coronavirus Infections; Cross-Sectional Studies; Female; Humans; Male; Medical Staff; Pneumonia, Viral; Self Efficacy; Sleep; Social Support; Stress, Psychological; Surveys and Questionnaires</schema:keywords>
    <j.0:identifier>10.12659/MSM.923549</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>26</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081379683</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079759591">
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Purpose: The aim of this case series is to illustrate the 18F-FDG PET/CT findings of patients with acute respiratory disease caused by COVID-19 in Wuhan, Hubei province of China. Methods: We describe the 18F-FDG PET/CT results from four patients who were admitted to the hospital with respiratory symptoms and fever between January 13 and January 20, 2020, when the COVID-19 outbreak was still unrecognized and the virus infectivity was unknown. A retrospective review of the patients’ medical history, clinical and laboratory data, as well as imaging findings strongly suggested a diagnosis of COVID-19. Results: All patients had peripheral ground-glass opacities and/or lung consolidations in more than two pulmonary lobes. Lung lesions were characterized by a high 18F-FDG uptake and there was evidence of lymph node involvement. Conversely, disseminated disease was absent, a finding suggesting that COVID-19 has pulmonary tropism. Conclusions: Although 18F-FDG PET/CT cannot be routinely used in an emergency setting and is generally not recommended for infectious diseases, our pilot data shed light on the potential clinical utility of this imaging technique in the differential diagnosis of complex cases. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079759591&amp;doi=10.1007%2fs00259-020-04734-w&amp;partnerID=40&amp;md5=92d1600b850d87779469ca93705bcf42&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <j.0:title>18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_Journal_of_Nuclear_Medicine_and_Molecular_Imaging">
        <j.1:name>European Journal of Nuclear Medicine and Molecular Imaging</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1007/s00259-020-04734-w</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85079759591</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:creator>Qin C., Liu F., Yen T.-C., Lan X.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082188750">
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85082188750</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <j.0:title>COVID-19: lessons from the Italian reproductive medical experience</j.0:title>
    <j.0:identifier>10.1016/j.fertnstert.2020.03.021</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Fertility_and_Sterility">
        <j.1:name>Fertility and Sterility</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier Inc.</j.0:publisher>
    <dc:creator>La Marca A., Niederberger C., Pellicer A., Nelson S.M.</dc:creator>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082188750&amp;doi=10.1016%2fj.fertnstert.2020.03.021&amp;partnerID=40&amp;md5=5adaaf58f0b4438f92896e76cb930089&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081749455">
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <j.0:identifier>10.1016/j.tmaid.2020.101629</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081749455</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?</j.0:title>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081749455&amp;doi=10.1016%2fj.tmaid.2020.101629&amp;partnerID=40&amp;md5=b7e00c4715daa72296c64a16921124ef&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Al-Tawfiq J.A.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081072048">
    <myOnto:volume>368</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081072048&amp;doi=10.1136%2fbmj.m751&amp;partnerID=40&amp;md5=9e32b09468f4fe84450b5b688810a4a5&gt;</schema:url>
    <dc:creator>Day M.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Covid-19: surge in cases in Italy and South Korea makes pandemic look more likely</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1136/bmj.m751</j.0:identifier>
    <j.0:identifier>2-s2.0-85081072048</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082048714">
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.10.2003121</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin">
        <j.1:name>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85082048714</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>10</myOnto:issue>
    <myOnto:volume>25</myOnto:volume>
    <dc:creator>Eurosurveillance Editorial Team</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Updated rapid risk assessment from ECDC on the novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082048714&amp;doi=10.2807%2f1560-7917.ES.2020.25.10.2003121&amp;partnerID=40&amp;md5=037102987aab736956551835a78136f7&gt;</schema:url>
    <schema:keywords>COVID-19; Coronavirus infection; Europe; health survey; human; pandemic; public health; risk assessment; social distance; United Kingdom; virus pneumonia; Coronavirus Infections; Europe; Humans; Pandemics; Pneumonia, Viral; Population Surveillance; Public Health; Risk Assessment; Social Distance; United Kingdom</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080126011">
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue>4</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/j.mayocp.2020.02.003</j.0:identifier>
    <dc:creator>Shah A., Kashyap R., Tosh P., Sampathkumar P., O'Horo J.C.</dc:creator>
    <j.0:title>Guide to Understanding the 2019 Novel Coronavirus</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Mayo_Clinic_Proceedings">
        <j.1:name>Mayo Clinic Proceedings</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080126011</j.0:identifier>
    <j.0:type>Short Survey</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080126011&amp;doi=10.1016%2fj.mayocp.2020.02.003&amp;partnerID=40&amp;md5=1bc91c1b808f30d4b379584b2a0441d1&gt;</schema:url>
    <myOnto:volume>95</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081738714">
    <j.0:identifier>2-s2.0-85081738714</j.0:identifier>
    <j.0:title>Brain Awareness Week, CoVID-19 infection and Neurological Sciences</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1007/s10072-020-04338-0</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081738714&amp;doi=10.1007%2fs10072-020-04338-0&amp;partnerID=40&amp;md5=cb1e356adfc3eadb9446ad8a18522186&gt;</schema:url>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Neurological_Sciences">
        <j.1:name>Neurological Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Federico A.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081947709">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1136/bmj.m1054</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081947709&amp;doi=10.1136%2fbmj.m1054&amp;partnerID=40&amp;md5=09cf9429606d2120796deb2a89653204&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Rimmer A.</dc:creator>
    <j.0:title>Covid-19: Medical conferences around the world are cancelled after US cases are linked to Massachusetts meeting</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081947709</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081205676">
    <j.0:title>Research frontiers of health emergency and disaster risk management: What do we know so far?</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:volume>17</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>Canada; coronavirus disease 2019; Coronavirus infection; disaster; disease transmission; Editorial; food packaging; government; hand washing; health care need; health care policy; health emergency and disaster risk management; human; influenza A (H7N9); law; medical research; Middle East respiratory syndrome; non communicable disease; population research; practice guideline; prophylaxis; psychometry; psychosocial wellbeing; risk management; severe acute respiratory syndrome; South Korea; wellbeing; editorial; health hazard</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Environmental_Research_and_Public_Health"/>
    <dc:date>2020</dc:date>
    <myOnto:issue>5</myOnto:issue>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Chan E.Y.Y., Lam H.C.Y.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.3390/ijerph17051807</j.0:identifier>
    <j.0:identifier>2-s2.0-85081205676</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081205676&amp;doi=10.3390%2fijerph17051807&amp;partnerID=40&amp;md5=aaf67aa533658c64e2ebf05beff764e6&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085077990983">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:identifier>2-s2.0-85077990983</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:title>New virus in China requires international control effort</j.0:title>
    <myOnto:issue>7791</myOnto:issue>
    <myOnto:volume>577</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1038/d41586-020-00135-z</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Liu S.-L.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <schema:keywords>2019 novel coronavirus; animal product; China; Coronavirinae; diagnostic error; disease re-emergence; food contamination; gene sequence; human; infection control; international cooperation; Letter; meat; microbiological examination; nonhuman; priority journal; sea food; severe acute respiratory syndrome; United States; viral contamination; virology; virus carrier; virus genome; virus identification; virus isolation; virus transmission</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077990983&amp;doi=10.1038%2fd41586-020-00135-z&amp;partnerID=40&amp;md5=6d8196359febf4b507df417c31328439&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082054604">
    <dc:date>2020</dc:date>
    <schema:keywords>COVID-19; Asian continental ancestry group; Coronavirus infection; human; prejudice; prevention and control; university; virus pneumonia; xenophobia; Asian Continental Ancestry Group; Coronavirus Infections; Humans; Pneumonia, Viral; Prejudice; Universities; Xenophobia</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Science">
        <j.1:name>Science</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>6484</myOnto:issue>
    <j.0:title>Preventing COVID-19 prejudice in academia</j.0:title>
    <j.0:identifier>10.1126/science.abb4870</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <dc:creator>Rzymski P., Nowicki M.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>367</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082054604&amp;doi=10.1126%2fscience.abb4870&amp;partnerID=40&amp;md5=f745d5b4b5a9289cfce8f0eea66704cf&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082054604</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078930202">
    <dc:creator>Moberly T.</dc:creator>
    <myOnto:volume>368</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85078930202</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Following the evidence, from coronavirus to terrorism response</j.0:title>
    <j.0:identifier>10.1136/bmj.m344</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078930202&amp;doi=10.1136%2fbmj.m344&amp;partnerID=40&amp;md5=3c7a36a1c0da4c8adb1441f593764d68&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Note</j.0:type>
    <schema:keywords>drinking water; 2019 novel coronavirus; cancer screening; China; Coronavirinae; Coronavirus infection; fermented soybean; food intake; human; mortality; Note; priority journal; quarantine; sanitation; social welfare; soy food; survival; terrorism; travel; uterine cervix cancer</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081991318">
    <dc:date>2020</dc:date>
    <j.0:title>On the front lines of coronavirus: the Italian response to covid-19</j.0:title>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081991318</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081991318&amp;doi=10.1136%2fbmj.m1065&amp;partnerID=40&amp;md5=4e4868061d0b8b0e5429ab8ff13a5dee&gt;</schema:url>
    <dc:creator>Paterlini M.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1136/bmj.m1065</j.0:identifier>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078500139">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <rdfs:comment>A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization. We performed bioinformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes. Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike’s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
    <j.0:identifier>10.1080/22221751.2020.1719902</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078500139&amp;doi=10.1080%2f22221751.2020.1719902&amp;partnerID=40&amp;md5=b5227b5475bb2082cd3e093d6ba63f27&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:citeyBy>25</myOnto:citeyBy>
    <j.0:title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</j.0:title>
    <dc:creator>Chan J.F.-W., Kok K.-H., Zhu Z., Chu H., To K.K.-W., Yuan S., Yuen K.-Y.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:volume>9</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords>coronavirus spike glycoprotein; membrane protein; nonstructural protein 1; nonstructural protein 10; nonstructural protein 11; nonstructural protein 12; nonstructural protein 13; nonstructural protein 14; nonstructural protein 15; nonstructural protein 16; nonstructural protein 2; nonstructural protein 3; nonstructural protein 4; nonstructural protein 5; nonstructural protein 6; nonstructural protein 7; nonstructural protein 8; nonstructural protein 9; nucleotide; open reading frame 3a protein; open reading frame 3b protein; open reading frame 6 protein; open reading frame 7a protein; open reading frame 7b protein; open reading frame 9b protein; single stranded RNA; unclassified drug; viral protein; virus envelope protein; virus nucleoprotein; virus RNA; COVID-19; severe acute respiratory syndrome coronavirus 2; viral protein; 2019 novel coronavirus; alpha helix; amino acid sequence; Article; bat; beta sheet; Betacoronavirus; bioinformatics; camel; China; civet (animal); Coronavirus infection; genome analysis; Middle East respiratory syndrome coronavirus; nonhuman; nucleotide sequence; nucleotide sequence; open reading frame; phylogenetic tree; priority journal; protein structure; receptor binding domain; SARS coronavirus; SARS-related coronavirus; strain difference; virus envelope; virus genome; virus isolation; virus pneumonia; virus spike; Betacoronavirus; chemistry; genetics; human; isolation and purification; phylogeny; sequence analysis; travel; virology; Amino Acid Sequence; Betacoronavirus; China; Coronavirus Infections; Genome, Viral; Humans; Phylogeny; Pneumonia, Viral; Sequence Analysis, Protein; Travel; Viral Proteins</schema:keywords>
    <j.0:identifier>2-s2.0-85078500139</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079445119">
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <rdfs:comment>To investigate the genetic diversity, time origin, and evolutionary history of the 2019-nCoV outbreak in China and Thailand, a total of 12 genome sequences of the virus with known sampling date (24 December 2019 and 13 January 2020) and geographic location (primarily Wuhan city, Hubei Province, China, but also Bangkok, Thailand) were analyzed. Phylogenetic and likelihood-mapping analyses of these genome sequences were performed. On the basis of our results, the star-like signal and topology of 2019-nCoV may be indicative of potentially large “first generation” human-to-human virus transmission. We estimated that 2019-nCoV likely originated in Wuhan on 9 November 2019 (95% credible interval: 25 September 2019 and 19 December 2019), and that Wuhan is the major hub for the spread of the 2019-nCoV outbreak in China and elsewhere. Our results could be useful for designing effective prevention strategies for 2019-nCoV in China and beyond. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25693</j.0:identifier>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85079445119</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <dc:creator>Li X., Zai J., Wang X., Li Y.</dc:creator>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079445119&amp;doi=10.1002%2fjmv.25693&amp;partnerID=40&amp;md5=0708c338195e9127bc1ba69d756b2ed9&gt;</schema:url>
    <schema:keywords>article; China; genetic variability; human; Thailand; virus transmission; animal; bat; Betacoronavirus; Coronavirinae; epidemic; phylogeny; pneumonia; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; China; Chiroptera; Coronavirus; Disease Outbreaks; Humans; Phylogeny; Pneumonia; Thailand</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:title>Potential of large “first generation” human-to-human transmission of 2019-nCoV</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081683293">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:identifier>2-s2.0-85081683293</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_Internal_Medicine">
        <j.1:name>JAMA Internal Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <dc:creator>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., Zhang Y., Song J., Wang S., Chao Y., Yang Z., Xu J., Zhou X., Chen D., Xiong W., Xu L., Zhou F., Jiang J., Bai C., Zheng J., Song Y.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China</j.0:title>
    <j.0:identifier>10.1001/jamainternmed.2020.0994</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081683293&amp;doi=10.1001%2fjamainternmed.2020.0994&amp;partnerID=40&amp;md5=ac099e7fdae821edd1a7983519bc6fc4&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Importance: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and has subsequently spread worldwide. Risk factors for the clinical outcomes of COVID-19 pneumonia have not yet been well delineated. Objective: To describe the clinical characteristics and outcomes in patients with COVID-19 pneumonia who developed acute respiratory distress syndrome (ARDS) or died. Design, Setting, and Participants: Retrospective cohort study of 201 patients with confirmed COVID-19 pneumonia admitted to Wuhan Jinyintan Hospital in China between December 25, 2019, and January 26, 2020. The final date of follow-up was February 13, 2020. Exposures: Confirmed COVID-19 pneumonia. Main Outcomes and Measures: The development of ARDS and death. Epidemiological, demographic, clinical, laboratory, management, treatment, and outcome data were also collected and analyzed. Results: Of 201 patients, the median age was 51 years (interquartile range, 43-60 years), and 128 (63.7%) patients were men. Eighty-four patients (41.8%) developed ARDS, and of those 84 patients, 44 (52.4%) died. In those who developed ARDS, compared with those who did not, more patients presented with dyspnea (50 of 84 [59.5%] patients and 30 of 117 [25.6%] patients, respectively [difference, 33.9%; 95% CI, 19.7%-48.1%]) and had comorbidities such as hypertension (23 of 84 [27.4%] patients and 16 of 117 [13.7%] patients, respectively [difference, 13.7%; 95% CI, 1.3%-26.1%]) and diabetes (16 of 84 [19.0%] patients and 6 of 117 [5.1%] patients, respectively [difference, 13.9%; 95% CI, 3.6%-24.2%]). In bivariate Cox regression analysis, risk factors associated with the development of ARDS and progression from ARDS to death included older age (hazard ratio [HR], 3.26; 95% CI 2.08-5.11; and HR, 6.17; 95% CI, 3.26-11.67, respectively), neutrophilia (HR, 1.14; 95% CI, 1.09-1.19; and HR, 1.08; 95% CI, 1.01-1.17, respectively), and organ and coagulation dysfunction (eg, higher lactate dehydrogenase [HR, 1.61; 95% CI, 1.44-1.79; and HR, 1.30; 95% CI, 1.11-1.52, respectively] and D-dimer [HR, 1.03; 95% CI, 1.01-1.04; and HR, 1.02; 95% CI, 1.01-1.04, respectively]). High fever (?39 °C) was associated with higher likelihood of ARDS development (HR, 1.77; 95% CI, 1.11-2.84) and lower likelihood of death (HR, 0.41; 95% CI, 0.21-0.82). Among patients with ARDS, treatment with methylprednisolone decreased the risk of death (HR, 0.38; 95% CI, 0.20-0.72). Conclusions and Relevance: Older age was associated with greater risk of development of ARDS and death likely owing to less rigorous immune response. Although high fever was associated with the development of ARDS, it was also associated with better outcomes among patients with ARDS. Moreover, treatment with methylprednisolone may be beneficial for patients who develop ARDS. © 2020 American Medical Association. All rights reserved.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081020293">
    <dc:creator>Chen C., Zhou Y., Wang D.W.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Herz">
        <j.1:name>Herz</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081020293&amp;doi=10.1007%2fs00059-020-04909-z&amp;partnerID=40&amp;md5=8eeec92c989ec307d07e59e2735b5b4c&gt;</schema:url>
    <j.0:publisher>Springer Medizin</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:title>SARS-CoV-2: a potential novel etiology of fulminant myocarditis</j.0:title>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85081020293</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1007/s00059-020-04909-z</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082188246">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>20</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082188246&amp;doi=10.1016%2fS1473-3099%2820%2930141-9&amp;partnerID=40&amp;md5=b09bb5d7e1f50cf3f8ec962d3c10b40c&gt;</schema:url>
    <dc:creator>Chen L., Xiong J., Bao L., Shi Y.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Convalescent plasma as a potential therapy for COVID-19</j.0:title>
    <j.0:identifier>2-s2.0-85082188246</j.0:identifier>
    <j.0:identifier>10.1016/S1473-3099(20)30141-9</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases">
        <j.1:name>The Lancet Infectious Diseases</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079280925">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079280925&amp;doi=10.1016%2fS0140-6736%2820%2930365-2&amp;partnerID=40&amp;md5=95b7f7d29d0d5ab6ceda5f2e94d61b3a&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S0140-6736(20)30365-2</j.0:identifier>
    <myOnto:volume>395</myOnto:volume>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; female; human; medical record; pregnancy; retrospective study; vertical transmission; Betacoronavirus; Female; Humans; Infections; Infectious Disease Transmission, Vertical; Medical Records; Pregnancy; Retrospective Studies</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:language>English</dc:language>
    <j.0:title>What are the risks of COVID-19 infection in pregnant women?</j.0:title>
    <j.0:identifier>2-s2.0-85079280925</j.0:identifier>
    <myOnto:issue>10226</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:creator>Qiao J.</dc:creator>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081020956">
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081020956&amp;doi=10.2471%2fBLT.20.251561&amp;partnerID=40&amp;md5=1c1ae52e083f1d6e79badfc65a493549&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081020956</j.0:identifier>
    <dc:creator>Moorthy V., Restrepo A.M.H., Preziosi M.-P., Swaminathan S.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords>2019 novel coronavirus; coronavirus disease 2019; disease carrier; disease control; disease transmission; Editorial; human; information processing; peer review; public health; publication; World Health Organization; Betacoronavirus; Coronavirus infection; information dissemination; Coronavirus; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus Infections; Humans; Information Dissemination</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>3</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.2471/BLT.20.251561</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Bulletin_of_the_World_Health_Organization"/>
    <j.0:publisher>World Health Organization</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Data sharing for novel coronavirus (COVID-19)</j.0:title>
    <myOnto:volume>98</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082096467">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>14</myOnto:volume>
    <j.0:identifier>10.5582/bst.2020.01020</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Bioscience_trends"/>
    <dc:language>English</dc:language>
    <myOnto:issue>1</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:title>Drug treatment options for the 2019-new coronavirus (2019-nCoV)</j.0:title>
    <j.0:identifier>2-s2.0-85082096467</j.0:identifier>
    <dc:creator>Lu H.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>alanine; antivirus agent; COVID-19; lopinavir; lopinavir-ritonavir drug combination; nucleoside; remdesivir; ribonucleotide; ritonavir; severe acute respiratory syndrome coronavirus 2; sialidase; Betacoronavirus; Coronavirus infection; drug combination; drug development; human; virus pneumonia; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Drug Combinations; Drug Discovery; Humans; Lopinavir; Neuraminidase; Nucleosides; Pneumonia, Viral; Ribonucleotides; Ritonavir</schema:keywords>
    <myOnto:citeyBy>16</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082096467&amp;doi=10.5582%2fbst.2020.01020&amp;partnerID=40&amp;md5=ee0b3b4d0e5984ec7fcc7297c99fefa9&gt;</schema:url>
    <rdfs:comment>As of January 22, 2020, a total of 571 cases of the 2019-new coronavirus (2019-nCoV) have been reported in 25 provinces (districts and cities) in China. At present, there is no vaccine or antiviral treatment for human and animal coronavirus, so that identifying the drug treatment options as soon as possible is critical for the response to the 2019-nCoV outbreak. Three general methods, which include existing broad-spectrum antiviral drugs using standard assays, screening of a chemical library containing many existing compounds or databases, and the redevelopment of new specific drugs based on the genome and biophysical understanding of individual coronaviruses, are used to discover the potential antiviral treatment of human pathogen coronavirus. Lopinavir /Ritonavir, Nucleoside analogues, Neuraminidase inhibitors, Remdesivir, peptide (EK1), abidol, RNA synthesis inhibitors (such as TDF, 3TC), anti-inflammatory drugs (such as hormones and other molecules), Chinese traditional medicine, such ShuFengJieDu Capsules and Lianhuaqingwen Capsule, could be the drug treatment options for 2019-nCoV. However, the efficacy and safety of these drugs for 2019- nCoV still need to be further confirmed by clinical experiments.</rdfs:comment>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081995497">
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/j.acra.2020.03.003</j.0:identifier>
    <rdfs:comment>Coronavirus disease is an emerging infection caused by a novel coronavirus that is moving rapidly. High resolution computed tomography (CT) allows objective evaluation of the lung lesions, thus enabling us to better understand the pathogenesis of the disease. With serial CT examinations, the occurrence, development, and prognosis of the disease can be better understood. The imaging can be sorted into four phases: early phase, progressive phase, severe phase, and dissipative phase. The CT appearance of each phase and temporal progression of the imaging findings are demonstrated. © 2020 The Association of University Radiologists</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081995497</j.0:identifier>
    <j.0:title>Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease</j.0:title>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081995497&amp;doi=10.1016%2fj.acra.2020.03.003&amp;partnerID=40&amp;md5=cad06b30296bf3ee82ff6d2428c37758&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Academic_Radiology">
        <j.1:name>Academic Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <dc:creator>Li M., Lei P., Zeng B., Li Z., Yu P., Fan B., Wang C., Li Z., Zhou J., Hu S., Liu H.</dc:creator>
    <j.0:type>Review</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079360064">
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <schema:keywords>COVID-19; cytochrome P450 3A inhibitor; lopinavir; lopinavir-ritonavir drug combination; ritonavir; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; case report; China; complication; Coronavirus infection; drug combination; genetics; human; male; middle aged; pneumonia; real time polymerase chain reaction; South Korea; virus load; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Humans; Lopinavir; Male; Middle Aged; Pneumonia; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Republic of Korea; Ritonavir; Viral Load</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:creator>Lim J., Jeon S., Shin H.-Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.-W., Kang Y.M., Lee B., Park S.-J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079360064&amp;doi=10.3346%2fjkms.2020.35.e79&amp;partnerID=40&amp;md5=79193553671cffd7a4eaa0a0095eb847&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>35</myOnto:volume>
    <j.0:identifier>10.3346/jkms.2020.35.e79</j.0:identifier>
    <j.0:title>Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:issue>6</myOnto:issue>
    <rdfs:comment>Since mid-December of 2019, coronavirus disease 2019 (COVID-19) has been spreading from Wuhan, China. The confirmed COVID-19 patients in South Korea are those who came from or visited China. As secondary transmissions have occurred and the speed of transmission is accelerating, there are rising concerns about community infections. The 54-year old male is the third patient diagnosed with COVID-19 in Korea. He is a worker for a clothing business and had mild respiratory symptoms and intermittent fever in the beginning of hospitalization, and pneumonia symptoms on chest computerized tomography scan on day 6 of admission. This patient caused one case of secondary transmission and three cases of tertiary transmission. Hereby, we report the clinical findings of the index patient who was the first to cause tertiary transmission outside China. Interestingly, after lopinavir/ritonavir (Kaletra, AbbVie) was administered, ?-coronavirus viral loads significantly decreased and no or little coronavirus titers were observed. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079360064</j.0:identifier>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081608728">
    <j.0:identifier>2-s2.0-85081608728</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Osong_Public_Health_and_Research_Perspectives">
        <j.1:name>Osong Public Health and Research Perspectives</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Park O., Park Y.J., Park S.Y., Kim Y.-M., Kim J., Lee J., Park E., Kim D., Jeon B.-H., Ryu B., Ko D., Kim E., Kim H., Lee H., Gwack J., Jo J., Lee J.H., Hyun J., Kim J., Park J.K., Lee S., Kim S.S., Shin S.H., Choi S.W., Kim T., Kim U.-N., Woo Y., Jin Y., Jang Y.S., Park Y., Yum M.</dc:creator>
    <j.0:title>Contact transmission of Covid-19 in South Korea: Novel investigation techniques for tracing contacts</j.0:title>
    <j.0:identifier>10.24171/j.phrp.2020.11.1.09</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; Article; case management; contact examination; Coronavirinae; Coronavirus infection; credit card transaction log; disease control; exposure; global positioning system; human; infection prevention; information processing; interview; medical record; patient identification; priority journal; proxy; risk assessment; South Korea; virus transmission</schema:keywords>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>In the epidemiological investigation of an infectious disease, investigating, classifying, tracking, and managing contacts by identifying the patient’s route are important for preventing further transmission of the disease. However, omissions and errors in previous activities can occur when the investigation is performed through only a proxy interview with the patient. To overcome these limitations, methods that can objectively verify the patient’s claims (medical facility records, Global Positioning System, card transactions, and closed-circuit television) were used for the recent ongoing coronavirus disease 2019 contact investigations in South Korea. © 2020 Korea Centers for Disease Control and Prevention.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Korea Centers for Disease Control and Prevention</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081608728&amp;doi=10.24171%2fj.phrp.2020.11.1.09&amp;partnerID=40&amp;md5=5d3ad519e9dccd17623d7f4fec6c74a7&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081925039">
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081925039</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081925039&amp;doi=10.1136%2fbmj.m1001&amp;partnerID=40&amp;md5=78b56de30548c68b0e4958addb85fe0e&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1136/bmj.m1001</j.0:identifier>
    <j.0:title>Covid-19: UK budget gives £94 a week statutory sick pay to self-isolators and their carers</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>368</myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <dc:creator>Mahase E.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081897558">
    <j.0:publisher>Springer</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081897558&amp;doi=10.1007%2fs00247-020-04656-7&amp;partnerID=40&amp;md5=844d982d2b3c1a709efa24615500f9c7&gt;</schema:url>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Background: Infection with COVID-19 is currently rare in children. Objective: To describe chest CT findings in children with COVID-19. Materials and methods: We studied children at a large tertiary-care hospital in China, during the period from 28 January 2019 to 8 February 2020, who had positive reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19. We recorded findings at any chest CT performed in the included children, along with core clinical observations. Results: We included five children from 10 months to 6 years of age (mean 3.4 years). All had had at least one CT scan after admission. Three of these five had CT abnormality on the first CT scan (at 2 days, 4 days and 9 days, respectively, after onset of symptoms) in the form of patchy ground-glass opacities; all normalised during treatment. Conclusion: Compared to reports in adults, we found similar but more modest lung abnormalities at CT in our small paediatric cohort. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pediatric_Radiology">
        <j.1:name>Pediatric Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1007/s00247-020-04656-7</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081897558</j.0:identifier>
    <dc:creator>Li W., Cui H., Li K., Fang Y., Li S.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:title>Chest computed tomography in children with COVID-19 respiratory infection</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081951055">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:title>The Wuhan SARS-CoV-2—What's next for China</j.0:title>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1002/jmv.25738</j.0:identifier>
    <j.0:identifier>2-s2.0-85081951055</j.0:identifier>
    <dc:creator>Lu H., Stratton C.W., Tang Y.-W.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081951055&amp;doi=10.1002%2fjmv.25738&amp;partnerID=40&amp;md5=2b4b484fa721e72fe59624086d042e56&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079804076">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Mowbray H.</dc:creator>
    <j.0:identifier>2-s2.0-85079804076</j.0:identifier>
    <j.0:title>Letter from China: Covid-19 on the grapevine, on the internet, and in commerce</j.0:title>
    <j.0:identifier>10.1136/bmj.m643</j.0:identifier>
    <j.0:type>Short Survey</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079804076&amp;doi=10.1136%2fbmj.m643&amp;partnerID=40&amp;md5=1e1480224b192c0bf46801b774f5d6ac&gt;</schema:url>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081283505">
    <j.0:identifier></j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Publicaciones Permanyer</j.0:publisher>
    <rdfs:comment>Since the first report of a cluster of pneumonia cases in Wuhan (China) at the end of 2019 due to a new airborne highly transmissible coronavirus known as SARS-CoV-2, large-scale spreading has rapidly become a global concern. Up to the end of February 2020, more than 85,000 cases had been confirmed worldwide, mostly in China, with more than 3,000 deaths. Figures are increasing on a daily basis, being unpredictable what will happen next. Table 1 summarizes figures for major outbreaks due to acute viral infections recorded during the past 50 years. © 2020, Publicaciones Permanyer. All rights reserved.</rdfs:comment>
    <dc:creator>Soriano V., Barreiro P.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081283505&amp;partnerID=40&amp;md5=969900d323d4c2495b726915409574ed&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081283505</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords>guanine nucleotide binding protein; virus spike protein; Coronavirus infection; diarrhea; Ebolavirus; epidemic; Hepatitis C virus; human; Human immunodeficiency virus infection; Human respiratory syncytial virus; Influenza A virus (H7N9); Influenza virus; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; mixed infection; mortality rate; myelitis; Nipah virus; nonhuman; Note; novel coronavirus 2019; novel coronavirus disease 2019; pneumonia; polymerase chain reaction; reinfection; respiratory tract infection; Rhinovirus; RNA virus; SARS coronavirus; severe acute respiratory syndrome; virus genome; virus load; virus replication; virus transmission; zoonosis</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <j.0:title>Impact of new coronavirus epidemics on HIV-infected patients</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/AIDS_Reviews">
        <j.1:name>AIDS Reviews</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>22</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080108033">
    <myOnto:issue></myOnto:issue>
    <j.0:title>Covid-19: Italy confirms 11 deaths as cases spread from north</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1136/bmj.m757</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080108033&amp;doi=10.1136%2fbmj.m757&amp;partnerID=40&amp;md5=da62d5617f4ceac390ec27be43232ff3&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>2-s2.0-85080108033</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <dc:creator>Day M.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081969336">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <dc:date>2020</dc:date>
    <j.0:title>Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <rdfs:comment>We argue that enhanced Traffic Control Bundling (eTCB) can interrupt the community-hospital-community transmission cycle, thereby limiting COVID-19’s impact. Enhanced TCB is an expansion of the traditional TCB that proved highly effective during Taiwan's 2003 SARS outbreak. TCB's success derived from ensuring that Health Care Workers (HCWs) and patients were protected from fomite, contact and droplet transmission within hospitals. Although TCB proved successful during SARS, achieving a similar level of success with the COVID-19 outbreak requires adapting TCB to the unique manifestations of this new disease. These manifestations include asymptomatic infection, a hyper-affinity to ACE2 receptors resulting in high transmissibility, false negatives, and an incubation period of up to 22 days. Enhanced TCB incorporates the necessary adaptations. In particular, eTCB includes expanding the TCB transition zone to incorporate a new sector – the quarantine ward. This ward houses patients exhibiting atypical manifestations or awaiting definitive diagnosis. A second adaptation involves enhancing the checkpoint hand disinfection and gowning up with Personal Protective Equipment deployed in traditional TCB. Under eTCB, checkpoint hand disinfection and donning of face masks are now required of all visitors who seek to enter hospitals. These enhancements ensure that transmissions by droplets, fomites and contact are disrupted both within hospitals and between hospitals and the broader community. Evidencing eTCB effectiveness is Taiwan's success to date in containing and controlling the community-hospital-community transmission cycle. © 2020</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081969336&amp;doi=10.1016%2fj.jmii.2020.03.011&amp;partnerID=40&amp;md5=7749f45d51797e991e1bd3b83f267234&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081969336</j.0:identifier>
    <dc:creator>Yen M.-Y., Schwartz J., Chen S.-Y., King C.-C., Yang G.-Y., Hsueh P.-R.</dc:creator>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.jmii.2020.03.011</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081902597">
    <dc:creator>Batlle D., Wysocki J., Satchell K.</dc:creator>
    <schema:keywords>angiotensin converting enzyme 2; COVID-19; dipeptidyl carboxypeptidase; recombinant protein; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; cell line; Coronavirus infection; Haplorhini; human; pathogenicity; physiology; SARS coronavirus; solubility; virus attachment; virus pneumonia; virus replication; Animals; Betacoronavirus; Cell Line; Coronavirus Infections; Haplorhini; Humans; Peptidyl-Dipeptidase A; Pneumonia, Viral; Recombinant Proteins; SARS Virus; Solubility; Virus Attachment; Virus Replication</schema:keywords>
    <myOnto:volume>134</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_science_(London,_England_:_1979)">
        <j.1:name>Clinical science (London, England : 1979)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081902597&amp;doi=10.1042%2fCS20200163&amp;partnerID=40&amp;md5=7dd863a05a549d00bc6cfd749299d9e8&gt;</schema:url>
    <j.0:title>Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1042/CS20200163</j.0:identifier>
    <j.0:identifier>2-s2.0-85081902597</j.0:identifier>
    <rdfs:comment>A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of January, 2020. It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy. © 2020 The Author(s).</rdfs:comment>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081528982">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:identifier>2-s2.0-85081528982</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1136/bmj.m919</j.0:identifier>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081528982&amp;doi=10.1136%2fbmj.m919&amp;partnerID=40&amp;md5=29148f9fcb37ab0c67769ebdf267d8d5&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Covid-19: Are we getting the communications right?</j.0:title>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Cowper A.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081115583">
    <j.0:identifier>10.1016/S2542-5196(20)30035-8</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Kock R.A., Karesh W.B., Veas F., Velavan T.P., Simons D., Mboera L.E.G., Dar O., Arruda L.B., Zumla A.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081115583</j.0:identifier>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081115583&amp;doi=10.1016%2fS2542-5196%2820%2930035-8&amp;partnerID=40&amp;md5=50f7d372d639d083fc47fffb03f2b6c1&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>2019-nCoV in context: lessons learned?</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Planetary_Health">
        <j.1:name>The Lancet Planetary Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>4</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080982309">
    <j.0:identifier>2-s2.0-85080982309</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:creator>Yeo C., Kaushal S., Yeo D.</dc:creator>
    <myOnto:volume>5</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080982309&amp;doi=10.1016%2fS2468-1253%2820%2930048-0&amp;partnerID=40&amp;md5=56c6741f85d7cd0f9f8854fbd3d51ea7&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Gastroenterology_and_Hepatology">
        <j.1:name>The Lancet Gastroenterology and Hepatology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Note</j.0:type>
    <j.0:title>Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/S2468-1253(20)30048-0</j.0:identifier>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:keywords>angiotensin converting enzyme 2; chlorine; disinfectant agent; virus RNA; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; abdominal pain; brain infection; convalescence; coronavirus disease 2019; diarrhea; disease severity; faecal oral transmission; feces analysis; fever; gastrointestinal infection; gene sequence; human; humidity; intestine infection; Middle East respiratory syndrome; nausea; Note; priority journal; SARS coronavirus; temperature; virus infectivity; virus pneumonia; virus transmission; vomiting; Betacoronavirus; complication; Coronavirus infection; feces; mouth; pathogenicity; severe acute respiratory syndrome; virology; virus shedding; Betacoronavirus; Coronavirus Infections; Diarrhea; Feces; Humans; Mouth; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Virus Shedding</schema:keywords>
    <myOnto:issue>4</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078156226">
    <dc:date>2020</dc:date>
    <myOnto:issue>2</myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Microbiology">
        <j.1:name>Nature Microbiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>2019 novel coronavirus; access to information; China; Coronavirinae; Coronavirus infection; disease surveillance; disease transmission; Editorial; epidemic; human; infection control; infection sensitivity; information dissemination; nonhuman; pneumonia; priority journal; public health; SARS-related coronavirus; severe acute respiratory syndrome; virus identification; virus isolation; Betacoronavirus; classification; Coronavirus infection; epidemic; ethics; genetics; isolation and purification; trust; virology; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Humans; Infection Control; Information Dissemination; Pneumonia, Viral; Trust</schema:keywords>
    <dc:language>English</dc:language>
    <dc:creator>[No author name available]</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:title>Rapid outbreak response requires trust</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>5</myOnto:volume>
    <j.0:identifier>2-s2.0-85078156226</j.0:identifier>
    <j.0:identifier>10.1038/s41564-020-0670-8</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078156226&amp;doi=10.1038%2fs41564-020-0670-8&amp;partnerID=40&amp;md5=699f4531255992b1adf82ad286c108bb&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082066056">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1186/s12916-020-01556-3</j.0:identifier>
    <myOnto:volume>18</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082066056&amp;doi=10.1186%2fs12916-020-01556-3&amp;partnerID=40&amp;md5=a5a05b11854ebab84079f9def1716ad7&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Mian A., Khan S.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>2-s2.0-85082066056</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Coronavirus: the spread of misinformation</j.0:title>
    <schema:keywords>China; Coronavirinae; Coronavirus infection; human; interpersonal communication; public health; China; Communication; Coronavirus; Coronavirus Infections; Humans; Public Health</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/BMC_medicine">
        <j.1:name>BMC medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081973139">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:type>Article</j.0:type>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Lung J., Lin Y.-S., Yang Y.-H., Chou Y.-L., Shu L.-H., Cheng Y.-C., Liu H.T., Wu C.-Y.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:identifier>10.1002/jmv.25761</j.0:identifier>
    <j.0:identifier>2-s2.0-85081973139</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081973139&amp;doi=10.1002%2fjmv.25761&amp;partnerID=40&amp;md5=f24517404479a3cde0e08f7e16a4ab73&gt;</schema:url>
    <rdfs:comment>An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan and it has rapidly spread to almost all parts of the world. For coronaviruses, RNA-dependent RNA polymerase (RdRp) is an important protease that catalyzes the replication of RNA from RNA template and is an attractive therapeutic target. In this study, we screened these chemical structures from traditional Chinese medicinal compounds proven to show antiviral activity in severe acute respiratory syndrome coronavirus (SARS-CoV) and the similar chemical structures through a molecular docking study to target RdRp of SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV). We found that theaflavin has a lower idock score in the catalytic pocket of RdRp in SARS-CoV-2 (?9.11 kcal/mol), SARS-CoV (?8.03 kcal/mol), and MERS-CoV (?8.26 kcal/mol) from idock. To confirm the result, we discovered that theaflavin has lower binding energy of ?8.8 kcal/mol when it docks in the catalytic pocket of SARS-CoV-2 RdRp by using the Blind Docking server. Regarding contact modes, hydrophobic interactions contribute significantly in binding and additional hydrogen bonds were found between theaflavin and RdRp. Moreover, one ?-cation interaction was formed between theaflavin and Arg553 from the Blind Docking server. Our results suggest that theaflavin could be a potential SARS-CoV-2 RdRp inhibitor for further study. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:title>The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082058915">
    <j.0:identifier>2-s2.0-85082058915</j.0:identifier>
    <dc:creator>Li Y.H., Shen L., Li J.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082058915&amp;doi=10.3760%2fcma.j.cn.441530-20200225-00089&amp;partnerID=40&amp;md5=fcb4f11bdc1d94923540836a30da203a&gt;</schema:url>
    <rdfs:comment>?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????.The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.</rdfs:comment>
    <dc:language>Chinese</dc:language>
    <j.0:title>Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Zhonghua_wei_chang_wai_ke_za_zhi_=_Chinese_journal_of_gastrointestinal_surgery">
        <j.1:name>Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.3760/cma.j.cn.441530-20200225-00089</j.0:identifier>
    <schema:keywords>antineoplastic agent; COVID-19; adjuvant chemotherapy; colorectal tumor; complication; Coronavirus infection; epidemic; human; virus pneumonia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral</schema:keywords>
    <myOnto:volume>23</myOnto:volume>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081534615">
    <dc:creator>Xie J., Tong Z., Guan X., Du B., Qiu H., Slutsky A.S.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Critical care crisis and some recommendations during the COVID-19 epidemic in China</j.0:title>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:identifier>2-s2.0-85081534615</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081534615&amp;doi=10.1007%2fs00134-020-05979-7&amp;partnerID=40&amp;md5=2af8b839b9830e9ed2ae46ffe4f31383&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1007/s00134-020-05979-7</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082013854">
    <myOnto:volume>23</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1590/1980-549720200021</j.0:identifier>
    <j.0:identifier>2-s2.0-85082013854</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <schema:keywords>COVID-19; Coronavirus infection; human; mortality; pandemic; virus pneumonia; Coronavirus Infections; Humans; Mortality; Pandemics; Pneumonia, Viral</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Revista_Brasileira_de_Epidemiologia">
        <j.1:name>Revista Brasileira de Epidemiologia</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>On the possibility of interrupting the coronavirus (Covid-19) epidemic based on the best available scientific evidence [Sobre a possibilidade de interrupção da epidemia pelo coronavírus (Covid-19) com base nas melhores evidências científicas disponíveis]</j.0:title>
    <dc:creator>da Silva A.A.M.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082013854&amp;doi=10.1590%2f1980-549720200021&amp;partnerID=40&amp;md5=f841a3f5a4411462a5af0c86c5ac6705&gt;</schema:url>
    <j.0:publisher>Assocaicao Brasileira de Pos, Gradacao em Saude Coletiva</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081207396">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1136/bmj.m864</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081207396&amp;doi=10.1136%2fbmj.m864&amp;partnerID=40&amp;md5=21345db6f7fce67ae35bee3f4067915c&gt;</schema:url>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>2-s2.0-85081207396</j.0:identifier>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <dc:creator>Hurley R.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Prepare for a pandemic</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <schema:keywords>cardiovascular risk; coronavirus disease 2019; disease association; disease exacerbation; global health; government; health care personnel; health care planning; heart protection; human; immunocompromised patient; mortality rate; national health service; Note; pandemic; priority journal; severe acute respiratory syndrome; social care; United Kingdom; virus transmission; welfare</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081693256">
    <j.0:identifier>10.1016/j.jmii.2020.02.012</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081693256&amp;doi=10.1016%2fj.jmii.2020.02.012&amp;partnerID=40&amp;md5=799b8fc6d2ebc05b401954a853c8cdeb&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081693256</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:title>Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths</j.0:title>
    <dc:creator>Lai C.-C., Liu Y.H., Wang C.-Y., Wang Y.-H., Hsueh S.-C., Yen M.-Y., Ko W.-C., Hsueh P.-R.</dc:creator>
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,000 cases have been reported in 32 countries/regions, resulting in more than 2000 deaths worldwide. Despite the fact that most COVID-19 cases and mortalities were reported in China, the WHO has declared this outbreak as the sixth public health emergency of international concern. The COVID-19 can present as an asymptomatic carrier state, acute respiratory disease, and pneumonia. Adults represent the population with the highest infection rate; however, neonates, children, and elderly patients can also be infected by SARS-CoV-2. In addition, nosocomial infection of hospitalized patients and healthcare workers, and viral transmission from asymptomatic carriers are possible. The most common finding on chest imaging among patients with pneumonia was ground-glass opacity with bilateral involvement. Severe cases are more likely to be older patients with underlying comorbidities compared to mild cases. Indeed, age and disease severity may be correlated with the outcomes of COVID-19. To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS-CoV-2. © 2020</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082193464">
    <j.0:identifier>2-s2.0-85082193464</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Estimation of COVID-19 outbreak size in Italy</j.0:title>
    <dc:language>English</dc:language>
    <dc:creator>Tuite A.R., Ng V., Rees E., Fisman D.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/S1473-3099(20)30227-9</j.0:identifier>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082193464&amp;doi=10.1016%2fS1473-3099%2820%2930227-9&amp;partnerID=40&amp;md5=09180cdd4e6e9b18e9b55a740c3daf81&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080864296">
    <j.0:identifier>10.1016/j.tmaid.2020.101604</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>The COVID-19 outbreak and implications for the Tokyo 2020 Summer Olympic Games</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85080864296</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Gallego V., Nishiura H., Sah R., Rodriguez-Morales A.J.</dc:creator>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080864296&amp;doi=10.1016%2fj.tmaid.2020.101604&amp;partnerID=40&amp;md5=9f6aa71b06e6b1da9fe79759f798da70&gt;</schema:url>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079932856">
    <dc:creator>COVID-19 National Incident Room Surveillance Team</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)"/>
    <j.0:title>COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020)</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079932856</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.33321/cdi.2020.44.14</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Australia; Betacoronavirus; Coronavirus infection; epidemic; human; virus pneumonia; Australia; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079932856&amp;doi=10.33321%2fcdi.2020.44.14&amp;partnerID=40&amp;md5=885b7e173e55d26f7d82ca50bac41c49&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>This is the second epidemiological report for coronavirus disease (COVID-19), previously known as novel coronavirus (2019-nCoV), reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 8 February 2020. It includes data on Australian cases notified during the week ending 19:00 AEDT 8 February 2020, the international situation and current information on the severity, transmission and spread of the COVID-19 infection. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <myOnto:volume>44</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081566598">
    <j.0:identifier>10.24171/j.phrp.2020.11.1.02</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081566598&amp;doi=10.24171%2fj.phrp.2020.11.1.02&amp;partnerID=40&amp;md5=dbd0fe84eda4bf1e5ecbde8aac70f199&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:title>Identification of coronavirus isolated from a patient in Korea with covid-19</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Osong_Public_Health_and_Research_Perspectives"/>
    <j.0:publisher>Korea Centers for Disease Control and Prevention</j.0:publisher>
    <rdfs:comment>Objectives: Following reports of patients with unexplained pneumonia at the end of December 2019 in Wuhan, China, the causative agent was identified as coronavirus (SARS-CoV-2), and the 2019 novel coronavirus disease was named COVID-19 by the World Health Organization. Putative patients with COVID-19 have been identified in South Korea, and attempts have been made to isolate the pathogen from these patients. Methods: Upper and lower respiratory tract secretion samples from putative patients with COVID-19 were inoculated onto cells to isolate the virus. Full genome sequencing and electron microscopy were used to identify the virus. Results: The virus replicated in Vero cells and cytopathic effects were observed. Full genome sequencing showed that the virus genome exhibited sequence homology of more than 99.9% with SARS-CoV-2 which was isolated from patients from other countries, for instance China. Sequence homology of SARS-CoV-2 with SARS-CoV, and MERS-CoV was 77.5% and 50%, respectively. Coronavirus-specific morphology was observed by electron microscopy in virus-infected Vero cells. Conclusion: SARS-CoV-2 was isolated from putative patients with unexplained pneumonia and intermittent coughing and fever. The isolated virus was named BetaCoV/Korea/KCDC03/2020. © 2020 Korea Centers for Disease Control and Prevention.</rdfs:comment>
    <schema:keywords>2019 novel coronavirus; animal cell; Article; China; Coronavirinae; Coronavirus infection; cytopathogenic effect; disease control; human; in vitro study; inoculation; Korea; lower respiratory tract; Middle East respiratory syndrome coronavirus; nonhuman; priority journal; real time reverse transcription polymerase chain reaction; SARS coronavirus; sequence homology; serology; transmission electron microscopy; upper respiratory tract; Vero cell line; virus genome; virus isolation; virus pneumonia; virus replication; virus strain; whole genome sequencing</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Kim J.-M., Chung Y.-S., Jo H.J., Lee N.-J., Kim M.S., Woo S.H., Park S., Kim J.W., Kim H.M., Han M.-G.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85081566598</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078490773">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078490773&amp;doi=10.1038%2fs41591-020-0771-1&amp;partnerID=40&amp;md5=4f72c51e5e0cbe37544c73708ea8f6a7&gt;</schema:url>
    <dc:creator>Nkengasong J.</dc:creator>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <myOnto:volume>26</myOnto:volume>
    <j.0:type>Note</j.0:type>
    <schema:keywords>2019 novel coronavirus; behavior; China; communicable disease control; Coronavirinae; Coronavirus infection; diplomacy; drug response; environmental factor; epidemic; global health; government; health care policy; human; Note; priority journal; severe acute respiratory syndrome; travel; treatment response</schema:keywords>
    <j.0:title>China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85078490773</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1038/s41591-020-0771-1</j.0:identifier>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Medicine">
        <j.1:name>Nature Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081198190">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Environmental_Research_and_Public_Health"/>
    <rdfs:comment>Background: The 2019 coronavirus disease (COVID-19) epidemic is a public health emergency of international concern and poses a challenge to psychological resilience. Research data are needed to develop evidence-driven strategies to reduce adverse psychological impacts and psychiatric symptoms during the epidemic. The aim of this study was to survey the general public in China to better understand their levels of psychological impact, anxiety, depression, and stress during the initial stage of the COVID-19 outbreak. The data will be used for future reference. Methods: From 31 January to 2 February 2020, we conducted an online survey using snowball sampling techniques. The online survey collected information on demographic data, physical symptoms in the past 14 days, contact history with COVID-19, knowledge and concerns about COVID-19, precautionary measures against COVID-19, and additional information required with respect to COVID-19. Psychological impact was assessed by the Impact of Event Scale-Revised (IES-R), and mental health status was assessed by the Depression, Anxiety and Stress Scale (DASS-21). Results: This study included 1210 respondents from 194 cities in China. In total, 53.8% of respondents rated the psychological impact of the outbreak as moderate or severe; 16.5% reported moderate to severe depressive symptoms; 28.8% reported moderate to severe anxiety symptoms; and 8.1% reported moderate to severe stress levels. Most respondents spent 20–24 h per day at home (84.7%); were worried about their family members contracting COVID-19 (75.2%); and were satisfied with the amount of health information available (75.1%). Female gender, student status, specific physical symptoms (e.g., myalgia, dizziness, coryza), and poor self-rated health status were significantly associated with a greater psychological impact of the outbreak and higher levels of stress, anxiety, and depression (p &lt; 0.05). Specific up-to-date and accurate health information (e.g., treatment, local outbreak situation) and particular precautionary measures (e.g., hand hygiene, wearing a mask) were associated with a lower psychological impact of the outbreak and lower levels of stress, anxiety, and depression (p &lt; 0.05). Conclusions: During the initial phase of the COVID-19 outbreak in China, more than half of the respondents rated the psychological impact as moderate-to-severe, and about one-third reported moderate-to-severe anxiety. Our findings identify factors associated with a lower level of psychological impact and better mental health status that can be used to formulate psychological interventions to improve the mental health of vulnerable groups during the COVID-19 epidemic. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <j.0:title>Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081198190</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <schema:keywords>disease spread; epidemic; health status; knowledge; mental health; psychology; public health; severe acute respiratory syndrome; symptom; anxiety; Article; attitude to health; China; common cold; coronavirus disease 2019; Coronavirus infection; demography; depression; Depression Anxiety Stress Scale; disease association; disease severity; dizziness; epidemic; gender; hand washing; health status; health survey; human; Impact of Events Scale; medical history; medical information; mental stress; myalgia; online system; snowball sample; symptomatology; universal precaution; virus transmission; adolescent; adult; aged; anxiety disorder; child; complication; Coronavirinae; Coronavirus infection; cross-sectional study; depression; female; male; mental health; middle aged; psychological resilience; psychology; questionnaire; virus pneumonia; young adult; China; Coronavirus; COVID-19; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Child; China; Coronavirus; Coronavirus Infections; Cross-Sectional Studies; Depression; Disease Outbreaks; Epidemics; Female; Health Status; Humans; Male; Mental Health; Middle Aged; Pneumonia, Viral; Resilience, Psychological; Surveys and Questionnaires; Young Adult</schema:keywords>
    <myOnto:volume>17</myOnto:volume>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081198190&amp;doi=10.3390%2fijerph17051729&amp;partnerID=40&amp;md5=26155a6452c89a9bbb2fbbd054e35aeb&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:identifier>10.3390/ijerph17051729</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <dc:creator>Wang C., Pan R., Wan X., Tan Y., Xu L., Ho C.S., Ho R.C.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079895106">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:creator>Thompson R.</dc:creator>
    <schema:keywords>2019 novel coronavirus; China; Coronavirinae; Coronavirus infection; epidemic; human; Influenza virus; isolation; Letter; pandemic; priority journal; self isolation; severe acute respiratory syndrome; virus detection; virus transmission; Betacoronavirus; Coronavirinae; pandemic; pneumonia; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus; Humans; Pandemics; Pneumonia</schema:keywords>
    <j.0:identifier>2-s2.0-85079895106</j.0:identifier>
    <j.0:title>Pandemic potential of 2019-nCoV</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079895106&amp;doi=10.1016%2fS1473-3099%2820%2930068-2&amp;partnerID=40&amp;md5=44a41dbdf9ffe6b8bba2fab23790a7ac&gt;</schema:url>
    <myOnto:volume>20</myOnto:volume>
    <j.0:identifier>10.1016/S1473-3099(20)30068-2</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>3</myOnto:issue>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081899519">
    <dc:creator>Ko W.-C., Rolain J.-M., Lee N.-Y., Chen P.-L., Huang C.-T., Lee P.-I., Hsueh P.-R.</dc:creator>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081899519&amp;doi=10.1016%2fj.ijantimicag.2020.105933&amp;partnerID=40&amp;md5=7ab14b3d3e7b188734f9bc7f86131490&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Antimicrobial_Agents"/>
    <j.0:identifier>2-s2.0-85081899519</j.0:identifier>
    <j.0:title>Arguments in favour of remdesivir for treating SARS-CoV-2 infections</j.0:title>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.ijantimicag.2020.105933</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081208593">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081208593&amp;doi=10.1016%2fj.tmaid.2020.101615&amp;partnerID=40&amp;md5=03d0082820b60476c873bedcd86c55c3&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Remdesivir as a possible therapeutic option for the COVID-19</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <dc:creator>Al-Tawfiq J.A., Al-Homoud A.H., Memish Z.A.</dc:creator>
    <j.0:identifier>2-s2.0-85081208593</j.0:identifier>
    <j.0:identifier>10.1016/j.tmaid.2020.101615</j.0:identifier>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081751138">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081751138</j.0:identifier>
    <j.0:identifier>10.1111/jgs.16426</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081751138&amp;doi=10.1111%2fjgs.16426&amp;partnerID=40&amp;md5=e8c65b37f5526721fa534bc2b402b00f&gt;</schema:url>
    <j.0:publisher>Blackwell Publishing Inc.</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:title>COVID-19 Presents High Risk to Older Persons</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_American_Geriatrics_Society">
        <j.1:name>Journal of the American Geriatrics Society</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Applegate W.B., Ouslander J.G.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081386948">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:volume>97</myOnto:volume>
    <dc:creator>Tárnok A.</dc:creator>
    <j.0:publisher>Wiley-Liss Inc.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1002/cyto.a.23990</j.0:identifier>
    <j.0:title>Machine Learning, COVID-19 (2019-nCoV), and multi-OMICS</j.0:title>
    <j.0:identifier>2-s2.0-85081386948</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; genetics; genomics; human; machine learning; metabolism; virus pneumonia; Betacoronavirus; Coronavirus Infections; Genomics; Humans; Machine Learning; Pneumonia, Viral</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cytometry_Part_A">
        <j.1:name>Cytometry Part A</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081386948&amp;doi=10.1002%2fcyto.a.23990&amp;partnerID=40&amp;md5=0eaff53ab8ffd4d42f3bc784f47f0940&gt;</schema:url>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079686882">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Liu Y., Li J., Feng Y.</dc:creator>
    <j.0:identifier>10.1186/s13054-020-2786-x</j.0:identifier>
    <j.0:title>Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>corticosteroid; interferon; lopinavir plus ritonavir; COVID-19; severe acute respiratory syndrome coronavirus 2; China; clinical feature; coronavirus disease 2019; Coronavirus infection; Editorial; epidemic; extracorporeal oxygenation; health care personnel; hospital admission; hospital infection; human; infection prevention; infection risk; intensive care; intubation; mental stress; mortality; neuromuscular blocking; priority journal; prone position; thorax radiography; virus transmission; Betacoronavirus; Coronavirus infection; disaster planning; epidemic; epidemiology; intensive care unit; psychology; risk; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Critical Care; Disaster Planning; Disease Outbreaks; Health Personnel; Humans; Intensive Care Units; Pneumonia, Viral; Risk; Stress, Psychological</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>24</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079686882&amp;doi=10.1186%2fs13054-020-2786-x&amp;partnerID=40&amp;md5=59b12b3f2dfa59df470cdca525843e51&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Critical_Care">
        <j.1:name>Critical Care</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079686882</j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079889190">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079889190&amp;doi=10.1016%2fS1473-3099%2820%2930072-4&amp;partnerID=40&amp;md5=b5c1aa9872c6eb57fbe26000325a98b4&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:issue>3</myOnto:issue>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:title>Challenges of coronavirus disease 2019</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>20</myOnto:volume>
    <dc:creator>The Lancet Infectious Diseases</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079889190</j.0:identifier>
    <j.0:identifier>10.1016/S1473-3099(20)30072-4</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081680314">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Surgery">
        <j.1:name>International Journal of Surgery</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Coronavirus infection; emergency care; global health; government; human; Letter; pandemic; prevalence; priority journal; prognosis; public health; quarantine; World Health Organization</schema:keywords>
    <j.0:identifier>10.1016/j.ijsu.2020.03.001</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>76</myOnto:volume>
    <j.0:title>A commentary on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)”</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:creator>Shah S.G.S., Farrow A.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081680314</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081680314&amp;doi=10.1016%2fj.ijsu.2020.03.001&amp;partnerID=40&amp;md5=096cb25e2aaa6298bfb544cd9d3c6fb7&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079861948">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Pneumonia associated with 2019 novel coronavirus: Can computed tomographic findings help predict the prognosis of the disease?</j.0:title>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Korean Radiological Society</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079861948&amp;doi=10.3348%2fkjr.2020.0096&amp;partnerID=40&amp;md5=a864c67442a6aa9aa8992687685c9fd0&gt;</schema:url>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Lee K.S.</dc:creator>
    <j.0:identifier>2-s2.0-85079861948</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.3348/kjr.2020.0096</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; antibiotic therapy; bronchopneumonia; clinical outcome; computer assisted tomography; Coronavirinae; Coronavirus infection; differential diagnosis; disease exacerbation; Editorial; follow up; ground glass opacity; human; immunocompetence; influenza A; lung injury; lung nodule; lung ventilation; Middle East respiratory syndrome; nonhuman; organizing pneumonia; patient care; pleura effusion; pneumonia; prognosis; radiological parameters; severe acute respiratory syndrome; treatment response; virus pneumonia</schema:keywords>
    <myOnto:volume>21</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Korean_Journal_of_Radiology">
        <j.1:name>Korean Journal of Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080988227">
    <schema:keywords>Coronavirinae; human; incidence; major clinical study; nonhuman; quarantine; review; virus transmission; World Health Organization</schema:keywords>
    <j.0:title>World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Surgery"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/j.ijsu.2020.02.034</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:identifier>2-s2.0-85080988227</j.0:identifier>
    <rdfs:comment>An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19. © 2020 IJS Publishing Group Ltd</rdfs:comment>
    <dc:creator>Sohrabi C., Alsafi Z., O'Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080988227&amp;doi=10.1016%2fj.ijsu.2020.02.034&amp;partnerID=40&amp;md5=6f14615e718590d1168d9cc25772fa3f&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>76</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079180879">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079180879&amp;doi=10.1016%2fj.ijid.2020.01.050&amp;partnerID=40&amp;md5=26a5a286c06b1de73fb6b98b653d88ac&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Backgrounds: An ongoing outbreak of a novel coronavirus (2019-nCoV) pneumonia hit a major city in China, Wuhan, December 2019 and subsequently reached other provinces/regions of China and other countries. We present estimates of the basic reproduction number, R0, of 2019-nCoV in the early phase of the outbreak. Methods: Accounting for the impact of the variations in disease reporting rate, we modelled the epidemic curve of 2019-nCoV cases time series, in mainland China from January 10 to January 24, 2020, through the exponential growth. With the estimated intrinsic growth rate (?), we estimated R0 by using the serial intervals (SI) of two other well-known coronavirus diseases, MERS and SARS, as approximations for the true unknown SI. Findings: The early outbreak data largely follows the exponential growth. We estimated that the mean R0 ranges from 2.24 (95%CI: 1.96–2.55) to 3.58 (95%CI: 2.89–4.39) associated with 8-fold to 2-fold increase in the reporting rate. We demonstrated that changes in reporting rate substantially affect estimates of R0. Conclusion: The mean estimate of R0 for the 2019-nCoV ranges from 2.24 to 3.58, and is significantly larger than 1. Our findings indicate the potential of 2019-nCoV to cause outbreaks. © 2020 The Author(s)</rdfs:comment>
    <schema:keywords>2019 novel coronavirus; Article; basic reproduction number; China; clinical assessment; clinical evaluation; Coronavirinae; Coronavirus infection; epidemic; growth rate; human; Middle East respiratory syndrome; outcome assessment; severe acute respiratory syndrome; time series analysis; virus transmission; Betacoronavirus; Coronavirus infection; epidemic; Middle East respiratory syndrome coronavirus; physiology; SARS coronavirus; World Health Organization; severe acute respiratory syndrome coronavirus 2; Basic Reproduction Number; Betacoronavirus; China; Coronavirus Infections; Epidemics; Humans; Middle East Respiratory Syndrome Coronavirus; SARS Virus; World Health Organization</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases">
        <j.1:name>International Journal of Infectious Diseases</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:volume>92</myOnto:volume>
    <j.0:identifier>2-s2.0-85079180879</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.ijid.2020.01.050</j.0:identifier>
    <myOnto:citeyBy>19</myOnto:citeyBy>
    <dc:creator>Zhao S., Lin Q., Ran J., Musa S.S., Yang G., Wang W., Lou Y., Gao D., Yang L., He D., Wang M.H.</dc:creator>
    <j.0:title>Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081684606">
    <j.0:publisher>MA Healthcare Ltd</j.0:publisher>
    <schema:keywords>Coronavirinae; human; nonhuman; practice guideline; review</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Midwifery">
        <j.1:name>British Journal of Midwifery</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.12968/bjom.2020.28.3.146</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:volume>28</myOnto:volume>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081684606&amp;doi=10.12968%2fbjom.2020.28.3.146&amp;partnerID=40&amp;md5=3ff199d9623b8125c085efa8467353dd&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Duncan D., Lyall G.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Understanding the coronavirus</j.0:title>
    <rdfs:comment>It is important to note that the current outbreak of novel coronavirus is rapidly changing, therefore, guidelines are likely to be updated as more data regarding COVID-19 becomes available (PHE, 2020; HPS, 2020). In the absence of any known treatment apart from supportive measures, healthcare professionals should keep up to date with the recommended guidelines in conjunction with local IPC guidance. © 2020 MA Healthcare Ltd. All rights reserved.</rdfs:comment>
    <j.0:identifier>2-s2.0-85081684606</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081991867">
    <j.0:title>Covid-19: BMA calls for rapid testing and appropriate protective equipment for doctors</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Rimmer A.</dc:creator>
    <j.0:identifier>2-s2.0-85081991867</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1136/bmj.m1099</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081991867&amp;doi=10.1136%2fbmj.m1099&amp;partnerID=40&amp;md5=5697b91c1b6be172abd57d7005133aad&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081932342">
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1111/ajt.15832</j.0:identifier>
    <j.0:title>Coronavirus disease 2019: Implications of emerging infections for transplantation</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_Journal_of_Transplantation">
        <j.1:name>American Journal of Transplantation</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Michaels M.G., La Hoz R.M., Danziger-Isakov L., Blumberg E.A., Kumar D., Green M., Pruett T.L., Wolfe C.R.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081932342&amp;doi=10.1111%2fajt.15832&amp;partnerID=40&amp;md5=a1121b0a8084f9f5f2c2e678ca848508&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>The recent identification of an outbreak of 2019- novel Coronavirus is currently evolving, and the impact on transplantation is unknown. However, it is imperative that we anticipate the potential impact on the transplant community in order to avert severe consequences of this infection on both the transplant community and contacts of transplant patients. © 2020 The American Society of Transplantation and the American Society of Transplant Surgeons</rdfs:comment>
    <j.0:identifier>2-s2.0-85081932342</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081251137">
    <j.0:identifier>10.3390/v12030254</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Viruses">
        <j.1:name>Viruses</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081251137&amp;doi=10.3390%2fv12030254&amp;partnerID=40&amp;md5=19a102c3a5a503347f3f5d4fea415d4a&gt;</schema:url>
    <schema:keywords>2019 novel coronavirus vaccine; epitope; HLA A antigen; HLA B antigen; HLA C antigen; HLA DRB1 antigen; M protein; nucleocapsid protein; unclassified drug; virus spike protein; virus vaccine; coronavirus spike glycoprotein; COVID-19; nucleocapsid protein, Coronavirus; severe acute respiratory syndrome coronavirus 2; virus vaccine; 2019 novel coronavirus; allele; amino acid sequence; antigen binding; Article; B lymphocyte; binding assay; bioinformatics; cell assay; data processing; drug design; drug targeting; enzyme linked immunosorbent assay; enzyme linked immunospot assay; epitope mapping; genetic similarity; human; immune response; maximum likelihood method; Middle East respiratory syndrome coronavirus; nonhuman; nucleotide sequence; phylogenetic tree; SARS coronavirus; sequence alignment; sequence analysis; T lymphocyte; whole genome sequencing; Betacoronavirus; Coronavirus infection; genetics; immunology; phylogeny; protein tertiary structure; virus genome; virus pneumonia; Betacoronavirus; Coronavirus Infections; Epitope Mapping; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Genome, Viral; Humans; Nucleocapsid Proteins; Phylogeny; Pneumonia, Viral; Protein Structure, Tertiary; SARS Virus; Spike Glycoprotein, Coronavirus; Viral Vaccines</schema:keywords>
    <myOnto:issue>3</myOnto:issue>
    <j.0:title>Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies</j.0:title>
    <dc:creator>Ahmed S.F., Quadeer A.A., McKay M.R.</dc:creator>
    <rdfs:comment>The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an imminent need to better understand this new virus and to develop ways to control its spread. In this study, we sought to gain insights for vaccine design against SARS-CoV-2 by considering the high genetic similarity between SARS-CoV-2 and SARS-CoV, which caused the outbreak in 2003, and leveraging existing immunological studies of SARS-CoV. By screening the experimentallydetermined SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins. As no mutation has been observed in these identified epitopes among the 120 available SARS-CoV-2 sequences (as of 21 February 2020), immune targeting of these epitopes may potentially offer protection against this novel virus. For the T cell epitopes, we performed a population coverage analysis of the associated MHC alleles and proposed a set of epitopes that is estimated to provide broad coverage globally, as well as in China. Our findings provide a screened set of epitopes that can help guide experimental efforts towards the development of vaccines against SARS-CoV-2. © 2020 by the authors.</rdfs:comment>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <j.0:identifier>2-s2.0-85081251137</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:volume>12</myOnto:volume>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080894366">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080894366</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S0140-6736(20)30427-X</j.0:identifier>
    <myOnto:issue>10226</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:creator>Harman S.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080894366&amp;doi=10.1016%2fS0140-6736%2820%2930427-X&amp;partnerID=40&amp;md5=5250f1ec022be10e40205d2fa2970521&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>The danger of stories in global health</j.0:title>
    <myOnto:volume>395</myOnto:volume>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>acquired immune deficiency syndrome; Article; coronavirus disease 2019; Ebola hemorrhagic fever; epidemic; fear; global health; human; Human immunodeficiency virus infection; humanities; low income country; measles; middle income country; priority journal; severe acute respiratory syndrome; storytelling; communicable disease; female; interpersonal communication; male; sex factor; verbal communication; Communicable Diseases; Communication; Fear; Female; Global Health; Humans; Male; Narration; Sex Factors; Truth Disclosure</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081998325">
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:volume>136</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Ivanov D.</dc:creator>
    <j.0:identifier>10.1016/j.tre.2020.101922</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <schema:keywords>computer simulation; decision making; disease spread; economic impact; epidemic; future prospect; prediction; risk assessment; severe acute respiratory syndrome; supply chain management; Coronavirus; SARS coronavirus</schema:keywords>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081998325&amp;doi=10.1016%2fj.tre.2020.101922&amp;partnerID=40&amp;md5=8498f3b8ae38cfec272338bdd6e7ff89&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Predicting the impacts of epidemic outbreaks on global supply chains: A simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case</j.0:title>
    <rdfs:comment>Epidemic outbreaks are a special case of supply chain (SC) risks which is distinctively characterized by a long-term disruption existence, disruption propagations (i.e., the ripple effect), and high uncertainty. We present the results of a simulation study that opens some new research tensions on the impact of COVID-19 (SARS-CoV-2) on the global SCs. First, we articulate the specific features that frame epidemic outbreaks as a unique type of SC disruption risks. Second, we demonstrate how simulation-based methodology can be used to examine and predict the impacts of epidemic outbreaks on the SC performance using the example of coronavirus COVID-19 and anyLogistix simulation and optimization software. We offer an analysis for observing and predicting both short-term and long-term impacts of epidemic outbreaks on the SCs along with managerial insights. A set of sensitivity experiments for different scenarios allows illustrating the model's behavior and its value for decision-makers. The major observation from the simulation experiments is that the timing of the closing and opening of the facilities at different echelons might become a major factor that determines the epidemic outbreak impact on the SC performance rather than an upstream disruption duration or the speed of epidemic propagation. Other important factors are lead-time, speed of epidemic propagation, and the upstream and downstream disruption durations in the SC. The outcomes of this research can be used by decision-makers to predict the operative and long-term impacts of epidemic outbreaks on the SCs and develop pandemic SC plans. Our approach can also help to identify the successful and wrong elements of risk mitigation/preparedness and recovery policies in case of epidemic outbreaks. The paper is concluded by summarizing the most important insights and outlining future research agenda. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Transportation_Research_Part_E:_Logistics_and_Transportation_Review">
        <j.1:name>Transportation Research Part E: Logistics and Transportation Review</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081998325</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082199073">
    <myOnto:issue>10229</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Kandel N., Chungong S., Omaar A., Xing J.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082199073&amp;doi=10.1016%2fS0140-6736%2820%2930553-5&amp;partnerID=40&amp;md5=a8f48b7ba5153a7947079e1e052a12ca&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:title>Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries</j.0:title>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>2-s2.0-85082199073</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <rdfs:comment>Background: Public health measures to prevent, detect, and respond to events are essential to control public health risks, including infectious disease outbreaks, as highlighted in the International Health Regulations (IHR). In light of the outbreak of 2019 novel coronavirus disease (COVID-19), we aimed to review existing health security capacities against public health risks and events. Methods: We used 18 indicators from the IHR State Party Annual Reporting (SPAR) tool and associated data from national SPAR reports to develop five indices: (1) prevent, (2) detect, (3) respond, (4) enabling function, and (5) operational readiness. We used SPAR 2018 data for all of the indicators and categorised countries into five levels across the indices, in which level 1 indicated the lowest level of national capacity and level 5 the highest. We also analysed data at the regional level (using the six geographical WHO regions). Findings: Of 182 countries, 52 (28%) had prevent capacities at levels 1 or 2, and 60 (33%) had response capacities at levels 1 or 2. 81 (45%) countries had prevent capacities and 78 (43%) had response capacities at levels 4 or 5, indicating that these countries were operationally ready. 138 (76%) countries scored more highly in the detect index than in the other indices. 44 (24%) countries did not have an effective enabling function for public health risks and events, including infectious disease outbreaks (7 [4%] at level 1 and 37 [20%] at level 2). 102 (56%) countries had level 4 or level 5 enabling function capacities in place. 32 (18%) countries had low readiness (2 [1%] at level 1 and 30 [17%] at level 2), and 104 (57%) countries were operationally ready to prevent, detect, and control an outbreak of a novel infectious disease (66 [36%] at level 4 and 38 [21%] at level 5). Interpretation: Countries vary widely in terms of their capacity to prevent, detect, and respond to outbreaks. Half of all countries analysed have strong operational readiness capacities in place, which suggests that an effective response to potential health emergencies could be enabled, including to COVID-19. Findings from local risk assessments are needed to fully understand national readiness capacities in relation to COVID-19. Capacity building and collaboration between countries are needed to strengthen global readiness for outbreak control. Funding: None. © 2020 World Health Organization. Published by Elsevier Ltd. All rights reserved.</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1016/S0140-6736(20)30553-5</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081120801">
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>COVID-19 and the anti-lessons of history</j.0:title>
    <j.0:identifier>2-s2.0-85081120801</j.0:identifier>
    <j.0:identifier>10.1016/S0140-6736(20)30468-2</j.0:identifier>
    <myOnto:issue>10227</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081120801&amp;doi=10.1016%2fS0140-6736%2820%2930468-2&amp;partnerID=40&amp;md5=7f2a34991ccc0950b35f65907a0adb1b&gt;</schema:url>
    <dc:creator>Peckham R.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:volume>395</myOnto:volume>
    <schema:keywords>China; coronavirus disease 2019; Coronavirus infection; deja vu; disease re-emergence; epidemic; genetic strain; history of medicine; Hong Kong; human; life threat; nonhuman; Note; pandemic; pandemic influenza; prevention and control; priority journal; protection; SARS coronavirus; severe acute respiratory syndrome</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081715177">
    <j.0:identifier>10.1002/jmv.25752</j.0:identifier>
    <dc:creator>Cimolai N.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081715177&amp;doi=10.1002%2fjmv.25752&amp;partnerID=40&amp;md5=4c847c31b9f9803a056049554bb08c99&gt;</schema:url>
    <j.0:title>Potentially repurposing adamantanes for COVID-19</j.0:title>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081715177</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081645570">
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081645570&amp;doi=10.1016%2fS0140-6736%2820%2930520-1&amp;partnerID=40&amp;md5=8f75fd5a6cac6160068ea7a6972ebba4&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:identifier>10.1016/S0140-6736(20)30520-1</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:title>Mass masking in the COVID-19 epidemic: people need guidance</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081645570</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>10228</myOnto:issue>
    <dc:creator>Leung C.C., Lam T.H., Cheng K.K.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080941921">
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:volume>9</myOnto:volume>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Zhan S., Yang Y.Y., Fu C.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080941921&amp;doi=10.1080%2f22221751.2020.1732232&amp;partnerID=40&amp;md5=8959e1da18a06fe1ec2a8f29909e0ac6&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080941921</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <j.0:identifier>10.1080/22221751.2020.1732232</j.0:identifier>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <j.0:title>Public’s early response to the novel coronavirus–infected pneumonia</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <schema:keywords>antivirus agent; virus vaccine; COVID-19; adult; antiviral therapy; attitude to health; attitude to illness; China; Coronavirus infection; female; hand washing; health education; human; infection prevention; Letter; male; middle aged; normal human; novel coronavirus infected pneumonia; priority journal; quarantine; virus pneumonia; young adult; anxiety; Coronavirus infection; epidemic; health behavior; public health; virus pneumonia; Anxiety; China; Coronavirus Infections; Disease Outbreaks; Health Behavior; Humans; Pneumonia, Viral; Public Health</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081701936">
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Complementary_Therapies_in_Clinical_Practice">
        <j.1:name>Complementary Therapies in Clinical Practice</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081701936&amp;doi=10.1016%2fj.ctcp.2020.101132&amp;partnerID=40&amp;md5=762312b9e87881622d441aff316e9153&gt;</schema:url>
    <j.0:publisher>Churchill Livingstone</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/j.ctcp.2020.101132</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Background: Patients with Coronavirus Disease 2019(COVID-19) will experience high levels of anxiety and low sleep quality due to isolation treatment. Some sleep-improving drugs may inhibit the respiratory system and worsen the condition. Prolonged bedside instruction may increase the risk of medical infections. Objective: To investigate the effect of progressive muscle relaxation on anxiety and sleep quality of COVID-19. Methods: In this randomized controlled clinical trial, a total of 51 patients who entered the isolation ward were included in the study and randomly divided into experimental and control groups. The experimental group used progressive muscle relaxation (PMR) technology for 30 min per day for 5 consecutive days. During this period, the control group received only routine care and treatment. Before and after the intervention, the Spielberger State-Trait Anxiety Scale (STAI) and Sleep State Self-Rating Scale (SRSS) were used to measure and record patient anxiety and sleep quality. Finally, data analysis was performed using SPSS 25.0 software. Results: The average anxiety score (STAI) before intervention was not statistically significant (P = 0.730), and the average anxiety score after intervention was statistically significant (P &lt; 0.001). The average sleep quality score (SRSS) of the two groups before intervention was not statistically significant (P = 0.838), and it was statistically significant after intervention (P &lt; 0.001). Conclusion: Progressive muscle relaxation as an auxiliary method can reduce anxiety and improve sleep quality in patients with COVID-19. © 2020 The Authors</rdfs:comment>
    <dc:creator>Liu K., Chen Y., Wu D., Lin R., Wang Z., Pan L.</dc:creator>
    <j.0:title>Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19</j.0:title>
    <myOnto:volume>39</myOnto:volume>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081701936</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081702276">
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Critical_Care">
        <j.1:name>Journal of Critical Care</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Cortegiani A., Ingoglia G., Ippolito M., Giarratano A., Einav S.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081702276&amp;doi=10.1016%2fj.jcrc.2020.03.005&amp;partnerID=40&amp;md5=afc5b617ea6e0e71aa48ec2cc302e276&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.jcrc.2020.03.005</j.0:identifier>
    <rdfs:comment>Purpose: COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is no known effective pharmaceutical treatment, although it is much needed for patient contracting the severe form of the disease. The aim of this systematic review was to summarize the evidence regarding chloroquine for the treatment of COVID-19. Methods: PubMed, EMBASE, and three trial Registries were searched for studies on the use of chloroquine in patients with COVID-19. Results: We included six articles (one narrative letter, one in-vitro study, one editorial, expert consensus paper, two national guideline documents) and 23 ongoing clinical trials in China. Chloroquine seems to be effective in limiting the replication of SARS-CoV-2 (virus causing COVID-19) in vitro. Conclusions: There is rationale, pre-clinical evidence of effectiveness and evidence of safety from long-time clinical use for other indications to justify clinical research on chloroquine in patients with COVID-19. However, clinical use should either adhere to the Monitored Emergency Use of Unregistered Interventions (MEURI) framework or be ethically approved as a trial as stated by the World Health Organization. Safety data and data from high-quality clinical trials are urgently needed. © 2020 Elsevier Inc.</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:title>A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19</j.0:title>
    <j.0:identifier>2-s2.0-85081702276</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>W.B. Saunders</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081042361">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020</j.0:title>
    <myOnto:issue>8</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>25</myOnto:volume>
    <dc:creator>Okada P., Buathong R., Phuygun S., Thanadachakul T., Parnmen S., Wongboot W., Waicharoen S., Wacharapluesadee S., Uttayamakul S., Vachiraphan A., Chittaganpitch M., Mekha N., Janejai N., Iamsirithaworn S., Lee R.T., Maurer-Stroh S.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081042361</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081042361&amp;doi=10.2807%2f1560-7917.ES.2020.25.8.2000097&amp;partnerID=40&amp;md5=d1a9af3ecc45ac021a3189d3f7ea5f63&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.8.2000097</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; aged; anamnesis; Betacoronavirus; case report; China; chromosomal mapping; Coronavirus infection; epidemic; female; genetics; human; isolation and purification; middle aged; phylogeny; reverse transcription polymerase chain reaction; Thailand; travel; virus genome; virus pneumonia; Aged; Betacoronavirus; China; Chromosome Mapping; Coronavirus Infections; Disease Outbreaks; Female; Genome, Viral; Humans; Medical History Taking; Middle Aged; Phylogeny; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Thailand; Travel</schema:keywords>
    <rdfs:comment>We report two cases of coronavirus disease 2019 (COVID-19) in travellers from Wuhan, China to Thailand. Both were independent introductions on separate flights, discovered with thermoscanners and confirmed with RT-PCR and genome sequencing. Both cases do not seem directly linked to the Huanan Seafood Market in Hubei but the viral genomes are identical to four other sequences from Wuhan, suggesting early spread within the city already in the first week of January.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082073585">
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <rdfs:comment>The city of Wuhan, Hubei province, China, was the origin of a severe pneumonia outbreak in December 2019, attributed to a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), causing a total of 2761 deaths and 81109 cases (25 February 2020). SARS-CoV-2 belongs to genus Betacoronavirus, subgenus Sarbecovirus. The polyprotein 1ab (pp1ab) remains unstudied thoroughly since it is similar to other sarbecoviruses. In this short communication, we performed phylogenetic-structural sequence analysis of pp1ab protein of SARS-CoV-2. The analysis showed that the viral pp1ab has not changed in most isolates throughout the outbreak time, but interestingly a deletion of 8 aa in the virulence factor nonstructural protein 1 was found in a virus isolated from a Japanese patient that did not display critical symptoms. While comparing pp1ab protein with other betacoronaviruses, we found a 42 amino acid signature that is only present in SARS-CoV-2 (AS-SCoV2). Members from clade 2 of sarbecoviruses have traces of this signature. The AS-SCoV2 located in the acidic-domain of papain-like protein of SARS-CoV-2 and bat-SL-CoV-RatG13 guided us to suggest that the novel 2019 coronavirus probably emerged by genetic drift from bat-SL-CoV-RaTG13. The implication of this amino acid signature in papain-like protein structure arrangement and function is something worth to be explored. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25758</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:title>An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2)</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082073585</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Cárdenas-Conejo Y., Liñan-Rico A., García-Rodríguez D.A., Centeno-Leija S., Serrano-Posada H.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082073585&amp;doi=10.1002%2fjmv.25758&amp;partnerID=40&amp;md5=4eaedc12c455da7f4eeb039e768c3416&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081408849">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081408849&amp;doi=10.1002%2fjmv.25732&amp;partnerID=40&amp;md5=ef0ea1f7187359a1ab4a8fc7f4db2250&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081408849</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Zhu F., Cao Y., Xu S., Zhou M.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>10.1002/jmv.25732</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081889146">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081889146&amp;doi=10.1186%2fs12916-020-01551-8&amp;partnerID=40&amp;md5=a18788f3e85da3ce747adaf4a0307f6f&gt;</schema:url>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>18</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:title>What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures?</j.0:title>
    <schema:keywords>China; clinical effectiveness; contact examination; coronavirus disease 2019; Coronavirus infection; disease control; disease transmission; epidemic; isolation; Note; pandemic; population density; prediction; process optimization; simulation; World Health Organization; Betacoronavirus; epidemic; feasibility study; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Contact Tracing; Disease Outbreaks; Feasibility Studies</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <j.0:identifier>2-s2.0-85081889146</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/BMC_Medicine">
        <j.1:name>BMC Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>He Z.</dc:creator>
    <j.0:identifier>10.1186/s12916-020-01551-8</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:issue>1</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080905437">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080905437&amp;doi=10.1126%2fscience.367.6481.963&amp;partnerID=40&amp;md5=6e299c840fac61415b31de02ad07559b&gt;</schema:url>
    <schema:keywords>China; clinical research; Coronavirinae; coronavirus disease 2019; Coronavirus infection; Ebola hemorrhagic fever; France; Germany; human; Human immunodeficiency virus; interview; nonhuman; Note; peer review; primate model; priority journal; publication; scientific literature; scientist; Severe acute respiratory syndrome coronavirus 2; social media; United States; Zika fever</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Preprints bring 'firehose' of outbreak data: COVID-19 has upended the ways researchers share findings and collaborate</j.0:title>
    <myOnto:issue>6481</myOnto:issue>
    <myOnto:volume>367</myOnto:volume>
    <j.0:identifier>10.1126/science.367.6481.963</j.0:identifier>
    <dc:creator>Kupferschmidt K.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080905437</j.0:identifier>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081663607">
    <schema:keywords>lopinavir plus ritonavir; remdesivir; child health care; coronavirus disease 2019; disease severity; drug safety; epidemic; hospital admission; human; intensive care unit; Letter; newborn; patient isolation; patient monitoring; practice guideline; public health problem; respiratory failure; risk benefit analysis; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; vertical transmission; virus transmission</schema:keywords>
    <j.0:identifier>2-s2.0-85081663607</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:volume>4</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Managing neonates with respiratory failure due to SARS-CoV-2</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081663607&amp;doi=10.1016%2fS2352-4642%2820%2930073-0&amp;partnerID=40&amp;md5=1cc98494aa4976d0d5a83babea02f042&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Child_and_Adolescent_Health"/>
    <myOnto:issue>4</myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:creator>De Luca D.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S2352-4642(20)30073-0</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081347109">
    <dc:language>English</dc:language>
    <dc:creator>Li Y.-C., Bai W.-Z., Hashikawa T.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081347109&amp;doi=10.1002%2fjmv.25728&amp;partnerID=40&amp;md5=8f23b89e9304db7f79ece60391a9c23c&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <rdfs:comment>Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. In light of the high similarity between SARS-CoV and SARS-CoV2, it is quite likely that the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this will have important guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients</j.0:title>
    <j.0:identifier>2-s2.0-85081347109</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1002/jmv.25728</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081731028">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081731028&amp;doi=10.1007%2fs12630-020-01630-7&amp;partnerID=40&amp;md5=a6eee38c7d5dcea976684a90a8058cff&gt;</schema:url>
    <j.0:title>Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients [Sécurité et efficacité de différents modes d’anesthésie pour des parturientes infectées par la COVID-19 accouchant par césarienne : une série de 17 cas]</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1007/s12630-020-01630-7</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Chen R., Zhang Y., Huang L., Cheng B.-H., Xia Z.-Y., Meng Q.-T.</dc:creator>
    <j.0:identifier>2-s2.0-85081731028</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Purpose: To assess the management and safety of epidural or general anesthesia for Cesarean delivery in parturients with coronavirus disease (COVID-19) and their newborns, and to evaluate the standardized procedures for protecting medical staff. Methods: We retrospectively reviewed the cases of parturients diagnosed with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection disease (COVID-19). Their epidemiologic history, chest computed tomography scans, laboratory measurements, and SARS-CoV-2 nucleic acid positivity were evaluated. We also recorded the patients’ demographic and clinical characteristics, anesthesia and surgery-related data, maternal and neonatal complications, as well as the health status of the involved medical staff. Results: The clinical characteristics of 17 pregnant women infected with SARS-CoV-2 were similar to those previously reported in non-pregnant adult patients. All of the 17 patients underwent Cesarean delivery with anesthesia performed according to standardized anesthesia/surgery procedures. Fourteen of the patients underwent continuous epidural anesthesia with 12 experiencing significant intraoperative hypotension. Three patients received general anesthesia with tracheal intubation because emergency surgery was needed. Three of the parturients are still recovering from their Cesarean delivery and are receiving in-hospital treatment for COVID-19. Three neonates were born prematurely. There were no deaths or serious neonatal asphyxia events. All neonatal SARS-CoV-2 nucleic acid tests were negative. No medical staff were infected throughout the patient care period. Conclusions: Both epidural and general anesthesia were safely used for Cesarean delivery in the parturients with COVID-19. Nevertheless, the incidence of hypotension during epidural anesthesia appeared excessive. Proper patient transfer, medical staff access procedures, and effective biosafety precautions are important to protect medical staff from COVID-19. © 2020, Canadian Anesthesiologists' Society.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Springer</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Canadian_Journal_of_Anesthesia">
        <j.1:name>Canadian Journal of Anesthesia</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081607280">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Gut">
        <j.1:name>Gut</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1136/gutjnl-2020-320891</j.0:identifier>
    <j.0:title>SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081607280&amp;doi=10.1136%2fgutjnl-2020-320891&amp;partnerID=40&amp;md5=985cb69bd05af5cec1282f022ca4cf03&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081607280</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:creator>Song Y., Liu P., Shi X.L., Chu Y.L., Zhang J., Xia J., Gao X.Z., Qu T., Wang M.Y.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082019557">
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082019557</j.0:identifier>
    <myOnto:issue>4</myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082019557&amp;doi=10.1016%2fS1473-3099%2820%2930114-6&amp;partnerID=40&amp;md5=c5b18e8bdc24fffd2d79ed94634b0795&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:title>Asymptomatic cases in a family cluster with SARS-CoV-2 infection</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <dc:creator>Pan X., Chen D., Xia Y., Wu X., Li T., Ou X., Zhou L., Liu J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>20</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S1473-3099(20)30114-6</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082146561">
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1136/bmj.m1156</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Covid-19: medical students to be employed by NHS as part of epidemic response</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082146561&amp;doi=10.1136%2fbmj.m1156&amp;partnerID=40&amp;md5=46aee1961a13b2eb060c8063863fe82f&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85082146561</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081971948">
    <j.0:identifier>2-s2.0-85081971948</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia</j.0:title>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; China; civil defense; Coronavirus infection; cross infection; epidemic; global health; human; Middle East respiratory syndrome coronavirus; Saudi Arabia; severe acute respiratory syndrome; travel; virus pneumonia; China; Civil Defense; Coronavirus Infections; Cross Infection; Disease Outbreaks; Global Health; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; Saudi Arabia; Severe Acute Respiratory Syndrome; Travel</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>10</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081971948&amp;doi=10.2991%2fjegh.k.200218.003&amp;partnerID=40&amp;md5=21af4727b1a61c104c6c5f05113e1fc5&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_epidemiology_and_global_health">
        <j.1:name>Journal of epidemiology and global health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Barry M., Al Amri M., Memish Z.A.</dc:creator>
    <j.0:identifier>10.2991/jegh.k.200218.003</j.0:identifier>
    <rdfs:comment>Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has plagued the Middle East since it was first reported in 2012. Recently, at the end of December 2019, a cluster of pneumonia cases were reported from Wuhan city, Hubei Province, China, linked to a wet seafood market with a new coronavirus identified as the etiologic agent currently named SARS-CoV-2. Most cases are in Mainland China with international spread to 25 countries. The novelty of the virus, the rapid national and international spread, and the lack of therapeutic and preventative strategies have led the WHO International Health Regulation emergency committee to declare the disease as Public Health Emergency of International Concern (PHEIC) on January 30, 2020. As it relates to countries with the ongoing MERS-CoV community cases and hospital acquired infections, there will be a huge challenge for HCWs to deal with both coronaviruses, especially with the lack of standardized and approved point of care testing. This challenge will now be faced by the whole global health community dealing with COVID-19 since both coronaviruses have similar presentation. Those patients should now be tested for both MERS-CoV and SARS-CoV-2 simultaneously, and with the continuing wide international spread of SARS-CoV-2, the travel history to China in the last 14 days will be of less significance. © 2020 The Authors. Published by Atlantis Press International B.V.</rdfs:comment>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081646597">
    <j.0:title>Online mental health services in China during the COVID-19 outbreak</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081646597&amp;doi=10.1016%2fS2215-0366%2820%2930077-8&amp;partnerID=40&amp;md5=41c10dba2e83f7401ab632b0d416c08e&gt;</schema:url>
    <myOnto:volume>7</myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Liu S., Yang L., Zhang C., Xiang Y.-T., Liu Z., Hu S., Zhang B.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>4</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <schema:keywords>anxiety disorder; artificial intelligence; China; cognitive behavioral therapy; coronavirus disease 2019; Coronavirus infection; counseling; crisis intervention; depression; epidemic; hotline; human; information service; insomnia; Letter; medical staff; mental disease; mental health care personnel; mental health service; mental stress; priority journal</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry">
        <j.1:name>The Lancet Psychiatry</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081646597</j.0:identifier>
    <j.0:identifier>10.1016/S2215-0366(20)30077-8</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081531589">
    <rdfs:comment>The 2019 Novel Corona virus infection (COVID 19) is an ongoing public health emergency of international significance. There are significant knowledge gaps in the epidemiology, transmission dynamics, investigation tools and management. In this article, we review the available evidence about this disease. Every decade has witnessed the evolution of a new coronavirus epidemic since the last three decades. The varying transmission patterns, namely, nosocomial transmission and spread through mildly symptomatic cases is an area of concern. There is a spectrum of clinical features from mild to severe life threatening disease with major complications like severe pneumonia, ARDS, acute cardiac injury and septic shock. Presence of bilateral ground glass opacity and consolidation on imaging in appropriate clinical background should raise a suspicion about COVID 19. Poor prognostic factors include Multilobular infiltration on chest imaging, Lymphopenia, Bacterial co-infection, Smoking history, Chronic medical conditions like Hypertension and age &gt;60 years (MuLBSTA score). Diagnosis is confirmed with PCR based testing of appropriate respiratory samples. Management is primarily supportive, with newer antivirals (lopinavir ritonavir and Remdesivir) under investigation. Role of steroids is still inconclusive. Standard infection control and prevention techniques should be followed. Vigilant screening of suspected cases and their contacts is important. Isolation of symptomatic cases and home quarantine of asymptomatic contacts is recommended. To conclude, controlling this highly transmissible disease requires international co-ordination. © Journal of the Association of Physicians of India 2011.</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirinae; Coronavirus infection; epidemic; human; Betacoronavirus; Coronavirus; Coronavirus Infections; Disease Outbreaks; Humans</schema:keywords>
    <myOnto:volume>68</myOnto:volume>
    <j.0:title>The 2019 Novel Coronavirus Outbreak - A Global Threat</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue>3</myOnto:issue>
    <j.0:identifier>2-s2.0-85081531589</j.0:identifier>
    <dc:creator>Khot W.Y., Nadkar M.Y.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:identifier></j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Journal_of_the_Association_of_Physicians_of_India">
        <j.1:name>The Journal of the Association of Physicians of India</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081531589&amp;partnerID=40&amp;md5=1edf3d361e61efdb8cd0e89ada8cd80e&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081906970">
    <j.0:title>Does the COVID-19 outbreak mark the onset of a sustainable consumption transition?</j.0:title>
    <j.0:identifier>10.1080/15487733.2020.1740472</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:creator>Cohen M.J.</dc:creator>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>16</myOnto:volume>
    <j.0:publisher>Taylor and Francis Inc.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Sustainability:_Science,_Practice,_and_Policy">
        <j.1:name>Sustainability: Science, Practice, and Policy</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081906970&amp;doi=10.1080%2f15487733.2020.1740472&amp;partnerID=40&amp;md5=9fa6c1f2f9e8766f49de0de12c3945c2&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081906970</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082187927">
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Gastroenterology_and_Hepatology"/>
    <j.0:title>Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082187927&amp;doi=10.1016%2fS2468-1253%2820%2930082-0&amp;partnerID=40&amp;md5=12c84e12f5c202f6c796490f8124060f&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082187927</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:creator>Ianiro G., Mullish B.H., Kelly C.R., Sokol H., Kassam Z., Ng S., Fischer M., Allegretti J.R., Masucci L., Zhang F., Keller J., Sanguinetti M., Costello S.P., Tilg H., Gasbarrini A., Cammarota G.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/S2468-1253(20)30082-0</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081896575">
    <dc:date>2020</dc:date>
    <j.0:title>Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore [Se préparer pour la pandémie de COVID-19: revue des moyens déployés dans un bloc opératoire d’un grand hôpital tertiaire au Singapour]</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Canadian_Journal_of_Anesthesia"/>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1007/s12630-020-01620-9</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081896575</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Springer</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081896575&amp;doi=10.1007%2fs12630-020-01620-9&amp;partnerID=40&amp;md5=e23bee164e4084ddc07f0cfaca46baf4&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>The coronavirus disease 2019 (COVID-19) outbreak has been designated a public health emergency of international concern. To prepare for a pandemic, hospitals need a strategy to manage their space, staff, and supplies so that optimum care is provided to patients. In addition, infection prevention measures need to be implemented to reduce in-hospital transmission. In the operating room, these preparations involve multiple stakeholders and can present a significant challenge. Here, we describe the outbreak response measures of the anesthetic department staffing the largest (1,700-bed) academic tertiary level acute care hospital in Singapore (Singapore General Hospital) and a smaller regional hospital (Sengkang General Hospital). These include engineering controls such as identification and preparation of an isolation operating room, administrative measures such as modification of workflow and processes, introduction of personal protective equipment for staff, and formulation of clinical guidelines for anesthetic management. Simulation was valuable in evaluating the feasibility of new operating room set-ups or workflow. We also discuss how the hierarchy of controls can be used as a framework to plan the necessary measures during each phase of a pandemic, and review the evidence for the measures taken. These containment measures are necessary to optimize the quality of care provided to COVID-19 patients and to reduce the risk of viral transmission to other patients or healthcare workers. © 2020, Canadian Anesthesiologists' Society.</rdfs:comment>
    <dc:creator>Wong J., Goh Q.Y., Tan Z., Lie S.A., Tay Y.C., Ng S.Y., Soh C.R.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082143057">
    <schema:keywords>COVID-19; algorithm; artificial intelligence; Coronavirus infection; decision making; epidemic; forecasting; health care delivery; human; machine learning; virus pneumonia; Algorithms; Artificial Intelligence; Coronavirus Infections; Decision Making; Delivery of Health Care; Disease Outbreaks; Forecasting; Humans; Machine Learning; Pneumonia, Viral</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_medical_systems">
        <j.1:name>Journal of medical systems</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:creator>Santosh K.C.</dc:creator>
    <rdfs:comment>The novel coronavirus (COVID-19) outbreak, which was identified in late 2019, requires special attention because of its future epidemics and possible global threats. Beside clinical procedures and treatments, since Artificial Intelligence (AI) promises a new paradigm for healthcare, several different AI tools that are built upon Machine Learning (ML) algorithms are employed for analyzing data and decision-making processes. This means that AI-driven tools help identify COVID-19 outbreaks as well as forecast their nature of spread across the globe. However, unlike other healthcare issues, for COVID-19, to detect COVID-19, AI-driven tools are expected to have active learning-based cross-population train/test models that employs multitudinal and multimodal data, which is the primary purpose of the paper.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082143057&amp;doi=10.1007%2fs10916-020-01562-1&amp;partnerID=40&amp;md5=587b1dde04495c771e6f18361e2759ac&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:issue>5</myOnto:issue>
    <j.0:identifier>2-s2.0-85082143057</j.0:identifier>
    <myOnto:volume>44</myOnto:volume>
    <j.0:identifier>10.1007/s10916-020-01562-1</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:title>AI-Driven Tools for Coronavirus Outbreak: Need of Active Learning and Cross-Population Train/Test Models on Multitudinal/Multimodal Data</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082021284">
    <myOnto:volume>368</myOnto:volume>
    <j.0:title>Covid-19: Trump sought to buy vaccine developer exclusively for US, say German officials</j.0:title>
    <j.0:identifier>2-s2.0-85082021284</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1136/bmj.m1100</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <dc:creator>Dyer O.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082021284&amp;doi=10.1136%2fbmj.m1100&amp;partnerID=40&amp;md5=2416d0f49914bd22748a47038b2cc5e1&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081528855">
    <dc:language>English</dc:language>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>368</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081528855</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081528855&amp;doi=10.1136%2fbmj.m918&amp;partnerID=40&amp;md5=ec9647157ce6df3c9eabcf7d5e845d4f&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Covid-19: 90% of cases will hit NHS over nine week period, chief medical officer warns</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m918</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081898318">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>In December 2019, a new virus (initially called 'Novel Coronavirus 2019-nCoV' and later renamed to SARS-CoV-2) causing severe acute respiratory syndrome (coronavirus disease COVID-19) emerged in Wuhan, Hubei Province, China, and rapidly spread to other parts of China and other countries around the world, despite China's massive efforts to contain the disease within Hubei. As with the original SARS-CoV epidemic of 2002/2003 and with seasonal influenza, geographic information systems and methods, including, among other application possibilities, online real-or near-real-time mapping of disease cases and of social media reactions to disease spread, predictive risk mapping using population travel data, and tracing and mapping super-spreader trajectories and contacts across space and time, are proving indispensable for timely and effective epidemic monitoring and response. This paper offers pointers to, and describes, a range of practical online/mobile GIS and mapping dashboards and applications for tracking the 2019/2020 coronavirus epidemic and associated events as they unfold around the world. Some of these dashboards and applications are receiving data updates in near-real-time (at the time of writing), and one of them is meant for individual users (in China) to check if the app user has had any close contact with a person confirmed or suspected to have been infected with SARS-CoV-2 in the recent past. We also discuss additional ways GIS can support the fight against infectious disease outbreaks and epidemics.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081898318&amp;doi=10.1186%2fs12942-020-00202-8&amp;partnerID=40&amp;md5=0160b6748f1b7cd067fb6aafb362d8fd&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081898318</j.0:identifier>
    <j.0:identifier>10.1186/s12942-020-00202-8</j.0:identifier>
    <j.0:title>Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_journal_of_health_geographics">
        <j.1:name>International journal of health geographics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Kamel Boulos M.N., Geraghty E.M.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>19</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; geographic information system; human; pandemic; public health; virus pneumonia; Betacoronavirus; Coronavirus Infections; Geographic Information Systems; Humans; Pandemics; Pneumonia, Viral; Public Health</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078262578">
    <j.0:identifier>2-s2.0-85078262578</j.0:identifier>
    <rdfs:comment>Background: A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods: All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings: By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNF?. Interpretation: The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding: Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue>10223</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>243</myOnto:citeyBy>
    <j.0:title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078262578&amp;doi=10.1016%2fS0140-6736%2820%2930183-5&amp;partnerID=40&amp;md5=ec31b8386712376b44af67cd05d36394&gt;</schema:url>
    <dc:language>English</dc:language>
    <schema:keywords>antibiotic agent; gamma interferon inducible protein 10; granulocyte colony stimulating factor; interleukin 10; interleukin 2; interleukin 7; macrophage inflammatory protein 1alpha; methylprednisolone; monocyte chemotactic protein 1; oseltamivir; oxygen; tumor necrosis factor; COVID-19; 2019 novel coronavirus; adult; adult respiratory distress syndrome; Article; cardiovascular disease; China; clinical article; clinical feature; clinical outcome; cohort analysis; community acquired pneumonia; computer assisted tomography; controlled study; Coronavirinae; coronavirus disease 2019; Coronavirus infection; coughing; diabetes mellitus; diarrhea; disease severity; dyspnea; electronic medical record; environmental exposure; family study; fatigue; female; fever; gamma interferon inducible protein 10 blood level; granulocyte colony stimulating factor blood level; headache; heart injury; hemoptysis; high throughput sequencing; hospital admission; human; human cell; hypertension; hypoxemia; intensive care unit; interleukin 10 blood level; interleukin 2 blood level; interleukin 7 blood level; laboratory test; lymphocytopenia; macrophage inflammatory protein 1alpha blood level; male; monocyte chemotactic protein 1 blood level; mortality rate; myalgia; nonhuman; pneumonia; priority journal; prospective study; protein blood level; radiodiagnosis; real time reverse transcription polymerase chain reaction; RNA virus infection; RNAaemia; sea food; secondary infection; sputum; standardization; symptom; thorax radiography; treatment response; tumor necrosis factor blood level; virus pneumonia; World Health Organization; adult respiratory distress syndrome; age distribution; aged; comorbidity; complication; Coronavirus infection; coughing; fever; hospitalization; middle aged; myalgia; prognosis; time factor; virology; virus pneumonia; x-ray computed tomography; young adult; Adult; Age Distribution; Aged; China; Comorbidity; Coronavirus Infections; Cough; Female; Fever; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Myalgia; Pneumonia, Viral; Prognosis; Radiography, Thoracic; Respiratory Distress Syndrome, Adult; Time Factors; Tomography, X-Ray Computed; Young Adult</schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30183-5</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:creator>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081542040">
    <dc:creator>Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081542040</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Review</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_General_Internal_Medicine">
        <j.1:name>Journal of General Internal Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>In late December 2019, a cluster of cases with 2019 Novel Coronavirus pneumonia (SARS-CoV-2) in Wuhan, China, aroused worldwide concern. Previous studies have reported epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19). The purpose of this brief review is to summarize those published studies as of late February 2020 on the clinical features, symptoms, complications, and treatments of COVID-19 and help provide guidance for frontline medical staff in the clinical management of this outbreak. © 2020, Society of General Internal Medicine.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1007/s11606-020-05762-w</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081542040&amp;doi=10.1007%2fs11606-020-05762-w&amp;partnerID=40&amp;md5=f75ab3c33c49fef3039a61eda001735f&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:title>Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092285">
    <rdfs:comment>The 2019-novel coronavirus (nCoV) is a major source of disaster in the 21th century. However, the lack of specific drugs to prevent/treat an attack is a major need at this current point of time. In this regard, we conducted a systematic review to identify major druggable targets in coronavirus (CoV). We searched PubMed and RCSB database with keywords HCoV, NCoV, corona virus, SERS-CoV, MERS-CoV, 2019-nCoV, crystal structure, X-ray crystallography structure, NMR structure, target, and drug target till Feb 3, 2020. The search identified seven major targets (spike protein, envelop protein, membrane protein, protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs. © 2020 Indian Journal of Pharmacology Published by Wolters Kluwer. Medknow.</rdfs:comment>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Wolters Kluwer Medknow Publications</j.0:publisher>
    <myOnto:volume>52</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082092285</j.0:identifier>
    <j.0:title>Drug targets for corona virus: A systematic review</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Review</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Indian_Journal_of_Pharmacology">
        <j.1:name>Indian Journal of Pharmacology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Prajapat M., Sarma P., Shekhar N., Avti P., Sinha S., Kaur H., Kumar S., Bhattacharyya A., Kumar H., Bansal S., Medhi B.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092285&amp;doi=10.4103%2fijp.IJP_115_20&amp;partnerID=40&amp;md5=81a6974f6fe124d5ff9a2955c8e86aef&gt;</schema:url>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>10.4103/ijp.IJP_115_20</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079715573">
    <dc:date>2020</dc:date>
    <dc:creator>Pan Y., Guan H., Zhou S., Wang Y., Li Q., Zhu T., Hu Q., Xia L.</dc:creator>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:identifier>10.1007/s00330-020-06731-x</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079715573&amp;doi=10.1007%2fs00330-020-06731-x&amp;partnerID=40&amp;md5=a3816ac551e0a189444f2027fc42351f&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_Radiology">
        <j.1:name>European Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China</j.0:title>
    <j.0:identifier>2-s2.0-85079715573</j.0:identifier>
    <myOnto:citeyBy>10</myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>Objectives: The purpose of this study was to observe the imaging characteristics of the novel coronavirus pneumonia. Methods: Sixty-three confirmed patients were enrolled from December 30, 2019 to January 31, 2020. High-resolution CT (HRCT) of the chest was performed. The number of affected lobes, ground glass nodules (GGO), patchy/punctate ground glass opacities, patchy consolidation, fibrous stripes and irregular solid nodules in each patient's chest CT image were recorded. Additionally, we performed imaging follow-up of these patients. Results: CT images of 63 confirmed patients were collected. M/F ratio: 33/30. The mean age was 44.9 ± 15.2 years. The mean number of affected lobes was 3.3 ± 1.8. Nineteen (30.2%) patients had one affected lobe, five (7.9%) patients had two affected lobes, four (6.3%) patients had three affected lobes, seven (11.1%) patients had four affected lobes while 28 (44.4%) patients had 5 affected lobes. Fifty-four (85.7%) patients had patchy/punctate ground glass opacities, 14 (22.2%) patients had GGO, 12 (19.0%) patients had patchy consolidation, 11 (17.5%) patients had fibrous stripes and 8 (12.7%) patients had irregular solid nodules. Fifty-four (85.7%) patients progressed, including single GGO increased, enlarged and consolidated; fibrous stripe enlarged, while solid nodules increased and enlarged. Conclusions: Imaging changes in novel viral pneumonia are rapid. The manifestations of the novel coronavirus pneumonia are diverse. Imaging changes of typical viral pneumonia and some specific imaging features were observed. Therefore, we need to strengthen the recognition of image changes to help clinicians to diagnose quickly and accurately. Key Points: • High-resolution CT (HRCT) of the chest is critical for early detection, evaluation of disease severity and follow-up of patients with the novel coronavirus pneumonia. • The manifestations of the novel coronavirus pneumonia are diverse and change rapidly. • Radiologists should be aware of the various features of the disease and temporal changes. © 2020, European Society of Radiology.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079109884">
    <dc:date>2020</dc:date>
    <myOnto:issue>6478</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Will novel virus go pandemic or be contained?</j.0:title>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <j.0:identifier>2-s2.0-85079109884</j.0:identifier>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <dc:creator>Kupferschmidt K., Cohen J.</dc:creator>
    <j.0:identifier>10.1126/science.367.6478.610</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:keywords>2019 novel coronavirus; China; climate; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease severity; epidemic; forecasting; human; infection control; Japanese (people); mass screening; mortality rate; Note; pandemic; priority journal; quarantine; risk reduction; virus detection; virus isolation; virus transmission</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079109884&amp;doi=10.1126%2fscience.367.6478.610&amp;partnerID=40&amp;md5=cf228d315d13eb33633148abd48f2f1e&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082190084">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cell">
        <j.1:name>Cell</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.cell.2020.02.052</j.0:identifier>
    <j.0:identifier>2-s2.0-85082190084</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082190084&amp;doi=10.1016%2fj.cell.2020.02.052&amp;partnerID=40&amp;md5=a549c04ed86e9a113811e0f95610e9f4&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <dc:creator>Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>Cell Press</j.0:publisher>
    <j.0:title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</j.0:title>
    <rdfs:comment>The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option. Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention. The emerging SARS-coronavirus 2 (SARS-CoV-2) threatens public health. Hoffmann and coworkers show that SARS-CoV-2 infection depends on the host cell factors ACE2 and TMPRSS2 and can be blocked by a clinically proven protease inhibitor. These findings might help to establish options for prevention and treatment. © 2020 Elsevier Inc.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080959363">
    <myOnto:volume>69</myOnto:volume>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; airport; Betacoronavirus; contact examination; Coronavirus infection; epidemic; human; isolation and purification; laboratory; mass screening; practice guideline; public health service; travel related disease; United States; virology; Airports; Betacoronavirus; Centers for Disease Control and Prevention, U.S.; Contact Tracing; Coronavirus Infections; Disease Outbreaks; Humans; Laboratories; Mass Screening; Practice Guidelines as Topic; Public Health Practice; Travel-Related Illness; United States</schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080959363</j.0:identifier>
    <j.0:title>Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>10.15585/mmwr.mm6908e1</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:creator>Jernigan D.B., CDC COVID-19 Response Team</dc:creator>
    <myOnto:issue>8</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080959363&amp;doi=10.15585%2fmmwr.mm6908e1&amp;partnerID=40&amp;md5=98d8715e7df1c50405d5a63b1e75f842&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/MMWR._Morbidity_and_mortality_weekly_report">
        <j.1:name>MMWR. Morbidity and mortality weekly report</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy>1</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081947441">
    <j.0:type>Short Survey</j.0:type>
    <j.0:title>Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081947441</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:creator>Hong H., Wang Y., Chung H.-T., Chen C.-J.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pediatrics_and_Neonatology">
        <j.1:name>Pediatrics and Neonatology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/j.pedneo.2020.03.001</j.0:identifier>
    <j.0:publisher>Elsevier (Singapore) Pte Ltd</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081947441&amp;doi=10.1016%2fj.pedneo.2020.03.001&amp;partnerID=40&amp;md5=02fbb9d2b266dd970b611b7a6fb310d8&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079336019">
    <j.0:identifier>2-s2.0-85079336019</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079336019&amp;partnerID=40&amp;md5=d6969729843f21bc2a39797445a9c617&gt;</schema:url>
    <myOnto:issue>2</myOnto:issue>
    <dc:date>2020</dc:date>
    <rdfs:comment>Since December 2019, a cluster of patients have been diagnosed to be infected with 2019 novel coronavirus (2019-nCoV) in Wuhan, China. The epidemic has been spreading to other areas of the country and abroad. A few cases have progressed rapidly to acute respiratory distress syndrome and/or multiple organ function failure. The epidemiological survey has indicated that the general population is susceptible to 2019-nCoV. A total of 14 children (6 months to 14 years of age, including 5 cases in Wuhan) have been confirmed to be infected with 2019-nCoV in China so far. In order to further standardize and enhance the clinical management of 2019-nCoV infection in children, reduce the incidence, and decrease the number of severe cases, we have formulated this diagnosis and treatment recommendation according to the recent information at home and abroad.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier></j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Zhongguo_dang_dai_er_ke_za_zhi_=_Chinese_journal_of_contemporary_pediatrics">
        <j.1:name>Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>Chinese</dc:language>
    <schema:keywords>adolescent; child; China; Coronavirinae; Coronavirus infection; human; infant; multiple organ failure; preschool child; Adolescent; Child; Child, Preschool; China; Coronavirus; Coronavirus Infections; Humans; Infant; Multiple Organ Failure</schema:keywords>
    <dc:creator>Pediatric Branch of Hubei Medical Association, Pediatric Branch of Wuhan Medical Association, Pediatric Medical Quality Control Center of Hubei</dc:creator>
    <myOnto:volume>22</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1)</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080037652">
    <rdfs:comment>The purpose of this case report is to describe the imaging and associated clinical features of an asymptomatic novel coronavirus pneumonia (COVID-19) patient outside Wuhan, China. The principle findings are that in this patient with laboratory-confirmed COVID-19, CT findings preceded symptoms and included bilateral pleural effusions, previously not reported in association with COVID-19. The role of this case report is promotion of potential recognition amongst radiologists of this new disease, which has been declared a global health emergency by the World Health Organization (WHO). © 2020</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.clinimag.2020.02.008</j.0:identifier>
    <dc:creator>Lin C., Ding Y., Xie B., Sun Z., Li X., Chen Z., Niu M.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_Imaging">
        <j.1:name>Clinical Imaging</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords>2019-nCoV; Coronaviruses; COVID-19; Ground-glass opacity; Pleural effusion; Computerized tomography; C reactive protein; interferon; lopinavir plus ritonavir; methylprednisolone; adult; Article; asymptomatic infection; case report; Chinese; clinical article; coronavirus disease 2019; Coronavirus infection; dyspnea; ground glass opacity; high resolution computer tomography; human; lung lesion; male; middle aged; nucleic acid analysis; pleura effusion; priority journal; radiological parameters; throat culture; virus pneumonia</schema:keywords>
    <myOnto:volume>63</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080037652&amp;doi=10.1016%2fj.clinimag.2020.02.008&amp;partnerID=40&amp;md5=c28a769dfe3f483102674be10a0937f3&gt;</schema:url>
    <j.0:title>Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85080037652</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081731599">
    <myOnto:issue></myOnto:issue>
    <j.0:title>Identification of coronavirus sequences in carp cDNA from Wuhan, China</j.0:title>
    <dc:creator>Conway M.J.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081731599&amp;doi=10.1002%2fjmv.25751&amp;partnerID=40&amp;md5=37f3fabe539857b0207a7eed30ba6f51&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1002/jmv.25751</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:identifier>2-s2.0-85081731599</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <rdfs:comment>Severe acute respiratory syndrome (SARS)-like coronavirus sequences were identified in two separate complementary DNA (cDNA) pools. The first pool was from a Carassius auratus (crusian carp) cell line and the second was from Ctenopharyngodon idella (grass carp) head kidney tissue. BLAST analysis suggests that these sequences belong to SARS-like coronaviruses, and that they are not evolutionarily conserved in other species. Investigation of the submitting laboratories revealed that two laboratories from the Institute of Hydrobiology at the Chinese Academy of Sciences in Wuhan, China performed the research and submitted the cDNA libraries to GenBank. This institution is very close in proximity to the Wuhan South China Seafood Wholesale Market where SARS-CoV-2 first amplified in the human population. It is possible that these sequences are an artifact of the bioinformatics pipeline that was used. It is also possible that SARS-like coronaviruses are a common environmental pathogen in the region that may be in aquatic habitats. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081586166">
    <j.0:publisher>Springer</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <dc:creator>Zhang W.</dc:creator>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>2-s2.0-85081586166</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Imaging changes in severe COVID-19 pneumonia</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1007/s00134-020-05976-w</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081586166&amp;doi=10.1007%2fs00134-020-05976-w&amp;partnerID=40&amp;md5=3c7780056c836a257e1dc25872575836&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079455708">
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079455708&amp;doi=10.1007%2fs11427-020-1643-8&amp;partnerID=40&amp;md5=7b7cf6ddbf2da3aed00d00a6859f3582&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079455708</j.0:identifier>
    <j.0:identifier>10.1007/s11427-020-1643-8</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Science_China_Life_Sciences">
        <j.1:name>Science China Life Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury</j.0:title>
    <rdfs:comment>The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province, and rapidly spread to many provinces in China as well as other countries. Here we report the epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China. All 12 cases of the 2019-nCoV-infected patients developed pneumonia and half of them developed acute respiratory distress syndrome (ARDS). The most common laboratory abnormalities were hypoalbuminemia, lymphopenia, decreased percentage of lymphocytes (LYM) and neutrophils (NEU), elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH), and decreased CD8 count. The viral load of 2019-nCoV detected from patient respiratory tracts was positively linked to lung disease severity. ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. Age, viral load, lung injury score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease severity. Moreover, the Angiotensin II level in the plasma sample from 2019-nCoV infected patients was markedly elevated and linearly associated to viral load and lung injury. Our results suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker (ARB) drugs for potential repurposing treatment of 2019-nCoV infection. © 2020, Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <schema:keywords>angiotensin II; biological marker; COVID-19; severe acute respiratory syndrome coronavirus 2; adult; adult respiratory distress syndrome; aged; Betacoronavirus; blood; blood analysis; child; complication; Coronavirus infection; human; lung injury; male; middle aged; pathogenicity; pathology; severity of illness index; virus load; virus pneumonia; Adult; Aged; Angiotensin II; Betacoronavirus; Biomarkers; Blood Chemical Analysis; Child; Coronavirus Infections; Humans; Lung Injury; Male; Middle Aged; Pneumonia, Viral; Respiratory Distress Syndrome, Adult; Severity of Illness Index; Viral Load</schema:keywords>
    <dc:creator>Liu Y., Yang Y., Zhang C., Huang F., Wang F., Yuan J., Wang Z., Li J., Li J., Feng C., Zhang Z., Wang L., Peng L., Chen L., Qin Y., Zhao D., Tan S., Yin L., Xu J., Zhou C., Jiang C., Liu L.</dc:creator>
    <myOnto:issue>3</myOnto:issue>
    <j.0:publisher>Science in China Press</j.0:publisher>
    <myOnto:volume>63</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079618621">
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1016/S0140-6736(20)30405-0</j.0:identifier>
    <j.0:identifier>2-s2.0-85079618621</j.0:identifier>
    <schema:keywords>coronavirus disease 2019; Coronavirus infection; disease burden; economic aspect; global health; health care disparity; health care quality; health insurance; health status; infection control; malnutrition; migration; Note; political system; priority journal; public health; social aspect; social discrimination; urbanization</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079618621&amp;doi=10.1016%2fS0140-6736%2820%2930405-0&amp;partnerID=40&amp;md5=d155747487ce643b7db9a577306f5c79&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:title>Offline: Facts are not enough</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10224</myOnto:issue>
    <dc:creator>Horton R.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081752113">
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>angiotensin converting enzyme 2; antiretrovirus agent; proteinase inhibitor; 2019 novel coronavirus; clinical outcome; coronavirus disease 2019; coughing; Editorial; fever; human; Human immunodeficiency virus infection; immune response; Measles virus; mortality rate; nonhuman; pandemic; pneumonia; priority journal; prognosis; SARS coronavirus; virus load; virus transmission; weakness</schema:keywords>
    <j.0:title>Coronavirus pandemic and HIV infection</j.0:title>
    <j.0:publisher>Bentham Science Publishers</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Brichacek B., Bukrinsky M.</dc:creator>
    <j.0:identifier>2-s2.0-85081752113</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>14</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.2174/1874613602014010010</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Open_AIDS_Journal">
        <j.1:name>Open AIDS Journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081752113&amp;doi=10.2174%2f1874613602014010010&amp;partnerID=40&amp;md5=144e070f6ea5cc37672fea1cd73e63e8&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080120084">
    <myOnto:issue>4</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080120084</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Guarner J.</dc:creator>
    <myOnto:volume>153</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_Journal_of_Clinical_Pathology">
        <j.1:name>American Journal of Clinical Pathology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Oxford University Press</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080120084&amp;doi=10.1093%2fajcp%2faqaa029&amp;partnerID=40&amp;md5=8e987f329afdd57b440c8e27134e88ee&gt;</schema:url>
    <j.0:identifier>10.1093/ajcp/aqaa029</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords>autopsy; case fatality rate; China; communicable disease; coronavirus disease 2019; Coronavirus infection; diagnostic imaging; Editorial; electron microscopy; epidemic; gene sequence; government; histopathology; human; Middle East; Middle East respiratory syndrome; nonhuman; priority journal; severe acute respiratory syndrome; United States; virus identification; virus transmission; World Health Organization; Betacoronavirus; Coronavirus infection; epidemic; genetics; Middle East respiratory syndrome coronavirus; pathogenicity; SARS coronavirus; severe acute respiratory syndrome; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome</schema:keywords>
    <j.0:title>Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079410907">
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:title>The global spread of 2019-nCoV: a molecular evolutionary analysis</j.0:title>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079410907&amp;doi=10.1080%2f20477724.2020.1725339&amp;partnerID=40&amp;md5=6dfe1b433dbc23454499c296efe3abb0&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079410907</j.0:identifier>
    <dc:creator>Benvenuto D., Giovanetti M., Salemi M., Prosperi M., De Flora C., Junior Alcantara L.C., Angeletti S., Ciccozzi M.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary phylodynamic and phylogeographic analysis of this new virus. A Maximum Clade Credibility tree has been built using the 29 available whole genome sequences of 2019-nCoV and two whole genome sequences that are highly similar sequences from Bat SARS-like Coronavirus available in GeneBank. We are able to clarify the mechanism of transmission among the countries which have provided the 2019-nCoV sequence isolates from their patients. The Bayesian phylogeographic reconstruction shows that the 2019–2020 nCoV most probably originated from the Bat SARS-like Coronavirus circulating in the Rhinolophus bat family. In agreement with epidemiological observations, the most likely geographic origin of the new outbreak was the city of Wuhan, China, where 2019-nCoV time of the most recent common ancestor emerged, according to molecular clock analysis, around November 25th, 2019. These results, together with previously recorded epidemics, suggest a recurring pattern of periodical epizootic outbreaks due to Betacoronavirus. Moreover, our study describes the same population genetic dynamic underlying the SARS 2003 epidemic, and suggests the urgent need for the development of effective molecular surveillance strategies of Betacoronavirus among animals and Rhinolophus of the bat family. © 2020, © 2020 Informa UK Limited, trading as Taylor &amp; Francis Group.</rdfs:comment>
    <j.0:identifier>10.1080/20477724.2020.1725339</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pathogens_and_Global_Health">
        <j.1:name>Pathogens and Global Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082113796">
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <dc:creator>Tilocca B., Soggiu A., Musella V., Britti D., Sanguinetti M., Urbani A., Roncada P.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082113796</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Microbes_and_Infection">
        <j.1:name>Microbes and Infection</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1016/j.micinf.2020.03.002</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082113796&amp;doi=10.1016%2fj.micinf.2020.03.002&amp;partnerID=40&amp;md5=5910320621f4b1e6b7c697fc65b488eb&gt;</schema:url>
    <j.0:title>Molecular basis of COVID-19 relationships in different species: a one health perspective</j.0:title>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>Outside the Hubei province, China, the mild form of infection and the progressive recover of the COVID-19 patients suggest the intervention of “unconventional” biological mechanisms worthy of attention. Based on the high-homology between the Spike protein epitopes of taxonomically-related coronaviruses, we hypothesized that past contact with infected dogs shield humans against the circulating SARS-CoV-2. Elseways, the recurrent virus exposure over a short time-lapse might result in the Antibody Dependent Enhancement, triggering the violent immune reaction responsible for the severe clinical outcomes observed in the Hubei province. Nevertheless, further experimental studies are desired for a confidential evaluation of the postulated hypotheses. © 2020 Institut Pasteur</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082054027">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1177/1534735420912811</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>COVID-19; herbaceous agent; severe acute respiratory syndrome coronavirus 2; acupuncture; Betacoronavirus; Chinese medicine; comorbidity; Coronavirus infection; epidemic; human; integrative oncology; lung tumor; massage; pandemic; pathogenicity; procedures; virus pneumonia; Acupuncture Therapy; Betacoronavirus; Comorbidity; Coronavirus Infections; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Integrative Oncology; Lung Neoplasms; Massage; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral</schema:keywords>
    <dc:creator>Yang G., Zhang H., Yang Y.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082054027&amp;doi=10.1177%2f1534735420912811&amp;partnerID=40&amp;md5=5db5db4c27ed863aed3669f1cb73fc42&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082054027</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Integrative_cancer_therapies">
        <j.1:name>Integrative cancer therapies</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19</j.0:title>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>19</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081665201">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30308-1</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>10228</myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>Full spectrum of COVID-19 severity still being depicted</j.0:title>
    <dc:creator>Xu Z., Li S., Tian S., Li H., Kong L.-Q.</dc:creator>
    <j.0:identifier>2-s2.0-85081665201</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081665201&amp;doi=10.1016%2fS0140-6736%2820%2930308-1&amp;partnerID=40&amp;md5=364f50a99244fecfe7260f207f9284cd&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081933896">
    <j.0:identifier>2-s2.0-85081933896</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Covid-19: UK ramps up testing by 500% as health minister tests positive for virus</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Mahase E.</dc:creator>
    <j.0:identifier>10.1136/bmj.m1003</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081933896&amp;doi=10.1136%2fbmj.m1003&amp;partnerID=40&amp;md5=53a4b16c15dd735f28e3e3cb4833eede&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:volume>368</myOnto:volume>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080043890">
    <dc:date>2020</dc:date>
    <schema:keywords>angiotensin converting enzyme 2; COVID-19; severe acute respiratory syndrome coronavirus 2; age; artificial ventilation; Betacoronavirus; cancer chemotherapy; cancer incidence; cancer patient; cancer surgery; cancer survivor; China; comorbidity; computer assisted tomography; coronavirus disease 2019; Coronavirus infection; death; disease severity; disease surveillance; epidemic; follow up; hospital admission; human; immune deficiency; infection sensitivity; intensive care unit; Japan; lung cancer; medical history; Middle East respiratory syndrome coronavirus; multiple organ failure; Note; priority journal; prognosis; public health problem; respiratory failure; risk factor; SARS-related coronavirus; Severe acute respiratory syndrome coronavirus 2; sex difference; smoking; Spain; tachypnea; thorax radiography; United States; virus transmission; World Health Organization; aged; anamnesis; China; complication; middle aged; neoplasm; prospective study; severity of illness index; very elderly; virus pneumonia; Age Factors; Aged; Aged, 80 and over; Betacoronavirus; China; Coronavirus Infections; Humans; Medical History Taking; Middle Aged; Neoplasms; Pneumonia, Viral; Prognosis; Prospective Studies; Respiration, Artificial; Risk Factors; Severity of Illness Index</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Oncology">
        <j.1:name>The Lancet Oncology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>21</myOnto:volume>
    <j.0:title>Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080043890&amp;doi=10.1016%2fS1470-2045%2820%2930096-6&amp;partnerID=40&amp;md5=392a60cebbc771f491f0b63bf7ae7f97&gt;</schema:url>
    <dc:creator>Liang W., Guan W., Chen R., Wang W., Li J., Xu K., Li C., Ai Q., Lu W., Liang H., Li S., He J.</dc:creator>
    <j.0:identifier>10.1016/S1470-2045(20)30096-6</j.0:identifier>
    <j.0:identifier>2-s2.0-85080043890</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079859013">
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S0140-6736(20)30359-7</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>10225</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079859013&amp;doi=10.1016%2fS0140-6736%2820%2930359-7&amp;partnerID=40&amp;md5=919f8db27b2db6a0310e036ffaba5f61&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; acute respiratory failure; China; Coronavirus infection; human; infection prevention; intensive care unit; Letter; noninvasive ventilation; pandemic; priority journal; virus transmission; Betacoronavirus; Coronavirinae; cross infection; epidemic; global health; respiratory failure; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus; Cross Infection; Disease Outbreaks; Global Health; Humans; Respiratory Insufficiency</schema:keywords>
    <dc:creator>Cabrini L., Landoni G., Zangrillo A.</dc:creator>
    <j.0:identifier>2-s2.0-85079859013</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082042624">
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>368</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1136/bmj.m1104</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:title>Covid-19: pregnant doctors should speak to occupational health, say experts</j.0:title>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082042624</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082042624&amp;doi=10.1136%2fbmj.m1104&amp;partnerID=40&amp;md5=7679212028e8bb5b9bb75a70e934913d&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:creator>Rimmer A.</dc:creator>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079337792">
    <schema:keywords>2019 novel coronavirus; advertising; animal welfare; China; conservation biology; Coronavirinae; endangered species; epidemic; health status; human; illegal wildlife trade; Letter; meat consumption; nonhuman; online system; priority journal; quarantine; restaurant; social marketing; traditional medicine</schema:keywords>
    <j.0:identifier>10.1038/d41586-020-00378-w</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>China: clamp down on violations of wildlife trade ban</j.0:title>
    <j.0:publisher>Nature Research</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079337792&amp;doi=10.1038%2fd41586-020-00378-w&amp;partnerID=40&amp;md5=99ca9db653720fe835061856a575201a&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079337792</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <myOnto:volume>578</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Zhou Z.-M., Buesching C.D., Macdonald D.W., Newman C.</dc:creator>
    <myOnto:issue>7794</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082045386">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <j.0:title>COVID-19: Vulnerability and the power of privilege in a pandemic</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082045386&amp;doi=10.1002%2fhpja.333&amp;partnerID=40&amp;md5=7c99241ca1678c9b74265f5174a2dc10&gt;</schema:url>
    <dc:creator>Smith J.A., Judd J.</dc:creator>
    <j.0:identifier>2-s2.0-85082045386</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1002/hpja.333</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Health_Promotion_Journal_of_Australia">
        <j.1:name>Health Promotion Journal of Australia</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079789438">
    <dc:language>Chinese</dc:language>
    <myOnto:issue></myOnto:issue>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; disease predisposition; epidemic; human; immunocompromised patient; lung tumor; pathogenicity; patient care planning; risk; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Disease Susceptibility; Humans; Immunocompromised Host; Lung Neoplasms; Patient Care Planning; Pneumonia, Viral; Risk</schema:keywords>
    <rdfs:comment>??????????????????????????? ???????2019?12??????????????????????????????????2019 novel coronavirus disease?COVID-19????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ???????????????? ?????????.Since late December 2019, an outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. With the spread of COVID-19, the routine clinical diagnosis and treatment for lung cancer patients has been disturbed. Due to the systemic immunosuppressive of lung cancer patients caused by the malignancy and anticancer treatments, lung cancer patients are more susceptible to infection than healthy individuals. Furthermore, patients with cancer had poorer prognosis from infection. Lung cancer patients should be the priority group for COVID-19 prevention. The protection provisions and control measures aiming to protect lung cancer patients from COVID-19 have been increasingly concerned. During the COVID-19 outbreak period, it should be carefully differentiated for fever and respiratory symptoms for lung cancer patients receiving anti-tumor treatment, in order to evaluate the risk of COVID-19. Moreover, it is necessary to carry out meticulous and individualized clinical management for lung cancer patients to effectively protect the patients from COVID-19.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079789438&amp;doi=10.3779%2fj.issn.1009-3419.2020.03.02&amp;partnerID=40&amp;md5=be9bb11b666a05150471d65f685e677a&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Xu Y., Liu H., Hu K., Wang M.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Zhongguo_fei_ai_za_zhi_=_Chinese_journal_of_lung_cancer">
        <j.1:name>Zhongguo fei ai za zhi = Chinese journal of lung cancer</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079789438</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.3779/j.issn.1009-3419.2020.03.02</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>23</myOnto:volume>
    <j.0:title>Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078690530">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85078690530</j.0:identifier>
    <myOnto:citeyBy>7</myOnto:citeyBy>
    <dc:creator>Yoo J.-H.</dc:creator>
    <myOnto:volume>35</myOnto:volume>
    <schema:keywords>COVID-19; community care; Coronavirus infection; disaster planning; epidemic; health care personnel; human; private hospital; South Korea; virus pneumonia; Community Health Services; Coronavirus Infections; Disaster Planning; Disease Outbreaks; Health Personnel; Hospitals, Private; Humans; Pneumonia, Viral; Republic of Korea</schema:keywords>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078690530&amp;doi=10.3346%2fjkms.2020.35.e56&amp;partnerID=40&amp;md5=3c4f6fe7241581429abcdb3c0813c9eb&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun</j.0:title>
    <j.0:identifier>10.3346/jkms.2020.35.e56</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147518">
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>38</myOnto:volume>
    <j.0:identifier>2-s2.0-85082147518</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic</j.0:title>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; virus vaccine; adaptive immunity; Betacoronavirus; Coronavirus infection; epidemic; host pathogen interaction; human; immune evasion; immunology; innate immunity; Middle East respiratory syndrome coronavirus; SARS coronavirus; severe acute respiratory syndrome; virus pneumonia; Adaptive Immunity; Betacoronavirus; Coronavirus Infections; Epidemics; Host-Pathogen Interactions; Humans; Immune Evasion; Immunity, Innate; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome; Viral Vaccines</schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Prompetchara E., Ketloy C., Palaga T.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Pacific_journal_of_allergy_and_immunology">
        <j.1:name>Asian Pacific journal of allergy and immunology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147518&amp;doi=10.12932%2fAP-200220-0772&amp;partnerID=40&amp;md5=2fa11c2f7f52b35ae098a6a195497917&gt;</schema:url>
    <j.0:identifier>10.12932/AP-200220-0772</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082187185">
    <myOnto:volume>133</myOnto:volume>
    <j.0:identifier>2-s2.0-85082187185</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Psychosomatic_Research">
        <j.1:name>Journal of Psychosomatic Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1016/j.jpsychores.2020.110102</j.0:identifier>
    <j.0:title>Screening for Chinese medical staff mental health by SDS and SAS during the outbreak of COVID-19</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082187185&amp;doi=10.1016%2fj.jpsychores.2020.110102&amp;partnerID=40&amp;md5=eb3e4f9a3e25f5757da0a8df037231fb&gt;</schema:url>
    <dc:creator>Liang Y., Chen M., Zheng X., Liu J.</dc:creator>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier Inc.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081256500">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection">
        <j.1:name>Journal of Infection</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:identifier>2-s2.0-85081256500</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.jinf.2020.02.016</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081256500&amp;doi=10.1016%2fj.jinf.2020.02.016&amp;partnerID=40&amp;md5=dd846f096f30db03cf6edf694feb6573&gt;</schema:url>
    <dc:creator>Yang W., Cao Q., Qin L., Wang X., Cheng Z., Pan A., Dai J., Sun Q., Zhao F., Qu J., Yan F.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China</j.0:title>
    <rdfs:comment>Background: Little is known about COVID-19 outside Hubei. The aim of this paper was to describe the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection in Wenzhou, Zhejiang, China. Methods: In this retrospective cohort study, 149 RT-PCR confirmed positive patients were consecutively enrolled from January 17th to February 10th, 2020 in three tertiary hospitals of Wenzhou. Outcomes were followed up until Feb 15th, 2020. Findings: A total of 85 patients had Hubei travel/residence history, while another 49 had contact with people from Hubei and 15 had no traceable exposure history to Hubei. Fever, cough and expectoration were the most common symptoms, 14 patients had decreased oxygen saturation, 33 had leukopenia, 53 had lymphopenia, and 82 had elevated C-reactive protein. On chest computed tomography (CT), lung segments 6 and 10 were mostly involved. A total of 287 segments presented ground glass opacity, 637 presented mixed opacity and 170 presented consolidation. Lesions were more localized in the peripheral lung with a patchy form. No significant difference was found between patients with or without Hubei exposure history. Seventeen patients had normal CT on admission of these, 12 had negative findings even10 days later. Interpretation: Most patients presented with a mild infection in our study. The imaging pattern of multifocal peripheral ground glass or mixed opacity with predominance in the lower lung is highly suspicious of COVID-19 in the first week of disease onset. Nevetheless, some patients can present with a normal chest finding despite testing positive for COVID-19. Funding: We did not receive any fundings. © 2020</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081910424">
    <schema:keywords>Cell proliferation; Commerce; Viruses; Basic reproduction number; Coronaviruses; Fractional derivatives; Fractional model; Numerical results; Parameterized; Real data; Stability results; Meats</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Alexandria_Engineering_Journal">
        <j.1:name>Alexandria Engineering Journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Khan M.A., Atangana A.</dc:creator>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081910424&amp;doi=10.1016%2fj.aej.2020.02.033&amp;partnerID=40&amp;md5=5174a599de421637d2cd883b09823062&gt;</schema:url>
    <j.0:identifier>10.1016/j.aej.2020.02.033</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:title>Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>The present paper describes the mathematical modeling and dynamics of a novel corona virus (2019-nCoV). We describe the brief details of interaction among the bats and unknown hosts, then among the peoples and the infections reservoir (seafood market). The seafood marked are considered the main source of infection when the bats and the unknown hosts (may be wild animals) leaves the infection there. The purchasing of items from the seafood market by peoples have the ability to infect either asymptomatically or symptomatically. We reduced the model with the assumptions that the seafood market has enough source of infection that can be effective to infect people. We present the mathematical results of the model and then formulate a fractional model. We consider the available infection cases for January 21, 2020, till January 28, 2020 and parameterized the model. We compute the basic reproduction number for the data is R0?2.4829. The fractional model is then solved numerically by presenting many graphical results, which can be helpful for the infection minimization. © 2020 Faculty of Engineering, Alexandria University</rdfs:comment>
    <j.0:identifier>2-s2.0-85081910424</j.0:identifier>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080989272">
    <myOnto:volume>579</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; Coronavirus infection; economics; global health; human; international cooperation; legislation and jurisprudence; migration; Nigeria; organization and management; pandemic; personnel; science; travel; United States; virus pneumonia; Coronavirus Infections; Emigration and Immigration; Global Health; Humans; International Cooperation; Nigeria; Pandemics; Pneumonia, Viral; Research Personnel; Science; Travel; United States</schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Extended US travel ban harms global science</j.0:title>
    <j.0:identifier>10.1038/d41586-020-00588-2</j.0:identifier>
    <j.0:identifier>2-s2.0-85080989272</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080989272&amp;doi=10.1038%2fd41586-020-00588-2&amp;partnerID=40&amp;md5=bfb112c9642cbba801384b3ba6afdc39&gt;</schema:url>
    <myOnto:issue>7797</myOnto:issue>
    <dc:creator>Ndodo N.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081314502">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>93</myOnto:volume>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Albarello F., Pianura E., Di Stefano F., Cristofaro M., Petrone A., Marchioni L., Palazzolo C., Schininà V., Nicastri E., Petrosillo N., Campioni P., Eskild P., Zumla A., Ippolito G., Abbonizio M.A., Agrati C., Amadei G., Amendola A., Antonini M., Barbaro R., Bartolini B., Benigni M., Bevilacqua N., Bordi L., Bordoni V., Branca M., Capobianchi M.R., Caporale C., Caravella I., Carletti F., Castilletti C., Chiappini R., Ciaralli C., Colavita F., Corpolongo A., Curiale S., D'Abramo A., Dantimi C., Angelis A.D., Angelis G.D., Lorenzo R.D., Stefano F.D., Ferraro F., Fiorentini L., Frustaci A., Gallì P., Garotto G., Giancola M.L., Giansante F., Giombini E., Greci M.C., Lalle E., Lanini S., Lapa D., Lepore L., Lucia A., Lufrani F., Macchione M., Marani A., Mariano A., Marini M.C., Maritti M., Matusali G., Meschi S., Montaldo F.M.C., Murachelli S., Noto R., Pallini E., Passeri V., Pelliccioni F., Petrecchia A., Pisciotta M., Pittalis S., Proietti C., Puro V., Rinonapoli G., Rueca M., Sacchi A., Sanasi F., Santagata C., Scarcia S., Scognamiglio P., Scorzolini L., Stazi G., Vaia F., Vairo F., Valli M.B.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081314502&amp;doi=10.1016%2fj.ijid.2020.02.043&amp;partnerID=40&amp;md5=15ae51488524ecc3e33836a14c5d8488&gt;</schema:url>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <rdfs:comment>Introduction: Several recent case reports have described common early chest imaging findings of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be similar to those seen previously in SARS-CoV and MERS-CoV infected patients. Objective: We present some remarkable imaging findings of the first two patients identified in Italy with COVID-19 infection travelling from Wuhan, China. The follow-up with chest X-Rays and CT scans was also included, showing a progressive adult respiratory distress syndrome (ARDS). Results: Moderate to severe progression of the lung infiltrates, with increasing percentage of high-density infiltrates sustained by a bilateral and multi-segmental extension of lung opacities, were seen. During the follow-up, apart from pleural effusions, a tubular and enlarged appearance of pulmonary vessels with a sudden caliber reduction was seen, mainly found in the dichotomic tracts, where the center of a new insurgent pulmonary lesion was seen. It could be an early alert radiological sign to predict initial lung deterioration. Another uncommon element was the presence of mediastinal lymphadenopathy with short-axis oval nodes. Conclusions: Although only two patients have been studied, these findings are consistent with the radiological pattern described in literature. Finally, the pulmonary vessels enlargement in areas where new lung infiltrates develop in the follow-up CT scan, could describe an early predictor radiological sign of lung impairment. © 2020 The Authors</rdfs:comment>
    <j.0:identifier>10.1016/j.ijid.2020.02.043</j.0:identifier>
    <j.0:title>2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation</j.0:title>
    <j.0:identifier>2-s2.0-85081314502</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <schema:keywords>2019 novel coronavirus; adult respiratory distress syndrome; aged; Article; artificial ventilation; case report; China; clinical article; computer assisted tomography; cone beam computed tomography; Coronavirinae; Coronavirus infection; female; follow up; human; human tissue; intensive care unit; Italy; laboratory test; lung blood vessel; lung infiltrate; lung lesion; male; mediastinum lymphadenopathy; multidetector computed tomography; pericardial effusion; pleura effusion; real time reverse transcription polymerase chain reaction; spiral computer assisted tomography; thorax radiography</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081557718">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081557718&amp;doi=10.1007%2fs00134-020-05985-9&amp;partnerID=40&amp;md5=4e5ecaf5b59cffac984db3d4cda637bd&gt;</schema:url>
    <j.0:identifier>10.1007/s00134-020-05985-9</j.0:identifier>
    <j.0:identifier>2-s2.0-85081557718</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S.</dc:creator>
    <j.0:title>Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082005057">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <dc:creator>Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutiérrez-Ocampo E., Villamizar-Peña R., Holguin-Rivera Y., Escalera-Antezana J.P., Alvarado-Arnez L.E., Bonilla-Aldana D.K., Franco-Paredes C., Henao-Martinez A.F., Paniz-Mondolfi A., Lagos-Grisales G.J., Ramírez-Vallejo E., Suárez J.A., Zambrano L.I., Villamil-Gómez W.E., Balbin-Ramon G.J., Rabaan A.A., Harapan H., Dhama K., Nishiura H., Kataoka H., Ahmad T., Sah R., Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19)</dc:creator>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Introduction: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date. Methods: We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI). Results: 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5–92.9%), cough (57.6%, 95%CI 40.8–74.4%) and dyspnea (45.6%, 95%CI 10.9–80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0–30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7–51.8), 6.2% (95%CI 3.1–9.3) with shock. Some 13.9% (95%CI 6.2–21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR). Conclusion: COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of &gt;13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19. © 2020 Elsevier Ltd</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:type>Review</j.0:type>
    <j.0:title>Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis</j.0:title>
    <j.0:identifier>10.1016/j.tmaid.2020.101623</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082005057&amp;doi=10.1016%2fj.tmaid.2020.101623&amp;partnerID=40&amp;md5=df985d2f1b4f0780933d2df2d679eb70&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082005057</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081980796">
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Nuclear_medicine_communications">
        <j.1:name>Nuclear medicine communications</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Huang H.L., Allie R., Gnanasegaran G., Bomanji J.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081980796</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:volume>41</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>COVID19 -Nuclear Medicine Departments, be prepared!</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081980796&amp;doi=10.1097%2fMNM.0000000000001183&amp;partnerID=40&amp;md5=ff9bd3d4462f08ac7a02930953afc25f&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1097/MNM.0000000000001183</j.0:identifier>
    <myOnto:issue>4</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081067232">
    <j.0:type>Note</j.0:type>
    <j.0:title>COVID-19: Lessons from SARS and MERS</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1002/eji.202070035</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_journal_of_immunology">
        <j.1:name>European journal of immunology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>50</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081067232&amp;doi=10.1002%2feji.202070035&amp;partnerID=40&amp;md5=c1d7fd503877a30dbfafd4bd5dabebf7&gt;</schema:url>
    <dc:creator>Park M., Thwaites R.S., Openshaw P.J.M.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85081067232</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081072506">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m799</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Covid-19: Preparedness, decentralisation, and the hunt for patient zero</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081072506&amp;doi=10.1136%2fbmj.m799&amp;partnerID=40&amp;md5=851b0d7efcd62ebf31a850aeaa2d4233&gt;</schema:url>
    <schema:keywords>Chinese; clinical protocol; contact examination; coronavirus disease 2019; Coronavirus infection; decentralization; disease severity; disease surveillance; Editorial; emergency; epidemic; government; health care; high risk population; human; infection control; Italy; medical information; priority journal; rural area; Coronavirus infection; global health; health care planning; pandemic; politics; virus pneumonia; COVID-19; Coronavirus Infections; Global Health; Health Planning; Humans; Italy; Pandemics; Pneumonia, Viral; Politics</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Carinci F.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081072506</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081678816">
    <j.0:identifier>10.1001/jama.2020.3972</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:creator>Adams J.G., Walls R.M.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081678816</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081678816&amp;doi=10.1001%2fjama.2020.3972&amp;partnerID=40&amp;md5=9be0c9fcdb2ddb025da2e4dabf395571&gt;</schema:url>
    <j.0:title>Supporting the Health Care Workforce during the COVID-19 Global Epidemic</j.0:title>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078468946">
    <schema:keywords>angiotensin converting enzyme 2; beta interferon; cell receptor; coronavirus spike glycoprotein; dipeptidyl peptidase IV; glycoprotein; lopinavir plus ritonavir; messenger RNA; remdesivir; 2019 novel coronavirus; acute kidney failure; aerosol; airborne virus; artificial ventilation; biological model; case fatality rate; China; Chinese; common cold; comorbidity; Coronavirinae; Coronavirus infection; coughing; disease severity; disease transmission; dyspnea; environmental exposure; epidemic; fever; gastrointestinal symptom; gastrointestinal tract; gene mutation; gene sequence; general practitioner; genetic recombination; genetic variability; health care cost; health care system; Hong Kong; hospital infection; hospitalization; host interaction; host range; human; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus NL63; Human coronavirus OC43; lower respiratory tract; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; morbidity; mortality; Note; pandemic; patient isolation; phase 1 clinical trial (topic); priority journal; public health service; raccoon dog; respiratory failure; respiratory tract intubation; SARS-related coronavirus; Saudi; sea food; severe acute respiratory syndrome; social marketing; therapy effect; travel; United States; upper respiratory tract infection; virology; virus cell interaction; virus envelope; virus pneumonia; virus shedding; virus virulence</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <myOnto:volume>323</myOnto:volume>
    <dc:creator>Paules C.I., Marston H.D., Fauci A.S.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078468946&amp;doi=10.1001%2fjama.2020.0757&amp;partnerID=40&amp;md5=2094cb8997dd657e94c932c83af94d6a&gt;</schema:url>
    <j.0:identifier>2-s2.0-85078468946</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>29</myOnto:citeyBy>
    <myOnto:issue>8</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:title>Coronavirus Infections-More Than Just the Common Cold</j.0:title>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1001/jama.2020.0757</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081995335">
    <myOnto:issue>2</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; human; pandemic; risk factor; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Risk Factors</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>5</myOnto:volume>
    <j.0:identifier>10.1128/mSphere.00203-20</j.0:identifier>
    <j.0:title>COVID-19: Knowns, Unknowns, and Questions</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/mSphere">
        <j.1:name>mSphere</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081995335</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081995335&amp;doi=10.1128%2fmSphere.00203-20&amp;partnerID=40&amp;md5=0989cd6822f4f5cdb9d3f419e2be2ba7&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Weston S., Frieman M.B.</dc:creator>
    <rdfs:comment>The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Hubei province in China in late 2019 demonstrates the epidemic potential of coronaviruses. The rapid spread of this virus across the world in only 2 months highlights the transmissibility of this family of viruses and the significant morbidity and mortality that they can cause. We highlight the current state of knowledge of coronavirus biology while answering questions concerning the current outbreak of SARS-CoV-2. Copyright © 2020 Weston and Frieman.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078864717">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <dc:creator>Wu J.T., Leung K., Leung G.M.</dc:creator>
    <j.0:title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078864717&amp;doi=10.1016%2fS0140-6736%2820%2930260-9&amp;partnerID=40&amp;md5=0a3deda21971a6baa6d185965e4e33c5&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:issue>10225</myOnto:issue>
    <j.0:identifier>2-s2.0-85078864717</j.0:identifier>
    <rdfs:comment>Background: Since Dec 31, 2019, the Chinese city of Wuhan has reported an outbreak of atypical pneumonia caused by the 2019 novel coronavirus (2019-nCoV). Cases have been exported to other Chinese cities, as well as internationally, threatening to trigger a global outbreak. Here, we provide an estimate of the size of the epidemic in Wuhan on the basis of the number of cases exported from Wuhan to cities outside mainland China and forecast the extent of the domestic and global public health risks of epidemics, accounting for social and non-pharmaceutical prevention interventions. Methods: We used data from Dec 31, 2019, to Jan 28, 2020, on the number of cases exported from Wuhan internationally (known days of symptom onset from Dec 25, 2019, to Jan 19, 2020) to infer the number of infections in Wuhan from Dec 1, 2019, to Jan 25, 2020. Cases exported domestically were then estimated. We forecasted the national and global spread of 2019-nCoV, accounting for the effect of the metropolitan-wide quarantine of Wuhan and surrounding cities, which began Jan 23–24, 2020. We used data on monthly flight bookings from the Official Aviation Guide and data on human mobility across more than 300 prefecture-level cities in mainland China from the Tencent database. Data on confirmed cases were obtained from the reports published by the Chinese Center for Disease Control and Prevention. Serial interval estimates were based on previous studies of severe acute respiratory syndrome coronavirus (SARS-CoV). A susceptible-exposed-infectious-recovered metapopulation model was used to simulate the epidemics across all major cities in China. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credibile interval (CrI). Findings: In our baseline scenario, we estimated that the basic reproductive number for 2019-nCoV was 2·68 (95% CrI 2·47–2·86) and that 75 815 individuals (95% CrI 37 304–130 330) have been infected in Wuhan as of Jan 25, 2020. The epidemic doubling time was 6·4 days (95% CrI 5·8–7·1). We estimated that in the baseline scenario, Chongqing, Beijing, Shanghai, Guangzhou, and Shenzhen had imported 461 (95% CrI 227–805), 113 (57–193), 98 (49–168), 111 (56–191), and 80 (40–139) infections from Wuhan, respectively. If the transmissibility of 2019-nCoV were similar everywhere domestically and over time, we inferred that epidemics are already growing exponentially in multiple major cities of China with a lag time behind the Wuhan outbreak of about 1–2 weeks. Interpretation: Given that 2019-nCoV is no longer contained within Wuhan, other major Chinese cities are probably sustaining localised outbreaks. Large cities overseas with close transport links to China could also become outbreak epicentres, unless substantial public health interventions at both the population and personal levels are implemented immediately. Independent self-sustaining outbreaks in major cities globally could become inevitable because of substantial exportation of presymptomatic cases and in the absence of large-scale public health interventions. Preparedness plans and mitigation interventions should be readied for quick deployment globally. Funding: Health and Medical Research Fund (Hong Kong, China). © 2020 Elsevier Ltd</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>51</myOnto:citeyBy>
    <schema:keywords>Article; basic reproduction number; China; controlled study; Coronavirus infection; coronavirus infection 2019; disease transmission; epidemic; forecasting; human; incidence; incubation time; intervention study; Markov Chain Monte Carlo method; metapopulation; Monte Carlo method; nowcasting and forecasting; prevalence; priority journal; quarantine; severe acute respiratory syndrome; simulation; computer simulation; Coronavirus infection; epidemic; forecasting; hospitalization; international cooperation; Markov chain; China; Computer Simulation; Coronavirus Infections; Epidemics; Forecasting; Hospitalization; Humans; Infectious Disease Incubation Period; Internationality; Markov Chains; Monte Carlo Method; Prevalence</schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30260-9</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082124062">
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <rdfs:comment>Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-CoV (SARS-CoV) outbreak in 2002. The continuous evolution of coronaviruses was further highlighted with the emergence of the Middle East Respiratory Syndrome-CoV (MERS-CoV) outbreak in 2012. Currently, the world is concerned about the 2019 novel CoV (SARS-CoV-2) that was initially identified in the city of Wuhan, China in December 2019. Patients presented with severe viral pneumonia and respiratory illness. The number of cases has been mounting since then. As of late February 2020, tens of thousands of cases and several thousand deaths have been reported in China alone, in addition to thousands of cases in other countries. Although the fatality rate of SARS-CoV-2 is currently lower than SARS-CoV, the virus seems to be highly contagious based on the number of infected cases to date. In this review, we discuss structure, genome organization, entry of CoVs into target cells, and provide insights into past and present outbreaks. The future of human CoV outbreaks will not only depend on how the viruses will evolve, but will also depend on how we develop efficient prevention and treatment strategies to deal with this continuous threat. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>9</myOnto:volume>
    <j.0:title>Insights into the recent 2019 novel coronavirus (Sars-coV-2) in light of past human coronavirus outbreaks</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082124062</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pathogens">
        <j.1:name>Pathogens</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:identifier>10.3390/pathogens9030186</j.0:identifier>
    <schema:keywords>adult; China; genome analysis; human; mortality rate; nonhuman; review; SARS coronavirus; target cell</schema:keywords>
    <dc:creator>Ashour H.M., Elkhatib W.F., Rahman M.M., Elshabrawy H.A.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082124062&amp;doi=10.3390%2fpathogens9030186&amp;partnerID=40&amp;md5=bc7506cd7b9bc51c4663deca34de34fb&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082146092">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>coronavirus spike glycoprotein; COVID-19; monoclonal antibody; neutralizing antibody; severe acute respiratory syndrome coronavirus 2; spike glycoprotein, COVID-19 virus; virus antibody; virus receptor; Betacoronavirus; binding site; chemistry; China; Coronavirus infection; human; immunotherapy; Middle East respiratory syndrome coronavirus; protein tertiary structure; SARS coronavirus; virus pneumonia; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Betacoronavirus; Binding Sites; China; Coronavirus Infections; Humans; Immunotherapy; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; Protein Structure, Tertiary; Receptors, Virus; SARS Virus; Spike Glycoprotein, Coronavirus</schema:keywords>
    <rdfs:comment>Last decade witnessed the outbreak of many life-threatening human pathogens including Nipah, Ebola, Chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe Acute respiratory syndrome coronavirus (SARS-CoV) and more recently novel coronavirus (2019-nCoV or SARS-CoV-2). The disease condition associated with novel coronavirus, referred to as Coronavirus disease (COVID-19). The emergence of novel coronavirus in 2019 in Wuhan, China marked the third highly pathogenic coronavirus infecting humans in the 21st century. The continuing emergence of coronaviruses at regular intervals poses a significant threat to human health and economy. Ironically, even after a decade of research on coronavirus, still there are no licensed vaccines or therapeutic agents to treat coronavirus infection which highlights an urgent need to develop effective vaccines or post-exposure prophylaxis to prevent future epidemics. Several clinical, genetic and epidemiological features of COVID-19 resemble SARS-CoV infection. Hence, the research advancements on SARS-CoV treatment might help scientific community in quick understanding of this virus pathogenesis and develop effective therapeutic/prophylactic agents to treat and prevent this infection. Monoclonal antibodies represent the major class of biotherapeutics for passive immunotherapy to fight against viral infection. The therapeutic potential of monoclonal antibodies has been well recognized in the treatment of many diseases. Here, we summarize the potential monoclonal antibody based therapeutic intervention for COVID-19 by considering the existing knowledge on the neutralizing monoclonal antibodies against similar coronaviruses SARS-CoV and MERS-CoV. Further research on COVID-19 pathogenesis could identify appropriate therapeutic targets to develop specific anti-virals against this newly emerging pathogen.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>10.12932/AP-200220-0773</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Pacific_journal_of_allergy_and_immunology"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082146092&amp;doi=10.12932%2fAP-200220-0773&amp;partnerID=40&amp;md5=e00cba68313449a86d9e36757544da5e&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:volume>38</myOnto:volume>
    <dc:creator>Shanmugaraj B., Siriwattananon K., Wangkanont K., Phoolcharoen W.</dc:creator>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>2-s2.0-85082146092</j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.00242414407">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Medecine/Sciences">
        <j.1:name>Medecine/Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>19</myOnto:volume>
    <myOnto:issue>11</myOnto:issue>
    <dc:creator>Flahault A.</dc:creator>
    <dc:date>2003</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-0242414407&amp;partnerID=40&amp;md5=8961f5cf2de27fd27644c10dbad29f9d&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier></j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>acute disease; disease transmission; epidemic; human; infection control; mathematical model; respiratory tract infection; review; severe acute respiratory syndrome; virus infection; Disease Outbreaks; Humans; Models, Theoretical; SARS Virus; Severe Acute Respiratory Syndrome; SARS CoV; severe acute respiratory syndrome virus</schema:keywords>
    <dc:language>French</dc:language>
    <j.0:title>SARS-Cov: 2. Modeling SARS epidemic [SRAS: 2. La Modélisation de l'épidémie]</j.0:title>
    <j.0:identifier>2-s2.0-0242414407</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <j.0:publisher></j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081373570">
    <dc:creator>Lu S.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081373570</j.0:identifier>
    <j.0:identifier>10.1080/22221751.2020.1737580</j.0:identifier>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>9</myOnto:volume>
    <schema:keywords>adenovirus vector; inactivated virus vaccine; nucleic acid; severe acute respiratory syndrome vaccine; subunit vaccine; virus vector; COVID-19; severe acute respiratory syndrome coronavirus 2; virus vaccine; drug industry; epidemic; human; immune response; infection control; Note; priority journal; SARS coronavirus; scale up; severe acute respiratory syndrome; vaccination; animal; Betacoronavirus; Coronavirus infection; drug design; immunology; virus pneumonia; Animals; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Drug Design; Humans; Pneumonia, Viral; Viral Vaccines</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081373570&amp;doi=10.1080%2f22221751.2020.1737580&amp;partnerID=40&amp;md5=8d45892f5020e6deae76a08119afb185&gt;</schema:url>
    <j.0:title>Timely development of vaccines against SARS-CoV-2</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081209668">
    <dc:creator>Legido-Quigley H., Asgari N., Teo Y.Y., Leung G.M., Oshitani H., Fukuda K., Cook A.R., Hsu L.Y., Shibuya K., Heymann D.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:volume>395</myOnto:volume>
    <j.0:title>Are high-performing health systems resilient against the COVID-19 epidemic?</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081209668</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081209668&amp;doi=10.1016%2fS0140-6736%2820%2930551-1&amp;partnerID=40&amp;md5=c29da3111d865917d13ad6fbdeb87ae2&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S0140-6736(20)30551-1</j.0:identifier>
    <schema:keywords>Coronavirus disease 2019; Coronavirus infection; disease surveillance; disinformation; government regulation; health care access; health care availability; health care cost; health care delivery; health care financing; health care system; health promotion; Hong Kong; human; infection control; information dissemination; integrated health care system; intensive care; Japan; laboratory test; medical education; medical information system; Note; political system; priority journal; protocol compliance; public health; quarantine; risk management; Singapore; South Korea; travel; treatment planning; virus transmission</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>10227</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081073725">
    <dc:language>English</dc:language>
    <j.0:title>Outbreak of coronavirus disease 2019</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081073725</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S1473-3099(20)30076-1</j.0:identifier>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081073725&amp;doi=10.1016%2fS1473-3099%2820%2930076-1&amp;partnerID=40&amp;md5=3b43135e70ab4793fc8aff2644e9f0ee&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet._Infectious_diseases">
        <j.1:name>The Lancet. Infectious diseases</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Burki T.</dc:creator>
    <myOnto:volume>20</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081970015">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:title>Trainees and covid-19: your questions answered</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081970015</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m1059</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:creator>Rimmer A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081970015&amp;doi=10.1136%2fbmj.m1059&amp;partnerID=40&amp;md5=b377d8f42a9f6da757030d118ede1735&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081041920">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <dc:creator>Colson P., La Scola B., Esteves-Vieira V., Ninove L., Zandotti C., Jimeno M.-T., Gazin C., Bedotto M., Filosa V., Giraud-Gatineau A., Chaudet H., Brouqui P., Lagier J.-C., Raoult D.</dc:creator>
    <j.0:identifier>2-s2.0-85081041920</j.0:identifier>
    <myOnto:volume>25</myOnto:volume>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.8.2000171</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; classification; Coronavirinae; Coronavirus infection; genetics; human; mortality; polymerase chain reaction; SARS coronavirus; virus pneumonia; Betacoronavirus; Coronavirus; Coronavirus Infections; Humans; Pneumonia, Viral; Polymerase Chain Reaction; SARS Virus</schema:keywords>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:title>Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081041920&amp;doi=10.2807%2f1560-7917.ES.2020.25.8.2000171&amp;partnerID=40&amp;md5=b3d0a623c9ab9db4120c69afceb0d80f&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>8</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079755488">
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>9</myOnto:citeyBy>
    <j.0:identifier>10.1038/d41573-020-00016-0</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <dc:creator>Li G., De Clercq E.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Nature_reviews._Drug_discovery">
        <j.1:name>Nature reviews. Drug discovery</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079755488&amp;doi=10.1038%2fd41573-020-00016-0&amp;partnerID=40&amp;md5=710760bfac8a85a05e54f56855afc77e&gt;</schema:url>
    <myOnto:issue>3</myOnto:issue>
    <schema:keywords>adenosine phosphate; alanine; alpha interferon; antivirus agent; coronavirus spike glycoprotein; COVID-19; macrogol; nucleoside; peginterferon alpha2a; proteinase inhibitor; recombinant protein; remdesivir; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; drug effect; drug repositioning; genetics; hepatitis B; hepatitis C; human; Human immunodeficiency virus infection; influenza; Middle East respiratory syndrome coronavirus; pathogenicity; SARS coronavirus; virus pneumonia; Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Drug Repositioning; Hepatitis B; Hepatitis C; HIV Infections; Humans; Influenza, Human; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Nucleosides; Pneumonia, Viral; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; SARS Virus; Spike Glycoprotein, Coronavirus</schema:keywords>
    <j.0:title>Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079755488</j.0:identifier>
    <myOnto:volume>19</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079688163">
    <schema:keywords>2019 novel coronavirus; China; conjunctiva epithelium; Coronavirinae; coronavirus disease 2019; Coronavirus infection; eye; human; infection risk; Letter; medical expert; mucosa; nonhuman; ophthalmologist; priority journal; SARS coronavirus; virus transmission; Betacoronavirus; Coronavirus infection; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus; Coronavirus Infections; Humans</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:identifier>2-s2.0-85079688163</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079688163&amp;doi=10.1016%2fS0140-6736%2820%2930313-5&amp;partnerID=40&amp;md5=9c723540249901f7cbcdf6e8c75b86c7&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S0140-6736(20)30313-5</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>14</myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:issue>10224</myOnto:issue>
    <j.0:title>2019-nCoV transmission through the ocular surface must not be ignored</j.0:title>
    <dc:creator>Lu C.-W., Liu X.-F., Jia Z.-F.</dc:creator>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081125581">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:title>Lessons for managing high-consequence infections from first COVID-19 cases in the UK</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>10227</myOnto:issue>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>2-s2.0-85081125581</j.0:identifier>
    <schema:keywords>coronavirus disease 2019; human; infection control; Letter; nonhuman; priority journal; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; United Kingdom</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081125581&amp;doi=10.1016%2fS0140-6736%2820%2930463-3&amp;partnerID=40&amp;md5=b20cf874f6493e19962749388193f164&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/S0140-6736(20)30463-3</j.0:identifier>
    <dc:creator>Moss P., Barlow G., Easom N., Lillie P., Samson A.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080072717">
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/S2213-2600(20)30070-9</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <dc:creator>Ippolito G., Hui D.S., Ntoumi F., Maeurer M., Zumla A.</dc:creator>
    <myOnto:issue>3</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:volume>8</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords>China; comorbidity; coronavirus disease 2019; Coronavirus infection; diagnostic test; Ebola hemorrhagic fever; epidemic; health disparity; human; incubation time; infection control; interpersonal communication; mass screening; medical information; Middle East respiratory syndrome; mortality rate; Note; patient risk; perception; priority journal; Saudi Arabia; severe acute respiratory syndrome; social media; virus detection; Betacoronavirus; communicable disease; hope; pandemic; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Communicable Diseases, Emerging; Hope; Humans; Pandemics</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Toning down the 2019-nCoV media hype—and restoring hope</j.0:title>
    <j.0:identifier>2-s2.0-85080072717</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080072717&amp;doi=10.1016%2fS2213-2600%2820%2930070-9&amp;partnerID=40&amp;md5=22d7bd4e8ed66e93c74af6d29d521dd2&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147050">
    <j.0:identifier>2-s2.0-85082147050</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>antivirus agent; COVID-19; antibiotic prophylaxis; artificial ventilation; China; Chinese medicine; Coronavirus infection; critical illness; electrolyte balance; human; mental stress; nutritional support; psychology; shock; virus pneumonia; Antibiotic Prophylaxis; Antiviral Agents; China; Coronavirus Infections; Critical Illness; Humans; Medicine, Chinese Traditional; Nutritional Support; Pneumonia, Viral; Respiration, Artificial; Shock; Stress, Psychological; Water-Electrolyte Balance</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier></j.0:identifier>
    <dc:creator>Xu K., Cai H., Shen Y., Ni Q., Chen Y., Hu S., Li J., Wang H., Yu L., Huang H., Qiu Y., Wei G., Fang Q., Zhou J., Sheng J., Liang T., Li L.</dc:creator>
    <dc:language>Chinese</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Zhejiang_da_xue_xue_bao._Yi_xue_ban_=_Journal_of_Zhejiang_University._Medical_sciences">
        <j.1:name>Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <rdfs:comment>The current epidemic situation of corona virus disease-19 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 inZhejiang Province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance"strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinarypersonalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in10% patients'blood samples at acute periodand 50% of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifyingcytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance"strategyeffectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviraleffects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favoredthe balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short periods of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis should be prescribed rationally and was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbialdysbiosis with decreasedprobiotics such as Lactobacillus and Bifidobacterium. Nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore, we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the SARS-CoV-2 infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience above and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.</rdfs:comment>
    <j.0:title>Management of corona virus disease-19 (COVID-19): the Zhejiang experience</j.0:title>
    <myOnto:volume>49</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147050&amp;partnerID=40&amp;md5=2789cc99698bc9b5307ec9dff0b46ef4&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082201221">
    <j.0:identifier>10.1016/S2468-2667(20)30060-8</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>2-s2.0-85082201221</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>The resilience of the Spanish health system against the COVID-19 pandemic</j.0:title>
    <dc:creator>Legido-Quigley H., Mateos-García J.T., Campos V.R., Gea-Sánchez M., Muntaner C., McKee M.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Public_Health">
        <j.1:name>The Lancet Public Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082201221&amp;doi=10.1016%2fS2468-2667%2820%2930060-8&amp;partnerID=40&amp;md5=f700ac0cd651801dbbe4fea47993c3bd&gt;</schema:url>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081683741">
    <myOnto:volume>7</myOnto:volume>
    <j.0:title>Mental health care for international Chinese students affected by the COVID-19 outbreak</j.0:title>
    <dc:creator>Zhai Y., Du X.</dc:creator>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/S2215-0366(20)30089-4</j.0:identifier>
    <j.0:identifier>2-s2.0-85081683741</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081683741&amp;doi=10.1016%2fS2215-0366%2820%2930089-4&amp;partnerID=40&amp;md5=b4d88abb4c6a5f2d584217da23e29809&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082179834">
    <myOnto:issue></myOnto:issue>
    <j.0:title>COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082179834&amp;doi=10.1080%2f21645515.2020.1735227&amp;partnerID=40&amp;md5=2b67d758a5d6b27635eb9782a97e9d7f&gt;</schema:url>
    <dc:creator>Dhama K., Sharun K., Tiwari R., Dadar M., Malik Y.S., Singh K.P., Chaicumpa W.</dc:creator>
    <rdfs:comment>The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS in the past decades. However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS. Most of the efforts for developing CoV vaccines and drugs target the spike glycoprotein or S protein, the major inducer of neutralizing antibodies. Although a few candidates have shown efficacy in in vitro studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt this emerging virus infection. © 2020, © 2020 Taylor &amp; Francis Group, LLC.</rdfs:comment>
    <j.0:type>Review</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082179834</j.0:identifier>
    <j.0:publisher>Taylor and Francis Inc.</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Human_Vaccines_and_Immunotherapeutics">
        <j.1:name>Human Vaccines and Immunotherapeutics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1080/21645515.2020.1735227</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080112605">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <myOnto:issue>9</myOnto:issue>
    <dc:creator>Rubin E.J., Baden L.R., Morrissey S.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080112605&amp;doi=10.1056%2fNEJMe2003319&amp;partnerID=40&amp;md5=41a2fbe319673feca91b0bd351e5c2a7&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <j.0:title>Audio interview: Preparing for the spread of covid-19</j.0:title>
    <myOnto:volume>382</myOnto:volume>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; disease transmission; health care planning; health care policy; human; infection control; information dissemination; Japan; organization and management; pandemic; prevention and control; procedures; publication; publishing; United States; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disease Transmission, Infectious; Editorial Policies; Health Planning; Health Policy; Humans; Infection Control; Information Dissemination; Japan; Pandemics; Periodicals as Topic; Pneumonia, Viral; United States</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080112605</j.0:identifier>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <j.0:identifier>10.1056/NEJMe2003319</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079802097">
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:title>Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079802097</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>• Novel coronavirus (COVID-19)-infected pneumonia usually manifests as bilateral ground-glass opacities in the lung periphery on chest CT scans. • Role of radiologists includes not only early detection of lung abnormality, but also suggestion of disease severity, potential progression to acute respiratory distress syndrome, and possible bacterial co-infection in hospitalized patients. © 2020, European Society of Radiology.</rdfs:comment>
    <dc:creator>Kim H.</dc:creator>
    <j.0:identifier>10.1007/s00330-020-06748-2</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079802097&amp;doi=10.1007%2fs00330-020-06748-2&amp;partnerID=40&amp;md5=a3c3c9975e428ac01e99bf95a1627f97&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_Radiology"/>
    <j.0:publisher>Springer</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081270365">
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:issue>10228</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/S0140-6736(20)30567-5</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081270365&amp;doi=10.1016%2fS0140-6736%2820%2930567-5&amp;partnerID=40&amp;md5=9b5d95f99664b37a20c72e28ee8b2006&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>How will country-based mitigation measures influence the course of the COVID-19 epidemic?</j.0:title>
    <schema:keywords></schema:keywords>
    <myOnto:volume>395</myOnto:volume>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Anderson R.M., Heesterbeek H., Klinkenberg D., Hollingsworth T.D.</dc:creator>
    <j.0:identifier>2-s2.0-85081270365</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081614187">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081614187&amp;doi=10.1007%2fs40475-020-00201-6&amp;partnerID=40&amp;md5=6594991fc09fbadf108d82da2827020e&gt;</schema:url>
    <dc:creator>Chen W.-H., Strych U., Hotez P.J., Bottazzi M.E.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:language>English</dc:language>
    <rdfs:comment>Purpose of Review: The goal of this review is to provide a timely overview on efforts to develop a vaccine for the 2019 novel coronavirus SARS-CoV-2, the causative agent of coronavirus disease (COVID-19). Recent Findings: Previous research efforts to develop a severe acute respiratory syndrome coronavirus (SARS-CoV) vaccine in the years following the 2003 pandemic have opened the door for investigators to design vaccine concepts and approaches for the COVID-19 epidemic in China. Both SARS-CoV and SARS-CoV-2 exhibit a high degree of genetic similarity and bind to the same host cell ACE2 receptor. Based on previous experience with SARS-CoV vaccines, it is expected that all COVID-19 vaccines will require careful safety evaluations for immunopotentiation that could lead to increased infectivity or eosinophilic infiltration. Besides this, a COVID-19 vaccine target product profile must address vaccinating at-risk human populations including frontline healthcare workers, individuals over the age of 60, and those with underlying and debilitating chronic conditions. Among the vaccine technologies under evaluation are whole virus vaccines, recombinant protein subunit vaccines, and nucleic acid vaccines. Summary: Each current vaccine strategy has distinct advantages and disadvantages. Therefore, it is paramount that multiple strategies be advanced quickly and then evaluated for safety and efficacy. Ultimately, the safety studies to minimize undesired immunopotentiation will become the most significant bottleneck in terms of time. © 2020, Springer Nature Switzerland AG.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Review</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1007/s40475-020-00201-6</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Current_Tropical_Medicine_Reports">
        <j.1:name>Current Tropical Medicine Reports</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The SARS-CoV-2 Vaccine Pipeline: an Overview</j.0:title>
    <j.0:identifier>2-s2.0-85081614187</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081903439">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Covid-19: UK trade talks with EU must not hinder cooperation in tackling threat, BMA warns</j.0:title>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081903439</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Rimmer A.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1136/bmj.m988</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081903439&amp;doi=10.1136%2fbmj.m988&amp;partnerID=40&amp;md5=17e8bd0e6122471ece43b14fe38b91aa&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>368</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080104612">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; communicable disease; Coronavirus infection; epidemic; human; Middle East respiratory syndrome coronavirus; pathogenicity; pathology; SARS coronavirus; severe acute respiratory syndrome; virology; virus pneumonia; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Disease Outbreaks; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080104612&amp;doi=10.1002%2fjmv.25709&amp;partnerID=40&amp;md5=f0e6d5bbcb5f65d7b126dc3a032df4a7&gt;</schema:url>
    <myOnto:volume>92</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85080104612</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1002/jmv.25709</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_medical_virology">
        <j.1:name>Journal of medical virology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>5</myOnto:issue>
    <rdfs:comment>First reported from Wuhan, The People's Republic of China, on 31 December 2019, the ongoing outbreak of a novel coronavirus (2019-nCoV) causes great global concerns. Based on the advice of the International Health Regulations Emergency Committee and the fact that to date 24 other countries also reported cases, the WHO Director-General declared that the outbreak of 2019-nCoV constitutes a Public Health Emergency of International Concern on 30 January 2020. Together with the other two highly pathogenic coronaviruses, the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), 2019-nCov and other yet to be identified coronaviruses pose a global threat to public health. In this mini-review, we provide a brief introduction to the pathology and pathogenesis of SARS-CoV and MERS-CoV and extrapolate this knowledge to the newly identified 2019-nCoV. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:type>Review</j.0:type>
    <dc:creator>Liu J., Zheng X., Tong Q., Li W., Wang B., Sutter K., Trilling M., Lu M., Dittmer U., Yang D.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081257852">
    <j.0:title>Coronavirus disinfection in histopathology</j.0:title>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1080/01478885.2020.1734718</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081257852&amp;doi=10.1080%2f01478885.2020.1734718&amp;partnerID=40&amp;md5=dc54aea50f131a1a59292bb7b94e9524&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Histotechnology">
        <j.1:name>Journal of Histotechnology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Henwood A.F.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85081257852</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>The 2019 Coronavirus epidemic, provisionally called 2019-nCoV, was first identified in Wuhan, China, in persons exposed to a seafood or wet market. There is an international push to contain the virus and prevent its spread. It is feasible that potentially infectious samples may be received in histopathology laboratories for diagnosis. This technical note presents disinfection procedures and histotechnology processes that should alleviate the risk of infection to laboratory staff. Using data obtained from similar coronaviruses, e.g. severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), experts are confident that 70% ethanol and 0.1% sodium hypochlorite should inactivate the virus. Formalin fixation and heating samples to 56oC, as used in routine tissue processing, were found to inactivate several coronaviruses and it is believed that 2019-nCoV would be similarly affected. © 2020, © 2020 National Society for Histotechnology.</rdfs:comment>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081664551">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Xi'an Jiaotong University</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Shen C., Yu N., Cai S., Zhou J., Sheng J., Liu K., Zhou H., Guo Y., Niu G.</dc:creator>
    <j.0:identifier>2-s2.0-85081664551</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081664551&amp;doi=10.1016%2fj.jpha.2020.03.004&amp;partnerID=40&amp;md5=e6eeee95068abc01fbe6541f8dd54c74&gt;</schema:url>
    <j.0:identifier>10.1016/j.jpha.2020.03.004</j.0:identifier>
    <schema:keywords></schema:keywords>
    <rdfs:comment>Purpose: To examine the feasibility of using a computer tool for stratifying the severity of Coronavirus Disease 2019 (COVID-19) based on computed tomography (CT) images. Materials and methods: We retrospectively examined 44 confirmed COVID-19 cases. All cases were evaluated separately by radiologists (visually) and through an in-house computer software. The degree of lesions was visually scored by the radiologist, as follows, for each of the 5 lung lobes: 0, no lesion present; 1, &amp;lt;1/3 involvement; 2, &amp;gt;1/3 and &amp;lt; 2/3 involvement; and 3, &amp;gt;2/3 involvement. Lesion density was assessed based on the proportion of ground-glass opacity (GGO), consolidation and fibrosis of the lesions. The parameters obtained using the computer tool included lung volume (mL), lesion volume (mL), lesion percentage (%), and mean lesion density (HU) of the whole lung, right lung, left lung, and each lobe. The scores obtained by the radiologists and quantitative results generated by the computer software were tested for correlation. A Chi-square test was used to test the consistency of radiologist- and computer-derived lesion percentage in the right/left lung, upper/lower lobe, and each of the 5 lobes. Result: The results showed a strong to moderate correlation between lesion percentage scores obtained by radiologists and the computer software (r ranged from 0.7679 to 0.8373, P &amp;lt; 0.05), and a moderate correlation between the proportion of GGO and mean lesion density (r = ?0.5894, P &amp;lt; 0.05), and proportion of consolidation and mean lesion density (r = 0.6282, P &amp;lt; 0.05). Computer-aided quantification showed a statistical significant higher lesion percentage for lower lobes than that assessed by the radiologists (?2 = 8.160, P = 0.004). Conclusions: Our experiments demonstrated that the computer tool could reliably and accurately assess the severity and distribution of pneumonia on CT scans. © 2020 Xi&amp;apos;an Jiaotong University</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Pharmaceutical_Analysis">
        <j.1:name>Journal of Pharmaceutical Analysis</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <j.0:title>Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081330940">
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:title>Does SARS-CoV-2 has a longer incubation period than SARS and MERS?</j.0:title>
    <myOnto:volume>92</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1002/jmv.25708</j.0:identifier>
    <rdfs:comment>The outbreak of a novel coronavirus (SARS-CoV-2) since December 2019 in Wuhan, the major transportation hub in central China, became an emergency of major international concern. While several etiological studies have begun to reveal the specific biological features of this virus, the epidemic characteristics need to be elucidated. Notably, a long incubation time was reported to be associated with SARS-CoV-2 infection, leading to adjustments in screening and control policies. To avoid the risk of virus spread, all potentially exposed subjects are required to be isolated for 14 days, which is the longest predicted incubation time. However, based on our analysis of a larger dataset available so far, we find there is no observable difference between the incubation time for SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV), and middle east respiratory syndrome coronavirus (MERS-CoV), highlighting the need for larger and well-annotated datasets. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:issue>5</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081330940&amp;doi=10.1002%2fjmv.25708&amp;partnerID=40&amp;md5=1d4509fc82bb2474358e33b90307a7a9&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081330940</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; basic reproduction number; Betacoronavirus; China; Coronavirus infection; human; incubation time; information processing; Middle East respiratory syndrome coronavirus; pathogenicity; pathology; SARS coronavirus; severe acute respiratory syndrome; time factor; virology; virus pneumonia; Basic Reproduction Number; Betacoronavirus; China; Coronavirus Infections; Datasets as Topic; Humans; Infectious Disease Incubation Period; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome; Time Factors</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Jiang X., Rayner S., Luo M.-H.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081275949">
    <j.0:identifier>10.1136/bmj.m800</j.0:identifier>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Coronavirus disease 2019 (covid-19): A guide for UK GPS</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081275949&amp;doi=10.1136%2fbmj.m800&amp;partnerID=40&amp;md5=dcba54075ee28f29dce8ec62d5e5547e&gt;</schema:url>
    <dc:creator>Razai M.S., Doerholt K., Ladhani S., Oakeshott P.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>2-s2.0-85081275949</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:volume>368</myOnto:volume>
    <schema:keywords>clinical protocol; comorbidity; convalescence; Coronavirinae; coronavirus disease 2019; coughing; critically ill patient; disease severity; dyspnea; fever; general practitioner; high risk population; human; mortality rate; nonhuman; Note; patient assessment; patient isolation; primary medical care; priority journal; public health; severe acute respiratory syndrome; United Kingdom; virus transmission; virus virulence; Coronavirus infection; practice guideline; Coronavirus Infections; General Practitioners; Humans; Practice Guidelines as Topic; United Kingdom</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081655719">
    <dc:creator>Konrad R., Eberle U., Dangel A., Treis B., Berger A., Bengs K., Fingerle V., Liebl B., Ackermann N., Sing A.</dc:creator>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.9.2000173</j.0:identifier>
    <j.0:identifier>2-s2.0-85081655719</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:volume>25</myOnto:volume>
    <rdfs:comment>The need for timely establishment of diagnostic assays arose when Germany was confronted with the first travel-associated outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Europe. We describe our laboratory experiences during a large contact tracing investigation, comparing previously published real-time RT-PCR assays in different PCR systems and a commercial kit. We found that assay performance using the same primers and probes with different PCR systems varied and the commercial kit performed well.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081655719&amp;doi=10.2807%2f1560-7917.ES.2020.25.9.2000173&amp;partnerID=40&amp;md5=aac2e284f51a0c10ff1e2459163d2e87&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:issue>9</myOnto:issue>
    <j.0:title>Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020</j.0:title>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; virus envelope protein; Betacoronavirus; Coronavirus infection; DNA microarray; genetics; Germany; human; isolation and purification; procedures; real time polymerase chain reaction; sensitivity and specificity; time factor; virus pneumonia; workflow; Betacoronavirus; Coronavirus Infections; Germany; Humans; Oligonucleotide Array Sequence Analysis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors; Viral Envelope Proteins; Workflow</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079840316">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079840316</j.0:identifier>
    <schema:keywords>leucine; serine; COVID-19; proteome; severe acute respiratory syndrome coronavirus 2; virus RNA; Article; Bat coronavirus; Betacoronavirus; comparative proteomics; gene sequence; genetic heterogeneity; genetic variability; nonhuman; nucleotide sequence; open reading frame; phylogenetic tree; SARS coronavirus; sequence homology; Severe acute respiratory syndrome coronavirus 2; virus genome; amino acid sequence; animal; bat; Betacoronavirus; biological model; classification; Coronavirus infection; genetic variation; genetics; human; phylogeny; virology; virus pneumonia; Amino Acid Sequence; Animals; Base Sequence; Betacoronavirus; Chiroptera; Coronavirus Infections; Genetic Variation; Genome, Viral; Humans; Models, Genetic; Phylogeny; Pneumonia, Viral; Proteome; RNA, Viral</schema:keywords>
    <rdfs:comment>There is a rising global concern for the recently emerged novel coronavirus (2019-nCoV). Full genomic sequences have been released by the worldwide scientific community in the last few weeks to understand the evolutionary origin and molecular characteristics of this virus. Taking advantage of all the genomic information currently available, we constructed a phylogenetic tree including also representatives of other coronaviridae, such as Bat coronavirus (BCoV) and severe acute respiratory syndrome. We confirm high sequence similarity (&gt;99%) between all sequenced 2019-nCoVs genomes available, with the closest BCoV sequence sharing 96.2% sequence identity, confirming the notion of a zoonotic origin of 2019-nCoV. Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hypervariable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein. Finally, we perform a full proteomic comparison with other coronaviridae, identifying key aminoacidic differences to be considered for antiviral strategies deriving from previous anti-coronavirus approaches. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25700</j.0:identifier>
    <myOnto:volume>92</myOnto:volume>
    <dc:creator>Ceraolo C., Giorgi F.M.</dc:creator>
    <j.0:type>Article</j.0:type>
    <j.0:title>Genomic variance of the 2019-nCoV coronavirus</j.0:title>
    <myOnto:issue>5</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079840316&amp;doi=10.1002%2fjmv.25700&amp;partnerID=40&amp;md5=c4f6f1b2282961a8dfe2cb5fd8fb427b&gt;</schema:url>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:citeyBy>3</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082201244">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
    <schema:keywords></schema:keywords>
    <dc:creator>Hosoda T., Sakamoto M., Shimizu H., Okabe N.</dc:creator>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082201244&amp;doi=10.1017%2fice.2020.87&amp;partnerID=40&amp;md5=faba36dc363cf3aba6f20efe373b2bbb&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1017/ice.2020.87</j.0:identifier>
    <j.0:title>SARS-CoV-2 enterocolitis with persisting to excrete the virus for about two weeks after recovering from diarrhea: A case report</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082201244</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082127487">
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1001/jamapediatrics.2020.0828</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_Pediatrics">
        <j.1:name>JAMA Pediatrics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082127487</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <dc:creator>Thompson L.A., Rasmussen S.A.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082127487&amp;doi=10.1001%2fjamapediatrics.2020.0828&amp;partnerID=40&amp;md5=04bee4e54db729ef34b5f73c8c640785&gt;</schema:url>
    <j.0:title>What Does the Coronavirus Disease 2019 (COVID-19) Mean for Families?</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081277908">
    <j.0:title>COVID-19 and Blood Safety: Help with a Dilemma</j.0:title>
    <j.0:identifier>2-s2.0-85081277908</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.tmrv.2020.02.004</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081277908&amp;doi=10.1016%2fj.tmrv.2020.02.004&amp;partnerID=40&amp;md5=6efa4735828b51886fce5a3ee4e21f34&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Transfusion_Medicine_Reviews">
        <j.1:name>Transfusion Medicine Reviews</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:publisher>W.B. Saunders</j.0:publisher>
    <dc:creator>Dodd R.Y., Stramer S.L.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081884656">
    <j.0:title>Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0): Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <rdfs:comment>Since December 2019, China has been experiencing an outbreak of a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical features include fever, coughing, shortness of breath, and inflammatory lung infiltration. China rapidly listed SARS-CoV-2-related pneumonia as a statutory infectious disease. To standardize the diagnosis and treatment of this new infectious disease, an operational recommendation for the diagnosis and management of SARS-CoV-2 infection is developed by Peking Union Medical College Hospital. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081884656&amp;doi=10.1080%2f22221751.2020.1735265&amp;partnerID=40&amp;md5=722b1d22453e83b52fe240b4ad10b244&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>COVID-19; Coronavirus infection; health care personnel; hospital; human; occupational exposure; patient isolation; practice guideline; virus pneumonia; Coronavirus Infections; Health Personnel; Hospitals; Humans; Occupational Exposure; Patient Isolation; Pneumonia, Viral; Practice Guidelines as Topic</schema:keywords>
    <myOnto:volume>9</myOnto:volume>
    <j.0:identifier>10.1080/22221751.2020.1735265</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081884656</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:creator>Li T.</dc:creator>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081683655">
    <myOnto:volume>12</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081683655&amp;doi=10.1126%2fscitranslmed.abb1469&amp;partnerID=40&amp;md5=9bd82fb6371b44aa3773dd87bdc50b2d&gt;</schema:url>
    <dc:creator>Layne S.P., Hyman J.M., Morens D.M., Taubenberger J.K.</dc:creator>
    <j.0:identifier>2-s2.0-85081683655</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; epidemiological monitoring; Europe; forecasting; host pathogen interaction; human; information dissemination; pandemic; pathogenicity; public health; quarantine; social status; theoretical model; United States; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Epidemiological Monitoring; Europe; Forecasting; Host-Pathogen Interactions; Humans; Information Dissemination; Models, Theoretical; Pandemics; Pneumonia, Viral; Public Health; Quarantine; Social Conditions; United States</schema:keywords>
    <myOnto:issue>534</myOnto:issue>
    <j.0:title>New coronavirus outbreak: Framing questions for pandemic prevention</j.0:title>
    <rdfs:comment>We need to understand and quantify the dominant variables that govern the SARS-CoV-2 outbreak, rather than relying exclusively on confirmed cases and their geospatial spread. Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Science_translational_medicine">
        <j.1:name>Science translational medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1126/scitranslmed.abb1469</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079147633">
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>33</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079147633&amp;doi=10.1016%2fj.tmaid.2020.101572&amp;partnerID=40&amp;md5=da4292d499450e7a60d4bf4df72770fc&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079147633</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <dc:creator>Wilson M.E.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>2019 novel coronavirus; Aedes; aircraft; Anopheles; Coronavirinae; Dengue virus; Editorial; emporiatrics; human; nonhuman; priority journal; Salmonella; virus transmission; Zika virus; animal; Betacoronavirus; Coronavirus infection; dengue; environmental exposure; hygiene; infection control; isolation and purification; mass screening; pathogenicity; virus pneumonia; Zika fever; COVID-19; severe acute respiratory syndrome coronavirus 2; Aedes; Aircraft; Animals; Anopheles; Betacoronavirus; Coronavirus Infections; Dengue; Environmental Exposure; Humans; Hygiene; Infection Control; Mass Screening; Pneumonia, Viral; Salmonella; Travel Medicine; Zika Virus; Zika Virus Infection</schema:keywords>
    <j.0:identifier>10.1016/j.tmaid.2020.101572</j.0:identifier>
    <j.0:title>What goes on board aircraft? Passengers include Aedes, Anopheles, 2019-nCoV, dengue, Salmonella, Zika, et al</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082018971">
    <j.0:title>Using public health law to contain the spread of COVID-19</j.0:title>
    <j.0:identifier>10.12968/bjon.2020.29.5.326</j.0:identifier>
    <j.0:identifier>2-s2.0-85082018971</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082018971&amp;doi=10.12968%2fbjon.2020.29.5.326&amp;partnerID=40&amp;md5=21694133915fcfaaf5580d6b2a36875c&gt;</schema:url>
    <myOnto:volume>29</myOnto:volume>
    <j.0:type>Short Survey</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; human; legislation and jurisprudence; national health service; public health; United Kingdom; virus pneumonia; Betacoronavirus; Coronavirus Infections; Humans; Pneumonia, Viral; Public Health; State Medicine; United Kingdom</schema:keywords>
    <myOnto:issue>5</myOnto:issue>
    <dc:creator>Griffith R.</dc:creator>
    <j.0:publisher>MA Healthcare Ltd</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Nursing">
        <j.1:name>British Journal of Nursing</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081229235">
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Clinical_Nursing">
        <j.1:name>Journal of Clinical Nursing</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081229235&amp;doi=10.1111%2fjocn.15231&amp;partnerID=40&amp;md5=a65883793db32d093538d580618168db&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:title>COVID-19: Emerging compassion, courage and resilience in the face of misinformation and adversity</j.0:title>
    <j.0:identifier>10.1111/jocn.15231</j.0:identifier>
    <j.0:identifier>2-s2.0-85081229235</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <dc:creator>Smith G.D., Ng F., Ho Cheung Li W.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081667424">
    <rdfs:comment>There is currently a lack of pathologic data on the novel coronavirus (severe acute respiratory syndrome coronavirus 2) pneumonia, or coronavirus disease 2019 (COVID-19), from autopsy or biopsy. Two patients who recently underwent lung lobectomies for adenocarcinoma were retrospectively found to have had COVID-19 at the time of the operation. These two cases thus provide important first opportunities to study the pathology of COVID-19. Pathologic examinations revealed that apart from the tumors, the lungs of both patients exhibited edema, proteinaceous exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular infiltration, and multinucleated giant cells. Hyaline membranes were not prominent. Because both patients did not exhibit symptoms of pneumonia at the time of operation, these changes likely represent an early phase of the lung pathology of COVID-19 pneumonia. © 2020 International Association for the Study of Lung Cancer</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Thoracic_Oncology">
        <j.1:name>Journal of Thoracic Oncology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier Inc</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081667424&amp;doi=10.1016%2fj.jtho.2020.02.010&amp;partnerID=40&amp;md5=d2ccf24a4e0f73bfb5debf718b6d641c&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081667424</j.0:identifier>
    <j.0:title>Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <dc:creator>Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.-Y.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jtho.2020.02.010</j.0:identifier>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082063693">
    <myOnto:volume>35</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:title>First pediatric case of coronavirus disease 2019 in Korea</j.0:title>
    <myOnto:issue>11</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082063693&amp;doi=10.3346%2fjkms.2020.35.e124&amp;partnerID=40&amp;md5=060b0b70e6b220bcc224d44f89918115&gt;</schema:url>
    <dc:creator>Park J.Y., Han M.S., Park K.U., Kim J.Y., Choi E.H.</dc:creator>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; case report; child; Coronavirus infection; diagnostic imaging; female; human; isolation and purification; lung; South Korea; virus pneumonia; Betacoronavirus; Child; Coronavirus Infections; Female; Humans; Lung; Pneumonia, Viral; Republic of Korea</schema:keywords>
    <rdfs:comment>The large outbreak of coronavirus disease 2019 (COVID-19) that started in Wuhan, China has now spread to many countries worldwide. Current epidemiologic knowledge suggests that relatively few cases are seen among children, which limits opportunities to address pediatric specific issues on infection control and the children's contribution to viral spread in the community. Here, we report the first pediatric case of COVID-19 in Korea. The 10-year-old girl was a close contact of her uncle and mother who were confirmed to have COVID-19. In this report, we present mild clinical course of her pneumonia that did not require antiviral treatment and serial viral test results from multiple specimens. Lastly, we raise concerns on the optimal strategy of self-quarantine and patient care in a negative isolation room for children. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>10.3346/jkms.2020.35.e124</j.0:identifier>
    <j.0:identifier>2-s2.0-85082063693</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081894912">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081894912</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <schema:keywords>2019 novel coronavirus; audio interview; clinical decision making; Coronavirinae; disease transmission; Editorial; general practitioner; health care management; human; intersectoral collaboration; interview; priority journal; public health; SARS coronavirus; SARS coronavirus 2; Betacoronavirus; Coronavirus infection; patient care; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus Infections; Humans; Patient Care; Pneumonia, Viral</schema:keywords>
    <j.0:title>Audio interview: Making decisions about testing and treatment for your patients</j.0:title>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
    <myOnto:issue>11</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081894912&amp;doi=10.1056%2fNEJMe2004856&amp;partnerID=40&amp;md5=94974c03605ef4cc230fdcb3c39dc113&gt;</schema:url>
    <dc:creator>Rubin E.J., Baden L.R., Morrissey S.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <myOnto:volume>382</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1056/NEJMe2004856</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079886204">
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>10225</myOnto:issue>
    <j.0:identifier>2-s2.0-85079886204</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <dc:creator>Shimizu K.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>10.1016/S0140-6736(20)30357-3</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079886204&amp;doi=10.1016%2fS0140-6736%2820%2930357-3&amp;partnerID=40&amp;md5=e490a56198b34e38e04944236e334d20&gt;</schema:url>
    <j.0:title>2019-nCoV, fake news, and racism</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; asymptomatic infection; China; Coronavirinae; Coronavirus infection; disinformation; epidemic; global health; health care facility; health care planning; human; infection risk; interpersonal communication; Japan; Japanese (people); Letter; nonhuman; priority journal; quarantine; racism; social media; virus transmission; xenophobia; Coronavirus infection; racism; social media; virus pneumonia; COVID-19; China; Coronavirus Infections; Disease Outbreaks; Humans; Japan; Pneumonia, Viral; Racism; Social Media</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081001439">
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081001439&amp;doi=10.1007%2fs12264-020-00476-9&amp;partnerID=40&amp;md5=2a73094f8245ce164c3fbff102f7bdfc&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Zhu Y., Chen L., Ji H., Xi M., Fang Y., Li Y.</dc:creator>
    <j.0:title>The Risk and Prevention of Novel Coronavirus Pneumonia Infections Among Inpatients in Psychiatric Hospitals</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Neuroscience_Bulletin">
        <j.1:name>Neuroscience Bulletin</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081001439</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume>36</myOnto:volume>
    <j.0:publisher>Springer</j.0:publisher>
    <schema:keywords>COVID-19; coping behavior; Coronavirus infection; epidemic; hospital patient; human; mental hospital; risk factor; virus pneumonia; Adaptation, Psychological; Coronavirus Infections; Disease Outbreaks; Hospitals, Psychiatric; Humans; Inpatients; Pneumonia, Viral; Risk Factors</schema:keywords>
    <j.0:identifier>10.1007/s12264-020-00476-9</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080040954">
    <j.0:identifier>10.1016/j.tmaid.2020.101606</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <dc:creator>Huang Y., Tu M., Wang S., Chen S., Zhou W., Chen D., Zhou L., Wang M., Zhao Y., Zeng W., Huang Q., Xu H., Liu Z., Guo L.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080040954&amp;doi=10.1016%2fj.tmaid.2020.101606&amp;partnerID=40&amp;md5=33bd36403bc7866477e75c66025ffd13&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080040954</j.0:identifier>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082093259">
    <j.0:identifier>10.1186/s40779-020-00240-0</j.0:identifier>
    <j.0:title>The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status</j.0:title>
    <schema:keywords>angiotensin converting enzyme 2; COVID-19; dipeptidyl carboxypeptidase; severe acute respiratory syndrome coronavirus 2; virus envelope protein; adult; aged; Alphacoronavirus; animal; bat; Betacoronavirus; China; Coronavirus infection; coughing; diarrhea; disease carrier; epidemic; fatigue; female; fever; genetics; human; male; middle aged; Middle East respiratory syndrome coronavirus; pathogenicity; SARS coronavirus; virulence; virus pneumonia; virus replication; Adult; Aged; Alphacoronavirus; Animals; Betacoronavirus; China; Chiroptera; Coronavirus Infections; Cough; Diarrhea; Disease Outbreaks; Disease Reservoirs; Fatigue; Female; Fever; Humans; Male; Middle Aged; Middle East Respiratory Syndrome Coronavirus; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS Virus; Viral Envelope Proteins; Virulence; Virus Replication</schema:keywords>
    <j.0:identifier>2-s2.0-85082093259</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Military_Medical_Research"/>
    <rdfs:comment>An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. The emergence of SARS-CoV-2, since the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century. As of 1 March 2020, a total of 87,137 confirmed cases globally, 79,968 confirmed in China and 7169 outside of China, with 2977 deaths (3.4%) had been reported by WHO. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to ?-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the natural host. The novel coronavirus uses the same receptor, angiotensin-converting enzyme 2 (ACE2) as that for SARS-CoV, and mainly spreads through the respiratory tract. Importantly, increasingly evidence showed sustained human-to-human transmission, along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, cough, fatigue and a small population of patients appeared gastrointestinal infection symptoms. The elderly and people with underlying diseases are susceptible to infection and prone to serious outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. Currently, there are few specific antiviral strategies, but several potent candidates of antivirals and repurposed drugs are under urgent investigation. In this review, we summarized the latest research progress of the epidemiology, pathogenesis, and clinical characteristics of COVID-19, and discussed the current treatment and scientific advancements to combat the epidemic novel coronavirus.</rdfs:comment>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082093259&amp;doi=10.1186%2fs40779-020-00240-0&amp;partnerID=40&amp;md5=2ef445be15dce7e706a38e9e6a621380&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Review</j.0:type>
    <dc:creator>Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., Tan K.-S., Wang D.-Y., Yan Y.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>7</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079396997">
    <myOnto:volume>5</myOnto:volume>
    <schema:keywords>2019 novel coronavirus; Article; basic reproduction number; control strategy; coronavirus disease 2019; disease control; disease transmission; infectious agent; mathematical model; public health; risk factor; RNA virus; virus transmission</schema:keywords>
    <rdfs:comment>The basic reproduction number of an infectious agent is the average number of infections one case can generate over the course of the infectious period, in a naïve, uninfected population. It is well-known that the estimation of this number may vary due to several methodological issues, including different assumptions and choice of parameters, utilized models, used datasets and estimation period. With the spreading of the novel coronavirus (2019-nCoV) infection, the reproduction number has been found to vary, reflecting the dynamics of transmission of the coronavirus outbreak as well as the case reporting rate. Due to significant variations in the control strategies, which have been changing over time, and thanks to the introduction of detection technologies that have been rapidly improved, enabling to shorten the time from infection/symptoms onset to diagnosis, leading to faster confirmation of the new coronavirus cases, our previous estimations on the transmission risk of the 2019-nCoV need to be revised. By using time-dependent contact and diagnose rates, we refit our previously proposed dynamics transmission model to the data available until January 29th, 2020 and re-estimated the effective daily reproduction ratio that better quantifies the evolution of the interventions. We estimated when the effective daily reproduction ratio has fallen below 1 and when the epidemics will peak. Our updated findings suggest that the best measure is persistent and strict self-isolation. The epidemics will continue to grow, and can peak soon with the peak time depending highly on the public health interventions practically implemented. © 2020 The Authors</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Disease_Modelling">
        <j.1:name>Infectious Disease Modelling</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079396997&amp;doi=10.1016%2fj.idm.2020.02.001&amp;partnerID=40&amp;md5=f283ab69bffd4605bbbfb069074ed340&gt;</schema:url>
    <j.0:publisher>KeAi Communications Co.</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85079396997</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:creator>Tang B., Bragazzi N.L., Li Q., Tang S., Xiao Y., Wu J.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.idm.2020.02.001</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081889457">
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <j.0:title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <dc:date>2020</dc:date>
    <dc:creator>Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.-L., Abiona O., Graham B.S., McLellan J.S.</dc:creator>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <rdfs:comment>The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis. © 2020 American Association for the Advancement of Science. All rights reserved.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081889457&amp;doi=10.1126%2fscience.aax0902&amp;partnerID=40&amp;md5=4f6b0cd6bcc5ff5d73415c13ce8efd4b&gt;</schema:url>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:issue>6483</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords>2019 nCoV S protein; angiotensin converting enzyme 2; unclassified drug; viral protein; angiotensin converting enzyme 2; coronavirus spike glycoprotein; dipeptidyl carboxypeptidase; monoclonal antibody; protein binding; severe acute respiratory syndrome coronavirus 2; virus antibody; virus receptor; antibody; detection method; electron microscopy; protein; public health; severe acute respiratory syndrome; virus; Article; binding affinity; biophysics; corona virus disease 2019; Coronavirus infection; cross reaction; cryoelectron microscopy; molecular dynamics; nonhuman; priority journal; protein binding; protein structure; SARS coronavirus; virus transmission; virus virulence; Betacoronavirus; chemistry; cryoelectron microscopy; image processing; immunology; metabolism; molecular model; protein conformation; protein domain; protein multimerization; ultrastructure; Coronavirus; SARS coronavirus; Antibodies, Monoclonal; Antibodies, Viral; Betacoronavirus; Cross Reactions; Cryoelectron Microscopy; Image Processing, Computer-Assisted; Models, Molecular; Peptidyl-Dipeptidase A; Protein Binding; Protein Conformation; Protein Domains; Protein Multimerization; Receptors, Virus; SARS Virus; Spike Glycoprotein, Coronavirus</schema:keywords>
    <j.0:identifier>2-s2.0-85081889457</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1126/science.aax0902</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081982403">
    <dc:creator>McCloskey B., Zumla A., Ippolito G., Blumberg L., Arbon P., Cicero A., Endericks T., Lim P.L., Borodina M., WHO Novel Coronavirus-19 Mass Gatherings Expert Group</dc:creator>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081982403&amp;doi=10.1016%2fS0140-6736%2820%2930681-4&amp;partnerID=40&amp;md5=1c3e16789c560428b4b816af44823841&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1016/S0140-6736(20)30681-4</j.0:identifier>
    <j.0:identifier>2-s2.0-85081982403</j.0:identifier>
    <j.0:title>Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma</j.0:title>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081674852">
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081674852&amp;doi=10.1016%2fS0140-6736%2820%2930644-9&amp;partnerID=40&amp;md5=0ec1db12b590e67e3c1b84822dbe06fd&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:creator>The Lancet</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>COVID-19: protecting health-care workers</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30644-9</j.0:identifier>
    <j.0:identifier>2-s2.0-85081674852</j.0:identifier>
    <myOnto:issue>10228</myOnto:issue>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081267145">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081267145</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081267145&amp;doi=10.1007%2fs00134-020-05991-x&amp;partnerID=40&amp;md5=c45f9df8d6be453604f57c1f97de36f2&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <j.0:title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</j.0:title>
    <dc:creator>Ruan Q., Yang K., Wang W., Jiang L., Song J.</dc:creator>
    <j.0:identifier>10.1007/s00134-020-05991-x</j.0:identifier>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081643309">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081643309&amp;doi=10.1016%2fS2215-0366%2820%2930076-6&amp;partnerID=40&amp;md5=0ec686b65a32e6da47ba9634e997d154&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Liem A., Wang C., Wariyanti Y., Latkin C.A., Hall B.J.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>4</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
    <dc:date>2020</dc:date>
    <myOnto:volume>7</myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>10.1016/S2215-0366(20)30076-6</j.0:identifier>
    <j.0:identifier>2-s2.0-85081643309</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:title>The neglected health of international migrant workers in the COVID-19 epidemic</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079750962">
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Oral_Science">
        <j.1:name>International Journal of Oral Science</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas (TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life. © 2020, The Author(s).</rdfs:comment>
    <j.0:title>High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</j.0:title>
    <j.0:identifier>10.1038/s41368-020-0074-x</j.0:identifier>
    <myOnto:volume>12</myOnto:volume>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079750962&amp;doi=10.1038%2fs41368-020-0074-x&amp;partnerID=40&amp;md5=fa1fa4a4df670a136dc8acd16e717f6e&gt;</schema:url>
    <schema:keywords>angiotensin converting enzyme 2; COVID-19; dipeptidyl carboxypeptidase; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; enzymology; epithelium cell; gene expression profiling; genetic database; genetics; human; metabolism; mouth mucosa; pathogenicity; tongue; virology; virus pneumonia; Betacoronavirus; Coronavirus Infections; Databases, Genetic; Epithelial Cells; Gene Expression Profiling; Humans; Mouth Mucosa; Peptidyl-Dipeptidase A; Pneumonia, Viral; Tongue</schema:keywords>
    <j.0:identifier>2-s2.0-85079750962</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <dc:creator>Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., Li T., Chen Q.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079760608">
    <dc:language>English</dc:language>
    <myOnto:volume>368</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series</j.0:title>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <schema:keywords>adolescent; adult; child; China; clinical trial; Coronavirus infection; coughing; female; fever; human; male; middle aged; multicenter study; prognosis; retrospective study; severe acute respiratory syndrome; thorax radiography; virology; x-ray computed tomography; young adult; Adolescent; Adult; Child; China; Coronavirus Infections; Cough; Female; Fever; Humans; Male; Middle Aged; Prognosis; Radiography, Thoracic; Retrospective Studies; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Young Adult</schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Xu X.-W., Wu X.-X., Jiang X.-G., Xu K.-J., Ying L.-J., Ma C.-L., Li S.-B., Wang H.-Y., Zhang S., Gao H.-N., Sheng J.-F., Cai H.-L., Qiu Y.-Q., Li L.-J.</dc:creator>
    <rdfs:comment>AbstractObjective To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019). Design Retrospective case series. Setting Seven hospitals in Zhejiang province, China. Participants 62 patients admitted to hospital with laboratory confirmed SARS-Cov-2 infection. Data were collected from 10 January 2020 to 26 January 2020. Main outcome measures Clinical data, collected using a standardised case report form, such as temperature, history of exposure, incubation period. If information was not clear, the working group in Hangzhou contacted the doctor responsible for treating the patient for clarification. Results Of the 62 patients studied (median age 41 years), only one was admitted to an intensive care unit, and no patients died during the study. According to research, none of the infected patients in Zhejiang province were ever exposed to the Huanan seafood market, the original source of the virus; all studied cases were infected by human to human transmission. The most common symptoms at onset of illness were fever in 48 (77%) patients, cough in 50 (81%), expectoration in 35 (56%), headache in 21 (34%), myalgia or fatigue in 32 (52%), diarrhoea in 3 (8%), and haemoptysis in 2 (3%). Only two patients (3%) developed shortness of breath on admission. The median time from exposure to onset of illness was 4 days (interquartile range 3-5 days), and from onset of symptoms to first hospital admission was 2 (1-4) days. Conclusion As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild. © Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079760608</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079760608&amp;doi=10.1136%2fbmj.m606&amp;partnerID=40&amp;md5=24a52da43031b7aaf2956e63619e23fe&gt;</schema:url>
    <j.0:identifier>10.1136/bmj.m606</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147646">
    <dc:creator>Coombes R.</dc:creator>
    <myOnto:volume>368</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Covid-19: experts question the evidence behind closing London Underground and city metros during the pandemic</j.0:title>
    <j.0:identifier>10.1136/bmj.m1154</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082147646</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147646&amp;doi=10.1136%2fbmj.m1154&amp;partnerID=40&amp;md5=e0e98daf6e5c0520211a72184688f9ac&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080931731">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080931731&amp;doi=10.1056%2fNEJMc2001621&amp;partnerID=40&amp;md5=e15c781196291227a0558fc673fccb33&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>11</myOnto:issue>
    <dc:creator>Pongpirul W.A., Pongpirul K., Ratnarathon A.C., Prasithsirikul W.</dc:creator>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <j.0:identifier>10.1056/NEJMc2001621</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <myOnto:volume>382</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; adult; case report; Chinese; clinical article; Coronavirinae; coughing; dyspnea; fever; hospital admission; hospital discharge; human; human tissue; hypertension; Letter; lung infiltrate; male; middle aged; myalgia; non insulin dependent diabetes mellitus; nonmedical occupations; patient isolation; patient referral; prescription; priority journal; real time reverse transcription polymerase chain reaction; SARS coronavirus; severe acute respiratory syndrome; taxi driver; Thai (people); Thailand; thorax radiography; throat culture; tourism; Betacoronavirus; China; complication; Coronavirus infection; dyspnea; fever; genetics; isolation and purification; occupational exposure; traffic and transport; travel; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Dyspnea; Fever; Humans; Male; Middle Aged; Occupational Exposure; Pneumonia, Viral; Thailand; Transportation; Travel</schema:keywords>
    <j.0:identifier>2-s2.0-85080931731</j.0:identifier>
    <j.0:title>Journey of a Thai Taxi driver and novel coronavirus</j.0:title>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081279880">
    <j.0:type>Note</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1001/jama.2020.2342</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:title>Preparing for the Most Critically Ill Patients with COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation</j.0:title>
    <dc:creator>Maclaren G., Fisher D., Brodie D.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081279880&amp;doi=10.1001%2fjama.2020.2342&amp;partnerID=40&amp;md5=70a717a37557bb55215f4ebd02a7379d&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081279880</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080967262">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080967262&amp;doi=10.1136%2fbmj.m764&amp;partnerID=40&amp;md5=58dc6d6dbce5de10df48d1280a38268a&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>368</myOnto:volume>
    <dc:date>2020</dc:date>
    <dc:creator>Chiolero A.</dc:creator>
    <j.0:identifier>10.1136/bmj.m764</j.0:identifier>
    <j.0:title>Covid-19: A digital epidemic</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080967262</j.0:identifier>
    <schema:keywords>Coronavirus disease 2019; Coronavirus infection; epidemic; health care cost; infection risk; Letter; mortality rate; priority journal; quarantine</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081104990">
    <j.0:type>Review</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>9</myOnto:issue>
    <j.0:identifier>2-s2.0-85081104990</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081104990&amp;doi=10.1093%2ffemspd%2fftaa006&amp;partnerID=40&amp;md5=efdd043653d5dbe2735de25e3dca3282&gt;</schema:url>
    <j.0:publisher>Oxford University Press</j.0:publisher>
    <j.0:title>Coronaviruses: A paradigm of new emerging zoonotic diseases</j.0:title>
    <schema:keywords>2019 novel coronavirus; Coronavirus infection; human; priority journal; Review; virus; virus transmission; animal; bat; Betacoronavirus; China; Coronavirus infection; genetics; molecular evolution; mortality; pandemic; virology; virus pneumonia; zoonosis; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; China; Chiroptera; Coronavirus Infections; Evolution, Molecular; Humans; Pandemics; Pneumonia, Viral; Zoonoses</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1093/femspd/ftaa006</j.0:identifier>
    <dc:creator>Salata C., Calistri A., Parolin C., Palù G.</dc:creator>
    <myOnto:volume>77</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pathogens_and_Disease">
        <j.1:name>Pathogens and Disease</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>A novel type of coronavirus (2019-nCoV) infecting humans appeared in Wuhan, China, at the end of December 2019. Since the identification of the outbreak the infection quickly spread involving in one month more than 31,000 confirmed cases with 638 death. Molecular analysis suggest that 2019-nCoV could be originated from bats after passaging in intermediate hosts, highlighting the high zoonotic potential of coronaviruses. © FEMS 2020.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082112664">
    <myOnto:issue>3</myOnto:issue>
    <j.0:title>Sars-cov-2 and coronavirus disease 2019: What we know so far</j.0:title>
    <dc:language>English</dc:language>
    <rdfs:comment>In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <j.0:identifier>10.3390/pathogens9030231</j.0:identifier>
    <j.0:identifier>2-s2.0-85082112664</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Pathogens"/>
    <myOnto:volume>9</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082112664&amp;doi=10.3390%2fpathogens9030231&amp;partnerID=40&amp;md5=79cda7265021485bba57ac92ee27a1b1&gt;</schema:url>
    <dc:creator>Rabi F.A., Al Zoubi M.S., Al-Nasser A.D., Kasasbeh G.A., Salameh D.M.</dc:creator>
    <j.0:type>Review</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081402984">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081402984</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing</j.0:title>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <dc:creator>Wang C.J., Ng C.Y., Brook R.H.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1001/jama.2020.3151</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081402984&amp;doi=10.1001%2fjama.2020.3151&amp;partnerID=40&amp;md5=ec134e559c75871cbf6b96ee86ca11f9&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy>2</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082144683">
    <j.0:identifier>2-s2.0-85082144683</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <rdfs:comment>???? 2019????, ??????????? (COVID-19) ????????, ????????????????????, ?????????????????????, ???????3 000??????????, ??????????????????, ???????????, ????????????????????????????????????????, ??????????????????, ????????????????????????????????????????????????????????????, ?????????????, ?????????????.Since the end of 2019, the coronavirus disease 2019 (COVID-19) has been extensively epidemic in China, which not only seriously threatens the safety and health of Chinese people, but also challenges the management of other infectious diseases. Currently, there are still approximately three thousand malaria cases imported into China every year. If the diagnosis and treatment of malaria cases as well as the investigation and response of the epidemic foci are not carried out timely, it may endanger patients'lives and cause the possible of secondary transmission, which threatens the achievements of malaria elimination in China. Due to the extensive spread and high transmission ability of the COVID-19, there is a possibility of virus infections among malaria cases during the medical care-seeking behaviors and among healthcare professionals during clinical diagnosis and treatment, sample collection and testing and epidemiological surveys. This paper analyzes the challenges of the COVID-19 for Chinese malaria elimination programme, and proposes the countermeasures in response to the COVID-19 outbreak, so as to provide the reference for healthcare professionals.</rdfs:comment>
    <myOnto:volume>32</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.16250/j.32.1374.2020036</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Zhongguo_xue_xi_chong_bing_fang_zhi_za_zhi_=_Chinese_journal_of_schistosomiasis_control">
        <j.1:name>Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; epidemic; human; malaria; public health; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Humans; Malaria; National Health Programs; Pneumonia, Viral</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082144683&amp;doi=10.16250%2fj.32.1374.2020036&amp;partnerID=40&amp;md5=03f1f2ade993be3bfa5fc3c70c474401&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Zhu G.D., Cao J.</dc:creator>
    <j.0:title>Challenges and countermeasures on Chinese malaria elimination programme during the coronavirus disease 2019 (COVID-19) outbreak</j.0:title>
    <dc:language>Chinese</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079840094">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079840094&amp;doi=10.30773%2fpi.2020.0058&amp;partnerID=40&amp;md5=696273195236f0515246695e02b3c42e&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079840094</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>2019 novel coronavirus; anxiety; coronavirus disease 2019; disease exacerbation; distress syndrome; Editorial; health care personnel; hemodialysis; human; insomnia; Middle East respiratory syndrome; pneumonia; practice guideline; psychiatric treatment; upper respiratory tract infection</schema:keywords>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>10.30773/pi.2020.0058</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Psychiatry_Investigation">
        <j.1:name>Psychiatry Investigation</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Park S.-C., Park Y.C.</dc:creator>
    <j.0:publisher>Korean Neuropsychiatric Association</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>17</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Mental health care measures in response to the 2019 novel coronavirus outbreak in Korea</j.0:title>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081574242">
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Qiu J., Shen B., Zhao M., Wang Z., Xie B., Xu Y.</dc:creator>
    <dc:language>English</dc:language>
    <rdfs:comment>The Coronavirus Disease 2019 (COVID-19) epidemic emerged in Wuhan, China, spread nationwide and then onto half a dozen other countries between December 2019 and early 2020. The implementation of unprecedented strict quarantine measures in China has kept a large number of people in isolation and affected many aspects of people's lives. It has also triggered a wide variety of psychological problems, such as panic disorder, anxiety and depression. This study is the first nationwide large-scale survey of psychological distress in the general population of China during the COVID-19 epidemic. © Author(s) (or their employer(s)) 2020.</rdfs:comment>
    <j.0:title>A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations</j.0:title>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081574242</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/General_Psychiatry">
        <j.1:name>General Psychiatry</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081574242&amp;doi=10.1136%2fgpsych-2020-100213&amp;partnerID=40&amp;md5=28f24eb05fe17f1b1083395bee8262d4&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:identifier>10.1136/gpsych-2020-100213</j.0:identifier>
    <myOnto:volume>33</myOnto:volume>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079756488">
    <j.0:identifier>2-s2.0-85079756488</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079756488&amp;doi=10.1136%2fbjophthalmol-2020-315994&amp;partnerID=40&amp;md5=5eb9ca22f70addbce51cab70c7914fa9&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>coronavirus disease 2019; Coronavirus infection; Editorial; eye disease; eye protection; hand washing; human; Human coronavirus NL63; infection prevention; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; mortality; nonhuman; ophthalmologist; pandemic; prevalence; priority journal; SARS coronavirus; severe acute respiratory syndrome; viral conjunctivitis; viral contamination; Betacoronavirus; Coronavirus infection; eye; eye protective device; isolation and purification; virology; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus Infections; Eye; Eye Protective Devices; Humans; Pneumonia, Viral</schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:volume>104</myOnto:volume>
    <j.0:identifier>10.1136/bjophthalmol-2020-315994</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:issue>3</myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Ophthalmology">
        <j.1:name>British Journal of Ophthalmology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear</j.0:title>
    <dc:creator>Li J.-P.O., Lam D.S.C., Chen Y., Ting D.S.W.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082084350">
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1002/ppul.24737</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Yasri S., Wiwanitkit V.</dc:creator>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082084350&amp;doi=10.1002%2fppul.24737&amp;partnerID=40&amp;md5=8175a2107f6316830083c1b8973671c4&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082084350</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pediatric_Pulmonology">
        <j.1:name>Pediatric Pulmonology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Clinical features in pediatric COVID-19</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081610362">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081610362&amp;doi=10.1007%2fs11427-020-1660-2&amp;partnerID=40&amp;md5=055145340acd4f84747bd9779f43a290&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need</j.0:title>
    <j.0:identifier>2-s2.0-85081610362</j.0:identifier>
    <j.0:publisher>Science in China Press</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1007/s11427-020-1660-2</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science_China_Life_Sciences"/>
    <dc:date>2020</dc:date>
    <dc:creator>Zhang T., He Y., Xu W., Ma A., Yang Y., Xu K.-F.</dc:creator>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082038349">
    <myOnto:volume>91</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.23750/abm.v91i1.9402</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082038349&amp;doi=10.23750%2fabm.v91i1.9402&amp;partnerID=40&amp;md5=138968e9bfaddb0ad472b4eec1adc2e1&gt;</schema:url>
    <dc:creator>Baglivo M., Baronio M., Natalini G., Beccari T., Chiurazzi P., Fulcheri E., Petralia P.P., Michelini S., Fiorentini G., Miggiano G.A., Morresi A., Tonini G., Bertelli M.</dc:creator>
    <myOnto:issue>1</myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Acta_bio-medica_:_Atenei_Parmensis">
        <j.1:name>Acta bio-medica : Atenei Parmensis</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>antivirus agent; COVID-19; lipid; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; chemistry; Coronavirus infection; drug effect; human; molecular library; pharmacology; physiology; virus attachment; virus pneumonia; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Humans; Lipids; Pneumonia, Viral; Small Molecule Libraries; Virus Attachment</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85082038349</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>BACKGROUND: Viral infectivity depends on interactions between components of the host cell plasma membrane and the virus envelope. Here we review strategies that could help stem the advance of the SARS-COV-2 epidemic. METHODS AND RESULTS: We focus on the role of lipid structures, such as lipid rafts and cholesterol, involved in the process, mediated by endocytosis, by which viruses attach to and infect cells. Previous studies have shown that many naturally derived substances, such as cyclodextrin and sterols, could reduce the infectivity of many types of viruses, including the coronavirus family, through interference with lipid-dependent attachment to human host cells. CONCLUSIONS: Certain molecules prove able to reduce the infectivity of some coronaviruses, possibly by inhibiting viral lipid-dependent attachment to host cells. More research into these molecules and methods would be worthwhile as it could provide insights the mechanism of transmission of SARS-COV-2 and, into how they could become a basis for new antiviral strategies.</rdfs:comment>
    <j.0:title>Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080089938">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <schema:keywords>alanine aminotransferase; amoxicillin plus clavulanic acid; antitussive agent; aspartate aminotransferase; C reactive protein; ceftriaxone; lactate dehydrogenase; COVID-19; severe acute respiratory syndrome coronavirus 2; abnormal respiratory sound; adult; antibiotic therapy; Article; blood pressure; body temperature; breathing rate; case report; China; clinical article; comparative study; computer assisted tomography; Coronavirus infection; coughing; dyspnea; fatigue; female; fever; follow up; hospital admission; hospital discharge; human; hypothyroidism; laboratory test; lymphocytopenia; medical history; middle aged; oxygen saturation; physical examination; pneumonia; quarantine; real time reverse transcription polymerase chain reaction; SARS coronavirus; sore throat; Streptococcus gallolyticus; Taiwan; urinalysis; urine culture; Betacoronavirus; Coronavirus infection; isolation and purification; virology; virus pneumonia; watchful waiting; Betacoronavirus; Coronavirus Infections; Female; Humans; Middle Aged; Pneumonia, Viral; Taiwan; Watchful Waiting</schema:keywords>
    <dc:creator>Cheng S.-C., Chang Y.-C., Fan Chiang Y.-L., Chien Y.-C., Cheng M., Yang C.-H., Huang C.-H., Hsu Y.-N.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:volume>119</myOnto:volume>
    <j.0:identifier>10.1016/j.jfma.2020.02.007</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_Formosan_Medical_Association">
        <j.1:name>Journal of the Formosan Medical Association</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>3</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080089938&amp;doi=10.1016%2fj.jfma.2020.02.007&amp;partnerID=40&amp;md5=64f0c72ac85183c0340e46eefc96ce34&gt;</schema:url>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <rdfs:comment>An outbreak of respiratory illness proved to be infected by a 2019 novel coronavirus, officially named Coronavirus Disease 2019 (COVID-19), was notified first in Wuhan, China, and has spread rapidly in China and to other parts of the world. Herein, we reported the first confirmed case of novel coronavirus pneumonia (NCP) imported from China in Taiwan. This case report revealed a natural course of NCP with self-recovery, which may be a good example in comparison with medical treatments. © 2020</rdfs:comment>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080089938</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080886294">
    <myOnto:issue>8</myOnto:issue>
    <j.0:identifier>10.1136/vr.m740</j.0:identifier>
    <j.0:title>Where did SARS-CoV-2 come from?</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080886294</j.0:identifier>
    <dc:creator>Zhai S.-L., Wei W.-K., Lv D.-H., Xu Z.-H., Chen Q.-L., Sun M.-F., Li F., Wang D.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; bat; Betacoronavirus; Coronavirus infection; disease carrier; human; pandemic; veterinary medicine; virology; virus pneumonia; zoonosis; Animals; Betacoronavirus; Chiroptera; Coronavirus Infections; Disease Reservoirs; Humans; Pandemics; Pneumonia, Viral; Zoonoses</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Veterinary_Record">
        <j.1:name>Veterinary Record</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>186</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>British Veterinary Association</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080886294&amp;doi=10.1136%2fvr.m740&amp;partnerID=40&amp;md5=162231f8cc8837d66e71f6a2490677ec&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082179878">
    <j.0:identifier>2-s2.0-85082179878</j.0:identifier>
    <dc:creator>Chan K.W., Wong V.T., Tang S.C.W.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082179878&amp;doi=10.1142%2fS0192415X20500378&amp;partnerID=40&amp;md5=cd860c9262f559efd8412cf678307cc1&gt;</schema:url>
    <j.0:identifier>10.1142/S0192415X20500378</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>World Scientific Publishing Co. Pte Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:title>COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease</j.0:title>
    <dc:language>English</dc:language>
    <rdfs:comment>As of 22 February 2020, more than 77662 cases of confirmed COVID-19 have been documented globally with over 2360 deaths. Common presentations of confirmed cases include fever, fatigue, dry cough, upper airway congestion, sputum production, shortness of breath, myalgia/arthralgia with lymphopenia, prolonged prothrombin time, elevated C-reactive protein, and elevated lactate dehydrogenase. The reported severe/critical case ratio is approximately 7-10% and median time to intensive care admission is 9.5-10.5 days with mortality of around 1-2% varied geographically. Similar to outbreaks of other newly identified virus, there is no proven regimen from conventional medicine and most reports managed the patients with lopinavir/ritonavir, ribavirin, beta-interferon, glucocorticoid and supportive treatment with remdesivir undergoing clinical trial. In China, Chinese medicine is proposed as a treatment option by national and provincial guidelines with substantial utilization. We reviewed the latest national and provincial clinical guidelines, retrospective cohort studies, and case series regarding the treatment of COVID-19 by add-on Chinese medicine. We have also reviewed the clinical evidence generated from SARS and H1N1 management with hypothesized mechanisms and latest in silico findings to identify candidate Chinese medicines for the consideration of possible trials and management. Given the paucity of strongly evidence-based regimens, the available data suggest that Chinese medicine could be considered as an adjunctive therapeutic option in the management of COVID-19. © 2020 World Scientific Publishing Company. Institute for Advanced Research in Asian Science and Medicine.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_Journal_of_Chinese_Medicine">
        <j.1:name>American Journal of Chinese Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081032556">
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Journal_of_Psychiatry">
        <j.1:name>Asian Journal of Psychiatry</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081032556</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081032556&amp;doi=10.1016%2fj.ajp.2020.101990&amp;partnerID=40&amp;md5=b244933224ff21ed3b8618fa3cce98dd&gt;</schema:url>
    <dc:creator>Zandifar A., Badrfam R.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:title>Iranian mental health during the COVID-19 epidemic</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume>51</myOnto:volume>
    <j.0:identifier>10.1016/j.ajp.2020.101990</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:keywords>anxiety disorder; coronavirus disease 2019; Coronavirus infection; depression; disease association; disease severity; epidemic; geography; health care system; health program; human; Iranian people; Letter; mental health; mental health care; priority journal</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081687456">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081687456&amp;doi=10.1016%2fj.ijid.2020.02.049&amp;partnerID=40&amp;md5=b725a4f158dd3f608f16065ede41380f&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081687456</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel Coronavirus; Africa; China; Coronavirus infection; Democratic Republic Congo; disease control; Ebolavirus; Editorial; epidemic; epidemiologist; health care personnel; human; Nigeria; nonhuman; public health; SARS coronavirus; World Health Organization</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Kapata N., Ihekweazu C., Ntoumi F., Raji T., Chanda-Kapata P., Mwaba P., Mukonka V., Bates M., Tembo J., Corman V., Mfinanga S., Asogun D., Elton L., Arruda L.B., Thomason M.J., Mboera L., Yavlinsky A., Haider N., Simons D., Hollmann L., Lule S.A., Veas F., Abdel Hamid M.M., Dar O., Edwards S., Vairo F., McHugh T.D., Drosten C., Kock R., Ippolito G., Zumla A.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.ijid.2020.02.049</j.0:identifier>
    <myOnto:volume>93</myOnto:volume>
    <j.0:title>Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081916231">
    <j.0:identifier>2-s2.0-85081916231</j.0:identifier>
    <j.0:publisher>Springer Medizin</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Medizinische_Klinik_-_Intensivmedizin_und_Notfallmedizin">
        <j.1:name>Medizinische Klinik - Intensivmedizin und Notfallmedizin</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081916231&amp;doi=10.1007%2fs00063-020-00674-3&amp;partnerID=40&amp;md5=747808610bed3ea755c748bb46489665&gt;</schema:url>
    <dc:language>German</dc:language>
    <j.0:identifier>10.1007/s00063-020-00674-3</j.0:identifier>
    <dc:creator>Kluge S., Janssens U., Welte T., Weber-Carstens S., Marx G., Karagiannidis C.</dc:creator>
    <j.0:title>Recommendations for critically ill patients with COVID-19 [Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19]</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081380582">
    <j.0:identifier>2-s2.0-85081380582</j.0:identifier>
    <dc:creator>Chung M., Bernheim A., Mei X., Zhang N., Huang M., Zeng X., Cui J., Xu W., Yang Y., Fayad Z.A., Jacobi A., Li K., Li S., Shan H.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Radiology">
        <j.1:name>Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081380582&amp;doi=10.1148%2fradiol.2020200230&amp;partnerID=40&amp;md5=ea5c47f80988f947d59da674716aeace&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; aged; Betacoronavirus; complication; Coronavirus infection; diagnostic imaging; disease exacerbation; female; human; isolation and purification; lung; male; middle aged; pathology; retrospective study; severe acute respiratory syndrome; virus pneumonia; x-ray computed tomography; Adult; Aged; Betacoronavirus; Coronavirus Infections; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pneumonia, Viral; Retrospective Studies; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>23</myOnto:citeyBy>
    <myOnto:volume>295</myOnto:volume>
    <myOnto:issue>1</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1148/radiol.2020200230</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>CT imaging features of 2019 novel coronavirus (2019-NCoV)</j.0:title>
    <rdfs:comment>In this retrospective case series, chest CT scans of 21 symptomatic patients from China infected with the 2019 novel coronavirus (2019-nCoV) were reviewed, with emphasis on identifying and characterizing the most common findings. Typical CT findings included bilateral pulmonary parenchymal ground-glass and consolidative pulmonary opacities, sometimes with a rounded morphology and a peripheral lung distribution. Notably, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy were absent. Follow-up imaging in a subset of patients during the study time window often demonstrated mild or moderate progression of disease, as manifested by increasing extent and density of lung opacities. © RSNA, 2020.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081988129">
    <dc:creator>Vincent J.-L., Slutsky A.S.</dc:creator>
    <j.0:identifier>10.1186/s13054-020-2824-8</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:volume>24</myOnto:volume>
    <j.0:title>Coronavirus: just imagine…</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081988129</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Critical_care_(London,_England)">
        <j.1:name>Critical care (London, England)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; epidemic; health care personnel; hospital bed utilization; human; intensive care unit; organization and management; pandemic; virus pneumonia; Bed Occupancy; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Health Personnel; Health Workforce; Humans; Intensive Care Units; Pandemics; Pneumonia, Viral</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081988129&amp;doi=10.1186%2fs13054-020-2824-8&amp;partnerID=40&amp;md5=93100fe7eb9b9f11915e3b781012bb7e&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081908667">
    <j.0:type>Note</j.0:type>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>The COVID-19 caused by a novel strain of Coronavirus has been spreading rapidly since its onset in Wuhan, the capital city of central China’s Hubei Province, in December 2019. It is highly communicable through human-to-human transmission. China has been making unprecedented efforts in treating the confirmed cases, identifying and isolating their close contacts and suspected cases to control the source of infection and cut the route of transmission. China’s devotion in handling this epidemic has effectively and efficiently curbed communication domestically and across the border. Representative measures adopted by Wenzhou, the worst hit city out of Hubei Province, are examined to elucidate those massive undertakings with the aim of enhancing international understanding and building global rapport in fighting this evolving epidemic situation. © 2020, Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081908667&amp;doi=10.1007%2fs11684-020-0755-z&amp;partnerID=40&amp;md5=f31c5026f73fa3407dca41416aa1d662&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Gong F., Xiong Y., Xiao J., Lin L., Liu X., Wang D., Li X.</dc:creator>
    <j.0:publisher>Higher Education Press</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Frontiers_of_Medicine">
        <j.1:name>Frontiers of Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:title>China’s local governments are combating COVID-19 with unprecedented responses — from a Wenzhou governance perspective</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081908667</j.0:identifier>
    <j.0:identifier>10.1007/s11684-020-0755-z</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082018536">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:identifier>2-s2.0-85082018536</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082018536&amp;doi=10.1055%2fa-1112-8430&amp;partnerID=40&amp;md5=3ed44125bbf75d8e1c9fb539a42fb857&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>4</myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/RoFo_:_Fortschritte_auf_dem_Gebiete_der_Rontgenstrahlen_und_der_Nuklearmedizin">
        <j.1:name>RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>192</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>German</dc:language>
    <j.0:identifier>10.1055/a-1112-8430</j.0:identifier>
    <j.0:title>COVID-19 – Information der AG Thoraxdiagnostik der Deutschen Röntgengesellschaft</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081650201">
    <dc:language>Chinese</dc:language>
    <myOnto:volume>20</myOnto:volume>
    <rdfs:comment>The epidemic of the SARS-CoV-2 infection has presented as a critical period. Until February 14th 2020, more than 55 000 cases of SARS-CoV-2 infection has been confirmed in China, which has a great impact on economy and society, and also seriously interfering with ordinary medical practice of ophthalmology. In order to protect ophthalmology medical staff from SARS-CoV-2 infection during the outbreak period, this paper suggests the necessary medical protective measures for ophthalmology outpatient and ward. Copyright 2020 by the IJO Press.</rdfs:comment>
    <j.0:identifier>2-s2.0-85081650201</j.0:identifier>
    <j.0:publisher>International Journal of Ophthalmology (c/o Editorial Office)</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Chen B., Zhang X., Sun X.-F.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.3980/j.issn.1672-5123.2020.3.41</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <schema:keywords>adult; article; case report; China; clinical article; economic aspect; female; human; male; medical practice; medical staff; nonhuman; ophthalmology; outpatient; SARS coronavirus</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081650201&amp;doi=10.3980%2fj.issn.1672-5123.2020.3.41&amp;partnerID=40&amp;md5=b2f5d02eacc5b84ee0489e55ddd1230e&gt;</schema:url>
    <j.0:title>Precaution of SARS-CoV-2 infection in ophthalmology medical staff [????????????????????]</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Eye_Science"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081007711">
    <j.0:identifier>10.1002/jmv.25723</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081007711&amp;doi=10.1002%2fjmv.25723&amp;partnerID=40&amp;md5=500da161833ea0958f5233de35477ba2&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081007711</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:creator>Lai A., Bergna A., Acciarri C., Galli M., Zehender G.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>To reconstruct the evolutionary dynamics of the 2019 novel-coronavirus recently causing an outbreak in Wuhan, China, 52 SARS-CoV-2 genomes available on 4 February 2020 at Global Initiative on Sharing All Influenza Data were analyzed. The two models used to estimate the reproduction number (coalescent-based exponential growth and a birth-death skyline method) indicated an estimated mean evolutionary rate of 7.8 × 10?4 subs/site/year (range, 1.1 × 10?4-15 × 10?4) and a mean tMRCA of the tree root of 73 days. The estimated R value was 2.6 (range, 2.1-5.1), and increased from 0.8 to 2.4 in December 2019. The estimated mean doubling time of the epidemic was between 3.6 and 4.1 days. This study proves the usefulness of phylogeny in supporting the surveillance of emerging new infections even as the epidemic is growing. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081643941">
    <myOnto:issue>7798</myOnto:issue>
    <dc:creator>Maxmen A.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:volume>579</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The race to unravel the biggest coronavirus outbreak in the United States</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1038/d41586-020-00676-3</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:identifier>2-s2.0-85081643941</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>COVID-19; Coronavirus infection; economics; epidemic; genetics; human; molecular diagnosis; organization; United States; virus genome; virus pneumonia; Academies and Institutes; Coronavirus Infections; Disease Outbreaks; Genome, Viral; Humans; Molecular Diagnostic Techniques; Pneumonia, Viral; United States</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081643941&amp;doi=10.1038%2fd41586-020-00676-3&amp;partnerID=40&amp;md5=368542225326ab237f6148319eb59c72&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081208379">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081208379&amp;doi=10.1016%2fj.cca.2020.03.009&amp;partnerID=40&amp;md5=12902133c2d0291d9f4e66fd7fa9e5f1&gt;</schema:url>
    <myOnto:volume>505</myOnto:volume>
    <dc:creator>Liu R., Han H., Liu F., Lv Z., Wu K., Liu Y., Feng Y., Zhu C.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020</j.0:title>
    <schema:keywords>adult; age; aged; Article; China; coronavirus disease 2019; female; hospital; human; infection risk; major clinical study; male; nose smear; nucleic acid analysis; priority journal; real time polymerase chain reaction; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; sex difference; throat culture; viral nucleic acid test; virus detection</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081208379</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinica_Chimica_Acta">
        <j.1:name>Clinica Chimica Acta</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>10.1016/j.cca.2020.03.009</j.0:identifier>
    <rdfs:comment>Background: There's an outbreak of a novel coronavirus (SARS-CoV-2) infection since December 2019, first in China, and currently with more than 80 thousand confirmed infection globally in 29 countries till March 2, 2020. Identification, isolation and caring for patients early are essential to limit human-to-human transmission including reducing secondary infections among close contacts and health care workers, preventing transmission amplification events. The RT-PCR detection of viral nucleic acid test (NAT) was one of the most quickly established laboratory diagnosis method in a novel viral pandemic, just as in this COVID-19 outbreak. Methods: 4880 cases that had respiratory infection symptoms or close contact with COVID-19 patients in hospital in Wuhan, China, were tested for SARS-CoV-2 infection by use of quantitative RT-PCR (qRT-PCR) on samples from the respiratory tract. Positive rates were calculated in groups divided by genders or ages. Results: The positive rate was about 38% for the total 4880 specimens. Male and older population had a significant higher positive rates. However, 57% was positive among the specimens from the Fever Clinics. Binary logistic regression analysis showed that age, not gender, was the risk factor for SARS-CoV-2 infection in fever clinics. Conclusions: Therefore, we concluded that viral NAT played an important role in identifying SARS-CoV-2 infection. © 2020 Elsevier B.V.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081251362">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.dsx.2020.03.002</j.0:identifier>
    <schema:keywords>angiotensin converting enzyme 2; ascorbic acid; beta interferon; chloroquine; glucose; lopinavir; remdesivir; ritonavir; RNA directed RNA polymerase inhibitor; 2019 novel coronavirus; Coronavirinae; Coronavirus infection; coughing; diabetes mellitus; diabetic patient; disease course; disease severity; dyspnea; epidemic; fever; glucose blood level; glycemic control; human; hydration; infection prevention; infection risk; mortality rate; non insulin dependent diabetes mellitus; patient isolation; prevalence; priority journal; protein intake; respiratory tract infection; Review; vaccination; virus load</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>2-s2.0-85081251362</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081251362&amp;doi=10.1016%2fj.dsx.2020.03.002&amp;partnerID=40&amp;md5=94028cc1cc6315089e4aec8142c8a00e&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:title>Clinical considerations for patients with diabetes in times of COVID-19 epidemic</j.0:title>
    <myOnto:volume>14</myOnto:volume>
    <dc:creator>Gupta R., Ghosh A., Singh A.K., Misra A.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Diabetes_and_Metabolic_Syndrome:_Clinical_Research_and_Reviews">
        <j.1:name>Diabetes and Metabolic Syndrome: Clinical Research and Reviews</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082195288">
    <dc:creator>Stevens M.P., Patel P.K., Nori P.</dc:creator>
    <j.0:identifier>10.1017/ice.2020.69</j.0:identifier>
    <j.0:title>Involving Antimicrobial Stewardship Programs in COVID-19 Response Efforts: All Hands on Deck</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
    <j.0:type>Letter</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85082195288</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082195288&amp;doi=10.1017%2fice.2020.69&amp;partnerID=40&amp;md5=b25cc014b40060bf2c315018d5e40c82&gt;</schema:url>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080026376">
    <j.0:title>Corona Virus International Public Health Emergencies: Implications for Radiology Management</j.0:title>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <j.0:identifier>2-s2.0-85080026376</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:creator>Zhang H.-W., Yu J., Xu H.-J., Lei Y., Pu Z.-H., Dai W.-C., Lin F., Wang Y.-L., Wu X.-L., Liu L.-H., Li M., Mo Y.-Q., Zhang H., Luo S.-P., Chen H., Lyu G.-W., Zhou Z.-G., Liu W.-M., Liu X.-L., Song H.-Y., Chen F.-Z., Zeng L., Zhong H., Guo T.-T., Hu Y.-Q., Yang X.-X., Liu P.-N., Li D.-F.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>Article; clinical classification; clinical effectiveness; clinical examination; computer assisted tomography; contact isolation; Coronavirinae; coronavirus disease 2019; Coronavirus infection; emergency care; hand washing; human; infection prevention; managed care; pneumonia; priority journal; public health; radiology; radiology department; treatment response time</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>The outbreak of 2019 novel coronavirus (2019-nCoV) pneumonia was reported in Wuhan, Hubei Province, China in December 2019 and has spread internationally. This article discusses how radiology departments can most effectively respond to this public health emergency. © 2020 The Association of University Radiologists</rdfs:comment>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>10.1016/j.acra.2020.02.003</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Academic_Radiology"/>
    <myOnto:volume>27</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080026376&amp;doi=10.1016%2fj.acra.2020.02.003&amp;partnerID=40&amp;md5=3450b9ceb9976d426f8a44453e55d8bd&gt;</schema:url>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081241418">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081241418&amp;doi=10.1148%2fradiol.2020200274&amp;partnerID=40&amp;md5=947e4504391d6d91c5cb8b1643759d41&gt;</schema:url>
    <myOnto:issue>1</myOnto:issue>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adolescent; adult; age; Betacoronavirus; China; complication; Coronavirus infection; coughing; diagnostic imaging; epidemiology; female; fever; human; isolation and purification; leukocyte count; lung; male; middle aged; pathology; real time polymerase chain reaction; retrospective study; virus pneumonia; x-ray computed tomography; young adult; Adolescent; Adult; Age Factors; Betacoronavirus; China; Coronavirus Infections; Cough; Female; Fever; Humans; Leukocyte Count; Lung; Male; Middle Aged; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; Tomography, X-Ray Computed; Young Adult</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081241418</j.0:identifier>
    <dc:creator>Song F., Shi N., Shan F., Zhang Z., Shen J., Lu H., Ling Y., Jiang Y., Shi Y.</dc:creator>
    <j.0:identifier>10.1148/radiol.2020200274</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <j.0:title>Emerging 2019 novel coronavirus (2019-NCoV) pneumonia</j.0:title>
    <myOnto:volume>295</myOnto:volume>
    <rdfs:comment>Background: The chest CT findings of patients with 2019 Novel Coronavirus (2019-nCoV) pneumonia have not previously been described in detail. Purpose: To investigate the clinical, laboratory, and imaging findings of emerging 2019-nCoV pneumonia in humans. Materials and Methods: Fifty-one patients (25 men and 26 women; age range 16–76 years) with laboratory-confirmed 2019-nCoV infection by using real-time reverse transcription polymerase chain reaction underwent thin-section CT. The imaging findings, clinical data, and laboratory data were evaluated. Results: Fifty of 51 patients (98%) had a history of contact with individuals from the endemic center in Wuhan, China. Fever (49 of 51, 96%) and cough (24 of 51, 47%) were the most common symptoms. Most patients had a normal white blood cell count (37 of 51, 73%), neutrophil count (44 of 51, 86%), and either normal (17 of 51, 35%) or reduced (33 of 51, 65%) lymphocyte count. CT images showed pure ground-glass opacity (GGO) in 39 of 51 (77%) patients and GGO with reticular and/ or interlobular septal thickening in 38 of 51 (75%) patients. GGO with consolidation was present in 30 of 51 (59%) patients, and pure consolidation was present in 28 of 51 (55%) patients. Forty-four of 51 (86%) patients had bilateral lung involvement, while 41 of 51 (80%) involved the posterior part of the lungs and 44 of 51 (86%) were peripheral. There were more consolidated lung lesions in patients 5 days or more from disease onset to CT scan versus 4 days or fewer (431 of 712 lesions vs 129 of 612 lesions; P , .001). Patients older than 50 years had more consolidated lung lesions than did those aged 50 years or younger (212 of 470 vs 198 of 854; P , .001). Follow-up CT in 13 patients showed improvement in seven (54%) patients and progression in four (31%) patients. Conclusion: Patients with fever and/or cough and with conspicuous ground-glass opacity lesions in the peripheral and posterior lungs on CT images, combined with normal or decreased white blood cells and a history of epidemic exposure, are highly suspected of having 2019 Novel Coronavirus (2019-nCoV) pneumonia. © RSNA, 2020.</rdfs:comment>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079124425">
    <j.0:identifier>10.1016/S0140-6736(20)30252-X</j.0:identifier>
    <j.0:identifier>2-s2.0-85079124425</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079124425&amp;doi=10.1016%2fS0140-6736%2820%2930252-X&amp;partnerID=40&amp;md5=0fd2ccb70e8e036de6ea0b3fb9811986&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Erratum</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:issue>10223</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:creator>[No author name available]</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; published online Jan 24. https://doi.org/10.1016/S0140-6736(20)30183-5—In this Article, in Procedures, we have corrected the primer sequences for targeting the envelope gene of coronavirus; in the Summary and Data collection, we have corrected the text to reflect that the modified case record form for severe acute respiratory infection clinical characterisation was developed by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) together; we have updated the margin link to the ISARIC–WHO case record form; we have updated the Acknowledgments; and in the tables, we updated p values (three in table 2 and one each in tables 1 and 3) so that they are all given to two significant figures. These corrections have been made to the online version as of Jan 30, 2020, and will be made to the printed version. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:title>Department of Error: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (The Lancet (2020) 395(10223) (497–506), (S0140673620301835), (10.1016/S0140-6736(20)30183-5))</j.0:title>
    <schema:keywords>erratum</schema:keywords>
    <myOnto:volume>395</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082017750">
    <myOnto:volume>134</myOnto:volume>
    <rdfs:comment>In this note we analyze the temporal dynamics of the coronavirus disease 2019 outbreak in China, Italy and France in the time window 22/01?15/03/2020. A first analysis of simple day-lag maps points to some universality in the epidemic spreading, suggesting that simple mean-field models can be meaningfully used to gather a quantitative picture of the epidemic spreading, and notably the height and time of the peak of confirmed infected individuals. The analysis of the same data within a simple susceptible-infected-recovered-deaths model indicates that the kinetic parameter that describes the rate of recovery seems to be the same, irrespective of the country, while the infection and death rates appear to be more variable. The model places the peak in Italy around March 21st 2020, with a peak number of infected individuals of about 26000 (not including recovered and dead) and a number of deaths at the end of the epidemics of about 18,000. Since the confirmed cases are believed to be between 10 and 20% of the real number of individuals who eventually get infected, the apparent mortality rate of COVID-19 falls between 4% and 8% in Italy, while it appears substantially lower, between 1% and 3% in China. Based on our calculations, we estimate that 2500 ventilation units should represent a fair figure for the peak requirement to be considered by health authorities in Italy for their strategic planning. Finally, a simulation of the effects of drastic containment measures on the outbreak in Italy indicates that a reduction of the infection rate indeed causes a quench of the epidemic peak. However, it is also seen that the infection rate needs to be cut down drastically and quickly to observe an appreciable decrease of the epidemic peak and mortality rate. This appears only possible through a concerted and disciplined, albeit painful, effort of the population as a whole. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:title>Analysis and forecast of COVID-19 spreading in China, Italy and France</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>Epidemiology; Mean field theory; Recovery; Covid-19; Epidemic spreading; Infection rates; Mean field models; Mortality rate; Nonlinear fitting; Population model; Temporal dynamics; Population statistics</schema:keywords>
    <j.0:identifier>2-s2.0-85082017750</j.0:identifier>
    <j.0:identifier>10.1016/j.chaos.2020.109761</j.0:identifier>
    <dc:creator>Fanelli D., Piazza F.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Chaos,_Solitons_and_Fractals">
        <j.1:name>Chaos, Solitons and Fractals</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082017750&amp;doi=10.1016%2fj.chaos.2020.109761&amp;partnerID=40&amp;md5=c17c6be5f3e6136f9f983dc7ffd412bc&gt;</schema:url>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082118829">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Medical_Hypotheses">
        <j.1:name>Medical Hypotheses</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:publisher>Churchill Livingstone</j.0:publisher>
    <j.0:identifier>10.1016/j.mehy.2020.109686</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:volume>140</myOnto:volume>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Roncati L., Gallo G., Manenti A., Palmieri B.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082118829&amp;doi=10.1016%2fj.mehy.2020.109686&amp;partnerID=40&amp;md5=e8511cf25134c1a17f48bb3c33c4cb88&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082118829</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078856946">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078856946&amp;doi=10.1002%2fjmv.25681&amp;partnerID=40&amp;md5=2962270fe25bb245787246b1fde31cd2&gt;</schema:url>
    <j.0:title>Emerging coronaviruses: Genome structure, replication, and pathogenesis</j.0:title>
    <myOnto:volume>92</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:keywords>recombinant interferon; ribavirin; viral protein; COVID-19; severe acute respiratory syndrome coronavirus 2; viral protein; 2019 novel Coronavirus; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; gene replication; gene structure; human; infection risk; nonhuman; pathogenesis; protein function; protein structure; public health; Review; virus pneumonia; wildlife; animal; Betacoronavirus; communicable disease; Coronavirinae; Coronavirus infection; genetics; host range; pathogenicity; physiology; veterinary medicine; virology; virus genome; virus replication; Animals; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus; Coronavirus Infections; Genome, Viral; Host Specificity; Humans; Pneumonia, Viral; Viral Nonstructural Proteins; Viral Structural Proteins; Virus Replication</schema:keywords>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:creator>Chen Y., Liu Q., Guo D.</dc:creator>
    <j.0:identifier>2-s2.0-85078856946</j.0:identifier>
    <j.0:identifier>10.1002/jmv.25681</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>27</myOnto:citeyBy>
    <rdfs:comment>The recent emergence of a novel coronavirus (2019-nCoV), which is causing an outbreak of unusual viral pneumonia in patients in Wuhan, a central city in China, is another warning of the risk of CoVs posed to public health. In this minireview, we provide a brief introduction of the general features of CoVs and describe diseases caused by different CoVs in humans and animals. This review will help understand the biology and potential risk of CoVs that exist in richness in wildlife such as bats. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:issue>4</myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080843714">
    <dc:creator>Cowling B.J., Leung G.M.</dc:creator>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; Coronavirus infection; disease predisposition; epidemic; human; immunity; infection control; public health; research; severity of illness index; virus pneumonia; Coronavirus Infections; Disease Outbreaks; Disease Susceptibility; Epidemiologic Studies; Humans; Immunity; Infection Control; Pneumonia, Viral; Public Health; Research; Severity of Illness Index</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:title>Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak</j.0:title>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.6.2000110</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080843714&amp;doi=10.2807%2f1560-7917.ES.2020.25.6.2000110&amp;partnerID=40&amp;md5=99c7759781552347254a262deba52635&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>6</myOnto:issue>
    <j.0:identifier>2-s2.0-85080843714</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078850258">
    <myOnto:volume>395</myOnto:volume>
    <schema:keywords>alpha interferon; lopinavir plus ritonavir; remdesivir; 2019 novel coronavirus; asymptomatic infection; Betacoronavirus; China; clinical feature; confusion; Coronavirinae; Coronavirus infection; coughing; diarrhea; early diagnosis; epidemic; epidemiological data; fatality; fever; headache; high throughput sequencing; human; infection control; lung lavage; mortality rate; nausea and vomiting; nonhuman; Note; polymerase chain reaction; practice guideline; priority journal; public health problem; reverse transcription polymerase chain reaction; rhinorrhea; severe acute respiratory syndrome; sore throat; thorax pain; virus pneumonia; virus transmission; World Health Organization; Coronavirus infection; epidemic; pneumonia; China; Coronavirus; Coronavirus Infections; Epidemics; Humans; Pneumonia</schema:keywords>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <j.0:identifier>10.1016/S0140-6736(20)30300-7</j.0:identifier>
    <j.0:identifier>2-s2.0-85078850258</j.0:identifier>
    <myOnto:issue>10222</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>What to do next to control the 2019-nCoV epidemic?</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Wang F.-S., Zhang C.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078850258&amp;doi=10.1016%2fS0140-6736%2820%2930300-7&amp;partnerID=40&amp;md5=eb74c122dac9f1ee908f389a98d11c13&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078839120">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078839120&amp;doi=10.1136%2fbmj.m400&amp;partnerID=40&amp;md5=370cd643848ba7de91746257b30264c7&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Flear M., De Ruijter A., McKee M.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85078839120</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; Article; Coronavirinae; Coronavirus infection; disease control; European Union; government regulation; health care need; health hazard; health promotion; human; international cooperation; participatory management; preventive health service; priority journal; Switzerland; United Kingdom; World Health Organization</schema:keywords>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m400</j.0:identifier>
    <j.0:title>Coronavirus shows how UK must act quickly before being shut out of Europe's health protection systems</j.0:title>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082181700">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082181700&amp;doi=10.4081%2fpr.2020.8495&amp;partnerID=40&amp;md5=56de0a3cf5f48bb6625f10bc0b168265&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Page Press Publications</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pediatric_Reports">
        <j.1:name>Pediatric Reports</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>2019-NCoV: Polite with children!</j.0:title>
    <j.0:identifier>2-s2.0-85082181700</j.0:identifier>
    <dc:creator>Caselli D., Aricò M.</dc:creator>
    <j.0:identifier>10.4081/pr.2020.8495</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:volume>12</myOnto:volume>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081279603">
    <myOnto:citeyBy>16</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_New_England_journal_of_medicine">
        <j.1:name>The New England journal of medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081279603&amp;doi=10.1056%2fNEJMc2001737&amp;partnerID=40&amp;md5=211fc901edfe30507dec6a9259490f20&gt;</schema:url>
    <j.0:identifier>10.1056/NEJMc2001737</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., Yu J., Kang M., Song Y., Xia J., Guo Q., Song T., He J., Yen H.-L., Peiris M., Wu J.</dc:creator>
    <myOnto:volume>382</myOnto:volume>
    <myOnto:issue>12</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients</j.0:title>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>2-s2.0-85081279603</j.0:identifier>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079126550">
    <myOnto:volume>30</myOnto:volume>
    <dc:creator>Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G.</dc:creator>
    <myOnto:citeyBy>28</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079126550</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Research">
        <j.1:name>Cell Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079126550&amp;doi=10.1038%2fs41422-020-0282-0&amp;partnerID=40&amp;md5=4bbae9b5f9252ad7e5525a4fb900956a&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1038/s41422-020-0282-0</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <myOnto:issue>3</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>adenosine phosphate; alanine; antimalarial agent; antivirus agent; chloroquine; cholecystokinin octapeptide; COVID-19; remdesivir; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; bioassay; Chlorocebus aethiops; Coronavirus infection; drug development; drug effect; human; Middle East respiratory syndrome coronavirus; pathogenicity; preclinical study; SARS coronavirus; Vero cell line; virus pneumonia; Adenosine Monophosphate; Alanine; Animals; Antimalarials; Antiviral Agents; Betacoronavirus; Biological Assay; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; Drug Discovery; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS Virus; Sincalide; Vero Cells</schema:keywords>
    <j.0:title>Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080879436">
    <schema:keywords></schema:keywords>
    <j.0:title>Characteristics of COVID-19 infection in Beijing</j.0:title>
    <j.0:type>Article</j.0:type>
    <dc:creator>Tian S., Hu N., Lou J., Chen K., Kang X., Xiang Z., Chen H., Wang D., Liu N., Liu D., Chen G., Zhang Y., Li D., Li J., Lian H., Niu S., Zhang L., Zhang J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jinf.2020.02.018</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080879436&amp;doi=10.1016%2fj.jinf.2020.02.018&amp;partnerID=40&amp;md5=e40ddadd3a5057dc5226c071772ebbb9&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Background: Since the first case of a novel coronavirus (COVID-19) infection pneumonia was detected in Wuhan, China, a series of confirmed cases of the COVID-19 were found in Beijing. We analyzed the data of 262 confirmed cases to determine the clinical and epidemiological characteristics of COVID-19 in Beijing. Methods: We collected patients who were transferred by Beijing Emergency Medical Service to the designated hospitals. The information on demographic, epidemiological, clinical, laboratory test for the COVID-19 virus, diagnostic classification, cluster case and outcome were obtained. Furthermore we compared the characteristics between severe and common confirmed cases which including mild cases, no-pneumonia cases and asymptomatic cases, and we also compared the features between COVID-19 and 2003 SARS. Findings: By Feb 10, 2020, 262 patients were transferred from the hospitals across Beijing to the designated hospitals for special treatment of the COVID-19 infected by Beijing emergency medical service. Among of 262 patients, 46 (17.6%) were severe cases, 216 (82.4%) were common cases, which including 192 (73.3%) mild cases, 11(4.2%) non-pneumonia cases and 13 (5.0%) asymptomatic cases respectively. The median age of patients was 47.5 years old and 48.5% were male. 192 (73.3%) patients were residents of Beijing, 50 (26.0%) of which had been to Wuhan, 116 (60.4%) had close contact with confirmed cases, 21 (10.9%) had no contact history. The most common symptoms at the onset of illness were fever (82.1%), cough (45.8%), fatigue (26.3%), dyspnea (6.9%) and headache (6.5%). The median incubation period was 6.7 days, the interval time from between illness onset and seeing a doctor was 4.5 days. As of Feb 10, 17.2% patients have discharged and 81.7% patients remain in hospital in our study, the fatality of COVID-19 infection in Beijing was 0.9%. Interpretation: On the basis of this study, we provided the ratio of the COVID-19 infection on the severe cases to the mild, asymptomatic and non-pneumonia cases in Beijing. Population was generally susceptible, and with a relatively low fatality rate. The measures to prevent transmission was very successful at early stage, the next steps on the COVID-19 infection should be focused on early isolation of patients and quarantine for close contacts in families and communities in Beijing. Funding: Beijing Municipal Science and Technology Commission and Ministry of Science and Technology. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080879436</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080859882">
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <j.0:title>A mathematical model for simulating the phase-based transmissibility of a novel coronavirus</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Background: As reported by the World Health Organization, a novel coronavirus (2019-nCoV) was identified as the causative virus of Wuhan pneumonia of unknown etiology by Chinese authorities on 7 January, 2020. The virus was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by International Committee on Taxonomy of Viruses on 11 February, 2020. This study aimed to develop a mathematical model for calculating the transmissibility of the virus. Methods: In this study, we developed a Bats-Hosts-Reservoir-People transmission network model for simulating the potential transmission from the infection source (probably be bats) to the human infection. Since the Bats-Hosts-Reservoir network was hard to explore clearly and public concerns were focusing on the transmission from Huanan Seafood Wholesale Market (reservoir) to people, we simplified the model as Reservoir-People (RP) transmission network model. The next generation matrix approach was adopted to calculate the basic reproduction number (R 0) from the RP model to assess the transmissibility of the SARS-CoV-2. Results: The value of R 0 was estimated of 2.30 from reservoir to person and 3.58 from person to person which means that the expected number of secondary infections that result from introducing a single infected individual into an otherwise susceptible population was 3.58. Conclusions: Our model showed that the transmissibility of SARS-CoV-2 was higher than the Middle East respiratory syndrome in the Middle East countries, similar to severe acute respiratory syndrome, but lower than MERS in the Republic of Korea. © 2020 The Author(s).</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080859882&amp;doi=10.1186%2fs40249-020-00640-3&amp;partnerID=40&amp;md5=9ba3dacdf7c07f39447a7d1e617e48d2&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Diseases_of_Poverty">
        <j.1:name>Infectious Diseases of Poverty</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>9</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <dc:creator>Chen T.-M., Rui J., Wang Q.-P., Zhao Z.-Y., Cui J.-A., Yin L.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>2019 novel coronavirus; Article; computer simulation; Coronavirinae; coronavirus disease 2019; disease carrier; high throughput sequencing; human; incubation time; infection risk; mathematical model; mortality rate; nonhuman; priority journal; SARS coronavirus; secondary infection; virus transmission; animal; bat; Betacoronavirus; Coronavirus infection; disease transmission; growth, development and aging; theoretical model; time factor; veterinary medicine; virology; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; Chiroptera; Coronavirus Infections; Disease Reservoirs; Disease Transmission, Infectious; Humans; Models, Theoretical; Pneumonia, Viral; Time Factors</schema:keywords>
    <j.0:identifier>10.1186/s40249-020-00640-3</j.0:identifier>
    <j.0:identifier>2-s2.0-85080859882</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080906252">
    <j.0:identifier>10.12998/wjcc.v8.i4.652</j.0:identifier>
    <rdfs:comment>The current corona virus disease 2019 outbreak caused by severe acute respiratory syndrome coronavirus 2 started in Wuhan, China in December 2019 and has put the world on alert. To safeguard Chinese citizens and to strengthen global health security, China has made great efforts to control the epidemic. Many in the global community have joined China to limit the epidemic. However, discrimination and prejudice driven by fear or misinformation have been flowing globally, superseding evidence and jeopardizing the anti-severe acute respiratory syndrome coronavirus 2 efforts. We analyze this phenomenon and its underlying causes and suggest practical solutions. © Baishideng Publishing Group Co.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Baishideng Publishing Group Co</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080906252&amp;doi=10.12998%2fwjcc.v8.i4.652&amp;partnerID=40&amp;md5=24d41575dc463b880041380e60eb1958&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85080906252</j.0:identifier>
    <j.0:title>Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic</j.0:title>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/World_Journal_of_Clinical_Cases">
        <j.1:name>World Journal of Clinical Cases</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>8</myOnto:volume>
    <dc:creator>Ren S.-Y., Gao R.-D., Chen Y.-L.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>Article; China; corona virus disease 2019; epidemic; fear; geographic distribution; government; hand washing; human; mental health; prejudice; risk factor; SARS coronavirus; scientific literature; severe acute respiratory syndrome; stigma; virus infection; World Health Organization</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079146891">
    <dc:date>2020</dc:date>
    <dc:creator>Kelvin D.J., Rubino S.</dc:creator>
    <j.0:publisher>Journal of Infection in Developing Countries</j.0:publisher>
    <schema:keywords>vaccine; community health nursing; Coronaviridae; disease transmission; Editorial; emergency ward; health care utilization; health program; human; International Society for Infectious Diseases; nonhuman; novel coronavirus 2019; polymerase chain reaction; sequence homology; severe acute respiratory syndrome; social phobia; travel related disease; violence; zoonosis; China; Coronavirinae; Coronavirus infection; fear; pneumonia; China; Coronavirus; Coronavirus Infections; Fear; Humans; Pneumonia</schema:keywords>
    <j.0:title>Fear of the novel coronavirus</j.0:title>
    <j.0:identifier>10.3855/jidc.12496</j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>2-s2.0-85079146891</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection_in_Developing_Countries">
        <j.1:name>Journal of Infection in Developing Countries</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079146891&amp;doi=10.3855%2fjidc.12496&amp;partnerID=40&amp;md5=ff39bde388c1d4befeb14dbba2dee3a7&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>14</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082144428">
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082144428&amp;doi=10.15585%2fmmwr.mm6911e1&amp;partnerID=40&amp;md5=8663311df4790aed1d2148a920b51ff8&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082144428</j.0:identifier>
    <schema:keywords>COVID-19; adult; Coronavirus infection; epidemic; female; health survey; human; male; middle aged; procedures; Singapore; virus pneumonia; Adult; Coronavirus Infections; Disease Outbreaks; Female; Humans; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Singapore</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/MMWR._Morbidity_and_mortality_weekly_report"/>
    <rdfs:comment>Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019, and has since spread globally, resulting in &gt;95,000 confirmed COVID-19 cases worldwide by March 5, 2020 (1). Singapore adopted a multipronged surveillance strategy that included applying the case definition at medical consults, tracing contacts of patients with laboratory-confirmed COVID-19, enhancing surveillance among different patient groups (all patients with pneumonia, hospitalized patients in intensive care units [ICUs] with possible infectious diseases, primary care patients with influenza-like illness, and deaths from possible infectious etiologies), and allowing clinician discretion (i.e., option to order a test based on clinical suspicion, even if the case definition was not met) to identify COVID-19 patients. Containment measures, including patient isolation and quarantine, active monitoring of contacts, border controls, and community education and precautions, were performed to minimize disease spread. As of March 5, 2020, a total of 117 COVID-19 cases had been identified in Singapore. This report analyzes the first 100 COVID-19 patients in Singapore to determine the effectiveness of the surveillance and containment measures. COVID-19 patients were classified by the primary means by which they were detected. Application of the case definition and contact tracing identified 73 patients, 16 were detected by enhanced surveillance, and 11 were identified by laboratory testing based on providers' clinical discretion. Effectiveness of these measures was assessed by calculating the 7-day moving average of the interval from symptom onset to isolation in hospital or quarantine, which indicated significant decreasing trends for both local and imported COVID-19 cases. Rapid identification and isolation of cases, quarantine of close contacts, and active monitoring of other contacts have been effective in suppressing expansion of the outbreak and have implications for other countries experiencing outbreaks.</rdfs:comment>
    <j.0:title>Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020</j.0:title>
    <j.0:identifier>10.15585/mmwr.mm6911e1</j.0:identifier>
    <dc:creator>Ng Y., Li Z., Chua Y.X., Chaw W.L., Zhao Z., Er B., Pung R., Chiew C.J., Lye D.C., Heng D., Lee V.J.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>69</myOnto:volume>
    <myOnto:issue>11</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081353291">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081353291&amp;doi=10.1002%2fjmv.25721&amp;partnerID=40&amp;md5=39f3ef8104078b7fa821fd10dc4ff470&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <dc:creator>Wang Y., Kang H., Liu X., Tong Z.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>10.1002/jmv.25721</j.0:identifier>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081353291</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081655104">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Dental_Sciences">
        <j.1:name>Journal of Dental Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Guo H., Zhou Y., Liu X., Tan J.</dc:creator>
    <j.0:publisher>Association for Dental Sciences of the Republic of China</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:title>The impact of the COVID-19 epidemic on the utilization of emergency dental services</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.jds.2020.02.002</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081655104&amp;doi=10.1016%2fj.jds.2020.02.002&amp;partnerID=40&amp;md5=916c0f04e414047907d0d927426a5659&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85081655104</j.0:identifier>
    <rdfs:comment>Background/Purpose: To assess how the current COVID-19 epidemic influenced peoples' utilization of emergency dental services in Beijing, China. Methods: The first-visit patients seeking emergency dental services before or at the beginning of the COVID-19 epidemic were retrieved. Their demographic characteristics and the reasons for visiting were recorded and analyzed. Results: There were 2,537 patients involved in this study. Thirty-eight percent fewer patients visited the dental urgency at the beginning of the COVID-19 epidemic than before. The distribution of dental problems has changed significantly. The proportion of dental and oral infection raised from 51.0% of pre-COVID-19 to 71.9% during COVID-19, and dental trauma decreased from 14.2% to 10.5%. Meanwhile, the non-urgency cases reduced to three-tenths of pre-COVID-19. Conclusion: Within the limitation of this study, the COVID-19 epidemic had a strong influence on the utilization of emergency dental services. © 2020 Association for Dental Sciences of the Republic of China</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081655213">
    <j.0:title>Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment</j.0:title>
    <dc:creator>Chen J., Hu C., Chen L., Tang L., Zhu Y., Xu X., Chen L., Gao H., Lu X., Yu L., Dai X., Xiang C., Li L.</dc:creator>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.eng.2020.02.006</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081655213&amp;doi=10.1016%2fj.eng.2020.02.006&amp;partnerID=40&amp;md5=3c719a199051a80e2d6c7f26f0fd721e&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <schema:keywords>Biological organs; Cell culture; Clinical research; Disease control; Flowcharting; Mammals; Medical applications; Respiratory mechanics; Viruses; Acute respiratory distress syndrome; COVID-19; H7N9; Influenza A; Mesenchymal stem cell; Stem cells</schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081655213</j.0:identifier>
    <rdfs:comment>H7N9 viruses quickly spread between mammalian hosts and carry the risk of human-to-human transmission, as shown by the 2013 outbreak. Acute respiratory distress syndrome (ARDS), lung failure, and fulminant pneumonia are major lung diseases in H7N9 patients. Transplantation of mesenchymal stem cells (MSCs) is a promising choice for treating virus-induced pneumonia, and was used to treat H7N9-induced ARDS in 2013. The transplant of MSCs into patients with H7N9-induced ARDS was conducted at a single center through an open-label clinical trial. Based on the principles of voluntariness and informed consent, 44 patients with H7N9-induced ARDS were included as a control group, while 17 patients with H7N9-induced ARDS acted as an experimental group with allogeneic menstrual-blood-derived MSCs. It was notable that MSC transplantation significantly lowered the mortality of the experimental group, compared with the control group (17.6% died in the experimental group while 54.5% died in the control group). Furthermore, MSC transplantation did not result in harmful effects in the bodies of four of the patients who were part of the five-year follow-up period. Collectively, these results suggest that MSCs significantly improve the survival rate of H7N9-induced ARDS and provide a theoretical basis for the treatment of H7N9-induced ARDS in both preclinical research and clinical studies. Because H7N9 and the corona virus disease 2019 (COVID-19) share similar complications (e.g., ARDS and lung failure) and corresponding multi-organ dysfunction, MSC-based therapy could be a possible alternative for treating COVID-19. © 2020</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Engineering">
        <j.1:name>Engineering</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081207319">
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1186/s41182-020-00201-2</j.0:identifier>
    <schema:keywords>airport; Article; asymptomatic infection; body temperature; Coronavirus disease 2019; Coronavirus infection; fever; high risk population; human; reverse transcription polymerase chain reaction; virus transmission; World Health Organization</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Tropical_Medicine_and_Health">
        <j.1:name>Tropical Medicine and Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081207319</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Bwire G.M., Paulo L.S.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Coronavirus disease-2019: Is fever an adequate screening for the returning travelers?</j.0:title>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081207319&amp;doi=10.1186%2fs41182-020-00201-2&amp;partnerID=40&amp;md5=9dc0cc20c2a77a2a6d0308f3bb1f4b9b&gt;</schema:url>
    <myOnto:volume>48</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>On Thursday, 30 January 2020, World Health Organization declared Coronavirus disease-2019 (COVID-2019) a Public Health Emergency of International Concern. Since its identification in late December 2019 in Wuhan, Hubei Province, People's Republic of China, the number of cases imported into other countries is increasing, and the epidemiological map is changing rapidly. On the other hand, body temperature screening (fever) is the major test performed at points of entry, i.e., airports, in the returning travelers in most of the countries with limited resources. However, the recent report on asymptomatic contact transmission of COVID-19 and travelers who passed the symptoms-based screening and tested positive for COVID-19 using reverse transcription polymerase chain reaction (RT-PCR) challenges this approach as body temperature screening may miss travelers incubating the disease or travelers concealing fever during travel. On this note, travel restrictions to and from high risk areas and/or 14 days quarantine of travelers coming from high risk areas are recommended to prevent possible importation of COVID-19. Currently, RT-PCR is a reliable test in detecting both symptomatic and asymptomatic COVID-19. © 2020 The Author(s).</rdfs:comment>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081380710">
    <myOnto:citeyBy>12</myOnto:citeyBy>
    <myOnto:issue>1</myOnto:issue>
    <j.0:type>Note</j.0:type>
    <myOnto:volume>295</myOnto:volume>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <dc:creator>Lei J., Li J., Li X., Qi X.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <schema:keywords>biological marker; COVID-19; abnormal respiratory sound; adult; case report; China; complication; Coronavirus infection; coughing; diagnostic imaging; female; fever; human; lung; metabolism; pathology; travel; virus pneumonia; x-ray computed tomography; Adult; Biomarkers; China; Coronavirus Infections; Cough; Female; Fever; Humans; Lung; Pneumonia, Viral; Respiratory Sounds; Tomography, X-Ray Computed; Travel</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1148/radiol.2020200236</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081380710</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081380710&amp;doi=10.1148%2fradiol.2020200236&amp;partnerID=40&amp;md5=4b79a096f434acdf36165d80c8a4a66f&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:title>CT imaging of the 2019 novel coronavirus (2019-NCoV) pneumonia</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079904368">
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:identifier>10.1016/S0140-6736(20)30370-6</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079904368&amp;doi=10.1016%2fS0140-6736%2820%2930370-6&amp;partnerID=40&amp;md5=39ceb259b24a5103740b3ddd2bfc51f5&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:creator>Silverstein W.K., Stroud L., Cleghorn G.E., Leis J.A.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079904368</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:issue>10225</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>Canada; China; contact examination; coronavirus disease 2019; Coronavirus infection; coughing; fever; hemoptysis; human; hypertension; Note; patient isolation; polymerase chain reaction; priority journal; rhinorrhea; thorax radiography; throat culture; thrombocytopenia; travel; virus pneumonia; case report; communicable disease; complication; Coronavirinae; Coronavirus infection; fever; genetics; hemoptysis; male; middle aged; Ontario; severity of illness index; virus pneumonia; virus RNA; Canada; China; Communicable Diseases, Imported; Coronavirus; Coronavirus Infections; Fever; Hemoptysis; Humans; Male; Middle Aged; Ontario; Pneumonia, Viral; Polymerase Chain Reaction; Radiography, Thoracic; RNA, Viral; Severity of Illness Index</schema:keywords>
    <j.0:title>First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079706210">
    <myOnto:issue>2</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079706210&amp;doi=10.3390%2fbiom10020331&amp;partnerID=40&amp;md5=508ffd54b371aa82b19bcb0897f382a7&gt;</schema:url>
    <schema:keywords>M protein; nucleocapsid protein; viral protein; COVID-19; severe acute respiratory syndrome coronavirus 2; viral protein; 2019 novel coronavirus; coronavirus disease 2019; Editorial; epidemic; human; Middle East respiratory syndrome coronavirus; molecular model; nonhuman; prediction; protein intrinsic disorder; protein structure; rigidity; SARS coronavirus; virus infectivity; virus morphology; virus particle; virus transmission; animal; Betacoronavirus; Coronavirus infection; genetics; metabolism; pandemic; physiology; virus entry; virus pneumonia; Animals; Betacoronavirus; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Viral Proteins; Virus Internalization</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079706210</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>The world is currently witnessing an outbreak of a new coronavirus spreading quickly across China and affecting at least 24 other countries. With almost 65,000 infected, a worldwide death toll of at least 1370 (as of 14 February 2020), and with the potential to affect up to two-thirds of the world population, COVID-19 is considered by the World Health Organization (WHO) to be a global health emergency. The speed of spread and infectivity of COVID-19 (also known as Wuhan-2019-nCoV) are dramatically exceeding those of the Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). In fact, since September 2012, the WHO has been notified of 2494 laboratory-confirmed cases of infection with MERS-CoV, whereas the 2002–2003 epidemic of SARS affected 26 countries and resulted in more than 8000 cases. Therefore, although SARS, MERS, and COVID-19 are all the result of coronaviral infections, the causes of the coronaviruses differ dramatically in their transmissibility. It is likely that these differences in infectivity of coronaviruses can be attributed to the differences in the rigidity of their shells which can be evaluated using computational tools for predicting intrinsic disorder predisposition of the corresponding viral proteins. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>10</myOnto:volume>
    <dc:creator>Goh G.K.-M., Keith Dunker A., Foster J.A., Uversky V.N.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Biomolecules">
        <j.1:name>Biomolecules</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <j.0:title>Rigidity of the outer shell predicted by a protein intrinsic disorder model sheds light on the COVID-19 (Wuhan-2019-nCoV) infectivity</j.0:title>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>10.3390/biom10020331</j.0:identifier>
    <j.0:publisher>MDPI AG</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081033339">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <myOnto:volume>29</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier Inc.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081033339</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Data_in_Brief">
        <j.1:name>Data in Brief</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Benvenuto D., Giovanetti M., Vassallo L., Angeletti S., Ciccozzi M.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081033339&amp;doi=10.1016%2fj.dib.2020.105340&amp;partnerID=40&amp;md5=c1225da4928df5b419e9f0bd4e83d560&gt;</schema:url>
    <j.0:type>Data Paper</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Application of the ARIMA model on the COVID-2019 epidemic dataset</j.0:title>
    <j.0:identifier>10.1016/j.dib.2020.105340</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Coronavirus disease 2019 (COVID-2019) has been recognized as a global threat, and several studies are being conducted using various mathematical models to predict the probable evolution of this epidemic. These mathematical models based on various factors and analyses are subject to potential bias. Here, we propose a simple econometric model that could be useful to predict the spread of COVID-2019. We performed Auto Regressive Integrated Moving Average (ARIMA) model prediction on the Johns Hopkins epidemiological data to predict the epidemiological trend of the prevalence and incidence of COVID-2019. For further comparison or for future perspective, case definition and data collection have to be maintained in real time. © 2020 The Authors</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082056596">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m1143</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <dc:creator>Kar P.</dc:creator>
    <j.0:title>Partha Kar: Covid-19-we must keep faith in our experts</j.0:title>
    <j.0:identifier>2-s2.0-85082056596</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:volume>368</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082056596&amp;doi=10.1136%2fbmj.m1143&amp;partnerID=40&amp;md5=c722308a69a61fb0f4d4969423768dd3&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082037214">
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Iacobucci G.</dc:creator>
    <myOnto:volume>368</myOnto:volume>
    <j.0:title>Covid-19: all non-urgent elective surgery is suspended for at least three months in England</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85082037214</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1136/bmj.m1106</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082037214&amp;doi=10.1136%2fbmj.m1106&amp;partnerID=40&amp;md5=8992b69fc802025bb7b323b9850c6819&gt;</schema:url>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081033206">
    <j.0:title>Covid-19: UK could delay non-urgent care and call doctors back from leave and retirement</j.0:title>
    <j.0:identifier>10.1136/bmj.m854</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85081033206</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081033206&amp;doi=10.1136%2fbmj.m854&amp;partnerID=40&amp;md5=012b4da33b5215b9053a4ceab30b4c10&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:volume>368</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079844271">
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:title>Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Digital_Health">
        <j.1:name>The Lancet Digital Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>4</myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <rdfs:comment>Background: As the outbreak of coronavirus disease 2019 (COVID-19) progresses, epidemiological data are needed to guide situational awareness and intervention strategies. Here we describe efforts to compile and disseminate epidemiological information on COVID-19 from news media and social networks. Methods: In this population-level observational study, we searched DXY.cn, a health-care-oriented social network that is currently streaming news reports on COVID-19 from local and national Chinese health agencies. We compiled a list of individual patients with COVID-19 and daily province-level case counts between Jan 13 and Jan 31, 2020, in China. We also compiled a list of internationally exported cases of COVID-19 from global news media sources (Kyodo News, The Straits Times, and CNN), national governments, and health authorities. We assessed trends in the epidemiology of COVID-19 and studied the outbreak progression across China, assessing delays between symptom onset, seeking care at a hospital or clinic, and reporting, before and after Jan 18, 2020, as awareness of the outbreak increased. All data were made publicly available in real time. Findings: We collected data for 507 patients with COVID-19 reported between Jan 13 and Jan 31, 2020, including 364 from mainland China and 143 from outside of China. 281 (55%) patients were male and the median age was 46 years (IQR 35–60). Few patients (13 [3%]) were younger than 15 years and the age profile of Chinese patients adjusted for baseline demographics confirmed a deficit of infections among children. Across the analysed period, delays between symptom onset and seeking care at a hospital or clinic were longer in Hubei province than in other provinces in mainland China and internationally. In mainland China, these delays decreased from 5 days before Jan 18, 2020, to 2 days thereafter until Jan 31, 2020 (p=0·0009). Although our sample captures only 507 (5·2%) of 9826 patients with COVID-19 reported by official sources during the analysed period, our data align with an official report published by Chinese authorities on Jan 28, 2020. Interpretation: News reports and social media can help reconstruct the progression of an outbreak and provide detailed patient-level data in the context of a health emergency. The availability of a central physician-oriented social network facilitated the compilation of publicly available COVID-19 data in China. As the outbreak progresses, social media and news reports will probably capture a diminishing fraction of COVID-19 cases globally due to reporting fatigue and overwhelmed health-care systems. In the early stages of an outbreak, availability of public datasets is important to encourage analytical efforts by independent teams and provide robust evidence to guide interventions. Funding: Fogarty International Center, US National Institutes of Health. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license</rdfs:comment>
    <j.0:identifier>2-s2.0-85079844271</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>2</myOnto:volume>
    <j.0:identifier>10.1016/S2589-7500(20)30026-1</j.0:identifier>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079844271&amp;doi=10.1016%2fS2589-7500%2820%2930026-1&amp;partnerID=40&amp;md5=c834123870ea0389a5274358108680e3&gt;</schema:url>
    <dc:creator>Sun K., Chen J., Viboud C.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>3</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082184354">
    <j.0:identifier>10.1016/S2214-109X(20)30114-5</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <dc:creator>Mitjà O., Clotet B.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:title>Use of antiviral drugs to reduce COVID-19 transmission</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Global_Health"/>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082184354&amp;doi=10.1016%2fS2214-109X%2820%2930114-5&amp;partnerID=40&amp;md5=15733566f53311664f85253569b5976e&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85082184354</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081214652">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081214652&amp;doi=10.1001%2fjama.2020.3204&amp;partnerID=40&amp;md5=966620e5f9a2a376caeb447599e98da5&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <rdfs:comment>Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019 and has spread globally with sustained human-to-human transmission outside China. Objective: To report the initial experience in Singapore with the epidemiologic investigation of this outbreak, clinical features, and management. Design, Setting, and Participants: Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020. Exposures: Confirmed SARS-CoV-2 infection. Main Outcomes and Measures: Clinical, laboratory, and radiologic data were collected, including PCR cycle threshold values from nasopharyngeal swabs and viral shedding in blood, urine, and stool. Clinical course was summarized, including requirement for supplemental oxygen and intensive care and use of empirical treatment with lopinavir-ritonavir. Results: Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%). Six individuals (33%) required supplemental oxygen; of these, 2 required intensive care. There were no deaths. Virus was detectable in the stool (4/8 [50%]) and blood (1/12 [8%]) by PCR but not in urine. Five individuals requiring supplemental oxygen were treated with lopinavir-ritonavir. For 3 of the 5 patients, fever resolved and supplemental oxygen requirement was reduced within 3 days, whereas 2 deteriorated with progressive respiratory failure. Four of the 5 patients treated with lopinavir-ritonavir developed nausea, vomiting, and/or diarrhea, and 3 developed abnormal liver function test results. Conclusions and Relevance: Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection. Some patients required supplemental oxygen and had variable clinical outcomes following treatment with an antiretroviral agent.. © 2020 The Author(s).</rdfs:comment>
    <j.0:identifier>10.1001/jama.2020.3204</j.0:identifier>
    <j.0:identifier>2-s2.0-85081214652</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J., Ng O.-T., Marimuthu K., Ang L.W., Mak T.M., Lau S.K., Anderson D.E., Chan K.S., Tan T.Y., Ng T.Y., Cui L., Said Z., Kurupatham L., Chen M.I.-C., Chan M., Vasoo S., Wang L.-F., Tan B.H., Lin R.T.P., Lee V.J.M., Leo Y.-S., Lye D.C.</dc:creator>
    <j.0:title>Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore</j.0:title>
    <j.0:publisher>American Medical Association</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081212233">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081212233</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Deutsche_Medizinische_Wochenschrift">
        <j.1:name>Deutsche Medizinische Wochenschrift</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>5</myOnto:issue>
    <j.0:publisher>Georg Thieme Verlag</j.0:publisher>
    <dc:creator>[No author name available]</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081212233&amp;doi=10.1055%2fa-1113-3096&amp;partnerID=40&amp;md5=1b4a4ba417d53c5d5751e8c59bf756d9&gt;</schema:url>
    <j.0:title>Neuartiges Coronavirus (SARS-CoV-2)</j.0:title>
    <myOnto:volume>145</myOnto:volume>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <dc:language>German</dc:language>
    <j.0:identifier>10.1055/a-1113-3096</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079141403">
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection_in_Developing_Countries"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.3855/jidc.12425</j.0:identifier>
    <myOnto:volume>14</myOnto:volume>
    <j.0:title>2019-nCoV (Wuhan virus), a novel Coronavirus: Human-to-human transmission, travel-related cases, and vaccine readiness</j.0:title>
    <dc:creator>Ralph R., Lew J., Zeng T., Francis M., Xue B., Roux M., Ostadgavahi A.T., Rubino S., Dawe N.J., Al-Ahdal M.N., Kelvin D.J., Richardson C.D., Kindrachuk J., Falzarano D., Kelvin A.A.</dc:creator>
    <j.0:publisher>Journal of Infection in Developing Countries</j.0:publisher>
    <rdfs:comment>On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with &gt; 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus. Copyright © 2020 Ralph et al.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079141403&amp;doi=10.3855%2fjidc.12425&amp;partnerID=40&amp;md5=bb143bf2c90d69e8457201d45f98cb38&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079141403</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; 2019 novel coronavirus infection; adult respiratory distress syndrome; Article; chill; China; computer model; Coronavirinae; Coronavirus infection; disease course; disease transmission; disseminated intravascular clotting; dyspnea; fever; headache; health care personnel; human; infectious disease medicine; knowledge; lymphocytopenia; malaise; medical research; Middle East respiratory syndrome coronavirus; nonhuman; pathogenesis; phylogeny; public health; receptor binding; SARS coronavirus; thrombocytopenia; travel related disease; university hospital; vaccination; virology; virus isolation; virus replication; animal; Betacoronavirus; chemistry; Coronavirus infection; disease carrier; genetics; pandemic; sequence analysis; travel; vaccination; veterinary medicine; virus pneumonia; zoonosis; COVID-19; severe acute respiratory syndrome coronavirus 2; viral protein; Animals; Betacoronavirus; Coronavirus Infections; Disease Reservoirs; Disease Transmission, Infectious; Humans; Pandemics; Pneumonia, Viral; Sequence Analysis, Protein; Travel; Vaccination; Viral Proteins; Zoonoses</schema:keywords>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082192659">
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.jfma.2020.03.007</j.0:identifier>
    <j.0:identifier>2-s2.0-85082192659</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_Formosan_Medical_Association"/>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Cheng H.-Y., Li S.-Y., Yang C.-H.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082192659&amp;doi=10.1016%2fj.jfma.2020.03.007&amp;partnerID=40&amp;md5=653b8581f888323960bafeb1dfb31661&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:type>Short Survey</j.0:type>
    <schema:keywords></schema:keywords>
    <j.0:title>Initial rapid and proactive response for the COVID-19 outbreak — Taiwan's experience</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081021532">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Authors' response: Plenty of coronaviruses but no SARS-CoV-2</j.0:title>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.8.2000197</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081021532&amp;doi=10.2807%2f1560-7917.ES.2020.25.8.2000197&amp;partnerID=40&amp;md5=f3d9b29687ee759ccad9758b84e49f00&gt;</schema:url>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <dc:creator>Reusken C.B., Haagmans B., Meijer A., Corman V.M., Papa A., Charrel R., Drosten C., Koopmans M.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>25</myOnto:volume>
    <j.0:identifier>2-s2.0-85081021532</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>8</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>Middle East respiratory syndrome coronavirus; phylogeny; SARS coronavirus; Middle East Respiratory Syndrome Coronavirus; Phylogeny; SARS Virus</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081657231">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Sarli L., Artioli G., Cosentino C.</dc:creator>
    <j.0:publisher>Mattioli 1885</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Acta_Biomedica"/>
    <schema:keywords>2019 novel coronavirus; coronavirus disease 2019; doctor patient relationship; Editorial; health care; health care personnel; health care quality; human; interpersonal communication; learning; medical profession; nonhuman; professional standard; professionalism; research; training</schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Editorial</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081657231&amp;doi=10.23750%2fabm.v91i2-S.9380&amp;partnerID=40&amp;md5=2977f87341db50cac723054bc456d92a&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>91</myOnto:volume>
    <j.0:identifier>2-s2.0-85081657231</j.0:identifier>
    <j.0:identifier>10.23750/abm.v91i2-S.9380</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079708329">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>22</myOnto:volume>
    <rdfs:comment>A zoonotic coronavirus, tentatively labeled as 2019-nCoV by the World Health Organization (WHO), has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. Although 2019-nCoV can cause a severe respiratory illness like SARS and MERS, evidence from clinics suggested that 2019-nCoV is generally less pathogenic than SARS-CoV, and much less than MERS-CoV. The transmissibility of 2019-nCoV is still debated and needs to be further assessed. To avoid the 2019-nCoV outbreak turning into an epidemic or even a pandemic and to minimize the mortality rate, China activated emergency response procedures, but much remains to be learned about the features of the virus to refine the risk assessment and response. Here, the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted. © 2020 The Author(s)</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079708329</j.0:identifier>
    <dc:creator>Chen J.</dc:creator>
    <j.0:title>Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses</j.0:title>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079708329&amp;doi=10.1016%2fj.micinf.2020.01.004&amp;partnerID=40&amp;md5=34ea4396498ffd73d4a22483ce6edb21&gt;</schema:url>
    <schema:keywords>2019 novel coronavirus; Article; China; Coronavirinae; Coronavirus infection; human; Middle East respiratory syndrome coronavirus; mortality rate; nonhuman; priority journal; SARS coronavirus; virus pneumonia; virus transmission; virus virulence; basic reproduction number; Betacoronavirus; pandemic; pathogenicity; virology; virulence; COVID-19; severe acute respiratory syndrome coronavirus 2; Basic Reproduction Number; Betacoronavirus; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Virulence</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:issue>2</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Microbes_and_Infection"/>
    <j.0:identifier>10.1016/j.micinf.2020.01.004</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081301501">
    <dc:creator>Poon L.L.M., Peiris M.</dc:creator>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>2-s2.0-85081301501</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Medicine"/>
    <dc:date>2020</dc:date>
    <j.0:title>Emergence of a novel human coronavirus threatening human health</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081301501&amp;doi=10.1038%2fs41591-020-0796-5&amp;partnerID=40&amp;md5=848a879b9dca9cece8a5795d4f001aa7&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Nature Research</j.0:publisher>
    <myOnto:volume>26</myOnto:volume>
    <j.0:identifier>10.1038/s41591-020-0796-5</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>virus RNA; 2009 H1N1 influenza; antibody response; artificial ventilation; Betacoronavirus; China; common cold; Coronavirus disease 2019; Coronavirus infection; coughing; disease severity; dyspnea; epidemic; fever; global health; human; intermediate host; myalgia; nonhuman; Note; oxygen therapy; pneumonia; priority journal; public health; rhinorrhea; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; sore throat</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081987742">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081987742</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:creator>Salisbury H.</dc:creator>
    <j.0:identifier>10.1136/bmj.m1087</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081987742&amp;doi=10.1136%2fbmj.m1087&amp;partnerID=40&amp;md5=d0434358618f0b36f89eacdb2af4dca1&gt;</schema:url>
    <j.0:title>Helen Salisbury: What might we learn from the covid-19 pandemic?</j.0:title>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081042747">
    <schema:keywords>COVID-19; animal; bat; Coronavirinae; Coronavirus infection; genetics; human; isolation and purification; placental mammal; reproducibility; uncertainty; virology; virus pneumonia; zoonosis; Animals; Chiroptera; Coronavirus; Coronavirus Infections; Eutheria; Humans; Pneumonia, Viral; Reproducibility of Results; Uncertainty; Zoonoses</schema:keywords>
    <dc:creator>Cyranoski D.</dc:creator>
    <myOnto:issue>7797</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Mystery deepens over animal source of coronavirus</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081042747&amp;doi=10.1038%2fd41586-020-00548-w&amp;partnerID=40&amp;md5=ffc214570bbb55d5bbaf912ebc7c3b87&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>579</myOnto:volume>
    <j.0:identifier>2-s2.0-85081042747</j.0:identifier>
    <j.0:identifier>10.1038/d41586-020-00548-w</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081262641">
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>10227</myOnto:issue>
    <schema:keywords>Coronavirus disease 2019; Coronavirus infection; disease transmission; emergency health service; epidemic; human; infection risk; Italy; Letter; population risk; priority journal; public health; risk factor</schema:keywords>
    <j.0:title>The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30493-1</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081262641&amp;doi=10.1016%2fS0140-6736%2820%2930493-1&amp;partnerID=40&amp;md5=7974f652f5c86feb5fab6abd1cc076b7&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <dc:creator>Spina S., Marrazzo F., Migliari M., Stucchi R., Sforza A., Fumagalli R.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>2-s2.0-85081262641</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081671698">
    <myOnto:issue>9</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081671698&amp;doi=10.2807%2f1560-7917.ES.2020.25.9.2003051&amp;partnerID=40&amp;md5=f3ec5e922aaa2e65f828acef39d41366&gt;</schema:url>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; civil defense; Coronavirus infection; epidemic; Europe; global health; health care delivery; health survey; human; pathogenicity; risk assessment; time factor; virus pneumonia; Betacoronavirus; China; Civil Defense; Coronavirus Infections; Delivery of Health Care; Disease Outbreaks; Europe; Global Health; Humans; Pneumonia, Viral; Population Surveillance; Risk Assessment; Time Factors</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>25</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.9.2003051</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081671698</j.0:identifier>
    <dc:creator>Eurosurveillance Editorial Team</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <j.0:title>Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079717915">
    <j.0:title>Critical care management of adults with community-acquired severe respiratory viral infection</j.0:title>
    <j.0:identifier>2-s2.0-85079717915</j.0:identifier>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:creator>Arabi Y.M., Fowler R., Hayden F.G.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079717915&amp;doi=10.1007%2fs00134-020-05943-5&amp;partnerID=40&amp;md5=159c4e61041e7abc719e13ed4bb4e565&gt;</schema:url>
    <schema:keywords>antivirus agent; ascorbic acid; baloxavir; corticosteroid; cyclooxygenase 2 inhibitor; hydroxymethylglutaryl coenzyme A reductase inhibitor; macrolide; rapamycin; sialidase inhibitor; antivirus agent; COVID-19; macrolide; oseltamivir; 2019 novel coronavirus; antiviral therapy; community acquired infection; Coronavirus infection; human; intensive care; Middle East respiratory syndrome; nonhuman; pneumonia; respiratory failure; Review; severe acute respiratory syndrome; viral respiratory tract infection; virus; adult; artificial ventilation; community acquired infection; Coronavirus infection; critical illness; evidence based medicine; influenza; intensive care; intensive care unit; noninvasive ventilation; severe acute respiratory syndrome; severity of illness index; virus pneumonia; Adult; Antiviral Agents; Community-Acquired Infections; Coronavirus Infections; Critical Care; Critical Illness; Evidence-Based Medicine; Humans; Influenza, Human; Intensive Care Units; Macrolides; Noninvasive Ventilation; Oseltamivir; Pneumonia; Pneumonia, Viral; Respiration, Artificial; Severe Acute Respiratory Syndrome; Severity of Illness Index</schema:keywords>
    <rdfs:comment>With the expanding use of molecular assays, viral pathogens are increasingly recognized among critically ill adult patients with community-acquired severe respiratory illness; studies have detected respiratory viral infections (RVIs) in 17–53% of such patients. In addition, novel pathogens including zoonotic coronaviruses like the agents causing Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the 2019 novel coronavirus (2019 nCoV) are still being identified. Patients with severe RVIs requiring ICU care present typically with hypoxemic respiratory failure. Oseltamivir is the most widely used neuraminidase inhibitor for treatment of influenza; data suggest that early use is associated with reduced mortality in critically ill patients with influenza. At present, there are no antiviral therapies of proven efficacy for other severe RVIs. Several adjunctive pharmacologic interventions have been studied for their immunomodulatory effects, including macrolides, corticosteroids, cyclooxygenase-2 inhibitors, sirolimus, statins, anti-influenza immune plasma, and vitamin C, but none is recommended at present in severe RVIs. Evidence-based supportive care is the mainstay for management of severe respiratory viral infection. Non-invasive ventilation in patients with severe RVI causing acute hypoxemic respiratory failure and pneumonia is associated with a high likelihood of transition to invasive ventilation. Limited existing knowledge highlights the need for data regarding supportive care and adjunctive pharmacologic therapy that is specific for critically ill patients with severe RVI. There is a need for more pragmatic and efficient designs to test different therapeutics both individually and in combination. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Review</j.0:type>
    <myOnto:volume>46</myOnto:volume>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1007/s00134-020-05943-5</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082189718">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082189718&amp;doi=10.1016%2fS0140-6736%2820%2930727-3&amp;partnerID=40&amp;md5=981e4b32324ada9c1699d36c3b737495&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:title>Offline: COVID-19 and the NHS—“a national scandal”</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>2-s2.0-85082189718</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/S0140-6736(20)30727-3</j.0:identifier>
    <dc:creator>Horton R.</dc:creator>
    <myOnto:issue>10229</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080137616">
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Letters_in_Applied_Microbiology">
        <j.1:name>Letters in Applied Microbiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85080137616</j.0:identifier>
    <rdfs:comment>The current outbreak of a novel severe acute respiratory syndrome-like coronavirus, 2019_nCoV (now named SARS-CoV-2), illustrated difficulties in identifying a novel coronavirus and its natural host, as the coding sequences of various Betacoronavirus species can be highly diverse. By means of whole-genome sequence comparisons, we demonstrate that the noncoding flanks of the viral genome can be used to correctly separate the recognized four betacoronavirus subspecies. The conservation would be sufficient to define target sequences that could, in theory, classify novel virus species into their subspecies. Only 253 upstream noncoding sequences of Sarbecovirus are sufficient to identify genetic similarities between species of this subgenus. Furthermore, it was investigated which bat species have commercial value in China, and would thus likely be handled for trading purposes. A number of coronavirus genomes have been published that were obtained from such bat species. These bats are used in Traditional Chinese Medicine, and their handling poses a potential risk to cause zoonotic coronavirus epidemics. Significance and Impact of the Study: The noncoding upstream and downstream flanks of coronavirus genomes allow for rapid classification of novel Betacoronavirus species and correct identification of genetic relationships. Although bats are the likely natural host of 2019_nCoV, the exact bat species that serves as the natural host of the virus remains as yet unknown. Chinese bat species with commercial value were identified as natural reservoirs of coronaviruses and are used in Traditional Chinese Medicine. Since their trading provides a potential risk for spreading zoonoses, a change in these practices is highly recommended. © 2020 The Authors. Letters in Applied Microbiology published by John Wiley &amp; Sons Ltd on behalf of Society for Applied Microbiology.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:title>2019_nCoV/SARS-CoV-2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses</j.0:title>
    <dc:language>English</dc:language>
    <dc:creator>Wassenaar T.M., Zou Y.</dc:creator>
    <j.0:identifier>10.1111/lam.13285</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080137616&amp;doi=10.1111%2flam.13285&amp;partnerID=40&amp;md5=507ab844a4d80171f4187e24020fd831&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082045077">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082045077&amp;doi=10.1097%2fRTI.0000000000000506&amp;partnerID=40&amp;md5=1547c4aabc1d62cdd9e913fa25da485e&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Thoracic_Imaging">
        <j.1:name>Journal of Thoracic Imaging</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Lippincott Williams and Wilkins</j.0:publisher>
    <j.0:title>A Diabetic Patient with 2019-nCoV Infection Who Recovered and Was Discharged from Hospital</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082045077</j.0:identifier>
    <rdfs:comment>Novel coronavirus has become a global health hazard and its high infectivity is alarming. The imaging findings of the 2019-nCoV infection in our young diabetic patient featured ground-glass opacities and consolidations in both lungs. The lung lesions may involute rapidly during the course. The patient showed improvement both clinically and on computed tomography imaging at discharged after 2 weeks'treatment. Computed tomography scans of patients helped monitor the changes continuously, which could timely provide the information of the evolution of the disease or therapeutic effect to clinicians. © 2020 Lippincott Williams and Wilkins. All rights reserved.</rdfs:comment>
    <dc:creator>Han X., Fan Y., Wan Y.-L., Shi H.</dc:creator>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1097/RTI.0000000000000506</j.0:identifier>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079756319">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079756319&amp;doi=10.1136%2fbmj.m627&amp;partnerID=40&amp;md5=4eb6d5563054f1ff98488a35625a16a2&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:title>Covid-19: A puzzle with many missing pieces</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>2-s2.0-85079756319</j.0:identifier>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Vetter P., Eckerle I., Kaiser L.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m627</j.0:identifier>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080034896">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <rdfs:comment>In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. Copyright © 2020 Massachusetts Medical Society.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W., China Novel Coronavirus Investigating and Research Team</dc:creator>
    <schema:keywords>adult; airway epithelium cell; Article; artificial ventilation; case report; China; clinical article; computer assisted tomography; controlled study; coronavirus disease 2019; Coronavirus infection; coughing; disease surveillance; epidemic; female; fever; human; male; middle aged; Middle East respiratory syndrome coronavirus; pneumonia; priority journal; respiratory distress; SARS coronavirus; thorax pain; transmission electron microscopy; virus detection; virus isolation; whole genome sequencing; Betacoronavirus; bronchoalveolar lavage fluid; cell culture; Coronavirus infection; diagnostic imaging; epithelium cell; genetics; isolation and purification; lung; pathology; phylogeny; respiratory system; thorax radiography; ultrastructure; virology; virus genome; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Adult; Betacoronavirus; Bronchoalveolar Lavage Fluid; Cells, Cultured; China; Coronavirus Infections; Epithelial Cells; Female; Genome, Viral; Humans; Lung; Male; Microscopy, Electron, Transmission; Middle Aged; Phylogeny; Pneumonia, Viral; Radiography, Thoracic; Respiratory System</schema:keywords>
    <j.0:identifier>2-s2.0-85080034896</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>175</myOnto:citeyBy>
    <myOnto:volume>382</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080034896&amp;doi=10.1056%2fNEJMoa2001017&amp;partnerID=40&amp;md5=03ca1e66534a3ac0c28d1c42393a7717&gt;</schema:url>
    <myOnto:issue>8</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <j.0:title>A novel coronavirus from patients with pneumonia in China, 2019</j.0:title>
    <j.0:identifier>10.1056/NEJMoa2001017</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078975424">
    <dc:date>2020</dc:date>
    <myOnto:volume>9</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords>antiinfective agent; antivirus agent; RNA; COVID-19; severe acute respiratory syndrome coronavirus 2; virus RNA; adult; amino acid sequence; Article; bronchoalveolar lavage fluid; Capnocytophaga; case report; clinical article; clinical feature; computer assisted tomography; Coronaviridae infection; Coronavirinae; coughing; dyspnea; epidemic; fever; gene mapping; high throughput sequencing; human; male; mental health; metagenomics; nucleotide sequence; phylogeny; pleura effusion; pneumonia; priority journal; respiratory failure; RNA extraction; RNA sequence; SARS coronavirus; sequence homology; single nucleotide polymorphism; statistically significant result; Veillonella; virus genome; virus identification; virus infection; young adult; Betacoronavirus; China; Coronavirus infection; epidemic; female; genetics; virus pneumonia; Adult; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Female; Genome, Viral; Humans; Male; Phylogeny; Pneumonia, Viral; RNA, Viral; Young Adult</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85078975424</j.0:identifier>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <j.0:title>RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak</j.0:title>
    <rdfs:comment>From December 2019, an outbreak of unusual pneumonia was reported in Wuhan with many cases linked to Huanan Seafood Market that sells seafood as well as live exotic animals. We investigated two patients who developed acute respiratory syndromes after independent contact history with this market. The two patients shared common clinical features including fever, cough, and multiple ground-glass opacities in the bilateral lung field with patchy infiltration. Here, we highlight the use of a low-input metagenomic next-generation sequencing (mNGS) approach on RNA extracted from bronchoalveolar lavage fluid (BALF). It rapidly identified a novel coronavirus (named 2019-nCoV according to World Health Organization announcement) which was the sole pathogens in the sample with very high abundance level (1.5% and 0.62% of total RNA sequenced). The entire viral genome is 29,881 nt in length (GenBank MN988668 and MN988669, Sequence Read Archive database Bioproject accession PRJNA601736) and is classified into ?-coronavirus genus. Phylogenetic analysis indicates that 2019-nCoV is close to coronaviruses (CoVs) circulating in Rhinolophus (Horseshoe bats), such as 98.7% nucleotide identity to partial RdRp gene of bat coronavirus strain BtCoV/4991 (GenBank KP876546, 370 nt sequence of RdRp and lack of other genome sequence) and 87.9% nucleotide identity to bat coronavirus strain bat-SL-CoVZC45 and bat-SL-CoVZXC21. Evolutionary analysis based on ORF1a/1b, S, and N genes also suggests 2019-nCoV is more likely a novel CoV independently introduced from animals to humans. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
    <j.0:identifier>10.1080/22221751.2020.1725399</j.0:identifier>
    <dc:creator>Chen L., Liu W., Zhang Q., Xu K., Ye G., Wu W., Sun Z., Liu F., Wu K., Zhong B., Mei Y., Zhang W., Chen Y., Li Y., Shi M., Lan K., Liu Y.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078975424&amp;doi=10.1080%2f22221751.2020.1725399&amp;partnerID=40&amp;md5=32a0885b42bc138f19c9d3e19c46c5d8&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081562443">
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1148/radiol.2020200323</j.0:identifier>
    <j.0:identifier>2-s2.0-85081562443</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081562443&amp;doi=10.1148%2fradiol.2020200323&amp;partnerID=40&amp;md5=bd7e21bfe2204a9eadf252250bb5f6d0&gt;</schema:url>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <schema:keywords>COVID-19; interferon; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; case report; complication; Coronavirus infection; diagnostic imaging; female; fever; human; inhalational drug administration; isolation and purification; lung; middle aged; pathology; real time polymerase chain reaction; virus pneumonia; x-ray computed tomography; Administration, Inhalation; Betacoronavirus; Coronavirus Infections; Female; Fever; Humans; Interferons; Lung; Middle Aged; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed</schema:keywords>
    <j.0:type>Note</j.0:type>
    <dc:creator>Duan Y.-N., Qin J.</dc:creator>
    <myOnto:volume>295</myOnto:volume>
    <j.0:title>Pre- And posttreatment chest CT findings: 2019 novel coronavirus (2019-NCoV) pneumonia</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081298581">
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:title>A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081298581</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Huang N.E., Qiao F.</dc:creator>
    <myOnto:issue>6</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081298581&amp;doi=10.1016%2fj.scib.2020.02.005&amp;partnerID=40&amp;md5=74dce09a6fe86e719ce9522464d30612&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/j.scib.2020.02.005</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Science_Bulletin">
        <j.1:name>Science Bulletin</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>65</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079603164">
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079603164&amp;doi=10.2807%2f1560-7917.ES.2020.25.6.2002131&amp;partnerID=40&amp;md5=c17bdff91e181869bb4355e911c84852&gt;</schema:url>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.6.2002131</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>6</myOnto:issue>
    <j.0:identifier>2-s2.0-85079603164</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <dc:creator>Eurosurveillance Editorial Team</dc:creator>
    <schema:keywords>COVID-19; Coronavirus infection; epidemic; Europe; health care planning; human; infection control; practice guideline; procedures; public health; virus pneumonia; Coronavirus Infections; Disease Outbreaks; Europe; Guidelines as Topic; Health Planning; Humans; Infection Control; Pneumonia, Viral; Public Health</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:title>Latest updates on COVID-19 from the European Centre for Disease Prevention and Control</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>25</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082036235">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1126/science.367.6484.1287</j.0:identifier>
    <j.0:title>Countries test tactics in 'war' against COVID-19</j.0:title>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Short Survey</j.0:type>
    <dc:creator>Cohen J., Kupferschmidt K.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>public health; testing method; viral disease; virus; COVID-19; China; communicable disease control; Coronavirus infection; Europe; human; pandemic; South Korea; United States; virus pneumonia; China; Communicable Disease Control; Coronavirus Infections; Europe; Humans; Pandemics; Pneumonia, Viral; Republic of Korea; United States</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:issue>6484</myOnto:issue>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082036235&amp;doi=10.1126%2fscience.367.6484.1287&amp;partnerID=40&amp;md5=30f782943652ded7e0322c785c51405d&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082036235</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.033846009302">
    <j.0:identifier></j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:publisher></j.0:publisher>
    <j.0:title>A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846009302&amp;partnerID=40&amp;md5=9b4451f4f9283e66d69f0f717dc1d92d&gt;</schema:url>
    <j.0:identifier>2-s2.0-33846009302</j.0:identifier>
    <dc:creator>Cao L., Wang T.Y., Chen H.Z., Qian Y., Chen B.W., Fang P., Sun Y.X., Zhu R.N., Deng J., Zhao L.Q., Mi J., Zhang T.</dc:creator>
    <dc:date>2004</dc:date>
    <rdfs:comment>OBJECTIVE: The severe acute respiratory syndrome (SARS) is a highly contagious infection caused by a newly discovered strain of coronavirus (SARS-CoV). During the outbreak of SARS in the first half of 2003, children appeared to be less susceptible to the SARS coronavirus and pediatric patients presented with a less aggressive clinical course than adult patients did, demonstrating the traits which were rarely observed in other viral contagious disease. The present study aimed to preliminarily examine the presence of serum specific antibodies against severe acute respiratory syndrome (SARS)-associated coronavirus virus (SARS-CoV) in pediatric SARS patients and explore the possibility of subclinical infection in children/adults through close association with SARS cases. METHODS: (1) Clinicians and nurses visited families and collected general and epidemiological information about the subjects using a standard questionnaire and took serum specimens. (2) Specific antibodies against SARS-CoV were assayed with two methods, indirect immunofluorescence assay (IFA) for detecting IgG antibodies and enzyme linked immunosorbent assay (ELISA) for mixed antibodies. Serum specimens tested included those from 21 clinically confirmed pediatric SARS cases (aged from 8 months to 14 years, 11 male and 10 female) and their 23 parents who had close contact with the children, 36 adult patients in convalescence stage of SARS, 24 children (aged 1.5 to 14 years) and other 34 adults who had close contact with infected adults. RESULTS: (1) The positive rates of specific IgG and mixed antibodies against SARS-CoV were 38% (8/21) and 33% (7/21) in pediatric cases; whereas the rates were 75% (27/36) and 69% (25/36) in adult patients. (2) The proportion of the patients who had close contact to SARS patients was 7/8 among the antibody-positive group vs. 1/13 for the antibody-negative group (P &lt; 0.05). (3) The IgG antibody emerged in one of 24 children, whose mother, a nurse, had suffered from SARS (4%). (4) Among 23 parents of children with SARS, one was positive for IgG and the mixed antibodies, whose grandson and husband suffered from SARS; The IgG antibody and the mixed antibodies were also positive in another adult who had close contact with adult SARS cases (3%). CONCLUSIONS: (1) SARS-CoV infection was confirmed by serological methods in 38.1% of clinically diagnosed pediatric SARS cases, which leads to the assumption that correct diagnosis of pediatric SARS requires more accurate and efficient ways, for example, screening for antigen or gene of SARS-CoV. (2) The proportion of the patients who had close contact to SARS patients among antibody-positive cases was higher than that in antibody-negative cases. (3) It is possible that subclinical SARS CoV infection exists in children and adults, although the rate of occurrence is low. The data of the present study did not confirm that SARS had subclinical infection among adults who had close contact to pediatric SARS cases.</rdfs:comment>
    <schema:keywords>immunoglobulin G; virus antibody; adolescent; adult; article; blood; child; enzyme linked immunosorbent assay; female; fluorescent antibody technique; human; immunology; infant; male; preschool child; SARS coronavirus; severe acute respiratory syndrome; Adolescent; Adult; Antibodies, Viral; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Infant; Male; SARS Virus; Severe Acute Respiratory Syndrome</schema:keywords>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Zhonghua_er_ke_za_zhi._Chinese_journal_of_pediatrics">
        <j.1:name>Zhonghua er ke za zhi. Chinese journal of pediatrics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>11</myOnto:issue>
    <myOnto:volume>42</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>Chinese</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082065544">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082065544&amp;doi=10.1136%2fbmj.m1118&amp;partnerID=40&amp;md5=f7dcb6efd41c0dbcdba38c0e0aa33441&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m1118</j.0:identifier>
    <j.0:title>Covid-19: UK government calls on industry to help boost testing capacity to 25?000 people a day</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Iacobucci G.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>2-s2.0-85082065544</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082178543">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Medicine"/>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:identifier>2-s2.0-85082178543</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082178543&amp;doi=10.1038%2fs41591-020-0817-4&amp;partnerID=40&amp;md5=c0df1d34772ee11e691bc18d40bb9ded&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>We report epidemiological and clinical investigations on ten pediatric SARS-CoV-2 infection cases confirmed by real-time reverse transcription PCR assay of SARS-CoV-2 RNA. Symptoms in these cases were nonspecific and no children required respiratory support or intensive care. Chest X-rays lacked definite signs of pneumonia, a defining feature of the infection in adult cases. Notably, eight children persistently tested positive on rectal swabs even after nasopharyngeal testing was negative, raising the possibility of fecal–oral transmission. © 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.</rdfs:comment>
    <j.0:identifier>10.1038/s41591-020-0817-4</j.0:identifier>
    <j.0:title>Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding</j.0:title>
    <dc:creator>Xu Y., Li X., Zhu B., Liang H., Fang C., Gong Y., Guo Q., Sun X., Zhao D., Shen J., Zhang H., Liu H., Xia H., Tang J., Zhang K., Gong S.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079876785">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Anti-Chinese sentiment during the 2019-nCoV outbreak</j.0:title>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079876785&amp;doi=10.1016%2fS0140-6736%2820%2930358-5&amp;partnerID=40&amp;md5=e4b33000268c64fb8446b9481cafb880&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S0140-6736(20)30358-5</j.0:identifier>
    <dc:creator>Chung R.Y.-N., Li M.M.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10225</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079876785</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>2019 novel coronavirus; China; Chinese; Coronavirinae; epidemic; health care personnel; health care policy; high risk population; Hong Kong; Letter; Macao; medical ethics; priority journal; public health; social media; Taiwan; Coronavirus infection; epidemiology; ethnology; human; psychology; racism; virus pneumonia; COVID-19; China; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; Racism</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081892683">
    <dc:language>English</dc:language>
    <j.0:publisher>Mosby Inc.</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.ajic.2020.01.023</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081892683&amp;doi=10.1016%2fj.ajic.2020.01.023&amp;partnerID=40&amp;md5=62cd602ca163506723374a21c34411a5&gt;</schema:url>
    <rdfs:comment>Cases of 2019-nCoV are now being reported in different regions around the globe, concerning for a possible SARS like epidemic that infected for than 8000 people in 2002-03. Though, major health authorities are still working on understanding the virus and its transmission, here we present a brief report regarding the 2019-nCoV outbreak and what is known so far. © 2020 Association for Professionals in Infection Control and Epidemiology, Inc.</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_Journal_of_Infection_Control">
        <j.1:name>American Journal of Infection Control</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Ammad Ud Din M., Boppana L.K.T.</dc:creator>
    <j.0:identifier>2-s2.0-85081892683</j.0:identifier>
    <j.0:title>An update on the 2019-nCoV outbreak</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082108980">
    <dc:creator>Yoon S.H., Lee K.H., Kim J.Y., Lee Y.K., Ko H., Kim K.H., Park C.M., Kim Y.-H.</dc:creator>
    <schema:keywords>COVID-19; Coronavirus infection; diagnostic imaging; female; human; lung; male; middle aged; South Korea; thorax; thorax radiography; virus pneumonia; x-ray computed tomography; Coronavirus Infections; Female; Humans; Lung; Male; Middle Aged; Pneumonia, Viral; Radiography, Thoracic; Republic of Korea; Thorax; Tomography, X-Ray Computed</schema:keywords>
    <rdfs:comment>Objective: This study presents a preliminary report on the chest radiographic and computed tomography (CT) findings of the 2019 novel coronavirus disease (COVID-19) pneumonia in Korea. Materials and Methods: As part of a multi-institutional collaboration coordinated by the Korean Society of Thoracic Radiology, we collected nine patients with COVID-19 infections who had undergone chest radiography and CT scans. We analyzed the radiographic and CT findings of COVID-19 pneumonia at baseline. Fisher’s exact test was used to compare CT findings depending on the shape of pulmonary lesions. Results: Three of the nine patients (33.3%) had parenchymal abnormalities detected by chest radiography, and most of the abnormalities were peripheral consolidations. Chest CT images showed bilateral involvement in eight of the nine patients, and a unilobar reversed halo sign in the other patient. In total, 77 pulmonary lesions were found, including patchy lesions (39%), large confluent lesions (13%), and small nodular lesions (48%). The peripheral and posterior lung fields were involved in 78% and 67% of the lesions, respectively. The lesions were typically ill-defined and were composed of mixed ground-glass opacities and consolidation or pure ground-glass opacities. Patchy to confluent lesions were primarily distributed in the lower lobes (p = 0.040) and along the pleura (p &lt; 0.001), whereas nodular lesions were primarily distributed along the bronchovascular bundles (p = 0.006). Conclusion: COVID-19 pneumonia in Korea primarily manifested as pure to mixed ground-glass opacities with a patchy to confluent or nodular shape in the bilateral peripheral posterior lungs. A considerable proportion of patients with COVID-19 pneumonia had normal chest radiographs. © 2020 The Korean Society of Radiology.</rdfs:comment>
    <j.0:identifier>2-s2.0-85082108980</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Korean_Journal_of_Radiology"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Chest radiographic and ct findings of the 2019 novel coronavirus disease (Covid-19): Analysis of nine patients treated in korea</j.0:title>
    <j.0:publisher>Korean Radiological Society</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>10.3348/kjr.2020.0132</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>21</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082108980&amp;doi=10.3348%2fkjr.2020.0132&amp;partnerID=40&amp;md5=abe689c51f19985927da5ad7c87902ab&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147494">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85082147494</j.0:identifier>
    <j.0:identifier></j.0:identifier>
    <schema:keywords>COVID-19; China; Coronavirus infection; diagnostic imaging; hospitalization; human; lung; pathology; physiologic monitoring; time factor; virus pneumonia; x-ray computed tomography; China; Coronavirus Infections; Hospitalization; Humans; Lung; Monitoring, Physiologic; Pneumonia, Viral; Time Factors; Tomography, X-Ray Computed</schema:keywords>
    <myOnto:volume>49</myOnto:volume>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>OBJECTIVE: To analyze the dynamic changes of chest CT images of patients with corona virus disease-19 (COVID-19). METHODS: Fifty-two cases of COVID-19 were admitted in the First Affiliated Hospital of Zhejiang University School of Medicine. The consecutive chest CT scans were followed up for all patients with an average of 4 scans performed per patient during the hospitalization. The shortest interval between each scan was 2 days and the longest was 7 days. The shape, number and distribution of lung shadows, as well as the characteristics of the lesions on the CT images were reviewed. RESULTS: The obvious shadows infiltrating the lungs were shown on CT images in 50 cases, for other 2 cases there was no abnormal changes in the lungs during the first CT examination. Ground-glass opacities (GGO) were found in 48 cases (92.3%), and 19 cases (36.5%) had patchy consolidation and sub-consolidation, which were accompanied with air bronchi sign in 17 cases (32.7%). Forty one cases (78.8%) showed a thickened leaflet interval, 4 cases (7.6%) had a small number of fibrous stripes. During hospitalization, GGO lesions in COVID-19 patients gradually became rare, the fibrous strip shadows increased and it became the most common imaging manifestation. The lesions rapidly progressed in 39 cases (75.0%) within 6-9 days after admission. On days 10-14 of admission, the lesions distinctly resolved in 40 cases (76.9%). CONCLUSIONS: The chest CT images of patients with COVID-19 have certain characteristics with dynamic changes, which are of value for monitoring disease progress and clinical treatment.</rdfs:comment>
    <j.0:title>Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)</j.0:title>
    <dc:creator>Wang J., Liu J., Wang Y., Liu W., Chen X., Sun C., Shen X., Wang Q., Wu Y., Liang W., Ruan L.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhejiang_da_xue_xue_bao._Yi_xue_ban_=_Journal_of_Zhejiang_University._Medical_sciences"/>
    <dc:language>Chinese</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147494&amp;partnerID=40&amp;md5=ae957a1a971f67582d9856b9619fdb07&gt;</schema:url>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079754203">
    <dc:language>English</dc:language>
    <j.0:title>Emergence of a novel coronavirus causing respiratory illness from Wuhan, China</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079754203</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <schema:keywords>adult; case fatality rate; case report; chill; China; clinical article; comorbidity; coronavirus disease 2019; Coronavirus infection; coughing; disease transmission; dyspnea; fatigue; female; fever; headache; health service; hospital admission; hospital discharge; human; infection control; Letter; male; middle aged; Middle East respiratory syndrome; patient isolation; phylogeny; pneumonia; respiratory tract disease; rhinorrhea; seroprevalence; severe acute respiratory syndrome; sore throat; thorax radiography; animal; Betacoronavirus; Coronavirus infection; genetics; virus genome; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; China; Coronavirus Infections; Genome, Viral; Humans; Phylogeny; Pneumonia, Viral</schema:keywords>
    <j.0:identifier>10.1016/j.jinf.2020.01.014</j.0:identifier>
    <myOnto:volume>80</myOnto:volume>
    <dc:creator>Tang J.W., Tambyah P.A., Hui D.S.C.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079754203&amp;doi=10.1016%2fj.jinf.2020.01.014&amp;partnerID=40&amp;md5=e66b68c0b0bd1eb827e8cbe3cdc0c0da&gt;</schema:url>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081740101">
    <rdfs:comment>Using the parameterized susceptible-exposed-infectious-recovered model, we simulated the spread dynamics of coronavirus disease 2019 (COVID-19) outbreak and impact of different control measures, conducted the sensitivity analysis to identify the key factor, plotted the trend curve of effective reproductive number (R), and performed data fitting after the simulation. By simulation and data fitting, the model showed the peak existing confirmed cases of 59 769 arriving on 15 February 2020, with the coefficient of determination close to 1 and the fitting bias 3.02%, suggesting high precision of the data-fitting results. More rigorous government control policies were associated with a slower increase in the infected population. Isolation and protective procedures would be less effective as more cases accrue, so the optimization of the treatment plan and the development of specific drugs would be of more importance. There was an upward trend of R in the beginning, followed by a downward trend, a temporary rebound, and another continuous decline. The feature of high infectiousness for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) led to an upward trend, and government measures contributed to the temporary rebound and declines. The declines of R could be exploited as strong evidence for the effectiveness of the interventions. Evidence from the four-phase stringent measures showed that it was significant to ensure early detection, early isolation, early treatment, adequate medical supplies, patients’ being admitted to designated hospitals, and comprehensive therapeutic strategy. Collaborative efforts are required to combat the novel coronavirus, focusing on both persistent strict domestic interventions and vigilance against exogenous imported cases. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:title>Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis</j.0:title>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1002/jmv.25750</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081740101&amp;doi=10.1002%2fjmv.25750&amp;partnerID=40&amp;md5=8177034c4f27d95ad1627be1bdc7da8a&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <dc:creator>Fang Y., Nie Y., Penny M.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081740101</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080979697">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <j.0:identifier>10.1016/j.jinf.2020.02.026</j.0:identifier>
    <dc:creator>Ibrahim I.M., Abdelmalek D.H., Elshahat M.E., Elfiky A.A.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080979697&amp;doi=10.1016%2fj.jinf.2020.02.026&amp;partnerID=40&amp;md5=b37530eb243fcb23122147331b96fb9f&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080979697</j.0:identifier>
    <j.0:title>COVID-19 spike-host cell receptor GRP78 binding site prediction</j.0:title>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <rdfs:comment>Objectives: Understanding the novel coronavirus (COVID-19) mode of host cell recognition may help to fight the disease and save lives. The spike protein of coronaviruses is the main driving force for host cell recognition. Methods: In this study, the COVID-19 spike binding site to the cell-surface receptor (Glucose Regulated Protein 78 (GRP78)) is predicted using combined molecular modeling docking and structural bioinformatics. The COVID-19 spike protein is modeled using its counterpart, the SARS spike. Results: Sequence and structural alignments show that four regions, in addition to its cyclic nature have sequence and physicochemical similarities to the cyclic Pep42. Protein-protein docking was performed to test the four regions of the spike that fit tightly in the GRP78 Substrate Binding Domain ? (SBD?). The docking pose revealed the involvement of the SBD? of GRP78 and the receptor-binding domain of the coronavirus spike protein in recognition of the host cell receptor. Conclusions: We reveal that the binding is more favorable between regions III (C391-C525) and IV (C480-C488) of the spike protein model and GRP78. Region IV is the main driving force for GRP78 binding with the predicted binding affinity of -9.8 kcal/mol. These nine residues can be used to develop therapeutics specific against COVID-19. © 2020</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092432">
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092432&amp;doi=10.1136%2fbmj.m1117&amp;partnerID=40&amp;md5=8d7d680b21e18f35fbe15a2c225cc51b&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>368</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:title>Challenges for NHS hospitals during covid-19 epidemic</j.0:title>
    <dc:creator>Willan J., King A.J., Jeffery K., Bienz N.</dc:creator>
    <j.0:identifier>10.1136/bmj.m1117</j.0:identifier>
    <j.0:identifier>2-s2.0-85082092432</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081696166">
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081696166&amp;doi=10.1016%2fj.jmii.2020.03.002&amp;partnerID=40&amp;md5=a79ee9420cb68370170c337494080fc9&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081696166</j.0:identifier>
    <rdfs:comment>Translation of a genetic codon without a cognate tRNA gene is affected by both the cognate tRNA availability and the interaction with non-cognate isoacceptor tRNAs. Moreover, two consecutive slow codons (slow di-codons) lead to a much slower translation rate. Calculating the composition of host specific slow codons and slow di-codons in the viral protein coding sequences can predict the order of viral protein synthesis rates between different virus strains. Comparison of human-specific slow codon and slow di-codon compositions in the genomes of 590 coronaviruses infect humans revealed that the protein synthetic rates of 2019 novel coronavirus (2019-nCoV) and severe acute respiratory syndrome-related coronavirus (SARS-CoV) may be much faster than other coronaviruses infect humans. Analysis of host-specific slow codon and di-codon compositions provides links between viral genomic sequences and capability of virus replication in host cells that may be useful for surveillance of the transmission potential of novel viruses. © 2020</rdfs:comment>
    <j.0:title>Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/j.jmii.2020.03.002</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Yang C.-W., Chen M.-F.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081562008">
    <j.0:publisher>Korea Centers for Disease Control and Prevention</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>10.24171/j.phrp.2020.11.1.03</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Objectives: The first confirmed case of coronavirus disease 2019 (COVID-19) in South Korea was reported in January 2020, with 28 confirmed cases reported as of February 14th, 2020. The epidemiological and clinical characteristics of all 28 cases were analyzed in response to this disease. Methods: The epidemiological characteristics and early clinical features of the 28 patients from Korea with confirmed COVID-19 were analyzed using COVID-19 reporting and surveillance data and the epidemiological investigation reports prepared by the rapid response team. Results: There were 16 patients that entered Korea from foreign countries: Wuhan, China (11 patients), Zhuhai, China, (1 patient), Singapore (2 patients), Japan (1 patient), and Thailand (1 patient). The early symptoms were fever, sore throat, cough or sputum production, chills, and muscle ache. Three patients were asymptomatic, however, 18 developed pneumonia. Of the 28 cases, 16 were index cases imported from abroad, with 10 cases of secondary infection originating in Korea, and the route of transmission still under investigation for 2 patients. The 10 patients with secondary infection were infected from contact with family members or acquaintances of primary patients, and the suspected sites of transmission were mostly at home. Conclusion: COVID-19 in Korea was spread by 16 infected individuals traveling from other countries, leading to second-generation cases. The initial symptoms were mostly minor, but the disease was infectious at this stage, resulting from close contact, particularly at home. Establishing an early detection strategy for COVID-19 is crucial for managing the transmission of the disease. © 2020 Korea Centers for Disease Control and Prevention.</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords>analgesic agent; antibiotic agent; adult; aged; Article; asymptomatic infection; case study; chill; China; clinical article; clinical feature; coronavirus disease 2019; Coronavirus infection; coughing; family; female; fever; headache; home; human; Japan; male; middle aged; myalgia; priority journal; secondary infection; Singapore; sore throat; South Korea; sputum; Thailand; travel; virus pneumonia; virus transmission; weakness</schema:keywords>
    <j.0:title>Early epidemiological and clinical characteristics of 28 cases of coronavirus disease in South Korea</j.0:title>
    <myOnto:issue>1</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081562008&amp;doi=10.24171%2fj.phrp.2020.11.1.03&amp;partnerID=40&amp;md5=4fbff505b99a3dc931cb6ac90b3ebe28&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Kong I., Park Y., Woo Y., Lee J., Cha J., Choi J., Kim Y., Kim J., Park S., Yum M., Kim T., Jo J., Kim M., Lee D., Kim J., Park S., Bahk H., Yu J., Kwon J., Kim H., Shin N., Lee S., In H., Jung J., Cho S., Jeon B., Kim D., Jin G., Kim S., Kim S., Kim Y., Kim E., Kim B.I., Kim H., Lee H., Jin Y., Kim J., Kim H., Ryu B., Shin S., Shin E., Lee J., Lee S., Jang Y., Choi E., Hyun J., Ko D., Seo G., Kwon S., Park E., Choi S., Hwang S., Lee S., Kang B., Park J., Lee D., Jo S., Choi S., Lee J., Cho S., Park J., Kim J., Lee E., Kim J., Kim S., Kim U., COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention</dc:creator>
    <j.0:identifier>2-s2.0-85081562008</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Osong_Public_Health_and_Research_Perspectives"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082023874">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082023874&amp;doi=10.1186%2fs13054-020-2833-7&amp;partnerID=40&amp;md5=5a82c72393782bbc4e640935a470963c&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan</j.0:title>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>10.1186/s13054-020-2833-7</j.0:identifier>
    <j.0:identifier>2-s2.0-85082023874</j.0:identifier>
    <myOnto:volume>24</myOnto:volume>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Critical_care_(London,_England)"/>
    <dc:creator>Shi Y., Yu X., Zhao H., Wang H., Zhao R., Sheng J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; aged; Betacoronavirus; China; Coronavirus infection; disease exacerbation; disease predisposition; epidemiology; female; human; male; middle aged; mortality; risk assessment; risk factor; virus pneumonia; Aged; Betacoronavirus; China; Coronavirus Infections; Disease Progression; Disease Susceptibility; Female; Humans; Male; Middle Aged; Pneumonia, Viral; Risk Assessment; Risk Factors</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081968739">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Bearing the brunt of covid-19: Older people in low and middle income countries</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081968739&amp;doi=10.1136%2fbmj.m1052&amp;partnerID=40&amp;md5=7121e2877b81ff6993a377d057a76b26&gt;</schema:url>
    <dc:creator>Lloyd-Sherlock P., Ebrahim S., Geffen L., McKee M.</dc:creator>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:identifier>10.1136/bmj.m1052</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; aged; aging; Betacoronavirus; Coronavirus infection; developing country; home for the aged; human; immunology; very elderly; virus pneumonia; vulnerable population; Aged; Aged, 80 and over; Aging; Betacoronavirus; Coronavirus Infections; Developing Countries; Homes for the Aged; Humans; Pneumonia, Viral; Vulnerable Populations</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>2-s2.0-85081968739</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081587501">
    <schema:keywords></schema:keywords>
    <rdfs:comment>Purpose: Coronavirus disease (COVID-19) has rapidly emerged as a global health threat. The purpose of this article is to share our local experience of stepping up infection control measures in ophthalmology to minimise COVID-19 infection of both healthcare workers and patients. Methods: Infection control measures implemented in our ophthalmology clinic are discussed. The measures are based on detailed risk assessment by both local ophthalmologists and infection control experts. Results: A three-level hierarchy of control measures was adopted. First, for administrative control, in order to lower patient attendance, text messages with an enquiry phone number were sent to patients to reschedule appointments or arrange drug refill. In order to minimise cross-infection of COVID-19, a triage system was set up to identify patients with fever, respiratory symptoms, acute conjunctivitis or recent travel to outbreak areas and to encourage these individuals to postpone their appointments for at least 14 days. Micro-aerosol generating procedures, such as non-contact tonometry and operations under general anaesthesia were avoided. Nasal endoscopy was avoided as it may provoke sneezing and cause generation of droplets. All elective clinical services were suspended. Infection control training was provided to all clinical staff. Second, for environmental control, to reduce droplet transmission of COVID-19, installation of protective shields on slit lamps, frequent disinfection of equipment, and provision of eye protection to staff were implemented. All staff were advised to measure their own body temperatures before work and promptly report any symptoms of upper respiratory tract infection, vomiting or diarrhoea. Third, universal masking, hand hygiene, and appropriate use of personal protective equipment (PPE) were promoted. Conclusion: We hope our initial experience in stepping up infection control measures for COVID-19 infection in ophthalmology can help ophthalmologists globally to prepare for the potential community outbreak or pandemic. In order to minimise transmission of COVID-19, ophthalmologists should work closely with local infection control teams to implement infection control measures that are appropriate for their own clinical settings. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Graefe&apos;s_Archive_for_Clinical_and_Experimental_Ophthalmology">
        <j.1:name>Graefe's Archive for Clinical and Experimental Ophthalmology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1007/s00417-020-04641-8</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Lai T.H.T., Tang E.W.H., Chau S.K.Y., Fung K.S.C., Li K.K.W.</dc:creator>
    <j.0:identifier>2-s2.0-85081587501</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081587501&amp;doi=10.1007%2fs00417-020-04641-8&amp;partnerID=40&amp;md5=38a22d718ea1264dd3eb3c190166f3a3&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.080055066817">
    <j.0:identifier>10.1371/journal.ppat.1002294</j.0:identifier>
    <myOnto:volume>7</myOnto:volume>
    <schema:keywords>methyltransferase; nonstructural protein 10; nonstructural protein 16; s adenosylmethionine; unclassified drug; virus protein; virus RNA; capped RNA; m7GpppA; methyltransferase; Nsp10 protein, SARS virus; Nsp16 protein, SARS virus; S adenosyl L methionine dependent N methyltransferase; s adenosylmethionine; S-adenosyl-L-methionine-dependent N-methyltransferase; virus protein; virus RNA; amino acid sequence; article; chemical analysis; controlled study; crystal structure; nonhuman; protein function; protein methylation; RNA binding; SARS coronavirus; virus morphology; chemical structure; chemistry; genetics; metabolism; methylation; molecular genetics; protein binding; protein secondary structure; protein tertiary structure; X ray crystallography; Coronavirus; Eukaryota; SARS coronavirus; Crystallography, X-Ray; Methylation; Methyltransferases; Models, Molecular; Molecular Sequence Data; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; RNA Cap Analogs; RNA Caps; RNA, Viral; S-Adenosylmethionine; SARS Virus; Viral Nonstructural Proteins</schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2011</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher></j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/PLoS_Pathogens">
        <j.1:name>PLoS Pathogens</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-80055066817</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-80055066817&amp;doi=10.1371%2fjournal.ppat.1002294&amp;partnerID=40&amp;md5=7a46bf80236a8f6ffe530cff80caff13&gt;</schema:url>
    <myOnto:issue>10</myOnto:issue>
    <dc:creator>Chen Y., Su C., Ke M., Jin X., Xu L., Zhang Z., Wu A., Sun Y., Yang Z., Tien P., Ahola T., Liang Y., Liu X., Guo D.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:title>Biochemical and structural insights into the mechanisms of sars coronavirus RNA ribose 2?-O-methylation by nsp16/nsp10 protein complex</j.0:title>
    <myOnto:citeyBy>58</myOnto:citeyBy>
    <rdfs:comment>The 5?-cap structure is a distinct feature of eukaryotic mRNAs, and eukaryotic viruses generally modify the 5?-end of viral RNAs to mimic cellular mRNA structure, which is important for RNA stability, protein translation and viral immune escape. SARS coronavirus (SARS-CoV) encodes two S-adenosyl-L-methionine (SAM)-dependent methyltransferases (MTase) which sequentially methylate the RNA cap at guanosine-N7 and ribose 2?-O positions, catalyzed by nsp14 N7-MTase and nsp16 2?-O-MTase, respectively. A unique feature for SARS-CoV is that nsp16 requires non-structural protein nsp10 as a stimulatory factor to execute its MTase activity. Here we report the biochemical characterization of SARS-CoV 2?-O-MTase and the crystal structure of nsp16/nsp10 complex bound with methyl donor SAM. We found that SARS-CoV nsp16 MTase methylated m7GpppA-RNA but not m7GpppG-RNA, which is in contrast with nsp14 MTase that functions in a sequence-independent manner. We demonstrated that nsp10 is required for nsp16 to bind both m7GpppA-RNA substrate and SAM cofactor. Structural analysis revealed that nsp16 possesses the canonical scaffold of MTase and associates with nsp10 at 1:1 ratio. The structure of the nsp16/nsp10 interaction interface shows that nsp10 may stabilize the SAM-binding pocket and extend the substrate RNA-binding groove of nsp16, consistent with the findings in biochemical assays. These results suggest that nsp16/nsp10 interface may represent a better drug target than the viral MTase active site for developing highly specific anti-coronavirus drugs. © 2011 Chen et al.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081226278">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Clinica_Chimica_Acta"/>
    <j.0:identifier>2-s2.0-85081226278</j.0:identifier>
    <j.0:title>Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081226278&amp;doi=10.1016%2fj.cca.2020.03.004&amp;partnerID=40&amp;md5=788889928c8bd2bfd092fedf826d30e1&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>gamma interferon; interleukin 1beta; interleukin 6; procalcitonin; tumor necrosis factor; adult respiratory distress syndrome; artificial ventilation; clinical decision making; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease severity; high risk population; hospital admission; human; intensive care unit; Letter; nonhuman; pneumonia; priority journal; severe acute respiratory syndrome coronavirus 2</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>505</myOnto:volume>
    <dc:date>2020</dc:date>
    <dc:creator>Lippi G., Plebani M.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.cca.2020.03.004</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079753489">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <j.0:title>Coronavirus epidemic snarls science worldwide</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:issue>6480</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>China; coronavirus disease 2019; emergency health service; epidemic; health care access; human; nonhuman; Note; pandemic; priority journal; severe acute respiratory syndrome; virus isolation; virus transmission; Coronavirus</schema:keywords>
    <dc:creator>Service R.F.</dc:creator>
    <j.0:identifier>2-s2.0-85079753489</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079753489&amp;doi=10.1126%2fscience.367.6480.836&amp;partnerID=40&amp;md5=5700cb1b1f65205d87d29bc543c6a0f9&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1126/science.367.6480.836</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>367</myOnto:volume>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081540807">
    <schema:keywords>antimicrobial stewardship; coronavirus disease 2019; Coronavirus infection; disease severity; emergency health service; fever; general practice; general practitioner; human; infection risk; medical education; Note; pandemic; prescription; priority journal; symptom; viral respiratory tract infection</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081540807&amp;doi=10.1136%2fbmj.m944&amp;partnerID=40&amp;md5=f942a82f6d9a399f12c2bd00ce27ebac&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Salisbury H.</dc:creator>
    <j.0:identifier>2-s2.0-85081540807</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <myOnto:volume>368</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Helen salisbury: Is general practice prepared for a pandemic?</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1136/bmj.m944</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079081422">
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079081422&amp;doi=10.1136%2fbmj.m516&amp;partnerID=40&amp;md5=93678e25a2c7ce444043c1fbfb4d5580&gt;</schema:url>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m516</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <schema:keywords>2019 novel coronavirus; attitude to health; China; Coronavirinae; epidemic; health care system; health hazard; human; infection control; misinformation; Note; patient isolation; priority journal; public health</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079081422</j.0:identifier>
    <j.0:title>In Beijing, coronavirus 2019-nCoV has created a siege mentality</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>368</myOnto:volume>
    <dc:creator>Mowbray H.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082022545">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082022545&amp;doi=10.1186%2fs13054-020-2818-6&amp;partnerID=40&amp;md5=beb1d5d0e62e0d45b1bddf056ea9d2ac&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:title>Treatment of COVID-19: old tricks for new challenges</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Critical_care_(London,_England)"/>
    <j.0:identifier>2-s2.0-85082022545</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Cunningham A.C., Goh H.P., Koh D.</dc:creator>
    <myOnto:issue>1</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>24</myOnto:volume>
    <j.0:identifier>10.1186/s13054-020-2818-6</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords>antiserum; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; epidemic; human; immunology; pandemic; plasma; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Immune Sera; Pandemics; Plasma; Pneumonia, Viral</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079784315">
    <myOnto:volume>6</myOnto:volume>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <dc:creator>Cao Y., Li L., Feng Z., Wan S., Huang P., Sun X., Wen F., Huang X., Ning G., Wang W.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1038/s41421-020-0147-1</j.0:identifier>
    <j.0:identifier>2-s2.0-85079784315</j.0:identifier>
    <schema:keywords>angiotensin converting enzyme 2; lysine; tyrosine; vitronectin; 2019 novel coronavirus; amino acid sequence; Asian; comparative gene mapping; Coronavirinae; Coronavirus infection; East Asian; expression quantitative trait locus; gene expression level; gene frequency; genetic analysis; genetic susceptibility; genetic variability; human; in vitro study; Letter; male; mutation rate; priority journal; RNA sequencing; SARS coronavirus</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Discovery">
        <j.1:name>Cell Discovery</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079784315&amp;doi=10.1038%2fs41421-020-0147-1&amp;partnerID=40&amp;md5=e102b20e9b1029d90f49ff23601c28c0&gt;</schema:url>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081699322">
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>10.1002/jmv.25729</j.0:identifier>
    <j.0:title>A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease-19 treatment option</j.0:title>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081699322&amp;doi=10.1002%2fjmv.25729&amp;partnerID=40&amp;md5=2c00369bafb1107aee31d18ca89c4f11&gt;</schema:url>
    <dc:creator>Yao T.-T., Qian J.-D., Zhu W.-Y., Wang Y., Wang G.-Q.</dc:creator>
    <j.0:identifier>2-s2.0-85081699322</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <rdfs:comment>In the past few decades, coronaviruses have risen as a global threat to public health. Currently, the outbreak of coronavirus disease-19 (COVID-19) from Wuhan caused a worldwide panic. There are no specific antiviral therapies for COVID-19. However, there are agents that were used during the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) epidemics. We could learn from SARS and MERS. Lopinavir (LPV) is an effective agent that inhibits the protease activity of coronavirus. In this review, we discuss the literature on the efficacy of LPV in vitro and in vivo, especially in patients with SARS and MERS, so that we might clarify the potential for the use of LPV in patients with COVID-19. © 2020 The Authors. Journal of Medical Virology published by Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082146869">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:volume>52</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082146869</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:title>COVID-19 - what should anaethesiologists and intensivists know about it?</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Anaesthesiology_intensive_therapy">
        <j.1:name>Anaesthesiology intensive therapy</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Wujtewicz M., Dylczyk-Sommer A., Aszkie?owicz A., Zdanowski S., Piwowarczyk S., Owczuk R.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <rdfs:comment>Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus.</rdfs:comment>
    <j.0:identifier>10.5114/ait.2020.93756</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082146869&amp;doi=10.5114%2fait.2020.93756&amp;partnerID=40&amp;md5=f4eb5f86e748608919ae25c47f6d11d3&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081986566">
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081986566</j.0:identifier>
    <j.0:publisher>Wiley-Liss Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081986566&amp;doi=10.1002%2fajh.25774&amp;partnerID=40&amp;md5=d51c8438320fd2292524bfbb2aea02b9&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Fan B.E., Chong V.C.L., Chan S.S.W., Lim G.H., Lim K.G.E., Tan G.B., Mucheli S.S., Kuperan P., Ong K.H.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_Journal_of_Hematology">
        <j.1:name>American Journal of Hematology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1002/ajh.25774</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Hematologic parameters in patients with COVID-19 infection</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082201405">
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>2-s2.0-85082201405</j.0:identifier>
    <dc:creator>The Lancet</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30686-3</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>10229</myOnto:issue>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <j.0:title>COVID-19: learning from experience</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082201405&amp;doi=10.1016%2fS0140-6736%2820%2930686-3&amp;partnerID=40&amp;md5=d6f0e7752fbd8d5093e604619e36b857&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082097047">
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; tumor necrosis factor receptor associated factor 6; Betacoronavirus; civil defense; Coronavirus infection; economics; emergency; global health; human; pandemic; pathogenicity; procedures; public health; virus pneumonia; Betacoronavirus; Civil Defense; Coronavirus Infections; Economics; Emergencies; Global Health; Humans; Pandemics; Pneumonia, Viral; Public Health; TNF Receptor-Associated Factor 6</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Prehospital_and_Disaster_Medicine">
        <j.1:name>Prehospital and Disaster Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume></myOnto:volume>
    <j.0:title>COVID-19: Not a Simple Public Health Emergency</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85082097047</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1017/S1049023X2000031X</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Stratton S.J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082097047&amp;doi=10.1017%2fS1049023X2000031X&amp;partnerID=40&amp;md5=ab9681af8d2f65674feb3465e4946098&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079006613">
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.4.2000057</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079006613&amp;doi=10.2807%2f1560-7917.ES.2020.25.4.2000057&amp;partnerID=40&amp;md5=cb8ae3e92f9b1733133562885ec650eb&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <rdfs:comment>As at 27 January 2020, 42 novel coronavirus (2019-nCoV) cases were confirmed outside China. We estimate the risk of case importation to Europe from affected areas in China via air travel. We consider travel restrictions in place, three reported cases in France, one in Germany. Estimated risk in Europe remains high. The United Kingdom, Germany and France are at highest risk. Importation from Beijing and Shanghai would lead to higher and widespread risk for Europe.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079006613</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue>4</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; aviation; Betacoronavirus; China; Coronavirus infection; epidemic; Europe; human; public policy; risk assessment; theoretical model; virus pneumonia; Air Travel; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Europe; Humans; Models, Theoretical; Pneumonia, Viral; Public Policy; Risk Assessment</schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:title>Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020</j.0:title>
    <dc:creator>Pullano G., Pinotti F., Valdano E., Boëlle P.-Y., Poletto C., Colizza V.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081947637">
    <dc:creator>Rimmer A.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m1055</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081947637&amp;doi=10.1136%2fbmj.m1055&amp;partnerID=40&amp;md5=21485c52e6ede543874b3c07dc876d87&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081947637</j.0:identifier>
    <j.0:title>Covid-19: GPs call for same personal protective equipment as hospital doctors</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081930419">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081930419</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1136/vr.m1009</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue>10</myOnto:issue>
    <myOnto:volume>186</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081930419&amp;doi=10.1136%2fvr.m1009&amp;partnerID=40&amp;md5=93196db119ef1a42187f0ebbce9c91f7&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Veterinary_Record"/>
    <dc:creator>Loeb J.</dc:creator>
    <j.0:publisher>British Veterinary Association</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; Coronavirus infection; human; procedures; psychology; public health; self care; veterinarian; veterinary medicine; virus pneumonia; Animals; Betacoronavirus; Coronavirus Infections; Humans; Pneumonia, Viral; Public Health; Self Care; Veterinarians; Veterinary Medicine</schema:keywords>
    <j.0:title>RCVS may relax guidance due to Covid-19</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081579421">
    <dc:language>English</dc:language>
    <j.0:identifier></j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081579421&amp;partnerID=40&amp;md5=78c309ae5550e858c8c3c5c64fadbb38&gt;</schema:url>
    <myOnto:volume>24</myOnto:volume>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>2-s2.0-85081579421</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Turkish_Journal_of_Endocrinology_and_Metabolism">
        <j.1:name>Turkish Journal of Endocrinology and Metabolism</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Turkiye Klinikleri</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <j.0:title>Editorial</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; asthma; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; diabetes mellitus; disease severity; Editorial; glucose blood level; heart disease; human; incidence; mortality rate; pneumonia; World Health Organization</schema:keywords>
    <dc:creator>Ba?kal N.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.033744899303">
    <j.0:title>Specificity and epitope mapping of four monoclonal antibodies against SARS-CoV nucleocapsid protein</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <dc:creator>Wang J.-W., Wang Y.-B., Chang Z.-R., Yan K.-X., Tan W.-J., Qu J.-G., Xia N.-S., Ruan L., Hung T.</dc:creator>
    <dc:date>2006</dc:date>
    <dc:language>Chinese</dc:language>
    <myOnto:volume>21</myOnto:volume>
    <schema:keywords>amino acid; monoclonal antibody; monoclonal antibody 1 1C2; monoclonal antibody 1 1D6; monoclonal antibody 2 2E5; monoclonal antibody 2 8F11; nucleocapsid protein; unclassified drug; antibody specificity; article; controlled study; epitope mapping; Escherichia coli; fluorescent antibody technique; immunoassay; nonhuman; nucleotide sequence; protein analysis; protein expression; protein localization; SARS coronavirus; Western blotting; Coronavirus; SARS coronavirus</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744899303&amp;partnerID=40&amp;md5=8059a9ef924183beba79ffee649d14b5&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>In order to characterize the specificity of the monoclonal antibodies (McAbs) against SARS-associated coronavirus (SARS-CoV) nucleocapsid protein and to identify the epitopes recognized by the McAbs, the nucleocapsid proteins of human coronavirus OC43 (HCoV-OC43) and 229E (HCoV-229E) was expressed in E.coli. The specificities of four McAbs (1-1C2, 2-2E5, 1-1D6, and 2-8F11) were examined by Western blotting as well as indirect fluorescence assay. Twelve different recombinant truncated N proteins were then used to identify the epitopes recognized by the McAbs by Western blotting. The results showed that: (1) McAbs 1-1C2, 2-2E5, and 1-1D6 recognized neither human coronviruses HCoV-OC43 and HCoV-229E nor their nucleocapsid proteins, implying a possible specificity of these 3 McAbs to SARS-CoV; (2) The epitopes recognized by McAbs 2-8F11, 2-2E5, and 1-1D6 were located between the 30th and 60th amino acid (a.a.) residues of the SARS-CoV N protein, while the epitopes recognized by the McAb1-1C2 were located between 170th and 184th a.a. residues. The identification of the specific epitopes of SARS-CoV N protein is paramount for the immunological characterization, the development of accurate immunological assay as well as for exploring the pathogenesis of SARS-CoV.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher></j.0:publisher>
    <j.0:identifier></j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Virologica_Sinica">
        <j.1:name>Virologica Sinica</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-33744899303</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079335720">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079335720&amp;doi=10.3390%2fv12020194&amp;partnerID=40&amp;md5=4e8ed67d5664c96f1d73a062b5ceb9b9&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; case fatality rate; coronavirus disease 2019; enzyme immunoassay; epidemic; female; fetus outcome; human; immunofluorescence test; infant; infection prevention; maternal morbidity; maternal mortality; Middle East respiratory syndrome; newborn morbidity; placenta disorder; pneumonia; pregnancy; pregnancy outcome; pregnant woman; prevalence; reverse transcription polymerase chain reaction; Review; safety; severe acute respiratory syndrome; virus transmission; China; Coronavirinae; Coronavirus infection; immunology; maternal exposure; newborn; pathology; placenta; pregnancy; pregnancy complication; severe acute respiratory syndrome; vertical transmission; virus pneumonia; COVID-19; virus vaccine; China; Coronavirus; Coronavirus Infections; Disease Outbreaks; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Exposure; Placenta; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Severe Acute Respiratory Syndrome; Viral Vaccines</schema:keywords>
    <dc:creator>Schwartz D.A., Graham A.L.</dc:creator>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Potential maternal and infant outcomes from coronavirus 2019-NCOV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections</j.0:title>
    <j.0:identifier>2-s2.0-85079335720</j.0:identifier>
    <j.0:identifier>10.3390/v12020194</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Viruses"/>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:volume>12</myOnto:volume>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <rdfs:comment>In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People’s Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, initially termed 2019-nCoV and subsequently SARS-CoV-2. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the new coronavirus was reported to spread via natural aerosols from human-to-human. In the early stages of this epidemic the case fatality rate is estimated to be approximately 2%, with the majority of deaths occurring in special populations. Unfortunately, there is limited experience with coronavirus infections during pregnancy, and it now appears certain that pregnant women have become infected during the present 2019-nCoV epidemic. In order to assess the potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of SARS, MERS, and other coronavirus infections on pregnant women and their infants. Recommendations are also made for the consideration of pregnant women in the design, clinical trials, and implementation of future 2019-nCoV vaccines. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).</rdfs:comment>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081897184">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081897184&amp;doi=10.1136%2fbmj.m998&amp;partnerID=40&amp;md5=e371422aa420dce3d75a018175ee5578&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Greenhalgh T., Wherton J., Shaw S., Morrison C.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081897184</j.0:identifier>
    <myOnto:volume>368</myOnto:volume>
    <j.0:title>Video consultations for covid-19</j.0:title>
    <j.0:type>Editorial</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:identifier>10.1136/bmj.m998</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>COVID-19; Coronavirus infection; health care delivery; human; organization; procedures; teleconsultation; videorecording; virus pneumonia; Coronavirus Infections; Delivery of Health Care; Humans; Organizational Innovation; Pneumonia, Viral; Remote Consultation; Video Recording</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081039805">
    <myOnto:volume>177</myOnto:volume>
    <j.0:identifier>10.1016/j.antiviral.2020.104759</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:title>A potential role for integrins in host cell entry by SARS-CoV-2</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Antiviral_Research">
        <j.1:name>Antiviral Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081039805&amp;doi=10.1016%2fj.antiviral.2020.104759&amp;partnerID=40&amp;md5=860ff0567a1a602798ad5f3daea4d4be&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081039805</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <dc:creator>Sigrist C.J., Bridge A., Le Mercier P.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081643652">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.9.2000152</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081643652&amp;doi=10.2807%2f1560-7917.ES.2020.25.9.2000152&amp;partnerID=40&amp;md5=4b2765f97dbe96449b395e4c71643493&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system</j.0:title>
    <rdfs:comment>Facing the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), high-volume respiratory testing is demanded in laboratories worldwide. We evaluated the performance of a molecular assay for the detection of SARS-CoV-2 on a high-throughput platform, the cobas 6800, using the 'open channel' for integration of a laboratory-developed assay. We observed good analytical performance in clinical specimens. The fully automated workflow enables high-throughput testing with minimal hands-on time, while offering fast and reliable results.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <dc:creator>Pfefferle S., Reucher S., Nörz D., Lütgehetmann M.</dc:creator>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirinae; human; reverse transcription polymerase chain reaction; SARS coronavirus; sensitivity and specificity; severe acute respiratory syndrome; Betacoronavirus; Coronavirus; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS Virus; Sensitivity and Specificity; Severe Acute Respiratory Syndrome</schema:keywords>
    <j.0:identifier>2-s2.0-85081643652</j.0:identifier>
    <myOnto:issue>9</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081693207">
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Wang J., Qi H., Bao L., Li F., Shi Y., National Clinical Research Center for Child Health and Disorders and Pediatric Committee of Medical Association of Chinese People's Liberation Army</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Child_and_Adolescent_Health"/>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081693207</j.0:identifier>
    <j.0:identifier>10.1016/S2352-4642(20)30040-7</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <j.0:title>A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units</j.0:title>
    <myOnto:volume>4</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081693207&amp;doi=10.1016%2fS2352-4642%2820%2930040-7&amp;partnerID=40&amp;md5=cd8b30d3426f74b579a03cf0e68628db&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079758648">
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079758648</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Higher Education Press</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079758648&amp;doi=10.1007%2fs13238-020-00693-y&amp;partnerID=40&amp;md5=34987ce0c927042b9ca370e249420401&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:title>Puzzle of highly pathogenic human coronaviruses (2019-nCoV)</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1007/s13238-020-00693-y</j.0:identifier>
    <dc:creator>Li J., Liu W.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Protein_and_Cell">
        <j.1:name>Protein and Cell</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079870863">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>10225</myOnto:issue>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>Do not violate the International Health Regulations during the COVID-19 outbreak</j.0:title>
    <schema:keywords>China; consensus; coronavirus disease 2019; Coronavirus infection; epidemic; fear; freedom; health care policy; human; human dignity; human rights; infection prevention; infection risk; medicolegal aspect; multinational corporation; Note; patient care; priority journal; program effectiveness; public health service; racism; social stigma; travel; World Health Organization; xenophobia; Coronavirus infection; global health; international law; legislation and jurisprudence; pandemic; virus pneumonia; COVID-19; Coronavirus Infections; Global Health; Humans; International Health Regulations; International Law; Pandemics; Pneumonia, Viral; Travel; World Health Organization</schema:keywords>
    <j.0:identifier>2-s2.0-85079870863</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079870863&amp;doi=10.1016%2fS0140-6736%2820%2930373-1&amp;partnerID=40&amp;md5=d2c577935a7aaffa1ba48c4735d04633&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30373-1</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:date>2020</dc:date>
    <myOnto:volume>395</myOnto:volume>
    <dc:creator>Habibi R., Burci G.L., de Campos T.C., Chirwa D., Cinà M., Dagron S., Eccleston-Turner M., Forman L., Gostin L.O., Meier B.M., Negri S., Ooms G., Sekalala S., Taylor A., Yamin A.E., Hoffman S.J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082191760">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/S1473-3099(20)30132-8</j.0:identifier>
    <dc:creator>Stebbing J., Phelan A., Griffin I., Tucker C., Oechsle O., Smith D., Richardson P.</dc:creator>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>20</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082191760</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082191760&amp;doi=10.1016%2fS1473-3099%2820%2930132-8&amp;partnerID=40&amp;md5=758d64156d35bcda4f217608d2afec19&gt;</schema:url>
    <j.0:title>COVID-19: combining antiviral and anti-inflammatory treatments</j.0:title>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082021457">
    <myOnto:issue>1</myOnto:issue>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Discovery"/>
    <rdfs:comment>Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. Drug repurposing, representing as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery. In this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV–host interactome and drug targets in the human protein–protein interaction network. Phylogenetic analyses of 15 HCoV whole genomes reveal that 2019-nCoV/SARS-CoV-2 shares the highest nucleotide sequence identity with SARS-CoV (79.7%). Specifically, the envelope and nucleocapsid proteins of 2019-nCoV/SARS-CoV-2 are two evolutionarily conserved regions, having the sequence identities of 96% and 89.6%, respectively, compared to SARS-CoV. Using network proximity analyses of drug targets and HCoV–host interactions in the human interactome, we prioritize 16 potential anti-HCoV repurposable drugs (e.g., melatonin, mercaptopurine, and sirolimus) that are further validated by enrichment analyses of drug-gene signatures and HCoV-induced transcriptomics data in human cell lines. We further identify three potential drug combinations (e.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the “Complementary Exposure” pattern: the targets of the drugs both hit the HCoV–host subnetwork, but target separate neighborhoods in the human interactome network. In summary, this study offers powerful network-based methodologies for rapid identification of candidate repurposable drugs and potential drug combinations targeting 2019-nCoV/SARS-CoV-2. © 2020, The Author(s).</rdfs:comment>
    <j.0:identifier>2-s2.0-85082021457</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082021457&amp;doi=10.1038%2fs41421-020-0153-3&amp;partnerID=40&amp;md5=7301cb30bcac95e0d1089895e6376a3d&gt;</schema:url>
    <j.0:title>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1038/s41421-020-0153-3</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Zhou Y., Hou Y., Shen J., Huang Y., Martin W., Cheng F.</dc:creator>
    <myOnto:volume>6</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079899881">
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:keywords>2019 novel coronavirus; Australia; Canada; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease control; disease surveillance; disease transmission; Editorial; exposure; Finland; health care system; human; infection risk; Japan; low income country; middle income country; nonhuman; patient monitoring; pneumonia; South America; United Kingdom; United States; Viet Nam; virus isolation; virus transmission; workforce; World Health Organization; Betacoronavirus; China; contact examination; Coronavirinae; Coronavirus infection; epidemic; global health; infection control; isolation and purification; pneumonia; virus pneumonia; Coronavirus; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Contact Tracing; Coronavirus; Coronavirus Infections; Disease Outbreaks; Global Health; Humans; Infection Control; Pneumonia; Pneumonia, Viral</schema:keywords>
    <j.0:identifier>2-s2.0-85079899881</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Public_Health">
        <j.1:name>Public Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1016/j.puhe.2020.02.001</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Lee A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079899881&amp;doi=10.1016%2fj.puhe.2020.02.001&amp;partnerID=40&amp;md5=9c98105102a58d6ddc36cbf098c22d7e&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>179</myOnto:volume>
    <j.0:title>Wuhan novel coronavirus (COVID-19): why global control is challenging?</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080830097">
    <j.0:title>Novel coronavirus COVID-19: an overview for emergency clinicians</j.0:title>
    <dc:creator>Giwa A., Desai A.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier></j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080830097</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Emergency_medicine_practice">
        <j.1:name>Emergency medicine practice</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:issue>2</myOnto:issue>
    <schema:keywords>COVID-19; Coronavirus infection; emergency health service; human; pathogenicity; public health; SARS coronavirus; virus pneumonia; Coronavirus Infections; Emergency Medical Services; Humans; Pneumonia, Viral; Public Health; SARS Virus</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080830097&amp;partnerID=40&amp;md5=f750432d0edd69b230d19e648c8bc487&gt;</schema:url>
    <myOnto:volume>22</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Prior to the global outbreak of SARS-CoV in 2003, HCoV-229E and HCoV-OC43 were the only coronaviruses known to infect humans. Following the SARS outbreak, 5 additional coronaviruses have been discovered in humans, most recently the novel coronavirus COVID-19, believed to have originated in Wuhan, Hubei Province, China. SARS-CoV and MERSCoV are particularly pathogenic in humans and are associated with high mortality. In this review, the epidemiology, pathophysiology, and management of the recently discovered COVID-19 are reviewed, with a focus on best practices and the public health implications.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081997738">
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <j.0:identifier>2-s2.0-85081997738</j.0:identifier>
    <j.0:identifier>10.1038/s41392-020-0127-9</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:title>Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081997738&amp;doi=10.1038%2fs41392-020-0127-9&amp;partnerID=40&amp;md5=c920262c349ff3736322ddb2eba31181&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Signal_Transduction_and_Targeted_Therapy">
        <j.1:name>Signal Transduction and Targeted Therapy</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>5</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Zhou W., Liu Y., Tian D., Wang C., Wang S., Cheng J., Hu M., Fang M., Gao Y.</dc:creator>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082029772">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; asymptomatic disease; Betacoronavirus; Coronavirus infection; global health; human; infection control; pandemic; pathogenicity; patient isolation; procedures; quarantine; ship; travel; virus pneumonia; Asymptomatic Diseases; Betacoronavirus; Coronavirus Infections; Global Health; Humans; Infection Control; Pandemics; Patient Isolation; Pneumonia, Viral; Quarantine; Ships; Travel</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082029772</j.0:identifier>
    <myOnto:volume>30</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Public_health_research_&amp;_practice">
        <j.1:name>Public health research &amp; practice</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>On a knife's edge of a COVID-19 pandemic: is containment still possible?</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:creator>MacIntyre C.R.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082029772&amp;doi=10.17061%2fphrp3012000&amp;partnerID=40&amp;md5=5f89a9e6820d9a0af02c71cb705b642f&gt;</schema:url>
    <j.0:identifier>10.17061/phrp3012000</j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081682166">
    <j.0:title>COVID-19: delay, mitigate, and communicate</j.0:title>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <dc:creator>The Lancet Respiratory Medicine</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081682166&amp;doi=10.1016%2fS2213-2600%2820%2930128-4&amp;partnerID=40&amp;md5=59f145f15866616837f173b5c20dac35&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081682166</j.0:identifier>
    <j.0:identifier>10.1016/S2213-2600(20)30128-4</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081227123">
    <rdfs:comment>The seventh novel human infecting Betacoronavirus that causes pneumonia (2019 novel coronavirus, 2019-nCoV) originated in Wuhan, China. The evolutionary relationship between 2019-nCoV and the other human respiratory illness-causing coronavirus is not closely related. We sought to characterize the relationship of the translated proteins of 2019-nCoV with other species of Orthocoronavirinae. A phylogenetic tree was constructed from the genome sequences. A cluster tree was developed from the profiles retrieved from the presence and absence of homologs of ten 2019-nCoV proteins. The combined data were used to characterize the relationship of the translated proteins of 2019-nCoV to other species of Orthocoronavirinae. Our analysis reliably suggests that 2019-nCoV is most closely related to BatCoV RaTG13 and belongs to subgenus Sarbecovirus of Betacoronavirus, together with SARS coronavirus and Bat-SARS-like coronavirus. The phylogenetic profiling cluster of homolog proteins of one annotated 2019-nCoV protein against other genome sequences revealed two clades of ten 2019-nCoV proteins. Clade 1 consisted of a group of conserved proteins in Orthocoronavirinae comprising Orf1ab polyprotein, Nucleocapsid protein, Spike glycoprotein, and Membrane protein. Clade 2 comprised six proteins exclusive to Sarbecovirus and Hibecovirus. Two of six Clade 2 nonstructural proteins, NS7b and NS8, were exclusively conserved among 2019-nCoV, BetaCoV_RaTG, and BatSARS-like Cov. NS7b and NS8 have previously been shown to affect immune response signaling in the SARS-CoV experimental model. Thus, we speculated that knowledge of the functional changes in the NS7b and NS8 proteins during evolution may provide important information to explore the human infective property of 2019-nCoV. © 2020 The Authors</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1016/j.meegid.2020.104272</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:volume>81</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081227123&amp;doi=10.1016%2fj.meegid.2020.104272&amp;partnerID=40&amp;md5=8746c7d6cb00519ec9e2c4757f91e719&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Nonstructural proteins NS7b and NS8 are likely to be phylogenetically associated with evolution of 2019-nCoV</j.0:title>
    <j.0:identifier>2-s2.0-85081227123</j.0:identifier>
    <dc:creator>Fahmi M., Kubota Y., Ito M.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords>nonstructural protein NS7b; nonstructural protein NS8; unclassified drug; viral protein; Article; Bat SARS like coronavirus; Betacoronavirus; cladistics; Coronavirinae; evolution; gene sequence; Hibecovirus; nonhuman; phylogeny; priority journal; Sarbecovirus; SARS coronavirus; SARS-related coronavirus; sequence homology; Severe acute respiratory syndrome coronavirus 2; virus genome</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Infection,_Genetics_and_Evolution">
        <j.1:name>Infection, Genetics and Evolution</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081024272">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1007/s12250-020-00207-4</j.0:identifier>
    <j.0:title>Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools</j.0:title>
    <schema:keywords></schema:keywords>
    <dc:creator>Fu Y., Cheng Y., Wu Y.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081024272&amp;doi=10.1007%2fs12250-020-00207-4&amp;partnerID=40&amp;md5=ef3be9383e6a81fc2e7f183a56e05461&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Science Press</j.0:publisher>
    <rdfs:comment>Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness. © 2020, Wuhan Institute of Virology, CAS.</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081024272</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Virologica_Sinica"/>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079850063">
    <dc:creator>Xu X., Yu C., Zhang L., Luo L., Liu J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079850063&amp;doi=10.1007%2fs00259-020-04720-2&amp;partnerID=40&amp;md5=6cc3af6246276e76e03b04ce17c135a2&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_Journal_of_Nuclear_Medicine_and_Molecular_Imaging"/>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85079850063</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>Springer</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1007/s00259-020-04720-2</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>Imaging features of 2019 novel coronavirus pneumonia</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079372059">
    <schema:keywords>angiotensin converting enzyme 2; coronavirus spike glycoprotein; COVID-19; dipeptidyl carboxypeptidase; severe acute respiratory syndrome coronavirus 2; virus receptor; amino acid sequence; animal; bat; Betacoronavirus; chemistry; China; classification; Coronavirus infection; host range; human; molecular model; phylogeny; physiology; protein domain; SARS coronavirus; sequence alignment; virology; virus pneumonia; Amino Acid Sequence; Animals; Betacoronavirus; China; Chiroptera; Coronavirus Infections; Host Specificity; Humans; Models, Molecular; Peptidyl-Dipeptidase A; Phylogeny; Pneumonia, Viral; Protein Domains; Receptors, Virus; SARS Virus; Sequence Alignment; Spike Glycoprotein, Coronavirus</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Wan Y., Shang J., Graham R., Baric R.S., Li F.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079372059&amp;doi=10.1128%2fJVI.00127-20&amp;partnerID=40&amp;md5=8fcf70d48b69e2d07a0bb4399a41da1e&gt;</schema:url>
    <j.0:identifier>10.1128/JVI.00127-20</j.0:identifier>
    <rdfs:comment>Recently, a novel coronavirus (2019-nCoV) has emerged from Wuhan, China, causing symptoms in humans similar to those caused by severe acute respiratory syndrome coronavirus (SARS-CoV). Since the SARS-CoV outbreak in 2002, extensive structural analyses have revealed key atomic-level interactions between the SARS-CoV spike protein receptor-binding domain (RBD) and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV. Here, we analyzed the potential receptor usage by 2019-nCoV, based on the rich knowledge about SARS-CoV and the newly released sequence of 2019-nCoV. First, the sequence of 2019-nCoV RBD, including its receptor-binding motif (RBM) that directly contacts ACE2, is similar to that of SARS-CoV, strongly suggesting that 2019-nCoV uses ACE2 as its receptor. Second, several critical residues in 2019-nCoV RBM (particularly Gln493) provide favorable interactions with human ACE2, consistent with 2019-nCoV's capacity for human cell infection. Third, several other critical residues in 2019-nCoV RBM (particularly Asn501) are compatible with, but not ideal for, binding human ACE2, suggesting that 2019-nCoV has acquired some capacity for human-to-human transmission. Last, while phylogenetic analysis indicates a bat origin of 2019-nCoV, 2019-nCoV also potentially recognizes ACE2 from a diversity of animal species (except mice and rats), implicating these animal species as possible intermediate hosts or animal models for 2019-nCoV infections. These analyses provide insights into the receptor usage, cell entry, host cell infectivity and animal origin of 2019-nCoV and may help epidemic surveillance and preventive measures against 2019-nCoV.IMPORTANCE The recent emergence of Wuhan coronavirus (2019-nCoV) puts the world on alert. 2019-nCoV is reminiscent of the SARS-CoV outbreak in 2002 to 2003. Our decade-long structural studies on the receptor recognition by SARS-CoV have identified key interactions between SARS-CoV spike protein and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV. One of the goals of SARS-CoV research was to build an atomic-level iterative framework of virus-receptor interactions to facilitate epidemic surveillance, predict species-specific receptor usage, and identify potential animal hosts and animal models of viruses. Based on the sequence of 2019-nCoV spike protein, we apply this predictive framework to provide novel insights into the receptor usage and likely host range of 2019-nCoV. This study provides a robust test of this reiterative framework, providing the basic, translational, and public health research communities with predictive insights that may help study and battle this novel 2019-nCoV. Copyright © 2020 American Society for Microbiology.</rdfs:comment>
    <myOnto:volume>94</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_virology">
        <j.1:name>Journal of virology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus</j.0:title>
    <myOnto:issue>7</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079372059</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>29</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079409508">
    <dc:creator>Asmundson G.J.G., Taylor S.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>Coronaphobia: Fear and the 2019-nCoV outbreak</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079409508</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079409508&amp;doi=10.1016%2fj.janxdis.2020.102196&amp;partnerID=40&amp;md5=524fa61095a7ba541c49cd751e4e0d32&gt;</schema:url>
    <schema:keywords>2019 novel coronavirus; coronaphobia; Coronavirinae; coronavirus disease 2019; Coronavirus infection; Editorial; epidemic; fear; human; social discrimination; xenophobia</schema:keywords>
    <myOnto:volume>70</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.janxdis.2020.102196</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Anxiety_Disorders"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081932858">
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province, China in December 2019. There have been around 96,000 reported cases of coronavirus disease 2019 (COVID-2019) and 3300 reported deaths to date (05/03/2020). The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 d. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and those with comorbidities), it may progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. Many people are asymptomatic. The case fatality rate is estimated to range from 2 to 3%. Diagnosis is by demonstration of the virus in respiratory secretions by special molecular tests. Common laboratory findings include normal/ low white cell counts with elevated C-reactive protein (CRP). The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Treatment is essentially supportive; role of antiviral agents is yet to be established. Prevention entails home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality. The global impact of this new epidemic is yet uncertain. © 2020, Dr. K C Chaudhuri Foundation.</rdfs:comment>
    <dc:creator>Singhal T.</dc:creator>
    <myOnto:volume>87</myOnto:volume>
    <j.0:identifier>2-s2.0-85081932858</j.0:identifier>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:title>A Review of Coronavirus Disease-2019 (COVID-19)</j.0:title>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; complication; Coronavirus infection; coughing; dyspnea; epidemic; fatigue; fever; human; pharyngitis; virus pneumonia; Betacoronavirus; Coronavirus Infections; Cough; Disease Outbreaks; Dyspnea; Fatigue; Fever; Humans; Pharyngitis; Pneumonia, Viral</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Indian_Journal_of_Pediatrics">
        <j.1:name>Indian Journal of Pediatrics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>4</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081932858&amp;doi=10.1007%2fs12098-020-03263-6&amp;partnerID=40&amp;md5=d21e8722dcc3dbc45151af81a8030ed6&gt;</schema:url>
    <j.0:identifier>10.1007/s12098-020-03263-6</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079734980">
    <j.0:title>Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs</j.0:title>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>Objective: Since December 2019, an outbreak of corona virus disease 2019 (COVID-19) occurred in Wuhan, and rapidly spread to almost all parts of China. This was followed by prevention programs recommending Chinese medicine (CM) for the prevention. In order to provide evidence for CM recommendations, we reviewed ancient classics and human studies. Methods: Historical records on prevention and treatment of infections in CM classics, clinical evidence of CM on the prevention of severe acute respiratory syndrome (SARS) and H1N1 influenza, and CM prevention programs issued by health authorities in China since the COVID-19 outbreak were retrieved from different databases and websites till 12 February, 2020. Research evidence included data from clinical trials, cohort or other population studies using CM for preventing contagious respiratory virus diseases. Results: The use of CM to prevent epidemics of infectious diseases was traced back to ancient Chinese practice cited in Huangdi’s Internal Classic (Huang Di Nei Jing) where preventive effects were recorded. There were 3 studies using CM for prevention of SARS and 4 studies for H1N1 influenza. None of the participants who took CM contracted SARS in the 3 studies. The infection rate of H1N1 influenza in the CM group was significantly lower than the non-CM group (relative risk 0.36, 95% confidence interval 0.24–0.52; n=4). For prevention of COVID-19, 23 provinces in China issued CM programs. The main principles of CM use were to tonify qi to protect from external pathogens, disperse wind and discharge heat, and resolve dampness. The most frequently used herbs included Radix astragali (Huangqi), Radix glycyrrhizae (Gancao), Radix saposhnikoviae (Fangfeng), Rhizoma Atractylodis Macrocephalae (Baizhu), Lonicerae Japonicae Flos (Jinyinhua), and Fructus forsythia (Lianqiao). Conclusions: Based on historical records and human evidence of SARS and H1N1 influenza prevention, Chinese herbal formula could be an alternative approach for prevention of COVID-19 in high-risk population. Prospective, rigorous population studies are warranted to confirm the potential preventive effect of CM. © 2020, The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079734980</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Chinese_Journal_of_Integrative_Medicine">
        <j.1:name>Chinese Journal of Integrative Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Luo H., Tang Q.-L., Shang Y.-X., Liang S.-B., Yang M., Robinson N., Liu J.-P.</dc:creator>
    <j.0:identifier>10.1007/s11655-020-3192-6</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079734980&amp;doi=10.1007%2fs11655-020-3192-6&amp;partnerID=40&amp;md5=20eb1dc79f7a99c7b01b3629ce910a4b&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082109654">
    <j.0:identifier>2-s2.0-85082109654</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082109654&amp;doi=10.1002%2fjmv.25763&amp;partnerID=40&amp;md5=0f354065dc75cb7875ba0a9fe6a6dc71&gt;</schema:url>
    <j.0:title>Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:creator>Zhu W., Xie K., Lu H., Xu L., Zhou S., Fang S.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>With an increasing number of Coronavirus Disease 2019 (COVID-19) cases outside of Hubei, emergency departments (EDs) and fever clinics are facing challenges posed by the large number of admissions of patients suspected to have COVID-19. Therefore, it is of crucial importance to study the initial clinical features of patients, to better differentiate between infected and uninfected patients outside Hubei. A total of 116 patients suspected of having COVID-19 who presented to two emergency departments in Anhui for the first time between 24 January 2020 and 20 February 2020 were enrolled in the study. The initial clinical data of these patients, such as epidemiological features, symptoms, laboratory results, and chest computed tomography (CT) findings were collected using a standard case report form on admission. Thirty-two patients were diagnosed with COVID-19; the remaining 84 patients were referred to as negative cases. The median age of the diagnosed patients was 46 years, but only 35 years for negative cases. History of exposure to Wuhan or COVID-19 patients in the previous 2 weeks was observed in 63% of the diagnosed and 44% of negative cases. Median time from illness onset to ED admission was 5 days for all patients, diagnosed patients, and negative cases, respectively. Fever was observed in 27 (84%) and 57 (68%) diagnosed and negative cases, respectively. Nineteen (59%) diagnosed and 24 (29%) negative cases had lymphopenia on admission in ED. A chest CT scan on admission revealed the presence of pneumonia in the majority of the diagnosed patients (30 out of 32, 94%) and in 56 (67%) negative cases. Bilateral involvement and ground-glass opacity (GGO) were present in 91% and 47% of the diagnosed patients. Thirty-two patients were diagnosed with COVID-19; the remaining 84 patients were referred to as negative cases. The median age of the diagnosed patients was 46 years, but only 35 years for negative cases. History of exposure to Wuhan or COVID-19 patients in the previous 2 weeks was observed in 63% of the diagnosed and 44% of negative cases. Median time from illness onset to ED admission was 5 days for all patients, diagnosed patients, and negative cases, respectively. Fever was observed in 27 (84%) and 57 (68%) diagnosed and negative cases, respectively. Nineteen (59%) diagnosed and 24 (29%) negative cases had lymphopenia on admission in ED. A chest CT scan on admission revealed the presence of pneumonia in the majority of the diagnosed patients (30 out of 32, 94%) and in 56 (67%) negative cases. Bilateral involvement and GGO were present in 91% and 47% of the diagnosed patients. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25763</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082084551">
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>26</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Medical_science_monitor_:_international_medical_journal_of_experimental_and_clinical_research"/>
    <rdfs:comment>BACKGROUND From the end of December 2019, coronavirus disease 2019 (COVID-19) began to spread in central China. Social capital is a measure of social trust, belonging, and participation. This study aimed to investigate the effects of social capital on sleep quality and the mechanisms involved in people who self-isolated at home for 14 days in January 2020 during the COVID-19 epidemic in central China. MATERIAL AND METHODS Individuals (n=170) who self-isolated at home for 14 days in central China, completed self-reported questionnaires on the third day of isolation. Individual social capital was assessed using the Personal Social Capital Scale 16 (PSCI-16) questionnaire. Anxiety was assessed using the Self-Rating Anxiety Scale (SAS) questionnaire, stress was assessed using the Stanford Acute Stress Reaction (SASR) questionnaire, and sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Path analysis was performed to evaluate the relationships between a dependent variable (social capital) and two or more independent variables, using Pearson's correlation analysis and structural equation modeling (SEM). RESULTS Low levels of social capital were associated with increased levels of anxiety and stress, but increased levels of social capital were positively associated with increased quality of sleep. Anxiety was associated with stress and reduced sleep quality, and the combination of anxiety and stress reduced the positive effects of social capital on sleep quality. CONCLUSIONS During a period of individual self-isolation during the COVID-19 virus epidemic in central China, increased social capital improved sleep quality by reducing anxiety and stress.</rdfs:comment>
    <j.0:identifier>10.12659/MSM.923921</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082084551&amp;doi=10.12659%2fMSM.923921&amp;partnerID=40&amp;md5=63f32763aff995b6d89974e5d997472a&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Social Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Disease 2019 (COVID-19) Outbreak in January 2020 in China</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; anxiety; Betacoronavirus; China; complication; Coronavirus infection; cross-sectional study; depression; epidemic; female; human; male; patient isolation; physiology; questionnaire; sleep; sleep disorder; social capital; social support; virus pneumonia; Adult; Anxiety; Betacoronavirus; China; Coronavirus Infections; Cross-Sectional Studies; Depression; Disease Outbreaks; Female; Humans; Male; Patient Isolation; Pneumonia, Viral; Sleep; Sleep Wake Disorders; Social Capital; Social Support; Surveys and Questionnaires</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082084551</j.0:identifier>
    <dc:creator>Xiao H., Zhang Y., Kong D., Li S., Yang N.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081655495">
    <dc:creator>Gu X., Cao B., Wang J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081655495&amp;doi=10.1016%2fS0140-6736%2820%2930371-8&amp;partnerID=40&amp;md5=be33c047768d1ffaa67e7ecd278e436d&gt;</schema:url>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>10228</myOnto:issue>
    <myOnto:volume>395</myOnto:volume>
    <j.0:title>Full spectrum of COVID-19 severity still being depicted – Authors' reply</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30371-8</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081655495</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078851496">
    <myOnto:volume>104</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Hospital_Infection">
        <j.1:name>Journal of Hospital Infection</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1016/j.jhin.2020.01.010</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords>China; coronavirus disease 2019; Coronavirus infection; diagnostic test; epidemic; health care planning; human; infection control; infection risk; influenza A (H5N1); Influenza A virus (H7N9); Letter; morbidity; mortality; risk factor; SARS-related coronavirus; virus genome; virus pneumonia; virus transmission</schema:keywords>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:identifier>2-s2.0-85078851496</j.0:identifier>
    <j.0:title>Preparedness and proactive infection control measures against the emerging novel coronavirus in China</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078851496&amp;doi=10.1016%2fj.jhin.2020.01.010&amp;partnerID=40&amp;md5=f3db556a08fe46cca2da7da016a474a4&gt;</schema:url>
    <dc:creator>Cheng V.C.C., Wong S.-C., To K.K.W., Ho P.L., Yuen K.-Y.</dc:creator>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081568608">
    <j.0:identifier>2-s2.0-85081568608</j.0:identifier>
    <dc:creator>Cheng A.C., Williamson D.A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.5694/mja2.50530</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081568608&amp;doi=10.5694%2fmja2.50530&amp;partnerID=40&amp;md5=91170ea2b21fbce1ed87ca98b0fc4e17&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:title>An outbreak of COVID-19 caused by a new coronavirus: what we know so far</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Medical_Journal_of_Australia">
        <j.1:name>Medical Journal of Australia</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082020541">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.tmaid.2020.101631</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082020541&amp;doi=10.1016%2fj.tmaid.2020.101631&amp;partnerID=40&amp;md5=266e4d2980b7922b5dced6bfcbf3e55e&gt;</schema:url>
    <dc:creator>Ahmed Q.A., Memish Z.A.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>Our recommendation, as experts who have monitored health hazards at the Hajj for over 15 years, especially if the situation with COVID-19 continues to escalate globally is that Hajj 2020 will be at risk of being suspended and a means for Muslims to fulfill their rights in the future either personally or even by proxy need to be announced. The same holds true for the Summer 2020 Olympics in Japan and for many other MGs and large gatherings. Decisions in the time of COVID-19 will be closely followed and will be a blueprint for other mass gatherings. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <schema:keywords>article; decision making; health hazard; human; Japan; Muslim; nonhuman; SARS coronavirus; summer</schema:keywords>
    <j.0:identifier>2-s2.0-85082020541</j.0:identifier>
    <j.0:title>The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081042657">
    <dc:creator>Peng X., Xu X., Li Y., Cheng L., Zhou X., Ren B.</dc:creator>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <rdfs:comment>A novel ?-coronavirus (2019-nCoV) caused severe and even fetal pneumonia explored in a seafood market of Wuhan city, Hubei province, China, and rapidly spread to other provinces of China and other countries. The 2019-nCoV was different from SARS-CoV, but shared the same host receptor the human angiotensin-converting enzyme 2 (ACE2). The natural host of 2019-nCoV may be the bat Rhinolophus affinis as 2019-nCoV showed 96.2% of whole-genome identity to BatCoV RaTG13. The person-to-person transmission routes of 2019-nCoV included direct transmission, such as cough, sneeze, droplet inhalation transmission, and contact transmission, such as the contact with oral, nasal, and eye mucous membranes. 2019-nCoV can also be transmitted through the saliva, and the fetal–oral routes may also be a potential person-to-person transmission route. The participants in dental practice expose to tremendous risk of 2019-nCoV infection due to the face-to-face communication and the exposure to saliva, blood, and other body fluids, and the handling of sharp instruments. Dental professionals play great roles in preventing the transmission of 2019-nCoV. Here we recommend the infection control measures during dental practice to block the person-to-person transmission routes in dental clinics and hospitals. © 2020, The Author(s).</rdfs:comment>
    <myOnto:volume>12</myOnto:volume>
    <j.0:identifier>2-s2.0-85081042657</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>10.1038/s41368-020-0075-9</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081042657&amp;doi=10.1038%2fs41368-020-0075-9&amp;partnerID=40&amp;md5=b4810b6b59dc136e167aed4b4dd2d531&gt;</schema:url>
    <j.0:type>Review</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Oral_Science"/>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; dental clinic; dental procedure; dentist; disease transmission; epidemic; health care personnel; human; infection control; pathogenicity; procedures; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Dental Care; Dental Clinics; Dentists; Disease Outbreaks; Health Personnel; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Pneumonia, Viral</schema:keywords>
    <j.0:title>Transmission routes of 2019-nCoV and controls in dental practice</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079872824">
    <j.0:type>Letter</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Early lessons from the frontline of the 2019-nCoV outbreak</j.0:title>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30356-1</j.0:identifier>
    <j.0:identifier>2-s2.0-85079872824</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079872824&amp;doi=10.1016%2fS0140-6736%2820%2930356-1&amp;partnerID=40&amp;md5=89440c643763bc4e7478034ab8ebff78&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:creator>Zhang H.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 nCoV infection; 2019 novel Coronavirinae; awareness; China; Chinese; clinical feature; contact transmission; Coronavirinae; Coronavirus infection; cross infection; disease association; disease control; disease severity; disease transmission; droplet transmission; early diagnosis; emergency care; epidemic; general hospital; health care delivery; help seeking behavior; human; infection risk; information processing; Letter; medical care; medical staff; morbidity; mortality; nonhuman; patient isolation; pneumonia; priority journal; public health; traffic control; World Health Organization; Wuhan; ambulatory care; Coronavirus infection; disease notification; health education; hospital bed capacity; hospital bed utilization; incubation time; leisure; protective equipment; travel; Ambulatory Care; Bed Occupancy; China; Coronavirus Infections; Cross Infection; Disease Notification; Disease Outbreaks; Early Diagnosis; Health Education; Holidays; Hospital Bed Capacity; Humans; Infectious Disease Incubation Period; Personal Protective Equipment; Travel; World Health Organization</schema:keywords>
    <myOnto:issue>10225</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078958617">
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85078958617</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078958617&amp;doi=10.1016%2fj.jmii.2020.02.001&amp;partnerID=40&amp;md5=3b69a10c9500861fcbe753f9bafc5f59&gt;</schema:url>
    <dc:creator>Lee P.-I., Hsueh P.-R.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:identifier>10.1016/j.jmii.2020.02.001</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV</j.0:title>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081698917">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1001/jama.2020.2783</j.0:identifier>
    <j.0:title>Positive RT-PCR Test Results in Patients Recovered from COVID-19</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Lan L., Xu D., Ye G., Xia C., Wang S., Li Y., Xu H.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081698917</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081698917&amp;doi=10.1001%2fjama.2020.2783&amp;partnerID=40&amp;md5=abbd62b78fee5326409b4470042919d8&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078260429">
    <myOnto:citeyBy>12</myOnto:citeyBy>
    <schema:keywords>2019 novel coronavirus; adult respiratory distress syndrome; China; Coronavirinae; Coronavirus infection; disease severity; disease transmission; Editorial; emergency care; global health; human; infection control; Japan; laboratory test; mortality; pathogenesis; priority journal; public health; respiratory tract disease; risk assessment; South Korea; Thailand; United States; virus pneumonia; virus transmission; Coronavirus infection; epidemic; information dissemination; Coronavirus Infections; Disease Outbreaks; Humans; Information Dissemination</schema:keywords>
    <j.0:title>Emerging understandings of 2019-nCoV</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <dc:creator>The Lancet</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078260429&amp;doi=10.1016%2fS0140-6736%2820%2930186-0&amp;partnerID=40&amp;md5=3d1007014577921399caca9c7b8da45e&gt;</schema:url>
    <j.0:identifier>2-s2.0-85078260429</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:volume>395</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>10221</myOnto:issue>
    <j.0:identifier>10.1016/S0140-6736(20)30186-0</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082001092">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_Simulation_and_Technology_Enhanced_Learning">
        <j.1:name>BMJ Simulation and Technology Enhanced Learning</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1136/bmjstel-2020-000609</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Li L., Li Y., Lin M., Wang X., Bao P.</dc:creator>
    <j.0:identifier>2-s2.0-85082001092</j.0:identifier>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:title>Preparing and responding to 2019 novel coronavirus with simulation and technology-enhanced learning for healthcare professionals: Challenges and opportunities in China</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082001092&amp;doi=10.1136%2fbmjstel-2020-000609&amp;partnerID=40&amp;md5=5c547682577e32b407bfeb9f5f8d0518&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078852923">
    <myOnto:issue>10</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1056/NEJMc2001468</j.0:identifier>
    <dc:creator>Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., Seilmaier M., Drosten C., Vollmar P., Zwirglmaier K., Zange S., Wölfel R., Hoelscher M.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078852923&amp;doi=10.1056%2fNEJMc2001468&amp;partnerID=40&amp;md5=4d03c994e8062a77cf8a9c166f483331&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>382</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <j.0:title>Transmission of 2019-NCOV infection from an asymptomatic contact in Germany</j.0:title>
    <j.0:identifier>2-s2.0-85078852923</j.0:identifier>
    <myOnto:citeyBy>60</myOnto:citeyBy>
    <schema:keywords>adult; asymptomatic infection; case report; chill; China; Chinese; clinical article; coronavirus disease 2019; Coronavirus infection; coughing; disease transmission; follow up; German (citizen); Germany; hospitalization; human; Letter; male; myalgia; nasopharyngeal aspiration; priority journal; real time reverse transcription polymerase chain reaction; sore throat; sputum smear; asymptomatic disease; Betacoronavirus; Coronavirus infection; female; isolation and purification; travel; urine; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Adult; Asymptomatic Diseases; Betacoronavirus; China; Coronavirus Infections; Female; Germany; Hospitalization; Humans; Male; Pneumonia, Viral; Travel</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081584835">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081584835&amp;doi=10.3352%2fjeehp.2020.17.10&amp;partnerID=40&amp;md5=83712c93042020409dd92cf126909092&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081584835</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.3352/jeehp.2020.17.10</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_educational_evaluation_for_health_professions">
        <j.1:name>Journal of educational evaluation for health professions</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Huh S.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>How to train the health personnel for protecting themselves from novel coronavirus (COVID-19) infection during their patient or suspected case care</j.0:title>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; anamnesis; Betacoronavirus; Coronavirus infection; disease transmission; education; hand disinfection; health care personnel; human; infection control; mass screening; patient isolation; prevention and control; procedures; protective equipment; South Korea; virus pneumonia; Betacoronavirus; Coronavirus Infections; Hand Disinfection; Health Personnel; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Mass Screening; Medical History Taking; Patient Isolation; Personal Protective Equipment; Pneumonia, Viral; Republic of Korea</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>17</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082178451">
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:volume>158</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Wang P., Chen K., Zhu S., Wang P., Zhang H.</dc:creator>
    <j.0:identifier>10.1016/j.resconrec.2020.104814</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Severe air pollution events not avoided by reduced anthropogenic activities during COVID-19 outbreak</j.0:title>
    <dc:language>English</dc:language>
    <rdfs:comment>Due to the pandemic of coronavirus disease 2019 in China, almost all avoidable activities in China are prohibited since Wuhan announced lockdown on January 23, 2020. With reduced activities, severe air pollution events still occurred in the North China Plain, causing discussions regarding why severe air pollution was not avoided. The Community Multi-scale Air Quality model was applied during January 01 to February 12, 2020 to study PM2.5 changes under emission reduction scenarios. The estimated emission reduction case (Case 3) better reproduced PM2.5. Compared with the case without emission change (Case 1), Case 3 predicted that PM2.5 concentrations decreased by up to 20% with absolute decreases of 5.35, 6.37, 9.23, 10.25, 10.30, 12.14, 12.75, 14.41, 18.00 and 30.79 ?g/m3 in Guangzhou, Shanghai, Beijing, Shijiazhuang, Tianjin, Jinan, Taiyuan, Xi'an, Zhengzhou, Wuhan, respectively. In high-pollution days with PM2.5 greater than 75 ?g/m3, the reductions of PM2.5 in Case 3 were 7.78, 9.51, 11.38, 13.42, 13.64, 14.15, 14.42, 16.95 and 22.08 ?g/m3 in Shanghai, Jinan, Shijiazhuang, Beijing, Taiyuan, Xi'an, Tianjin, Zhengzhou and Wuhan, respectively. The reductions in emissions of PM2.5 precursors were ~2 times of that in concentrations, indicating that meteorology was unfavorable during simulation episode. A further analysis shows that benefits of emission reductions were overwhelmed by adverse meteorology and severe air pollution events were not avoided. This study highlights that large emissions reduction in transportation and slight reduction in industrial would not help avoid severe air pollution in China, especially when meteorology is unfavorable. More efforts should be made to completely avoid severe air pollution. © 2020 Elsevier B.V.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Resources,_Conservation_and_Recycling">
        <j.1:name>Resources, Conservation and Recycling</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85082178451</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082178451&amp;doi=10.1016%2fj.resconrec.2020.104814&amp;partnerID=40&amp;md5=a7d801f5d18bc07c3eae7acc478d5eb5&gt;</schema:url>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080839720">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080839720&amp;doi=10.1016%2fS0140-6736%2820%2930459-1&amp;partnerID=40&amp;md5=27d53dab68e138efef02dd08fc0df5f1&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Lancet_(London,_England)">
        <j.1:name>Lancet (London, England)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85080839720</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Indian pharma threatened by COVID-19 shutdowns in China</j.0:title>
    <dc:creator>Chatterjee P.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/S0140-6736(20)30459-1</j.0:identifier>
    <schema:keywords>COVID-19; drug; China; Coronavirus infection; drug industry; human; India; medicinal chemistry; virus pneumonia; Chemistry, Pharmaceutical; China; Coronavirus Infections; Drug Industry; Humans; India; Pharmaceutical Preparations; Pneumonia, Viral</schema:keywords>
    <myOnto:issue>10225</myOnto:issue>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078672986">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85078672986</j.0:identifier>
    <dc:creator>Cyranoski D.</dc:creator>
    <myOnto:issue>7792</myOnto:issue>
    <j.0:identifier>10.1038/d41586-020-00190-6</j.0:identifier>
    <rdfs:comment>Structural biologist Rolf Hilgenfeld has been working on coronavirus treatments since the SARS outbreak. [Figure not available: see fulltext.]. © 2020, Nature.</rdfs:comment>
    <myOnto:volume>577</myOnto:volume>
    <j.0:publisher>Nature Research</j.0:publisher>
    <schema:keywords>antivirus agent; angiotensin converting enzyme 2; antivirus agent; COVID-19; dipeptidyl carboxypeptidase; China; Coronavirinae; Coronavirus infection; drug activity; drug design; drug screening; Enterovirus A71; human; Human rhinovirus; Middle East respiratory syndrome; mouse model; Note; preclinical study; priority journal; safety; severe acute respiratory syndrome; animal; clinical trial (topic); Coronavirus infection; disease model; drug effect; genetics; interview; metabolism; Middle East respiratory syndrome coronavirus; mouse; patient selection; preclinical study; SARS coronavirus; severe acute respiratory syndrome; time factor; veterinary medicine; virology; virus pneumonia; Animalia; Coronavirus; Animals; Antiviral Agents; China; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Mice; Middle East Respiratory Syndrome Coronavirus; Patient Selection; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome; Time Factors</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078672986&amp;doi=10.1038%2fd41586-020-00190-6&amp;partnerID=40&amp;md5=3c18917fb19b6c709f53bb5d8a981fd8&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:title>This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan</j.0:title>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081013965">
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <j.0:identifier>10.1016/j.ijid.2020.02.033</j.0:identifier>
    <dc:creator>Zhang S., Diao M., Yu W., Pei L., Lin Z., Chen D.</dc:creator>
    <myOnto:volume>93</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:title>Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis</j.0:title>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081013965&amp;doi=10.1016%2fj.ijid.2020.02.033&amp;partnerID=40&amp;md5=7bfbde4e0a5ac74e0555532ccdc19101&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081013965</j.0:identifier>
    <schema:keywords>2019 novel Coronavirus; Article; Coronavirinae; Coronavirus infection; human; incidence; major clinical study; ship</schema:keywords>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <rdfs:comment>Backgrounds: Up to February 16, 2020, 355 cases have been confirmed as having COVID-19 infection on the Diamond Princess cruise ship. It is of crucial importance to estimate the reproductive number (R0) of the novel virus in the early stage of outbreak and make a prediction of daily new cases on the ship. Method: We fitted the reported serial interval (mean and standard deviation) with a gamma distribution and applied “earlyR” package in R to estimate the R0 in the early stage of COVID-19 outbreak. We applied “projections” package in R to simulate the plausible cumulative epidemic trajectories and future daily incidence by fitting the data of existing daily incidence, a serial interval distribution, and the estimated R0 into a model based on the assumption that daily incidence obeys approximately Poisson distribution determined by daily infectiousness. Results: The Maximum-Likelihood (ML) value of R0 was 2.28 for COVID-19 outbreak at the early stage on the ship. The median with 95% confidence interval (CI) of R0 values was 2.28 (2.06–2.52) estimated by the bootstrap resampling method. The probable number of new cases for the next ten days would gradually increase, and the estimated cumulative cases would reach 1514 (1384–1656) at the tenth day in the future. However, if R0 value was reduced by 25% and 50%, the estimated total number of cumulative cases would be reduced to 1081 (981–1177) and 758 (697–817), respectively. Conclusion: The median with 95% CI of R0 of COVID-19 was about 2.28 (2.06–2.52) during the early stage experienced on the Diamond Princess cruise ship. The future daily incidence and probable outbreak size is largely dependent on the change of R0. Unless strict infection management and control are taken, our findings indicate the potential of COVID-19 to cause greater outbreak on the ship. © 2020 The Author(s)</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082020443">
    <myOnto:issue>1</myOnto:issue>
    <j.0:title>Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review</j.0:title>
    <rdfs:comment>Background: The coronavirus disease (COVID-19) has been identified as the cause of an outbreak of respiratory illness in Wuhan, Hubei Province, China beginning in December 2019. As of 31 January 2020, this epidemic had spread to 19 countries with 11 791 confirmed cases, including 213 deaths. The World Health Organization has declared it a Public Health Emergency of International Concern. Methods: A scoping review was conducted following the methodological framework suggested by Arksey and O'Malley. In this scoping review, 65 research articles published before 31 January 2020 were analyzed and discussed to better understand the epidemiology, causes, clinical diagnosis, prevention and control of this virus. The research domains, dates of publication, journal language, authors' affiliations, and methodological characteristics were included in the analysis. All the findings and statements in this review regarding the outbreak are based on published information as listed in the references. Results: Most of the publications were written using the English language (89.2%). The largest proportion of published articles were related to causes (38.5%) and a majority (67.7%) were published by Chinese scholars. Research articles initially focused on causes, but over time there was an increase of the articles related to prevention and control. Studies thus far have shown that the virus' origination is in connection to a seafood market in Wuhan, but specific animal associations have not been confirmed. Reported symptoms include fever, cough, fatigue, pneumonia, headache, diarrhea, hemoptysis, and dyspnea. Preventive measures such as masks, hand hygiene practices, avoidance of public contact, case detection, contact tracing, and quarantines have been discussed as ways to reduce transmission. To date, no specific antiviral treatment has proven effective; hence, infected people primarily rely on symptomatic treatment and supportive care. Conclusions: There has been a rapid surge in research in response to the outbreak of COVID-19. During this early period, published research primarily explored the epidemiology, causes, clinical manifestation and diagnosis, as well as prevention and control of the novel coronavirus. Although these studies are relevant to control the current public emergency, more high-quality research is needed to provide valid and reliable ways to manage this kind of public health emergency in both the short- and long-term. © 2020 The Author(s).</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082020443&amp;doi=10.1186%2fs40249-020-00646-x&amp;partnerID=40&amp;md5=be6536042dfd0cfa5e465cfff6b364aa&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>9</myOnto:volume>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1186/s40249-020-00646-x</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Diseases_of_Poverty"/>
    <schema:keywords>2019 novel coronavirus; coronavirus disease 2019; coughing; diarrhea; disease severity; disease surveillance; disease transmission; dyspnea; fatigue; fever; headache; health care; hemoptysis; high throughput sequencing; human; incubation time; meta analysis; mortality rate; pathogenesis; pneumonia; prevention and control; priority journal; public health; public health service; quality control; real time polymerase chain reaction; respiratory tract infection; Review; rhinorrhea; severe acute respiratory syndrome; systematic review; virology; Betacoronavirus; China; Coronavirus infection; coughing; dyspnea; epidemic; fatigue; fever; headache; infection control; virology; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Cough; Disease Outbreaks; Dyspnea; Fatigue; Fever; Headache; Humans; Infection Control; Pneumonia, Viral</schema:keywords>
    <dc:creator>Adhikari S.P., Meng S., Wu Y.-J., Mao Y.-P., Ye R.-X., Wang Q.-Z., Sun C., Sylvia S., Rozelle S., Raat H., Zhou H.</dc:creator>
    <j.0:identifier>2-s2.0-85082020443</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081991213">
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; communicable disease control; Coronavirus infection; emergency; epidemic; hospital equipment; human; organization and management; pandemic; protective equipment; public health; virus pneumonia; Betacoronavirus; China; Communicable Disease Control; Coronavirus Infections; Disease Outbreaks; Emergencies; Equipment and Supplies, Hospital; Humans; Pandemics; Personal Protective Equipment; Pneumonia, Viral; Public Health</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Bioscience_trends"/>
    <dc:creator>Wang X., Zhang X., He J.</dc:creator>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081991213&amp;doi=10.5582%2fbst.2020.01043&amp;partnerID=40&amp;md5=efc6555f9c4abafa68f244375c4adcfd&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081991213</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:title>Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>On December 31, 2019, the Wuhan Municipal Health Commission announced an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), China is now at a critical period in the control of the epidemic. The Chinese Government has been taking a series of rapid, comprehensive, and effective prevention and control measures. As the pandemic has developed, a fact has become apparent: there is a serious dearth of emergency medical supplies, and especially an extreme shortage of personal protective equipment such as masks and medical protective clothing. This is one of the major factors affecting the progress of epidemic prevention and control. Although China has made great efforts to strengthen the ability to quickly respond to public health emergencies since the SARS outbreak in 2003 and it has clarified requirements for emergency supplies through legislation, the emergency reserve supplies program has not been effectively implemented, and there are also deficiencies in the types, quantity, and availability of emergency medical supplies. A sound system of emergency reserve supplies is crucial to the management of public health emergencies. Based on international experiences with pandemic control, the world should emphasize improving the system of emergency reserve medical supplies in the process of establishing and improving public health emergency response systems, and it should promote the establishment of international cooperative programs to jointly deal with public health emergencies of international concern in the future.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>10.5582/bst.2020.01043</j.0:identifier>
    <myOnto:volume>14</myOnto:volume>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079719906">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079719906&amp;doi=10.1080%2f13032917.2020.1730621&amp;partnerID=40&amp;md5=a504bba26880c35574493c09caa33123&gt;</schema:url>
    <j.0:identifier>10.1080/13032917.2020.1730621</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:publisher>Routledge</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Note</j.0:type>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85079719906</j.0:identifier>
    <dc:creator>Wen J., Aston J., Liu X., Ying T.</dc:creator>
    <j.0:title>Effects of misleading media coverage on public health crisis: a case of the 2019 novel coronavirus outbreak in China</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>The coronavirus outbreak in Wuhan, China has sparked a global epidemic, which the World Health Organization declared a public health emergency of international concern on 31st January 2020 (Beijing time). This crisis has attracted intense media attention. Recently, some media outlets inappropriately labelled the coronavirus by race, using such headlines as “Chinese virus pandemonium” and even suggesting “China kids stay home.” The biased and misleading coverage presented via Western media channels has incited anger throughout the Chinese community and has placed undue stress upon Chinese individuals living outside China. This post-published review takes a tourism-focused perspective to examine findings from a quantitative study (Rodriguez-Seijas, Stohl, Hasin, &amp; Eaton, 2015) published in 2015 in JAMA Psychiatry. The current paper highlights the potential impacts of misleading and biased media coverage on Chinese individuals’ mental health. Specifically, this work considers perceived racial discrimination stemming from coronavirus as a public health crisis and the effects of such discrimination on individuals of Chinese heritage. Similarly imperative are pertinent effects on country image and destination image with respect to tourism marketing and tourist behaviour during times of crisis. By considering racism in the context of the coronavirus outbreak, this paper identifies potential avenues for relevant research in tourism and hospitality. © 2020, © 2020 Informa UK Limited, trading as Taylor &amp; Francis Group.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Anatolia">
        <j.1:name>Anatolia</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078864447">
    <j.0:identifier>10.1056/NEJMc2001272</j.0:identifier>
    <myOnto:citeyBy>19</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078864447&amp;doi=10.1056%2fNEJMc2001272&amp;partnerID=40&amp;md5=ee0ad62bb00f58500a481602344c0b37&gt;</schema:url>
    <myOnto:issue>9</myOnto:issue>
    <j.0:title>Importation and human-to-human transmission of a novel coronavirus in Vietnam</j.0:title>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <myOnto:volume>382</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85078864447</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <dc:creator>Phan L.T., Nguyen T.V., Luong Q.C., Nguyen T.V., Nguyen H.T., Le H.Q., Nguyen T.T., Cao T.M., Pham Q.D.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; aged; Betacoronavirus; case report; Coronavirus infection; diagnostic imaging; human; isolation and purification; lung; male; pathology; thorax radiography; virus pneumonia; Adult; Aged; Betacoronavirus; Coronavirus Infections; Humans; Lung; Male; Pneumonia, Viral; Radiography, Thoracic</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081681087">
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081681087</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081681087&amp;doi=10.3928%2f19382359-20200219-01&amp;partnerID=40&amp;md5=802f137587a0e3534f902bc1e8c5de34&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>49</myOnto:volume>
    <schema:keywords>COVID-19; adolescent; child; Coronavirus infection; human; infant; patient isolation; pediatrics; practice guideline; preschool child; protective clothing; virus pneumonia; Adolescent; Child; Child, Preschool; Coronavirus Infections; Humans; Infant; Patient Isolation; Pediatrics; Pneumonia, Viral; Practice Guidelines as Topic; Protective Clothing</schema:keywords>
    <j.0:identifier>10.3928/19382359-20200219-01</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The coronavirus disease 2019 (COVID-19)</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Hageman J.R.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pediatric_Annals">
        <j.1:name>Pediatric Annals</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Slack Incorporated</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080047795">
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Shi H., Han X., Zheng C.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1148/radiol.2020200269</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <schema:keywords>antiinflammatory agent; antivirus agent; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; case report; complication; Coronavirus infection; coughing; diagnostic imaging; fatigue; fever; hospital discharge; human; isolation and purification; lung; male; middle aged; pathology; real time polymerase chain reaction; thorax radiography; virus pneumonia; x-ray computed tomography; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; Fatigue; Fever; Humans; Lung; Male; Middle Aged; Patient Discharge; Pneumonia, Viral; Radiography, Thoracic; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed</schema:keywords>
    <j.0:title>Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-NCoV) pneumonia in Wuhan, China</j.0:title>
    <j.0:identifier>2-s2.0-85080047795</j.0:identifier>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080047795&amp;doi=10.1148%2fradiol.2020200269&amp;partnerID=40&amp;md5=2bb0508d35e1d4159e2504a2b9a372b2&gt;</schema:url>
    <myOnto:volume>295</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081692331">
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>Nature Research</j.0:publisher>
    <dc:creator>Stower H.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>26</myOnto:volume>
    <j.0:title>Lack of maternal–fetal SARS-CoV-2 transmission</j.0:title>
    <j.0:identifier>10.1038/s41591-020-0810-y</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081692331</j.0:identifier>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; female; human; medical record; pregnancy; retrospective study; severe acute respiratory syndrome; Betacoronavirus; Female; Humans; Medical Records; Pregnancy; Retrospective Studies; Severe Acute Respiratory Syndrome</schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>3</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Medicine"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081692331&amp;doi=10.1038%2fs41591-020-0810-y&amp;partnerID=40&amp;md5=a449acf36850ebfa8e623a0ab6625e5d&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081000939">
    <myOnto:volume></myOnto:volume>
    <j.0:title>Are children less susceptible to COVID-19?</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081000939</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:creator>Lee P.-I., Hu Y.-L., Chen P.-Y., Huang Y.-C., Hsueh P.-R.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/j.jmii.2020.02.011</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081000939&amp;doi=10.1016%2fj.jmii.2020.02.011&amp;partnerID=40&amp;md5=d64da1b4d3f19b09145ecf9eeed3e5bb&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082198942">
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:identifier>10.1016/S2468-2667(20)30053-0</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Public_Health"/>
    <j.0:identifier>2-s2.0-85082198942</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082198942&amp;doi=10.1016%2fS2468-2667%2820%2930053-0&amp;partnerID=40&amp;md5=ffc82b81f01b8355e0ddd11a0d985838&gt;</schema:url>
    <dc:creator>Tsai J., Wilson M.</dc:creator>
    <j.0:title>COVID-19: a potential public health problem for homeless populations</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081990124">
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081990124&amp;doi=10.1136%2fbmj.m1040&amp;partnerID=40&amp;md5=729b823b1e3ca74e5800d8b0a7f1b005&gt;</schema:url>
    <dc:creator>Karan A.</dc:creator>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>2-s2.0-85081990124</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1136/bmj.m1040</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:title>To control the covid-19 outbreak, young, healthy patients should avoid the emergency department</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078964053">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020</j.0:title>
    <myOnto:volume>25</myOnto:volume>
    <dc:creator>Riou J., Althaus C.L.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.4.2000058</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85078964053</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078964053&amp;doi=10.2807%2f1560-7917.ES.2020.25.4.2000058&amp;partnerID=40&amp;md5=0424240d550831a453f8838e4f3228a8&gt;</schema:url>
    <myOnto:issue>4</myOnto:issue>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <rdfs:comment>Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia. We estimated the basic reproduction number R0 of 2019-nCoV to be around 2.2 (90% high density interval: 1.4-3.8), indicating the potential for sustained human-to-human transmission. Transmission characteristics appear to be of similar magnitude to severe acute respiratory syndrome-related coronavirus (SARS-CoV) and pandemic influenza, indicating a risk of global spread.</rdfs:comment>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; epidemic; global health; human; infection control; influenza; Influenza A virus; pandemic; pathogenicity; risk; SARS coronavirus; severe acute respiratory syndrome; virus pneumonia; virus replication; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Global Health; Humans; Infection Control; Influenza A virus; Influenza, Human; Pandemics; Pneumonia, Viral; Risk; SARS Virus; Severe Acute Respiratory Syndrome; Virus Replication</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081008159">
    <j.0:publisher>MDPI AG</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>angiotensin converting enzyme 2; angiotensin converting enzyme 2; COVID-19; dipeptidyl carboxypeptidase; bat; drought; environmental conditions; enzyme; epidemic; epidemiology; health risk; host; pneumonia; severe acute respiratory syndrome; bat; China; cold; disease course; environmental factor; epidemic; human; humidity; infection control; nonhuman; recurrent infection; Review; risk factor; SARS coronavirus; SARS coronavirus 1; SARS coronavirus 2; SARS-related coronavirus; seasonal variation; severe acute respiratory syndrome; virus cell interaction; virus survival; virus transmission; winter; animal; Coronavirinae; Coronavirus infection; epidemic; pathogenicity; physiology; season; severe acute respiratory syndrome; social status; travel; virus pneumonia; zoonosis; China; Hubei; Wuhan; Coronavirus; SARS coronavirus; Animals; China; Chiroptera; Coronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS Virus; Seasons; Severe Acute Respiratory Syndrome; Social Conditions; Travel; Zoonoses</schema:keywords>
    <j.0:identifier>10.3390/ijerph17051633</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>2-s2.0-85081008159</j.0:identifier>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:volume>17</myOnto:volume>
    <j.0:title>Potential factors influencing repeated SARS outbreaks in China</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <rdfs:comment>Within last 17 years two widespread epidemics of severe acute respiratory syndrome (SARS) occurred in China, which were caused by related coronaviruses (CoVs): SARS-CoV and SARS-CoV-2. Although the origin(s) of these viruses are still unknown and their occurrences in nature are mysterious, some general patterns of their pathogenesis and epidemics are noticeable. Both viruses utilize the same receptor—angiotensin-converting enzyme 2 (ACE2)—for invading human bodies. Both epidemics occurred in cold dry winter seasons celebrated with major holidays, and started in regions where dietary consumption of wildlife is a fashion. Thus, if bats were the natural hosts of SARS-CoVs, cold temperature and low humidity in these times might provide conducive environmental conditions for prolonged viral survival in these regions concentrated with bats. The widespread existence of these bat-carried or-released viruses might have an easier time in breaking through human defenses when harsh winter makes human bodies more vulnerable. Once succeeding in making some initial human infections, spreading of the disease was made convenient with increased social gathering and holiday travel. These natural and social factors influenced the general progression and trajectory of the SARS epidemiology. However, some unique factors might also contribute to the origination of SARS in Wuhan. These factors are discussed in different scenarios in order to promote more research for achieving final validation. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <dc:creator>Sun Z., Thilakavathy K., Kumar S.S., He G., Liu S.V.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081008159&amp;doi=10.3390%2fijerph17051633&amp;partnerID=40&amp;md5=a32074512415f7f4b869100d1a3d3952&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Environmental_Research_and_Public_Health"/>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081953533">
    <j.0:title>COVID-19 in a patient with chronic lymphocytic leukaemia</j.0:title>
    <dc:creator>Jin X.-H., Zheng K.I., Pan K.-H., Xie Y.-P., Zheng M.-H.</dc:creator>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85081953533</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081953533&amp;doi=10.1016%2fS2352-3026%2820%2930074-0&amp;partnerID=40&amp;md5=b81d086bed13ec830bf325d427824f4a&gt;</schema:url>
    <schema:keywords>alpha interferon; beta 2 microglobulin; brain natriuretic peptide; C reactive protein; chlorambucil; hemoglobin; human immunoglobulin; immunoglobulin A; immunoglobulin G; immunoglobulin M; methylprednisolone; adult; blood examination; body temperature; bone marrow biopsy; case report; chronic lymphatic leukemia; clinical article; computer assisted tomography; coronavirus disease 2019; coronavirus disease 2019; coughing; drug dose reduction; dyspnea; echocardiography; estimated glomerular filtration rate; European Cooperative Oncology Group performance score; fever; follow up; hospital discharge; human; leukocyte count; male; nonhodgkin lymphoma; noninvasive ventilation; Note; platelet count; priority journal; real time polymerase chain reaction; scoring system; Sequential Organ Failure Assessment Score; social isolation; sore throat; virus load; virus transmission</schema:keywords>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Haematology">
        <j.1:name>The Lancet Haematology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S2352-3026(20)30074-0</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>7</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092426">
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082092426</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_lancet._Psychiatry">
        <j.1:name>The lancet. Psychiatry</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Patients with mental health disorders in the COVID-19 epidemic</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:volume>7</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092426&amp;doi=10.1016%2fS2215-0366%2820%2930090-0&amp;partnerID=40&amp;md5=1864ca9650ffd75b0c87d4895aef410f&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S2215-0366(20)30090-0</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Yao H., Chen J.-H., Xu Y.-F.</dc:creator>
    <myOnto:issue>4</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081898618">
    <myOnto:volume>367</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <j.0:identifier>10.1126/science.367.6483.1172</j.0:identifier>
    <j.0:identifier>2-s2.0-85081898618</j.0:identifier>
    <schema:keywords>chemical reaction; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; drug development; Editorial; mortality rate; national health organization; priority journal; public figure; public health service; publication; scientist; Severe acute respiratory syndrome coronavirus 2</schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Thorp H.H.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>6483</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:title>Do us a favor</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081898618&amp;doi=10.1126%2fscience.367.6483.1172&amp;partnerID=40&amp;md5=535840d67195d5e2a658d4f56882db0c&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079867190">
    <dc:language>English</dc:language>
    <dc:creator>Gilbert M., Pullano G., Pinotti F., Valdano E., Poletto C., Boëlle P.-Y., D'Ortenzio E., Yazdanpanah Y., Eholie S.P., Altmann M., Gutierrez B., Kraemer M.U.G., Colizza V.</dc:creator>
    <j.0:title>Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>10227</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords>2019 novel coronavirus; Africa; airport; alertness; Algeria; Angola; Article; aviation; China; controlled study; Coronavirinae; Egypt; emergency; epidemic; Ethiopia; Ghana; human; Infectious Disease Vulnerability Index; international health regulation; Kenya; medicolegal aspect; Monitoring and Evaluation Framework; Nigeria; nonhuman; priority journal; risk assessment; scoring system; South Africa; Sudan; Tanzania; World Health Organization</schema:keywords>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079867190</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>10.1016/S0140-6736(20)30411-6</j.0:identifier>
    <rdfs:comment>Background: The novel coronavirus disease 2019 (COVID-19) epidemic has spread from China to 25 countries. Local cycles of transmission have already occurred in 12 countries after case importation. In Africa, Egypt has so far confirmed one case. The management and control of COVID-19 importations heavily rely on a country's health capacity. Here we evaluate the preparedness and vulnerability of African countries against their risk of importation of COVID-19. Methods: We used data on the volume of air travel departing from airports in the infected provinces in China and directed to Africa to estimate the risk of importation per country. We determined the country's capacity to detect and respond to cases with two indicators: preparedness, using the WHO International Health Regulations Monitoring and Evaluation Framework; and vulnerability, using the Infectious Disease Vulnerability Index. Countries were clustered according to the Chinese regions contributing most to their risk. Findings: Countries with the highest importation risk (ie, Egypt, Algeria, and South Africa) have moderate to high capacity to respond to outbreaks. Countries at moderate risk (ie, Nigeria, Ethiopia, Sudan, Angola, Tanzania, Ghana, and Kenya) have variable capacity and high vulnerability. We identified three clusters of countries that share the same exposure to the risk originating from the provinces of Guangdong, Fujian, and the city of Beijing, respectively. Interpretation: Many countries in Africa are stepping up their preparedness to detect and cope with COVID-19 importations. Resources, intensified surveillance, and capacity building should be urgently prioritised in countries with moderate risk that might be ill-prepared to detect imported cases and to limit onward transmission. Funding: EU Framework Programme for Research and Innovation Horizon 2020, Agence Nationale de la Recherche. © 2020 Elsevier Ltd</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079867190&amp;doi=10.1016%2fS0140-6736%2820%2930411-6&amp;partnerID=40&amp;md5=c23d0ba7d4a4f61594891852562461ac&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079658976">
    <myOnto:issue>10224</myOnto:issue>
    <j.0:identifier>10.1016/S0140-6736(20)30309-3</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079658976&amp;doi=10.1016%2fS0140-6736%2820%2930309-3&amp;partnerID=40&amp;md5=c012196d128682fbe1d394f3d43221ba&gt;</schema:url>
    <j.0:title>2019-nCoV epidemic: address mental health care to empower society</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>2019 novel coronavirus; anxiety disorder; awareness; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; depression; disease severity; empowerment; epidemic; geographic distribution; health care personnel; health promotion; human; infection prevention; infectious pneumonia; information dissemination; Letter; medical information; mental health care; mental stress; mortality rate; nonhuman; panic; patient worry; posttraumatic stress disorder; practice guideline; priority journal; respiratory tract infection; virus transmission; World Health Organization; Betacoronavirus; Coronavirus infection; epidemic; etiology; global health; measurement accuracy; psychology; therapy; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Data Accuracy; Disease Outbreaks; Global Health; Humans; Stress, Psychological</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85079658976</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <dc:creator>Bao Y., Sun Y., Meng S., Shi J., Lu L.</dc:creator>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081029824">
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081029824</j.0:identifier>
    <rdfs:comment>The ongoing coronavirus disease 2019 (COVID-19) outbreak, emerged in Wuhan, China in the end of 2019, has claimed more than 2600 lives as of 24 February 2020 and posed a huge threat to global public health. The Chinese government has implemented control measures including setting up special hospitals and travel restriction to mitigate the spread. We propose conceptual models for the COVID-19 outbreak in Wuhan with the consideration of individual behavioural reaction and governmental actions, e.g., holiday extension, travel restriction, hospitalisation and quarantine. We employe the estimates of these two key components from the 1918 influenza pandemic in London, United Kingdom, incorporated zoonotic introductions and the emigration, and then compute future trends and the reporting ratio. The model is concise in structure, and it successfully captures the course of the COVID-19 outbreak, and thus sheds light on understanding the trends of the outbreak. © 2020</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:creator>Lin Q., Zhao S., Gao D., Lou Y., Yang S., Musa S.S., Wang M.H., Cai Y., Wang W., Yang L., He D.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>2019 novel coronavirus; Article; behavior; China; conceptual model; Coronavirinae; Coronavirus infection; disease transmission; epidemic; government; hospitalization; human; infection control; infection risk; pandemic; population size; public health; quarantine; simulation; travel</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081029824&amp;doi=10.1016%2fj.ijid.2020.02.058&amp;partnerID=40&amp;md5=479f83251826f8172beb1fc473c3a774&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>93</myOnto:volume>
    <j.0:title>A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action</j.0:title>
    <j.0:identifier>10.1016/j.ijid.2020.02.058</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081236303">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Recent advances and perspectives of nucleic acid detection for coronavirus</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Pharmaceutical_Analysis"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.jpha.2020.02.010</j.0:identifier>
    <j.0:publisher>Xi'an Jiaotong University</j.0:publisher>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <dc:creator>Shen M., Zhou Y., Ye J., Abdullah AL-maskri A.A., Kang Y., Zeng S., Cai S.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081236303&amp;doi=10.1016%2fj.jpha.2020.02.010&amp;partnerID=40&amp;md5=06147a50c20f39d309a1444f47f958f3&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>The recent pneumonia outbreak caused by a novel coronavirus (SARS-CoV-2) in Chinais posing a great threat to global public health. Therefore, rapid and a accurate identification of pathogenic viruses plays a vital role in selecting appropriate treatments, saving people's lives and preventing epidemics. It is important to establish a quick standard diagnostic test for the detection of the infectious disease (COVID-19) to prevent subsequent secondary spread. Polymerase chain reaction (PCR) is regarded as a gold standard test for the molecular diagnosis of viral and bacterial infections with high sensitivity and specificity. Isothermal nucleic acid amplification is considered to be a highly promising candidate method due to its fundamental advantage in quick procedure time at constant temperature without thermocycler operation. A variety of improved or new approaches also have been developed. This review summarizes the currently available detection methods for coronavirus nucleic acid. It is anticipated that this will assist researchers and clinicians in developing better techniques for timely and effective detection of coronavirus infection. © 2020 Xi'an Jiaotong University</rdfs:comment>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>2-s2.0-85081236303</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081948804">
    <rdfs:comment>Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection. © 2020 Xi'an Jiaotong University</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>10.1016/j.jpha.2020.03.001</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Pharmaceutical_Analysis"/>
    <j.0:title>Molecular immune pathogenesis and diagnosis of COVID-19</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Li X., Geng M., Peng Y., Meng L., Lu S.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Xi'an Jiaotong University</j.0:publisher>
    <j.0:identifier>2-s2.0-85081948804</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081948804&amp;doi=10.1016%2fj.jpha.2020.03.001&amp;partnerID=40&amp;md5=2e909ca1371bb12c5da9d0d36f6aa1e1&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082001838">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; China; Coronavirus infection; human; hygiene; organization and management; pandemic; public health; virus pneumonia; World Health Organization; zoonosis; Animals; Betacoronavirus; China; Coronavirus Infections; Humans; Hygiene; Pandemics; Pneumonia, Viral; Public Health; World Health Organization; Zoonoses</schema:keywords>
    <j.0:type>Short Survey</j.0:type>
    <dc:language>English</dc:language>
    <j.0:title>Potential global pandemics: The role of the WHO and other public health bodies</j.0:title>
    <myOnto:issue>5</myOnto:issue>
    <dc:creator>Glasper A.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.12968/bjon.2020.29.5.322</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>MA Healthcare Ltd</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Nursing"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082001838</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082001838&amp;doi=10.12968%2fbjon.2020.29.5.322&amp;partnerID=40&amp;md5=729b79857ff533c7dc5c531218df28bd&gt;</schema:url>
    <myOnto:volume>29</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079756628">
    <j.0:identifier>2-s2.0-85079756628</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Patel A., Jernigan D.B., 2019-nCoV CDC Response Team</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_journal_of_transplantation_:_official_journal_of_the_American_Society_of_Transplantation_and_the_American_Society_of_Transplant_Surgeons">
        <j.1:name>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume>20</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1111/ajt.15805</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079756628&amp;doi=10.1111%2fajt.15805&amp;partnerID=40&amp;md5=c5f256f8d4247f728064fb2aee206f5b&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079451848">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Objectives: To estimate the basic reproduction number of the Wuhan novel coronavirus (2019-nCoV). Methods: Based on the susceptible-exposed-infected-removed (SEIR) compartment model and the assumption that the infectious cases with symptoms occurred before 26 January, 2020 are resulted from free propagation without intervention, we estimate the basic reproduction number of 2019-nCoV according to the reported confirmed cases and suspected cases, as well as the theoretical estimated number of infected cases by other research teams, together with some epidemiological determinants learned from the severe acute respiratory syndrome (SARS). Results: The basic reproduction number fall between 2.8 and 3.3 by using the real-time reports on the number of 2019-nCoV-infected cases from People's Daily in China and fall between 3.2 and 3.9 on the basis of the predicted number of infected cases from international colleagues. Conclusions: The early transmission ability of 2019-nCoV is close to or slightly higher than SARS. It is a controllable disease with moderate to high transmissibility. Timely and effective control measures are needed to prevent the further transmissions. © 2020 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley &amp; Sons Australia, Ltd</rdfs:comment>
    <myOnto:volume>13</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079451848&amp;doi=10.1111%2fjebm.12376&amp;partnerID=40&amp;md5=64ca3ee69193b58716352cfc2e2a40e8&gt;</schema:url>
    <j.0:title>Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV</j.0:title>
    <dc:creator>Zhou T., Liu Q., Yang Z., Liao J., Yang K., Bai W., Lu X., Zhang W.</dc:creator>
    <j.0:identifier>10.1111/jebm.12376</j.0:identifier>
    <j.0:publisher>Blackwell Publishing</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079451848</j.0:identifier>
    <schema:keywords>Article; basic reproduction number; China; Coronavirinae; epidemic; human; infection control; infection prevention; nonhuman; prediction; priority journal; sensitivity analysis; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; virus transmission; Betacoronavirus; Coronavirus infection; forecasting; theoretical model; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Basic Reproduction Number; Betacoronavirus; China; Coronavirus Infections; Forecasting; Humans; Models, Theoretical; Pneumonia, Viral</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Evidence-Based_Medicine">
        <j.1:name>Journal of Evidence-Based Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081650606">
    <j.0:identifier>2-s2.0-85081650606</j.0:identifier>
    <j.0:identifier>10.1001/jama.2020.3882</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:title>From Containment to Mitigation of COVID-19 in the US</j.0:title>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081650606&amp;doi=10.1001%2fjama.2020.3882&amp;partnerID=40&amp;md5=28920731cf677d9309644f0890c6fe5d&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Parodi S.M., Liu V.X.</dc:creator>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082115581">
    <j.0:identifier>2-s2.0-85082115581</j.0:identifier>
    <j.0:publisher>Canadian Medical Association</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:type>Review</j.0:type>
    <j.0:title>What can early Canadian experience screening for COVID-19 teach us about how to prepare for a pandemic?</j.0:title>
    <dc:creator>Lin M., Beliavsky A., Katz K., Powis J.E., Ng W., Williams V., Science M., Groves H., Muller M.P., Vaisman A., Hota S., Johnstone J., Leis J.A.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>192</myOnto:volume>
    <j.0:identifier>10.1503/cmaj.200305</j.0:identifier>
    <myOnto:issue>12</myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/CMAJ">
        <j.1:name>CMAJ</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082115581&amp;doi=10.1503%2fcmaj.200305&amp;partnerID=40&amp;md5=65e599749e9d302089b14a75a9be5833&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080049428">
    <j.0:identifier>2-s2.0-85080049428</j.0:identifier>
    <j.0:publisher>Taylor and Francis Inc.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Baylor_University_Medical_Center_Proceedings">
        <j.1:name>Baylor University Medical Center Proceedings</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1080/08998280.2020.1731272</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080049428&amp;doi=10.1080%2f08998280.2020.1731272&amp;partnerID=40&amp;md5=df14c463c9f9408c426b202f0b5406cf&gt;</schema:url>
    <dc:creator>Columbus C., Brust K.B., Arroliga A.C.</dc:creator>
    <j.0:title>2019 novel coronavirus: an emerging global threat</j.0:title>
    <schema:keywords></schema:keywords>
    <rdfs:comment>The coronavirus (CoV) epidemic that began in China in December 2019 follows earlier epidemics of severe acute respiratory syndrome CoV in China and Middle East respiratory syndrome CoV in Saudi Arabia. The full genome of the 2019 novel coronavirus (2019-nCoV) has now been shared, and data have been gathered from several case series. As of February 11, 2020, there have been 45,182 laboratory-confirmed cases, the vast majority in China, with 1115 deaths, for an overall case-fatality rate of 2.5%. Cases have been confirmed in 27 countries. On average, each patient infects 2.2 other people. Symptomatic infection appears to predominantly affect adults, with a 5-day estimated incubation period between infection and symptom onset. The most common presenting symptoms are fever, cough, dyspnea, and myalgias and/or fatigue. All cases reported to date have shown radiographic evidence of pneumonia. 2019-nCoV is diagnosed by real-time reverse transcriptase polymerase chain reaction. Treatment is largely supportive, with regimens including antiviral therapy. Corticosteroids are not routinely recommended. Hand hygiene, prompt identification and isolation of suspect patients, and appropriate use of personal protective equipment are the most reliable methods to contain the epidemic. © 2020, © 2020 Baylor University Medical Center.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079891308">
    <j.0:identifier>2-s2.0-85079891308</j.0:identifier>
    <rdfs:comment>Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62–71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05–0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread. © 2020 The Healthcare Infection Society</rdfs:comment>
    <myOnto:volume>104</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:keywords>alcohol; benzalkonium chloride; biocide; chlorhexidine gluconate; glass; hydrogen peroxide; hypochlorite sodium; metal; plastic; COVID-19; disinfectant agent; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; Canine coronavirus; clinical effectiveness; Coronavirinae; disinfection; health care facility; hepatitis virus; human; Middle East respiratory syndrome coronavirus; nonhuman; Review; surface area; Transmissible gastroenteritis virus; virus inactivation; virus transmission; Betacoronavirus; Coronavirus infection; drug effect; environmental microbiology; growth, development and aging; microbial viability; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disinfectants; Environmental Microbiology; Humans; Microbial Viability; Pneumonia, Viral</schema:keywords>
    <dc:creator>Kampf G., Todt D., Pfaender S., Steinmann E.</dc:creator>
    <myOnto:issue>3</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Hospital_Infection"/>
    <j.0:title>Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents</j.0:title>
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy>8</myOnto:citeyBy>
    <j.0:identifier>10.1016/j.jhin.2020.01.022</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079891308&amp;doi=10.1016%2fj.jhin.2020.01.022&amp;partnerID=40&amp;md5=bd94ddc4fad97d68f09eaa2eed534ac8&gt;</schema:url>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079742900">
    <schema:keywords>lopinavir; ritonavir; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirinae; human; pneumonia; reverse transcription polymerase chain reaction; South Korea; Betacoronavirus; Coronavirus; Humans; Lopinavir; Pneumonia; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>7</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.3346/jkms.2020.35.e89</j.0:identifier>
    <j.0:identifier>2-s2.0-85079742900</j.0:identifier>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <dc:creator>Lim J., Jeon S., Shin H.-Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.-W., Kang Y.M., Lee B., Park S.-J.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:volume>35</myOnto:volume>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079742900&amp;doi=10.3346%2fjkms.2020.35.e89&amp;partnerID=40&amp;md5=db8a8ec21b00c98df3c232ddebef98de&gt;</schema:url>
    <j.0:title>The Author's response: Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The Application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081932813">
    <j.0:publisher>Institute of Pediatrics of Zhejiang University</j.0:publisher>
    <j.0:identifier>2-s2.0-85081932813</j.0:identifier>
    <j.0:title>Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1007/s12519-020-00353-5</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081932813&amp;doi=10.1007%2fs12519-020-00353-5&amp;partnerID=40&amp;md5=77663f1cce2ff23941e0d1e71d4adf73&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/World_Journal_of_Pediatrics"/>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <dc:creator>Wang Y., Zhu L.-Q.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080125040">
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080125040&amp;doi=10.1016%2fj.micinf.2020.02.004&amp;partnerID=40&amp;md5=707ccf74cffb02527798eb7f81993039&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Pan X., Ojcius D.M., Gao T., Li Z., Pan C., Pan C.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Microbes_and_Infection"/>
    <schema:keywords>Article; China; consultation; coronavirus disease 2019; Coronavirus infection; epidemic; financial management; government regulation; human; policy; preliminary data; priority journal; public health; social behavior; traffic; animal; bat; Betacoronavirus; Coronavirus infection; epidemic; government; interpersonal communication; pathogenicity; procedures; travel; virology; virus pneumonia; zoonosis; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; China; Chiroptera; Communication; Coronavirus Infections; Epidemics; Government; Humans; Pneumonia, Viral; Public Health; Travel; Zoonoses</schema:keywords>
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <rdfs:comment>Only a month after the outbreak of pneumonia caused by 2019-nCoV, more than forty-thousand people were infected. This put enormous pressure on the Chinese government, medical healthcare provider, and the general public, but also made the international community deeply nervous. On the 25th day after the outbreak, the Chinese government implemented strict traffic restrictions on the area where the 2019-nCoV had originated—Hubei province, whose capital city is Wuhan. Ten days later, the rate of increase of cases in Hubei showed a significant difference (p = 0.0001) compared with the total rate of increase in other provinces of China. These preliminary data suggest the effectiveness of a traffic restriction policy for this pandemic thus far. At the same time, solid financial support and improved research ability, along with network communication technology, also greatly facilitated the application of epidemic prevention measures. These measures were motivated by the need to provide effective treatment of patients, and involved consultation with three major groups in policy formulation—public health experts, the government, and the general public. It was also aided by media and information technology, as well as international cooperation. This experience will provide China and other countries with valuable lessons for quickly coordinating and coping with future public health emergencies. © 2020 Institut Pasteur</rdfs:comment>
    <j.0:title>Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases</j.0:title>
    <j.0:identifier>10.1016/j.micinf.2020.02.004</j.0:identifier>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>2-s2.0-85080125040</j.0:identifier>
    <myOnto:volume>22</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082082571">
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082082571&amp;doi=10.1371%2fjournal.pone.0230548&amp;partnerID=40&amp;md5=b882bb1df1ae213749d7c2aabdb19574&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/PLoS_ONE">
        <j.1:name>PLoS ONE</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China</j.0:title>
    <rdfs:comment>Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had not been fully understood are especially important for diagnosing and predicting prognosis. We retrospective studied 27 consecutive patients who were confirmed NCIP, the clinical characteristics and CT image findings were collected, and the association of radiologic findings with mortality of patients was evaluated. 27 patients included 12 men and 15 women, with median age of 60 years (IQR 47-69). 17 patients discharged in recovered condition and 10 patients died in hospital. The median age of mortality group was higher compared to survival group (68 (IQR 63-73) vs 55 (IQR 35-60), P = 0.003). The comorbidity rate in mortality group was significantly higher than in survival group (80% vs 29%, P = 0.018). The predominant CT characteristics consisted of ground glass opacity (67%), bilateral sides involved (86%), both peripheral and central distribution (74%), and lower zone involvement (96%). The median CT score of mortality group was higher compared to survival group (30 (IQR 7-13) vs 12 (IQR 11-43), P = 0.021), with more frequency of consolidation (40% vs 6%, P = 0.047) and air bronchogram (60% vs 12%, P = 0.025). An optimal cutoff value of a CT score of 24.5 had a sensitivity of 85.6% and a specificity of 84.5% for the prediction of mortality. 2019-nCoV was more likely to infect elderly people with chronic comorbidities. CT findings of NCIP were featured by predominant ground glass opacities mixed with consolidations, mainly peripheral or combined peripheral and central distributions, bilateral and lower lung zones being mostly involved. A simple CT scoring method was capable to predict mortality. © 2020 Public Library of Science. All rights reserved.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>15</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>3</myOnto:issue>
    <j.0:identifier>2-s2.0-85082082571</j.0:identifier>
    <j.0:identifier>10.1371/journal.pone.0230548</j.0:identifier>
    <j.0:publisher>Public Library of Science</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Yuan M., Yin W., Tao Z., Tan W., Hu Y.</dc:creator>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081011566">
    <myOnto:volume>368</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85081011566</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081011566&amp;doi=10.1136%2fbmj.m831&amp;partnerID=40&amp;md5=8ef995bccf340e23fd84a8a2dfc544c3&gt;</schema:url>
    <j.0:title>Covid-19: retired doctors could be asked to return to work, says Hancock</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m831</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092318">
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092318&amp;doi=10.1136%2fbmj.m1163&amp;partnerID=40&amp;md5=1ab9d3545c690ed81ae1614b6b1687f1&gt;</schema:url>
    <dc:creator>Peto J.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m1163</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082092318</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Covid-19 mass testing facilities could end the epidemic rapidly</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078718430">
    <j.0:title>Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission</j.0:title>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078718430&amp;doi=10.1007%2fs11427-020-1637-5&amp;partnerID=40&amp;md5=e8a53449938d992a66d9b174812ea7ba&gt;</schema:url>
    <dc:creator>Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., Zhong W., Hao P.</dc:creator>
    <myOnto:citeyBy>20</myOnto:citeyBy>
    <j.0:publisher>Science in China Press</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>3</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1007/s11427-020-1637-5</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>63</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85078718430</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science_China_Life_Sciences"/>
    <schema:keywords>angiotensin converting enzyme 2; coronavirus spike glycoprotein; COVID-19; dipeptidyl carboxypeptidase; severe acute respiratory syndrome coronavirus 2; Alphacoronavirus; Betacoronavirus; binding site; chemical model; China; Coronavirus infection; epidemic; genetic variation; genetics; human; Middle East respiratory syndrome coronavirus; pathogenicity; phylogeny; physiology; protein conformation; SARS coronavirus; theoretical model; virus pneumonia; Alphacoronavirus; Betacoronavirus; Binding Sites; China; Coronavirus Infections; Disease Outbreaks; Genetic Variation; Humans; Middle East Respiratory Syndrome Coronavirus; Models, Chemical; Models, Theoretical; Peptidyl-Dipeptidase A; Phylogeny; Pneumonia, Viral; Protein Conformation; SARS Virus; Spike Glycoprotein, Coronavirus</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082024936">
    <dc:language>English; Portuguese</dc:language>
    <myOnto:issue>3</myOnto:issue>
    <dc:creator>Lana R.M., Coelho F.C., Gomes M.F.D.C., Cruz O.G., Bastos L.S., Villela D.A.M., Codeço C.T.</dc:creator>
    <j.0:identifier>2-s2.0-85082024936</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cadernos_de_saude_publica">
        <j.1:name>Cadernos de saude publica</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>COVID-19; Brazil; Coronavirus infection; epidemic; health survey; human; virology; virus pneumonia; Brazil; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; Public Health Surveillance</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082024936&amp;doi=10.1590%2f0102-311x00019620&amp;partnerID=40&amp;md5=04e0e18267461900a9b247906673fc26&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1590/0102-311x00019620</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>36</myOnto:volume>
    <j.0:title>The novel coronavirus (SARS-CoV-2) emergency and the role of timely and effective national health surveillance [Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva]</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082188632">
    <j.0:identifier>10.1016/S1473-3099(20)30134-1</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85082188632</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:title>COVID-19 pneumonia: what has CT taught us?</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <dc:creator>Lee E.Y.P., Ng M.-Y., Khong P.-L.</dc:creator>
    <myOnto:volume>20</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082188632&amp;doi=10.1016%2fS1473-3099%2820%2930134-1&amp;partnerID=40&amp;md5=4bbac86ab6a7b4b2fa64443684aa6993&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079710932">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:title>Economic impacts of Wuhan 2019-nCoV on China and the world</j.0:title>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>92</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>5</myOnto:issue>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:identifier>2-s2.0-85079710932</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Ayittey F.K., Ayittey M.K., Chiwero N.B., Kamasah J.S., Dzuvor C.</dc:creator>
    <schema:keywords>2019 novel coronavirus; China; commercial phenomena; Coronavirinae; country economic status; economic development; economic recession; gross national product; human; International Monetary Fund; Note; tourism; travel; Betacoronavirus; Coronavirus infection; economics; pandemic; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Commerce; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Travel</schema:keywords>
    <j.0:identifier>10.1002/jmv.25706</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079710932&amp;doi=10.1002%2fjmv.25706&amp;partnerID=40&amp;md5=5d4225449254517e5e8d4270ec47ec6e&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082085844">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082085844&amp;doi=10.4045%2ftidsskr.20.0210&amp;partnerID=40&amp;md5=44e88d8ea673d26f084fad10fd1a25de&gt;</schema:url>
    <myOnto:volume>140</myOnto:volume>
    <j.0:identifier>2-s2.0-85082085844</j.0:identifier>
    <j.0:identifier>10.4045/tidsskr.20.0210</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Tidsskrift_for_den_Norske_laegeforening_:_tidsskrift_for_praktisk_medicin,_ny_raekke"/>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:language>Norwegian</dc:language>
    <dc:date>2020</dc:date>
    <dc:creator>Tveito K.</dc:creator>
    <j.0:title>Covid-19: Italiensk leksjon</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079740170">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>133</myOnto:volume>
    <myOnto:issue>1510</myOnto:issue>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; China; civil defense; communicable disease; Coronavirus infection; global health; health care planning; human; New Zealand; pandemic; pathogenicity; public health; virus pneumonia; zoonosis; Animals; Betacoronavirus; China; Civil Defense; Communicable Diseases, Emerging; Coronavirus Infections; Global Health; Health Planning; Humans; New Zealand; Pandemics; Pneumonia, Viral; Public Health; Zoonoses</schema:keywords>
    <j.0:identifier>2-s2.0-85079740170</j.0:identifier>
    <j.0:title>COVID-19: another infectious disease emerging at the animal-human interface</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079740170&amp;partnerID=40&amp;md5=c8e941c3831520d435354c1d6484339b&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_New_Zealand_medical_journal">
        <j.1:name>The New Zealand medical journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Murdoch D.R., French N.P.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier></j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079362164">
    <j.0:type>Note</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Research_in_Social_and_Administrative_Pharmacy">
        <j.1:name>Research in Social and Administrative Pharmacy</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>community pharmacist; consultation; Coronavirinae; human; Macao; nonhuman; note; pharmacy (shop); public health; article</schema:keywords>
    <j.0:publisher>Elsevier Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079362164&amp;doi=10.1016%2fj.sapharm.2020.02.003&amp;partnerID=40&amp;md5=ab27cc44dbeb064322d8dbb7d586e999&gt;</schema:url>
    <j.0:identifier>10.1016/j.sapharm.2020.02.003</j.0:identifier>
    <rdfs:comment>The 2019-nCoV infection that is caused by a novel strain of coronavirus was first detected in China in the end of December 2019 and declared a public health emergency of international concern by the World Health Organization on January 30, 2020. Community pharmacists in one of the first areas that had confirmed cases of the viral infection, Macau, joined the collaborative force in supporting the local health emergency preparedness and response arrangements. This paper aimed to improve the understanding of community pharmacists’ role in case of 2019-CoV outbreak based on the practical experiences in consultation with the recommendations made by the International Pharmaceutical Federation on the Coronavirus 2019-nCoV outbreak. © 2020 Elsevier Inc.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Ung C.O.L.</dc:creator>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079362164</j.0:identifier>
    <myOnto:volume>16</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081999776">
    <myOnto:issue>7799</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:title>Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081999776&amp;doi=10.1038%2fd41586-020-00751-9&amp;partnerID=40&amp;md5=5b2a027cab5d7422607d8d1cb7c2155d&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>579</myOnto:volume>
    <j.0:identifier>10.1038/d41586-020-00751-9</j.0:identifier>
    <j.0:identifier>2-s2.0-85081999776</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <dc:creator>Jiang S.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; virus vaccine; animal model; Betacoronavirus; China; clinical trial (topic); Coronavirus infection; drug effect; human; immunity; immunology; pathogenicity; patient safety; preclinical study; SARS coronavirus; severe acute respiratory syndrome; virus pneumonia; Betacoronavirus; China; Clinical Trials as Topic; Coronavirus Infections; Drug Evaluation, Preclinical; Humans; Immunity; Models, Animal; Patient Safety; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome; Viral Vaccines</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081659485">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Il Pensiero Scientifico Editore s.r.l.</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Recenti_Progressi_in_Medicina">
        <j.1:name>Recenti Progressi in Medicina</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>[No author name available]</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081659485</j.0:identifier>
    <dc:language>Italian</dc:language>
    <j.0:identifier>10.1701/3315.32860</j.0:identifier>
    <j.0:type>Short Survey</j.0:type>
    <j.0:title>Is the useful information about the coronavirus (SARS-CoV-2) not controlled? [L'informazione utile sul coronavirus (SARS-CoV-2) non è controllata?]</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081659485&amp;doi=10.1701%2f3315.32860&amp;partnerID=40&amp;md5=c5d2239cdec555d982c15b6ba6c644ed&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:volume>111</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081326614">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <dc:date>2020</dc:date>
    <dc:creator>Liu P., Tan X.-Z.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>295</myOnto:volume>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; Betacoronavirus; case report; complication; Coronavirus infection; diagnostic imaging; female; fever; human; isolation and purification; lung; pathology; real time polymerase chain reaction; thorax radiography; virus pneumonia; x-ray computed tomography; Adult; Betacoronavirus; Coronavirus Infections; Female; Fever; Humans; Lung; Pneumonia, Viral; Radiography, Thoracic; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed</schema:keywords>
    <j.0:identifier>10.1148/radiol.2020200257</j.0:identifier>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081326614</j.0:identifier>
    <j.0:title>2019 Novel coronavirus (2019-NCoV) pneumonia</j.0:title>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081326614&amp;doi=10.1148%2fradiol.2020200257&amp;partnerID=40&amp;md5=6b63bbcbfbd3e4a8f1408da6c092da88&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081226320">
    <j.0:identifier>10.1016/j.jfo.2020.02.001</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081226320&amp;doi=10.1016%2fj.jfo.2020.02.001&amp;partnerID=40&amp;md5=70507a52b3fe4dd88aecc31dee9fcf63&gt;</schema:url>
    <dc:creator>Tahiri Joutei Hassani R., Sandali O.</dc:creator>
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <j.0:identifier>2-s2.0-85081226320</j.0:identifier>
    <dc:language>English; French</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The novel coronavirus Covid-19: What are the ophthalmic risks? [Le nouveau Coronavirus Covid-19 : quels risques ophtalmiques ?]</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_Francais_d&apos;Ophtalmologie">
        <j.1:name>Journal Francais d'Ophtalmologie</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080906957">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_Journal_of_Nuclear_Medicine_and_Molecular_Imaging"/>
    <dc:language>English</dc:language>
    <rdfs:comment>Background: The pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2, also called 2019-nCoV) recently break out in Wuhan, China, and was named as COVID-19. With the spread of the disease, similar cases have also been confirmed in other regions of China. We aimed to report the imaging and clinical characteristics of these patients infected with SARS-CoV-2 in Guangzhou, China. Methods: All patients with laboratory-identified SARS-CoV-2 infection by real-time polymerase chain reaction (PCR) were collected between January 23, 2020, and February 4, 2020, in a designated hospital (Guangzhou Eighth People’s Hospital). This analysis included 90 patients (39 men and 51 women; median age, 50 years (age range, 18–86 years). All the included SARS-CoV-2-infected patients underwent non-contrast enhanced chest computed tomography (CT). We analyzed the clinical characteristics of the patients, as well as the distribution characteristics, pattern, morphology, and accompanying manifestations of lung lesions. In addition, after 1–6 days (mean 3.5 days), follow-up chest CT images were evaluated to assess radiological evolution. Findings: The majority of infected patients had a history of exposure in Wuhan or to infected patients and mostly presented with fever and cough. More than half of the patients presented bilateral, multifocal lung lesions, with peripheral distribution, and 53 (59%) patients had more than two lobes involved. Of all included patients, COVID-19 pneumonia presented with ground glass opacities in 65 (72%), consolidation in 12 (13%), crazy paving pattern in 11 (12%), interlobular thickening in 33 (37%), adjacent pleura thickening in 50 (56%), and linear opacities combined in 55 (61%). Pleural effusion, pericardial effusion, and lymphadenopathy were uncommon findings. In addition, baseline chest CT did not show any abnormalities in 21 patients (23%), but 3 patients presented bilateral ground glass opacities on the second CT after 3–4 days. Conclusion: SARS-CoV-2 infection can be confirmed based on the patient’s history, clinical manifestations, imaging characteristics, and laboratory tests. Chest CT examination plays an important role in the initial diagnosis of the novel coronavirus pneumonia. Multiple patchy ground glass opacities in bilateral multiple lobular with periphery distribution are typical chest CT imaging features of the COVID-19 pneumonia. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <dc:creator>Xu X., Yu C., Qu J., Zhang L., Jiang S., Huang D., Chen B., Zhang Z., Guan W., Ling Z., Jiang R., Hu T., Ding Y., Lin L., Gan Q., Luo L., Tang X., Liu J.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85080906957</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1007/s00259-020-04735-9</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080906957&amp;doi=10.1007%2fs00259-020-04735-9&amp;partnerID=40&amp;md5=f83a6ccb72a506f2ee3cec1255d458da&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092864">
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>44</myOnto:volume>
    <j.0:identifier>2-s2.0-85082092864</j.0:identifier>
    <j.0:title>COVID-19, Australia: Epidemiology Report 4 (Reporting week ending 19:00 AEDT 22 February 2020)</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.33321/cdi.2020.44.17</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092864&amp;doi=10.33321%2fcdi.2020.44.17&amp;partnerID=40&amp;md5=d46080ef856ae5b7a6008f14fa0985f3&gt;</schema:url>
    <dc:creator>COVID-19 National Incident Room Surveillance Team</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>This is the fourth epidemiological report for coronavirus disease 2019 (COVID-19), reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 22 February 2020. It includes data on COVID-19 cases diagnosed in Australia, the international situation and a review of current evidence. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Australia; Betacoronavirus; Coronavirus infection; human; virus pneumonia; Australia; Betacoronavirus; Coronavirus Infections; Humans; Pneumonia, Viral</schema:keywords>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080892572">
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>10.1016/j.accpm.2020.02.002</j.0:identifier>
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Anaesthesia_Critical_Care_and_Pain_Medicine"/>
    <dc:creator>Ling L., Joynt G.M., Lipman J., Constantin J.-M., Joannes-Boyau O.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080892572&amp;doi=10.1016%2fj.accpm.2020.02.002&amp;partnerID=40&amp;md5=1fcb8f31eeb17e719d3af33588e6bb18&gt;</schema:url>
    <j.0:title>COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080892572</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081894561">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <j.0:identifier>2-s2.0-85081894561</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081894561&amp;doi=10.1080%2f22221751.2020.1738905&amp;partnerID=40&amp;md5=8f98a7b29f335d9be5f91f31c1a06606&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1080/22221751.2020.1738905</j.0:identifier>
    <dc:creator>Ai J.-W., Zhang Y., Zhang H.-C., Xu T., Zhang W.-H.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; genetics; human; isolation and purification; molecular diagnosis; phylogeny; virus pneumonia; Betacoronavirus; Coronavirus Infections; Humans; Molecular Diagnostic Techniques; Phylogeny; Pneumonia, Viral</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>9</myOnto:volume>
    <rdfs:comment>Unexplained pneumonia (UP) caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged in China in late December 2019 and has infected more than 9000 cases by 31 January 2020. Shanghai reported the first imported case of COVID-19 (Coronavirus Disease 2019) in 20 January 2020. A combinative approach of real-time RT–PCR, CRISPR-based assay and metagenomic next-generation sequencing (mNGS) were used to diagnose this unexplained pneumonia patient. Real-time RT–PCR and CRISPR-based assay both reported positive. This sample belonged to Betacoronavirus and shared a more than 99% nucleotide (nt) identity with the Wuhan SARS-CoV-2 isolates. We further compared pros and cons of common molecular diagnostics in UP. In this study, we illustrated the importance of combining molecular diagnostics to rule out common pathogens and performed mNGS to obtain unbiased potential pathogen result for the diagnosis of UP. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080027813">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080027813&amp;doi=10.1002%2fjmv.25705&amp;partnerID=40&amp;md5=4511866391fd49e2c6685324694f54a9&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:creator>Wang G., Jin X.</dc:creator>
    <schema:keywords>China; coronavirus disease 2019; human; nonhuman; Note; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; trend study</schema:keywords>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>10.1002/jmv.25705</j.0:identifier>
    <j.0:identifier>2-s2.0-85080027813</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:title>The progress of 2019 novel coronavirus event in China</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081199276">
    <myOnto:issue>10227</myOnto:issue>
    <j.0:title>COVID-19: the gendered impacts of the outbreak</j.0:title>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081199276&amp;doi=10.1016%2fS0140-6736%2820%2930526-2&amp;partnerID=40&amp;md5=52765c164ffb414572f2811b88d76e92&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30526-2</j.0:identifier>
    <dc:creator>Wenham C., Smith J., Morgan R.</dc:creator>
    <j.0:identifier>2-s2.0-85081199276</j.0:identifier>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:date>2020</dc:date>
    <schema:keywords>caregiver; China; coronavirus disease 2019; Coronavirus infection; disease surveillance; emergency; epidemic; evidence based medicine; health care access; health care personnel; health care policy; human; mortality; Note; personal experience; prevalence; priority journal; public health; sex difference; smoking; uncertainty; vulnerable population; workforce; World Health Organization</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082017494">
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082017494&amp;doi=10.1016%2fj.jinf.2020.03.007&amp;partnerID=40&amp;md5=0af22dbc6889945fda0a4da6c0e378c0&gt;</schema:url>
    <dc:date>2020</dc:date>
    <rdfs:comment>Background: The ongoing outbreak of COVID-19 pneumonia is globally concerning. We aimed to investigate the clinical and CT features in the pregnant women and children with this disease, which have not been well reported. Methods: Clinical and CT data of 59 patients with COVID-19 from January 27 to February 14, 2020 were retrospectively reviewed, including 14 laboratory-confirmed non-pregnant adults, 16 laboratory-confirmed and 25 clinically-diagnosed pregnant women, and 4 laboratory-confirmed children. The clinical and CT features were analyzed and compared. Findings: Compared with the non-pregnant adults group (n = 14), initial normal body temperature (9 [56%] and 16 [64%]), leukocytosis (8 [50%] and 9 [36%]) and elevated neutrophil ratio (14 [88%] and 20 [80%]), and lymphopenia (9 [56%] and 16 [64%]) were more common in the laboratory-confirmed (n = 16) and clinically-diagnosed (n = 25) pregnant groups. Totally 614 lesions were detected with predominantly peripheral and bilateral distributions in 54 (98%) and 37 (67%) patients, respectively. Pure ground-glass opacity (GGO) was the predominant presence in 94/131 (72%) lesions for the non-pregnant adults. Mixed consolidation and complete consolidation were more common in the laboratory-confirmed (70/161 [43%]) and clinically-diagnosed (153/322 [48%]) pregnant groups than 37/131 (28%) in the non-pregnant adults (P = 0·007, P &lt; 0·001). GGO with reticulation was less common in 9/161 (6%) and 16/322 (5%) lesions for the two pregnant groups than 24/131 (18%) for the non-pregnant adults (P = 0·001, P &lt; 0·001). The pulmonary involvement in children with COVID-19 was mild with a focal GGO or consolidation. Twenty-three patients underwent follow-up CT, revealing progression in 9/13 (69%) at 3 days whereas improvement in 8/10 (80%) at 6–9 days after initial CT scans. Interpretation: Atypical clinical findings of pregnant women with COVID-19 could increase the difficulty in initial identification. Consolidation was more common in the pregnant groups. The clinically-diagnosed cases were vulnerable to more pulmonary involvement. CT was the modality of choice for early detection, severity assessment, and timely therapeutic effects evaluation for the cases with epidemic and clinical features of COVID-19 with or without laboratory confirmation. The exposure history and clinical symptoms were more helpful for screening in children versus chest CT. © 2020</rdfs:comment>
    <j.0:title>Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85082017494</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jinf.2020.03.007</j.0:identifier>
    <dc:creator>Liu H., Liu F., Li J., Zhang T., Wang D., Lan W.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081935465">
    <schema:keywords></schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Article</j.0:type>
    <j.0:title>First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30607-3</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:creator>Ghinai I., McPherson T.D., Hunter J.C., Kirking H.L., Christiansen D., Joshi K., Rubin R., Morales-Estrada S., Black S.R., Pacilli M., Fricchione M.J., Chugh R.K., Walblay K.A., Ahmed N.S., Stoecker W.C., Hasan N.F., Burdsall D.P., Reese H.E., Wallace M., Wang C., Moeller D., Korpics J., Novosad S.A., Benowitz I., Jacobs M.W., Dasari V.S., Patel M.T., Kauerauf J., Charles E.M., Ezike N.O., Chu V., Midgley C.M., Rolfes M.A., Gerber S.I., Lu X., Lindstrom S., Verani J.R., Layden J.E., Illinois COVID-19 Investigation Team</dc:creator>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Background: Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated the first case of COVID-19 in Illinois, USA. Methods: Patients with confirmed COVID-19 were defined as those with a positive SARS-CoV-2 test. Contacts were people with exposure to a patient with COVID-19 on or after the patient's symptom onset date. Contacts underwent active symptom monitoring for 14 days following their last exposure. Contacts who developed fever, cough, or shortness of breath became persons under investigation and were tested for SARS-CoV-2. A convenience sample of 32 asymptomatic health-care personnel contacts were also tested. Findings: Patient 1—a woman in her 60s—returned from China in mid-January, 2020. One week later, she was hospitalised with pneumonia and tested positive for SARS-CoV-2. Her husband (Patient 2) did not travel but had frequent close contact with his wife. He was admitted 8 days later and tested positive for SARS-CoV-2. Overall, 372 contacts of both cases were identified; 347 underwent active symptom monitoring, including 152 community contacts and 195 health-care personnel. Of monitored contacts, 43 became persons under investigation, in addition to Patient 2. These 43 persons under investigation and all 32 asymptomatic health-care personnel tested negative for SARS-CoV-2. Interpretation: Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while Patient 1 was symptomatic. Despite active symptom monitoring and testing of symptomatic and some asymptomatic contacts, no further transmission was detected. Funding: None. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081935465</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081935465&amp;doi=10.1016%2fS0140-6736%2820%2930607-3&amp;partnerID=40&amp;md5=75c02315ed9aebdbfb7abec1bb6fd9a9&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080978164">
    <j.0:identifier>10.1002/jmv.25711</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:creator>Han W., Quan B., Guo Y., Zhang J., Lu Y., Feng G., Wu Q., Fang F., Cheng L., Jiao N., Li X., Chen Q.</dc:creator>
    <j.0:title>The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019</j.0:title>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080978164&amp;doi=10.1002%2fjmv.25711&amp;partnerID=40&amp;md5=ffdb871b4f30df2b876c7d89293be74e&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <dc:language>English</dc:language>
    <schema:keywords>China; Coronavirus infection; human; Middle East respiratory syndrome coronavirus; pneumonia; China; Coronavirus Infections; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85080978164</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080872087">
    <schema:keywords>BCG vaccine; chemokine; cytokine; severe acute respiratory syndrome coronavirus 2; abdominal discomfort; abdominal pain; animal experiment; animal model; child; China; clinical feature; Coronavirus disease 2019; Coronavirus infection; coughing; diarrhea; disease transmission; dry cough; dynamics; epidemic; fatigue; fever; gastrointestinal symptom; human; immunization; influenza; Influenza virus; leukocyte count; Middle East respiratory syndrome; mouse; nausea; nonhuman; respiratory distress; SARS coronavirus; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2; Short Survey; virus replication; virus transmission; vomiting; Betacoronavirus; female; medical record; pregnancy; retrospective study; severe acute respiratory syndrome; vertical transmission; Betacoronavirus; Child; Female; Humans; Infectious Disease Transmission, Vertical; Medical Records; Pregnancy; Retrospective Studies; Severe Acute Respiratory Syndrome</schema:keywords>
    <j.0:title>SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080872087&amp;doi=10.1016%2fj.jfma.2020.02.009&amp;partnerID=40&amp;md5=fea44172413a6733a8d2a1432e284c05&gt;</schema:url>
    <j.0:identifier>2-s2.0-85080872087</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Cao Q., Chen Y.-C., Chen C.-L., Chiu C.-H.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_Formosan_Medical_Association"/>
    <myOnto:volume>119</myOnto:volume>
    <j.0:identifier>10.1016/j.jfma.2020.02.009</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:type>Short Survey</j.0:type>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079242706">
    <schema:keywords>azithromycin; ceftriaxone; glucocorticoid; lactate dehydrogenase; moxifloxacin; oseltamivir; adult; adult respiratory distress syndrome; aged; anorexia; antiviral therapy; Article; China; clinical feature; computer assisted tomography; Coronavirus disease 2019; Coronavirus infection; coughing; critically ill patient; disease transmission; dyspnea; extracorporeal oxygenation; fatigue; female; fever; follow up; health practitioner; heart arrhythmia; hospital admission; hospital infection; hospital patient; human; intensive care unit; lactate dehydrogenase blood level; length of stay; lymphocytopenia; major clinical study; male; mortality rate; noninvasive ventilation; oxygen therapy; priority journal; prothrombin time; retrospective study; risk factor; shock; virus pneumonia</schema:keywords>
    <myOnto:citeyBy>110</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>Importance: In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited. Objective: To describe the epidemiological and clinical characteristics of NCIP. Design, Setting, and Participants: Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University in Wuhan, China, from January 1 to January 28, 2020; final date of follow-up was February 3, 2020. Exposures: Documented NCIP. Main Outcomes and Measures: Epidemiological, demographic, clinical, laboratory, radiological, and treatment data were collected and analyzed. Outcomes of critically ill patients and noncritically ill patients were compared. Presumed hospital-related transmission was suspected if a cluster of health professionals or hospitalized patients in the same wards became infected and a possible source of infection could be tracked. Results: Of 138 hospitalized patients with NCIP, the median age was 56 years (interquartile range, 42-68; range, 22-92 years) and 75 (54.3%) were men. Hospital-associated transmission was suspected as the presumed mechanism of infection for affected health professionals (40 [29%]) and hospitalized patients (17 [12.3%]). Common symptoms included fever (136 [98.6%]), fatigue (96 [69.6%]), and dry cough (82 [59.4%]). Lymphopenia (lymphocyte count, 0.8 × 109/L [interquartile range {IQR}, 0.6-1.1]) occurred in 97 patients (70.3%), prolonged prothrombin time (13.0 seconds [IQR, 12.3-13.7]) in 80 patients (58%), and elevated lactate dehydrogenase (261 U/L [IQR, 182-403]) in 55 patients (39.9%). Chest computed tomographic scans showed bilateral patchy shadows or ground glass opacity in the lungs of all patients. Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]). Thirty-six patients (26.1%) were transferred to the intensive care unit (ICU) because of complications, including acute respiratory distress syndrome (22 [61.1%]), arrhythmia (16 [44.4%]), and shock (11 [30.6%]). The median time from first symptom to dyspnea was 5.0 days, to hospital admission was 7.0 days, and to ARDS was 8.0 days. Patients treated in the ICU (n = 36), compared with patients not treated in the ICU (n = 102), were older (median age, 66 years vs 51 years), were more likely to have underlying comorbidities (26 [72.2%] vs 38 [37.3%]), and were more likely to have dyspnea (23 [63.9%] vs 20 [19.6%]), and anorexia (24 [66.7%] vs 31 [30.4%]). Of the 36 cases in the ICU, 4 (11.1%) received high-flow oxygen therapy, 15 (41.7%) received noninvasive ventilation, and 17 (47.2%) received invasive ventilation (4 were switched to extracorporeal membrane oxygenation). As of February 3, 47 patients (34.1%) were discharged and 6 died (overall mortality, 4.3%), but the remaining patients are still hospitalized. Among those discharged alive (n = 47), the median hospital stay was 10 days (IQR, 7.0-14.0). Conclusions and Relevance: In this single-center case series of 138 hospitalized patients with confirmed NCIP in Wuhan, China, presumed hospital-related transmission of 2019-nCoV was suspected in 41% of patients, 26% of patients received ICU care, and mortality was 4.3%. © 2020 American Medical Association. All rights reserved.</rdfs:comment>
    <dc:date>2020</dc:date>
    <dc:creator>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z.</dc:creator>
    <j.0:identifier>10.1001/jama.2020.1585</j.0:identifier>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <myOnto:volume>323</myOnto:volume>
    <j.0:title>Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:identifier>2-s2.0-85079242706</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079242706&amp;doi=10.1001%2fjama.2020.1585&amp;partnerID=40&amp;md5=e00ade012dee7d014efde66de893d32d&gt;</schema:url>
    <myOnto:issue>11</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079848582">
    <myOnto:issue>2</myOnto:issue>
    <myOnto:volume>9</myOnto:volume>
    <j.0:identifier>2-s2.0-85079848582</j.0:identifier>
    <rdfs:comment>Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus’s reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <j.0:identifier>10.3390/pathogens9020148</j.0:identifier>
    <j.0:title>Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079848582&amp;doi=10.3390%2fpathogens9020148&amp;partnerID=40&amp;md5=45b599feb6124e8909ab3b88d3cf3753&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>angiotensin converting enzyme 2; biological product; monoclonal antibody; recombinant antigen; recombinant protein; viral protein; virus vaccine; virus vector; 2019 novel coronavirus; Article; communicable disease; coronavirus disease 2019; coughing; drug industry; dyspnea; epidemic; fever; gene expression system; human; immune response; incubation time; mortality; nonhuman; transient expression; virus transmission</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Pathogens"/>
    <dc:creator>Shanmugaraj B., Malla A., Phoolcharoen W.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082177276">
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85082177276</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/S0140-6736(20)30679-6</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Fisher D., Wilder-Smith A.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>The global community needs to swiftly ramp up the response to contain COVID-19</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082177276&amp;doi=10.1016%2fS0140-6736%2820%2930679-6&amp;partnerID=40&amp;md5=a2879efe11f01e50668ecbbf5b746547&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079815040">
    <myOnto:issue>3</myOnto:issue>
    <j.0:title>Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Nguyen T.M., Zhang Y., Pandolfi P.P.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>RNA; severe acute respiratory syndrome coronavirus 2; transcriptome; Betacoronavirus; clustered regularly interspaced short palindromic repeat; RNA virus; SARS coronavirus; Betacoronavirus; Clustered Regularly Interspaced Short Palindromic Repeats; RNA; RNA Viruses; SARS Virus; Transcriptome</schema:keywords>
    <myOnto:volume>30</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Research"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079815040&amp;doi=10.1038%2fs41422-020-0290-0&amp;partnerID=40&amp;md5=395a5b370f012a0106088dae44f52b46&gt;</schema:url>
    <j.0:identifier>10.1038/s41422-020-0290-0</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079815040</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080137864">
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1111/all.14238</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Allergy:_European_Journal_of_Allergy_and_Clinical_Immunology">
        <j.1:name>Allergy: European Journal of Allergy and Clinical Immunology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China</j.0:title>
    <rdfs:comment>Background: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2. Methods: Electronic medical records including demographics, clinical manifestation, comorbidities, laboratory data, and radiological materials of 140 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection, were extracted and analyzed. Results: An approximately 1:1 ratio of male (50.7%) and female COVID-19 patients was found, with an overall median age of 57.0 years. All patients were community-acquired cases. Fever (91.7%), cough (75.0%), fatigue (75.0%), and gastrointestinal symptoms (39.6%) were the most common clinical manifestations, whereas hypertension (30.0%) and diabetes mellitus (12.1%) were the most common comorbidities. Drug hypersensitivity (11.4%) and urticaria (1.4%) were self-reported by several patients. Asthma or other allergic diseases were not reported by any of the patients. Chronic obstructive pulmonary disease (COPD, 1.4%) patients and current smokers (1.4%) were rare. Bilateral ground-glass or patchy opacity (89.6%) was the most common sign of radiological finding. Lymphopenia (75.4%) and eosinopenia (52.9%) were observed in most patients. Blood eosinophil counts correlate positively with lymphocyte counts in severe (r =.486, P &lt;.001) and nonsevere (r =.469, P &lt;.001) patients after hospital admission. Significantly higher levels of D-dimer, C-reactive protein, and procalcitonin were associated with severe patients compared to nonsevere patients (all P &lt;.001). Conclusion: Detailed clinical investigation of 140 hospitalized COVID-19 cases suggests eosinopenia together with lymphopenia may be a potential indicator for diagnosis. Allergic diseases, asthma, and COPD are not risk factors for SARS-CoV-2 infection. Older age, high number of comorbidities, and more prominent laboratory abnormalities were associated with severe patients. © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85080137864</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <dc:creator>Zhang J.-J., Dong X., Cao Y.-Y., Yuan Y.-D., Yang Y.-B., Yan Y.-Q., Akdis C.A., Gao Y.-D.</dc:creator>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080137864&amp;doi=10.1111%2fall.14238&amp;partnerID=40&amp;md5=ea0367886c61eaead16de34a6e4f1ec5&gt;</schema:url>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085077914756">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077914756&amp;doi=10.1016%2fj.ijid.2020.01.009&amp;partnerID=40&amp;md5=c29edc58df18abb17abcf15bc9f12dd6&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>2-s2.0-85077914756</j.0:identifier>
    <j.0:identifier>10.1016/j.ijid.2020.01.009</j.0:identifier>
    <myOnto:citeyBy>46</myOnto:citeyBy>
    <dc:creator>Hui D.S., I Azhar E., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., Mchugh T.D., Memish Z.A., Drosten C., Zumla A., Petersen E.</dc:creator>
    <myOnto:volume>91</myOnto:volume>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>abdominal tumor; adult respiratory distress syndrome; case fatality rate; China; Coronavirus infection; coughing; dyspnea; Editorial; epidemic; fever; global health; human; leukopenia; liver cirrhosis; lymphocytopenia; malaise; Middle East respiratory syndrome; multiple organ failure; pneumonia; respiratory distress; respiratory failure; septic shock; severe acute respiratory syndrome; threat</schema:keywords>
    <j.0:title>The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China</j.0:title>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081587880">
    <j.0:identifier>2-s2.0-85081587880</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <dc:creator>Ong S.W.X., Tan Y.K., Chia P.Y., Lee T.H., Ng O.T., Wong M.S.Y., Marimuthu K.</dc:creator>
    <j.0:title>Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic Patient</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:identifier>10.1001/jama.2020.3227</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081587880&amp;doi=10.1001%2fjama.2020.3227&amp;partnerID=40&amp;md5=1a29fc03a58afb39be9f9af01dbac59a&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081691949">
    <j.0:type>Article</j.0:type>
    <j.0:title>Proposed protocol to keep COVID-19 out of hospitals</j.0:title>
    <j.0:identifier>2-s2.0-85081691949</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1503/cmaj.1095852</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081691949&amp;doi=10.1503%2fcmaj.1095852&amp;partnerID=40&amp;md5=f3aee91cf94df26ef2816e7267acdad0&gt;</schema:url>
    <schema:keywords>COVID-19; Canada; Coronavirus infection; cross infection; home care; hospital emergency service; human; infection control; paramedical personnel; procedures; professional standard; protective clothing; virus pneumonia; Allied Health Personnel; Canada; Coronavirus Infections; Cross Infection; Emergency Service, Hospital; Home Care Services; Humans; Infection Control; Pneumonia, Viral; Professional Role; Protective Clothing</schema:keywords>
    <dc:date>2020</dc:date>
    <dc:creator>Glauser W.</dc:creator>
    <myOnto:issue>10</myOnto:issue>
    <myOnto:volume>192</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/CMAJ_:_Canadian_Medical_Association_journal_=_journal_de_l&apos;Association_medicale_canadienne">
        <j.1:name>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080913753">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>395</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>The Lancet</dc:creator>
    <j.0:identifier>10.1016/S0140-6736(20)30522-5</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85080913753</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <myOnto:issue>10226</myOnto:issue>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>COVID-19: too little, too late?</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080913753&amp;doi=10.1016%2fS0140-6736%2820%2930522-5&amp;partnerID=40&amp;md5=6327b5b88158bf9129b44316f2e7b16c&gt;</schema:url>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; civil defense; Coronavirus infection; developing country; health care planning; human; politics; public health; public health service; virus pneumonia; Betacoronavirus; China; Civil Defense; Coronavirus Infections; Developed Countries; Health Planning; Humans; Pneumonia, Viral; Politics; Public Health; Public Health Administration</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078688052">
    <dc:creator>Eurosurveillance Editorial Team</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078688052&amp;doi=10.2807%2f1560-7917.ES.2020.25.3.2001231&amp;partnerID=40&amp;md5=36f32586f33db81826efe872588f3d53&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>China; classification; communicable disease; Coronavirinae; Coronavirus infection; epidemic; human; virology; China; Communicable Diseases, Emerging; Coronavirus; Coronavirus Infections; Disease Outbreaks; Humans</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85078688052</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:issue>3</myOnto:issue>
    <j.0:title>Note from the editors: novel coronavirus (2019-nCoV)</j.0:title>
    <myOnto:volume>25</myOnto:volume>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.3.2001231</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079905045">
    <myOnto:issue>3</myOnto:issue>
    <schema:keywords>2019 novel coronavirus; authority; China; decontamination; disease transmission; epidemic; global health; government; hospital; human; intensive care unit; Note; pneumonia; politics; preventive medicine; priority journal; public health; rapid response team; sanitation; sea food; travel</schema:keywords>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079905045&amp;doi=10.1016%2fS2468-2667%2820%2930030-X&amp;partnerID=40&amp;md5=89a3563e84bc0491f828f103d7744cd5&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079905045</j.0:identifier>
    <myOnto:volume>5</myOnto:volume>
    <j.0:title>Authoritarianism, outbreaks, and information politics</j.0:title>
    <dc:creator>Kavanagh M.M.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Public_Health"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/S2468-2667(20)30030-X</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082085668">
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>150</myOnto:volume>
    <j.0:identifier>2-s2.0-85082085668</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Swiss_medical_weekly">
        <j.1:name>Swiss medical weekly</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation</j.0:title>
    <rdfs:comment>Switzerland is among the countries with the highest number of coronavirus disease-2019 (COVID-19) cases per capita in the world. There are likely many people with undetected SARS-CoV-2 infection because testing efforts are currently not detecting all infected people, including some with clinical disease compatible with COVID-19. Testing on its own will not stop the spread of SARS-CoV-2. Testing is part of a strategy. The World Health Organization recommends a combination of measures: rapid diagnosis and immediate isolation of cases, rigorous tracking and precautionary self-isolation of close contacts. In this article, we explain why the testing strategy in Switzerland should be strengthened urgently, as a core component of a combination approach to control COVID-19.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082085668&amp;doi=10.4414%2fsmw.2020.20225&amp;partnerID=40&amp;md5=aa5cc76cc9ac3bc7ad2133c8442afd45&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.4414/smw.2020.20225</j.0:identifier>
    <dc:creator>Salathé M., Althaus C.L., Neher R., Stringhini S., Hodcroft E., Fellay J., Zwahlen M., Senti G., Battegay M., Wilder-Smith A., Eckerle I., Egger M., Low N.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082016518">
    <rdfs:comment>The recent outbreak of COVID-19 in Wuhan turned into a public health emergency of international concern. With no antiviral drugs nor vaccines, and the presence of carriers without obvious symptoms, traditional public health intervention measures are significantly less effective. Here, we report the epidemiological and virological characteristics of the COVID-19 outbreak. Originated in bats, 2019-nCoV/ severe acute respiratory syndrome coronavirus (SARS-CoV)-2 likely experienced adaptive evolution in intermediate hosts before transfer to humans at a concentrated source of transmission. Similarities of receptor sequence binding to 2019-nCoV between humans and animals suggest a low species barrier for transmission of the virus to farm animals. We propose, based on the One Health model, that veterinarians and animal specialists should be involved in a cross-disciplinary collaboration in the fight against this epidemic. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082016518</j.0:identifier>
    <j.0:title>COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.molmed.2020.02.008</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Sun J., He W.-T., Wang L., Lai A., Ji X., Zhai X., Li G., Suchard M.A., Tian J., Zhou J., Veit M., Su S.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Trends_in_Molecular_Medicine">
        <j.1:name>Trends in Molecular Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082016518&amp;doi=10.1016%2fj.molmed.2020.02.008&amp;partnerID=40&amp;md5=31b28db3ec32897914b5e2e0b60f9682&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082183078">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082183078&amp;doi=10.1016%2fS0140-6736%2820%2930559-6&amp;partnerID=40&amp;md5=d8b9e7bc02963bd5e7506eeb8425c0ec&gt;</schema:url>
    <dc:creator>Jacobsen K.H.</dc:creator>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>2-s2.0-85082183078</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:issue>10229</myOnto:issue>
    <j.0:title>Will COVID-19 generate global preparedness?</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30559-6</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081635230">
    <dc:creator>Xia W., Shao J., Guo Y., Peng X., Li Z., Hu D.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1002/ppul.24718</j.0:identifier>
    <j.0:title>Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081635230&amp;doi=10.1002%2fppul.24718&amp;partnerID=40&amp;md5=9d64c66128cbc9aea55906656beb099d&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Pediatric_Pulmonology"/>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081635230</j.0:identifier>
    <rdfs:comment>Purpose: To discuss the different characteristics of clinical, laboratory, and chest computed tomography (CT) in pediatric patients from adults with 2019 novel coronavirus (COVID-19) infection. Methods: The clinical, laboratory, and chest CT features of 20 pediatric inpatients with COVID-19 infection confirmed by pharyngeal swab COVID-19 nucleic acid test were retrospectively analyzed during 23 January and 8 February 2020. The clinical and laboratory information was obtained from inpatient records. All the patients were undergone chest CT in our hospital. Results: Thirteen pediatric patients (13/20, 65%) had an identified history of close contact with COVID-19 diagnosed family members. Fever (12/20, 60%) and cough (13/20, 65%) were the most common symptoms. For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. Coinfection (8/20, 40%) is common in pediatric patients. A total of 6 patients presented with unilateral pulmonary lesions (6/20, 30%), 10 with bilateral pulmonary lesions (10/20, 50%), and 4 cases showed no abnormality on chest CT (4/20, 20%). Consolidation with surrounding halo sign was observed in 10 patients (10/20, 50%), ground-glass opacities were observed in 12 patients (12/20, 60%), fine mesh shadow was observed in 4 patients (4/20, 20%), and tiny nodules were observed in 3 patients (3/20, 15%). Conclusion: Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults. It is suggested that underlying coinfection may be more common in pediatrics, and the consolidation with surrounding halo sign which is considered as a typical sign in pediatric patients. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081226128">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081226128&amp;doi=10.1016%2fj.phrs.2020.104743&amp;partnerID=40&amp;md5=97200bcb7b619851ef49302ae77e5ef8&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <dc:creator>Ren J.-L., Zhang A.-H., Wang X.-J.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pharmacological_Research">
        <j.1:name>Pharmacological Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Traditional Chinese medicine for COVID-19 treatment</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081226128</j.0:identifier>
    <myOnto:volume>155</myOnto:volume>
    <schema:keywords>Alismatis extract; antivirus agent; Armeniacae semen amarum extract; Asari extract; Asteris extract; Atractylodis macrocephalae extract; Aurantii fructus immaturus extract; Belamcandae extract; Bupleuri extract; Chinese medicinal formula; cinnamon extract; Citri reticulatae pericarpium extract; Dioscoreae extract; Ephedrae herba extract; Farfarae flos extract; gancaoganjiang; ginger extract; glycyrrhizae radix; Gypsum fibrosum extract; oseltamivir; Pinelliae extract; plant extract; Pogostemonis herba extract; Polyporus extract; Poria extract; qingfei paidu; qingfei touxie fuzheng; Scutellariae extract; sheganmahuang; unclassified drug; unindexed drug; acupuncture; Alismatis; antiviral activity; Armeniacae semen amarum; Asari; Asteris; Atractylodis macrocephalae; Aurantii fructus immaturus; Belamcandae; Bupleuri; China; Chinese medicine; cinnamon; Citri reticulatae pericarpium; clinical feature; computer assisted tomography; coronavirus disease 2019; Coronavirus infection; coughing; crackle; Dioscoreae; disease severity; drug efficacy; Ephedrae herba; Farfarae flos; fever; ginger; Glycyrrhiza; Gypsum fibrosum; human; image analysis; infection control; infection prevention; length of stay; Letter; medicinal plant; Pinelliae; pneumonia; Pogostemonis herba; Polyporus; Poria; priority journal; Scutellariae; thorax radiography; time to treatment; treatment response; virus replication</schema:keywords>
    <j.0:identifier>10.1016/j.phrs.2020.104743</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Academic Press</j.0:publisher>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082088826">
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082088826</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Since December 2019, 62 medical staff of Zhongnan Hospital in Wuhan, China have been hospitalised with coronavirus disease 2019. During the post-discharge surveillance after clinical recovery, swabs were positive in two asymptomatic cases (3.23%). Case 1 had presented typical clinical and radiological manifestations on admission, while manifestation in Case 2 was very mild. In conclusion, a small proportion of recovered patients may test positive after discharge, and post-discharge surveillance and isolation need to be strengthened.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <j.0:title>Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020</j.0:title>
    <myOnto:issue>10</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.10.2000191</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082088826&amp;doi=10.2807%2f1560-7917.ES.2020.25.10.2000191&amp;partnerID=40&amp;md5=dff66f784505665ef20508a17ef35184&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:volume>25</myOnto:volume>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; asymptomatic infection; Betacoronavirus; Coronavirus infection; disease transmission; female; genetics; hospital discharge; hospitalization; human; isolation and purification; male; pharynx; predictive value; radiography; real time polymerase chain reaction; virology; virus pneumonia; x-ray computed tomography; Adult; Asymptomatic Infections; Betacoronavirus; Coronavirus Infections; Female; Hospitalization; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Patient Discharge; Pharynx; Pneumonia, Viral; Predictive Value of Tests; Radiography; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed</schema:keywords>
    <dc:creator>Xing Y., Mo P., Xiao Y., Zhao O., Zhang Y., Wang F.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081727104">
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Taylor and Francis Ltd</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>In December 2019, a novel coronavirus (CoV) epidemic, caused by the severe acute respiratory syndrome coronavirus–2 (SARS-CoV-2) emerged from China. This virus causes the coronavirus disease 2019 (COVID-19). Since then, there have been anecdotal reports of ocular infection. The ocular implications of human CoV infections have not been widely studied. However, CoVs have been known to cause various ocular infections in animals. Clinical entities such as conjunctivitis, anterior uveitis, retinitis, and optic neuritis have been documented in feline and murine models. In this article, the current evidence suggesting possible human CoV infection of ocular tissue is reviewed. The review article will also highlight animal CoVs and their associated ocular infections. We hope that this article will serve as a start for further research into the ocular implications of human CoV infections. © 2020, © 2020 Taylor &amp; Francis Group, LLC.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Ocular_Immunology_and_Inflammation">
        <j.1:name>Ocular Immunology and Inflammation</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1080/09273948.2020.1738501</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081727104&amp;doi=10.1080%2f09273948.2020.1738501&amp;partnerID=40&amp;md5=3e5b41d9bbfb94d3fc7645e10d6a78c5&gt;</schema:url>
    <j.0:title>Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Seah I., Agrawal R.</dc:creator>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85081727104</j.0:identifier>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079496754">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:title>Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients [Directives concrètes à l’intention des équipes de soins intensifs et d’anesthésiologie prenant soin de patients atteints du coronavirus 2019-nCoV]</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Canadian_Journal_of_Anesthesia"/>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85079496754</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>7</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>A global health emergency has been declared by the World Health Organization as the 2019-nCoV outbreak spreads across the world, with confirmed patients in Canada. Patients infected with 2019-nCoV are at risk for developing respiratory failure and requiring admission to critical care units. While providing optimal treatment for these patients, careful execution of infection control measures is necessary to prevent nosocomial transmission to other patients and to healthcare workers providing care. Although the exact mechanisms of transmission are currently unclear, human-to-human transmission can occur, and the risk of airborne spread during aerosol-generating medical procedures remains a concern in specific circumstances. This paper summarizes important considerations regarding patient screening, environmental controls, personal protective equipment, resuscitation measures (including intubation), and critical care unit operations planning as we prepare for the possibility of new imported cases or local outbreaks of 2019-nCoV. Although understanding of the 2019-nCoV virus is evolving, lessons learned from prior infectious disease challenges such as Severe Acute Respiratory Syndrome will hopefully improve our state of readiness regardless of the number of cases we eventually manage in Canada. © 2020, Canadian Anesthesiologists' Society.</rdfs:comment>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079496754&amp;doi=10.1007%2fs12630-020-01591-x&amp;partnerID=40&amp;md5=7daf22ee152c1be95eb3bc2c89d2debc&gt;</schema:url>
    <j.0:identifier>10.1007/s12630-020-01591-x</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:creator>Wax R.S., Christian M.D.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081117620">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1016/S0140-6736(20)30466-9</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:creator>Ebrahim S.H., Memish Z.A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>10227</myOnto:issue>
    <myOnto:volume>395</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081117620&amp;doi=10.1016%2fS0140-6736%2820%2930466-9&amp;partnerID=40&amp;md5=7beb6887f000cfb5d6366368ae208bd5&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081117620</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords>asymptomatic infection; Coronavirinae; coronavirus disease 2019; Coronavirus infection; counseling; epidemic; exposure; hand washing; health service; human; Letter; Muslim; nonhuman; pneumonia; priority journal; prophylaxis; Saudi Arabia; severe acute respiratory syndrome coronavirus 2; virus transmission</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080982357">
    <j.0:identifier>2-s2.0-85080982357</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Disease_Modelling"/>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080982357&amp;doi=10.1016%2fj.idm.2020.02.003&amp;partnerID=40&amp;md5=a427eed527529e1daa0e70ccb9db3d6b&gt;</schema:url>
    <j.0:identifier>10.1016/j.idm.2020.02.003</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020</j.0:title>
    <myOnto:volume>5</myOnto:volume>
    <dc:creator>Mizumoto K., Chowell G.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>KeAi Communications Co.</j.0:publisher>
    <schema:keywords>2019 novel coronavirus; adolescent; adult; Article; child; China; coronavirus disease 2019; Coronavirus infection; disease transmission; epidemic; government; human; incidence; infant; Japan; newborn; polymerase chain reaction; public health; ship</schema:keywords>
    <rdfs:comment>An outbreak of COVID-19 developed aboard the Princess Cruises Ship during January–February 2020. Using mathematical modeling and time-series incidence data describing the trajectory of the outbreak among passengers and crew members, we characterize how the transmission potential varied over the course of the outbreak. Our estimate of the mean reproduction number in the confined setting reached values as high as ~11, which is higher than mean estimates reported from community-level transmission dynamics in China and Singapore (approximate range: 1.1–7). Our findings suggest that Rt decreased substantially compared to values during the early phase after the Japanese government implemented an enhanced quarantine control. Most recent estimates of Rt reached values largely below the epidemic threshold, indicating that a secondary outbreak of the novel coronavirus was unlikely to occur aboard the Diamond Princess Ship. © 2020 The Authors</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081905548">
    <j.0:identifier>2-s2.0-85081905548</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Cardiothoracic_and_Vascular_Anesthesia">
        <j.1:name>Journal of Cardiothoracic and Vascular Anesthesia</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:title>Anesthetic Management of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection During Emergency Procedures</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>W.B. Saunders</j.0:publisher>
    <j.0:identifier>10.1053/j.jvca.2020.02.039</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <rdfs:comment>Objectives: The aim of the present study was to prevent cross-infection in the operating room during emergency procedures for patients with confirmed or suspected 2019 novel coronavirus (2019-nCoV) by following anesthesia management protocols, and to document clinical- and anesthesia-related characteristics of these patients. Design: This was a retrospective, multicenter clinical study. Setting: This study used a multicenter dataset from 4 hospitals in Wuhan, China. Participants: Patients and health care providers with confirmed or suspected 2019-nCoV from January 23 to 31, 2020, at the Wuhan Union Hospital, the Wuhan Children's Hospital, The Central Hospital of Wuhan, and the Wuhan Fourth Hospital in Wuhan, China. Interventions: Anesthetic management and infection control guidelines for emergency procedures for patients with suspected 2019-nCoV were drafted and applied in 4 hospitals in Wuhan. Measurements and Main Results: Cross-infection in the operating rooms of the 4 hospitals was effectively reduced by implementing the new measures and procedures. The majority of patients with laboratory-confirmed 2019-nCoV infection or suspected infection were female (23 [62%] of 37), and the mean age was 41.0 years old (standard deviation 19.6; range 4-78). 10 (27%) patients had chronic medical illnesses, including 4 (11%) with diabetes, 8 (22%) with hypertension, and 8 (22%) with digestive system disease. Twenty-five (68%) patients presented with lymphopenia, and 23 (62%) patients exhibited multiple mottling and ground-glass opacity on computed tomography scanning. Conclusions: The present study indicates that COVID 19–specific guidelines for emergency procedures for patients with confirmed or suspected 2019-nCoV may effectively prevent cross-infection in the operating room. Most patients with confirmed or suspected COVID 19 presented with fever and dry cough and demonstrated bilateral multiple mottling and ground-glass opacity on chest computed tomography scans. © 2020 Elsevier Inc.</rdfs:comment>
    <dc:creator>Zhao S., Ling K., Yan H., Zhong L., Peng X., Yao S., Huang J., Chen X.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081905548&amp;doi=10.1053%2fj.jvca.2020.02.039&amp;partnerID=40&amp;md5=e3169f5fb91d2e1abdc2828cf93cf66e&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081626097">
    <myOnto:volume>579</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:identifier>10.1038/s41586-020-2008-3</j.0:identifier>
    <j.0:identifier>2-s2.0-85081626097</j.0:identifier>
    <rdfs:comment>Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health1–3. Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing4 of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here ‘WH-Human 1’ coronavirus (and has also been referred to as ‘2019-nCoV’). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China5. This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans. © 2020, The Author(s).</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>7798</myOnto:issue>
    <schema:keywords>antibiotic agent; antivirus agent; aspartate aminotransferase; creatine kinase; genomic RNA; glucocorticoid; lactate dehydrogenase; nucleotide; virus RNA; COVID-19; severe acute respiratory syndrome coronavirus 2; virus RNA; disease prevalence; epidemiology; genome; hospital sector; infectious disease; phylogenetics; public health; respiratory disease; severe acute respiratory syndrome; uncertainty analysis; virus; adult; arterial gas; Article; Betacoronavirus; bronchoalveolar lavage fluid; case report; chest tightness; China; clinical article; computer assisted tomography; Coronaviridae; coronavirus disease 2019; Coronavirus infection; coughing; diabetes mellitus; disease severity; dizziness; fever; hepatitis; hospital admission; human; human cell; hypoxemia; male; metagenomics; nonhuman; noninvasive ventilation; nucleotide sequence; pain; phylogeny; physical examination; priority journal; real time polymerase chain reaction; respiratory failure; reverse transcription polymerase chain reaction; RNA extraction; RNA sequencing; RNA virus; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; thorax radiography; tuberculosis; virus genome; virus identification; virus isolation; virus strain; weakness; classification; communicable disease; complication; Coronavirus infection; diagnostic imaging; genetic recombination; genetics; lung; pathology; severe acute respiratory syndrome; virology; virus pneumonia; whole genome sequencing; x-ray computed tomography; China; Hubei; Wuhan; Animalia; Coronaviridae; Coronavirus; RNA viruses; Zika virus; Adult; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Genome, Viral; Humans; Lung; Male; Phylogeny; Pneumonia, Viral; Recombination, Genetic; RNA, Viral; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Whole Genome Sequencing</schema:keywords>
    <myOnto:citeyBy>36</myOnto:citeyBy>
    <j.0:title>A new coronavirus associated with human respiratory disease in China</j.0:title>
    <j.0:publisher>Nature Research</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081626097&amp;doi=10.1038%2fs41586-020-2008-3&amp;partnerID=40&amp;md5=689f9f91591479535c9b2ce43850804c&gt;</schema:url>
    <dc:creator>Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y., Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080899340">
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:title>Uncertainties about the transmission routes of 2019 novel coronavirus</j.0:title>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Han Q., Lin Q., Ni Z., You L.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Influenza_and_other_Respiratory_Viruses">
        <j.1:name>Influenza and other Respiratory Viruses</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080899340&amp;doi=10.1111%2firv.12735&amp;partnerID=40&amp;md5=6d21648e9f0c871b188081b6674dc7f1&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1111/irv.12735</j.0:identifier>
    <j.0:identifier>2-s2.0-85080899340</j.0:identifier>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082055176">
    <schema:keywords>COVID-19; China; colorectal surgery; colorectal tumor; complication; Coronavirus infection; epidemic; human; laparoscopy; virus pneumonia; China; Colorectal Neoplasms; Colorectal Surgery; Coronavirus Infections; Disease Outbreaks; Humans; Laparoscopy; Pneumonia, Viral</schema:keywords>
    <rdfs:comment>?2019?12??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????.Pneumonia caused by 2019-nCoV infection has been reported in Wuhan since December 2019, and spread rapidly across the country. The radical operation of colorectal cancer is semi-elective operation. Patients with colorectal cancer should receive operation as soon as possible after elective operation is resumed in each hospital. 2019-nCoV virus can be transmitted by asymptomatic infectors, and it has been confirmed to be transmitted by droplets and contact. However, fecal-oral transmission and aerosol transmission have not been excluded. Based on our experience with laparoscopic colorectal operation, we propose some surgery strategies for colorectal cancer patients under the corona virus disease 2019(COVID-19) situation: the screening process should be strictly carried out before surgery to reduce the risk of nosocomial infection in the later stage; laparoscopic-assisted surgery is recommended for radical surgery for patients with colorectal cancer; strict aerosol management must be made during the operation; natural orifice specimen extraction surgery and transanal total mesorectal excision are should be performed prudently; scientific and reasonable prophylactic stoma should be done; personnel protection in surgical ward and operation room must be strengthened.</rdfs:comment>
    <j.0:title>Several suggestions of operation for colorectal cancer under the outbreak of corona virus disease 2019 in China</j.0:title>
    <dc:creator>Yu G.Y., Lou Z., Zhang W.</dc:creator>
    <j.0:identifier>10.3760/cma.j.cn.441530-20200224-00074</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:language>Chinese</dc:language>
    <j.0:identifier>2-s2.0-85082055176</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082055176&amp;doi=10.3760%2fcma.j.cn.441530-20200224-00074&amp;partnerID=40&amp;md5=6592cac1cc0ee1a7454291af50dc1521&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhonghua_wei_chang_wai_ke_za_zhi_=_Chinese_journal_of_gastrointestinal_surgery"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>23</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080999501">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak</j.0:title>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Petersen E., Hui D., Hamer D.H., Blumberg L., Madoff L.C., Pollack M., Lee S.S., McLellan S., Memish Z., Praharaj I., Wasserman S., Ntoumi F., Azhar E.I., Mchugh T.D., Kock R., Ippolito G., Zumla A., Koopmans M.</dc:creator>
    <schema:keywords>2019 novel Coronavirus; China; Coronavirinae; Coronavirus infection; Editorial; epidemic; health care personnel; high throughput sequencing; human; infection control; laboratory diagnosis; occupational hazard; physician</schema:keywords>
    <j.0:identifier>10.1016/j.ijid.2020.02.052</j.0:identifier>
    <myOnto:volume>93</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080999501</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080999501&amp;doi=10.1016%2fj.ijid.2020.02.052&amp;partnerID=40&amp;md5=0992cd051c923177fb5f47cce1341124&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079863367">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079863367&amp;doi=10.1016%2fj.meegid.2020.104260&amp;partnerID=40&amp;md5=23b9b8c5de23c7213b2351132513f0d7&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>COVID-19 is a viral respiratory illness caused by a new coronavirus called SARS-CoV-2. The World Health Organization declared the SARS-CoV-2 outbreak a global public health emergency. We performed genetic analyses of eighty-six complete or near-complete genomes of SARS-CoV-2 and revealed many mutations and deletions on coding and non-coding regions. These observations provided evidence of the genetic diversity and rapid evolution of this novel coronavirus. © 2020 Elsevier B.V.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>81</myOnto:volume>
    <j.0:title>Genetic diversity and evolution of SARS-CoV-2</j.0:title>
    <j.0:identifier>10.1016/j.meegid.2020.104260</j.0:identifier>
    <dc:creator>Phan T.</dc:creator>
    <schema:keywords>article; gene deletion; genetic analysis; genetic variability; nonhuman; SARS coronavirus</schema:keywords>
    <j.0:identifier>2-s2.0-85079863367</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection,_Genetics_and_Evolution"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081600081">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Osong_Public_Health_and_Research_Perspectives"/>
    <schema:keywords>2019 novel coronavirus; China; clinical effectiveness; Coronavirinae; Coronavirus infection; Editorial; epidemic; high throughput sequencing; human; Middle East respiratory syndrome; priority journal; public health; real time reverse transcription polymerase chain reaction; South Korea</schema:keywords>
    <j.0:identifier>10.24171/j.phrp.2020.11.1.01</j.0:identifier>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081600081</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Effectiveness for the response to CoviD-19: The MERS outbreak containment procedures</j.0:title>
    <j.0:publisher>Korea Centers for Disease Control and Prevention</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Cho H.-W.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081600081&amp;doi=10.24171%2fj.phrp.2020.11.1.01&amp;partnerID=40&amp;md5=78ba7e753941f233f7f17a56a9fedb6f&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080095327">
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>3</myOnto:issue>
    <dc:creator>Zhang J., Zhou L., Yang Y., Peng W., Wang W., Chen X.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080095327</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:title>Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics</j.0:title>
    <schema:keywords>amoxicillin; antivirus agent; arbidol; azithromycin; C reactive protein; dexamethasone; levofloxacin; linezolid; methylprednisolone; moxifloxacin; nemonoxacin; oxygen; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; anesthesiological procedure; antiviral therapy; blood cell count; body temperature measurement; China; clinical decision making; community acquired pneumonia; consultation; Coronavirinae; differential diagnosis; drug megadose; dyspnea; emergency health service; epidemic; fever; general practitioner; ground glass opacity; health care personnel; home care; hospital admission; hospital care; hospital discharge; host resistance; human; hypoxemia; hypoxia; immunocompromised patient; immunopathology; in vitro study; influenza; Letter; life threat; lung lesion; lymphocyte count; lymphocytopenia; methicillin resistant Staphylococcus aureus infection; Middle East respiratory syndrome; mixed infection; obstetrician; oxygen saturation; patient isolation; pneumococcal infection; pneumonia; positive end expiratory pressure; practice guideline; pregnancy termination; pregnant woman; prescription; priority journal; public health; respiratory syncytial virus infection; SARS coronavirus; SARS coronavirus 2; severe acute respiratory syndrome; Staphylococcus aureus; Staphylococcus aureus infection; Streptococcus pneumoniae; therapy effect; thorax radiography; virus pneumonia; Betacoronavirus; Coronavirus infection; emergency health service; Betacoronavirus; China; Coronavirus; Coronavirus Infections; Humans; Triage</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:volume>8</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080095327&amp;doi=10.1016%2fS2213-2600%2820%2930071-0&amp;partnerID=40&amp;md5=0bccbd1b4277cef53b31f7c3f0bc4e88&gt;</schema:url>
    <j.0:identifier>10.1016/S2213-2600(20)30071-0</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079331395">
    <j.0:title>Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>COVID-19; China; Coronavirus infection; emergency; global health; human; international cooperation; public health; risk assessment; virus pneumonia; World Health Organization; China; Coronavirus Infections; Emergencies; Global Health; Humans; International Cooperation; Pneumonia, Viral; Public Health; Risk Assessment; World Health Organization</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Eurosurveillance Editorial Team</dc:creator>
    <j.0:identifier>2-s2.0-85079331395</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079331395&amp;doi=10.2807%2f1560-7917.ES.2020.25.5.200131e&amp;partnerID=40&amp;md5=25a44ae3c7cfa3882f804dd74272bd6a&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.5.200131e</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:volume>25</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:issue>5</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081076439">
    <j.0:identifier>10.1136/bmj.m792</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>368</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081076439&amp;doi=10.1136%2fbmj.m792&amp;partnerID=40&amp;md5=701dbd88c2b7cca81bb5d28386ecf00e&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:type>Erratum</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Erratum: Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series (The BMJ (2020) 368 (m606) DOI:10.1136/bmj.m606)</j.0:title>
    <rdfs:comment>The number and percentage of male patients should have been 35 (56%) under the heading All patients and 16 (55%) under the heading Time since symptom onset =10 days in table 1 and in the results. The number and percentage of patients with fever should have been 24 (73%) under the heading Time since symptom onset &gt;10 days and 24 (83%) under the heading Time since symptom onset =10 days in table 1 and in the results. The exposure history heading in the left column of table 1 should have read Exposure history in Wuhan &gt;2 weeks. Table 2 should have stated creatinine instead of creatine throughout. In the methods, the second paragraph of the Laboratory confirmation and treatment section should state that the dosage of arbidol should have read 200 mg three times daily. The paper will be updated in due course. © 2020 BMJ Publishing Group. All rights reserved.</rdfs:comment>
    <schema:keywords>erratum</schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85081076439</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079894245">
    <schema:keywords>C reactive protein; glucose; virus DNA; COVID-19; 2019 novel coronavirus; adult; Article; aspartate aminotransferase blood level; case report; clinical article; computer assisted tomography; coronavirus disease 2019; coughing; fever; gene amplification; human; hyperglycemia; lymphocyte count; male; neutrophil count; physical examination; real time polymerase chain reaction; reverse transcription polymerase chain reaction; sputum analysis; throat disease; virus pneumonia; bronchus; China; Coronavirus infection; diagnostic imaging; epidemic; fever; lung; pathology; procedures; thorax radiography; virus pneumonia; World Health Organization; x-ray computed tomography; Adult; Bronchi; China; Coronavirus Infections; Disease Outbreaks; Fever; Humans; Lung; Male; Pneumonia, Viral; Radiography, Thoracic; Tomography, X-Ray Computed; World Health Organization</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <j.0:identifier>10.3348/kjr.2020.0078</j.0:identifier>
    <myOnto:volume>21</myOnto:volume>
    <rdfs:comment>Since the 2019 novel coronavirus (2019-nCoV or officially named by the World Health Organization as COVID-19) outbreak in Wuhan, Hubei Province, China in 2019, there have been a few reports of its imaging findings. Here, we report two confirmed cases of 2019-nCoV pneumonia with chest computed tomography findings of multiple regions of patchy consolidation and ground-glass opacities in both lungs. These findings were characteristically located along the bronchial bundle or subpleural lungs. © 2020 The Korean Society of Radiology.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079894245</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Korean Radiological Society</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Korean_Journal_of_Radiology"/>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Novel coronavirus pneumonia outbreak in 2019: Computed tomographic findings in two cases</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079894245&amp;doi=10.3348%2fkjr.2020.0078&amp;partnerID=40&amp;md5=26d03625a546a20c01934d0c5f6e6909&gt;</schema:url>
    <myOnto:issue>3</myOnto:issue>
    <dc:creator>Lin X., Gong Z., Xiao Z., Xiong J., Fan B., Liu J.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081627160">
    <j.0:identifier>10.1007/s00134-020-05977-9</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081627160&amp;doi=10.1007%2fs00134-020-05977-9&amp;partnerID=40&amp;md5=3f6c77a063630c3bccbe55cb050e42f9&gt;</schema:url>
    <j.0:publisher>Springer</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081627160</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <dc:date>2020</dc:date>
    <j.0:title>The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Zhang S., Diao M.Y., Duan L., Lin Z., Chen D.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078688163">
    <j.0:identifier>2-s2.0-85078688163</j.0:identifier>
    <dc:creator>Rubin G.J., Wessely S.</dc:creator>
    <j.0:title>The psychological effects of quarantining a city</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m313</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_BMJ"/>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <schema:keywords>2019 novel coronavirus; anxiety; China; Coronavirinae; Coronavirus infection; epidemic; health belief; health hazard; hospital; human; hysteria; incidence; low risk patient; medical information; mental health; nonhuman; panic; priority journal; psychological aspect; quarantine; Short Survey</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078688163&amp;doi=10.1136%2fbmj.m313&amp;partnerID=40&amp;md5=16587b29507ec9fc4511c6e043204aca&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>368</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:type>Short Survey</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078228768">
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85078228768</j.0:identifier>
    <rdfs:comment>The recently emerged coronavirus in Wuhan, China has claimed at least two lives as of January 17 and infected hundreds if not thousands of individuals. The situation has drawn international attention, including from the virology community. We applaud the rapid release to the public of the genome sequence of the new virus by Chinese virologists, but we also believe that increased transparency on disease reporting and data sharing with international colleagues are crucial for curbing the spread of this newly emerging virus to other parts of the world.</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Viruses"/>
    <j.0:identifier>10.3390/v12020130</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:issue>2</myOnto:issue>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; communicable disease; Coronavirus infection; genetics; human; information dissemination; international cooperation; virology; virus genome; virus pneumonia; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Genome, Viral; Humans; Information Dissemination; International Cooperation; Pneumonia, Viral</schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>12</myOnto:volume>
    <j.0:title>Emerging Viruses without Borders: The Wuhan Coronavirus</j.0:title>
    <dc:creator>Liu S.-L., Saif L.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078228768&amp;doi=10.3390%2fv12020130&amp;partnerID=40&amp;md5=f220a4156bb63b04a824291f153b8d15&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079361955">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>Gag protein; virus glycoprotein; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; biological warfare agent; Coronavirinae; gene insertion sequence; genetic manipulation; genetic similarity; host cell; human; Human immunodeficiency virus 1; nonhuman; Note; phylogeny; priority journal; protein structure; sequence database; virus genome; virus strain; animal; Betacoronavirus; Coronavirus infection; genetic database; genetics; Human immunodeficiency virus 1; virus pneumonia; Animals; Betacoronavirus; Coronavirus Infections; Databases, Genetic; Genome, Viral; HIV-1; Humans; Phylogeny; Pneumonia, Viral</schema:keywords>
    <j.0:identifier>10.1080/22221751.2020.1727299</j.0:identifier>
    <myOnto:volume>9</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <j.0:identifier>2-s2.0-85079361955</j.0:identifier>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079361955&amp;doi=10.1080%2f22221751.2020.1727299&amp;partnerID=40&amp;md5=dfd3094d9b3f695880d8e041a560680c&gt;</schema:url>
    <j.0:title>HIV-1 did not contribute to the 2019-nCoV genome</j.0:title>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Xiao C., Li X., Liu S., Sang Y., Gao S.-J., Gao F.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082066665">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082066665&amp;doi=10.1136%2fbmj.m1140&amp;partnerID=40&amp;md5=c733e7813a6941e9c93d395badd73919&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082066665</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Covid-19: schools set to close across UK except for children of health and social care workers</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <myOnto:volume>368</myOnto:volume>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1136/bmj.m1140</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081679428">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>8</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Global_Health"/>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Potential association between COVID-19 mortality and health-care resource availability</j.0:title>
    <j.0:identifier>10.1016/S2214-109X(20)30068-1</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; China; coronavirus disease 2019; disease association; disease burden; disease control; epidemic; government; health care availability; health care personnel; human; incidence; Letter; mortality; mortality rate; priority journal; treatment outcome</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081679428&amp;doi=10.1016%2fS2214-109X%2820%2930068-1&amp;partnerID=40&amp;md5=32af3dc1a17896e1a51bfca210a155b5&gt;</schema:url>
    <dc:creator>Ji Y., Ma Z., Peppelenbosch M.P., Pan Q.</dc:creator>
    <j.0:identifier>2-s2.0-85081679428</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082028740">
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <dc:creator>Wang C., Liu Z., Chen Z., Huang X., Xu M., He T., Zhang Z.</dc:creator>
    <j.0:identifier>10.1002/jmv.25762</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082028740</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082028740&amp;doi=10.1002%2fjmv.25762&amp;partnerID=40&amp;md5=94714c3253c5f324b09e3bd78efe88df&gt;</schema:url>
    <rdfs:comment>Starting around December 2019, an epidemic of pneumonia, which was named COVID-19 by the World Health Organization, broke out in Wuhan, China, and is spreading throughout the world. A new coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses was soon found to be the cause. At present, the sensitivity of clinical nucleic acid detection is limited, and it is still unclear whether it is related to genetic variation. In this study, we retrieved 95 full-length genomic sequences of SARAS-CoV-2 strains from the National Center for Biotechnology Information and GISAID databases, established the reference sequence by conducting multiple sequence alignment and phylogenetic analyses, and analyzed sequence variations along the SARS-CoV-2 genome. The homology among all viral strains was generally high, among them, 99.99% (99.91%-100%) at the nucleotide level and 99.99% (99.79%-100%) at the amino acid level. Although overall variation in open-reading frame (ORF) regions is low, 13 variation sites in 1a, 1b, S, 3a, M, 8, and N regions were identified, among which positions nt28144 in ORF 8 and nt8782 in ORF 1a showed mutation rate of 30.53% (29/95) and 29.47% (28/95), respectively. These findings suggested that there may be selective mutations in SARS-COV-2, and it is necessary to avoid certain regions when designing primers and probes. Establishment of the reference sequence for SARS-CoV-2 could benefit not only biological study of this virus but also diagnosis, clinical monitoring and intervention of SARS-CoV-2 infection in the future. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:title>The establishment of reference sequence for SARS-CoV-2 and variation analysis</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082033605">
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <j.0:identifier>10.1017/ice.2020.62</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Diao M., Zhang S., Chen D., Hu W.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <j.0:title>The novel coronavirus (COVID-19) infection in Hangzhou: An experience to share</j.0:title>
    <j.0:identifier>2-s2.0-85082033605</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082033605&amp;doi=10.1017%2fice.2020.62&amp;partnerID=40&amp;md5=f129ebff09ff1992251b18f694cfbce0&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082033738">
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082033738&amp;doi=10.1017%2fice.2020.81&amp;partnerID=40&amp;md5=21ac030522a43309c0e22d0227ae7e83&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082033738</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and non-travelers: The need of a longer quarantine period</j.0:title>
    <dc:creator>Leung C.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
    <schema:keywords>article; controlled study; human; incubation time; nonhuman; quarantine; SARS coronavirus; travel</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Data collected from the individual cases reported by the media were used to estimate the distribution of the incubation period of travelers to Hubei and non-travelers. Upon the finding of longer and more volatile incubation period in travelers, the duration of quarantine should be extended to three weeks. © 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1017/ice.2020.81</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081138742">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/S0140-6736(20)30464-5</j.0:identifier>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>10227</myOnto:issue>
    <schema:keywords>Africa; air transportation; clinical protocol; coronavirus disease 2019; Coronavirus infection; high risk population; human; infection control; infection risk; Note; pandemic; priority journal; quarantine; social aspects and related phenomena; social distancing; social interaction; anxiety; Betacoronavirus; severe acute respiratory syndrome coronavirus 2; Africa; Anxiety; Betacoronavirus; Humans; Infections</schema:keywords>
    <j.0:identifier>2-s2.0-85081138742</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081138742&amp;doi=10.1016%2fS0140-6736%2820%2930464-5&amp;partnerID=40&amp;md5=a4f511882825a8d6fade604ff53cddb2&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Looming threat of COVID-19 infection in Africa: act collectively, and fast</j.0:title>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <dc:creator>Nkengasong J.N., Mankoula W.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081042444">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai</j.0:title>
    <j.0:identifier>2-s2.0-85081042444</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; epidemiology; human; internal medicine; isolation and purification; physician; practice guideline; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Humans; Internal Medicine; Physicians; Pneumonia, Viral; Practice Guidelines as Topic</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Swiss_medical_weekly"/>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>150</myOnto:volume>
    <j.0:identifier>10.4414/smw.2020.20216</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081042444&amp;doi=10.4414%2fsmw.2020.20216&amp;partnerID=40&amp;md5=c45cf638dd0c5fe04465e351ca066d06&gt;</schema:url>
    <dc:creator>Bischof E., Chen G., Ferretti M.T.</dc:creator>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081151582">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>4</myOnto:volume>
    <j.0:identifier>10.1016/S2542-5196(20)30032-2</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>2-s2.0-85081151582</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081151582&amp;doi=10.1016%2fS2542-5196%2820%2930032-2&amp;partnerID=40&amp;md5=fc3230e89c4ef71b36abbac9808a3f3e&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Planetary_Health"/>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <dc:creator>Ji J.S.</dc:creator>
    <j.0:title>Origins of MERS-CoV, and lessons for 2019-nCoV</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080070481">
    <myOnto:issue>2</myOnto:issue>
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:volume>22</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <rdfs:comment>One of the most perplexing questions regarding the current COVID-19 coronavirus epidemic is the discrepancy between the severity of cases observed in the Hubei province of China and those occurring elsewhere in the world. One possible answer is antibody dependent enhancement (ADE) of SARS-CoV-2 due to prior exposure to other coronaviruses. ADE modulates the immune response and can elicit sustained inflammation, lymphopenia, and/or cytokine storm, one or all of which have been documented in severe cases and deaths. ADE also requires prior exposure to similar antigenic epitopes, presumably circulating in local viruses, making it a possible explanation for the observed geographic limitation of severe cases and deaths. © 2020 Institut Pasteur</rdfs:comment>
    <j.0:identifier>2-s2.0-85080070481</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Microbes_and_Infection"/>
    <schema:keywords>epitope; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; adult respiratory distress syndrome; antibody dependent enhancement; Article; Coronavirinae; Coronavirus infection; cytokine storm; epidemic; immune response; priority journal; SARS coronavirus; seroconversion; seroprevalence; Betacoronavirus; China; epidemiology; human; immunology; medical geography; mortality; pandemic; pathogenicity; pathology; virus pneumonia; Antibody-Dependent Enhancement; Betacoronavirus; China; Coronavirus Infections; Geography, Medical; Humans; Pandemics; Pneumonia, Viral</schema:keywords>
    <j.0:identifier>10.1016/j.micinf.2020.02.006</j.0:identifier>
    <j.0:title>Is COVID-19 receiving ADE from other coronaviruses?</j.0:title>
    <j.0:type>Article</j.0:type>
    <dc:creator>Tetro J.A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080070481&amp;doi=10.1016%2fj.micinf.2020.02.006&amp;partnerID=40&amp;md5=f6e8144f574092359979a220c6ad1c76&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081254175">
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>2-s2.0-85081254175</j.0:identifier>
    <dc:creator>Del Rio C., Malani P.N.</dc:creator>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1001/jama.2020.3072</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081254175&amp;doi=10.1001%2fjama.2020.3072&amp;partnerID=40&amp;md5=0a269006f90fd3c368917c4223c623c1&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>COVID-19-New Insights on a Rapidly Changing Epidemic</j.0:title>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080892225">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:type>Article</j.0:type>
    <j.0:title>Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Bhattacharya M., Sharma A.R., Patra P., Ghosh P., Sharma G., Patra B.C., Lee S.-S., Chakraborty C.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080892225&amp;doi=10.1002%2fjmv.25736&amp;partnerID=40&amp;md5=2d404f639a9bec1be7a59112d6a404bc&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85080892225</j.0:identifier>
    <rdfs:comment>Recently, a novel coronavirus (SARS-COV-2) emerged which is responsible for the recent outbreak in Wuhan, China. Genetically, it is closely related to SARS-CoV and MERS-CoV. The situation is getting worse and worse, therefore, there is an urgent need for designing a suitable peptide vaccine component against the SARS-COV-2. Here, we characterized spike glycoprotein to obtain immunogenic epitopes. Next, we chose 13 Major Histocompatibility Complex-(MHC) I and 3 MHC-II epitopes, having antigenic properties. These epitopes are usually linked to specific linkers to build vaccine components and molecularly dock on toll-like receptor-5 to get binding affinity. Therefore, to provide a fast immunogenic profile of these epitopes, we performed immunoinformatics analysis so that the rapid development of the vaccine might bring this disastrous situation to the end earlier. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25736</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081601171">
    <j.0:identifier>2-s2.0-85081601171</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Springer</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081601171&amp;doi=10.1007%2fs00134-020-05955-1&amp;partnerID=40&amp;md5=b729f3759e53f863bd59cfc42797f686&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:title>COVID-19: a novel coronavirus and a novel challenge for critical care</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <dc:creator>Arabi Y.M., Murthy S., Webb S.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1007/s00134-020-05955-1</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079594954">
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1016/S2215-0366(20)30047-X</j.0:identifier>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <myOnto:volume>7</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus</j.0:title>
    <myOnto:issue>3</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079594954</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:creator>Kang L., Li Y., Hu S., Chen M., Yang C., Yang B.X., Wang Y., Hu J., Lai J., Ma X., Chen J., Guan L., Wang G., Ma H., Liu Z.</dc:creator>
    <schema:keywords>anger; anxiety; China; Chinese; Coronavirinae; Coronavirus infection; denial; depression; epidemic; fear; general hospital; human; insomnia; Letter; medical personnel; mental health; nonhuman; pneumonia; priority journal; stress; Betacoronavirus; Coronavirinae; global health; mental health; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus; Disease Outbreaks; Global Health; Humans; Mental Health</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079594954&amp;doi=10.1016%2fS2215-0366%2820%2930047-X&amp;partnerID=40&amp;md5=651b09efcf4cce6d63dd79a03d2ae7dc&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080081887">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Psychiatry_Research">
        <j.1:name>Psychiatry Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080081887&amp;doi=10.1016%2fj.psychres.2020.112895&amp;partnerID=40&amp;md5=f7c846c364775934fc02b54f37fde8bf&gt;</schema:url>
    <schema:keywords>China; coronavirus disease 2019; Coronavirus infection; disease transmission; Ebola hemorrhagic fever; emotional disorder; epidemic; fear; guilt; health hazard; helplessness; human; infection control; influenza A (H1N1); Letter; medical personnel; mental disease; mixed anxiety and depression; poliomyelitis; population structure; priority journal; virus infectivity; Zika fever</schema:keywords>
    <dc:creator>Zhou X.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>286</myOnto:volume>
    <j.0:title>Psychological crisis interventions in Sichuan Province during the 2019 novel coronavirus outbreak</j.0:title>
    <j.0:publisher>Elsevier Ireland Ltd</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85080081887</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.psychres.2020.112895</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081595289">
    <rdfs:comment>Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395: 809–15—In table 1 of this Article, the AST value for patient 4 was 76 U/L. And in the figure the chest CT images and descriptions for patient 6 and patient 7 were out of order: the CT images and figure legend have been updated accordingly. These corrections have been made to the online version as of March 23, 2020. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:creator>[No author name available]</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081595289&amp;doi=10.1016%2fS0140-6736%2820%2930606-1&amp;partnerID=40&amp;md5=c82bcfdad4d40232192203596abc577d&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081595289</j.0:identifier>
    <schema:keywords>erratum</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:identifier>10.1016/S0140-6736(20)30606-1</j.0:identifier>
    <j.0:title>Erratum: Department of Error (The Lancet (2020) 395(10226) (809–815), (S0140673620303603), (10.1016/S0140-6736(20)30360-3))</j.0:title>
    <myOnto:volume>395</myOnto:volume>
    <j.0:type>Erratum</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:issue>10229</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079051459">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Host_and_Microbe">
        <j.1:name>Cell Host and Microbe</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses. A systematic comparison identified 380 amino acid substitutions between these coronaviruses, which may have caused functional and pathogenic divergence of 2019-nCoV. © 2020 Elsevier Inc.An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or SARS-like coronaviruses. A systematic comparison identified 380 amino acid substitutions between these coronaviruses, which may have caused functional and pathogenic divergence of 2019-nCoV. © 2020 Elsevier Inc.</rdfs:comment>
    <dc:creator>Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J., Sheng J., Quan L., Xia Z., Tan W., Cheng G., Jiang T.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.chom.2020.02.001</j.0:identifier>
    <myOnto:citeyBy>10</myOnto:citeyBy>
    <myOnto:volume>27</myOnto:volume>
    <j.0:title>Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China</j.0:title>
    <j.0:identifier>2-s2.0-85079051459</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079051459&amp;doi=10.1016%2fj.chom.2020.02.001&amp;partnerID=40&amp;md5=ae74badf0c4a43f8d0005d0c6d5fedb0&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>3</myOnto:issue>
    <j.0:publisher>Cell Press</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:keywords>amino acid substitution; article; China; nonhuman; SARS-related coronavirus; Betacoronavirus; China; classification; Middle East respiratory syndrome coronavirus; phylogeny; SARS coronavirus; virus genome; severe acute respiratory syndrome coronavirus 2; Amino Acid Substitution; Betacoronavirus; China; Genome, Viral; Middle East Respiratory Syndrome Coronavirus; Phylogeny; SARS Virus</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080087259">
    <j.0:title>Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/ChemBioChem">
        <j.1:name>ChemBioChem</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>3clpro 1; antivirus agent; aurintricarboxylic acid; coronavirus spike glycoprotein; proteinase; proteinase inhibitor; remdesivir; ribavirin; RNA directed RNA polymerase; unclassified drug; 3C-like proteinase, Coronavirus; antivirus agent; COVID-19; cysteine proteinase; severe acute respiratory syndrome coronavirus 2; antiviral susceptibility; Article; Coronavirinae; coronavirus disease 2019; Coronavirus infection; drug structure; drug targeting; epidemic; gene mutation; human; infection control; inhibition kinetics; medical decision making; nonhuman; priority journal; public health service; SARS coronavirus; sequence analysis; sequence homology; severe acute respiratory syndrome coronavirus 2; structure activity relation; virus cell interaction; virus genome; virus inhibition; virus replication; Betacoronavirus; chemistry; Coronavirus infection; drug design; enzymology; genetics; metabolism; virus pneumonia; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cysteine Endopeptidases; Drug Design; Humans; Pneumonia, Viral; RNA Replicase</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080087259&amp;doi=10.1002%2fcbic.202000047&amp;partnerID=40&amp;md5=3476208702ae03da80298083818f4ffd&gt;</schema:url>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080087259</j.0:identifier>
    <j.0:publisher>Wiley-VCH Verlag</j.0:publisher>
    <myOnto:issue>5</myOnto:issue>
    <dc:date>2020</dc:date>
    <rdfs:comment>With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes. Although little is known about the virus, an examination of the genome sequence shows strong homology with its better-studied cousin, SARS-CoV. The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides. Other key drug targets, including RNA-dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (&gt;95 %) homology to SARS-CoV. Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV. We also summarize previous efforts into drugging these targets and hope to help in the development of broad-spectrum anti-coronaviral agents for future epidemics. © 2020 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rdfs:comment>
    <myOnto:volume>21</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Morse J.S., Lalonde T., Xu S., Liu W.R.</dc:creator>
    <j.0:identifier>10.1002/cbic.202000047</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079375610">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Virologica_Sinica"/>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1007/s12250-020-00205-6</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85079375610</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:title>Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury</j.0:title>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Wu Y.</dc:creator>
    <j.0:publisher>Science Press</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079375610&amp;doi=10.1007%2fs12250-020-00205-6&amp;partnerID=40&amp;md5=9988a8d449ffd7275f91156e11b7821f&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081924197">
    <myOnto:issue>1</myOnto:issue>
    <myOnto:volume>295</myOnto:volume>
    <dc:creator>Huang P., Liu T., Huang L., Liu H., Lei M., Xu W., Hu X., Chen J., Liu B.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <j.0:identifier>10.1148/radiol.2020200330</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081924197&amp;doi=10.1148%2fradiol.2020200330&amp;partnerID=40&amp;md5=d6d0b4c77d27a2ab9dae1ef5b2936558&gt;</schema:url>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081924197</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion</j.0:title>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>2</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081528188">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Dyer O.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m941</j.0:identifier>
    <j.0:title>Trump claims public health warnings on covid-19 are a conspiracy against him</j.0:title>
    <j.0:identifier>2-s2.0-85081528188</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081528188&amp;doi=10.1136%2fbmj.m941&amp;partnerID=40&amp;md5=104975d93fce2af1e238df767bce5f27&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081920435">
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081920435&amp;doi=10.1136%2fbmj.m969&amp;partnerID=40&amp;md5=fe43595348ca67fa07c0e034efa1741f&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081920435</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m969</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Covid-19: roundup of latest news</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:creator>Iacobucci G.</dc:creator>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081237619">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Mosby Inc.</j.0:publisher>
    <myOnto:volume>82</myOnto:volume>
    <j.0:identifier>2-s2.0-85081237619</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Coronavirus infection; Editorial; epidemic; human; infection control; isolation; necrotizing fasciitis; nonhuman; patient safety; priority journal; Streptococcus infection; virus transmission; Betacoronavirus; Coronavirinae; dermatology; outpatient; patient safety; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus; Dermatology; Humans; Outpatients; Patient Safety</schema:keywords>
    <dc:creator>Elston D.M.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_American_Academy_of_Dermatology"/>
    <j.0:identifier>10.1016/j.jaad.2020.02.031</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081237619&amp;doi=10.1016%2fj.jaad.2020.02.031&amp;partnerID=40&amp;md5=cbad33a1f2e43090564808cb8c0c2ae6&gt;</schema:url>
    <j.0:title>The coronavirus (COVID-19) epidemic and patient safety</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080952985">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <dc:creator>Yang Y., Shang W., Rao X.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85080952985</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1002/jmv.25720</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Facing the COVID-19 outbreak: What should we know and what could we do?</j.0:title>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080952985&amp;doi=10.1002%2fjmv.25720&amp;partnerID=40&amp;md5=815e4c9474a6b33a25c2a8927c85395a&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079156775">
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079156775</j.0:identifier>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079156775&amp;doi=10.1093%2fjtm%2ftaaa011&amp;partnerID=40&amp;md5=d1bfd5ff110e4b39ca307c1dbeb96a1e&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Bogoch I.I., Watts A., Thomas-Bachli A., Huber C., Kraemer M.U.G., Khan K.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_travel_medicine"/>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; aviation; Betacoronavirus; China; contact examination; Coronavirus infection; epidemic; global health; human; isolation and purification; public health; travel; veterinary medicine; virology; virus pneumonia; zoonosis; Air Travel; Animals; Betacoronavirus; China; Contact Tracing; Coronavirus Infections; Disease Outbreaks; Global Health; Humans; Pneumonia, Viral; Public Health; Travel; Zoonoses</schema:keywords>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>10.1093/jtm/taaa011</j.0:identifier>
    <myOnto:volume>27</myOnto:volume>
    <j.0:title>Potential for global spread of a novel coronavirus from China</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081923085">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_New_Zealand_medical_journal"/>
    <schema:keywords>COVID-19; civil defense; Coronavirus infection; evidence based medicine; health care personnel; human; interpersonal communication; leadership; New Zealand; politics; public relations; virus pneumonia; Civil Defense; Communication; Coronavirus Infections; Evidence-Based Medicine; Health Personnel; Humans; Interprofessional Relations; Leadership; New Zealand; Pneumonia, Viral; Politics</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>1511</myOnto:issue>
    <dc:creator>Murdoch D., Addidle M., Andersson H.-S., Arnold B., Balm M., Benschop J., Betty B., Birch M., Bloomfield M., Brunton C., Burns A., Chambers S., Cook L., Dalton S., Duncan H., Elvy J., Everts R., Freeman J., French N., Grimwade K., Hammer D., Hayman D., Holland D., Hudson B., Huggan P., Ikram R., Jack S., Kelly M., Lamont I., Maze M., McAuliffe G., McBride S., Metcalf S., Morpeth S., Morris A., Murton S., Pink R., Pithie A., Pitout M., Priest P., Raymond N., Read K., Ritchie S., Rogers M., Schroeder P., Taylor S., Taylor J., Thomas M., Upton A., Ussher J., Werno A., Wiles S.</dc:creator>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081923085&amp;partnerID=40&amp;md5=256f4443016662173556340d5f67d898&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081923085</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Politicians: please work together to minimise the spread of COVID-19</j.0:title>
    <j.0:identifier></j.0:identifier>
    <myOnto:volume>133</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081350216">
    <rdfs:comment>In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. Copyright © 2020, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)</rdfs:comment>
    <myOnto:volume>83</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_Chinese_Medical_Association">
        <j.1:name>Journal of the Chinese Medical Association</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>The outbreak of COVID-19: An overview</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081350216&amp;doi=10.1097%2fJCMA.0000000000000270&amp;partnerID=40&amp;md5=fe14d156904bf9b7c0aa882d00dfb51e&gt;</schema:url>
    <j.0:publisher>Wolters Kluwer Health</j.0:publisher>
    <myOnto:issue>3</myOnto:issue>
    <j.0:identifier>10.1097/JCMA.0000000000000270</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Wu Y.-C., Chen C.-S., Chan Y.-J.</dc:creator>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>2-s2.0-85081350216</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Asia; Betacoronavirus; China; Coronavirus infection; disease transmission; global health; human; infection control; pathogenicity; procedures; United States; virus pneumonia; Asia; Betacoronavirus; China; Coronavirus Infections; Global Health; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Pneumonia, Viral; United States</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079762182">
    <schema:keywords>2019 novel coronavirus; Coronavirus infection; disease control; health care; health care policy; human; questionnaire; Review</schema:keywords>
    <j.0:title>Disease control of 2019-novel coronavirus infection in hospital: West China urgent recommendation [????????????????????]</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Review</j.0:type>
    <rdfs:comment>China is facing the serious situation of 2019-novel coronavirus (2019-nCoV) infection. The health care institutions have actively participated in the prevention, diagnosis, and treatment of the disease. Proper regulation of in-hospital policy may help control virus spreading. We developed seven key clinical questions about the prevention and control of 2019-novel coronavirus infection in a hospital, and provided recommendations based on the best available evidence and expert experience. We interpret the recommendations for better feasibility in Chinese hospital. We hope to provide evidence and reference for the domestic medical institutions to reasonably adjust the hospital workflow during 2019-nCoV infection period. © 2020 West China University of Medical Science. All rights reserved.</rdfs:comment>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>2-s2.0-85079762182</j.0:identifier>
    <j.0:publisher>West China University of Medical Science</j.0:publisher>
    <j.0:identifier>10.7507/1672-2531.202001121</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Chinese_Journal_of_Evidence-Based_Medicine">
        <j.1:name>Chinese Journal of Evidence-Based Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Li S., Huang W., Liao X., Li D., Du L., Song J., Zhou Y., Zhao S., Wang Y., Cao X., Wang J., Liu J., Wang Y., Zhu S., Li L., Hao Q., Zong Z., Sun X., Li W.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079762182&amp;doi=10.7507%2f1672-2531.202001121&amp;partnerID=40&amp;md5=a1851dd565452ddb8a90c7353dc00aca&gt;</schema:url>
    <dc:language>Chinese</dc:language>
    <myOnto:volume>20</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081945574">
    <j.0:identifier>10.15585/mmwr.mm6909e1</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/MMWR._Morbidity_and_mortality_weekly_report"/>
    <myOnto:issue>9</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081945574&amp;doi=10.15585%2fmmwr.mm6909e1&amp;partnerID=40&amp;md5=41fc24afe6f05e11bc426d7f3015aee9&gt;</schema:url>
    <dc:date>2020</dc:date>
    <dc:creator>Burke R.M., Midgley C.M., Dratch A., Fenstersheib M., Haupt T., Holshue M., Ghinai I., Jarashow M.C., Lo J., McPherson T.D., Rudman S., Scott S., Hall A.J., Fry A.M., Rolfes M.A.</dc:creator>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; contact examination; Coronavirus infection; environmental exposure; epidemic; health survey; human; isolation and purification; travel related disease; United States; virology; Betacoronavirus; China; Contact Tracing; Coronavirus Infections; Disease Outbreaks; Environmental Exposure; Humans; Public Health Surveillance; Travel-Related Illness; United States</schema:keywords>
    <myOnto:volume>69</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:title>Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact† with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.</rdfs:comment>
    <j.0:identifier>2-s2.0-85081945574</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081998644">
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081998644&amp;doi=10.4414%2fsmw.2020.20224&amp;partnerID=40&amp;md5=6209f69c944b7fdf6812a8979933af3a&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.4414/smw.2020.20224</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:creator>Neher R.A., Dyrdak R., Druelle V., Hodcroft E.B., Albert J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081998644</j.0:identifier>
    <rdfs:comment>A novel coronavirus (SARS-CoV-2) first detected in Wuhan, China, has spread rapidly since December 2019, causing more than 100,000 confirmed infections and 4000 fatalities (as of 10 March 2020). The outbreak has been declared a pandemic by the WHO on Mar 11, 2020. Here, we explore how seasonal variation in transmissibility could modulate a SARS-CoV-2 pandemic. Data from routine diagnostics show a strong and consistent seasonal variation of the four endemic coronaviruses (229E, HKU1, NL63, OC43) and we parameterise our model for SARS-CoV-2 using these data. The model allows for many subpopulations of different size with variable parameters. Simulations of different scenarios show that plausible parameters result in a small peak in early 2020 in temperate regions of the Northern Hemisphere and a larger peak in winter 2020/2021. Variation in transmission and migration rates can result in substantial variation in prevalence between regions. While the uncertainty in parameters is large, the scenarios we explore show that transient reductions in the incidence rate might be due to a combination of seasonal variation and infection control efforts but do not necessarily mean the epidemic is contained. Seasonal forcing on SARS-CoV-2 should thus be taken into account in the further monitoring of the global transmission. The likely aggregated effect of seasonal variation, infection control measures, and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Swiss_medical_weekly"/>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>COVID-19; China; Coronavirus infection; forecasting; human; incidence; pandemic; prevalence; season; theoretical model; virus pneumonia; China; Coronavirus Infections; Forecasting; Humans; Incidence; Models, Theoretical; Pandemics; Pneumonia, Viral; Prevalence; Seasons</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:volume>150</myOnto:volume>
    <j.0:title>Potential impact of seasonal forcing on a SARS-CoV-2 pandemic</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081990544">
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>368</myOnto:volume>
    <dc:creator>Mahase E.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1136/bmj.m1089</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081990544</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081990544&amp;doi=10.1136%2fbmj.m1089&amp;partnerID=40&amp;md5=22acbcc8131693af3e0bd52e36c44097&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Covid-19: UK starts social distancing after new model points to 260?000 potential deaths</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081656175">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>The 2019-nCoV epidemic control strategies and future challenges of building healthy smart cities</j.0:title>
    <j.0:identifier>2-s2.0-85081656175</j.0:identifier>
    <dc:creator>Xu C., Luo X., Yu C., Cao S.-J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081656175&amp;doi=10.1177%2f1420326X20910408&amp;partnerID=40&amp;md5=5db8fc7d47c45c739bbbe0b1b247f2f9&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Editorial</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Indoor_and_Built_Environment">
        <j.1:name>Indoor and Built Environment</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>SAGE Publications Ltd</j.0:publisher>
    <j.0:identifier>10.1177/1420326X20910408</j.0:identifier>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081930346">
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients who are infected and require intensive care for SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be 30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start to decrease within 3–4 days, departing from the exponential trend. However, this cannot currently be predicted because of differences between social distancing measures and the capacity to quickly build dedicated facilities in China. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:type>Review</j.0:type>
    <dc:creator>Remuzzi A., Remuzzi G.</dc:creator>
    <j.0:identifier>2-s2.0-85081930346</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/S0140-6736(20)30627-9</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081930346&amp;doi=10.1016%2fS0140-6736%2820%2930627-9&amp;partnerID=40&amp;md5=302879ad9b9f7550926c329a71dbdc0e&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>COVID-19 and Italy: what next?</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082004731">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:creator>Li R., Qiao S., Zhang G.</dc:creator>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>80</myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1016/j.jinf.2020.02.013</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082004731&amp;doi=10.1016%2fj.jinf.2020.02.013&amp;partnerID=40&amp;md5=6cb3452c7ff2a439c26287bcda7a1d4e&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082004731</j.0:identifier>
    <j.0:title>Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV</j.0:title>
    <schema:keywords></schema:keywords>
    <myOnto:issue>4</myOnto:issue>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080094632">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080094632&amp;doi=10.1016%2fj.bja.2020.02.008&amp;partnerID=40&amp;md5=ea1163cb8ecd6ee0d1d70bc4514c23fd&gt;</schema:url>
    <j.0:identifier>2-s2.0-85080094632</j.0:identifier>
    <dc:creator>Peng P.W.H., Ho P.-L., Hota S.S.</dc:creator>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Anaesthesia">
        <j.1:name>British Journal of Anaesthesia</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Outbreak of a new coronavirus: what anaesthetists should know</j.0:title>
    <j.0:identifier>10.1016/j.bja.2020.02.008</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082144000">
    <myOnto:citeyBy>10</myOnto:citeyBy>
    <rdfs:comment>There is currently an outbreak of pneumonia of unknown aetiology in Wuhan, China. Although there are still several unanswered questions about this infection, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue. © International Society of Travel Medicine 2020. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1093/jtm/taaa008</j.0:identifier>
    <myOnto:volume>27</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082144000&amp;doi=10.1093%2fjtm%2ftaaa008&amp;partnerID=40&amp;md5=cea58fff907177955d101f162166b35a&gt;</schema:url>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; aviation; Betacoronavirus; China; contact examination; Coronavirus infection; genetics; human; isolation and purification; public health; virology; virus pneumonia; zoonosis; Air Travel; Animals; Betacoronavirus; China; Contact Tracing; Coronavirus Infections; Humans; Pneumonia, Viral; Public Health; Zoonoses</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>2</myOnto:issue>
    <j.0:title>Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_travel_medicine"/>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082144000</j.0:identifier>
    <dc:creator>Bogoch I.I., Watts A., Thomas-Bachli A., Huber C., Kraemer M.U.G., Khan K.</dc:creator>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080049910">
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85080049910</j.0:identifier>
    <j.0:title>Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Viruses"/>
    <dc:creator>Xu J., Zhao S., Teng T., Abdalla A.E., Zhu W., Xie L., Wang Y., Guo X.</dc:creator>
    <rdfs:comment>After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections. Recently, a new emerged HCoV isolated from the respiratory epithelium of unexplained pneumonia patients in theWuhan seafood market caused a major disease outbreak and has been named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes acute lung symptoms, leading to a condition that has been named as "coronavirus disease 2019" (COVID-19). The emergence of SARS-CoV-2 and of SARS-CoV caused widespread fear and concern and has threatened global health security. There are some similarities and differences in the epidemiology and clinical features between these two viruses and diseases that are caused by these viruses. The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms. © 2020 by the authors.</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080049910&amp;doi=10.3390%2fv12020244&amp;partnerID=40&amp;md5=2c84aeb5c3aa0d8a64b21385f5fc6ebb&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:volume>12</myOnto:volume>
    <schema:keywords>adult respiratory distress syndrome; amino acid sequence; Article; artificial ventilation; breathing rate; China; computer assisted tomography; Coronavirinae; coughing; dyspnea; epidemic; fatigue; gene sequence; hospital personnel; hospitalization; human; Human immunodeficiency virus infection; intensive care unit; Middle East respiratory syndrome; mortality rate; myalgia; nonhuman; novel coronavirus 2019; novel coronavirus disease 2019; phylogeny; pneumonia; prevalence; respiratory distress; respiratory epithelium; reverse transcription polymerase chain reaction; SARS coronavirus; sequence alignment; sequence homology; upregulation; virus isolation; virus pneumonia; virus replication; virus transmission; zoonosis; animal; bat; Betacoronavirus; chemistry; comparative study; Coronavirus infection; disease carrier; disease predisposition; genetics; global health; incubation time; pathogenicity; placental mammal; severe acute respiratory syndrome; virology; virus genome; virus pneumonia; COVID-19; proteome; severe acute respiratory syndrome coronavirus 2; viral protein; Animals; Betacoronavirus; China; Chiroptera; Coronavirus Infections; Disease Reservoirs; Disease Susceptibility; Eutheria; Genome, Viral; Global Health; Humans; Infectious Disease Incubation Period; Pneumonia, Viral; Proteome; SARS Virus; Sequence Alignment; Severe Acute Respiratory Syndrome; Viral Proteins</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.3390/v12020244</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081897631">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_business_continuity_&amp;_emergency_planning">
        <j.1:name>Journal of business continuity &amp; emergency planning</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>4</myOnto:issue>
    <schema:keywords>COVID-19; commercial phenomena; Coronavirinae; Coronavirus infection; disaster planning; epidemic; health care delivery; human; influenza; organization and management; pandemic; virus pneumonia; Commerce; Coronavirus; Coronavirus Infections; Delivery of Health Care; Disaster Planning; Disease Outbreaks; Humans; Influenza, Human; Pandemics; Pneumonia, Viral</schema:keywords>
    <j.0:title>Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>13</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier></j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081897631&amp;partnerID=40&amp;md5=604b78d7536ceb21fcdb56d4bca2ecb8&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081897631</j.0:identifier>
    <dc:creator>Koonin L.M.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <rdfs:comment>This article outlines practical steps that businesses can take now to prepare for a pandemic. Given the current growing spread of coronavirus disease 2019 (COVID-19) around the world, it is imperative that businesses review their pandemic plans and be prepared in case this epidemic expands and affects more people and communities. Preparing for a potential infectious disease pandemic from influenza or a novel corona virus is an essential component of a business continuity plan, especially for businesses that provide critical healthcare and infrastructure services. Although many businesses and organisations have a pandemic plan or address pandemic preparedness in their business continuity plans, few have recently tested and updated their plans. Pandemics can not only interrupt an organisation's operations and compromise long-term viability of an enterprise, but also disrupt the provision of critical functions. Businesses that regularly test and update their pandemic plan can significantly reduce harmful impacts to the business, play a key role in protecting employees' and customers' health and safety, and limit the negative impact of a pandemic on the community and economy.</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082186609">
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082186609</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection</j.0:title>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Bermejo-Martin J.F., Almansa R., Menéndez R., Mendez R., Kelvin D.J., Torres A.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jinf.2020.02.029</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082186609&amp;doi=10.1016%2fj.jinf.2020.02.029&amp;partnerID=40&amp;md5=1ce063c1e38b3d2386d797f4cfbf5ac0&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080979608">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)"/>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080979608&amp;doi=10.33321%2fcdi.2020.44.20&amp;partnerID=40&amp;md5=ee468798e4dc522c83635b9ba356723f&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; adolescent; adult; aged; Australia; child; China; Coronavirus infection; epidemic; female; global health; health survey; human; incidence; male; middle aged; preschool child; travel; virus pneumonia; young adult; Adolescent; Adult; Aged; Australia; Child; Child, Preschool; China; Coronavirus Infections; Disease Outbreaks; Female; Global Health; Humans; Incidence; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Travel; Young Adult</schema:keywords>
    <myOnto:volume>44</myOnto:volume>
    <dc:date>2020</dc:date>
    <rdfs:comment>This is the fifth epidemiological report for coronavirus disease 2019 (COVID-19), reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 29 February 2020. It includes data on COVID-19 cases diagnosed in Australia, the international situation and a review of current evidence. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <j.0:title>COVID-19, Australia: Epidemiology Report 5 (Reporting week ending 19:00 AEDT 29 February 2020)</j.0:title>
    <dc:creator>COVID-19 National Incident Room Surveillance Team</dc:creator>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85080979608</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.33321/cdi.2020.44.20</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079539502">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079539502</j.0:identifier>
    <j.0:title>Africa prepares for coronavirus</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30355-X</j.0:identifier>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Lancet_(London,_England)"/>
    <myOnto:issue>10223</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079539502&amp;doi=10.1016%2fS0140-6736%2820%2930355-X&amp;partnerID=40&amp;md5=f908a5829dbb5ca75605aabb8ae2775d&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <dc:creator>Makoni M.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>COVID-19; Africa; Coronavirus infection; epidemic; human; virus pneumonia; World Health Organization; Africa; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; World Health Organization</schema:keywords>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082192340">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Initiation of a new infection control system for the COVID-19 outbreak</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082192340</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082192340&amp;doi=10.1016%2fS1473-3099%2820%2930110-9&amp;partnerID=40&amp;md5=2fa065ea3457f925a0fca9b7bd822925&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S1473-3099(20)30110-9</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>4</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <dc:creator>Chen X., Tian J., Li G., Li G.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>20</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081685093">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <dc:creator>Murthy S., Gomersall C.D., Fowler R.A.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081685093&amp;doi=10.1001%2fjama.2020.3633&amp;partnerID=40&amp;md5=4413cd344d8802da89acf27dd73029b8&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:identifier>2-s2.0-85081685093</j.0:identifier>
    <j.0:identifier>10.1001/jama.2020.3633</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:title>Care for Critically Ill Patients with COVID-19</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081375950">
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2</j.0:title>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:identifier>10.1016/j.jinf.2020.02.017</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081375950&amp;doi=10.1016%2fj.jinf.2020.02.017&amp;partnerID=40&amp;md5=0e38e77f9a88fdcca964276955e81b95&gt;</schema:url>
    <dc:date>2020</dc:date>
    <dc:creator>Xu Y.-H., Dong J.-H., An W.-M., Lv X.-Y., Yin X.-P., Zhang J.-Z., Dong L., Ma X., Zhang H.-J., Gao B.-L.</dc:creator>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <j.0:identifier>2-s2.0-85081375950</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>Purpose: To investigate the clinical and imaging characteristics of computed tomography (CT) in novel coronavirus pneumonia (NCP) caused by SARS-CoV-2. Materials and methods: A retrospective analysis was performed on the imaging findings of patients confirmed with COVID-19 pneumonia who had chest CT scanning and treatment after disease onset. The clinical and imaging data were analyzed. Results: Fifty patients were enrolled, including mild type in nine, common in 28, severe in 10 and critically severe in the rest three. Mild patients (29 years) were significantly (P&lt;0.03) younger than either common (44.5 years) or severe (54.7) and critically severe (65.7 years) patients, and common patients were also significantly (P&lt;0.03) younger than severe and critically severe patients. Mild patients had low to moderate fever (&lt;39.1 °C), 49 (98%) patients had normal or slightly reduced leukocyte count, 14 (28%) had decreased counts of lymphocytes, and 26 (52%) patients had increased C-reactive protein. Nine mild patients were negative in CT imaging. For all the other types of NCP, the lesion was in the right upper lobe in 30 cases, right middle lobe in 22, right lower lobe in 39, left upper lobe in 33 and left lower lobe in 36. The lesion was primarily located in the peripheral area under the pleura with possible extension towards the pulmonary hilum. Symmetrical lesions were seen in 26 cases and asymmetrical in 15. The density of lesion was mostly uneven with ground glass opacity as the primary presentation accompanied by partial consolidation and fibrosis. Conclusion: CT imaging presentations of NCP are mostly patchy ground glass opacities in the peripheral areas under the pleura with partial consolidation which will be absorbed with formation of fibrotic stripes if improved. CT scanning provides important bases for early diagnosis and treatment of NCP. © 2020 The British Infection Association</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078134971">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85078134971</j.0:identifier>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:identifier>10.1038/d41586-020-00153-x</j.0:identifier>
    <j.0:title>Stop the Wuhan virus</j.0:title>
    <schema:keywords>2019 nCOV; alertness; China; Coronavirinae; coughing; dyspnea; Editorial; emergency; epidemic; gene sequence; global health; human; infection prevention; interpersonal communication; intersectoral collaboration; Japan; lower respiratory tract infection; market; medical personnel; Middle East respiratory syndrome coronavirus; new species; nonhuman; pneumonia; preparedness; priority journal; SARS coronavirus; South Korea; Thailand; travel; viral clearance; virus genome; virus infection; virus transmission; World Health Organization; Wuhan</schema:keywords>
    <myOnto:volume>577</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:creator>[No author name available]</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078134971&amp;doi=10.1038%2fd41586-020-00153-x&amp;partnerID=40&amp;md5=49def650002e526da58005e814d2629a&gt;</schema:url>
    <myOnto:issue>7791</myOnto:issue>
    <rdfs:comment>Vigilance, preparedness, speed, transparency and global coordination are now crucial to stopping a new infectious disease from becoming a global emergency. [Figure not available: see fulltext.]. © 2020, Nature.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082024690">
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <dc:creator>Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082024690&amp;doi=10.1016%2fS1473-3099%2820%2930086-4&amp;partnerID=40&amp;md5=c8d95aec59e648997540935730072ea9&gt;</schema:url>
    <rdfs:comment>Background: A cluster of patients with coronavirus disease 2019 (COVID-19) pneumonia caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were successively reported in Wuhan, China. We aimed to describe the CT findings across different timepoints throughout the disease course. Methods: Patients with COVID-19 pneumonia (confirmed by next-generation sequencing or RT-PCR) who were admitted to one of two hospitals in Wuhan and who underwent serial chest CT scans were retrospectively enrolled. Patients were grouped on the basis of the interval between symptom onset and the first CT scan: group 1 (subclinical patients; scans done before symptom onset), group 2 (scans done ?1 week after symptom onset), group 3 (&gt;1 week to 2 weeks), and group 4 (&gt;2 weeks to 3 weeks). Imaging features and their distribution were analysed and compared across the four groups. Findings: 81 patients admitted to hospital between Dec 20, 2019, and Jan 23, 2020, were retrospectively enrolled. The cohort included 42 (52%) men and 39 (48%) women, and the mean age was 49·5 years (SD 11·0). The mean number of involved lung segments was 10·5 (SD 6·4) overall, 2·8 (3·3) in group 1, 11·1 (5·4) in group 2, 13·0 (5·7) in group 3, and 12·1 (5·9) in group 4. The predominant pattern of abnormality observed was bilateral (64 [79%] patients), peripheral (44 [54%]), ill-defined (66 [81%]), and ground-glass opacification (53 [65%]), mainly involving the right lower lobes (225 [27%] of 849 affected segments). In group 1 (n=15), the predominant pattern was unilateral (nine [60%]) and multifocal (eight [53%]) ground-glass opacities (14 [93%]). Lesions quickly evolved to bilateral (19 [90%]), diffuse (11 [52%]) ground-glass opacity predominance (17 [81%]) in group 2 (n=21). Thereafter, the prevalence of ground-glass opacities continued to decrease (17 [57%] of 30 patients in group 3, and five [33%] of 15 in group 4), and consolidation and mixed patterns became more frequent (12 [40%] in group 3, eight [53%] in group 4). Interpretation: COVID-19 pneumonia manifests with chest CT imaging abnormalities, even in asymptomatic patients, with rapid evolution from focal unilateral to diffuse bilateral ground-glass opacities that progressed to or co-existed with consolidations within 1–3 weeks. Combining assessment of imaging features with clinical and laboratory findings could facilitate early diagnosis of COVID-19 pneumonia. Funding: None. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85082024690</j.0:identifier>
    <j.0:title>Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study</j.0:title>
    <j.0:identifier>10.1016/S1473-3099(20)30086-4</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:volume>20</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080845809">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Silverstein WK, Stroud L, Cleghorn GE, Leis JA. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. Lancet 2020; 395: 734—In this Clinical Picture, the last sentence should have read: “Further, it suggests that the identification of individuals—like our patient—who could be managed by being isolated at home, rather than in hospital, might be an important strategy for containing this outbreak.” This correction has been made to the online version as of Feb 27, 2020, and the printed version is correct. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080845809&amp;doi=10.1016%2fS0140-6736%2820%2930423-2&amp;partnerID=40&amp;md5=4d2d23df55576865212f5865e604fa83&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:issue>10225</myOnto:issue>
    <j.0:type>Erratum</j.0:type>
    <j.0:identifier>2-s2.0-85080845809</j.0:identifier>
    <j.0:title>Department of Error: First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia (The Lancet (2020) 395(10225) (734), (S0140673620303706), (10.1016/S0140-6736(20)30370-6))</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/S0140-6736(20)30423-2</j.0:identifier>
    <dc:creator>[No author name available]</dc:creator>
    <schema:keywords>erratum</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078241697">
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078241697&amp;doi=10.1016%2fS0140-6736%2820%2930154-9&amp;partnerID=40&amp;md5=d04ed2e8ed7ef8ed5722435d468dc09c&gt;</schema:url>
    <schema:keywords>C reactive protein; RNA directed DNA polymerase; virus spike protein; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; adult; aged; amplicon; Article; child; China; clinical article; clinical examination; controlled study; Coronavirinae; Coronavirus infection; diarrhea; disease association; disease transmission; exposure variable; family; female; fever; gene sequence; genetic code; genomics; high throughput sequencing; history; human; laboratory test; lower respiratory tract infection; lymphocytopenia; male; microbiological examination; nonhuman; phylogeny; pneumonia; priority journal; radiodiagnosis; real time polymerase chain reaction; Sanger sequencing; school child; throat culture; thrombocytopenia; travel; upper respiratory tract infection; virus transmission; Betacoronavirus; classification; Coronavirus infection; family health; genetics; middle aged; procedures; thorax radiography; virus genome; virus pneumonia; whole genome sequencing; x-ray computed tomography; Adult; Aged; Betacoronavirus; China; Coronavirus Infections; Family Health; Genome, Viral; Humans; Middle Aged; Phylogeny; Pneumonia, Viral; Radiography, Thoracic; Tomography, X-Ray Computed; Whole Genome Sequencing</schema:keywords>
    <dc:language>English</dc:language>
    <dc:creator>Chan J.F.-W., Yuan S., Kok K.-H., To K.K.-W., Chu H., Yang J., Xing F., Liu J., Yip C.C.-Y., Poon R.W.-S., Tsoi H.-W., Lo S.K.-F., Chan K.-H., Poon V.K.-M., Chan W.-M., Ip J.D., Cai J.-P., Cheng V.C.-C., Chen H., Hui C.K.-M., Yuen K.-Y.</dc:creator>
    <j.0:identifier>10.1016/S0140-6736(20)30154-9</j.0:identifier>
    <j.0:identifier>2-s2.0-85078241697</j.0:identifier>
    <j.0:title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:issue>10223</myOnto:issue>
    <rdfs:comment>Background: An ongoing outbreak of pneumonia associated with a novel coronavirus was reported in Wuhan city, Hubei province, China. Affected patients were geographically linked with a local wet market as a potential source. No data on person-to-person or nosocomial transmission have been published to date. Methods: In this study, we report the epidemiological, clinical, laboratory, radiological, and microbiological findings of five patients in a family cluster who presented with unexplained pneumonia after returning to Shenzhen, Guangdong province, China, after a visit to Wuhan, and an additional family member who did not travel to Wuhan. Phylogenetic analysis of genetic sequences from these patients were done. Findings: From Jan 10, 2020, we enrolled a family of six patients who travelled to Wuhan from Shenzhen between Dec 29, 2019 and Jan 4, 2020. Of six family members who travelled to Wuhan, five were identified as infected with the novel coronavirus. Additionally, one family member, who did not travel to Wuhan, became infected with the virus after several days of contact with four of the family members. None of the family members had contacts with Wuhan markets or animals, although two had visited a Wuhan hospital. Five family members (aged 36–66 years) presented with fever, upper or lower respiratory tract symptoms, or diarrhoea, or a combination of these 3–6 days after exposure. They presented to our hospital (The University of Hong Kong-Shenzhen Hospital, Shenzhen) 6–10 days after symptom onset. They and one asymptomatic child (aged 10 years) had radiological ground-glass lung opacities. Older patients (aged &gt;60 years) had more systemic symptoms, extensive radiological ground-glass lung changes, lymphopenia, thrombocytopenia, and increased C-reactive protein and lactate dehydrogenase levels. The nasopharyngeal or throat swabs of these six patients were negative for known respiratory microbes by point-of-care multiplex RT-PCR, but five patients (four adults and the child) were RT-PCR positive for genes encoding the internal RNA-dependent RNA polymerase and surface Spike protein of this novel coronavirus, which were confirmed by Sanger sequencing. Phylogenetic analysis of these five patients' RT-PCR amplicons and two full genomes by next-generation sequencing showed that this is a novel coronavirus, which is closest to the bat severe acute respiatory syndrome (SARS)-related coronaviruses found in Chinese horseshoe bats. Interpretation: Our findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions. Funding: The Shaw Foundation Hong Kong, Michael Seak-Kan Tong, Respiratory Viral Research Foundation Limited, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Marina Man-Wai Lee, the Hong Kong Hainan Commercial Association South China Microbiology Research Fund, Sanming Project of Medicine (Shenzhen), and High Level-Hospital Program (Guangdong Health Commission). © 2020 Elsevier Ltd</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>132</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080104164">
    <j.0:identifier>10.1016/j.joim.2020.02.004</j.0:identifier>
    <myOnto:issue>2</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080104164&amp;doi=10.1016%2fj.joim.2020.02.004&amp;partnerID=40&amp;md5=ff00f1f4d15c9b8176408295d386a143&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>18</myOnto:volume>
    <schema:keywords>antivirus agent; herbaceous agent; natural product; severe acute respiratory syndrome vaccine; Chinese medicine; computer model; coronavirus disease 2019; Coronavirus infection; Editorial; epidemic; inflammation; Middle East respiratory syndrome coronavirus; priority journal; reliability; SARS coronavirus; screening; severe acute respiratory syndrome coronavirus 2; virus pneumonia</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Integrative_Medicine">
        <j.1:name>Journal of Integrative Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:title>Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)</j.0:title>
    <j.0:identifier>2-s2.0-85080104164</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier (Singapore) Pte Ltd</j.0:publisher>
    <dc:creator>Ling C.-Q.</dc:creator>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081593595">
    <myOnto:volume>82</myOnto:volume>
    <rdfs:comment>The Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a Public Health Emergency of International Concern. However, so far, there are still controversies about the source of the virus and its intermediate host. Here, we found the novel coronavirus was closely related to coronaviruses derived from five wild animals, including Paguma larvata, Paradoxurus hermaphroditus, Civet, Aselliscus stoliczkanus and Rhinolophus sinicus, and was in the same branch of the phylogenetic tree. However, genome and ORF1a homology show that the virus is not the same coronavirus as the coronavirus derived from these five animals, whereas the virus has the highest homology with Bat coronavirus isolate RaTG13. © 2020</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection,_Genetics_and_Evolution"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081593595&amp;doi=10.1016%2fj.meegid.2020.104285&amp;partnerID=40&amp;md5=479d18b7b3e010abcb6a72e6cb4acfe1&gt;</schema:url>
    <j.0:title>Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.meegid.2020.104285</j.0:identifier>
    <j.0:identifier>2-s2.0-85081593595</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:keywords>single stranded RNA; Aselliscus stoliczkanus; Betacoronavirus; China; civet (animal); cladistics; Coronavirinae; genetic analysis; genetic similarity; health hazard; human; infection risk; Letter; molecular evolution; molecular phylogeny; nonhuman; open reading frame; Paguma larvata; Paradoxurus hermaphroditus; phylogenetic tree; priority journal; public health problem; Rhinolophus sinicus; risk assessment; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; virus genome; virus recombination; virus strain; virus transmission; wild animal; World Health Organization</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Li C., Yang Y., Ren L.</dc:creator>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:type>Letter</j.0:type>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082136047">
    <schema:keywords></schema:keywords>
    <dc:creator>Fedson D.S., Opal S.M., Rordam O.M.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082136047&amp;doi=10.1128%2fmBio.00398-20&amp;partnerID=40&amp;md5=81f4dd7d2ed0d693411fd1b8bd146f98&gt;</schema:url>
    <myOnto:volume>11</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/mBio">
        <j.1:name>mBio</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>Patients with COVID-19 infection are at risk of acute respiratory disease syndrome (ARDS) and death. The tissue receptor for COVID-19 is ACE2, and higher levels of ACE2 can protect against ARDS. Angiotensin receptor blockers and statins upregulate ACE2. Clinical trials are needed to determine whether this drug combination might be used to treat patients with severe COVID-19 infection. © 2020 Fedson et al.</rdfs:comment>
    <myOnto:issue>2</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>American Society for Microbiology</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1128/mBio.00398-20</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082136047</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Hiding in plain sight: An approach to treating patients with severe covid-19 infection</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079317994">
    <j.0:identifier>10.1038/s41591-020-0775-x</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:issue>2</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079317994&amp;doi=10.1038%2fs41591-020-0775-x&amp;partnerID=40&amp;md5=28da0e59c6be1a966c65b0b494fd0d59&gt;</schema:url>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Medicine"/>
    <j.0:publisher>Nature Research</j.0:publisher>
    <myOnto:volume>26</myOnto:volume>
    <j.0:title>Communication, collaboration and cooperation can stop the 2019 coronavirus</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079317994</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; China; cooperation; Coronavirinae; Coronavirus infection; Editorial; epidemic; human; interpersonal communication; intersectoral collaboration; Middle East respiratory syndrome coronavirus; phylogeny; priority journal; SARS coronavirus; virus spike; virus transmission; virus virulence</schema:keywords>
    <j.0:type>Editorial</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079817730">
    <j.0:identifier>10.1126/science.aba0376</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079817730&amp;doi=10.1126%2fscience.aba0376&amp;partnerID=40&amp;md5=996761c96a1e1a34a5c84f6c22a5c92b&gt;</schema:url>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Promoting biosecurity by professionalizing biosecurity A credential system could improve policy and practice</j.0:title>
    <schema:keywords>toxin; biosafety; credit provision; economic analysis; policy implementation; policy making; 2019 novel coronavirus; accreditation; Article; biomedicine; biosafety; biotechnology; computer security; Coronavirinae; cyberattack; documentation; Ebolavirus; health hazard; human; infectious agent; information security; information system; interdisciplinary research; knowledge; material control and accountability; medical practice; microorganism; personal security; personnel suitability; physical security; policy; priority journal; professional competence; professional practice; professional standard; program management; protocol compliance; public health; risk management; skill; stakeholder engagement; synthetic biology; threat; transport security</schema:keywords>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Moritz R.L., Berger K.M., Owen B.R., Gillum D.R.</dc:creator>
    <myOnto:issue>6480</myOnto:issue>
    <j.0:identifier>2-s2.0-85079817730</j.0:identifier>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081274886">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081274886&amp;doi=10.1016%2fS2214-109X%2820%2930074-7&amp;partnerID=40&amp;md5=77daac45777015d04462761151368d2f&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:creator>Hellewell J., Abbott S., Gimma A., Bosse N.I., Jarvis C.I., Russell T.W., Munday J.D., Kucharski A.J., Edmunds W.J., Sun F., Flasche S., Quilty B.J., Davies N., Liu Y., Clifford S., Klepac P., Jit M., Diamond C., Gibbs H., van Zandvoort K., Funk S., Eggo R.M., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:title>Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts</j.0:title>
    <j.0:identifier>2-s2.0-85081274886</j.0:identifier>
    <myOnto:issue>4</myOnto:issue>
    <rdfs:comment>Background: Isolation of cases and contact tracing is used to control outbreaks of infectious diseases, and has been used for coronavirus disease 2019 (COVID-19). Whether this strategy will achieve control depends on characteristics of both the pathogen and the response. Here we use a mathematical model to assess if isolation and contact tracing are able to control onwards transmission from imported cases of COVID-19. Methods: We developed a stochastic transmission model, parameterised to the COVID-19 outbreak. We used the model to quantify the potential effectiveness of contact tracing and isolation of cases at controlling a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-like pathogen. We considered scenarios that varied in the number of initial cases, the basic reproduction number (R0), the delay from symptom onset to isolation, the probability that contacts were traced, the proportion of transmission that occurred before symptom onset, and the proportion of subclinical infections. We assumed isolation prevented all further transmission in the model. Outbreaks were deemed controlled if transmission ended within 12 weeks or before 5000 cases in total. We measured the success of controlling outbreaks using isolation and contact tracing, and quantified the weekly maximum number of cases traced to measure feasibility of public health effort. Findings: Simulated outbreaks starting with five initial cases, an R0 of 1·5, and 0% transmission before symptom onset could be controlled even with low contact tracing probability; however, the probability of controlling an outbreak decreased with the number of initial cases, when R0 was 2·5 or 3·5 and with more transmission before symptom onset. Across different initial numbers of cases, the majority of scenarios with an R0 of 1·5 were controllable with less than 50% of contacts successfully traced. To control the majority of outbreaks, for R0 of 2·5 more than 70% of contacts had to be traced, and for an R0 of 3·5 more than 90% of contacts had to be traced. The delay between symptom onset and isolation had the largest role in determining whether an outbreak was controllable when R0 was 1·5. For R0 values of 2·5 or 3·5, if there were 40 initial cases, contact tracing and isolation were only potentially feasible when less than 1% of transmission occurred before symptom onset. Interpretation: In most scenarios, highly effective contact tracing and case isolation is enough to control a new outbreak of COVID-19 within 3 months. The probability of control decreases with long delays from symptom onset to isolation, fewer cases ascertained by contact tracing, and increasing transmission before symptoms. This model can be modified to reflect updated transmission characteristics and more specific definitions of outbreak control to assess the potential success of local response efforts. Funding: Wellcome Trust, Global Challenges Research Fund, and Health Data Research UK. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license</rdfs:comment>
    <myOnto:volume>8</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Global_Health"/>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>Article; basic reproduction number; binomial distribution; contact examination; disease transmission; dispersity; epidemic; feasibility study; human; infection control; nonhuman; novel coronavirus 2019; novel coronavirus disease 2019; priority journal; SARS coronavirus; sensitivity analysis; severe acute respiratory syndrome; social isolation; stochastic model; survival rate</schema:keywords>
    <j.0:identifier>10.1016/S2214-109X(20)30074-7</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080030605">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; abnormal respiratory sound; adult; Betacoronavirus; case report; China; complication; Coronavirus infection; coughing; diagnostic imaging; disease exacerbation; female; fever; human; isolation and purification; lung; male; middle aged; pathology; real time polymerase chain reaction; virus pneumonia; x-ray computed tomography; Adult; Betacoronavirus; China; Coronavirus Infections; Cough; Disease Progression; Female; Fever; Humans; Lung; Male; Middle Aged; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Respiratory Sounds; Tomography, X-Ray Computed</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1148/radiol.2020200280</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080030605&amp;doi=10.1148%2fradiol.2020200280&amp;partnerID=40&amp;md5=dd101d29641b180f3ed3351620a1e8a4&gt;</schema:url>
    <j.0:identifier>2-s2.0-85080030605</j.0:identifier>
    <dc:creator>Fang Y., Zhang H., Xu Y., Xie J., Pang P., Ji W.</dc:creator>
    <j.0:title>CT manifestations of two cases of 2019 novel coronavirus (2019-NCoV) pneumonia</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:volume>295</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082196100">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30668-1</j.0:identifier>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:issue>10229</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082196100&amp;doi=10.1016%2fS0140-6736%2820%2930668-1&amp;partnerID=40&amp;md5=25d05d0369d880225fe2e49a586ba66a&gt;</schema:url>
    <dc:creator>Takian A., Raoofi A., Kazempour-Ardebili S.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Letter</j.0:type>
    <j.0:title>COVID-19 battle during the toughest sanctions against Iran</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082196100</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082014098">
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Rimmer A.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m1088</j.0:identifier>
    <j.0:identifier>2-s2.0-85082014098</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082014098&amp;doi=10.1136%2fbmj.m1088&amp;partnerID=40&amp;md5=e2035b79ca17c3f84d4881c8ecd45956&gt;</schema:url>
    <j.0:title>Covid-19: trainees will not move jobs in April</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081693135">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Keep up with the latest coronavirus research</j.0:title>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:issue>7798</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081693135&amp;doi=10.1038%2fd41586-020-00694-1&amp;partnerID=40&amp;md5=9f0cd5642ee5f16087db97864ff55590&gt;</schema:url>
    <dc:creator>Chen Q., Allot A., Lu Z.</dc:creator>
    <schema:keywords>COVID-19; Coronavirus infection; human; national health organization; publication; research; United States; virology; virus pneumonia; Coronavirus Infections; Humans; National Institutes of Health (U.S.); Periodicals as Topic; Pneumonia, Viral; Research; United States; Virology</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>579</myOnto:volume>
    <j.0:identifier>10.1038/d41586-020-00694-1</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:identifier>2-s2.0-85081693135</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082188369">
    <dc:language>English</dc:language>
    <myOnto:issue>10229</myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082188369</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082188369&amp;doi=10.1016%2fS0140-6736%2820%2930630-9&amp;partnerID=40&amp;md5=1c12ce1f4b873c322dd61fbc25122d9c&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Green M.S.</dc:creator>
    <j.0:title>Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term?</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S0140-6736(20)30630-9</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082093079">
    <rdfs:comment>Preparing for public health emergencies is an ongoing process and involves a variety of approaches and tools. Tabletop exercises are one of the tools designed to simulate the emergence of a public health emergency and address some or all of the phases of emergency management: mitigation, preparedness, response, and recovery.1 They typically are designed to include participation of stakeholders from diverse and complementary backgrounds, including command, operations, logistics, planning, and finance.2 Effective tabletop exercises provide a plausible scenario that require cooperation and communication from these functional areas. Tabletops also require forward thinking and planning in a variety of scenarios. When a public health emergency occurs, decision makers may be overwhelmed with decisions that need their immediate attention. Tabletop exercises can provide a framework to help decision makers anticipate future challenges, which may provide the mental model encompassing knowledge and insights that inform both current and future decisions.</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082093079&amp;doi=10.5055%2fjem.2020.0463&amp;partnerID=40&amp;md5=d69c1c9941649f5ea7fb33ccfb0b9885&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>18</myOnto:volume>
    <j.0:identifier>10.5055/jem.2020.0463</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_emergency_management_(Weston,_Mass.)">
        <j.1:name>Journal of emergency management (Weston, Mass.)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Wendelboe A.M., Miller A., Drevets D., Salinas L., Miller E.J., Jackson D., Chou A., Raines J., Public Health Working Group</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082093079</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; disaster planning; emergency; epidemic; human; organization and management; pathogenicity; university; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disaster Planning; Disease Outbreaks; Emergencies; Humans; Pneumonia, Viral; Universities</schema:keywords>
    <j.0:title>Tabletop exercise to prepare institutions of higher education for an outbreak of COVID-19</j.0:title>
    <myOnto:issue>2</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081597734">
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081597734</j.0:identifier>
    <dc:creator>Porcheddu R., Serra C., Kelvin D., Kelvin N., Rubino S.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection_in_Developing_Countries"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.3855/jidc.12600</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:keywords>2019 novel coronavirus; Article; case fatality rate; China; comparative study; contact examination; coronavirus disease 2019; disease surveillance; disease transmission; epidemic; flu like syndrome; frailty; high risk population; hospitalization; human; intensive care unit; Italy; patient isolation; point of care system; quarantine; respiratory tract infection; SARS coronavirus; travel related disease; adolescent; adult; age distribution; aged; Betacoronavirus; child; Coronavirus infection; epidemiology; female; infant; male; middle aged; mortality; pandemic; preschool child; risk factor; very elderly; virus pneumonia; young adult; COVID-19; severe acute respiratory syndrome coronavirus 2; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Betacoronavirus; Child; Child, Preschool; China; Contact Tracing; Coronavirus Infections; Female; Humans; Infant; Italy; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Point-of-Care Systems; Risk Factors; Young Adult</schema:keywords>
    <j.0:publisher>Journal of Infection in Developing Countries</j.0:publisher>
    <j.0:title>Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China</j.0:title>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:volume>14</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081597734&amp;doi=10.3855%2fjidc.12600&amp;partnerID=40&amp;md5=a9f845082549ee864a504a35c02aa0af&gt;</schema:url>
    <rdfs:comment>As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease. © 2020 Porcheddu et al.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081579482">
    <j.0:title>From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081579482</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Kandeel M., Ibrahim A., Fayez M., Al-Nazawi M.</dc:creator>
    <rdfs:comment>Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of SARS-CoV-2 and the changes in SARS-CoV-2 in comparison with the two prior major COV epidemics, SARS and Middle East respiratory syndrome (MERS) coronaviruses. Methods: The genome composition, nucleotide analysis, codon usage indices, relative synonymous codons usage, and effective number of codons (ENc) were analyzed in the four structural genes; Spike (S), Envelope (E), membrane (M), and Nucleocapsid (N) genes, and two of the most important nonstructural genes comprising RNA-dependent RNA polymerase and main protease (Mpro) of SARS-CoV-2, Beta-CoV from pangolins, bat SARS, MERS, and SARS CoVs. Results: SARS-CoV-2 prefers pyrimidine rich codons to purines. Most high-frequency codons were ending with A or T, while the low frequency and rare codons were ending with G or C. SARS-CoV-2 structural proteins showed 5 to 20 lower ENc values, compared with SARS, bat SARS, and MERS CoVs. This implies higher codon bias and higher gene expression efficiency of SARS-CoV-2 structural proteins. SARS-CoV-2 encoded the highest number of over-biased and negatively biased codons. Pangolin Beta-CoV showed little differences with SARS-CoV-2 ENc values, compared with SARS, bat SARS, and MERS CoV. Conclusion: Extreme bias and lower ENc values of SARS-CoV-2, especially in Spike, Envelope, and Mpro genes, are suggestive for higher gene expression efficiency, compared with SARS, bat SARS, and MERS CoVs. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081579482&amp;doi=10.1002%2fjmv.25754&amp;partnerID=40&amp;md5=ed78569b78af041582b23c412ee6754e&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1002/jmv.25754</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081648239">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081648239&amp;doi=10.1016%2fS0140-6736%2820%2930547-X&amp;partnerID=40&amp;md5=5ab51f7190bfc8571dfbbf67eed92e15&gt;</schema:url>
    <myOnto:issue>10228</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Wang G., Zhang Y., Zhao J., Zhang J., Jiang F.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>395</myOnto:volume>
    <j.0:title>Mitigate the effects of home confinement on children during the COVID-19 outbreak</j.0:title>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85081648239</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30547-X</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079901699">
    <j.0:identifier>2-s2.0-85079901699</j.0:identifier>
    <dc:creator>Ji W., Wang W., Zhao X., Zai J., Li X.</dc:creator>
    <j.0:identifier>10.1002/jmv.25682</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079901699&amp;doi=10.1002%2fjmv.25682&amp;partnerID=40&amp;md5=068bb3d0245c6d2087b58e65af42e0e5&gt;</schema:url>
    <rdfs:comment>The current outbreak of viral pneumonia in the city of Wuhan, China, was caused by a novel coronavirus designated 2019-nCoV by the World Health Organization, as determined by sequencing the viral RNA genome. Many initial patients were exposed to wildlife animals at the Huanan seafood wholesale market, where poultry, snake, bats, and other farm animals were also sold. To investigate possible virus reservoir, we have carried out comprehensive sequence analysis and comparison in conjunction with relative synonymous codon usage (RSCU) bias among different animal species based on the 2019-nCoV sequence. Results obtained from our analyses suggest that the 2019-nCoV may appear to be a recombinant virus between the bat coronavirus and an origin-unknown coronavirus. The recombination may occurred within the viral spike glycoprotein, which recognizes a cell surface receptor. Additionally, our findings suggest that 2019-nCoV has most similar genetic information with bat coronovirus and most similar codon usage bias with snake. Taken together, our results suggest that homologous recombination may occur and contribute to the 2019-nCoV cross-species transmission. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>31</myOnto:citeyBy>
    <myOnto:issue>4</myOnto:issue>
    <schema:keywords>cell surface receptor; glycoprotein; virus RNA; coronavirus spike glycoprotein; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel Coronavirus; Article; bat; China; codon usage; controlled study; Coronavirinae; coronavirus disease 2019; Coronavirus infection; cross species transmission; disease carrier; farm animal; gene sequence; homologous recombination; human; market; nonhuman; phylogeny; poultry; sequence analysis; snake; virus pneumonia; virus transmission; wildlife; World Health Organization; animal; Betacoronavirus; Bungarus; classification; Coronavirus infection; disease carrier; epidemic; genetics; host range; molecular evolution; Naja naja; physiology; virology; virus genome; virus pneumonia; zoonosis; Animals; Betacoronavirus; Bungarus; Chiroptera; Codon Usage; Coronavirus Infections; Disease Outbreaks; Disease Reservoirs; Evolution, Molecular; Genome, Viral; Homologous Recombination; Host Specificity; Humans; Naja naja; Phylogeny; Pneumonia, Viral; Snakes; Spike Glycoprotein, Coronavirus; Zoonoses</schema:keywords>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Cross-species transmission of the newly identified coronavirus 2019-nCoV</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081740710">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Medicine"/>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081740710&amp;doi=10.1038%2fs41591-020-0819-2&amp;partnerID=40&amp;md5=c74a868dbc7a396ba0636bc7d3561075&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Thevarajan I., Nguyen T.H.O., Koutsakos M., Druce J., Caly L., van de Sandt C.E., Jia X., Nicholson S., Catton M., Cowie B., Tong S.Y.C., Lewin S.R., Kedzierska K.</dc:creator>
    <j.0:identifier>2-s2.0-85081740710</j.0:identifier>
    <j.0:identifier>10.1038/s41591-020-0819-2</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Nature Research</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082033625">
    <schema:keywords></schema:keywords>
    <j.0:title>Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants</j.0:title>
    <dc:creator>Li F., Feng Z.C., Shi Y.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85082033625</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1136/archdischild-2020-318996</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082033625&amp;doi=10.1136%2farchdischild-2020-318996&amp;partnerID=40&amp;md5=0f715bffcb45cec6490ada0b63990b19&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Archives_of_Disease_in_Childhood:_Fetal_and_Neonatal_Edition">
        <j.1:name>Archives of Disease in Childhood: Fetal and Neonatal Edition</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081008949">
    <dc:creator>Ma X.-L., Chen Z., Zhu J.-J., Shen X.-X., Wu M.-Y., Shi L.-P., Du L.-Z., Fu J.-F., Shu Q.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/World_Journal_of_Pediatrics"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081008949&amp;doi=10.1007%2fs12519-020-00347-3&amp;partnerID=40&amp;md5=ac1220b8d0ff805b13d43d494c0c5898&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081008949</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Institute of Pediatrics of Zhejiang University</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak</j.0:title>
    <rdfs:comment>The outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV) has become a most challenging health emergency. Owing to rigorous quarantine and control measures taken in China, routine neonatal health surveillance and follow-up have become challenging. Without follow-up surveillance, some rapid and progressive newborn diseases, such as bilirubin encephalopathy, may be ignored. The characteristics of onset age of kernicterus suggest that monitoring of bilirubin level at home provides a useful way to alert hospital visits and to prevent the development of extremely hyperbilirubinemia. Therefore, we developed an online follow-up program for convenient monitoring of bilirubin level of newborns that is based on our practical experiences. The aim is to make our management strategies of neonatal jaundice tailored to the infection prevention and control during the COVID-19 epidemic. © 2020, Children's Hospital, Zhejiang University School of Medicine.</rdfs:comment>
    <j.0:type>Review</j.0:type>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1007/s12519-020-00347-3</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081340190">
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <myOnto:volume>22</myOnto:volume>
    <j.0:identifier>10.1016/j.micinf.2020.02.002</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>2</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Microbes_and_Infection"/>
    <schema:keywords>antivirus agent; virus spike protein; COVID-19; severe acute respiratory syndrome coronavirus 2; virus receptor; 2019 novel coronavirus; antiviral therapy; Article; China; clinical feature; Coronaviridae; Coronavirus infection; epidemic; genomics; human; infection prevention; nonhuman; priority journal; public health; receptor binding; viral tropism; virus identification; virus pneumonia; virus transmission; Betacoronavirus; communicable disease; Coronavirus infection; epidemic; genetics; pathogenicity; phylogeny; virology; virus genome; virus pneumonia; Antiviral Agents; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Epidemics; Genome, Viral; Humans; Phylogeny; Pneumonia, Viral; Receptors, Virus; Viral Tropism</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081340190</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081340190&amp;doi=10.1016%2fj.micinf.2020.02.002&amp;partnerID=40&amp;md5=a4eadb54cb6507aca200811add441a66&gt;</schema:url>
    <j.0:title>The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future</j.0:title>
    <dc:creator>Li J.-Y., You Z., Wang Q., Zhou Z.-J., Qiu Y., Luo R., Ge X.-Y.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>At the end of December 2019, a novel coronavirus, 2019-nCoV, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to the whole country of China, which has posed great threats to public health and attracted enormous attention around the world. To date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections. Intensive research on the novel emerging human infectious coronaviruses is urgently needed to elucidate their route of transmission and pathogenic mechanisms, and to identify potential drug targets, which would promote the development of effective preventive and therapeutic countermeasures. Herein, we describe the epidemic and etiological characteristics of 2019-nCoV, discuss its essential biological features, including tropism and receptor usage, summarize approaches for disease prevention and treatment, and speculate on the transmission route of 2019-nCoV. © 2020 Institut Pasteur</rdfs:comment>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082141549">
    <dc:language>English</dc:language>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <j.0:title>Point-of-care RNA-based diagnostic device for Covid-19</j.0:title>
    <dc:creator>Yang T., Wang Y.-C., Shen C.-F., Cheng C.-M.</dc:creator>
    <j.0:identifier>2-s2.0-85082141549</j.0:identifier>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082141549&amp;doi=10.3390%2fdiagnostics10030165&amp;partnerID=40&amp;md5=b431ec96408eb7ccf2ce13b20f859ee5&gt;</schema:url>
    <j.0:type>Review</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.3390/diagnostics10030165</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>10</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Diagnostics">
        <j.1:name>Diagnostics</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081042222">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.8.2002271</j.0:identifier>
    <myOnto:issue>8</myOnto:issue>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:title>Latest assessment on COVID-19 from the European Centre for Disease Prevention and Control (ECDC)</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081042222</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081042222&amp;doi=10.2807%2f1560-7917.ES.2020.25.8.2002271&amp;partnerID=40&amp;md5=93fbd8624feaa2808041eda0139cf0f7&gt;</schema:url>
    <myOnto:volume>25</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <dc:creator>Eurosurveillance Editorial Team</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081665593">
    <j.0:identifier>10.1016/S2215-0366(20)30073-0</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081665593&amp;doi=10.1016%2fS2215-0366%2820%2930073-0&amp;partnerID=40&amp;md5=c105eb56c645701679c456e953b266e5&gt;</schema:url>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
    <j.0:title>Psychological interventions for people affected by the COVID-19 epidemic</j.0:title>
    <j.0:identifier>2-s2.0-85081665593</j.0:identifier>
    <schema:keywords>Coronavirus infection; crisis intervention; epidemic; human; mental health; Note; priority journal; psychotherapy</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>4</myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume>7</myOnto:volume>
    <dc:creator>Duan L., Zhu G.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080847870">
    <dc:creator>Catton H.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords>female; global health; health care delivery; human; midwife; nurse midwife; pregnancy; Delivery of Health Care; Female; Global Health; Humans; Midwifery; Nurse Midwives; Pregnancy</schema:keywords>
    <myOnto:volume>67</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080847870</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1111/inr.12578</j.0:identifier>
    <j.0:title>Global challenges in health and health care for nurses and midwives everywhere</j.0:title>
    <myOnto:issue>1</myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_nursing_review">
        <j.1:name>International nursing review</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080847870&amp;doi=10.1111%2finr.12578&amp;partnerID=40&amp;md5=458f933a1c8ec8d815d47f6845f7bfe4&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>The next decade is likely to produce any number of global challenges that will affect health and health care, including pan-national infections such as the new coronavirus COVID-19 and others that will be related to global warming. Nurses will be required to react to these events, even though they will also be affected as ordinary citizens. The future resilience of healthcare services will depend on having sufficient numbers of nurses who are adequately resourced to face the coming challenges. © 2020 International Council of Nurses.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079618761">
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords>antivirus agent; atorvastatin; cyclosporine; fibric acid derivative; glitazone derivative; interferon beta serine; interleukin 17; lopinavir plus ritonavir; metformin; monoclonal antibody; remdesivir; ribavirin; sartan derivative; tocilizumab; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; Coronavirinae; coronavirus disease 2019; Coronavirus infection; critically ill patient; cytokine storm; disease association; disease management; drug repositioning; drug safety; human; immune response; intensive care; Letter; lung fibrosis; mesenchymal stroma cell; mortality; nonhuman; pathogenesis; priority journal; public health; quality of life; T lymphocyte; Th2 cell; tissue regeneration; World Health Organization; Betacoronavirus; Coronavirus infection; drug development; global health; Betacoronavirus; Coronavirus Infections; Drug Discovery; Global Health; Humans</schema:keywords>
    <j.0:identifier>2-s2.0-85079618761</j.0:identifier>
    <myOnto:issue>10224</myOnto:issue>
    <dc:creator>Zumla A., Hui D.S., Azhar E.I., Memish Z.A., Maeurer M.</dc:creator>
    <j.0:title>Reducing mortality from 2019-nCoV: host-directed therapies should be an option</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30305-6</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079618761&amp;doi=10.1016%2fS0140-6736%2820%2930305-6&amp;partnerID=40&amp;md5=1a14a03d5cfc3998793c50f7f9352d38&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082123913">
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1038/s41421-020-0156-0</j.0:identifier>
    <dc:creator>Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., Li Y., Hu Z., Zhong W., Wang M.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>6</myOnto:volume>
    <j.0:identifier>2-s2.0-85082123913</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082123913&amp;doi=10.1038%2fs41421-020-0156-0&amp;partnerID=40&amp;md5=bb5c809118d0bd8a72fce3f8987a514f&gt;</schema:url>
    <j.0:title>Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Discovery"/>
    <j.0:publisher>Springer Nature</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079056243">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079056243&amp;doi=10.1016%2fS0140-6736%2820%2930317-2&amp;partnerID=40&amp;md5=eb6bb4dede288dbd14e2591801333909&gt;</schema:url>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>10223</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079056243</j.0:identifier>
    <j.0:identifier>10.1016/S0140-6736(20)30317-2</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy>19</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury</j.0:title>
    <dc:language>English</dc:language>
    <schema:keywords>corticosteroid; COVID-19; glucocorticoid; severe acute respiratory syndrome coronavirus 2; clinical effectiveness; clinical outcome; coronavirus disease 2019; coronavirus disease 2019; Coronavirus infection; corticosteroid therapy; drug efficacy; epidemic; evidence based medicine; health hazard; high risk patient; human; immune response; influenza; lung injury; Middle East respiratory syndrome; mortality; Note; priority journal; respiratory syncytial virus infection; respiratory tract infection; risk assessment; severe acute respiratory syndrome; treatment outcome; viral clearance; Betacoronavirus; Coronavirus infection; procedures; virus pneumonia; Betacoronavirus; Coronavirus Infections; Evidence-Based Medicine; Glucocorticoids; Humans; Pneumonia, Viral</schema:keywords>
    <dc:creator>Russell C.D., Millar J.E., Baillie J.K.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079709025">
    <j.0:type>Note</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079709025</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:identifier>10.1002/jmv.25702</j.0:identifier>
    <dc:creator>Xiao S.-Y., Wu Y., Liu H.</dc:creator>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; animal; bat; Betacoronavirus; Coronavirinae; Coronavirus infection; epidemic; pneumonia; Animals; Betacoronavirus; Chiroptera; Coronavirus; Coronavirus Infections; Disease Outbreaks; Pneumonia</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079709025&amp;doi=10.1002%2fjmv.25702&amp;partnerID=40&amp;md5=f45fbfdae1d3f70b8a36a00856d47b09&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081977217">
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <j.0:title>Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1016/j.acra.2020.03.002</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081977217</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Rationale and Objectives: To retrospectively analyze the chest imaging findings in patients with coronavirus disease 2019 (COVID-19) on thin-section CT. Materials and Methods: Fifty-three patients with confirmed COVID-19 infection underwent thin-section CT examination. Two chest radiologists independently evaluated the imaging in terms of distribution, ground-glass opacity (GGO), consolidation, air bronchogram, stripe, enlarged mediastinal lymph node, and pleural effusion. Results: Fourty-seven cases (88.7%) had findings of COVID-19 infection, and the other six (11.3%) were normal. Among the 47 cases, 78.7% involved both lungs, and 93.6% had peripheral infiltrates distributed along the subpleural area. All cases showed GGO, 59.6% of which were round and 40.4% patchy. Other imaging features included “crazy-paving pattern” (89.4%), consolidation (63.8%), and air bronchogram (76.6%). Air bronchograms were observed within GGO (61.7%) and consolidation (70.3%). Neither enlarged mediastinal lymph nodes nor pleural effusion were present. Thirty-three patients (62.3%) were followed an average interval of 6.2 ± 2.9 days. The lesions increased in 75.8% and resorbed in 24.2% of patients. Conclusion: COVID-19 showed the pulmonary lesions in patients infected with COVID-19 were predominantly distributed peripherally in the subpleural area. © 2020 The Association of University Radiologists</rdfs:comment>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081977217&amp;doi=10.1016%2fj.acra.2020.03.002&amp;partnerID=40&amp;md5=d6060c4add259a1621dd44ffb38aab74&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Academic_Radiology"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Guan C.S., Lv Z.B., Yan S., Du Y.N., Chen H., Wei L.G., Xie R.M., Chen B.D.</dc:creator>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081691193">
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Since December 2019, more than 79,000 people have been diagnosed with infection of the Corona Virus Disease 2019 (COVID-19). A large number of medical staff was sent to Wuhan city and Hubei province to aid COVID-19 control. Psychological stress, especially vicarious traumatization caused by the COVID-19 pandemic, should not be ignored. To address this concern, the study employed a total of 214 general public and 526 nurses (i.e., 234 front-line nurses and 292 non-front-line nurses) to evaluate vicarious traumatization scores via a mobile app-based questionnaire. Front-line nurses are engaged in the process of providing care for patients with COVID-19. The results showed that the vicarious traumatization scores for front-line nurses including scores for physiological and psychological responses, were significantly lower than those of non-front-line nurses (P &lt; 0.001). Interestingly, the vicarious traumatization scores of the general public were significantly higher than those of the front-line nurses (P &lt; 0.001); however, no statistical difference was observed compared to the scores of non-front-line nurses (P &gt; 0.05). Therefore, increased attention should be paid to the psychological problems of the medical staff, especially non-front-line nurses, and general public under the situation of the spread and control of COVID-19. Early strategies that aim to prevent and treat vicarious traumatization in medical staff and general public are extremely necessary. © 2020 Elsevier Inc.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081691193</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Brain,_Behavior,_and_Immunity">
        <j.1:name>Brain, Behavior, and Immunity</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:title>Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control</j.0:title>
    <j.0:identifier>10.1016/j.bbi.2020.03.007</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Academic Press Inc.</j.0:publisher>
    <dc:creator>Li Z., Ge J., Yang M., Feng J., Qiao M., Jiang R., Bi J., Zhan G., Xu X., Wang L., Zhou Q., Zhou C., Pan Y., Liu S., Zhang H., Yang J., Zhu B., Hu Y., Hashimoto K., Jia Y., Wang H., Wang R., Liu C., Yang C.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081691193&amp;doi=10.1016%2fj.bbi.2020.03.007&amp;partnerID=40&amp;md5=fcc5820180b380a6f701b922f6334503&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082063395">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adolescent; adult; age distribution; aged; asymptomatic infection; Betacoronavirus; child; Coronavirus infection; epidemic; female; genetics; human; infant; isolation and purification; male; middle aged; newborn; preschool child; quarantine; sex ratio; ship; statistical model; travel; very elderly; virus pneumonia; young adult; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Asymptomatic Infections; Betacoronavirus; Child; Child, Preschool; Coronavirus Infections; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Models, Statistical; Pneumonia, Viral; Quarantine; Sex Distribution; Ships; Travel; Young Adult</schema:keywords>
    <j.0:identifier>2-s2.0-85082063395</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082063395&amp;doi=10.2807%2f1560-7917.ES.2020.25.10.2000180&amp;partnerID=40&amp;md5=821e34f7daba09c68906a286669dc6d3&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>On 5 February 2020, in Yokohama, Japan, a cruise ship hosting 3,711 people underwent a 2-week quarantine after a former passenger was found with COVID-19 post-disembarking. As at 20 February, 634 persons on board tested positive for the causative virus. We conducted statistical modelling to derive the delay-adjusted asymptomatic proportion of infections, along with the infections' timeline. The estimated asymptomatic proportion was 17.9% (95% credible interval (CrI):?15.5-20.2%). Most infections occurred before the quarantine start.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <dc:creator>Mizumoto K., Kagaya K., Zarebski A., Chowell G.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.10.2000180</j.0:identifier>
    <j.0:title>Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020</j.0:title>
    <myOnto:issue>10</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079799485">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cell_Discovery"/>
    <j.0:identifier>2-s2.0-85079799485</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1038/s41421-020-0148-0</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>An outbreak of clusters of viral pneumonia due to a novel coronavirus (2019-nCoV/SARS-CoV-2) happened in Wuhan, Hubei Province in China in December 2019. Since the outbreak, several groups reported estimated R0 of Coronavirus Disease 2019 (COVID-19) and generated valuable prediction for the early phase of this outbreak. After implementation of strict prevention and control measures in China, new estimation is needed. An infectious disease dynamics SEIR (Susceptible, Exposed, Infectious, and Removed) model was applied to estimate the epidemic trend in Wuhan, China under two assumptions of Rt. In the first assumption, Rt was assumed to maintain over 1. The estimated number of infections would continue to increase throughout February without any indication of dropping with Rt = 1.9, 2.6, or 3.1. The number of infections would reach 11,044, 70,258, and 227,989, respectively, by 29 February 2020. In the second assumption, Rt was assumed to gradually decrease at different phases from high level of transmission (Rt = 3.1, 2.6, and 1.9) to below 1 (Rt = 0.9 or 0.5) owing to increasingly implemented public health intervention. Several phases were divided by the dates when various levels of prevention and control measures were taken in effect in Wuhan. The estimated number of infections would reach the peak in late February, which is 58,077–84,520 or 55,869–81,393. Whether or not the peak of the number of infections would occur in February 2020 may be an important index for evaluating the sufficiency of the current measures taken in China. Regardless of the occurrence of the peak, the currently strict measures in Wuhan should be continuously implemented and necessary strict public health measures should be applied in other locations in China with high number of COVID-19 cases, in order to reduce Rt to an ideal level and control the infection. © 2020, The Author(s).</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; Article; case fatality rate; China; Coronavirinae; Coronavirus infection; human; infection control; infection prevention; major clinical study; priority journal</schema:keywords>
    <myOnto:volume>6</myOnto:volume>
    <dc:creator>Wang H., Wang Z., Dong Y., Chang R., Xu C., Yu X., Zhang S., Tsamlag L., Shang M., Huang J., Wang Y., Xu G., Shen T., Zhang X., Cai Y.</dc:creator>
    <j.0:title>Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079799485&amp;doi=10.1038%2fs41421-020-0148-0&amp;partnerID=40&amp;md5=0725368d73311c24c1244cd58bb3861a&gt;</schema:url>
    <myOnto:issue>1</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082118216">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082118216</j.0:identifier>
    <j.0:title>DAZ-SPEZIAL COVID-19: Herausforderung COVID-19</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082118216&amp;partnerID=40&amp;md5=422193b5551ec9175f8c1555640430c2&gt;</schema:url>
    <dc:language>German</dc:language>
    <dc:creator>Blasius H.</dc:creator>
    <myOnto:volume>160</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Deutsche_Apotheker_Zeitung">
        <j.1:name>Deutsche Apotheker Zeitung</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Deutscher Apotheker Verlag</j.0:publisher>
    <j.0:identifier></j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>10</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079654261">
    <j.0:title>From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30350-0</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079654261&amp;doi=10.1016%2fS0140-6736%2820%2930350-0&amp;partnerID=40&amp;md5=c74ff6ca4ff48ff3eaaf7fc83e9aa05f&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <dc:creator>Wang L.-F., Anderson D.E., Mackenzie J.S., Merson M.H.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85079654261</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; bat; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease control; disease severity; early diagnosis; emerging zoonotic virus; epidemic; government; high throughput sequencing; human; mass medium; medical information; Middle East respiratory syndrome coronavirus; nonhuman; Note; panic; physician; priority journal; publication; SARS coronavirus; scientific literature; severe acute respiratory syndrome; virus detection; virus transmission; wildlife; animal; Betacoronavirus; communicable disease; epidemic; global health; pathogenicity; virology; zoonosis; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; Communicable Diseases, Emerging; Disease Outbreaks; Global Health; Humans; Zoonoses</schema:keywords>
    <j.0:type>Note</j.0:type>
    <myOnto:volume>395</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10224</myOnto:issue>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081898418">
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.15252/embr.202050334</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/EMBO_Reports">
        <j.1:name>EMBO Reports</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume></myOnto:volume>
    <j.0:publisher>Wiley-VCH Verlag</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>The spread of the COVID-19 coronavirus: Health agencies worldwide prepare for the seemingly inevitability of the COVID-19 coronavirus becoming endemic</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081898418&amp;doi=10.15252%2fembr.202050334&amp;partnerID=40&amp;md5=6b9468e55df44d5b5320ade6ff1d37d6&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081898418</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:type>Note</j.0:type>
    <dc:creator>Hunter P.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079080060">
    <myOnto:volume>44</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079080060&amp;doi=10.33321%2fcdi.2019.44.13&amp;partnerID=40&amp;md5=7a4bee7db8a8a67187483869714ece0b&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)"/>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Australia; Betacoronavirus; Coronavirus infection; epidemic; human; respiratory tract infection; virus pneumonia; Australia; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; Respiratory Tract Infections</schema:keywords>
    <j.0:identifier>2-s2.0-85079080060</j.0:identifier>
    <dc:creator>2019-nCoV National Incident Room Surveillance Team</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:title>2019-nCoV acute respiratory disease, Australia: Epidemiology Report 1 (Reporting week 26 January - 1 February 2020)</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <rdfs:comment>This is the first epidemiological report of novel coronavirus (2019-nCoV) acute respiratory disease infections reported in Australia at 19:00 Australian Eastern Daylight Time [AEDT] 1 February 2020. It includes data on Australian cases notified during the week 26 January to 1 February 2020 and in the previous week (19 to 25 January 2020), the international situation and current information on the severity, transmission and spread of the 2019-nCoV infection. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.33321/cdi.2019.44.13</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078687750">
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.3.2000045</j.0:identifier>
    <dc:creator>Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., Bleicker T., Brünink S., Schneider J., Schmidt M.L., Mulders D.G., Haagmans B.L., van der Veer B., van den Brink S., Wijsman L., Goderski G., Romette J.-L., Ellis J., Zambon M., Peiris M., Goossens H., Reusken C., Koopmans M.P., Drosten C.</dc:creator>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078687750&amp;doi=10.2807%2f1560-7917.ES.2020.25.3.2000045&amp;partnerID=40&amp;md5=57b65d3def631178a03267ac830007a5&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>virus RNA; classification; Coronavirinae; Coronavirus infection; epidemic; genetics; human; isolation and purification; laboratory technique; procedures; real time polymerase chain reaction; sensitivity and specificity; virology; Clinical Laboratory Techniques; Coronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Real-Time Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity</schema:keywords>
    <myOnto:issue>3</myOnto:issue>
    <j.0:identifier>2-s2.0-85078687750</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR</j.0:title>
    <myOnto:volume>25</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>29</myOnto:citeyBy>
    <rdfs:comment>BackgroundThe ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur.AimWe aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available.MethodsHere we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology.ResultsThe workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project.ConclusionThe present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080101669">
    <j.0:identifier>2-s2.0-85080101669</j.0:identifier>
    <j.0:title>Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists</j.0:title>
    <dc:creator>Bouadma L., Lescure F.-X., Lucet J.-C., Yazdanpanah Y., Timsit J.-F.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1007/s00134-020-05967-x</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080101669&amp;doi=10.1007%2fs00134-020-05967-x&amp;partnerID=40&amp;md5=e56facc8f16e39921017a4f6c3ef77f6&gt;</schema:url>
    <j.0:publisher>Springer</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081255962">
    <j.0:title>Understanding unreported cases in the COVID-19 epidemic outbreak in Wuhan, China, and the importance of major public health interventions</j.0:title>
    <j.0:identifier>2-s2.0-85081255962</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081255962&amp;doi=10.3390%2fbiology9030050&amp;partnerID=40&amp;md5=1b4a1a6ed77cb3bda92a2fa689f71b65&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:creator>Liu Z., Magal P., Seydi O., Webb G.</dc:creator>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.3390/biology9030050</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:volume>9</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>We develop a mathematical model to provide epidemic predictions for the COVID-19 epidemic in Wuhan, China. We use reported case data up to 31 January 2020 from the Chinese Center for Disease Control and Prevention and the Wuhan Municipal Health Commission to parameterize the model. From the parameterized model, we identify the number of unreported cases. We then use the model to project the epidemic forward with varying levels of public health interventions. The model predictions emphasize the importance of major public health interventions in controlling COVID-19 epidemics.. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Biology">
        <j.1:name>Biology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <j.0:publisher>MDPI AG</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081042790">
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <dc:creator>Rubin E.J., Baden L.R., Morrissey S.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <schema:keywords>audio recording; clinician; coronavirus disease 2019; diagnostic test; Editorial; human; interview; priority journal; public health; SARS coronavirus; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2; treatment planning; United States; virus transmission; World Health Organization; Coronavirus infection; laboratory technique; virus pneumonia; COVID-19; Clinical Laboratory Techniques; Coronavirus Infections; Humans; Pneumonia, Viral; United States</schema:keywords>
    <j.0:identifier>2-s2.0-85081042790</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:volume>382</myOnto:volume>
    <j.0:title>Audio interview: What clinicians need to know in diagnosing and treating covid-19</j.0:title>
    <j.0:identifier>10.1056/nejme2004244</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081042790&amp;doi=10.1056%2fnejme2004244&amp;partnerID=40&amp;md5=f17f4547e038f47566d225a849e5c57f&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>10</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085077941653">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077941653&amp;doi=10.1126%2fscience.367.6475.234&amp;partnerID=40&amp;md5=3dbbeb618d8786d895c348ac32c0ebb7&gt;</schema:url>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <dc:date>2020</dc:date>
    <myOnto:issue>6475</myOnto:issue>
    <j.0:identifier>10.1126/science.367.6475.234</j.0:identifier>
    <j.0:type>Short Survey</j.0:type>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <j.0:title>New SARS-like virus in China triggers alarm</j.0:title>
    <myOnto:volume>367</myOnto:volume>
    <schema:keywords>alarm signal; detection method; viral disease; virus; 2019 novel coronavirus; China; Chinese; Coronavirinae; Coronavirus infection; diagnostic test; disease transmission; epidemic; global health; human; immunoassay; market; mortality rate; nonhuman; nucleic acid analysis; pneumonia; priority journal; SARS-related coronavirus; severe acute respiratory syndrome; Short Survey; World Health Organization</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85077941653</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Cohen J., Normile D.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079789964">
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_Oral_Investigations">
        <j.1:name>Clinical Oral Investigations</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <dc:creator>Sabino-Silva R., Jardim A.C.G., Siqueira W.L.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Springer</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079789964&amp;doi=10.1007%2fs00784-020-03248-x&amp;partnerID=40&amp;md5=de34af39836973c4d51065c9dcbc3dda&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1007/s00784-020-03248-x</j.0:identifier>
    <j.0:title>Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079789964</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079815357">
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079815357&amp;doi=10.1136%2fbmj.m641&amp;partnerID=40&amp;md5=c872523f914dc43fad59230c689f4919&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:type>Article</j.0:type>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079815357</j.0:identifier>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m641</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079145439">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Medical journals and the 2019-nCoV outbreak</j.0:title>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <dc:creator>Rubin E.J., Baden L.R., Morrissey S., Campion E.W.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>clinician; coronavirus disease 2019; Coronavirus infection; Editorial; human; information processing; patient care; peer review; priority journal; public health; World Health Organization; Coronavirus infection; epidemic; publication; publishing; virus pneumonia; COVID-19; Coronavirus Infections; Disease Outbreaks; Editorial Policies; Humans; Periodicals as Topic; Pneumonia, Viral</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <j.0:identifier>10.1056/NEJMe2001329</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079145439&amp;doi=10.1056%2fNEJMe2001329&amp;partnerID=40&amp;md5=2c11bc2306c4b236a274b488f35aaada&gt;</schema:url>
    <myOnto:volume>382</myOnto:volume>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>9</myOnto:issue>
    <j.0:identifier>2-s2.0-85079145439</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081646498">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Occupational_Medicine">
        <j.1:name>Occupational Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Koh D.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Occupational risks for COVID-19 infection</j.0:title>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Oxford University Press</j.0:publisher>
    <schema:keywords>COVID-19; animal; China; commercial phenomena; Coronavirus infection; health care personnel; human; infection control; occupational disease; occupational exposure; risk factor; travel; virus pneumonia; zoonosis; Animals; China; Commerce; Coronavirus Infections; Health Personnel; Humans; Infection Control; Occupational Diseases; Occupational Exposure; Pneumonia, Viral; Risk Factors; Travel; Zoonoses</schema:keywords>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081646498&amp;doi=10.1093%2foccmed%2fkqaa036&amp;partnerID=40&amp;md5=aa0a4e861a7537815c36ada77744ec49&gt;</schema:url>
    <myOnto:volume>70</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081646498</j.0:identifier>
    <j.0:identifier>10.1093/occmed/kqaa036</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080049274">
    <schema:keywords>alanine aminotransferase; alkaline phosphatase; aspartate aminotransferase; cefepime; creatine kinase; guaifenesin; ibuprofen; lactate dehydrogenase; ondansetron; paracetamol; remdesivir; sodium chloride; vancomycin; virus RNA; COVID-19; severe acute respiratory syndrome coronavirus 2; abdominal discomfort; adult; alanine aminotransferase blood level; alkaline phosphatase blood level; Article; aspartate aminotransferase blood level; case report; clinical article; clinical feature; Coronavirinae; coronavirus disease 2019; Coronavirus infection; coughing; crackle; creatine kinase blood level; evening dosage; fatigue; feces analysis; fever; high throughput sequencing; hospital acquired pneumonia; human; lactate dehydrogenase blood level; leukopenia; loading drug dose; loose feces; lung auscultation; male; nausea; nausea and vomiting; oxygen saturation; patient isolation; pneumonia; priority journal; pulse oximetry; real time reverse transcription polymerase chain reaction; rhinorrhea; Sanger sequencing; Severe acute respiratory syndrome coronavirus 2; tachycardia; thorax radiography; throat culture; thrombocytopenia; United States; virus genome; virus pneumonia; wheezing; whole genome sequencing; Betacoronavirus; blood analysis; China; Coronavirus infection; diagnostic imaging; disease exacerbation; DNA sequence; genetics; isolation and purification; lung; pathology; travel; virus pneumonia; Adult; Betacoronavirus; Blood Chemical Analysis; China; Coronavirus Infections; Disease Progression; Genome, Viral; Humans; Lung; Male; Pneumonia, Viral; Radiography, Thoracic; Sequence Analysis, DNA; Travel; United States</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1056/NEJMoa2001191</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., Tural A., Diaz G., Cohn A., Fox L., Patel A., Gerber S.I., Kim L., Tong S., Lu X., Lindstrom S., Pallansch M.A., Weldon W.C., Biggs H.M., Uyeki T.M., Pillai S.K., Washington State 2019-nCoV Case Investigation Team</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient's initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection. Copyright © 2020 Massachusetts Medical Society.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080049274&amp;doi=10.1056%2fNEJMoa2001191&amp;partnerID=40&amp;md5=8790011cf809dfbbfbd970a8238c2437&gt;</schema:url>
    <myOnto:volume>382</myOnto:volume>
    <myOnto:citeyBy>66</myOnto:citeyBy>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <myOnto:issue>10</myOnto:issue>
    <j.0:identifier>2-s2.0-85080049274</j.0:identifier>
    <j.0:title>First case of 2019 novel coronavirus in the United States</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080904688">
    <dc:creator>Calisher C., Carroll D., Colwell R., Corley R.B., Daszak P., Drosten C., Enjuanes L., Farrar J., Field H., Golding J., Gorbalenya A., Haagmans B., Hughes J.M., Karesh W.B., Keusch G.T., Lam S.K., Lubroth J., Mackenzie J.S., Madoff L., Mazet J., Palese P., Perlman S., Poon L., Roizman B., Saif L., Subbarao K., Turner M.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:identifier>2-s2.0-85080904688</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:title>Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080904688&amp;doi=10.1016%2fS0140-6736%2820%2930418-9&amp;partnerID=40&amp;md5=134f882c6eb839d769c3d78920137cf3&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:issue>10226</myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <schema:keywords>2019 novel coronavirus infection; China; Chinese; Coronavirus infection; epidemic; global health; health care personnel; human; intersectoral collaboration; Letter; priority journal; public health; scientist; severe acute respiratory syndrome; virus identification; virus virulence; wellbeing; wildlife; Betacoronavirus; Coronavirus infection; information dissemination; interpersonal communication; medical research; public relations; science; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Biomedical Research; China; Coronavirus Infections; Health Personnel; Humans; Information Dissemination; Interprofessional Relations; Pneumonia, Viral; Public Health; Science; Truth Disclosure</schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30418-9</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079082904">
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079082904</j.0:identifier>
    <myOnto:volume>150</myOnto:volume>
    <j.0:title>2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution</j.0:title>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <schema:keywords>COVID-19; Coronavirus infection; human; mortality; virus pneumonia; Coronavirus Infections; Humans; Mortality; Pneumonia, Viral</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Swiss_medical_weekly"/>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079082904&amp;doi=10.4414%2fsmw.2020.20203&amp;partnerID=40&amp;md5=d8c5e1541d62c2b9167679f1bbb876fa&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Battegay M., Kuehl R., Tschudin-Sutter S., Hirsch H.H., Widmer A.F., Neher R.A.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:identifier>10.4414/smw.2020.20203</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081531337">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081531337&amp;doi=10.26355%2feurrev_202002_20379&amp;partnerID=40&amp;md5=452a394abe8ce358d4bc16a5345cfbf9&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>OBJECTIVE: Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. This study aimed at investigating the global prevalence, biological and clinical characteristics of novel coronavirus, Wuhan China (2019-nCoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection outbreaks. MATERIALS AND METHODS: The data on the global outbreak of "2019-nCoV, SARS-CoV, and MERS-CoV" were obtained from World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), concerned ministries and research institutes. We also recorded the information from research documents published in global scientific journals indexed in ISI Web of Science and research centers on the prevalence, biological and clinical characteristics of 2019-nCoV, SARS-CoV, and MERS-CoV. RESULTS: Worldwide, SARS-CoV involved 32 countries, with 8422 confirmed cases and 916 (10.87%) casualties from November 2002 to August 2003. MERS-CoV spread over 27 states, causing 2496 cases and 868 (34.77%) fatalities during the period April 2012 to December 2019. However, the novel coronavirus 2019-nCoV spread swiftly the global borders of 27 countries. It infected 34799 people and resulted in 724 (2.08%) casualties during the period December 29, 2019 to February 7, 2020. The fatality rate of coronavirus MERSCoV was (34.77%) higher than SARS-CoV (10.87%) and 2019-nCoV (2.08%); however, the 2019-nCoV transmitted rapidly in comparison to SARS-CoV and MERS-CoV. CONCLUSIONS: The novel coronavirus 2019-nCoV has diverse epidemiological and biological characteristics, making it more contagious than SARS-CoV and MERS-CoV. It has affected more people in a short time period compared to SARS-CoV and MERS-CoV, although the fatality rate of MERS-CoV was higher than SARS-CoV and 2019-nCoV. The major clinical manifestations in coronavirus infections 2019-nCoV, MERS-CoV, and SARS CoV are fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and pneumonia. Global health authorities should take immediate measures to prevent the outbreaks of such emerging and reemerging pathogens across the globe to minimize the disease burden locally and globally. © 2020 Verduci Editore s.r.l. All rights reserved.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <schema:keywords>2019 novel coronavirus; adult; aged; China; comparative study; Coronavirinae; Coronavirus infection; disease transmission; epidemic; female; human; human cell; major clinical study; male; middle aged; Middle East respiratory syndrome coronavirus; mortality rate; prevalence; public health service; Review; SARS coronavirus; Betacoronavirus; complication; Coronavirus infection; severe acute respiratory syndrome; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus Infections; Humans; Pneumonia, Viral; Prevalence; Severe Acute Respiratory Syndrome</schema:keywords>
    <myOnto:volume>24</myOnto:volume>
    <dc:creator>Meo S.A., Alhowikan A.M., Khlaiwi T.A.L., Meo I.M., Halepoto D.M., Iqbal M., Usmani A.M., Hajjar W., Ahmed N.</dc:creator>
    <j.0:identifier>10.26355/eurrev_202002_20379</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_Review_for_Medical_and_Pharmacological_Sciences"/>
    <myOnto:issue>4</myOnto:issue>
    <j.0:publisher>Verduci Editore s.r.l</j.0:publisher>
    <j.0:title>Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081531337</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079793129">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>methylprednisolone; corticosteroid; severe acute respiratory syndrome coronavirus 2; artificial ventilation; community acquired pneumonia; coronavirus disease 2019; coronavirus disease 2019; Coronavirus infection; drug use; evidence based practice; human; hypoxemia; influenza A (H1N1); length of stay; Letter; mortality rate; priority journal; prospective study; risk factor; severe acute respiratory syndrome; treatment duration; virus pneumonia; Betacoronavirus; lung injury; pneumonia; Adrenal Cortex Hormones; Betacoronavirus; Humans; Lung Injury; Pneumonia</schema:keywords>
    <myOnto:issue>10225</myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079793129&amp;doi=10.1016%2fS0140-6736%2820%2930361-5&amp;partnerID=40&amp;md5=31de9cdf3097e4cd2e67b0d7dafbbb5b&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30361-5</j.0:identifier>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079793129</j.0:identifier>
    <j.0:title>On the use of corticosteroids for 2019-nCoV pneumonia</j.0:title>
    <dc:creator>Shang L., Zhao J., Hu Y., Du R., Cao B.</dc:creator>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>395</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081725127">
    <j.0:identifier>10.1007/s00259-020-04762-6</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Springer</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>18F-FDG PET/CT and COVID-19</j.0:title>
    <j.0:identifier>2-s2.0-85081725127</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_Journal_of_Nuclear_Medicine_and_Molecular_Imaging"/>
    <dc:creator>Joob B., Wiwanitkit V.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081725127&amp;doi=10.1007%2fs00259-020-04762-6&amp;partnerID=40&amp;md5=0eed4efad6df0d0836b56487e321fa08&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081284827">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081284827&amp;doi=10.1016%2fj.tmaid.2020.101613&amp;partnerID=40&amp;md5=f47ef2b8f6548744dd4d4b472799807e&gt;</schema:url>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:creator>Rodriguez-Morales A.J., Gallego V., Escalera-Antezana J.P., Méndez C.A., Zambrano L.I., Franco-Paredes C., Suárez J.A., Rodriguez-Enciso H.D., Balbin-Ramon G.J., Savio-Larriera E., Risquez A., Cimerman S.</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081284827</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/j.tmaid.2020.101613</j.0:identifier>
    <j.0:title>COVID-19 in Latin America: The implications of the first confirmed case in Brazil</j.0:title>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081659817">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>A locally transmitted case of SARS-CoV-2 infection in Taiwan</j.0:title>
    <myOnto:volume>382</myOnto:volume>
    <j.0:identifier>2-s2.0-85081659817</j.0:identifier>
    <myOnto:issue>11</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1056/NEJMc2001573</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081659817&amp;doi=10.1056%2fNEJMc2001573&amp;partnerID=40&amp;md5=0876e5e208855116737b5e879e8a0992&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <dc:creator>Liu Y.-C., Liao C.-H., Chang C.-F., Chou C.-C., Lin Y.-R.</dc:creator>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; case report; China; complication; Coronavirus infection; diagnostic imaging; female; fever; human; isolation and purification; male; middle aged; myalgia; spouse; Taiwan; thorax radiography; travel; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Female; Fever; Humans; Male; Middle Aged; Myalgia; Pneumonia, Viral; Radiography, Thoracic; Spouses; Taiwan; Travel</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092271">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>395</myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85082092271</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1016/S0140-6736(20)30670-X</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092271&amp;doi=10.1016%2fS0140-6736%2820%2930670-X&amp;partnerID=40&amp;md5=d70e7d1640f85caf9007ab7b3f128851&gt;</schema:url>
    <j.0:title>Canada and COVID-19: learning from SARS</j.0:title>
    <dc:creator>Webster P.</dc:creator>
    <myOnto:issue>10228</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Lancet_(London,_England)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081205867">
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Digestive_Diseases">
        <j.1:name>Journal of Digestive Diseases</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Blackwell Publishing</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:title>2019 Novel coronavirus infection and gastrointestinal tract</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081205867&amp;doi=10.1111%2f1751-2980.12851&amp;partnerID=40&amp;md5=0d3c870f312c63bef42f5bb60da8d7c0&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081205867</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>10.1111/1751-2980.12851</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Gao Q.Y., Chen Y.X., Fang J.Y.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079138964">
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85079138964</j.0:identifier>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:title>The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report</j.0:title>
    <myOnto:volume>33</myOnto:volume>
    <schema:keywords>2019 novel coronavirus; China; Coronavirus infection; epidemic; human; Letter; priority journal; railway; traffic and transport; travel; virus transmission; Betacoronavirus; Coronavirus infection; data analysis; pathogenicity; statistical model; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Data Analysis; Disease Outbreaks; Humans; Models, Statistical; Pneumonia, Viral; Transportation; Travel</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/j.tmaid.2020.101568</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079138964&amp;doi=10.1016%2fj.tmaid.2020.101568&amp;partnerID=40&amp;md5=cf552c6f6eabcdb0caaf2abd3bc18312&gt;</schema:url>
    <dc:creator>Zhao S., Zhuang Z., Ran J., Lin J., Yang G., Yang L., He D.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081336819">
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081336819&amp;doi=10.1002%2fjmv.25735&amp;partnerID=40&amp;md5=165ce7234b5fe0bf9c23548745a702f1&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>We aim to summarize reliable evidence of evidence-based medicine for the treatment and prevention of the 2019 novel coronavirus (2019-nCoV) by analyzing all the published studies on the clinical characteristics of patients with 2019-nCoV. PubMed, Cochrane Library, Embase, and other databases were searched. Several studies on the clinical characteristics of 2019-nCoV infection were collected for meta-analysis. Ten studies were included in the meta-analysis, including a total number of 50 466 patients with 2019-nCoV infection. Meta-analysis shows that among these patients, the incidence of fever was 89.1%, the incidence of cough was 72.2%, and the incidence of muscle soreness or fatigue was 42.5%. The incidence of acute respiratory distress syndrome (ARDS) was 14.8%, the incidence of abnormal chest computer tomography (CT) was 96.6%, the percentage of severe cases in all infected cases was 18.1%, and the case fatality rate of patients with 2019-nCoV infection was 4.3%. Fever and cough are the most common symptoms in patients with 2019-nCoV infection, and most of these patients have abnormal chest CT examination. Several people have muscle soreness or fatigue as well as ARDS. Diarrhea, hemoptysis, headache, sore throat, shock, and other symptoms only occur in a small number of patients. The case fatality rate of patients with 2019-nCoV infection is lower than that of the severe acute respiratory syndrome and Middle East respiratory syndrome. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:title>Clinical characteristics of 50 466 hospitalized patients with 2019-nCoV infection</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1002/jmv.25735</j.0:identifier>
    <dc:creator>Sun P., Qie S., Liu Z., Ren J., Li K., Xi J.</dc:creator>
    <j.0:identifier>2-s2.0-85081336819</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>3</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081588550">
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/VirusDisease">
        <j.1:name>VirusDisease</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>The emergence of 2019 novel coronavirus (2019-nCoV) is of global concern and might have emerged from RNA recombination among existing coronaviruses. CoV spike (S) protein which is crucial for receptor binding, membrane fusion via conformational changes, internalization of the virus, host tissue tropism and comprises crucial targets for vaccine development, remain largely uncharacterized. Therefore, the present study has been planned to determine the sequence variation, structural and antigenic divergence of S glycoprotein which may be helpful for the management of 2019-nCoV infection. The sequences of spike glycoprotein of 2019-nCoV and SARS coronavirus (SARS-CoV) were used for the comparison. The sequence variations were determined using EMBOSS Needle pairwise sequence alignment tools. The variation in glycosylation sites was predicted by NetNGlyc 1.0 and validated by N-GlyDE server. Antigenicity was predicted by NetCTL 1.2 and validated by IEDB Analysis Resource server. The structural divergence was determined by using SuperPose Version 1.0 based on cryo-EM structure of the SARS coronavirus spike glycoprotein. Our data suggests that 2019-nCoV is newly spilled coronavirus into humans in China is closely related to SARS-CoV, which has only 12.8% of difference with SARS-CoV in S protein and has 83.9% similarity in minimal receptor-binding domain with SARS-CoV. Addition of a novel glycosylation sites were observed in 2019-nCoV. In addition, antigenic analysis proposes that great antigenic differences exist between both the viral strains, but some of the epitopes were found to be similar between both the S proteins. In spite of the variation in S protein amino acid composition, we found no significant difference in their structures. Collectively, for the first time our results exhibit the emergence of human 2019-nCoV is closely related to predecessor SARS-CoV and provide the evidence that 2019-nCoV uses various novel glycosylation sites as SARS-CoV and may have a potential to become pandemic owing its antigenic discrepancy. Further, demonstration of novel Cytotoxic T lymphocyte epitopes may impart opportunities for the development of peptide based vaccine for the prevention of 2019-nCoV. © 2020, Indian Virological Society.</rdfs:comment>
    <j.0:identifier>10.1007/s13337-020-00571-5</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081588550&amp;doi=10.1007%2fs13337-020-00571-5&amp;partnerID=40&amp;md5=8baa94ade0b4321dff765e075f2c1abd&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081588550</j.0:identifier>
    <dc:creator>Kumar S., Maurya V.K., Prasad A.K., Bhatt M.L.B., Saxena S.K.</dc:creator>
    <j.0:publisher>Springer</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:title>Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)</j.0:title>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080113143">
    <dc:creator>Robson B.</dc:creator>
    <j.0:identifier>2-s2.0-85080113143</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>This paper concerns study of the genome of the Wuhan Seafood Market isolate believed to represent the causative agent of the disease COVID-19. This is to find a short section or sections of viral protein sequence suitable for preliminary design proposal for a peptide synthetic vaccine and a peptidomimetic therapeutic, and to explore some design possibilities. The project was originally directed towards a use case for the Q-UEL language and its implementation in a knowledge management and automated inference system for medicine called the BioIngine, but focus here remains mostly on the virus itself. However, using Q-UEL systems to access relevant and emerging literature, and to interact with standard publically available bioinformatics tools on the Internet, did help quickly identify sequences of amino acids that are well conserved across many coronaviruses including 2019-nCoV. KRSFIEDLLFNKV was found to be particularly well conserved in this study and corresponds to the region around one of the known cleavage sites of the SARS virus that are believed to be required for virus activation for cell entry. This sequence motif and surrounding variations formed the basis for proposing a specific synthetic vaccine epitope and peptidomimetic agent. The work can, nonetheless, be described in traditional bioinformatics terms, and readily reproduced by others, albeit with the caveat that new data and research into 2019-nCoV is emerging and evolving at an explosive pace. Preliminary studies using molecular modeling and docking, and in that context the potential value of certain known herbal extracts, are also described. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:identifier>10.1016/j.compbiomed.2020.103670</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080113143&amp;doi=10.1016%2fj.compbiomed.2020.103670&amp;partnerID=40&amp;md5=20591589e42188a314929e38a2d3e90d&gt;</schema:url>
    <j.0:title>Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Computers_in_Biology_and_Medicine">
        <j.1:name>Computers in Biology and Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:issue></myOnto:issue>
    <schema:keywords>Bioinformatics; Commerce; Knowledge management; Plant extracts; Vaccines; Automatic browser; Coronaviruses; Peptidomimetics; Q-UEL language; Retroinverso; Synthetic vaccines; Diseases</schema:keywords>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082042823">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.4045/tidsskr.20.0190</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Ørstavik R.E.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082042823</j.0:identifier>
    <dc:language>English; Norwegian</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082042823&amp;doi=10.4045%2ftidsskr.20.0190&amp;partnerID=40&amp;md5=634d242a7f1c5c0550a9b3685dd0bbb5&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:issue>4</myOnto:issue>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; civil defense; Coronavirus infection; epidemic; human; virus pneumonia; Betacoronavirus; Civil Defense; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Tidsskrift_for_den_Norske_laegeforening_:_tidsskrift_for_praktisk_medicin,_ny_raekke"/>
    <j.0:type>Editorial</j.0:type>
    <j.0:title>Covid-19: The right amount of wolf [Covid-19: Akkurat passe ulv]</j.0:title>
    <myOnto:volume>140</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079163795">
    <j.0:title>Maps, masks and media – Traveller and practitioner resources for 2019 novel coronavirus (2019-nCoV) acute respiratory virus</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume>33</myOnto:volume>
    <j.0:identifier>2-s2.0-85079163795</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079163795&amp;doi=10.1016%2fj.tmaid.2020.101574&amp;partnerID=40&amp;md5=111ecd1be1ed28c43dc0ec85d21941f0&gt;</schema:url>
    <schema:keywords>acute respiratory tract disease; Coronavirinae; hand washing; health care personnel; human; international health regulation; Note; novel coronavirus 2019; primary medical care; priority journal; public health service; quarantine; respiratory virus; secondary health care; travel; World Health Organization; access to information; consumer health information; Coronavirus infection; emporiatrics; mask; patient education; United States; virus pneumonia; World Health Organization; COVID-19; Access to Information; Centers for Disease Control and Prevention, U.S.; Consumer Health Information; Coronavirus Infections; Humans; Masks; Patient Education as Topic; Pneumonia, Viral; Travel; Travel Medicine; United States; World Health Organization</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Chiodini J.</dc:creator>
    <j.0:identifier>10.1016/j.tmaid.2020.101574</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081989464">
    <dc:creator>Nishiura H., Linton N.M., Akhmetzhanov A.R.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081989464&amp;doi=10.1016%2fj.ijid.2020.02.060&amp;partnerID=40&amp;md5=99eae26c4cfc2b50c51561449f107456&gt;</schema:url>
    <dc:language>English</dc:language>
    <rdfs:comment>Objective: To estimate the serial interval of novel coronavirus (COVID-19) from information on 28 infector-infectee pairs. Methods: We collected dates of illness onset for primary cases (infectors) and secondary cases (infectees) from published research articles and case investigation reports. We subjectively ranked the credibility of the data and performed analyses on both the full dataset (n = 28) and a subset of pairs with highest certainty in reporting (n = 18). In addition, we adjust for right truncation of the data as the epidemic is still in its growth phase. Results: Accounting for right truncation and analyzing all pairs, we estimated the median serial interval at 4.0 days (95% credible interval [CrI]: 3.1, 4.9). Limiting our data to only the most certain pairs, the median serial interval was estimated at 4.6 days (95% CrI: 3.5, 5.9). Conclusions: The serial interval of COVID-19 is close to or shorter than its median incubation period. This suggests that a substantial proportion of secondary transmission may occur prior to illness onset. The COVID-19 serial interval is also shorter than the serial interval of severe acute respiratory syndrome (SARS), indicating that calculations made using the SARS serial interval may introduce bias. © 2020 The Author(s)</rdfs:comment>
    <j.0:title>Serial interval of novel coronavirus (COVID-19) infections</j.0:title>
    <j.0:identifier>2-s2.0-85081989464</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>93</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.ijid.2020.02.060</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081264594">
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:title>COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action</j.0:title>
    <j.0:identifier>10.1001/jama.2020.2467</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081264594&amp;doi=10.1001%2fjama.2020.2467&amp;partnerID=40&amp;md5=8fda6d769b3df3d9a5e8d5c8114c3b49&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081264594</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Wong J.E.L., Leo Y.S., Tan C.C.</dc:creator>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:type>Note</j.0:type>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082021380">
    <j.0:identifier>2-s2.0-85082021380</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082021380&amp;doi=10.1136%2fbmj.m1071&amp;partnerID=40&amp;md5=8d153c7d479b3b165e3835a7e3364f1e&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1136/bmj.m1071</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Covid-19: outbreak could last until spring 2021 and see 7.9 million hospitalised in the UK</j.0:title>
    <dc:creator>Mahase E.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>368</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081742934">
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>80</myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <dc:creator>Li Q., Feng W., Quan Y.-H.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:title>Trend and forecasting of the COVID-19 outbreak in China</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081742934&amp;doi=10.1016%2fj.jinf.2020.02.014&amp;partnerID=40&amp;md5=123778053e9132a8f3563c26bee14aae&gt;</schema:url>
    <j.0:identifier>10.1016/j.jinf.2020.02.014</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081742934</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078861706">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.tmaid.2020.101567</j.0:identifier>
    <j.0:title>The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI)</j.0:title>
    <j.0:identifier>2-s2.0-85078861706</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:keywords>Coronavirinae; Editorial; emporiatrics; global health; human; incubation time; life threat; priority journal; travel; Betacoronavirus; Coronavirus infection; emporiatrics; epidemic; medical society; Melia azedarach; pathogenicity; practice guideline; South and Central America; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Guidelines as Topic; Humans; Infectious Disease Incubation Period; Latin America; Melia azedarach; Pneumonia, Viral; Societies, Medical; Travel; Travel Medicine</schema:keywords>
    <myOnto:citeyBy>7</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:volume>33</myOnto:volume>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078861706&amp;doi=10.1016%2fj.tmaid.2020.101567&amp;partnerID=40&amp;md5=4c6b3aaae0f7ccbe3ad8acf074fc93d7&gt;</schema:url>
    <dc:creator>Biscayart C., Angeleri P., Lloveras S., Chaves T.D.S.S., Schlagenhauf P., Rodríguez-Morales A.J.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082181338">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082181338&amp;doi=10.1111%2fjth.14781&amp;partnerID=40&amp;md5=668d684d02ab46c038e8abfb5c7bb0a7&gt;</schema:url>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <dc:creator>Lillicrap D.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1111/jth.14781</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Thrombosis_and_Haemostasis">
        <j.1:name>Journal of Thrombosis and Haemostasis</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082181338</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079629819">
    <j.0:type>Editorial</j.0:type>
    <j.0:title>COVID-19: fighting panic with information</j.0:title>
    <schema:keywords>Coronavirus infection; disease transmission; Editorial; epidemic; human; panic; priority journal; public health; Betacoronavirus; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Disease Outbreaks; International Health Regulations</schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30379-2</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079629819&amp;doi=10.1016%2fS0140-6736%2820%2930379-2&amp;partnerID=40&amp;md5=e47aac0403b8e7e67090ed98123a9a4e&gt;</schema:url>
    <myOnto:issue>10224</myOnto:issue>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079629819</j.0:identifier>
    <dc:creator>The Lancet</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082033754">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Conforti C., Giuffrida R., Dianzani C., Di Meo N., Zalaudek I.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082033754&amp;doi=10.1111%2fdth.13298&amp;partnerID=40&amp;md5=33c9e7c139cdfa69fc3aba45adf2f547&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Dermatologic_Therapy">
        <j.1:name>Dermatologic Therapy</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082033754</j.0:identifier>
    <j.0:title>COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action</j.0:title>
    <j.0:identifier>10.1111/dth.13298</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Blackwell Publishing Inc.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081150234">
    <rdfs:comment>Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research and updates. In this sense, the objective of the present article was to review studies on the role of wild animals as reservoirs and/or dispersers of etiological agents of human infectious diseases in order to compile data on the main wild animals and etiological agents involved in zoonotic outbreaks. A systematic review was carried out using PRISMA guidelines, using the PubMed, Scopus and SciELO platforms as data banks. The descriptors used were 'zoonosis', 'human infectious diseases' and 'wild animals'. The results show that wild animals (mainly bats, birds and primates) play an important role in the dissemination of etiological agents (mainly viruses, as a new coronavirus called 2019 Novel Coronavirus) in extensive geographic regions. Moreover, these wild animal organisms can act as the site for essential biotic synergy among several pathogenic microorganisms, promoting a higher rate of adaptation, mutation and even genetic recombination, with consequent stimulation of new strains and subtypes, inducing new infectious agents with unknown virulent potential. In conclusion, the monitoring of these diseases and adequate preparation for possible epidemics and pandemics are fundamental conditions for the mitigation of their future impact. The zoonotic threat of these etiological agents and the impact on public health can be enormous as shown by the ongoing epidemic of 2019 novel coronavirus (2019- nCoV) infections. © 2020 Asian Pacific Journal of Tropical Medicine Produced by Wolters KluwerMedknow. All rights reserved.</rdfs:comment>
    <j.0:publisher>Wolters Kluwer Medknow Publications</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Cupertino M., Resende M., Mayer N., Carvalho L., Siqueira-Batista R.</dc:creator>
    <myOnto:issue>3</myOnto:issue>
    <j.0:title>Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Pacific_Journal_of_Tropical_Medicine"/>
    <j.0:identifier>10.4103/1995-7645.277535</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081150234&amp;doi=10.4103%2f1995-7645.277535&amp;partnerID=40&amp;md5=d3acf8efbf4b5ccc4121dbf2ce94a235&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081150234</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; bat; bird; Coronavirinae; epidemic; genetic recombination; human; infection; nonhuman; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; primate; priority journal; Review; systematic review; virus strain; wild animal; zoonosis</schema:keywords>
    <myOnto:volume>13</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082096324">
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>10.5582/bst.2020.01056</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082096324&amp;doi=10.5582%2fbst.2020.01056&amp;partnerID=40&amp;md5=3709178491e033b55b763ed2a53e6550&gt;</schema:url>
    <rdfs:comment>Rapidly sharing scientific information is an effective way to reduce public panic about COVID-19, and doing so is the key to providing real-time guidance to epidemiologists working to contain the outbreak, clinicians managing patients, and modelers helping to understand future developments and the possible effectiveness of various interventions. This issue has rapidly reviewed and published articles describing COVID-19, including the drug treatment options for SARS-CoV-2, its clinical characteristics, and therapies involving a combination of Chinese and Western medicine, the efficacy of chloroquine phosphate in the treatment of COVID-19 associated pneumonia according to clinical studies, and reflections on the system of reserve medical supplies for public health emergencies. As an academic journal, we will continue to quickly and transparently share data with frontline healthcare workers who need to know the epidemiological and clinical features of COVID-19.</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>14</myOnto:volume>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Song P., Karako T.</dc:creator>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; emergency; human; information dissemination; medical information; pandemic; public health; virus pneumonia; Betacoronavirus; Coronavirus Infections; Emergencies; Health Communication; Humans; Information Dissemination; Pandemics; Pneumonia, Viral; Public Health</schema:keywords>
    <j.0:identifier>2-s2.0-85082096324</j.0:identifier>
    <j.0:title>COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Bioscience_trends"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082201495">
    <j.0:identifier>2-s2.0-85082201495</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>Little is known about the maternal-to-neonatal intrapartum transmission of COVID-19 via vaginal route. In this study, we report the adverse pregnancy outcomes in pregnant women infected with COVID-19 pneumonia and the risk of intrapartum transmission of COVID-19 via vaginal route. None of the three neonates were infected with COVID-19 delivered via natural birth. Only one neonate was delivered prematurely. No neonatal death and stillbirth were observed in pregnant women infected with COVID-19. Moreover, all of the neonates had normal birth weight, birth length, and normal Apgar score. © 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.</rdfs:comment>
    <dc:creator>Khan S., Peng L., Siddique R., Nabi G., Nawsherwan, Xue M., Liu J., Han G.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082201495&amp;doi=10.1017%2fice.2020.84&amp;partnerID=40&amp;md5=3ea8ce4247d1a88840f3776962f8162a&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <j.0:title>Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
    <j.0:identifier>10.1017/ice.2020.84</j.0:identifier>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082180139">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1007/s11684-020-0766-9</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Frontiers_of_Medicine"/>
    <j.0:title>COVID-19 containment: China provides important lessons for global response</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>The world must act fast to contain wider international spread of the epidemic of COVID-19 now. The unprecedented public health efforts in China have contained the spread of this new virus. Measures taken in China are currently proven to reduce human-to-human transmission successfully. We summarized the effective intervention and prevention measures in the fields of public health response, clinical management, and research development in China, which may provide vital lessons for the global response. It is really important to take collaborative actions now to save more lives from the pandemic of COVID-19. © 2020, Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:creator>Zhang S., Wang Z., Chang R., Wang H., Xu C., Yu X., Tsamlag L., Dong Y., Wang H., Cai Y.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082180139&amp;doi=10.1007%2fs11684-020-0766-9&amp;partnerID=40&amp;md5=1ae1dba47bcdcd93ceea2b6b7fd5a45c&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082180139</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:publisher>Higher Education Press</j.0:publisher>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079468616">
    <j.0:identifier>2-s2.0-85079468616</j.0:identifier>
    <dc:creator>Shen K., Yang Y., Wang T., Zhao D., Jiang Y., Jin R., Zheng Y., Xu B., Xie Z., Lin L., Shang Y., Lu X., Shu S., Bai Y., Deng J., Lu M., Ye L., Wang X., Wang Y., Gao L., China National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China, Group of Respirology, Chinese Pediatric Society, Chinese Medical Association, Chinese Medical Doctor Association Committee on Respirology Pediatrics, China Medicine Education Association Committee on Pediatrics, Chinese Research Hospital Association Committee on Pediatrics, Chinese Non-government Medical Institutions Association Committee on Pediatrics, China Association of Traditional Chinese Medicine, Committee on Children's Health and Medicine Research, China News of Drug Information Association, Committee on Children's Safety Medication, Global Pediatric Pulmonology Alliance</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/World_Journal_of_Pediatrics"/>
    <j.0:title>Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079468616&amp;doi=10.1007%2fs12519-020-00343-7&amp;partnerID=40&amp;md5=c301eff962cbe3090fe23f5b6e9df3b4&gt;</schema:url>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1007/s12519-020-00343-7</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Institute of Pediatrics of Zhejiang University</j.0:publisher>
    <rdfs:comment>Since the outbreak of 2019 novel coronavirus infection (2019-nCoV) in Wuhan City, China, by January 30, 2020, a total of 9692 confirmed cases and 15,238 suspected cases have been reported around 31 provinces or cities in China. Among the confirmed cases, 1527 were severe cases, 171 had recovered and been discharged at home, and 213 died. And among these cases, a total of 28 children aged from 1 month to 17 years have been reported in China. For standardizing prevention and management of 2019-nCoV infections in children, we called up an experts’ committee to formulate this experts’ consensus statement. This statement is based on the Novel Coronavirus Infection Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National Health Committee) and other previous diagnosis and treatment strategies for pediatric virus infections. The present consensus statement summarizes current strategies on diagnosis, treatment, and prevention of 2019-nCoV infection in children. © 2020, Children's Hospital, Zhejiang University School of Medicine.</rdfs:comment>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079663023">
    <myOnto:volume>226</myOnto:volume>
    <rdfs:comment>The world is faced with a remarkable coronavirus outbreak with epicentre in Wuhan, China. Altogether 40554 cases have been confirmed globally with novel coronavirus (SARS-CoV-2) until February 10, 2020. Rigorous surveillance in other countries is required to prevent further global expansion of the outbreak, but resolving the exact mechanism of the initial transmission events is crucial. Most initial cases had visited Huanan South Seafood Market in Wuhan selling also various exotic live animals. Based on the limited initial human-to-human transmission and timely clustering of cases in Huanan market among elderly men, coupled with knowledge that coronaviruses are derived from animals and relationship of SARS-CoV-2 to bat coronavirus, zoonotic transmission in the first instance is probable. To target the actions, similar epidemiological actions to human cases are needed with animal or food exposures. According to current information, an exceptionally wide contamination of seafood market might explain the initiation of the SARS-CoV-2 outbreak. Seafood tanks, air contamination by live animals or rodents are possibilities, but sold animals normally come from various sources. The mode of transmission may become clearer in future: usually in outbreak investigations, hindsight is easy, but for now information about the initial source of this outbreak is limited. © 2020 Elsevier GmbH</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079663023</j.0:identifier>
    <j.0:publisher>Elsevier GmbH</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Hygiene_and_Environmental_Health">
        <j.1:name>International Journal of Hygiene and Environmental Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Jalava K.</dc:creator>
    <j.0:title>First respiratory transmitted food borne outbreak?</j.0:title>
    <j.0:identifier>10.1016/j.ijheh.2020.113490</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079663023&amp;doi=10.1016%2fj.ijheh.2020.113490&amp;partnerID=40&amp;md5=480df3d64b4d0d7048e2f91a190db252&gt;</schema:url>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082184759">
    <j.0:identifier>10.1016/S0140-6736(20)30633-4</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <dc:creator>Weiss P., Murdoch D.R.</dc:creator>
    <schema:keywords></schema:keywords>
    <myOnto:issue>10229</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082184759&amp;doi=10.1016%2fS0140-6736%2820%2930633-4&amp;partnerID=40&amp;md5=53dc16e718a437d5a3ce9d0ea2dd0ba7&gt;</schema:url>
    <j.0:title>Clinical course and mortality risk of severe COVID-19</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082184759</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081665262">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>Offline: COVID-19—a reckoning</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081665262</j.0:identifier>
    <myOnto:issue>10228</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081665262&amp;doi=10.1016%2fS0140-6736%2820%2930669-3&amp;partnerID=40&amp;md5=c5c352ad846ef92e2138c826d916cee8&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30669-3</j.0:identifier>
    <dc:creator>Horton R.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>395</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081886161">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1136/bmj.m953</j.0:identifier>
    <j.0:title>Covid-19: emergency departments lack proper isolation facilities, senior medic warns</j.0:title>
    <myOnto:volume>368</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081886161&amp;doi=10.1136%2fbmj.m953&amp;partnerID=40&amp;md5=23181b7e3cc5a92c962fb759daab3d93&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081886161</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:creator>Iacobucci G.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081342839">
    <j.0:identifier>10.1111/1753-0407.13027</j.0:identifier>
    <dc:creator>Bloomgarden Z.T.</dc:creator>
    <myOnto:volume>12</myOnto:volume>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081342839&amp;doi=10.1111%2f1753-0407.13027&amp;partnerID=40&amp;md5=80557dfbe5ca6657ecfb52c51bcb741f&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>dipeptidyl peptidase IV; severe acute respiratory syndrome coronavirus 2; China; coronavirus disease 2019; Coronavirus infection; diabetes mellitus; disease association; disease transmission; general condition deterioration; Hong Kong; human; influenza; lung alveolus cell; mortality rate; nonhuman; Note; pneumonia; priority journal; risk factor; Saudi Arabia; severe acute respiratory syndrome; Betacoronavirus; Coronavirinae; non insulin dependent diabetes mellitus; pneumonia; Betacoronavirus; China; Coronavirus; Diabetes Mellitus, Type 2; Humans; Pneumonia</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:title>Diabetes and COVID-19 [??????????COVID-19]</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Diabetes">
        <j.1:name>Journal of Diabetes</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081342839</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue>4</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082101482">
    <j.0:title>Under the epidemic situation of COVID-19, should special attention to pregnant women be given?</j.0:title>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Jiao J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1002/jmv.25771</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:type>Note</j.0:type>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082101482</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082101482&amp;doi=10.1002%2fjmv.25771&amp;partnerID=40&amp;md5=8503801e7229ad21c6d4ecb97ba6bd91&gt;</schema:url>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081964978">
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081964978</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Ye G., Pan Z., Pan Y., Deng Q., Chen L., Li J., Li Y., Wang X.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081964978&amp;doi=10.1016%2fj.jinf.2020.03.001&amp;partnerID=40&amp;md5=b3f379eec60b46a741edb36e0f88e66c&gt;</schema:url>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:title>Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation</j.0:title>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>Objectives: Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation. This study aimed to evaluate the clinical characteristics of the SARS-CoV-2 reactivation. Methods: Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for 55 patients with laboratory-confirmed COVID-19 pneumonia (i.e., with throat swab samples that were positive for SARS-CoV-2) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan. 8 to Feb. 10, 2020. Results: All 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus. Conclusions: Findings from this small group of cases suggested that there was currently evidence for reactivation of SARS-CoV-2 and there might be no specific clinical characteristics to distinguish them. © 2020</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/j.jinf.2020.03.001</j.0:identifier>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081575328">
    <j.0:identifier>10.1038/s41423-020-0385-z</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Zheng M., Song L.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:title>Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV</j.0:title>
    <j.0:identifier>2-s2.0-85081575328</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081575328&amp;doi=10.1038%2fs41423-020-0385-z&amp;partnerID=40&amp;md5=3a2ee717d0eb49769c2ae9851871ad66&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cellular_and_Molecular_Immunology">
        <j.1:name>Cellular and Molecular Immunology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081895389">
    <dc:language>English</dc:language>
    <j.0:title>First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>9</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081895389</j.0:identifier>
    <dc:date>2020</dc:date>
    <rdfs:comment>In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42?years; 25 were male. Late detection of the clusters' index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; virus envelope protein; adolescent; adult; aged; Betacoronavirus; child; China; Coronavirus infection; Europe; female; genetics; health survey; hospitalization; human; isolation and purification; male; middle aged; preschool child; real time polymerase chain reaction; risk factor; travel; very elderly; virus pneumonia; World Health Organization; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Child; Child, Preschool; China; Coronavirus Infections; Europe; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Real-Time Polymerase Chain Reaction; Risk Factors; Travel; Viral Envelope Proteins; World Health Organization; Young Adult</schema:keywords>
    <dc:creator>Spiteri G., Fielding J., Diercke M., Campese C., Enouf V., Gaymard A., Bella A., Sognamiglio P., Sierra Moros M.J., Riutort A.N., Demina Y.V., Mahieu R., Broas M., Bengnér M., Buda S., Schilling J., Filleul L., Lepoutre A., Saura C., Mailles A., Levy-Bruhl D., Coignard B., Bernard-Stoecklin S., Behillil S., van der Werf S., Valette M., Lina B., Riccardo F., Nicastri E., Casas I., Larrauri A., Salom Castell M., Pozo F., Maksyutov R.A., Martin C., Van Ranst M., Bossuyt N., Siira L., Sane J., Tegmark-Wisell K., Palmérus M., Broberg E.K., Beauté J., Jorgensen P., Bundle N., Pereyaslov D., Adlhoch C., Pukkila J., Pebody R., Olsen S., Ciancio B.C.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081895389&amp;doi=10.2807%2f1560-7917.ES.2020.25.9.2000178&amp;partnerID=40&amp;md5=11671e4546af36021930fbc6594d01fb&gt;</schema:url>
    <myOnto:volume>25</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.9.2000178</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082007846">
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:title>Will the third wave of coronavirus disease 2019 really come in korea</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082007846</j.0:identifier>
    <dc:creator>Yoo J.-H.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082007846&amp;doi=10.3346%2fjkms.2020.35.e110&amp;partnerID=40&amp;md5=790aa195fbf7e20e540d53a47c48ecb9&gt;</schema:url>
    <j.0:identifier>10.3346/jkms.2020.35.e110</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>10</myOnto:issue>
    <myOnto:volume>35</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081668552">
    <schema:keywords></schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>395</myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081668552&amp;doi=10.1016%2fS0140-6736%2820%2930558-4&amp;partnerID=40&amp;md5=3edf18c10d862772a000fdfdc54d046d&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Wang T., Du Z., Zhu F., Cao Z., An Y., Gao Y., Jiang B.</dc:creator>
    <j.0:identifier>10.1016/S0140-6736(20)30558-4</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081668552</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10228</myOnto:issue>
    <j.0:title>Comorbidities and multi-organ injuries in the treatment of COVID-19</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080067515">
    <j.0:title>Protecting health-care workers from subclinical coronavirus infection</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/S2213-2600(20)30066-7</j.0:identifier>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080067515</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080067515&amp;doi=10.1016%2fS2213-2600%2820%2930066-7&amp;partnerID=40&amp;md5=1e904411f004c054dc5e97a7d45b14fb&gt;</schema:url>
    <dc:creator>Chang D., Xu H., Rebaza A., Sharma L., Dela Cruz C.S.</dc:creator>
    <myOnto:volume>8</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <schema:keywords>acute disease; China; clinical effectiveness; coronavirus disease 2019; Coronavirus infection; coughing; epidemic; fever; health care personnel; human; Letter; nonhuman; occupational hazard; practice guideline; priority journal; severe acute respiratory syndrome; symptom; virus pneumonia; virus transmission</schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081041177">
    <myOnto:issue>8</myOnto:issue>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081041177</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; algorithm; Betacoronavirus; Coronavirus infection; differential diagnosis; epidemic; genetics; health survey; human; influenza; isolation and purification; Italy; mass screening; molecular diagnosis; procedures; respiratory tract infection; travel; virus pneumonia; Algorithms; Betacoronavirus; Coronavirus Infections; Diagnosis, Differential; Disease Outbreaks; Humans; Influenza, Human; Italy; Mass Screening; Molecular Diagnostic Techniques; Pneumonia, Viral; Population Surveillance; Respiratory Tract Infections; Travel</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:title>Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <rdfs:comment>A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.</rdfs:comment>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.8.2000170</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <dc:creator>Bordi L., Nicastri E., Scorzolini L., Di Caro A., Capobianchi M.R., Castilletti C., Lalle E., On Behalf Of Inmi Covid-Study Group And Collaborating Centers</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081041177&amp;doi=10.2807%2f1560-7917.ES.2020.25.8.2000170&amp;partnerID=40&amp;md5=08583a48049adbb8b41cd174897515a8&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078093062">
    <myOnto:volume>5</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Disease_Modelling"/>
    <dc:creator>Shao Y., Wu J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078093062&amp;doi=10.1016%2fj.idm.2020.01.003&amp;partnerID=40&amp;md5=feb1f3589bd3ef58aa1fd85354750495&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1016/j.idm.2020.01.003</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>KeAi Communications Co.</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <j.0:title>IDM editorial statement on the 2019-nCoV</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85078093062</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>2019 novel coronavirus; climate change; clinical decision making; Coronavirinae; decision making; disease model; Editorial; human; mathematical model; public health; severe acute respiratory syndrome; virus genome; virus pneumonia; World Health Organization</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081931149">
    <j.0:title>Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081931149&amp;doi=10.1136%2fbmj.m1036&amp;partnerID=40&amp;md5=7504fd5dcec5ba67ba118229d404964c&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <dc:creator>Mahase E.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85081931149</j.0:identifier>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m1036</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082143020">
    <myOnto:issue>11</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>69</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>COVID-19; Coronavirus infection; epidemic; human; Japan; quarantine; ship; virus pneumonia; Coronavirus Infections; Disease Outbreaks; Humans; Japan; Pneumonia, Viral; Quarantine; Ships</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>An outbreak of coronavirus disease 2019 (COVID-19) among passengers and crew on a cruise ship led to quarantine of approximately 3,700 passengers and crew that began on February 3, 2020, and lasted for nearly 4 weeks at the Port of Yokohama, Japan (1). By February 9, 20 cases had occurred among the ship's crew members. By the end of quarantine, approximately 700 cases of COVID-19 had been laboratory-confirmed among passengers and crew. This report describes findings from the initial phase of the cruise ship investigation into COVID-19 cases among crew members during February 4-12, 2020.</rdfs:comment>
    <dc:creator>Kakimoto K., Kamiya H., Yamagishi T., Matsui T., Suzuki M., Wakita T.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082143020&amp;doi=10.15585%2fmmwr.mm6911e2&amp;partnerID=40&amp;md5=bd9a6923abd944da20b7a3e7cf5fcb6c&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/MMWR._Morbidity_and_mortality_weekly_report"/>
    <j.0:identifier>10.15585/mmwr.mm6911e2</j.0:identifier>
    <j.0:title>Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082143020</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081669799">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>10228</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S0140-6736(20)30557-2</j.0:identifier>
    <j.0:identifier>2-s2.0-85081669799</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:creator>Wu Y., Ho W., Huang Y., Jin D.-Y., Li S., Liu S.-L., Liu X., Qiu J., Sang Y., Wang Q., Yuen K.-Y., Zheng Z.-M.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <j.0:title>SARS-CoV-2 is an appropriate name for the new coronavirus</j.0:title>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081669799&amp;doi=10.1016%2fS0140-6736%2820%2930557-2&amp;partnerID=40&amp;md5=1766d47953d44dbaa80807d656d8197c&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079793104">
    <myOnto:issue>7</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:title>Letter to the editor: Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Kim J.Y.</dc:creator>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <myOnto:volume>35</myOnto:volume>
    <j.0:identifier>2-s2.0-85079793104</j.0:identifier>
    <j.0:identifier>10.3346/jkms.2020.35.e88</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079793104&amp;doi=10.3346%2fjkms.2020.35.e88&amp;partnerID=40&amp;md5=d19073fb42954950e0df791c26b7c2b5&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <schema:keywords>lopinavir; ritonavir; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirinae; human; pneumonia; reverse transcription polymerase chain reaction; South Korea; Betacoronavirus; Coronavirus; Humans; Lopinavir; Pneumonia; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082197631">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082197631&amp;doi=10.1016%2fj.jinf.2020.02.025&amp;partnerID=40&amp;md5=cb6d09a68be466baeec215a7c62c503b&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Insights into the cross-species evolution of 2019 novel coronavirus</j.0:title>
    <dc:creator>Zhang J., Jia W., Zhu J., Li B., Xing J., Liao M., Qi W.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:identifier>10.1016/j.jinf.2020.02.025</j.0:identifier>
    <j.0:identifier>2-s2.0-85082197631</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081332789">
    <dc:creator>Yang Y., Peng F., Wang R., Guan K., Jiang T., Xu G., Sun J., Chang C.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.jaut.2020.102434</j.0:identifier>
    <schema:keywords></schema:keywords>
    <rdfs:comment>The 2019-nCoV is officially called SARS-CoV-2 and is the cause of the disease named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002–2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world. © 2020 Elsevier Ltd</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081332789&amp;doi=10.1016%2fj.jaut.2020.102434&amp;partnerID=40&amp;md5=822f4f95353d66bef7cfd07a8a71f264&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Autoimmunity">
        <j.1:name>Journal of Autoimmunity</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85081332789</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:title>The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China</j.0:title>
    <j.0:type>Review</j.0:type>
    <j.0:publisher>Academic Press</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081919598">
    <myOnto:volume>80</myOnto:volume>
    <myOnto:issue>4</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Hong N.T.T., Nghia H.D.T., Thanh T.T., Lan N.P.H., Ny N.T.H., Ngoc N.M., Hang V.T.T., Chau L.T.M., Quynh V.X., Diem L.T., Hanh B.T.B., Hanh N.H.H., Duc D.T., Man D.N.H., Campbell J., Oanh P.K.N., Day J., Phu N.H., Chau N.V.V., Thwaites G., Tan L.V.</dc:creator>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:identifier>2-s2.0-85081919598</j.0:identifier>
    <j.0:title>Cerebrospinal fluid MinION sequencing of 16S rRNA gene for rapid and accurate diagnosis of bacterial meningitis</j.0:title>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.jinf.2019.12.011</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081919598&amp;doi=10.1016%2fj.jinf.2019.12.011&amp;partnerID=40&amp;md5=f933280f661127768e2e9a61aabd53c3&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>angiotensin converting enzyme 2; virus glycoprotein; agricultural worker; amino acid sequence; binding affinity; Coronavirus disease 2019; Coronavirus infection; enzyme analysis; host receptor recognition; human; infection sensitivity; Letter; molecular recognition; nonhuman; pathogenesis; SARS coronavirus; SARS coronavirus 2; sequence alignment; species difference; travel; virus cell interaction; virus transmission</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080972220">
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.antiviral.2020.104762</j.0:identifier>
    <dc:date>2020</dc:date>
    <rdfs:comment>Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research. © 2020 Elsevier B.V.</rdfs:comment>
    <j.0:identifier>2-s2.0-85080972220</j.0:identifier>
    <j.0:title>Of chloroquine and COVID-19</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:type>Review</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080972220&amp;doi=10.1016%2fj.antiviral.2020.104762&amp;partnerID=40&amp;md5=e61399fca8b3df25f1f7245299ca5572&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>177</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Antiviral_Research"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Touret F., de Lamballerie X.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords>chloroquine; 2019 novel coronovirus; antiviral activity; clinical practice; Coronavirinae; Coronavirus infection; drug efficacy; human; medical research; nonhuman; priority journal; publication; Review; scientist</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079394767">
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>176</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <schema:keywords>furin; virus envelope protein; virus fusion protein; virus glycoprotein; virus hemagglutinin; vitronectin; coronavirus spike glycoprotein; furin; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; Article; cladistics; Coronavirinae; nonhuman; pathogenicity; priority journal; protein cleavage; SARS coronavirus; virus genome; virus particle; amino acid sequence; Betacoronavirus; chemistry; protein conformation; Amino Acid Sequence; Betacoronavirus; Furin; Genome, Viral; Protein Conformation; Spike Glycoprotein, Coronavirus</schema:keywords>
    <j.0:identifier>2-s2.0-85079394767</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>10.1016/j.antiviral.2020.104742</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Antiviral_Research"/>
    <j.0:title>The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079394767&amp;doi=10.1016%2fj.antiviral.2020.104742&amp;partnerID=40&amp;md5=30d4c75a66de468a80eb0394754d70a1&gt;</schema:url>
    <dc:creator>Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N.G., Decroly E.</dc:creator>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <rdfs:comment>In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China. Its genome has been sequenced and the genomic information promptly released. Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs. In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals. © 2020 Elsevier B.V.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081667331">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081667331&amp;doi=10.1016%2fS0140-6736%2820%2930673-5&amp;partnerID=40&amp;md5=32225286f67214c307a77f393b834821&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Bedford J., Enria D., Giesecke J., Heymann D.L., Ihekweazu C., Kobinger G., Lane H.C., Memish Z., Oh M.-D., Sall A.A., Schuchat A., Ungchusak K., Wieler L.H., WHO Strategic and Technical Advisory Group for Infectious Hazards</dc:creator>
    <j.0:identifier>2-s2.0-85081667331</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <schema:keywords></schema:keywords>
    <j.0:title>COVID-19: towards controlling of a pandemic</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30673-5</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10229</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079335354">
    <dc:language>English</dc:language>
    <j.0:title>Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)</j.0:title>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Quilty B.J., Clifford S., Flasche S., Eggo R.M., CMMID nCoV working group</dc:creator>
    <j.0:identifier>2-s2.0-85079335354</j.0:identifier>
    <schema:keywords>COVID-19; aviation; body temperature; communicable disease; Coronavirus infection; decision making; fever; health survey; human; mass screening; procedures; public health; theoretical model; virus pneumonia; Air Travel; Body Temperature; Communicable Diseases, Emerging; Coronavirus Infections; Decision Making; Fever; Humans; Mass Screening; Models, Theoretical; Pneumonia, Viral; Population Surveillance; Public Health</schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.5.2000080</j.0:identifier>
    <rdfs:comment>We evaluated effectiveness of thermal passenger screening for 2019-nCoV infection at airport exit and entry to inform public health decision-making. In our baseline scenario, we estimated that 46% (95% confidence interval: 36 to 58) of infected travellers would not be detected, depending on incubation period, sensitivity of exit and entry screening, and proportion of asymptomatic cases. Airport screening is unlikely to detect a sufficient proportion of 2019-nCoV infected travellers to avoid entry of infected travellers.</rdfs:comment>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:volume>25</myOnto:volume>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079335354&amp;doi=10.2807%2f1560-7917.ES.2020.25.5.2000080&amp;partnerID=40&amp;md5=f4a9636df14ee86b74d74d6f09bb1390&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080932522">
    <j.0:publisher>Deutscher Apotheker Verlag</j.0:publisher>
    <myOnto:issue>6</myOnto:issue>
    <j.0:identifier>2-s2.0-85080932522</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>German</dc:language>
    <j.0:identifier></j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Deutsche_Apotheker_Zeitung"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Coronavirus infection; medical literature; pandemic; Short Survey</schema:keywords>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Pandemic panic [DIE SEITE 3 Pandemie-Panik]</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:type>Short Survey</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080932522&amp;partnerID=40&amp;md5=eca19e725b50e6f2792968f814882c92&gt;</schema:url>
    <dc:creator>Uhl D.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079546081">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>In December 2019, a novel coronavirus (2019-nCoV) caused an outbreak in Wuhan, China, and soon spread to other parts of the world. It was believed that 2019-nCoV was transmitted through respiratory tract and then induced pneumonia, thus molecular diagnosis based on oral swabs was used for confirmation of this disease. Likewise, patient will be released upon two times of negative detection from oral swabs. However, many coronaviruses can also be transmitted through oral–fecal route by infecting intestines. Whether 2019-nCoV infected patients also carry virus in other organs like intestine need to be tested. We conducted investigation on patients in a local hospital who were infected with this virus. We found the presence of 2019-nCoV in anal swabs and blood as well, and more anal swab positives than oral swab positives in a later stage of infection, suggesting shedding and thereby transmitted through oral–fecal route. We also showed serology test can improve detection positive rate thus should be used in future epidemiology. Our report provides a cautionary warning that 2019-nCoV may be shed through multiple routes. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Zhang W., Du R.-H., Li B., Zheng X.-S., Yang X.-L., Hu B., Wang Y.-Y., Xiao G.-F., Yan B., Shi Z.-L., Zhou P.</dc:creator>
    <myOnto:issue>1</myOnto:issue>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079546081&amp;doi=10.1080%2f22221751.2020.1729071&amp;partnerID=40&amp;md5=fb96400eaa436d2b08553018ba65995a&gt;</schema:url>
    <j.0:identifier>10.1080/22221751.2020.1729071</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <myOnto:citeyBy>9</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:volume>9</myOnto:volume>
    <j.0:title>Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes</j.0:title>
    <schema:keywords>nucleotide; viral protein; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; antibody titer; Article; clinical article; controlled study; Coronavirinae; Coronavirus infection; feces analysis; hospital admission; human; molecular diagnosis; nonhuman; priority journal; real time polymerase chain reaction; serology; viremia; virus shedding; virus transmission; Betacoronavirus; China; Coronavirus infection; feces; isolation and purification; virology; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Feces; Humans; Pneumonia, Viral; Virus Shedding</schema:keywords>
    <j.0:identifier>2-s2.0-85079546081</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081532206">
    <dc:creator>Liew M.F., Siow W.T., MacLaren G., See K.C.</dc:creator>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>2-s2.0-85081532206</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; epidemic; human; intensive care; intensive care unit; Singapore; Betacoronavirus; China; Critical Care; Disease Outbreaks; Humans; Infections; Intensive Care Units; Singapore</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Critical_care_(London,_England)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081532206&amp;doi=10.1186%2fs13054-020-2814-x&amp;partnerID=40&amp;md5=393b278d999253f9bf5a73fb0740d536&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1186/s13054-020-2814-x</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:title>Preparing for COVID-19: early experience from an intensive care unit in Singapore</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>24</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081687386">
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
    <j.0:type>Article</j.0:type>
    <dc:creator>Lee N.-Y., Li C.-W., Tsai H.-P., Chen P.-L., Syue L.-S., Li M.-C., Tsai C.-S., Lo C.-L., Hsueh P.-R., Ko W.-C.</dc:creator>
    <j.0:title>A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081687386&amp;doi=10.1016%2fj.jmii.2020.03.003&amp;partnerID=40&amp;md5=0b594859ff0f16200b74986057102d07&gt;</schema:url>
    <rdfs:comment>A 46-year-old woman presented to the emergency department with 2-day fever and cough at seven days after returning from Macau. COVID-19 and pneumonia was diagnosed based on the positive real-time RT-PCR tests for oropharyngeal swab samples and the presence of anti-SARS-COV-2 IgG starting from the illness day 11 and post-exposure 18–21 days. © 2020</rdfs:comment>
    <j.0:identifier>2-s2.0-85081687386</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/j.jmii.2020.03.003</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081726943">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081726943&amp;doi=10.1111%2fbjh.16597&amp;partnerID=40&amp;md5=04c7770fc073c003f0a50bca160e2944&gt;</schema:url>
    <j.0:identifier>10.1111/bjh.16597</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081726943</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:title>How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?</j.0:title>
    <dc:creator>Dholaria B., Savani B.N.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Haematology">
        <j.1:name>British Journal of Haematology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079893796">
    <j.0:title>Correction to Game consumption and the 2019 novel coronavirus (The Lancet Infectious Diseases (2020) 20(3) (275–276), (S1473309920300633), (10.1016/S1473-3099(20)30063-3))</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Erratum</j.0:type>
    <rdfs:comment>Li J, Li J(J), Xie X, et al. Game consumption and the 2019 novel coronavirus. Lancet Infect Dis 2020; 20: 275–76—In this Comment, the date by which the wet market in Wuhan was closed after linkage to severe pneumonia was changed to Jan 1, 2020. Additionally, Jun (Justin) Li's name was amended to the correct spelling. These corrections have been made to the online version as of Feb 26, 2020, and the printed version is correct. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:identifier>10.1016/S1473-3099(20)30071-2</j.0:identifier>
    <schema:keywords>erratum</schema:keywords>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079893796&amp;doi=10.1016%2fS1473-3099%2820%2930071-2&amp;partnerID=40&amp;md5=c64ebf33e962b83b6ceb01194f9ce522&gt;</schema:url>
    <myOnto:issue>3</myOnto:issue>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:volume>20</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079893796</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <dc:creator>[No author name available]</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081702758">
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Science in China Press</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081702758&amp;doi=10.1007%2fs11427-020-1661-4&amp;partnerID=40&amp;md5=89125c7c32340bffd7fa8a1be26c2d02&gt;</schema:url>
    <j.0:identifier>10.1007/s11427-020-1661-4</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Hu Z., Song C., Xu C., Jin G., Chen Y., Xu X., Ma H., Chen W., Lin Y., Zheng Y., Wang J., Hu Z., Yi Y., Shen H.</dc:creator>
    <j.0:identifier>2-s2.0-85081702758</j.0:identifier>
    <rdfs:comment>Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged. © 2020, Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:title>Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science_China_Life_Sciences"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079871984">
    <myOnto:issue>2</myOnto:issue>
    <dc:creator>Xiao C.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079871984</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079871984&amp;doi=10.30773%2fpi.2020.0047&amp;partnerID=40&amp;md5=15e555692f5404171016eb6b5a0287ec&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.30773/pi.2020.0047</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; art therapy; China; consultation; coronavirus disease 2019; counselor; emergency; fear; human; interpersonal communication; letter; Letter; letter therapy; mental disease; patient counseling; patient worry; psychiatrist; quarantine</schema:keywords>
    <myOnto:volume>17</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Psychiatry_Investigation"/>
    <j.0:title>A novel approach of consultation on 2019 novel coronavirus (COVID-19)-related psychological and mental problems: Structured letter therapy</j.0:title>
    <j.0:publisher>Korean Neuropsychiatric Association</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080862177">
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m833</j.0:identifier>
    <j.0:identifier>2-s2.0-85080862177</j.0:identifier>
    <dc:language>English</dc:language>
    <dc:creator>Dyer O.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080862177&amp;doi=10.1136%2fbmj.m833&amp;partnerID=40&amp;md5=7085917987e075f7ab5ce83b683d64a7&gt;</schema:url>
    <j.0:title>Covid-19: US health department staff sent to meet citizens returning from China weren't protected, claims whistleblower</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081548737">
    <j.0:identifier>10.1007/s12630-020-01617-4</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>What we do when a COVID-19 patient needs an operation: operating room preparation and guidance</j.0:title>
    <dc:creator>Ti L.K., Ang L.S., Foong T.W., Ng B.S.W.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081548737&amp;doi=10.1007%2fs12630-020-01617-4&amp;partnerID=40&amp;md5=9fc5788a5f971fad38e93f1759b05e78&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:identifier>2-s2.0-85081548737</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Canadian_Journal_of_Anesthesia"/>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082182122">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Baud D., Giannoni E., Pomar L., Qi X., Nielsen-Saines K., Musso D., Favre G.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>COVID-19 in pregnant women – Authors' reply</j.0:title>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>2-s2.0-85082182122</j.0:identifier>
    <j.0:identifier>10.1016/S1473-3099(20)30192-4</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082182122&amp;doi=10.1016%2fS1473-3099%2820%2930192-4&amp;partnerID=40&amp;md5=3a37aa91fe1c6ae1845671f7064f5a69&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080887451">
    <j.0:identifier>10.1016/j.jcv.2020.104305</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Letter; nonhuman; priority journal; SARS coronavirus; virus detection</schema:keywords>
    <myOnto:volume>125</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080887451&amp;doi=10.1016%2fj.jcv.2020.104305&amp;partnerID=40&amp;md5=3edf9dcb36fff2b124eb7b8f8d9c02b9&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Clinical_Virology">
        <j.1:name>Journal of Clinical Virology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85080887451</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Cordes A.K., Heim A.</dc:creator>
    <j.0:title>Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion</j.0:title>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147084">
    <myOnto:volume></myOnto:volume>
    <schema:keywords>2019 novel coronavirus; Article; Coronavirinae; incubation time; nonhuman; virus transmission</schema:keywords>
    <j.0:identifier>2-s2.0-85082147084</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147084&amp;partnerID=40&amp;md5=1856555437902ea00f751e2d766b5d0f&gt;</schema:url>
    <j.0:title>New data on the 2019 nCoV: Transmission during the incubation period is possible [ARZNEIMITTEL UND THERAPIE Neue Daten zu 2019-nCoV übertragung während der Inkubationszeit möglich]</j.0:title>
    <j.0:publisher>Deutscher Apotheker Verlag</j.0:publisher>
    <dc:creator>[No author name available]</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Deutsche_Apotheker_Zeitung"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier></j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>6</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>German</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081543024">
    <dc:date>2020</dc:date>
    <j.0:title>Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2</j.0:title>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:creator>Liu Z., Xiao X., Wei X., Li J., Yang J., Tan H., Zhu J., Zhang Q., Wu J., Liu L.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>10.1002/jmv.25726</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081543024&amp;doi=10.1002%2fjmv.25726&amp;partnerID=40&amp;md5=a05ef8189be54ee8b4597752c2d779cf&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081543024</j.0:identifier>
    <rdfs:comment>From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively. Currently, a novel coronavirus (SARS-CoV-2), which has become the cause of the outbreak of Coronavirus Disease 2019 (COVID-19), was discovered. Until 18 February 2020, there were 72 533 confirmed COVID-19 cases (including 10 644 severe cases) and 1872 deaths in China. SARS-CoV-2 is spreading among the public and causing substantial burden due to its human-to-human transmission. However, the intermediate host of SARS-CoV-2 is still unclear. Finding the possible intermediate host of SARS-CoV-2 is imperative to prevent further spread of the epidemic. In this study, we used systematic comparison and analysis to predict the interaction between the receptor-binding domain (RBD) of coronavirus spike protein and the host receptor, angiotensin-converting enzyme 2 (ACE2). The interaction between the key amino acids of S protein RBD and ACE2 indicated that, other than pangolins and snakes, as previously suggested, turtles (Chrysemys picta bellii, Chelonia mydas, and Pelodiscus sinensis) may act as the potential intermediate hosts transmitting SARS-CoV-2 to humans. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081597154">
    <j.0:type>Note</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/npj_Vaccines">
        <j.1:name>npj Vaccines</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>DNA vaccine; inactivated virus vaccine; live vaccine; mRNA vaccine; subunit vaccine; unclassified drug; vaccine; virus vaccine; virus vector; 2019 novel coronavirus disease; antiviral activity; cellular immunity; Coronavirus infection; cross reaction; DNA immunization; drug efficacy; drug safety; epidemic; human; immune response; infection prevention; nonhuman; Note; SARS coronavirus 2; SARS-related coronavirus; vaccination; vaccine immunogenicity; vaccine production; virus immunity; virus pneumonia</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Shang W., Yang Y., Rao Y., Rao X.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:identifier>10.1038/s41541-020-0170-0</j.0:identifier>
    <j.0:title>The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081597154&amp;doi=10.1038%2fs41541-020-0170-0&amp;partnerID=40&amp;md5=9243aee07201787961979a228c06dc90&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>5</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>2-s2.0-85081597154</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081997309">
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.10.2000199</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Retrospective analysis of the possibility of predicting the COVID-19 outbreak from Internet searches and social media data, China, 2020</j.0:title>
    <dc:creator>Li C., Chen L.J., Chen X., Zhang M., Pang C.P., Chen H.</dc:creator>
    <schema:keywords>COVID-19; China; Coronavirus infection; epidemic; health survey; human; incidence; Internet; laboratory; procedures; public health service; search engine; social media; virus pneumonia; web browser; China; Coronavirus Infections; Disease Outbreaks; Humans; Incidence; Internet; Laboratories; Pneumonia, Viral; Population Surveillance; Public Health Practice; Search Engine; Social Media; Web Browser</schema:keywords>
    <j.0:identifier>2-s2.0-85081997309</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:issue>10</myOnto:issue>
    <rdfs:comment>The peak of Internet searches and social media data about the coronavirus disease 2019 (COVID-19) outbreak occurred 10-14 days earlier than the peak of daily incidences in China. Internet searches and social media data had high correlation with daily incidences, with the maximum r?&gt;?0.89 in all correlations. The lag correlations also showed a maximum correlation at 8-12 days for laboratory-confirmed cases and 6-8 days for suspected cases.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081997309&amp;doi=10.2807%2f1560-7917.ES.2020.25.10.2000199&amp;partnerID=40&amp;md5=51fc3b6cee834e8e5815faa25a1d9437&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081886739">
    <rdfs:comment>Background: Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19. Methods: A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Embase and PubMed were searched for relevant studies. Results: A total of six studies with 1527 patients were included in this analysis. The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively. The incidences of hypertension, cardia-cerebrovascular diseases and diabetes were about twofolds, threefolds and twofolds, respectively, higher in ICU/severe cases than in their non-ICU/severe counterparts. At least 8.0% patients with COVID-19 suffered the acute cardiac injury. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients. Conclusion: Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_Research_in_Cardiology">
        <j.1:name>Clinical Research in Cardiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1007/s00392-020-01626-9</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081886739&amp;doi=10.1007%2fs00392-020-01626-9&amp;partnerID=40&amp;md5=261dd316dd536ba18773061e78c20129&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081886739</j.0:identifier>
    <dc:creator>Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z., Zhao Y.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:title>Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China</j.0:title>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081560125">
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1038/s41423-020-0401-3</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cellular_and_Molecular_Immunology"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081560125</j.0:identifier>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients</j.0:title>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Zheng H.-Y., Zhang M., Yang C.-X., Zhang N., Wang X.-C., Yang X.-P., Dong X.-Q., Zheng Y.-T.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081560125&amp;doi=10.1038%2fs41423-020-0401-3&amp;partnerID=40&amp;md5=ffd21929a6d355acac24e0349397425a&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080881105">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080881105</j.0:identifier>
    <schema:keywords>antivirus agent; COVID-19; severe acute respiratory syndrome coronavirus 2; vaccine; coronavirus disease 2019; Coronavirus infection; coughing; diarrhea; disease severity; disease transmission; dry cough; epidemic; extracorporeal oxygenation; fatigue; fever; gene sequence; genetic analysis; hand washing; human; immunogenicity; influenza A (H1N1); nonhuman; nose obstruction; Note; risk assessment; SARS coronavirus; sequence homology; serology; Severe acute respiratory syndrome coronavirus 2; sore throat; symptomatology; artificial ventilation; Betacoronavirus; Coronavirus infection; differential diagnosis; global health; health service; migration; pathogenicity; travel; virus pneumonia; World Health Organization; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Diagnosis, Differential; Disease Outbreaks; Emigration and Immigration; Global Health; Humans; Pneumonia, Viral; Respiration, Artificial; Travel; Vaccines; Voluntary Health Agencies; World Health Organization</schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:title>Q&amp;A: The novel coronavirus outbreak causing COVID-19</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1186/s12916-020-01533-w</j.0:identifier>
    <myOnto:volume>18</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080881105&amp;doi=10.1186%2fs12916-020-01533-w&amp;partnerID=40&amp;md5=4f89a43b152968588efc34385a35f364&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMC_Medicine"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <dc:creator>Fisher D., Heymann D.</dc:creator>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080052300">
    <dc:creator>Liu S.-L., Saif L.J., Weiss S.R., Su L.</dc:creator>
    <j.0:identifier>2-s2.0-85080052300</j.0:identifier>
    <j.0:title>No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <j.0:identifier>10.1080/22221751.2020.1733440</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080052300&amp;doi=10.1080%2f22221751.2020.1733440&amp;partnerID=40&amp;md5=30a3548206d1b1d779d8f9934ed7e15e&gt;</schema:url>
    <myOnto:issue>1</myOnto:issue>
    <dc:date>2020</dc:date>
    <schema:keywords>acute respiratory tract disease; Betacoronavirus; bioengineering; bioinformatics; China; clinical laboratory; epidemic; gene mutation; genome analysis; government; Human immunodeficiency virus; intermediate host; life threat; Note; pathogenesis; priority journal; public health; SARS coronavirus; SARS coronavirus 2; severe acute respiratory syndrome; single nucleotide polymorphism; social media; virus culture; animal; Coronavirus infection; genetic engineering; genetics; human; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; Coronavirus Infections; Genetic Engineering; Humans; Pneumonia, Viral</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <myOnto:volume>9</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081694707">
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>10.1002/jmv.25749</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081694707</j.0:identifier>
    <j.0:title>The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective</j.0:title>
    <dc:creator>Han Y., Yang H.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081694707&amp;doi=10.1002%2fjmv.25749&amp;partnerID=40&amp;md5=5a8fc50dfa260f350abaf37ec6f9bc36&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>2019 novel coronavirus (SARS-CoV-2), which originated in Wuhan, China, has attracted the world's attention over the last month. The Chinese government has taken emergency measures to control the outbreak and has undertaken initial steps in the diagnosis and treatment of 2019 novel coronavirus infection disease (COVID-19). However, SARS-CoV-2 possesses powerful pathogenicity as well as transmissibility and still holds many mysteries that are yet to be solved, such as whether the virus can be transmitted by asymptomatic patients or by mothers to their infants. Our research presents selected available cases of COVID-19 in China to better understand the transmission and diagnosis regarding this infectious disease. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082190244">
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1002/mma.6345</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>2-s2.0-85082190244</j.0:identifier>
    <j.0:title>Dynamic models for Coronavirus Disease 2019 and data analysis</j.0:title>
    <dc:creator>Shao N., Zhong M., Yan Y., Pan H., Cheng J., Chen W.</dc:creator>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>In this letter, two time delay dynamic models, a Time Delay Dynamical–Novel Coronavirus Pneumonia (TDD-NCP) model and Fudan-Chinese Center for Disease Control and Prevention (CCDC) model, are introduced to track the data of Coronavirus Disease 2019 (COVID-19). The TDD-NCP model was developed recently by Cheng??s group in Fudan and Shanghai University of Finance and Economics (SUFE). The TDD-NCP model introduced the time delay process into the differential equations to describe the latent period of the epidemic. The Fudan-CDCC model was established when Wenbin Chen suggested to determine the kernel functions in the TDD-NCP model by the public data from CDCC. By the public data of the cumulative confirmed cases in different regions in China and different countries, these models can clearly illustrate that the containment of the epidemic highly depends on early and effective isolations. © 2020 John Wiley &amp; Sons, Ltd.</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <schema:keywords>Differential equations; Dynamic models; Time delay; Center for disease control and preventions; Coronaviruses; Kernel function; Public data; Time delay process; Disease control</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Mathematical_Methods_in_the_Applied_Sciences">
        <j.1:name>Mathematical Methods in the Applied Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082190244&amp;doi=10.1002%2fmma.6345&amp;partnerID=40&amp;md5=d0579c28716f1a542e0b55f7a2e52c0f&gt;</schema:url>
    <j.0:publisher>John Wiley and Sons Ltd</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081695375">
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adolescent; adult; aged; Australia; Betacoronavirus; child; Coronavirus infection; female; global health; health survey; human; incidence; infant; male; middle aged; pathogenicity; preschool child; travel; virus pneumonia; young adult; Adolescent; Adult; Aged; Australia; Betacoronavirus; Child; Child, Preschool; Coronavirus Infections; Female; Global Health; Humans; Incidence; Infant; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Travel; Young Adult</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081695375&amp;doi=10.33321%2fcdi.2020.44.21&amp;partnerID=40&amp;md5=07bd50378a31d77646010f99d7e883a4&gt;</schema:url>
    <j.0:title>COVID-19, Australia: Epidemiology Report 6 (Reporting week ending 19:00 AEDT 7 March 2020)</j.0:title>
    <myOnto:volume>44</myOnto:volume>
    <dc:creator>COVID-19 National Incident Room Surveillance Team</dc:creator>
    <j.0:identifier>10.33321/cdi.2020.44.21</j.0:identifier>
    <rdfs:comment>This is the sixth epidemiological report for coronavirus disease 2019 (COVID-19), reported in Australia as at 19:00 Australian Eastern Daylight Time [AEDT] 7 March 2020. It includes data on COVID-19 cases diagnosed in Australia, the international situation and a review of current evidence. © Commonwealth of Australia CC BY-NC-ND.</rdfs:comment>
    <j.0:identifier>2-s2.0-85081695375</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Communicable_diseases_intelligence_(2018)"/>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081901579">
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081901579</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <dc:creator>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B.</dc:creator>
    <rdfs:comment>Background: Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. Methods: In this retrospective, multicentre cohort study, we included all adult inpatients (?18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. Findings: 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p&lt;0·0001), and d-dimer greater than 1 ?g/mL (18·42, 2·64–128·55; p=0·0033) on admission. Median duration of viral shedding was 20·0 days (IQR 17·0–24·0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days. Interpretation: The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 ?g/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Funding: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081901579&amp;doi=10.1016%2fS0140-6736%2820%2930566-3&amp;partnerID=40&amp;md5=60b48cc828061e7b65a326e43414171d&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30566-3</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081885759">
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081885759</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081885759&amp;doi=10.1016%2fj.ijid.2020.02.050&amp;partnerID=40&amp;md5=6af9593c1b99d944950c48b7d1139491&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Xie C., Jiang L., Huang G., Pu H., Gong B., Lin H., Ma S., Chen X., Long B., Si G., Yu H., Jiang L., Yang X., Shi Y., Yang Z.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:title>Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests</j.0:title>
    <rdfs:comment>An ongoing outbreak of severe respiratory pneumonia associated with the 2019 novel coronavirus has recently emerged in China. Here we report the epidemiological, clinical, laboratory and radiological characteristics of 19 suspect cases. We compared the positive ratio of 2019-nCoV nucleic acid amplification test results from different samples including oropharyngeal swab, blood, urine and stool with 3 different fluorescent RT-PCR kits. Nine out of the 19 patients had 2019-nCoV infection detected using oropharyngeal swab samples, and the virus nucleic acid was also detected in eight of these nine patients using stool samples. None of positive results was identified in the blood and urine samples. These three different kits got the same result for each sample and the positive ratio of nucleic acid detection for 2019-nCoV was only 47.4% in the suspect patients. Therefore, it is possible that infected patients have been missed by using nucleic acid detection only. It might be better to make a diagnosis combining the computed tomography scans and nucleic acid detection. © 2020 University of Electronic Science and Technology of China, Chengdu, China</rdfs:comment>
    <j.0:identifier>10.1016/j.ijid.2020.02.050</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:volume>93</myOnto:volume>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081409326">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <j.0:title>Chest CT findings in 2019 novel coronavirus (2019-NCoV) infections from Wuhan, China: Key points for the radiologist</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081409326&amp;doi=10.1148%2fradiol.2020200241&amp;partnerID=40&amp;md5=4630dba4c07862e1fb1756a0bcac66ff&gt;</schema:url>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; anamnesis; Betacoronavirus; child; complication; Coronavirus infection; diagnostic imaging; disease exacerbation; human; lung; pathogenicity; pathology; radiologist; severe acute respiratory syndrome; thorax radiography; travel; virus pneumonia; x-ray computed tomography; Adult; Betacoronavirus; Child; Coronavirus Infections; Disease Progression; Humans; Lung; Medical History Taking; Pneumonia, Viral; Radiography, Thoracic; Radiologists; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Travel</schema:keywords>
    <j.0:publisher>Radiological Society of North America Inc.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <j.0:identifier>10.1148/radiol.2020200241</j.0:identifier>
    <dc:creator>Kanne J.P.</dc:creator>
    <j.0:identifier>2-s2.0-85081409326</j.0:identifier>
    <myOnto:volume>295</myOnto:volume>
    <j.0:type>Review</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Radiology"/>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079664163">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020</j.0:title>
    <rdfs:comment>A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079664163&amp;doi=10.2807%2f1560-7917.ES.2020.25.6.2000094&amp;partnerID=40&amp;md5=ad654efe4c4caef08a7a73316435fc51&gt;</schema:url>
    <myOnto:volume>25</myOnto:volume>
    <j.0:identifier>2-s2.0-85079664163</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.6.2000094</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; Betacoronavirus; case report; China; contact examination; Coronavirus infection; France; health survey; human; infection control; isolation and purification; male; middle aged; risk assessment; travel; virus pneumonia; Adult; Betacoronavirus; China; Contact Tracing; Coronavirus Infections; France; Humans; Infection Control; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Risk Assessment; Travel</schema:keywords>
    <dc:creator>Bernard Stoecklin S., Rolland P., Silue Y., Mailles A., Campese C., Simondon A., Mechain M., Meurice L., Nguyen M., Bassi C., Yamani E., Behillil S., Ismael S., Nguyen D., Malvy D., Lescure F.X., Georges S., Lazarus C., Tabaï A., Stempfelet M., Enouf V., Coignard B., Levy-Bruhl D., Investigation Team</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>6</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079481476">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079481476&amp;doi=10.1007%2fs00330-020-06713-z&amp;partnerID=40&amp;md5=5e9c1a2fd68f3e6b8f4b41a0f1b1a202&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_Radiology"/>
    <j.0:identifier>2-s2.0-85079481476</j.0:identifier>
    <j.0:identifier>10.1007/s00330-020-06713-z</j.0:identifier>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:title>Imaging changes in patients with 2019-nCov</j.0:title>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Pan Y., Guan H.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080072706">
    <dc:creator>Al-Tawfiq J.A.</dc:creator>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080072706&amp;doi=10.1016%2fj.tmaid.2020.101608&amp;partnerID=40&amp;md5=da6a3e69956b6efa994e1f1b64cc6711&gt;</schema:url>
    <j.0:title>Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)</j.0:title>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.tmaid.2020.101608</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85080072706</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081308923">
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <dc:creator>Zeng J., Huang J., Pan L.</dc:creator>
    <j.0:identifier>10.1007/s00134-020-05993-9</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081308923</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081308923&amp;doi=10.1007%2fs00134-020-05993-9&amp;partnerID=40&amp;md5=b66857a72c5fa81a272fa8f75e3d9efd&gt;</schema:url>
    <j.0:title>How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Springer</j.0:publisher>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079137326">
    <myOnto:volume>27</myOnto:volume>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <dc:creator>Wilson M.E., Chen L.H.</dc:creator>
    <j.0:identifier>10.1093/jtm/taaa015</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>2</myOnto:issue>
    <j.0:title>Travellers give wings to novel coronavirus (2019-nCoV)</j.0:title>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079137326</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; aviation; Betacoronavirus; China; cluster analysis; Coronavirus infection; disease transmission; epidemiology; genetics; human; isolation and purification; male; mortality; pandemic; pathogenicity; veterinary medicine; virology; virus pneumonia; zoonosis; Air Travel; Animals; Betacoronavirus; China; Cluster Analysis; Coronavirus Infections; Disease Transmission, Infectious; Humans; Male; Mortality; Pandemics; Pneumonia, Viral; Zoonoses</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_travel_medicine"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079137326&amp;doi=10.1093%2fjtm%2ftaaa015&amp;partnerID=40&amp;md5=efae89a5482d17a425108a627829bf2b&gt;</schema:url>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079210890">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China</j.0:title>
    <dc:creator>Chang D., Lin M., Wei L., Xie L., Zhu G., Dela Cruz C.S., Sharma L.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079210890</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <schema:keywords>adult; China; clinical article; clinical feature; Coronavirus disease 2019; Coronavirus infection; disease transmission; female; follow up; human; Letter; male; mortality rate; priority journal; risk factor</schema:keywords>
    <myOnto:volume>323</myOnto:volume>
    <myOnto:citeyBy>13</myOnto:citeyBy>
    <myOnto:issue>11</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1001/jama.2020.1623</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079210890&amp;doi=10.1001%2fjama.2020.1623&amp;partnerID=40&amp;md5=503423f29f03a0911450fae2eca678b9&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079746130">
    <rdfs:comment>As of February 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak started in China in December 2019 has been spreading in many countries in the world. With the numbers of confirmed cases are increasing, information on the epidemiologic investigation and clinical manifestation have been accumulated. However, data on viral load kinetics in confirmed cases are lacking. Here, we present the viral load kinetics of the first two confirmed patients with mild to moderate illnesses in Korea in whom distinct viral load kinetics are shown. This report suggests that viral load kinetics of SARS-CoV-2 may be different from that of previously reported other coronavirus infections such as SARS-CoV. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079746130&amp;doi=10.3346%2fjkms.2020.35.e86&amp;partnerID=40&amp;md5=21330a8cdef2be80ef3986b67224ce12&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85079746130</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; Betacoronavirus; case report; Coronavirus infection; female; human; kinetics; male; middle aged; pathogenicity; severity of illness index; virology; virus load; virus pneumonia; Adult; Betacoronavirus; Coronavirus Infections; Female; Humans; Kinetics; Male; Middle Aged; Pneumonia, Viral; Severity of Illness Index; Viral Load</schema:keywords>
    <myOnto:volume>35</myOnto:volume>
    <j.0:title>Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:issue>7</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <dc:date>2020</dc:date>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <dc:creator>Kim J.Y., Ko J.-H., Kim Y., Kim Y.-J., Kim J.-M., Chung Y.-S., Kim H.M., Han M.-G., Kim S.Y., Chin B.S.</dc:creator>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:identifier>10.3346/jkms.2020.35.e86</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081283286">
    <rdfs:comment>The emergence of SARS-CoV-2 has resulted in &amp;gt;90,000 infections and &amp;gt;3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans. We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs. We determined cryo-EM structures of the SARS-CoV-2 S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry. Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination. SARS-CoV-2, a newly emerged pathogen spreading worldwide, binds with high affinity to human ACE2 and uses it as an entry receptor to invade target cells. Cryo-EM structures of the SARS-CoV-2 spike glycoprotein in two distinct conformations, along with inhibition of spike-mediated entry by SARS-CoV polyclonal antibodies, provide a blueprint for the design of vaccines and therapeutics. © 2020 Elsevier Inc.</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.cell.2020.02.058</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</j.0:title>
    <j.0:identifier>2-s2.0-85081283286</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:creator>Walls A.C., Park Y.-J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.</dc:creator>
    <j.0:publisher>Cell Press</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cell"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081283286&amp;doi=10.1016%2fj.cell.2020.02.058&amp;partnerID=40&amp;md5=80e28a5a260e48945b97924e18a5ca41&gt;</schema:url>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081958518">
    <j.0:identifier>10.1136/bmj.m1060</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>2-s2.0-85081958518</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:creator>Mahase E.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:title>Covid-19: UK holds off closing schools and restricts testing to people in hospital</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081958518&amp;doi=10.1136%2fbmj.m1060&amp;partnerID=40&amp;md5=6a446788d2bc1be858ac889d91933ecb&gt;</schema:url>
    <myOnto:volume>368</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092288">
    <dc:creator>Rimmer A.</dc:creator>
    <j.0:title>Covid-19: GPs can stop health checks for over 75s and routine medicine reviews</j.0:title>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092288&amp;doi=10.1136%2fbmj.m1157&amp;partnerID=40&amp;md5=752bd75d641cbde931055cd5265b3b9f&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1136/bmj.m1157</j.0:identifier>
    <j.0:identifier>2-s2.0-85082092288</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>368</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081696467">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30600-0</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081696467&amp;doi=10.1016%2fS0140-6736%2820%2930600-0&amp;partnerID=40&amp;md5=0860526ba1b001bb3b9072bd5e8bbc63&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <dc:creator>Garrett L.</dc:creator>
    <j.0:title>COVID-19: the medium is the message</j.0:title>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081696467</j.0:identifier>
    <myOnto:issue>10228</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082197038">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082197038</j.0:identifier>
    <j.0:identifier>10.1016/S2468-1253(20)30057-1</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Note</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Gastroenterology_and_Hepatology"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Liver injury in COVID-19: management and challenges</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082197038&amp;doi=10.1016%2fS2468-1253%2820%2930057-1&amp;partnerID=40&amp;md5=d3bed3f72b13b5a338e393e74397aac1&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Zhang C., Shi L., Wang F.-S.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079433155">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:issue>5</myOnto:issue>
    <dc:creator>Giovanetti M., Benvenuto D., Angeletti S., Ciccozzi M.</dc:creator>
    <rdfs:comment>A novel Coronavirus, 2019-nCoV, has been identified as the causal pathogen of an ongoing epidemic, with the first cases reported in Wuhan, China, last December 2019, and has since spread to other countries worldwide, included Europe and very recently Italy. In this short report, phylogenetic reconstruction was used to better understand the transmission dynamics of the virus from its first introduction in China focusing on the more recent evidence of infection in a couple of Chinese tourists arrived in Italy on 23rd January 2020 and labeled as Coronavirus Italian cases. A maximum clade credibility tree has been built using a dataset of 54 genome sequences of 2019-nCoV plus two closely related bat strains (SARS-like CoV) available in GenBank. Bayesian time-scaled phylogenetic analysis was implemented in BEAST 1.10.4. The Bayesian phylogenetic reconstruction showed that 2019-2020 nCoV firstly introduced in Wuhan on 25 November 2019, started epidemic transmission reaching many countries worldwide, including Europe and Italy where the two strains isolated dated back 19 January 2020, the same that the Chinese tourists arrived in Italy. Strains isolated outside China were intermixed with strains isolated in China as evidence of likely imported cases in Rome, Italy, and Europe, as well. In conclusion, this report suggests that further spread of 2019-nCoV epidemic was supported by human mobility and that quarantine of suspected or diagnosed cases is useful to prevent further transmission. Viral genome phylogenetic analysis represents a useful tool for the evaluation of transmission dynamics and preventive action. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85079433155</j.0:identifier>
    <j.0:title>The first two cases of 2019-nCoV in Italy: Where they come from?</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079433155&amp;doi=10.1002%2fjmv.25699&amp;partnerID=40&amp;md5=b44d9c3ed1fdb3e573ac3790a052dd4d&gt;</schema:url>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1002/jmv.25699</j.0:identifier>
    <schema:keywords>Article; Bayes theorem; cladistics; Coronavirinae; coronavirus disease 2019; Coronavirus infection; epidemic; gene sequence; genetic distance; infection prevention; Italy; molecular epidemiology; molecular evolution; nonhuman; phylogeny; population dispersal; SARS-related coronavirus; sequence alignment; Severe acute respiratory syndrome coronavirus 2; virus genome; virus identification; virus isolation; virus strain; virus transmission; animal; bat; Betacoronavirus; biological model; Coronavirus infection; genetics; human; interatrial block; isolation and purification; Italy; mutation rate; pandemic; virology; virus genome; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Animals; Betacoronavirus; Chiroptera; Coronavirus Infections; Genome, Viral; Humans; Interatrial Block; Italy; Models, Genetic; Mutation Rate; Pandemics; Phylogeny; Pneumonia, Viral</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078959739">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>680</myOnto:issue>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>16</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>coronavirus disease 2019; Coronavirus infection; Note; interview</schema:keywords>
    <j.0:identifier>2-s2.0-85078959739</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Revue_Medicale_Suisse">
        <j.1:name>Revue Medicale Suisse</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <j.0:publisher>Editions Medecine et Hygiene</j.0:publisher>
    <j.0:identifier></j.0:identifier>
    <dc:language>French</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078959739&amp;partnerID=40&amp;md5=792c947f179f31cbb3e48510b3efac0c&gt;</schema:url>
    <j.0:title>Coronavirus: Stay proactive [Coronavirus: Rester proactif]</j.0:title>
    <dc:creator>Gardier S., Petignat D.C.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082044395">
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1002/alz.12093</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:identifier>2-s2.0-85082044395</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:title>Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2</j.0:title>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082044395&amp;doi=10.1002%2falz.12093&amp;partnerID=40&amp;md5=5ba66bdae9d3a077f8941b65d19383ca&gt;</schema:url>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Alzheimer&apos;s_and_Dementia">
        <j.1:name>Alzheimer's and Dementia</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080096056">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>3</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080096056&amp;doi=10.1016%2fS2213-2600%2820%2930060-6&amp;partnerID=40&amp;md5=7e81110ef3a1c4289c07d2128e7132cf&gt;</schema:url>
    <schema:keywords>cytokine; 2019 novel coronavirus; acute heart failure; acute respiratory failure; adult respiratory distress syndrome; aerosol; aging; Article; artificial ventilation; basic reproduction number; camel; cell regeneration; China; comorbidity; continuous hemodiafiltration; continuous hemofiltration; Coronavirinae; critically ill patient; disease course; disease severity; disease transmission; dyspnea; electron microscopy; emergency care; epidemic; Europe; extracorporeal circulation; extracorporeal oxygenation; extracorporeal therapy; health care delivery; health care personnel; heart function; hemadsorption; hemoperfusion; hospital admission; human; immune response; immune status; infection prevention; infection risk; inflammation; intensive care; intensive care unit; kidney function; liver cell; liver dysfunction; Middle East respiratory syndrome; multiple organ failure; pathophysiology; patient compliance; patient monitoring; prescription; priority journal; public health service; renal replacement therapy; Saudi Arabia; sea food; sequence analysis; severe acute respiratory syndrome; social marketing; treatment outcome; United States; virus identification; virus myocarditis</schema:keywords>
    <myOnto:volume>8</myOnto:volume>
    <j.0:title>Coronavirus epidemic: preparing for extracorporeal organ support in intensive care</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85080096056</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Ronco C., Navalesi P., Vincent J.L.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S2213-2600(20)30060-6</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081720053">
    <j.0:title>Modeling the epidemic dynamics and control of COVID-19 outbreak in China</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081720053&amp;doi=10.1007%2fs40484-020-0199-0&amp;partnerID=40&amp;md5=73242afc7f3de3f5f2ce9bbad988d566&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081720053</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:publisher>Higher Education Press</j.0:publisher>
    <dc:creator>Zhao S., Chen H.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Quantitative_Biology">
        <j.1:name>Quantitative Biology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>10.1007/s40484-020-0199-0</j.0:identifier>
    <rdfs:comment>Background: The coronavirus disease 2019 (COVID-19) is rapidly spreading in China and more than 30 countries over last two months. COVID-19 has multiple characteristics distinct from other infectious diseases, including high infectivity during incubation, time delay between real dynamics and daily observed number of confirmed cases, and the intervention effects of implemented quarantine and control measures. Methods: We develop a Susceptible, Un-quanrantined infected, Quarantined infected, Confirmed infected (SUQC) model to characterize the dynamics of COVID-19 and explicitly parameterize the intervention effects of control measures, which is more suitable for analysis than other existing epidemic models. Results: The SUQC model is applied to the daily released data of the confirmed infections to analyze the outbreak of COVID-19 in Wuhan, Hubei (excluding Wuhan), China (excluding Hubei) and four first-tier cities of China. We found that, before January 30, 2020, all these regions except Beijing had a reproductive number R &gt; 1, and after January 30, all regions had a reproductive number R &lt; 1, indicating that the quarantine and control measures are effective in preventing the spread of COVID-19. The confirmation rate of Wuhan estimated by our model is 0.0643, substantially lower than that of Hubei excluding Wuhan (0.1914), and that of China excluding Hubei (0.2189), but it jumps to 0.3229 after February 12 when clinical evidence was adopted in new diagnosis guidelines. The number of unquarantined infected cases in Wuhan on February 12, 2020 is estimated to be 3,509 and declines to 334 on February 21, 2020. After fitting the model with data as of February 21, 2020, we predict that the end time of COVID-19 in Wuhan and Hubei is around late March, around mid March for China excluding Hubei, and before early March 2020 for the four tier-one cities. A total of 80,511 individuals are estimated to be infected in China, among which 49,510 are from Wuhan, 17,679 from Hubei (excluding Wuhan), and the rest 13,322 from other regions of China (excluding Hubei). Note that the estimates are from a deterministic ODE model and should be interpreted with some uncertainty. Conclusions: We suggest that rigorous quarantine and control measures should be kept before early March in Beijing, Shanghai, Guangzhou and Shenzhen, and before late March in Hubei. The model can also be useful to predict the trend of epidemic and provide quantitative guide for other countries at high risk of outbreak, such as South Korea, Japan, Italy and Iran. [Figure not available: see fulltext.]. © 2020, Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079336498">
    <j.0:title>Emergency response plan for the neonatal intensive care unit during epidemic of 2019 novel coronavirus</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier></j.0:identifier>
    <myOnto:issue>2</myOnto:issue>
    <schema:keywords>China; Coronavirinae; human; neonatal intensive care unit; newborn; risk factor; China; Coronavirus; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Risk Factors</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079336498&amp;partnerID=40&amp;md5=5f6ef75a8e54220e39f15dd2cc8568ca&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079336498</j.0:identifier>
    <dc:language>Chinese</dc:language>
    <myOnto:volume>22</myOnto:volume>
    <rdfs:comment>2019 novel coronavirus (2019-nCoV) infection has been spreading in China since December 2019. Neonates are presumably the high-risk population susceptible to 2019-nCoV due to immature immune function. The neonatal intensive care unit (NICU) should be prepared for 2019-nCoV infections as far as possible. The emergency response plan enables the efficient response capability of NICU. During the epidemic of 2019-nCoV, the emergency response plan for the NICU should be based on the actual situation, including diagnosis, isolation, and treatment, as well as available equipment and staffing, and take into account the psychosocial needs of the families and neonatal care staff.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhongguo_dang_dai_er_ke_za_zhi_=_Chinese_journal_of_contemporary_pediatrics"/>
    <dc:creator>Pediatric Committee, Medical Association of Chinese People's Liberation Army, Editorial Committee of Chinese Journal of Contemporary Pediatrics</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081271552">
    <j.0:identifier>10.1002/ccd.28809</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Catheterization_and_Cardiovascular_Interventions">
        <j.1:name>Catheterization and Cardiovascular Interventions</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <myOnto:issue>S1</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081271552</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081271552&amp;doi=10.1002%2fccd.28809&amp;partnerID=40&amp;md5=df67da93574bb5671986cd02421c56b1&gt;</schema:url>
    <dc:creator>Bailey S.R.</dc:creator>
    <j.0:title>CCI 2020 CIT special issue</j.0:title>
    <schema:keywords>atherosclerosis; cardiovascular disease; China; clinical outcome; coronary artery disease; Coronavirus disease 2019; Coronavirus infection; Editorial; human; medical research; mortality rate; prediction; risk factor; SYNTAX score; technology</schema:keywords>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>95</myOnto:volume>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081898447">
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1002/jmv.25743</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081898447&amp;doi=10.1002%2fjmv.25743&amp;partnerID=40&amp;md5=79e247e37cb00933d723a3b6958183c3&gt;</schema:url>
    <j.0:title>Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach</j.0:title>
    <j.0:identifier>2-s2.0-85081898447</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>There is an obvious concern globally regarding the fact about the emerging coronavirus 2019 novel coronavirus (2019-nCoV) as a worldwide public health threat. As the outbreak of COVID-19 causes by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) progresses within China and beyond, rapidly available epidemiological data are needed to guide strategies for situational awareness and intervention. The recent outbreak of pneumonia in Wuhan, China, caused by the SARS-CoV-2 emphasizes the importance of analyzing the epidemiological data of this novel virus and predicting their risks of infecting people all around the globe. In this study, we present an effort to compile and analyze epidemiological outbreak information on COVID-19 based on the several open datasets on 2019-nCoV provided by the Johns Hopkins University, World Health Organization, Chinese Center for Disease Control and Prevention, National Health Commission, and DXY. An exploratory data analysis with visualizations has been made to understand the number of different cases reported (confirmed, death, and recovered) in different provinces of China and outside of China. Overall, at the outset of an outbreak like this, it is highly important to readily provide information to begin the evaluation necessary to understand the risks and begin containment activities. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <dc:creator>Dey S.K., Rahman M.M., Siddiqi U.R., Howlader A.</dc:creator>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081382200">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081382200&amp;doi=10.1111%2fjgs.16407&amp;partnerID=40&amp;md5=d28b1100c16041ac4d7e82160cffc94f&gt;</schema:url>
    <j.0:identifier>10.1111/jgs.16407</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:publisher>Blackwell Publishing Inc.</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:title>Novel Coronavirus (COVID-19) Epidemic: What Are the Risks for Older Patients?</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_the_American_Geriatrics_Society"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081382200</j.0:identifier>
    <dc:creator>Garnier-Crussard A., Forestier E., Gilbert T., Krolak-Salmon P.</dc:creator>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082201015">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082201015&amp;doi=10.1016%2fS2213-2600%2820%2930114-4&amp;partnerID=40&amp;md5=c848158a44d9b43a297ac012ff1d28c3&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <dc:creator>Ayebare R.R., Flick R., Okware S., Bodo B., Lamorde M.</dc:creator>
    <j.0:identifier>2-s2.0-85082201015</j.0:identifier>
    <j.0:title>Adoption of COVID-19 triage strategies for low-income settings</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S2213-2600(20)30114-4</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081683862">
    <j.0:title>Mental health care for medical staff in China during the COVID-19 outbreak</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
    <dc:creator>Chen Q., Liang M., Li Y., Guo J., Fei D., Wang L., He L., Sheng C., Cai Y., Li X., Wang J., Zhang Z.</dc:creator>
    <schema:keywords>2019 severe acute respiratory syndrome coronavirus 2; anxiety; China; coronavirus disease 2019; Coronavirus infection; critically ill patient; emotional disorder; epidemic; health care personnel management; human; irritability; job stress; Letter; medical staff; mental health care; mental stress; panic; priority journal; SARS coronavirus; skill; workplace</schema:keywords>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081683862&amp;doi=10.1016%2fS2215-0366%2820%2930078-X&amp;partnerID=40&amp;md5=3750d98579d78a5cd1447bdf130c7bf8&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081683862</j.0:identifier>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>10.1016/S2215-0366(20)30078-X</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>7</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081741973">
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Coronaviruses (CoV) are a huge family of viruses and they cause various diseases from the common cold to very serious illnesses. They also just like the Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). But novel coronavirus (nCoV) is a different strain and newly discovered in humans. Several known coronaviruses circulate in animals not yet infected by humans. It is also a zoonotic virus, which means that they are spread between animals and then to humans. Comprehensive studies showed that SARS-CoV was transmitted to humans by civet cats and MERS-CoV by dromedary camels. Respiratory symptoms, fever, cough, shortness of breath and difficulty in breathing are common signs of infection. It was started from Huanan wholesale seafood market with the admission of 2-3 patients and now crossed 37251 cases with 812 deaths as on 9th February. In some of the days, the number of new admissions was more than 3000 cases continuously. This review summarises the types, morphology, origin, transmission, symptoms, diagnostic methods, Chinese, global and Indian scenario of this novel deadly virus. The world health organization advises for the public about the avoiding of the spread of the virus, general recommendations for individuals and for the risk groups also reviewed. © International Journal of Research in Pharmaceutical Sciences and 2020 | All rights reserved.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Research_in_Pharmaceutical_Sciences">
        <j.1:name>International Journal of Research in Pharmaceutical Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>2019 novel coronavirus: A mysterious threat from Wuhan, China–A current review</j.0:title>
    <j.0:publisher>J. K. Welfare and Pharmascope Foundation</j.0:publisher>
    <dc:creator>Kothai R., Arul B.</dc:creator>
    <dc:date>2020</dc:date>
    <myOnto:issue>Special Issue 1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081741973&amp;doi=10.26452%2fijrps.v11iSPL1.1975&amp;partnerID=40&amp;md5=46011f19e59b1e3b89faf02630dc7aee&gt;</schema:url>
    <schema:keywords>alanine aminotransferase; aspartate aminotransferase; nucleocapsid protein; virus envelope protein; virus RNA; virus spike protein; 2019 novel coronavirus; acute respiratory tract disease; aerosol; artificial ventilation; Betacoronavirus; China; common cold; computer assisted tomography; coronavirus disease 2019; coughing; diarrhea; dyspnea; electron microscopy; epidemic; fever; growth rate; human; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus NL63; Human coronavirus OC43; immunocompromised patient; leukocytosis; leukopenia; lymphocytopenia; Middle East respiratory syndrome coronavirus; nonhuman; patient care; pneumonia; real time reverse transcription polymerase chain reaction; Review; rhinorrhea; SARS coronavirus; thorax pain; virus envelope; virus isolation; virus nucleocapsid; virus transmission; weakness</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081741973</j.0:identifier>
    <j.0:type>Review</j.0:type>
    <dc:language>English</dc:language>
    <j.0:identifier>10.26452/ijrps.v11iSPL1.1975</j.0:identifier>
    <myOnto:volume>11</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082073878">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082073878&amp;doi=10.3346%2fjkms.2020.35.e127&amp;partnerID=40&amp;md5=d13a90143773b8eee1896e5933e6d942&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082073878</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.3346/jkms.2020.35.e127</j.0:identifier>
    <dc:creator>Choe Y.J., Choi E.H.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:volume>35</myOnto:volume>
    <myOnto:issue>11</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; communicable disease control; Coronavirus infection; epidemic; human; procedures; school; South Korea; virus pneumonia; Betacoronavirus; Communicable Disease Control; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; Republic of Korea; Schools</schema:keywords>
    <j.0:title>Are we ready for coronavirus disease 2019 arriving at schools?</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082188927">
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.cub.2020.03.022</j.0:identifier>
    <j.0:identifier>2-s2.0-85082188927</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Current_Biology">
        <j.1:name>Current Biology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Zhang T., Wu Q., Zhang Z.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082188927&amp;doi=10.1016%2fj.cub.2020.03.022&amp;partnerID=40&amp;md5=288e7c2b28649733659b7786cf3b7568&gt;</schema:url>
    <rdfs:comment>An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in the city of Wuhan in China and has widely spread worldwide. Currently, it is vital to explore potential intermediate hosts of SARS-CoV-2 to control COVID-19 spread. Therefore, we reinvestigated published data from pangolin lung samples from which SARS-CoV-like CoVs were detected by Liu et al. [1]. We found genomic and evolutionary evidence of the occurrence of a SARS-CoV-2-like CoV (named Pangolin-CoV) in dead Malayan pangolins. Pangolin-CoV is 91.02% and 90.55% identical to SARS-CoV-2 and BatCoV RaTG13, respectively, at the whole-genome level. Aside from RaTG13, Pangolin-CoV is the most closely related CoV to SARS-CoV-2. The S1 protein of Pangolin-CoV is much more closely related to SARS-CoV-2 than to RaTG13. Five key amino acid residues involved in the interaction with human ACE2 are completely consistent between Pangolin-CoV and SARS-CoV-2, but four amino acid mutations are present in RaTG13. Both Pangolin-CoV and RaTG13 lost the putative furin recognition sequence motif at S1/S2 cleavage site that can be observed in the SARS-CoV-2. Conclusively, this study suggests that pangolin species are a natural reservoir of SARS-CoV-2-like CoVs. The emerging SARS-coronavirus 2 (SARS-CoV-2) poses tremendous threat to human health. Zhang, Wu et al. show that like bats, pangolin species are a natural reservoir of SARS-CoV-2-like CoVs. This finding might help to find the intermediate host of SARS-CoV-2 for blocking a global coronavirus pandemic. © 2020 Elsevier Inc.</rdfs:comment>
    <j.0:publisher>Cell Press</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082118377">
    <dc:date>2020</dc:date>
    <j.0:title>Where are we now with COVID-19?</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Thomson G.A.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Clinical_Practice">
        <j.1:name>International Journal of Clinical Practice</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85082118377</j.0:identifier>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:identifier>10.1111/ijcp.13497</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082118377&amp;doi=10.1111%2fijcp.13497&amp;partnerID=40&amp;md5=2ef1e2a2f7f8f8cb2d95323012c6e611&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082129893">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; Betacoronavirus; case report; Coronavirus infection; diagnostic imaging; false negative result; genetics; human; infant; isolation and purification; male; reverse transcription polymerase chain reaction; virology; virus pneumonia; x-ray computed tomography; Adult; Betacoronavirus; Coronavirus Infections; Deep Learning; False Negative Reactions; Humans; Infant; Male; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Tomography, X-Ray Computed</schema:keywords>
    <j.0:title>False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: Role of deep-learning-based ct diagnosis and insights from two cases</j.0:title>
    <j.0:publisher>Korean Radiological Society</j.0:publisher>
    <rdfs:comment>The epidemic of 2019 novel coronavirus, later named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is still gradually spreading worldwide. The nucleic acid test or genetic sequencing serves as the gold standard method for confirmation of infection, yet several recent studies have reported false-negative results of real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). Here, we report two representative false-negative cases and discuss the supplementary role of clinical data with rRT-PCR, including laboratory examination results and computed tomography features. Coinfection with SARS-COV-2 and other viruses has been discussed as well. © 2020 The Korean Society of Radiology.</rdfs:comment>
    <myOnto:issue>4</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Korean_Journal_of_Radiology"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Li D., Wang D., Dong J., Wang N., Huang H., Xu H., Xia C.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082129893</j.0:identifier>
    <myOnto:volume>21</myOnto:volume>
    <j.0:identifier>10.3348/kjr.2020.0146</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082129893&amp;doi=10.3348%2fkjr.2020.0146&amp;partnerID=40&amp;md5=9146ca4b1bc1b24b8551bf1e6a66abf5&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147725">
    <myOnto:volume>368</myOnto:volume>
    <dc:creator>Niforatos J.D., Melnick E.R., Faust J.S.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirinae; Coronavirus infection; human; retrospective study; SARS coronavirus; virus pneumonia; Betacoronavirus; China; Coronavirus; Coronavirus Infections; Humans; Pneumonia, Viral; Retrospective Studies; SARS Virus</schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85082147725</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147725&amp;doi=10.1136%2fbmj.m1113&amp;partnerID=40&amp;md5=4853cbf1fc777ef60d5c58d7ae9ebc89&gt;</schema:url>
    <j.0:title>Covid-19 fatality is likely overestimated</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m1113</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082178624">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <dc:creator>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., HLH Across Speciality Collaboration, UK</dc:creator>
    <j.0:title>COVID-19: consider cytokine storm syndromes and immunosuppression</j.0:title>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S0140-6736(20)30628-0</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85082178624</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>10229</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082178624&amp;doi=10.1016%2fS0140-6736%2820%2930628-0&amp;partnerID=40&amp;md5=feee7323eba6978a6f0c77d689d87dc1&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082033400">
    <rdfs:comment>2019?12??????????????????????2019-nCoV???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????.In December 2019, a new outbreak of corona virus disease 2019 began to occur. Its pathogen is 2019-nCoV, which has the characteristics of strong infectivity and general susceptibility. The current situation of prevention and control of new coronavirus pneumonia is severe. In this context, as front-line medical workers bearing important responsibilities and pressure, while through strict management strategy, we can minimize the risk of infection exposure. By summarizing the research progress and guidelines in recent years in the fields of colorectal cancer disease screening, treatment strategies (including early colorectal cancer, locally advanced colorectal cancer, obstructive colorectal cancer, metastatic colorectal cancer and the treatment of patients after neoadjuvant therapy), the choice of medication and time limit for adjuvant therapy, the protective measures for patients undergoing emergency surgery, the re-examination of postoperative patients and the protection of medical staff, etc., authors improve treatment strategies in order to provide more choices for patients to obtain the best treatment under the severe epidemic situation of new coronavirus pneumonia. Meanwhile we hope that it can also provide more timely treatment modeling schemes for colleagues.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>3</myOnto:issue>
    <schema:keywords>COVID-19; colorectal tumor; complication; Coronavirus infection; early cancer diagnosis; epidemic; human; virus pneumonia; Colorectal Neoplasms; Coronavirus Infections; Disease Outbreaks; Early Detection of Cancer; Humans; Pneumonia, Viral</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:title>Treatment strategies for colorectal cancer patients in tumor hospitals under the background of corona virus disease 2019</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhonghua_wei_chang_wai_ke_za_zhi_=_Chinese_journal_of_gastrointestinal_surgery"/>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85082033400</j.0:identifier>
    <dc:language>Chinese</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082033400&amp;doi=10.3760%2fcma.j.cn.441530-20200217-00058&amp;partnerID=40&amp;md5=fdaba30b5bdc2014c4bfaf53b93e7df9&gt;</schema:url>
    <myOnto:volume>23</myOnto:volume>
    <dc:creator>Hu X.H., Niu W.B., Zhang J.F., Li B.K., Yu B., Zhang Z.Y., Zhou C.X., Zhang X.N., Gao Y., Wang G.Y.</dc:creator>
    <j.0:identifier>10.3760/cma.j.cn.441530-20200217-00058</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080980290">
    <myOnto:issue>7797</myOnto:issue>
    <j.0:title>Coronavirus response: a focus on containment is still apt</j.0:title>
    <dc:date>2020</dc:date>
    <schema:keywords>Coronavirinae; editorial; nonhuman; virology; Coronavirus infection; human; influenza; Middle East respiratory syndrome coronavirus; pandemic; Coronavirus; Coronavirus Infections; Humans; Influenza, Human; Middle East Respiratory Syndrome Coronavirus; Pandemics</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1038/d41586-020-00623-2</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080980290&amp;doi=10.1038%2fd41586-020-00623-2&amp;partnerID=40&amp;md5=1ef98703cc5b3949ac778c98bcb7d95a&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <myOnto:volume>579</myOnto:volume>
    <dc:creator>[No author name available]</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Nature Research</j.0:publisher>
    <rdfs:comment>Despite COVID-19’s spread to new countries, the evidence suggests it is yet possible to curb the virus. [Figure not available: see fulltext.]. © 2020, Nature.</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
    <j.0:identifier>2-s2.0-85080980290</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078734857">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/j.meegid.2020.104211</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:title>Novel coronavirus: From discovery to clinical diagnostics</j.0:title>
    <dc:creator>Phan T.</dc:creator>
    <dc:language>English</dc:language>
    <rdfs:comment>A novel coronavirus designated as 2019-nCoV first appeared in Wuhan, China in late December 2019. Dozens of people died in China, and thousands of people infected as 2019-nCoV continues to spread around the world. We have described the discovery, emergence, genomic characteristics, and clinical diagnostics of 2019-nCoV. © 2020 Elsevier B.V.</rdfs:comment>
    <j.0:identifier>2-s2.0-85078734857</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection,_Genetics_and_Evolution"/>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>79</myOnto:volume>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:keywords>membrane protein; nucleocapsid protein; polyprotein; virus envelope protein; virus spike protein; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; bat; cell culture; China; Coronavirinae; Coronavirus infection; electron microscopy; high throughput sequencing; human; metagenomics; multiplex polymerase chain reaction; nonhuman; Note; nucleic acid amplification; open reading frame; priority journal; real time reverse transcription polymerase chain reaction; SARS coronavirus; sequence analysis; virus genome; virus pneumonia; virus transmission; Betacoronavirus; Coronavirus infection; genetic database; genetics; isolation and purification; virus pneumonia; Betacoronavirus; Coronavirus Infections; Databases, Genetic; Genome, Viral; Humans; Pneumonia, Viral</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078734857&amp;doi=10.1016%2fj.meegid.2020.104211&amp;partnerID=40&amp;md5=fabea9d442742860ce36da122403cb03&gt;</schema:url>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082199783">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>4</myOnto:issue>
    <dc:creator>Zhou C., Gao C., Xie Y., Xu M.</dc:creator>
    <j.0:identifier>10.1016/S1473-3099(20)30156-0</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:volume>20</myOnto:volume>
    <j.0:identifier>2-s2.0-85082199783</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082199783&amp;doi=10.1016%2fS1473-3099%2820%2930156-0&amp;partnerID=40&amp;md5=9d0f8e613e59a5ac206b09fb870efe72&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>COVID-19 with spontaneous pneumomediastinum</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081528685">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>6482</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <j.0:identifier>2-s2.0-85081528685</j.0:identifier>
    <j.0:type>Short Survey</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081528685&amp;doi=10.1126%2fscience.367.6482.1062&amp;partnerID=40&amp;md5=52589097950d55a96e0904f763b0faa6&gt;</schema:url>
    <schema:keywords>strategic approach; viral disease; virus; China; coronavirus disease 2019; Coronavirus infection; disease surveillance; disease transmission; epidemic; government regulation; health care system; human; human rights; infection control; prevalence; priority journal; public health; quarantine; respiratory failure; septic shock; Short Survey; social isolation; Coronavirus infection; global health; pandemic; virus pneumonia; China; COVID-19; China; Coronavirus Infections; Global Health; Humans; Pandemics; Pneumonia, Viral</schema:keywords>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Kupferschmidt K., Cohen J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1126/science.367.6482.1062</j.0:identifier>
    <j.0:title>Can China's COVID-19 strategy work elsewhere?</j.0:title>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081642799">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081642799&amp;doi=10.1016%2fS2215-0366%2820%2930079-1&amp;partnerID=40&amp;md5=445b195dd91a5cca9dc693adf30f7806&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
    <j.0:title>Mental health services for older adults in China during the COVID-19 outbreak</j.0:title>
    <dc:creator>Yang Y., Li W., Zhang Q., Zhang L., Cheung T., Xiang Y.-T.</dc:creator>
    <j.0:identifier>10.1016/S2215-0366(20)30079-1</j.0:identifier>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>2-s2.0-85081642799</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:volume>7</myOnto:volume>
    <myOnto:citeyBy>1</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081948208">
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>10.1016/j.bbrc.2020.03.047</j.0:identifier>
    <dc:creator>Luan J., Lu Y., Jin X., Zhang L.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Biochemical_and_Biophysical_Research_Communications">
        <j.1:name>Biochemical and Biophysical Research Communications</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081948208</j.0:identifier>
    <j.0:title>Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection</j.0:title>
    <rdfs:comment>SARS-CoV-2 causes the recent global COVID-19 public health emergency. ACE2 is the receptor for both SARS-CoV-2 and SARS-CoV. To predict the potential host range of SARS-CoV-2, we analyzed the key residues of ACE2 for recognizing S protein. We found that most of the selected mammals including pets (dog and cat), pangolin and Circetidae mammals remained the most of key residues for association with S protein from SARS-CoV and SARS-CoV-2. The interaction interface between cat/dog/pangolin/Chinese hamster ACE2 and SARS-CoV/SARS-CoV-2 S protein was simulated through homology modeling. We identified that N82 in ACE2 showed a closer contact with SARS-CoV-2 S protein than M82 in human ACE2. Our finding will provide important insights into the host range of SARS-CoV-2 and a new strategy to design an optimized ACE2 for SARS-CoV-2 infection. © 2020 Elsevier Inc.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081948208&amp;doi=10.1016%2fj.bbrc.2020.03.047&amp;partnerID=40&amp;md5=d016d0a958ed16d1071c49bd89019294&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Article</j.0:type>
    <schema:keywords>animal experiment; animal model; article; cat; Chinese hamster; dog; host range; human; molecular recognition; nonhuman; Pholidota (animal); SARS coronavirus; simulation; spike</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082146878">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m1155</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Covid-19: cases grow in US as Trump pushes promise of a malaria drug</j.0:title>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082146878</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Tanne J.H.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082146878&amp;doi=10.1136%2fbmj.m1155&amp;partnerID=40&amp;md5=211c5a575e3d9a21147c888a6b4e025c&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082045242">
    <dc:language>German</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1007/s15006-020-0246-9</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Springer Medizin</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082045242&amp;doi=10.1007%2fs15006-020-0246-9&amp;partnerID=40&amp;md5=ea4c0c4beb4e18c9cf0ef1ed9e300759&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85082045242</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Videosprechstunde wegen SARS-CoV-2?</j.0:title>
    <myOnto:volume>162</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/MMW_Fortschritte_der_Medizin">
        <j.1:name>MMW Fortschritte der Medizin</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092375">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>2-s2.0-85082092375</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092375&amp;doi=10.4103%2fijp.IJP_119_20&amp;partnerID=40&amp;md5=192804b65f1a8bf6507ce78021ea643c&gt;</schema:url>
    <myOnto:volume>52</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach</j.0:title>
    <dc:creator>Sarma P., Prajapat M., Avti P., Kaur H., Kumar S., Medhi B.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Editorial</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Indian_Journal_of_Pharmacology"/>
    <j.0:publisher>Wolters Kluwer Medknow Publications</j.0:publisher>
    <j.0:identifier>10.4103/ijp.IJP_119_20</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081956557">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.jmii.2020.03.005</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081956557</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>COVID-19 emerges as a pandemic disease with high mortality. Development of effective prevention and treatment is an urgent need. We reviewed TH17 responses in patients with SARS-CoV-2 and proposed an FDA approved JAK2 inhibitor Fedratinib for reducing mortality of patients with TH17 type immune profiles. © 2020</rdfs:comment>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:language>English</dc:language>
    <dc:creator>Wu D., Yang X.O.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:title>TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081956557&amp;doi=10.1016%2fj.jmii.2020.03.005&amp;partnerID=40&amp;md5=f45ffa1392caf1cb3a29c236b5cce3c7&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Microbiology,_Immunology_and_Infection"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082127342">
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>10.4167/jbv.2020.50.1.001</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Bacteriology_and_Virology">
        <j.1:name>Journal of Bacteriology and Virology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:identifier>2-s2.0-85082127342</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Jeong Y.S.</dc:creator>
    <rdfs:comment>The 2019 novel coronavirus disease (COVID-19) outbreaks that emerged in Wuhan city, Hubei province, have led to a formidable number of confirmed cases that resulted in &amp;gt;5,700 deaths globally, including 143 countries in all 6 continents. The World Health Organization declared a Public Health Emergency of International Concern with a very high level of global risk assessment. Severe acute respiratory syndrome (SARS)-coronavirus-2 (SARS-CoV-2), the agent of COVID-19, has &amp;gt;79% nucleotide sequence homology to SARS-CoV; therefore, both belong to the genus betacoronavirus and subgenus sarbecovirus. The S1 domains of the two appeared to share the cellular receptor ACE2, but revealed a much higher S1-ACE2 binding affinity. As seen in many other human coronaviruses, SARS-CoV-2 also shows respiratory infection, but the basic reproductive number (R0) in transmission and the clinical latency are quite dissimilar from those of SARS-or MERS-CoVs. Many scientists infer that the time point of cross-barrier transfer from bats to mediate animals or to humans should be a rather recent event based on the full-length genome analyses obtained from the very first patients. Copy-choice polymerization, which often leads to a significant genome recombination rate in most coronaviruses, predicts the continued emergence of novel coronaviruses. © 2020 Journal of Bacteriology and Virology.</rdfs:comment>
    <myOnto:volume>50</myOnto:volume>
    <j.0:title>2019 novel coronavirus disease outbreak and molecular genetic characteristics of severe acute respiratory syndrome-coronavirus-2</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082127342&amp;doi=10.4167%2fjbv.2020.50.1.001&amp;partnerID=40&amp;md5=1c81f94203c5dfd16976888444a16b4c&gt;</schema:url>
    <j.0:type>Review</j.0:type>
    <schema:keywords></schema:keywords>
    <dc:language>Korean</dc:language>
    <j.0:publisher>The Korean Society for Mocrobiology / The Korean Society of Virology</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079545159">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>395</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10224</myOnto:issue>
    <j.0:title>COVID-19: what is next for public health?</j.0:title>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079545159&amp;doi=10.1016%2fS0140-6736%2820%2930374-3&amp;partnerID=40&amp;md5=3b237ab2b9198264d52792a070638247&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30374-3</j.0:identifier>
    <dc:creator>Heymann D.L., Shindo N., WHO Scientific and Technical Advisory Group for Infectious Hazards</dc:creator>
    <schema:keywords>2019 novel coronavirus; adult respiratory distress syndrome; bat; case fatality rate; China; clinical feature; common cold; comorbidity; contact examination; Coronavirinae; Coronavirus infection; disease course; disease severity; epidemic; genetic analysis; health care facility; help seeking behavior; human; infection risk; Note; priority journal; risk assessment; social acceptance; virus isolation; virus replication; virus transmission; winter; World Health Organization; Betacoronavirus; Coronavirus infection; physiology; procedures; public health; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral; Public Health; World Health Organization</schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079545159</j.0:identifier>
    <myOnto:citeyBy>7</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079338695">
    <j.0:title>Novel coronavirus (2019-nCoV): Lessons of uncertainty and globalization [2019-NCoV: Leçons d'incertitudes et de mondialisation]</j.0:title>
    <dc:creator>Matter M.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>French</dc:language>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Revue_Medicale_Suisse"/>
    <j.0:identifier></j.0:identifier>
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Note</schema:keywords>
    <j.0:identifier>2-s2.0-85079338695</j.0:identifier>
    <myOnto:volume>16</myOnto:volume>
    <j.0:publisher>Editions Medecine et Hygiene</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:issue>681</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079338695&amp;partnerID=40&amp;md5=39a466802112c6432f6cbebe074ce854&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081732998">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081732998&amp;doi=10.26452%2fijrps.v11iSPL1.1973&amp;partnerID=40&amp;md5=8620deb1010c70751e0896ee075a21dc&gt;</schema:url>
    <schema:keywords>fluorouracil; lopinavir; proteinase; remdesivir; ribavirin; virus RNA; 2019 novel coronavirus; airway epithelium cell; antiviral activity; antiviral resistance; antiviral susceptibility; Article; CC50 (cytotoxic concentration); cell viability; coronavirus disease 2019; cytotoxicity; exon; human; human cell; Human immunodeficiency virus; hypothesis; IC50; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; Murine hepatitis virus; nonhuman; protein expression; real time polymerase chain reaction; SARS coronavirus; severe acute respiratory syndrome; viral plaque assay; virus inhibition; virus load; virus replication</schema:keywords>
    <j.0:identifier>10.26452/ijrps.v11iSPL1.1973</j.0:identifier>
    <myOnto:volume>11</myOnto:volume>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>J. K. Welfare and Pharmascope Foundation</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Research_in_Pharmaceutical_Sciences"/>
    <j.0:title>Role of GS-5734 (Remdesivir) in inhibiting SARS-CoV and MERS-CoV: The expected role of GS-5734 (remdesivir) in COVID-19 (2019-nCoV)-VYTR hypothesis</j.0:title>
    <rdfs:comment>Coronaviruses (CoVs) are enveloped RNA viruses related to the family Coro-naviridae, the order Nirdovales, and observed in humans and other mammals. In December 2019, many pneumonia cases reported by patients with unknown causes, mainly associated with seafood and wet animal market in Wuhan, China, and where clinically resembled viral pneumonia. At present, there is no existence of antiviral drugs for the treatment of CoV infections. The results of our study are GS-5734 strongly inhibits SARS-CoV and MERS-CoV in HAE cells, GS-5734 inhibits CoVs at early stages in replication by inhibiting viral RNA synthesis, the absence of ExoN-mediated proofreading in viruses sensitive to treatment with GS-5734. Protease inhibitors can show improved outcomes in some coronaviruses, but mostly 99% of protease inhibitors bind to proteins present in the human body, and only 1% attacks on existed viruses. The expected role of GS-5734 (Remdesivir) in COVID-19 (2019-nCoV)-VYTR hypothesis explained. As broad-spectrum drugs are capable of inhibiting CoV infections, GS-5734 is a broad-spectrum drug and may show inhibition on CoV infections and COVID-19. GS-5734 will show desired results regarding antiviral activity against 2019-nCoV as it showed potent antiviral activity in other CoVs. More clinical trials and experiments needed to prove that GS-5734 (Remdesivir) is a potential and effective drug to treat COVID-19. © 2020 International Journal of Research in Pharmaceutical Sciences. All rights reserved.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>Special Issue 1</myOnto:issue>
    <dc:creator>Yethindra V.</dc:creator>
    <j.0:identifier>2-s2.0-85081732998</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079606866">
    <j.0:title>Emergence of SARS-like coronavirus poses new challenge in China</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>80</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/j.jinf.2020.01.017</j.0:identifier>
    <j.0:identifier>2-s2.0-85079606866</j.0:identifier>
    <schema:keywords>2019 novel coronavirus; acute diarrhea; China; Coronavirus infection; epidemic; human; infection control; Letter; Middle East respiratory syndrome; nonhuman; public health; SARS-related coronavirus; sequence homology; severe acute respiratory syndrome; swine acute diarrhea syndrome coronavirus infection; virus detection; virus genome; virus transmission; wild animal</schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079606866&amp;doi=10.1016%2fj.jinf.2020.01.017&amp;partnerID=40&amp;md5=be7efdd998630a951b9e06565ea51d6a&gt;</schema:url>
    <dc:creator>Wang R., Zhang X., Irwin D.M., Shen Y.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082073981">
    <myOnto:volume></myOnto:volume>
    <dc:creator>Stoffel C., Schuppers M., Buholzer P., Muñoz V., Lechner I., Sperling U., Küker S., De Nardi M.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Transboundary_and_Emerging_Diseases"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:identifier>10.1111/tbed.13536</j.0:identifier>
    <j.0:identifier>2-s2.0-85082073981</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>The ongoing crises in China illustrate that the assessment of epidemics in isolation is no longer sufficient</j.0:title>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082073981&amp;doi=10.1111%2ftbed.13536&amp;partnerID=40&amp;md5=baeab414eee628d4801b308599e6c911&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080950913">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>6481</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <dc:creator>Cohen J., Kupferschmidt K.</dc:creator>
    <j.0:identifier>2-s2.0-85080950913</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1126/science.367.6481.962</j.0:identifier>
    <schema:keywords>aviation; China; Coronavirus infection; COVID 19; disease surveillance; economic aspect; hand washing; health care availability; health care system; home environment; human; infection control; infection prevention; mortality; Note; pandemic; physical well-being; priority journal; psychological well-being; public health; public health message; quarantine; travel restriction; virus transmission; World Health Organization; Coronavirus</schema:keywords>
    <j.0:title>Strategies shift as coronavirus pandemic looms: The virus seems unstoppable, but mitigating its speed and impact is possible</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080950913&amp;doi=10.1126%2fscience.367.6481.962&amp;partnerID=40&amp;md5=135b8b681d16d4e83e060d221c370c38&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081680373">
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_Journal_of_Radiology">
        <j.1:name>European Journal of Radiology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>Purpose: To report CT features of coronavirus disease-2019 (COVID-19) in patients with various disease severity. Methods: The CT manifestations and clinical data of 73 patients with COVID-19 were retrospectively collected in 6 hospitals from Jan 21 to Feb 3, 2020. We analyzed the initial and follow-up CT features of patients with disease severity, according to the Guidelines for the Diagnosis and Treatment of New Coronavirus Pneumonia. Results: Six patients (8%) were diagnosed as mild type pneumonia; these patients had no obvious abnormal CT findings or manifested mild changes of lung infection. All 43 patients (59 %) with common type presented unique or multiple ground-glass opacities (GGO) in the periphery of the lungs, with or without interlobular septal thickening. In the 21 patients (29 %) with severe type, extensive GGO and pulmonary consolidation were found in 16 cases (16/21, 76 %) and 5 cases (24 %), respectively. An extensive "white lung", with atelectasis and pleural effusion were found in critical type patients (3, 4%). On the resolutive phase of the disease, CT abnormalities showed complete resolution, or demonstrated residual linear opacities. Conclusions: Different CT features are seen according to disease severity, which can help COVID-19 stratification. © 2020 The Author(s)</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Elsevier Ireland Ltd</j.0:publisher>
    <j.0:title>CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity</j.0:title>
    <j.0:identifier>2-s2.0-85081680373</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.ejrad.2020.108941</j.0:identifier>
    <myOnto:volume>126</myOnto:volume>
    <schema:keywords>antivirus agent; adolescent; adult; aged; Article; atelectasis; child; clinical assessment; controlled study; coronavirus disease 2019; Coronavirus infection; disease severity; female; follow up; human; image analysis; image display; lung infection; major clinical study; male; multidetector computed tomography; pleura effusion; practice guideline; priority journal; retrospective study; virus pneumonia</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081680373&amp;doi=10.1016%2fj.ejrad.2020.108941&amp;partnerID=40&amp;md5=b73d4f15ad45f4e9b98b23ef3a8775a2&gt;</schema:url>
    <dc:creator>Liu K.-C., Xu P., Lv W.-F., Qiu X.-H., Yao J.-L., Gu J.-F., Wei W.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081600376">
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:title>COVID-19 Therapeutic and Prevention</j.0:title>
    <j.0:identifier>2-s2.0-85081600376</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Raoult D., Hsueh P.-R., Stefani S., Rolain J.-M.</dc:creator>
    <j.0:identifier>10.1016/j.ijantimicag.2020.105937</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Antimicrobial_Agents"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081600376&amp;doi=10.1016%2fj.ijantimicag.2020.105937&amp;partnerID=40&amp;md5=bd072596c4e557af1ad73b09e8b5f9f1&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079842700">
    <myOnto:issue>10225</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079842700</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020; published online Jan 31. https://doi.org/10.1016/10.1016/S0140-6736(20)30260-9—In this Article, the data sharing statement has been amended to clarify the sources from which data can be obtained. This correction has been made to the online version as of Feb 4, 2020, and will be made to the printed version. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:title>Department of Error: Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study (The Lancet (2020) 395(10225) (689–697), (S0140673620302609), (10.1016/S0140-6736(20)30260-9))</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30302-0</j.0:identifier>
    <schema:keywords>erratum</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Erratum</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079842700&amp;doi=10.1016%2fS0140-6736%2820%2930302-0&amp;partnerID=40&amp;md5=d6bb071d866aad636d432ab8eb932f5f&gt;</schema:url>
    <myOnto:volume>395</myOnto:volume>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079334297">
    <j.0:identifier>10.15585/mmwr.mm6906e1</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/MMWR._Morbidity_and_mortality_weekly_report"/>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue>6</myOnto:issue>
    <j.0:title>Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020</j.0:title>
    <j.0:identifier>2-s2.0-85079334297</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079334297&amp;doi=10.15585%2fmmwr.mm6906e1&amp;partnerID=40&amp;md5=7ae8f7dab8beea88a6948a1d1fe3aa14&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume>69</myOnto:volume>
    <rdfs:comment>In December 2019, a cluster of cases of pneumonia emerged in Wuhan City in central China's Hubei Province. Genetic sequencing of isolates obtained from patients with pneumonia identified a novel coronavirus (2019-nCoV) as the etiology (1). As of February 4, 2020, approximately 20,000 confirmed cases had been identified in China and an additional 159 confirmed cases in 23 other countries, including 11 in the United States (2,3). On January 17, CDC and the U.S. Department of Homeland Security's Customs and Border Protection began health screenings at U.S. airports to identify ill travelers returning from Wuhan City (4). CDC activated its Emergency Operations Center on January 21 and formalized a process for inquiries regarding persons suspected of having 2019-nCoV infection (2). As of January 31, 2020, CDC had responded to clinical inquiries from public health officials and health care providers to assist in evaluating approximately 650 persons thought to be at risk for 2019-nCoV infection. Guided by CDC criteria for the evaluation of persons under investigation (PUIs) (5), 210 symptomatic persons were tested for 2019-nCoV; among these persons, 148 (70%) had travel-related risk only, 42 (20%) had close contact with an ill laboratory-confirmed 2019-nCoV patient or PUI, and 18 (9%) had both travel- and contact-related risks. Eleven of these persons had laboratory-confirmed 2019-nCoV infection. Recognizing persons at risk for 2019-nCoV is critical to identifying cases and preventing further transmission. Health care providers should remain vigilant and adhere to recommended infection prevention and control practices when evaluating patients for possible 2019-nCoV infection (6). Providers should consult with their local and state health departments when assessing not only ill travelers from 2019-nCoV-affected countries but also ill persons who have been in close contact with patients with laboratory-confirmed 2019-nCoV infection in the United States.</rdfs:comment>
    <dc:language>English</dc:language>
    <dc:creator>Bajema K.L., Oster A.M., McGovern O.L., Lindstrom S., Stenger M.R., Anderson T.C., Isenhour C., Clarke K.R., Evans M.E., Chu V.T., Biggs H.M., Kirking H.L., Gerber S.I., Hall A.J., Fry A.M., Oliver S.E., 2019-nCoV Persons Under Investigation Team, 2019-CoV Persons Under Investigation Team</dc:creator>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; adolescent; adult; aged; Betacoronavirus; child; contact examination; Coronavirus infection; epidemic; female; human; isolation and purification; male; mass screening; middle aged; preschool child; risk assessment; travel related disease; United States; young adult; Adolescent; Adult; Aged; Betacoronavirus; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Contact Tracing; Coronavirus Infections; Disease Outbreaks; Female; Humans; Male; Mass Screening; Middle Aged; Risk Assessment; Travel-Related Illness; United States; Young Adult</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080875858">
    <j.0:type>Review</j.0:type>
    <dc:creator>Sun P., Lu X., Xu C., Sun W., Pan B.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Understanding of COVID-19 based on current evidence</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85080875858</j.0:identifier>
    <j.0:identifier>10.1002/jmv.25722</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019-nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019-nCoV as coronavirus disease (COVID-19). The COVID-19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID-19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID-19 epidemic. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080875858&amp;doi=10.1002%2fjmv.25722&amp;partnerID=40&amp;md5=28ab40b04e51511ded0a991412551180&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081624816">
    <schema:keywords>angiotensin converting enzyme 2; viral protein; angiotensin converting enzyme 2; COVID-19; dipeptidyl carboxypeptidase; severe acute respiratory syndrome coronavirus 2; virus antibody; cell; cell component; enzyme; enzyme activity; genome; pneumonia; protein; severe acute respiratory syndrome; virus; amino acid sequence; animal cell; Article; bat; bronchoalveolar lavage fluid; China; clinical article; controlled study; coronavirus disease 2019; critically ill patient; epidemic; high risk population; human; human cell; infection risk; mortality rate; nonhuman; pneumonia; priority journal; protein domain; risk factor; SARS coronavirus; sequence analysis; sequence homology; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; virus cell interaction; virus characterization; virus detection; virus entry; virus identification; virus isolation; virus neutralization; whole genome sequencing; animal; Betacoronavirus; blood; cell line; Chlorocebus aethiops; classification; Coronavirus infection; female; genetics; male; metabolism; phylogeny; SARS coronavirus; severe acute respiratory syndrome; ultrastructure; Vero cell line; virology; virus genome; virus pneumonia; China; Hubei; Wuhan; Coronavirus; SARS coronavirus; Animals; Antibodies, Viral; Betacoronavirus; Cell Line; China; Chiroptera; Chlorocebus aethiops; Coronavirus Infections; Disease Outbreaks; Female; Genome, Viral; Humans; Male; Peptidyl-Dipeptidase A; Phylogeny; Pneumonia, Viral; SARS Virus; Sequence Homology, Nucleic Acid; Severe Acute Respiratory Syndrome; Vero Cells</schema:keywords>
    <j.0:identifier>2-s2.0-85081624816</j.0:identifier>
    <myOnto:volume>579</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>103</myOnto:citeyBy>
    <j.0:identifier>10.1038/s41586-020-2012-7</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>7798</myOnto:issue>
    <j.0:title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats1–4. Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans5–7. Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor—angiotensin converting enzyme II (ACE2)—as SARS-CoV. © 2020, The Author(s).</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081624816&amp;doi=10.1038%2fs41586-020-2012-7&amp;partnerID=40&amp;md5=cb468d9ac2a240115884c1f298070ca8&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., Chen H.-D., Chen J., Luo Y., Guo H., Jiang R.-D., Liu M.-Q., Chen Y., Shen X.-R., Wang X., Zheng X.-S., Zhao K., Chen Q.-J., Deng F., Liu L.-L., Yan B., Zhan F.-X., Wang Y.-Y., Xiao G.-F., Shi Z.-L.</dc:creator>
    <j.0:publisher>Nature Research</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081892769">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <j.0:title>COVID-19 coronavirus: What implications for cardiology? [Coronavirus COVID-19: Quali implicazioni per la Cardiologia?]</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081892769&amp;partnerID=40&amp;md5=fc5833b785f1123b98252741e7224657&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081892769</j.0:identifier>
    <j.0:identifier></j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:creator>Di Pasquale G.</dc:creator>
    <dc:language>Italian</dc:language>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>21</myOnto:volume>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Giornale_Italiano_di_Cardiologia">
        <j.1:name>Giornale Italiano di Cardiologia</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Il Pensiero Scientifico Editore s.r.l.</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081674537">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081674537&amp;doi=10.2807%2f1560-7917.ES.2020.25.9.2000202&amp;partnerID=40&amp;md5=62534f940053862406bb544af598eeb5&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081674537</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.9.2000202</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; aged; Betacoronavirus; comorbidity; Coronavirus infection; disaster planning; epidemic; Europe; European Union; forecasting; health care planning; human; international cooperation; middle aged; pathogenicity; public health; risk factor; theoretical model; uncertainty; very elderly; virus pneumonia; Aged; Aged, 80 and over; Betacoronavirus; Comorbidity; Coronavirus Infections; Disaster Planning; Epidemics; Europe; European Union; Forecasting; Health Planning; Humans; Internationality; Middle Aged; Models, Theoretical; Pneumonia, Viral; Public Health; Risk Factors; Uncertainty</schema:keywords>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>9</myOnto:issue>
    <rdfs:comment>Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area (EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the 'limited sustained transmission' phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens.</rdfs:comment>
    <j.0:title>Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Johnson H.C., Gossner C.M., Colzani E., Kinsman J., Alexakis L., Beauté J., Würz A., Tsolova S., Bundle N., Ekdahl K.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079891488">
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>10.1016/S1473-3099(20)30067-0</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <j.0:identifier>2-s2.0-85079891488</j.0:identifier>
    <schema:keywords>antibiotic agent; 2019 novel coronavirus; adult; case report; clinical article; Coronavirinae; Coronavirus infection; coughing; crackle; dyspnea; follow up; hospital admission; human; informed consent; Letter; lung infiltrate; male; Nepalese; oxygen saturation; priority journal; real time reverse transcription polymerase chain reaction; thorax radiography; throat culture</schema:keywords>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079891488&amp;doi=10.1016%2fS1473-3099%2820%2930067-0&amp;partnerID=40&amp;md5=387f84f461ef442e0db107d5405f7a23&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Bastola A., Sah R., Rodriguez-Morales A.J., Lal B.K., Jha R., Ojha H.C., Shrestha B., Chu D.K.W., Poon L.L.M., Costello A., Morita K., Pandey B.D.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>20</myOnto:volume>
    <j.0:title>The first 2019 novel coronavirus case in Nepal</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082045900">
    <j.0:title>We have to write and share valid and reliable information on COVID-19</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>1</myOnto:issue>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <dc:creator>Liew S.M., Khoo E.M., Cheah W.K., Peariasamy K., Goh P.P., Ibrahim H.M.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Malaysian_Family_Physician"/>
    <j.0:identifier>2-s2.0-85082045900</j.0:identifier>
    <j.0:identifier></j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>15</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082045900&amp;partnerID=40&amp;md5=9e777e2316f987db5f21b2b1e1109570&gt;</schema:url>
    <j.0:publisher>Academy of Family Physicians of Malaysia</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082076199">
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Critical_care_(London,_England)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082076199&amp;doi=10.1186%2fs13054-020-2832-8&amp;partnerID=40&amp;md5=c7ba8c032afa76bc90112565458d1abe&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Wang H., Wang S., Yu K.</dc:creator>
    <j.0:title>COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China</j.0:title>
    <j.0:identifier>10.1186/s13054-020-2832-8</j.0:identifier>
    <j.0:identifier>2-s2.0-85082076199</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; critical illness; female; health care delivery; human; male; patient isolation; protective clothing; protective equipment; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Critical Illness; Female; Health Services Accessibility; Humans; Male; Patient Isolation; Personal Protective Equipment; Pneumonia, Viral; Protective Clothing</schema:keywords>
    <myOnto:volume>24</myOnto:volume>
    <j.0:type>Editorial</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080921550">
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85080921550</j.0:identifier>
    <j.0:title>Clinical trial analysis of 2019-nCoV therapy registered in China</j.0:title>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <rdfs:comment>So far, there is a lack of effective drugs for the new coronavirus pneumonia. With more and more patients diagnosed, China has carried out more than 100 clinical studies of new coronavirus infection, including antiviral drugs, antimalarial drugs, glucocorticoids, plasma therapy, virus vaccine, and other Western drugs, while Chinese medicine research accounted for half of the studies. Most of the trials were initiated by investigators and the study period would last for 1 to 11 months. The primary endpoints included symptom improvement and virus nucleic acid turning negative, but the optimal endpoint has not been determined. Although the final results of studies will take a long time to complete, the interim research data may provide some help for the current urgent demand for drug treatment. Compared with that of during SARS period in 2003, China has the stronger capability to carry out clinical trials of new drugs in emergency period. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:identifier>10.1002/jmv.25733</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080921550&amp;doi=10.1002%2fjmv.25733&amp;partnerID=40&amp;md5=33d3271d81617e1009c5e6e2e6238914&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Zhang Q., Wang Y., Qi C., Shen L., Li J.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081244162">
    <j.0:type>Review</j.0:type>
    <j.0:identifier>10.1016/j.jinf.2020.02.010</j.0:identifier>
    <j.0:title>Coronavirus 2019-nCoV: A brief perspective from the front line</j.0:title>
    <myOnto:volume>80</myOnto:volume>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85081244162</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Infection"/>
    <dc:date>2020</dc:date>
    <rdfs:comment>A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. As of 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for the human coronavirus. Therefore, it is critical to understand the nature of the virus and its clinical characteristics, in order to respond to the 2019-nCoV outbreak. Thus, the present study briefly but comprehensively summarizes the not much but timely reports on the 2019-nCoV. © 2020</rdfs:comment>
    <dc:creator>Han Q., Lin Q., Jin S., You L.</dc:creator>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081244162&amp;doi=10.1016%2fj.jinf.2020.02.010&amp;partnerID=40&amp;md5=f08095d14352fdc3e02b31a323a10f3d&gt;</schema:url>
    <myOnto:issue>4</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078306786">
    <myOnto:citeyBy>53</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078306786&amp;doi=10.1016%2fS0140-6736%2820%2930185-9&amp;partnerID=40&amp;md5=e5310c9aa143dc878d2e516021ff6bd5&gt;</schema:url>
    <j.0:identifier>2-s2.0-85078306786</j.0:identifier>
    <dc:creator>Wang C., Horby P.W., Hayden F.G., Gao G.F.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>A novel coronavirus outbreak of global health concern</j.0:title>
    <j.0:identifier>10.1016/S0140-6736(20)30185-9</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords>lopinavir; ritonavir; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease severity; disease surveillance; disease transmission; epidemic; gene sequence; global health; health care planning; health education; human; infection control; nonhuman; Note; priority journal; public health; real time polymerase chain reaction; risk assessment; universal precaution; virus transmission; Betacoronavirus; Coronavirinae; Coronavirus infection; epidemic; global health; pneumonia; Betacoronavirus; Coronavirus; Coronavirus Infections; Disease Outbreaks; Global Health; Humans; Pneumonia</schema:keywords>
    <myOnto:issue>10223</myOnto:issue>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079479827">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; Article; China; Coronavirinae; Coronavirus infection; disease classification; disease severity; epidemic; human; infection control; intensive care; medical staff; protection; staff training</schema:keywords>
    <dc:language>English</dc:language>
    <myOnto:volume>46</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079479827&amp;doi=10.1007%2fs00134-020-05954-2&amp;partnerID=40&amp;md5=7abdb1544a808fa15835ec8ec135820a&gt;</schema:url>
    <dc:creator>Liao X., Wang B., Kang Y.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079479827</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>2</myOnto:issue>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:identifier>10.1007/s00134-020-05954-2</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:title>Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078241976">
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:title>Data sharing and outbreaks: best practice exemplified</j.0:title>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; China; Chinese; Coronavirus infection; data processing; data sharing; epidemic; government; human; incubation time; Middle East respiratory syndrome; nonhuman; Note; online system; peer review; priority journal; publication; severe acute respiratory syndrome; virus transmission; Betacoronavirus; Coronavirinae; epidemic; information dissemination; pneumonia; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus; Disease Outbreaks; Humans; Information Dissemination; Pneumonia</schema:keywords>
    <j.0:identifier>2-s2.0-85078241976</j.0:identifier>
    <myOnto:issue>10223</myOnto:issue>
    <j.0:type>Note</j.0:type>
    <dc:creator>Heymann D.L.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30184-7</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078241976&amp;doi=10.1016%2fS0140-6736%2820%2930184-7&amp;partnerID=40&amp;md5=3b943345ce6b1457e91e4e9c261a9a7a&gt;</schema:url>
    <myOnto:citeyBy>7</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082180057">
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082180057</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S2468-2667(20)30058-X</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082180057&amp;doi=10.1016%2fS2468-2667%2820%2930058-X&amp;partnerID=40&amp;md5=78722d9cc86dce7b01296f4e8c90fc58&gt;</schema:url>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <dc:creator>Kinner S.A., Young J.T., Snow K., Southalan L., Lopez-Acuña D., Ferreira-Borges C., O'Moore É.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Public_Health"/>
    <j.0:title>Prisons and custodial settings are part of a comprehensive response to COVID-19</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078823813">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078823813&amp;doi=10.1002%2fjmv.25689&amp;partnerID=40&amp;md5=eec4aa0df9d8e5453c5b7de1d2d296c4&gt;</schema:url>
    <j.0:title>Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:identifier>10.1002/jmv.25689</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85078823813</j.0:identifier>
    <dc:creator>Wang W., Tang J., Wei F.</dc:creator>
    <rdfs:comment>To help health workers and the public recognize and deal with the 2019 novel coronavirus (2019-nCoV) quickly, effectively, and calmly with an updated understanding. A comprehensive search from Chinese and worldwide official websites and announcements was performed between 1 December 2019 and 9:30 am 26 January 2020 (Beijing time). A latest summary of 2019-nCoV and the current outbreak was drawn. Up to 24 pm, 25 January 2020, a total of 1975 cases of 2019-nCoV infection were confirmed in mainland China with a total of 56 deaths having occurred. The latest mortality was approximately 2.84% with a total of 2684 cases still suspected. The China National Health Commission reported the details of the first 17 deaths up to 24 pm, 22 January 2020. The deaths included 13 males and 4 females. The median age of the people who died was 75 (range 48-89) years. Fever (64.7%) and cough (52.9%) were the most common first symptoms among those who died. The median number of days from the occurence of the first symptom to death was 14.0 (range 6-41) days, and it tended to be shorter among people aged 70 years or more (11.5 [range 6-19] days) than those aged less than 70 years (20 [range 10-41] days; P =.033). The 2019-nCoV infection is spreading and its incidence is increasing nationwide. The first deaths occurred mostly in elderly people, among whom the disease might progress faster. The public should still be cautious in dealing with the virus and pay more attention to protecting the elderly people from the virus. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:citeyBy>16</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords>2019 novel coronavirus; adult; aged; Article; cause of death; China; Chinese; comorbidity; controlled study; Coronavirinae; Coronavirus infection; coronavirus infection 2019; coughing; disease course; female; fever; human; incidence; major clinical study; male; mortality; nonhuman; Coronavirus infection; epidemic; Hong Kong; Macao; middle aged; Taiwan; very elderly; virus pneumonia; COVID-19; Aged; Aged, 80 and over; China; Coronavirus Infections; Disease Outbreaks; Hong Kong; Humans; Macau; Middle Aged; Pneumonia, Viral; Taiwan</schema:keywords>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>92</myOnto:volume>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081277690">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081277690&amp;doi=10.1515%2fcclm-2020-0198&amp;partnerID=40&amp;md5=d2849f2c0aa7567bf56e8d8001a54346&gt;</schema:url>
    <j.0:publisher>De Gruyter</j.0:publisher>
    <j.0:identifier>2-s2.0-85081277690</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1515/cclm-2020-0198</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_Chemistry_and_Laboratory_Medicine">
        <j.1:name>Clinical Chemistry and Laboratory Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>Laboratory abnormalities in patients with COVID-2019 infection</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Letter</j.0:type>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Lippi G., Plebani M.</dc:creator>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079122891">
    <myOnto:citeyBy>9</myOnto:citeyBy>
    <dc:creator>Richardson P., Griffin I., Tucker C., Smith D., Oechsle O., Phelan A., Stebbing J.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>10223</myOnto:issue>
    <myOnto:volume>395</myOnto:volume>
    <schema:keywords>baricitinib; azetidine derivative; baricitinib; severe acute respiratory syndrome coronavirus 2; sulfonamide; 2019 novel coronavirus; acute respiratory tract disease; binding affinity; Coronavirinae; Coronavirus infection; drug blood level; drug inhibition; human; Letter; prediction; priority journal; scoring system; virus entry; virus genome; Betacoronavirus; Azetidines; Betacoronavirus; Humans; Sulfonamides</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:identifier>2-s2.0-85079122891</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S0140-6736(20)30304-4</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079122891&amp;doi=10.1016%2fS0140-6736%2820%2930304-4&amp;partnerID=40&amp;md5=fb582cbbd057aff09934bda2184b7160&gt;</schema:url>
    <j.0:title>Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081322895">
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081322895&amp;doi=10.1136%2fbmj.m869&amp;partnerID=40&amp;md5=2a083dcb42c0b707614eb4bc509b4382&gt;</schema:url>
    <dc:creator>Mahase E.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Covid-19: hoarding and misuse of protective gear is jeopardising the response, WHO warns</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m869</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081322895</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082060859">
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082060859&amp;doi=10.3346%2fjkms.2020.35.e123&amp;partnerID=40&amp;md5=32b448955391855e648f05868b9bf049&gt;</schema:url>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; car; communicable disease control; Coronavirus infection; human; mass screening; procedures; South Korea; virus pneumonia; Automobiles; Betacoronavirus; Communicable Disease Control; Coronavirus Infections; Humans; Mass Screening; Pneumonia, Viral; Republic of Korea</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <j.0:identifier>2-s2.0-85082060859</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>35</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>As the coronavirus disease 2019 (COVID-19) outbreak is ongoing, the number of individuals to be tested for COVID-19 is rapidly increasing. For safe and efficient screening for COVID-19, drive-through (DT) screening centers have been designed and implemented in Korea. Herein, we present the overall concept, advantages, and limitations of the COVID-19 DT screening centers. The steps of the DT centers include registration, examination, specimen collection, and instructions. The entire service takes about 10 minutes for one testee without leaving his or her cars. Increased testing capacity over 100 tests per day and prevention of cross-infection between testees in the waiting space are the major advantages, while protection of staff from the outdoor atmosphere is challenging. It could be implemented in other countries to cope with the global COVID-19 outbreak and transformed according to their own situations. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <myOnto:issue>11</myOnto:issue>
    <j.0:title>Drive-through screening center for covid-19: A safe and efficient screening system against massive community outbreak</j.0:title>
    <dc:creator>Kwon K.T., Ko J.-H., Shin H., Sung M., Kim J.Y.</dc:creator>
    <j.0:identifier>10.3346/jkms.2020.35.e123</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079845597">
    <j.0:identifier>10.1016/S0140-6736(20)30420-7</j.0:identifier>
    <dc:creator>Ghebreyesus T.A., Swaminathan S.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; China; Coronavirinae; coronavirus disease 2019; Coronavirus infection; diagnostic test; disease transmission; epidemic; global health; health care; human; incubation time; infection control; infection prevention; nonhuman; Note; priority journal; scientist; sociology; virus shedding; Betacoronavirus; Coronavirus infection; developing country; health care planning; medical research; Melia azedarach; organization and management; public relations; science; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Biomedical Research; Coronavirus Infections; Developing Countries; Health Planning; Humans; Interprofessional Relations; Melia azedarach; Pneumonia, Viral; Science</schema:keywords>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>10226</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079845597&amp;doi=10.1016%2fS0140-6736%2820%2930420-7&amp;partnerID=40&amp;md5=22835069fed2654c768dbd6b58c4810e&gt;</schema:url>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85079845597</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
    <j.0:title>Scientists are sprinting to outpace the novel coronavirus</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081905471">
    <schema:keywords>antipyretic agent; airport; airport; Article; body temperature measurement; China; contact examination; Coronavirinae; coronavirus disease 2019; Coronavirus infection; epidemic; false negative result; false positive result; fever; human; infection prevention; interview; Italy; medical examination; missed diagnosis; patient attitude; practice guideline; priority journal; questionnaire; screening test; severe acute respiratory syndrome coronavirus 2; skin temperature; South Korea; symptom; travel; United States; virus transmission; World Health Organization</schema:keywords>
    <dc:date>2020</dc:date>
    <dc:creator>Normile D.</dc:creator>
    <myOnto:issue>6483</myOnto:issue>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <myOnto:volume>367</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081905471&amp;doi=10.1126%2fscience.367.6483.1178&amp;partnerID=40&amp;md5=4443960243710e1217d8e4c18ef4df7f&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.1126/science.367.6483.1178</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Airport screening is largely futile, research shows</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081905471</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080839805">
    <j.0:identifier>2-s2.0-85080839805</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Lancet_(London,_England)"/>
    <j.0:title>How to fight an infodemic</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080839805&amp;doi=10.1016%2fS0140-6736%2820%2930461-X&amp;partnerID=40&amp;md5=79593265917fa2af3fa12adc6d204b0a&gt;</schema:url>
    <schema:keywords>COVID-19; Coronavirus infection; global health; human; pandemic; virus pneumonia; World Health Organization; Coronavirus Infections; Global Health; Humans; Pandemics; Pneumonia, Viral; World Health Organization</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:issue>10225</myOnto:issue>
    <j.0:identifier>10.1016/S0140-6736(20)30461-X</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <dc:creator>Zarocostas J.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082034401">
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1038/d41586-020-00782-2</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>COVID-19: don't forget deaf people</j.0:title>
    <myOnto:volume>579</myOnto:volume>
    <myOnto:issue>7799</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Castro H.C., Lins Ramos A.S., Amorim G., Ratcliffe N.A.</dc:creator>
    <schema:keywords>COVID-19; Brazil; Coronavirus infection; hearing impairment; human; organization and management; sign language; virus pneumonia; World Health Organization; writing; Brazil; Coronavirus Infections; Deafness; Humans; Pneumonia, Viral; Sign Language; World Health Organization; Writing</schema:keywords>
    <j.0:identifier>2-s2.0-85082034401</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082034401&amp;doi=10.1038%2fd41586-020-00782-2&amp;partnerID=40&amp;md5=67fbcfdbca7ecf75127e1966ca3e2061&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079618683">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079618683&amp;doi=10.1016%2fj.bbrc.2020.02.071&amp;partnerID=40&amp;md5=89b2527b7be75e401795bb213de4e38a&gt;</schema:url>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:volume>525</myOnto:volume>
    <dc:language>English</dc:language>
    <schema:keywords>angiotensin converting enzyme 2; coronavirus spike glycoprotein; glycine; phenylalanine; proline; amino acid sequence; Article; Betacoronavirus; binding site; human; human tissue; hydrophobicity; molecular interaction; molecular model; nonhuman; nucleotide sequence; priority journal; protein domain; protein expression; receptor binding; receptor binding domain; Severe acute respiratory syndrome coronavirus 2; structure analysis; virus cell interaction; virus transmission</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Chen Y., Guo Y., Pan Y., Zhao Z.J.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <rdfs:comment>2019-nCoV is a newly identified coronavirus with high similarity to SARS-CoV. We performed a structural analysis of the receptor binding domain (RBD) of spike glycoprotein responsible for entry of coronaviruses into host cells. The RBDs from the two viruses share 72% identity in amino acid sequences, and molecular simulation reveals highly similar ternary structures. However, 2019-nCoV has a distinct loop with flexible glycyl residues replacing rigid prolyl residues in SARS-CoV. Molecular modeling revealed that 2019-nCoV RBD has a stronger interaction with angiotensin converting enzyme 2 (ACE2). A unique phenylalanine F486 in the flexible loop likely plays a major role because its penetration into a deep hydrophobic pocket in ACE2. ACE2 is widely expressed with conserved primary structures throughout the animal kingdom from fish, amphibians, reptiles, birds, to mammals. Structural analysis suggests that ACE2 from these animals can potentially bind RBD of 2019-nCoV, making them all possible natural hosts for the virus. 2019-nCoV is thought to be transmitted through respiratory droplets. However, since ACE2 is predominantly expressed in intestines, testis, and kidney, fecal-oral and other routes of transmission are also possible. Finally, antibodies and small molecular inhibitors that can block the interaction of ACE2 with RBD should be developed to combat the virus. © 2020 The Authors</rdfs:comment>
    <j.0:identifier>10.1016/j.bbrc.2020.02.071</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Structure analysis of the receptor binding of 2019-nCoV</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Biochemical_and_Biophysical_Research_Communications"/>
    <j.0:identifier>2-s2.0-85079618683</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078834780">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <myOnto:volume>9</myOnto:volume>
    <schema:keywords>neutralizing antibody; COVID-19; epitope; monoclonal antibody; severe acute respiratory syndrome coronavirus 2; virus antibody; amino terminal sequence; Betacoronavirus; China; Coronavirus infection; epidemic; gene sequence; human; Middle East respiratory syndrome coronavirus; nonhuman; Note; phylogeny; pneumonia; priority journal; real time reverse transcription polymerase chain reaction; reverse transcription loop mediated isothermal amplification; reverse transcription polymerase chain reaction; SARS coronavirus; sea food; virus detection; virus identification; animal; bat; communicable disease; Coronavirus infection; nucleic acid amplification; pathogenicity; virology; virus pneumonia; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Betacoronavirus; China; Chiroptera; Communicable Diseases, Emerging; Coronavirus Infections; Epitopes; Humans; Nucleic Acid Amplification Techniques; Phylogeny; Pneumonia, Viral</schema:keywords>
    <myOnto:citeyBy>10</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078834780&amp;doi=10.1080%2f22221751.2020.1723441&amp;partnerID=40&amp;md5=37600598288e0432a042ff662c9ff5f8&gt;</schema:url>
    <j.0:title>An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies</j.0:title>
    <j.0:identifier>2-s2.0-85078834780</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1080/22221751.2020.1723441</j.0:identifier>
    <dc:creator>Jiang S., Du L., Shi Z.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>1</myOnto:issue>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079740917">
    <j.0:title>Preliminary Recommendations for Lung Surgery during 2019 Novel Coronavirus Disease (COVID-19) Epidemic Period</j.0:title>
    <j.0:type>Article</j.0:type>
    <dc:language>Chinese</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>23</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhongguo_fei_ai_za_zhi_=_Chinese_journal_of_lung_cancer"/>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>??????????????????????????? ??????2019?12????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????.In December 2019, China diagnosed the first patient with 2019 novel coronavirus disease (COVID-19), and the following development of the epidemic had a huge impact on China and the whole world. For patients with lung occupying lesions, the whole process of diagnosis and treatment can not be carried out as usual due to the epidemic. For thoracic surgeons, the timing of surgical intervention should be very carefully considered. All thoracic surgeons in China should work together to develop the proper procedures for the diagnosis and treatment in this special situation, and continuously update the recommendations based on epidemic changes and further understanding of COVID-19. Here, we only offer some preliminary suggestions based on our own knowledge for further reference and discussion.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Li X., Liu M., Zhao Q., Liu R., Zhang H., Dong M., Xu S., Zhao H., Wei S., Song Z., Chen G., Chen J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079740917&amp;doi=10.3779%2fj.issn.1009-3419.2020.03.01&amp;partnerID=40&amp;md5=2edf2eec0cadecacf60e45e4979d4adb&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079740917</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; epidemic; epidemiology; human; lung disease; pathogenicity; patient care planning; thorax surgery; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Epidemics; Humans; Lung Diseases; Patient Care Planning; Pneumonia, Viral; Thoracic Surgical Procedures</schema:keywords>
    <j.0:identifier>10.3779/j.issn.1009-3419.2020.03.01</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079439849">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; 2019 novel coronavirus epidemic; Betacoronavirus; China; Coronavirus infection; health care facility; human; incubation time; infection control; infection prevention; leisure; market; migrant worker; Note; pneumonia; quarantine; quarantine station; sequence analysis; traffic and transport; travel; virus isolation; virus pathogenesis; virus transmission; World Health Organization; Betacoronavirus; Coronavirinae; Coronavirus infection; pneumonia; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus; Coronavirus Infections; Humans; Pneumonia</schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <dc:creator>Kofi Ayittey F., Dzuvor C., Kormla Ayittey M., Bennita Chiwero N., Habib A.</dc:creator>
    <j.0:identifier>2-s2.0-85079439849</j.0:identifier>
    <myOnto:volume>92</myOnto:volume>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>10.1002/jmv.25695</j.0:identifier>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <j.0:title>Updates on Wuhan 2019 novel coronavirus epidemic</j.0:title>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079439849&amp;doi=10.1002%2fjmv.25695&amp;partnerID=40&amp;md5=7bd85de406497061b789db6b2be7bbec&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081615907">
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>baricitinib; 2019 novel coronavirus; basic reproduction number; case fatality rate; coronavirus disease 2019; Editorial; epidemic; global health; health education; health service; human; nonhuman; pandemic; pneumonia; quarantine; social distance; virus transmission</schema:keywords>
    <myOnto:volume>33</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Acta_Medica_Portuguesa">
        <j.1:name>Acta Medica Portuguesa</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:publisher>CELOM</j.0:publisher>
    <j.0:identifier>10.20344/amp.13547</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081615907&amp;doi=10.20344%2famp.13547&amp;partnerID=40&amp;md5=93d464f2a7c9eeddd79581502e4e3e21&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081615907</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>3</myOnto:issue>
    <dc:creator>Duarte R., Furtado I., Sousa L., Carvalho C.</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <j.0:title>The 2019 novel Coronavirus (2019-NCoV): Novel virus, old challenges [O Novo Coronavírus (2019-nCoV): Novo Vírus, Desafios Antigos]</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079699104">
    <schema:keywords>2019 novel coronavirus; Coronavirinae; Coronavirus infection; Editorial; epidemic; global disease burden; global health; human; incidence; morbidity; mortality; nonhuman; age; animal; bat; Betacoronavirus; China; Coronavirus infection; pandemic; risk factor; virology; virus pneumonia; zoonosis; COVID-19; severe acute respiratory syndrome coronavirus 2; Age Factors; Animals; Betacoronavirus; China; Chiroptera; Coronavirus Infections; Humans; Mortality; Pandemics; Pneumonia, Viral; Risk Factors; Zoonoses</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Tropical_Medicine_and_International_Health">
        <j.1:name>Tropical Medicine and International Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>25</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Editorial</j.0:type>
    <j.0:title>The COVID-19 epidemic</j.0:title>
    <j.0:identifier>2-s2.0-85079699104</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079699104&amp;doi=10.1111%2ftmi.13383&amp;partnerID=40&amp;md5=8ae763b599b5214af9cafb034b49c11f&gt;</schema:url>
    <myOnto:issue>3</myOnto:issue>
    <dc:date>2020</dc:date>
    <dc:creator>Velavan T.P., Meyer C.G.</dc:creator>
    <j.0:identifier>10.1111/tmi.13383</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>2</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081652766">
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081652766&amp;doi=10.1136%2fbmj.m986&amp;partnerID=40&amp;md5=550895a0bd47227a8376db40a4b53fa0&gt;</schema:url>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Mahase E.</dc:creator>
    <j.0:title>Covid-19: Portugal closes all medical schools after 31 cases confirmed in the country</j.0:title>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081652766</j.0:identifier>
    <myOnto:volume>368</myOnto:volume>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1136/bmj.m986</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081654989">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Detection of SARS-CoV-2 in Different Types of Clinical Specimens</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <dc:creator>Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., Tan W.</dc:creator>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:identifier>2-s2.0-85081654989</j.0:identifier>
    <j.0:identifier>10.1001/jama.2020.3786</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081654989&amp;doi=10.1001%2fjama.2020.3786&amp;partnerID=40&amp;md5=9b300f8598a6ae7283dd3ff7f73a1587&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081647278">
    <j.0:type>Article</j.0:type>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081647278&amp;doi=10.1177%2f0308518X20910162&amp;partnerID=40&amp;md5=b27b05ac653f503cb909ce340b06b843&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>SAGE Publications Ltd</j.0:publisher>
    <dc:creator>Gao P., Zhang H., Wu Z., Wang J.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1177/0308518X20910162</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Environment_and_Planning_A">
        <j.1:name>Environment and Planning A</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <rdfs:comment>Coronavirus disease 2019 (COVID-19) has emerged as a growing focus of global attention and a critical factor in public-health decision making. Towards fighting the COVID-19 outbreak, countries worldwide and international organisations have taken various actions, including promoting the transparency of and public access to disease data. In such public communications, maps have played an important role in that a map is worth a thousand words. Most of these have taken the form of a choropleth map. Here, we propose employing cartograms to visualise both the expansion and spread of COVID-19. We designed a combination of six circular cartograms containing the data of confirmed cases every 48 hours from 24 January to 3 February 2020. Such a design conveys both spatial and temporal information more intuitively and efficiently, so it can be expected to facilitate better public participation in the fight against COVID-19. © The Author(s) 2020.</rdfs:comment>
    <j.0:title>Visualising the expansion and spread of coronavirus disease 2019 by cartograms</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081647278</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080117464">
    <j.0:title>Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments</j.0:title>
    <myOnto:issue>1</myOnto:issue>
    <j.0:identifier>10.1080/01652176.2020.1727993</j.0:identifier>
    <myOnto:volume>40</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080117464&amp;doi=10.1080%2f01652176.2020.1727993&amp;partnerID=40&amp;md5=8865a7287514e6620669b8a28ffdfd34&gt;</schema:url>
    <j.0:identifier>2-s2.0-85080117464</j.0:identifier>
    <rdfs:comment>Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade’s first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as ‘Public Health Emergency of International Concern’ on January 30th, 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords>monoclonal antibody; remdesivir; virus spike protein; virus vaccine; vitronectin; severe acute respiratory syndrome coronavirus 2; adult respiratory distress syndrome; Alphacoronavirus; Article; Avian infectious bronchitis virus; Betacoronavirus; bioinformatics; Bovine coronavirus; Canine coronavirus; Canine respiratory coronavirus; China; Coronavirus infection; Deltacoronavirus; disease surveillance; drug efficacy; drug safety; emergency care; Equine coronavirus; Gammacoronavirus; gene sequence; genetic variability; genome analysis; high throughput sequencing; human; infection control; Middle East respiratory syndrome coronavirus; nonhuman; novel coronavirus 2019; novel coronavirus disease 2019; novel coronavirus disease 2019; phylogeny; Porcine epidemic diarrhea virus; Porcine respiratory coronavirus; reverse transcription polymerase chain reaction; SARS coronavirus; sequence alignment; Transmissible gastroenteritis virus; virus genome; virus isolation; virus transmission; zoonosis; animal; bat; Betacoronavirus; classification; communicable disease; Coronavirus infection; disease carrier; genetics; pandemic; veterinary medicine; virology; zoonosis; Animals; Betacoronavirus; Chiroptera; Communicable Diseases, Emerging; Coronavirus Infections; Disease Reservoirs; Humans; Pandemics; Phylogeny; Zoonoses</schema:keywords>
    <dc:creator>Malik Y.S., Sircar S., Bhat S., Sharun K., Dhama K., Dadar M., Tiwari R., Chaicumpa W.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Veterinary_Quarterly">
        <j.1:name>Veterinary Quarterly</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>2</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082020405">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>368</myOnto:volume>
    <dc:creator>Iacobucci G.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082020405&amp;doi=10.1136%2fbmj.m1097&amp;partnerID=40&amp;md5=04e7d6fc1147286c82877194d5b5c149&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85082020405</j.0:identifier>
    <j.0:identifier>10.1136/bmj.m1097</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:title>Covid-19: Doctors warn of humanitarian catastrophe at Europe's largest refugee camp</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081333164">
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; disease transmission; human; patient isolation; prevention and control; public health; quarantine; virus pneumonia; vulnerable population; Betacoronavirus; China; Coronavirus Infections; Disease Transmission, Infectious; Humans; Patient Isolation; Pneumonia, Viral; Public Health; Quarantine; Vulnerable Populations</schema:keywords>
    <j.0:title>Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081333164&amp;doi=10.1093%2fjtm%2ftaaa020&amp;partnerID=40&amp;md5=933f0347e1f61729b2c1c87485d0f5fd&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081333164</j.0:identifier>
    <myOnto:volume>27</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_travel_medicine"/>
    <dc:creator>Wilder-Smith A., Freedman D.O.</dc:creator>
    <j.0:identifier>10.1093/jtm/taaa020</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079340589">
    <j.0:type>Short Survey</j.0:type>
    <myOnto:volume>201</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/American_Journal_of_Respiratory_and_Critical_Care_Medicine">
        <j.1:name>American Journal of Respiratory and Critical Care Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Graham Carlos W., Dela Cruz C.S., Cao B., Pasnick S., Jamil S.</dc:creator>
    <j.0:publisher>American Thoracic Society</j.0:publisher>
    <myOnto:issue>4</myOnto:issue>
    <schema:keywords>2019 novel coronavirus; China; clinical feature; contact isolation; Coronavirus infection; exposure; human; infection prevention; priority journal; Short Survey; United States; virus transmission; Betacoronavirus; complication; Coronavirus infection; coughing; disease transmission; dyspnea; fever; global health; health care delivery; isolation and purification; pathogenicity; patient education; risk factor; travel; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Cough; Delivery of Health Care; Dyspnea; Fever; Global Health; Humans; Infectious Disease Transmission, Patient-to-Professional; Pneumonia, Viral; Risk Factors; Travel</schema:keywords>
    <myOnto:citeyBy>9</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079340589</j.0:identifier>
    <j.0:identifier>10.1164/rccm.2014P7</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Novel Wuhan (2019-NCoV) coronavirus</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079340589&amp;doi=10.1164%2frccm.2014P7&amp;partnerID=40&amp;md5=87c74407d9fedfe1e3dd5c69c1e1a28f&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081391474">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>British Veterinary Association</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:keywords>2019 novel coronavirus infection; agriculture; animal welfare; cat; Coronavirus infection; disease severity; dog; England; epidemic; government; Hong Kong; human; nonhuman; Note; pet animal; Pomeranian dog; quarantine; severe acute respiratory syndrome; veterinary medicine; virus detection; virus transmission</schema:keywords>
    <j.0:title>Pet dog confirmed to have coronavirus</j.0:title>
    <myOnto:volume>186</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:identifier>10.1136/vr.m892</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081391474&amp;doi=10.1136%2fvr.m892&amp;partnerID=40&amp;md5=8c1a53eaaab8cf6368bcc28938d365c9&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081391474</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Veterinary_Record"/>
    <myOnto:issue>9</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082075964">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082075964&amp;doi=10.1016%2fj.chest.2020.02.014&amp;partnerID=40&amp;md5=7f6d53294b57bf8567c4f58e219b2e9e&gt;</schema:url>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Zhang Y., Xu J., Li H., Cao B.</dc:creator>
    <myOnto:volume>157</myOnto:volume>
    <j.0:publisher>Elsevier Inc</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:title>A Novel Coronavirus (COVID-19) Outbreak: A Call for Action</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Chest">
        <j.1:name>Chest</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>4</myOnto:issue>
    <j.0:identifier>10.1016/j.chest.2020.02.014</j.0:identifier>
    <j.0:identifier>2-s2.0-85082075964</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081913196">
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081913196&amp;doi=10.1017%2fice.2020.61&amp;partnerID=40&amp;md5=3ca4d8fbbd11b3f2d94a4663f05aaefc&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081913196</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1017/ice.2020.61</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
    <dc:creator>Rao A.S.R.S., Vazquez J.A.</dc:creator>
    <j.0:title>Identification of COVID-19 Can be Quicker through Artificial Intelligence framework using a Mobile Phone-Based Survey in the Populations when Cities/Towns Are under Quarantine</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <rdfs:comment>We are proposing to use machine learning algorithms to be able to improve possible case identifications of COVID-19 more quicker when we use a mobile phone-based web survey. This will also reduce the spread in the susceptible populations. © 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081035695">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Fan C., Liu L., Guo W., Yang A., Ye C., Jilili M., Ren M., Xu P., Long H., Wang Y.</dc:creator>
    <myOnto:issue>5</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Environmental_Research_and_Public_Health"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081035695&amp;doi=10.3390%2fijerph17051679&amp;partnerID=40&amp;md5=5c7a30fed2905da1b2e625147ec27fc7&gt;</schema:url>
    <j.0:identifier>10.3390/ijerph17051679</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081035695</j.0:identifier>
    <rdfs:comment>After the 2019 novel coronavirus (2019?nCoV) outbreak, we estimated the distribution and scale of more than 5 million migrants residing in Wuhan after they returned to their hometown communities in Hubei Province or other provinces at the end of 2019 by using the data from the 2013–2018 China Migrants Dynamic Survey (CMDS). We found that the distribution of Wuhan’s migrants is centred in Hubei Province (approximately 75%) at a provincial level, gradually decreasing in the surrounding provinces in layers, with obvious spatial characteristics of circle layers and echelons. The scale of Wuhan’s migrants, whose origins in Hubei Province give rise to a gradient reduction from east to west within the province, and account for 66% of Wuhan’s total migrants, are from the surrounding prefectural?level cities of Wuhan. The distribution comprises 94 districts and counties in Hubei Province, and the cumulative percentage of the top 30 districts and counties exceeds 80%. Wuhan’s migrants have a large proportion of middle?aged and high?risk individuals. Their social characteristics include nuclear family migration (84%), migration with families of 3–4 members (71%), a rural household registration (85%), and working or doing business (84%) as the main reason for migration. Using a quasi?experimental analysis framework, we found that the size of Wuhan’s migrants was highly correlated with the daily number of confirmed cases. Furthermore, we compared the epidemic situation in different regions and found that the number of confirmed cases in some provinces and cities in Hubei Province may be underestimated, while the epidemic situation in some regions has increased rapidly. The results are conducive to monitoring the epidemic prevention and control in various regions. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:volume>17</myOnto:volume>
    <j.0:title>Prediction of epidemic spread of the 2019 novel coronavirus driven by spring festival transportation in China: A population?based study</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>disease spread; epidemic; experimental study; festival; immigrant; population size; prediction; severe acute respiratory syndrome; viral disease; Article; China; commercial phenomena; conceptual framework; controlled study; coronavirus disease 2019; Coronavirus infection; epidemic; geographic distribution; health survey; high risk population; household; human; infection control; infection prevention; infection risk; major clinical study; migrant; migration; nuclear family; population research; prediction; quasi experimental study; registration; rural area; social aspect; spring; adult; aged; Betacoronavirus; city; Coronavirinae; Coronavirus infection; epidemic; family health; family size; female; forecasting; history; isolation and purification; leisure; male; middle aged; pathogenicity; rural population; season; virus pneumonia; young adult; China; Hubei; Hubei; Wuhan; Coronavirus; COVID-19; severe acute respiratory syndrome coronavirus 2; Adult; Aged; Anniversaries and Special Events; Betacoronavirus; China; Cities; Coronavirus; Coronavirus Infections; Emigration and Immigration; Epidemics; Family Characteristics; Family Health; Female; Forecasting; Holidays; Humans; Male; Middle Aged; Pneumonia, Viral; Rural Population; Seasons; Young Adult</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081041602">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>579</myOnto:volume>
    <j.0:identifier>2-s2.0-85081041602</j.0:identifier>
    <j.0:identifier>10.1038/d41586-020-00613-4</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081041602&amp;doi=10.1038%2fd41586-020-00613-4&amp;partnerID=40&amp;md5=c955e8bc0cae71148b7e30fa7ab1971c&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <schema:keywords>COVID-19; Coronavirus infection; epidemic; human; information dissemination; open access publishing; peer review; procedures; time factor; virology; virus pneumonia; Coronavirus Infections; Disease Outbreaks; Humans; Information Dissemination; Open Access Publishing; Peer Review, Research; Pneumonia, Viral; Time Factors</schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>7797</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Open peer-review platform for COVID-19 preprints</j.0:title>
    <dc:creator>Johansson M.A., Saderi D.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080840805">
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85080840805</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080840805&amp;doi=10.1136%2fbmj.m806&amp;partnerID=40&amp;md5=793864df52682f7ea21bb6a9c738d6d0&gt;</schema:url>
    <j.0:title>Covid-19: school closures and bans on mass gatherings will need to be considered, says England's CMO</j.0:title>
    <dc:creator>Moberly T.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>368</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m806</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082117705">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082117705</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Lima C.K.T., Carvalho P.M.D.M., Lima I.D.A.A.S., Nunes J.V.A.D.O., Saraiva J.S., de Souza R.I., da Silva C.G.L., Neto M.L.R.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:title>The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease)</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Psychiatry_Research"/>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1016/j.psychres.2020.112915</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier Ireland Ltd</j.0:publisher>
    <myOnto:volume>287</myOnto:volume>
    <rdfs:comment>Background: : A novel form of Coronavirus (2019-nCoV) in Wuhan has created a confused and rapidly evolving situation. In this situational framework, patients and front-line healthcare workers are vulnerable. Method: : Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase. Results: : Populations of patients that may require tailored interventions are older adults and international migrant workers. Older adults with psychiatric conditions may be experiencing further distress. The COVID-19 epidemic has underscored potential gaps in mental health services during emergencies. Conclusions: : Most health professionals working in isolation units and hospitals do not receive any training for providing mental health care. Fear seems more certainly a consequence of mass quarantine. © 2020 Elsevier B.V.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082117705&amp;doi=10.1016%2fj.psychres.2020.112915&amp;partnerID=40&amp;md5=c27ab5cda61b7fc76f8ebb5fe9d1a98c&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079539431">
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cellular_and_Molecular_Immunology"/>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Xia S., Zhu Y., Liu M., Lan Q., Xu W., Wu Y., Ying T., Liu S., Shi Z., Jiang S., Lu L.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85079539431</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079539431&amp;doi=10.1038%2fs41423-020-0374-2&amp;partnerID=40&amp;md5=242a276e7bbc49b9534c47e3f95557ed&gt;</schema:url>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1038/s41423-020-0374-2</j.0:identifier>
    <j.0:title>Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein</j.0:title>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081904142">
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <dc:language>English; Spanish</dc:language>
    <j.0:identifier>10.1016/j.anpedi.2020.02.001</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081904142</j.0:identifier>
    <j.0:title>Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group [Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP)]</j.0:title>
    <dc:creator>Calvo C., García López-Hortelano M., de Carlos Vicente J.C., Vázquez Martínez J.L., Ramos J.T., Baquero-Artigao F., Navarro M.L., Rodrigo C., Neth O., Fumadó V., Menendez Suso J.J., Slocker Barrio M., Bustinza Arriortua A., Jordán García I., Pilar Orive J., Grupo de trabajo de la Asociacion Espanola de Pediatria para el brote de infeccion por Coronavirus, colaboradores con el Ministerio de Sanidad, Miembros del Grupo de Expertos de la AEP</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081904142&amp;doi=10.1016%2fj.anpedi.2020.02.001&amp;partnerID=40&amp;md5=82a1ac6c0bac6f421cc279301749835c&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier Doyma</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>On 31 December 2019, the Wuhan Municipal Committee of Health and Healthcare (Hubei Province, China) reported that there were 27 cases of pneumonia of unknown origin with symptoms starting on the 8 December. There were 7 serious cases with common exposure in market with shellfish, fish, and live animals, in the city of Wuhan. On 7 January 2020, the Chinese authorities identified that the agent causing the outbreak was a new type of virus of the Coronaviridae family, temporarily called «new coronavirus», 2019-nCoV. On January 30th, 2020, the World Health Organisation (WHO) declared the outbreak an International Emergency. On 11 February 2020 the WHO assigned it the name of SARS-CoV2 and COVID-19 (SARS-CoV2 and COVID-19). The Ministry of Health summoned the Specialties Societies to prepare a clinical protocol for the management of COVID-19. The Spanish Paediatric Association appointed a Working Group of the Societies of Paediatric Infectious Diseases and Paediatric Intensive Care to prepare the present recommendations with the evidence available at the time of preparing them. © 2020 Asociación Española de Pediatría</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Anales_de_Pediatria">
        <j.1:name>Anales de Pediatria</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081744574">
    <myOnto:volume>14</myOnto:volume>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081744574&amp;doi=10.2174%2f1874434602014010037&amp;partnerID=40&amp;md5=ee6cbfcffad1a82d9cb25ec29ba32422&gt;</schema:url>
    <j.0:identifier>10.2174/1874434602014010037</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Williamson G.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:publisher>Bentham Science Publishers</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85081744574</j.0:identifier>
    <j.0:title>Covid-19 epidemic editorial</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Editorial</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Open_Nursing_Journal">
        <j.1:name>Open Nursing Journal</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081591255">
    <j.0:title>Reverse logistics network design for effective management of medical waste in epidemic outbreaks: Insights from the coronavirus disease 2019 (COVID-19) outbreak in Wuhan (China)</j.0:title>
    <j.0:identifier>2-s2.0-85081591255</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081591255&amp;doi=10.3390%2fijerph17051770&amp;partnerID=40&amp;md5=1869bca0dbd7548fa2bd87bc4ba026be&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.3390/ijerph17051770</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:volume>17</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Environmental_Research_and_Public_Health"/>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Yu H., Sun X., Solvang W.D., Zhao X.</dc:creator>
    <rdfs:comment>The outbreak of an epidemic disease may pose significant treats to human beings and may further lead to a global crisis. In order to control the spread of an epidemic, the effective management of rapidly increased medical waste through establishing a temporary reverse logistics system is of vital importance. However, no research has been conducted with the focus on the design of an epidemic reverse logistics network for dealing with medical waste during epidemic outbreaks, which, if improperly treated, may accelerate disease spread and pose a significant risk for both medical staffs and patients. Therefore, this paper proposes a novel multi-objective multi-period mixed integer program for reverse logistics network design in epidemic outbreaks, which aims at determining the best locations of temporary facilities and the transportation strategies for effective management of the exponentially increased medical waste within a very short period. The application of the model is illustrated with a case study based on the outbreak of the coronavirus disease 2019 (COVID-19) in Wuhan, China. Even though the uncertainty of the future COVID-19 spread tendency is very high at the time of this research, several general policy recommendations can still be obtained based on computational experiments and quantitative analyses. Among other insights, the results suggest installing temporary incinerators may be an effective solution for managing the tremendous increase of medical waste during the COVID-19 outbreak in Wuhan, but the location selection of these temporary incinerators is of significant importance. Due to the limitation on available data and knowledge at present stage, more real-world information are needed to assess the effectiveness of the current solution. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>environmental policy; epidemiology; medical geography; network design; research work; risk assessment; solid waste; transportation system; waste facility; waste management; Article; case study; China; computer analysis; controlled study; coronavirus disease 2019; Coronavirus infection; hospital waste; incinerator; intermethod comparison; mathematical model; policy; quantitative analysis; research; reverse logistics network; traffic and transport; uncertainty; waste disposal facility; waste management; Betacoronavirus; Coronavirus infection; epidemic; human; problem solving; procedures; system analysis; virus pneumonia; waste disposal; waste management; China; Hubei; Wuhan; Coronavirus; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus Infections; Disease Outbreaks; Epidemics; Humans; Medical Waste; Medical Waste Disposal; Operations Research; Pneumonia, Viral; Problem Solving; Uncertainty; Waste Management</schema:keywords>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082197695">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Letter</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Anaesthesia"/>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/j.bja.2020.02.016</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85082197695</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082197695&amp;doi=10.1016%2fj.bja.2020.02.016&amp;partnerID=40&amp;md5=1df648c6b3e656a537141a7e274f29a3&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <j.0:title>Emergency Caesarean delivery in a patient with confirmed coronavirus disease 2019 under spinal anaesthesia</j.0:title>
    <dc:creator>Xia H., Zhao S., Wu Z., Luo H., Zhou C., Chen X.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081720938">
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Xia J., Tong J., Liu M., Shen Y., Guo D.</dc:creator>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <rdfs:comment>Objective: This study aimed to assess the presence of novel coronavirus in tears and conjunctival secretions of SARS–CoV-2-infected patients. Methods: A prospective interventional case series study was performed, and 30 confirmed novel coronavirus pneumonia (NCP) patients were selected at the First Affiliated Hospital of Zhejiang University from 26 January 2020 to 9 February 2020. At an interval of 2 to 3 days, tear and conjunctival secretions were collected twice with disposable sampling swabs for reverse-transcription polymerase chain reaction (RT-PCR) assay. Results: Twenty-one common-type and nine severe-type NCP patients were enrolled. Two samples of tear and conjunctival secretions were obtained from the only one patient with conjunctivitis yielded positive RT-PCR results. Fifty-eight samples from other patents were all negative. Conclusion: We speculate that SARS-CoV-2 may be detected in the tears and conjunctival secretions in NCP patients with conjunctivitis. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <j.0:title>Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1002/jmv.25725</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081720938&amp;doi=10.1002%2fjmv.25725&amp;partnerID=40&amp;md5=f48cf7a455c35dcc986d0a771a389f6e&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081720938</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082097737">
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; aged; asymptomatic disease; Betacoronavirus; contact examination; Coronavirus infection; family health; female; human; incubation time; isolation and purification; male; middle aged; pathogenicity; South Korea; virus pneumonia; young adult; Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Contact Tracing; Coronavirus Infections; Family Health; Female; Humans; Infectious Disease Incubation Period; Male; Middle Aged; Pneumonia, Viral; Republic of Korea; Young Adult</schema:keywords>
    <j.0:type>Article</j.0:type>
    <dc:creator>Ki M., Task Force for 2019-nCoV</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082097737&amp;doi=10.4178%2fepih.e2020007&amp;partnerID=40&amp;md5=19f04c7a928430b83a469b7e91a72a63&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.4178/epih.e2020007</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>In about 20 days since the diagnosis of the first case of the 2019 novel coronavirus (2019-nCoV) in Korea on January 20, 2020, 28 cases have been confirmed. Fifteen patients (53.6%) of them were male and median age of was 42 years (range, 20-73). Of the confirmed cases, 16, 9, and 3 were index (57.2%), first-generation (32.1%), and second-generation (10.7%) cases, respectively. All first-generation and second-generation patients were family members or intimate acquaintances of the index cases with close contacts. Fifteen among 16 index patients had entered Korea from January 19 to 24, 2020 while 1 patient had entered Korea on January 31, 2020. The average incubation period was 3.9 days (median, 3.0), and the reproduction number was estimated as 0.48. Three of the confirmed patients were asymptomatic when they were diagnosed. Epidemiological indicators will be revised with the availability of additional data in the future. Sharing epidemiological information among researchers worldwide is essential for efficient preparation and response in tackling this new infectious disease.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082097737</j.0:identifier>
    <myOnto:volume>42</myOnto:volume>
    <j.0:title>Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Epidemiology_and_health">
        <j.1:name>Epidemiology and health</j.1:name>
      </fabio:Journal>
    </j.0:source>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079685508">
    <j.0:title>2019-nCoV epidemic: what about pregnancies?</j.0:title>
    <schema:keywords>Coronavirus disease 2019; Coronavirus infection; disease severity; epidemic; female; human; infection risk; Letter; mortality rate; pregnancy; pregnancy outcome; priority journal; risk factor; Betacoronavirus; Middle East respiratory syndrome coronavirus; pregnancy; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Epidemics; Female; Humans; Infections; Middle East Respiratory Syndrome Coronavirus; Pregnancy</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S0140-6736(20)30311-1</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>10224</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079685508&amp;doi=10.1016%2fS0140-6736%2820%2930311-1&amp;partnerID=40&amp;md5=6085ebdfaaaee8f7b199deaacf827ad9&gt;</schema:url>
    <dc:creator>Favre G., Pomar L., Musso D., Baud D.</dc:creator>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>395</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85079685508</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081146254">
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel Coronavirus; avian influenza (H5N1); cardiovascular disease; chronic liver disease; chronic obstructive lung disease; clinical feature; comorbidity; consultation; Coronavirinae; Coronavirus infection; coughing; diabetes mellitus; diarrhea; dyspnea; Editorial; fever; headache; hemoptysis; human; hypertension; infection risk; intermediate host; international health regulation; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; myalgia; nonhuman; priority journal; SARS coronavirus; virus transmission; World Health Organization</schema:keywords>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081146254</j.0:identifier>
    <myOnto:volume>13</myOnto:volume>
    <j.0:title>Novel coronavirus (2019-nCoV) update: What we know and what is unknown</j.0:title>
    <dc:creator>Fasina F.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081146254&amp;doi=10.4103%2f1995-7645.277795&amp;partnerID=40&amp;md5=ac6b5e64cee5167bf0a9d37dae4a2863&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue>3</myOnto:issue>
    <j.0:identifier>10.4103/1995-7645.277795</j.0:identifier>
    <j.0:publisher>Wolters Kluwer Medknow Publications</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Pacific_Journal_of_Tropical_Medicine"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081999680">
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Covid-19 exposes weaknesses in European response to outbreaks</j.0:title>
    <myOnto:volume>368</myOnto:volume>
    <schema:keywords>COVID-19; civil defense; Coronavirus infection; Europe; financial management; health survey; human; information dissemination; international cooperation; pandemic; political activism; public relations; virus pneumonia; Civil Defense; Coronavirus Infections; Europe; Financing, Government; Humans; Information Dissemination; Interinstitutional Relations; Internationality; Pandemics; Pneumonia, Viral; Political Activism; Population Surveillance</schema:keywords>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Anderson M., Mckee M., Mossialos E.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081999680&amp;doi=10.1136%2fbmj.m1075&amp;partnerID=40&amp;md5=e5f9247035004922976d54a46df40a42&gt;</schema:url>
    <j.0:identifier>10.1136/bmj.m1075</j.0:identifier>
    <j.0:identifier>2-s2.0-85081999680</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081987950">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Mosby Inc.</j.0:publisher>
    <j.0:identifier>10.1016/j.hrtlng.2020.03.007</j.0:identifier>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081987950</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081987950&amp;doi=10.1016%2fj.hrtlng.2020.03.007&amp;partnerID=40&amp;md5=fc524b1c54124dcaadbe166cede0fb64&gt;</schema:url>
    <j.0:title>An update on CT chest findings in coronavirus disease-19 (COVID-19)</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Heart_and_Lung">
        <j.1:name>Heart and Lung</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:creator>Sahu K.K., Lal A., Mishra A.K.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081744684">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Canadian_Journal_of_Anesthesia"/>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Lidocaine during intubation and extubation in patients with coronavirus disease (COVID-19)</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1007/s12630-020-01627-2</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081744684&amp;doi=10.1007%2fs12630-020-01627-2&amp;partnerID=40&amp;md5=099ba2ef816454492b54be9d6c1c7da1&gt;</schema:url>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85081744684</j.0:identifier>
    <dc:creator>Aminnejad R., Salimi A., Saeidi M.</dc:creator>
    <j.0:publisher>Springer</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081996615">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:identifier>10.1136/bmj.m1066</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:creator>Ebrahim S.H., Ahmed Q.A., Gozzer E., Schlagenhauf P., Memish Z.A.</dc:creator>
    <j.0:identifier>2-s2.0-85081996615</j.0:identifier>
    <schema:keywords>COVID-19; Coronavirus infection; human; human relation; interpersonal communication; pandemic; public health; social status; travel; virus pneumonia; Communication; Coronavirus Infections; Humans; Interpersonal Relations; Pandemics; Pneumonia, Viral; Public Health; Social Conditions; Travel</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081996615&amp;doi=10.1136%2fbmj.m1066&amp;partnerID=40&amp;md5=36e800dff3be97ecfa5a7e542eac0f92&gt;</schema:url>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Covid-19 and community mitigation strategies in a pandemic</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081900884">
    <j.0:identifier>10.1136/bmj.m1037</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081900884&amp;doi=10.1136%2fbmj.m1037&amp;partnerID=40&amp;md5=dc9f9ee92c98e6f9c4a31a95f71853b8&gt;</schema:url>
    <j.0:title>Covid-19: Trump cancels all flights from Europe, apart from the UK</j.0:title>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>368</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85081900884</j.0:identifier>
    <dc:creator>Tanne J.H.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147262">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147262&amp;doi=10.1136%2fbmj.m1141&amp;partnerID=40&amp;md5=54c0835cac6cb5602021d70f22c01438&gt;</schema:url>
    <j.0:identifier>10.1136/bmj.m1141</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082147262</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <dc:creator>Berger Z.D., Evans N.G., Phelan A.L., Silverman R.D.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Editorial</j.0:type>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>368</myOnto:volume>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Covid-19: control measures must be equitable and inclusive</j.0:title>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079334646">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>2</myOnto:issue>
    <dc:language>Chinese</dc:language>
    <j.0:identifier>2-s2.0-85079334646</j.0:identifier>
    <rdfs:comment>Since December 2019, the novel coronavirus (2019-nCoV) infection has been prevalent in China. Due to immaturity of immune function and the possibility of mother-fetal vertical transmission, neonates are particularly susceptible to 2019-nCoV. The perinatal-neonatal departments should cooperate closely and take integrated approaches, and the neonatal intensive care unit should prepare the emergency plan for 2019-nCoV infection as far as possible, so as to ensure the optimal management and treatment of potential victims. According to the latest 2019-nCoV national management plan and the actual situation, the Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics puts forward recommendations for the prevention and control of 2019-nCoV infection in neonates.</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Perinatal and neonatal management plan for prevention and control of 2019 novel coronavirus infection (1st Edition)</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier></j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079334646&amp;partnerID=40&amp;md5=26cc5b64d24a2c74f02557354c0d7b0d&gt;</schema:url>
    <myOnto:volume>22</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhongguo_dang_dai_er_ke_za_zhi_=_Chinese_journal_of_contemporary_pediatrics"/>
    <schema:keywords>child; China; Coronavirus infection; female; human; neonatal intensive care unit; newborn; pregnancy; vertical transmission; Child; China; Coronavirus Infections; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Intensive Care Units, Neonatal; Pregnancy</schema:keywords>
    <dc:creator>Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080924715">
    <j.0:identifier>10.1126/science.abb4420</j.0:identifier>
    <j.0:title>The costs of secrecy</j.0:title>
    <schema:keywords>censorship; Chernobyl accident; Coronavirinae; coronavirus disease 2019; Coronavirus infection; Editorial; epidemic; Fukushima nuclear accident; human; infection control; information dissemination; nonhuman; priority journal; public health; severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus 2; World Health Organization</schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <myOnto:volume>367</myOnto:volume>
    <dc:creator>Holden Thorp H.</dc:creator>
    <myOnto:issue>6481</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080924715</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080924715&amp;doi=10.1126%2fscience.abb4420&amp;partnerID=40&amp;md5=9fa4d383d304e8d94c42752e479ce6cb&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079355506">
    <j.0:identifier>2-s2.0-85079355506</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Health">
        <j.1:name>International Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:keywords>adult; Article; China; ethnography; evidence based medicine; female; health care policy; health program; high risk population; human; information processing; interview; male; organismal interaction; priority journal; qualitative research; risk factor; rural population; adolescent; animal; attitude to health; Betacoronavirus; communicable disease; Coronavirus infection; epidemic; middle aged; risk factor; severe acute respiratory syndrome; virology; virus infection; virus pneumonia; wild animal; young adult; zoonosis; COVID-19; severe acute respiratory syndrome coronavirus 2; Adolescent; Adult; Animals; Animals, Wild; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Disease Outbreaks; Female; Health Knowledge, Attitudes, Practice; Humans; Interviews as Topic; Male; Middle Aged; Pneumonia, Viral; Qualitative Research; Risk Factors; Rural Population; Severe Acute Respiratory Syndrome; Virus Diseases; Young Adult; Zoonoses</schema:keywords>
    <myOnto:volume>12</myOnto:volume>
    <myOnto:issue>2</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1093/inthealth/ihaa001</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Oxford University Press</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2019</dc:date>
    <rdfs:comment>Strategies are urgently needed to mitigate the risk of zoonotic disease emergence in southern China, where pathogens with zoonotic potential are known to circulate in wild animal populations. However, the risk factors leading to emergence are poorly understood, which presents a challenge in developing appropriate mitigation strategies for local communities. Methods: Residents in rural communities of Yunnan, Guangxi and Guangdong provinces were recruited and enrolled in this study. Data were collected through ethnographic interviews and field observations, and thematically coded and analysed to identify both risk and protective factors for zoonotic disease emergence at the individual, community and policy levels. Results: Eighty-eight ethnographic interviews and 55 field observations were conducted at nine selected sites. Frequent human-animal interactions and low levels of environmental biosecurity in local communities were identified as risks for zoonotic disease emergence. Policies and programmes existing in the communities provide opportunities for zoonotic risk mitigation. Conclusions: This study explored the relationship among zoonotic risk and human behaviour, environment and policies in rural communities in southern China. It identifies key behavioural risk factors that can be targeted for development of tailored risk-mitigation strategies to reduce the threat of novel zoonoses. © 2020 The Author(s) 2020. Published by Oxford University Press.</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079355506&amp;doi=10.1093%2finthealth%2fihaa001&amp;partnerID=40&amp;md5=b2f0131bc3f081380c78a8a4e5190262&gt;</schema:url>
    <dc:creator>Li H.-Y., Zhu G.-J., Zhang Y.-Z., Zhang L.-B., Hagan E.A., Martinez S., Chmura A.A., Francisco L., Tai H., Miller M., Daszak P.</dc:creator>
    <j.0:title>A qualitative study of zoonotic risk factors among rural communities in southern China</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079226451">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>323</myOnto:volume>
    <myOnto:issue>11</myOnto:issue>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>lopinavir plus ritonavir; remdesivir; adult respiratory distress syndrome; China; comorbidity; coronavirus disease 2019; Coronavirus infection; epidemic; fever; gene sequence; health education; high throughput sequencing; human; incubation time; infection control; infection prevention; intensive care; mortality rate; nonhuman; Note; pneumonia; priority journal; quarantine; SARS coronavirus; sequence homology; Severe acute respiratory syndrome coronavirus 2; symptomatology; travel; virus identification; virus infectivity; virus transmission</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1001/jama.2020.1490</j.0:identifier>
    <j.0:title>2019 Novel Coronavirus - Important Information for Clinicians</j.0:title>
    <j.0:identifier>2-s2.0-85079226451</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079226451&amp;doi=10.1001%2fjama.2020.1490&amp;partnerID=40&amp;md5=9c2c53bec5750f88514c9d4fb7610921&gt;</schema:url>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <dc:creator>Del Rio C., Malani P.N.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080854126">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Bioscience_trends"/>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>14</myOnto:volume>
    <myOnto:citeyBy>5</myOnto:citeyBy>
    <myOnto:issue>1</myOnto:issue>
    <rdfs:comment>Pneumonia associated with the 2019 novel coronavirus (2019-nCoV) is continuously and rapidly circulating at present. No effective antiviral treatment has been verified thus far. We report here the clinical characteristics and therapeutic procedure for four patients with mild or severe 2019-nCoV pneumonia admitted to Shanghai Public Health Clinical Center. All the patients were given antiviral treatment including lopinavir/ritonavir (Kaletra®), arbidol, and Shufeng Jiedu Capsule (SFJDC, a traditional Chinese medicine) and other necessary support care. After treatment, three patients gained significant improvement in pneumonia associated symptoms, two of whom were confirmed 2019-nCoV negative and discharged, and one of whom was virus negative at the first test. The remaining patient with severe pneumonia had shown signs of improvement by the cutoff date for data collection. Results obtained in the current study may provide clues for treatment of 2019-nCoV pneumonia. The efficacy of antiviral treatment including lopinavir/ritonavir, arbidol, and SFJDC warrants further verification in future study.</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords>antivirus agent; arbidol; COVID-19; herbaceous agent; indole derivative; lopinavir; lopinavir-ritonavir drug combination; ritonavir; severe acute respiratory syndrome coronavirus 2; shufeng jiedu; adult; Betacoronavirus; case report; China; Coronavirus infection; drug combination; female; human; male; middle aged; retrospective study; virus pneumonia; young adult; Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; Drug Combinations; Drugs, Chinese Herbal; Female; Humans; Indoles; Lopinavir; Male; Middle Aged; Pneumonia, Viral; Retrospective Studies; Ritonavir; Young Adult</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Wang Z., Chen X., Lu Y., Chen F., Zhang W.</dc:creator>
    <j.0:identifier>2-s2.0-85080854126</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080854126&amp;doi=10.5582%2fbst.2020.01030&amp;partnerID=40&amp;md5=983f32fc34a52c75922457c2409f5496&gt;</schema:url>
    <j.0:identifier>10.5582/bst.2020.01030</j.0:identifier>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082086984">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082086984&amp;doi=10.4045%2ftidsskr.20.0219&amp;partnerID=40&amp;md5=1020ae94f85766c122f9e24ac1020498&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Covid-19: Slå ring!</j.0:title>
    <dc:creator>Tveito K.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.4045/tidsskr.20.0219</j.0:identifier>
    <dc:language>Norwegian</dc:language>
    <myOnto:volume>140</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85082086984</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Tidsskrift_for_den_Norske_laegeforening_:_tidsskrift_for_praktisk_medicin,_ny_raekke"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079445619">
    <j.0:type>Note</j.0:type>
    <j.0:identifier>2-s2.0-85079445619</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1038/s41423-020-0372-4</j.0:identifier>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079445619&amp;doi=10.1038%2fs41423-020-0372-4&amp;partnerID=40&amp;md5=cb9c6bffdf4c3218519ec346fd68f147&gt;</schema:url>
    <j.0:publisher>Springer Nature</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Cellular_and_Molecular_Immunology"/>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Jiang S., Xia S., Ying T., Lu L.</dc:creator>
    <j.0:title>A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079740412">
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_New_Zealand_medical_journal"/>
    <dc:creator>Dilcher M., Werno A., Jennings L.C.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>133</myOnto:volume>
    <j.0:identifier>2-s2.0-85079740412</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; communicable disease; Coronavirus infection; epidemiology; genetics; global health; human; international cooperation; mortality; pathogenicity; phylogeny; public health; risk factor; severity of illness index; travel; virus pneumonia; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Global Health; Humans; Internationality; Phylogeny; Pneumonia, Viral; Public Health; Risk Factors; Severity of Illness Index; Travel</schema:keywords>
    <j.0:identifier></j.0:identifier>
    <j.0:title>SARS-CoV-2: a novel deadly virus in a globalised world</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079740412&amp;partnerID=40&amp;md5=8d61215a401ea8b4e14f8078045c2418&gt;</schema:url>
    <myOnto:issue>1510</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079070836">
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <schema:keywords>angiotensin converting enzyme 2; dipeptidyl peptidase IV; gamma interferon; granulocyte colony stimulating factor receptor; lopinavir plus ritonavir; procalcitonin; remdesivir; tumor necrosis factor; COVID-19; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus infection; antiviral therapy; case fatality rate; computer assisted tomography; Coronavirus infection; drug efficacy; drug safety; dyspnea; Editorial; fatality; heart injury; hospital patient; human; intensive care unit; intermediate host; laboratory diagnosis; laboratory test; leukopenia; lower respiratory tract; lymphocytopenia; mathematical model; medical decision making; Middle East respiratory syndrome; positive-strand RNA virus; priority journal; randomized controlled trial (topic); SARS coronavirus; severe acute respiratory syndrome; virus pneumonia; Betacoronavirus; Coronavirus infection; genetics; pandemic; virus pneumonia; Betacoronavirus; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral</schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85079070836</j.0:identifier>
    <j.0:identifier>10.1111/eci.13209</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/European_Journal_of_Clinical_Investigation">
        <j.1:name>European Journal of Clinical Investigation</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079070836&amp;doi=10.1111%2feci.13209&amp;partnerID=40&amp;md5=ea1019d298371d8c057a838a2b3e8806&gt;</schema:url>
    <myOnto:volume>50</myOnto:volume>
    <dc:creator>Bassetti M., Vena A., Giacobbe D.R.</dc:creator>
    <j.0:title>The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082070787">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; communicable disease; Coronavirus infection; decision support system; differential diagnosis; emergency health service; Europe; hospital emergency service; human; isolation and purification; risk factor; travel; virus pneumonia; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Decision Support Techniques; Diagnosis, Differential; Emergency Medical Services; Emergency Service, Hospital; Europe; Humans; Pneumonia, Viral; Risk Factors; Travel</schema:keywords>
    <dc:language>English</dc:language>
    <dc:creator>Koenig K.L., Beÿ C.K., McDonald E.C.</dc:creator>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:volume>21</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082070787&amp;doi=10.5811%2fwestjem.2020.1.46760&amp;partnerID=40&amp;md5=2ee53d21bd3e7ae4ec75dc2a6b0b8a7d&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082070787</j.0:identifier>
    <j.0:title>2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.5811/westjem.2020.1.46760</j.0:identifier>
    <rdfs:comment>2019 Novel Coronavirus (2019-nCoV) is an emerging infectious disease closely related to MERS-CoV and SARS-CoV that was first reported in Wuhan City, Hubei Province, China in December 2019. As of January 2020, cases of 2019-nCoV are continuing to be reported in other Eastern Asian countries as well as in the United States, Europe, Australia, and numerous other countries. An unusually high volume of domestic and international travel corresponding to the beginning of the 2020 Chinese New Year complicated initial identification and containment of infected persons. Due to the rapidly rising number of cases and reported deaths, all countries should be considered at risk of imported 2019-nCoV. Therefore, it is essential for prehospital, clinic, and emergency department personnel to be able to rapidly assess 2019-nCoV risk and take immediate actions if indicated. The Identify-Isolate-Inform (3I) Tool, originally conceived for the initial detection and management of Ebola virus and later adjusted for other infectious agents, can be adapted for any emerging infectious disease. This paper reports a modification of the 3I Tool for use in the initial detection and management of patients under investigation for 2019-nCoV. After initial assessment for symptoms and epidemiological risk factors, including travel to affected areas and exposure to confirmed 2019-nCoV patients within 14 days, patients are classified in a risk-stratified system. Upon confirmation of a suspected 2019-nCoV case, affected persons must immediately be placed in airborne infection isolation and the appropriate public health agencies notified. This modified 3I Tool will assist emergency and primary care clinicians, as well as out-of-hospital providers, in effectively managing persons with suspected or confirmed 2019-nCoV.</rdfs:comment>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/The_western_journal_of_emergency_medicine">
        <j.1:name>The western journal of emergency medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079083658">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079083658&amp;doi=10.15585%2fmmwr.mm6905e1&amp;partnerID=40&amp;md5=157320727867b4c7dc0ab33bd24d7ae2&gt;</schema:url>
    <j.0:identifier>10.15585/mmwr.mm6905e1</j.0:identifier>
    <schema:keywords>Wuhan coronavirus; adult; aged; Betacoronavirus; Coronavirus infection; epidemic; female; human; infection control; isolation and purification; laboratory; male; middle aged; practice guideline; public health service; United States; virology; Adult; Aged; Betacoronavirus; Centers for Disease Control and Prevention, U.S.; Coronavirus Infections; Disease Outbreaks; Female; Humans; Infection Control; Laboratories; Male; Middle Aged; Practice Guidelines as Topic; Public Health Practice; United States</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <j.0:title>Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020</j.0:title>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:issue>5</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/MMWR._Morbidity_and_mortality_weekly_report"/>
    <j.0:identifier>2-s2.0-85079083658</j.0:identifier>
    <myOnto:volume>69</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern.† On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a "Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus," which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.</rdfs:comment>
    <dc:creator>Patel A., Jernigan D.B., 2019-nCoV CDC Response Team</dc:creator>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082022421">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Day M.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082022421&amp;doi=10.1136%2fbmj.m1086&amp;partnerID=40&amp;md5=3e68185418cc7f8161cfdb794c39220b&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082022421</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:title>Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists</j.0:title>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>368</myOnto:volume>
    <j.0:identifier>10.1136/bmj.m1086</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082173725">
    <j.0:type>Erratum</j.0:type>
    <myOnto:volume>395</myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082173725&amp;doi=10.1016%2fS0140-6736%2820%2930638-3&amp;partnerID=40&amp;md5=d0c33740f0d1da9334f0b117739854e5&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082173725</j.0:identifier>
    <schema:keywords>erratum</schema:keywords>
    <rdfs:comment>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; published online March 9. https://doi.org/10.1016/S0140-6736(20)30566-3—In this Article, the units for d-dimer, haemoglobin, and high-sensitivity cardiac troponin I have been corrected to ?g/mL (d-dimer), g/L (haemoglobin), and pg/mL (high-sensitivity cardiac troponin I). In figure 1, the start of systematic corticosteroid for non-survivors has been changed to day 13 after illness onset. The appendix has also been corrected. These corrections have been made to the online version as of March 12, 2020, and will be made to the printed version. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:creator>[No author name available]</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>Erratum: Department of Error (The Lancet (2020) 395(10229) (1054–1062), (S0140673620305663), (10.1016/S0140-6736(20)30566-3))</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <j.0:identifier>10.1016/S0140-6736(20)30638-3</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:issue>10229</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081203829">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1002/pbc.28248</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>2-s2.0-85081203829</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection</j.0:title>
    <schema:keywords></schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>67</myOnto:volume>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <dc:creator>Yang C., Li C., Wang S., National Clinical Research Center for Child Health and Disorders and Children's Oncology Committee of Chinese Research Hospital Association</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pediatric_Blood_and_Cancer">
        <j.1:name>Pediatric Blood and Cancer</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081203829&amp;doi=10.1002%2fpbc.28248&amp;partnerID=40&amp;md5=32dffb1e1718d0e0d0568d92ad575835&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082057870">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>German</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082057870&amp;doi=10.1007%2fs15006-020-0237-x&amp;partnerID=40&amp;md5=e043f2d42592139bff4fe60ab272b6b1&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1007/s15006-020-0237-x</j.0:identifier>
    <myOnto:issue>5</myOnto:issue>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:volume>162</myOnto:volume>
    <dc:creator>Bogner J.</dc:creator>
    <j.0:identifier>2-s2.0-85082057870</j.0:identifier>
    <j.0:title>COVID-19 in der Allgemeinarztpraxis</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/MMW_Fortschritte_der_Medizin"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082228140">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082228140&amp;doi=10.1016%2fj.tmrv.2020.02.003&amp;partnerID=40&amp;md5=01d8c43f6365c75caf82e03dc4ce8530&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <dc:creator>Chang L., Yan Y., Wang L.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Transfusion_Medicine_Reviews"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>W.B. Saunders</j.0:publisher>
    <j.0:identifier>2-s2.0-85082228140</j.0:identifier>
    <rdfs:comment>With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections—SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012—both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by ?-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS–CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses. © 2020 Elsevier Inc.</rdfs:comment>
    <j.0:title>Coronavirus Disease 2019: Coronaviruses and Blood Safety</j.0:title>
    <j.0:type>Review</j.0:type>
    <j.0:identifier>10.1016/j.tmrv.2020.02.003</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081994981">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Since the first case of coronavirus disease19 (COVID-19) was reported in Wuhan, China, as of March 2, 2020, the total number of confirmed cases of COVID-19 was 89,069 cases in 67 countries and regions. As of 0 AM, March 2, 2020, the Republic of Korea had the second-largest number of confirmed cases (n = 4,212) after China (n = 80,026). This report summarizes the epidemiologic features and the snapshots of the outbreak in the Republic of Korea from January 19 and March 2, 2020. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <j.0:identifier>2-s2.0-85081994981</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adolescent; adult; age distribution; aged; Betacoronavirus; child; Coronavirus infection; epidemic; female; human; infant; isolation and purification; male; middle aged; pathogenicity; preschool child; sex ratio; South Korea; very elderly; virus pneumonia; young adult; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Betacoronavirus; Child; Child, Preschool; Coronavirus Infections; Disease Outbreaks; Female; Humans; Infant; Male; Middle Aged; Pneumonia, Viral; Republic of Korea; Sex Distribution; Young Adult</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>35</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:identifier>10.3346/jkms.2020.35.e112</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081994981&amp;doi=10.3346%2fjkms.2020.35.e112&amp;partnerID=40&amp;md5=fc501fe05ecd697524d46081b6370dca&gt;</schema:url>
    <j.0:title>Report on the epidemiological features of coronavirus disease 2019 (covid-19) outbreak in the republic of korea from january 19 to march 2, 2020</j.0:title>
    <j.0:type>Article</j.0:type>
    <myOnto:issue>10</myOnto:issue>
    <dc:creator>Korean Society of Infectious Diseases</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082179536">
    <j.0:title>Correction to The first Vietnamese case of COVID-19 acquired from China (The Lancet Infectious Diseases (2020) 20(4) (408–409), (S1473309920301110), (10.1016/S1473-3099(20)30111-0))</j.0:title>
    <myOnto:volume></myOnto:volume>
    <dc:creator>[No author name available]</dc:creator>
    <j.0:identifier>2-s2.0-85082179536</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <rdfs:comment>Cuong LV, Giang HTN, Linh LC, et al. The first Vietnamese case of COVID-19 acquired from China. Lancet Infectious Diseases 2020; published online Feb 18. https://doi.org/10.1016/S1473-3099(20)30111-0—In this Letter, parts A and B in the figure were labelled the wrong way around. This correction has been made to the online version as of Feb 24, 2020, and will be made to the printed version. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1016/S1473-3099(20)30128-6</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082179536&amp;doi=10.1016%2fS1473-3099%2820%2930128-6&amp;partnerID=40&amp;md5=b1c06bf42fd48aae680d997050b9101b&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:type>Erratum</j.0:type>
    <schema:keywords>erratum</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080843760">
    <myOnto:volume>25</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:keywords>COVID-19; virus RNA; classification; Coronavirinae; Coronavirus infection; epidemic; European Union; genetics; human; isolation and purification; laboratory; laboratory technique; procedures; reverse transcription polymerase chain reaction; sensitivity and specificity; sentinel surveillance; sequence analysis; standard; virology; virus pneumonia; Clinical Laboratory Techniques; Coronavirus; Coronavirus Infections; Disease Outbreaks; European Union; Humans; Laboratories; Pneumonia, Viral; Reference Standards; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Sentinel Surveillance; Sequence Analysis</schema:keywords>
    <myOnto:issue>6</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.6.2000082</j.0:identifier>
    <j.0:identifier>2-s2.0-85080843760</j.0:identifier>
    <j.0:title>Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020</j.0:title>
    <rdfs:comment>Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.</rdfs:comment>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080843760&amp;doi=10.2807%2f1560-7917.ES.2020.25.6.2000082&amp;partnerID=40&amp;md5=330759161f3e21da5c3c6329568702cf&gt;</schema:url>
    <dc:creator>Reusken C.B.E.M., Broberg E.K., Haagmans B., Meijer A., Corman V.M., Papa A., Charrel R., Drosten C., Koopmans M., Leitmeyer K., On Behalf Of Evd-LabNet And Erli-Net</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082200345">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>KeAi Communications Co.</j.0:publisher>
    <j.0:title>Why is it difficult to accurately predict the COVID-19 epidemic?</j.0:title>
    <myOnto:volume>5</myOnto:volume>
    <dc:creator>Roda W.C., Varughese M.B., Han D., Li M.Y.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85082200345</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/j.idm.2020.03.001</j.0:identifier>
    <rdfs:comment>Since the COVID-19 outbreak in Wuhan City in December of 2019, numerous model predictions on the COVID-19 epidemics in Wuhan and other parts of China have been reported. These model predictions have shown a wide range of variations. In our study, we demonstrate that nonidentifiability in model calibrations using the confirmed-case data is the main reason for such wide variations. Using the Akaike Information Criterion (AIC) for model selection, we show that an SIR model performs much better than an SEIR model in representing the information contained in the confirmed-case data. This indicates that predictions using more complex models may not be more reliable compared to using a simpler model. We present our model predictions for the COVID-19 epidemic in Wuhan after the lockdown and quarantine of the city on January 23, 2020. We also report our results of modeling the impacts of the strict quarantine measures undertaken in the city after February 7 on the time course of the epidemic, and modeling the potential of a second outbreak after the return-to-work in the city. © 2020 The Authors</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Disease_Modelling"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082200345&amp;doi=10.1016%2fj.idm.2020.03.001&amp;partnerID=40&amp;md5=0340bf455b718e512bec8c3d8ff7482b&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078688361">
    <j.0:identifier>2-s2.0-85078688361</j.0:identifier>
    <dc:creator>Gralinski L.E., Menachery V.D.</dc:creator>
    <myOnto:volume>12</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>virus RNA; coronavirus spike glycoprotein; COVID-19; nucleocapsid protein; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; antiviral susceptibility; biodiversity; coronavirus disease 2019; diagnostic test; disease association; disease severity; disease surveillance; environmental protection; epidemic; extracorporeal oxygenation; fever; government; health care; health care personnel; human; immune response; kidney function; Middle East respiratory syndrome coronavirus; mortality rate; nucleotide sequence; pneumonia; public health; respiratory tract disease; Review; SARS coronavirus; sea food; social media; virus attachment; virus nucleocapsid; virus transmission; animal; Betacoronavirus; chemistry; China; communicable disease; Coronavirus infection; disease carrier; disease predisposition; epidemic; genetics; isolation and purification; metabolism; severe acute respiratory syndrome; virology; virus genome; virus pneumonia; zoonosis; Animals; Betacoronavirus; China; Communicable Diseases, Emerging; Coronavirus Infections; Disease Outbreaks; Disease Reservoirs; Disease Susceptibility; Genome, Viral; Humans; Nucleocapsid Proteins; Pneumonia, Viral; SARS Virus; Severe Acute Respiratory Syndrome; Social Media; Spike Glycoprotein, Coronavirus; Zoonoses</schema:keywords>
    <rdfs:comment>The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARSCoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus. © 2020 by the authors.</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Viruses"/>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <j.0:type>Review</j.0:type>
    <dc:language>English</dc:language>
    <j.0:title>Return of the coronavirus: 2019-nCoV</j.0:title>
    <j.0:publisher>MDPI AG</j.0:publisher>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>10.3390/v12020135</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078688361&amp;doi=10.3390%2fv12020135&amp;partnerID=40&amp;md5=3dbf1e6430096abfd7676f32b2158359&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081656421">
    <myOnto:volume></myOnto:volume>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast during an Emergency Response</j.0:title>
    <myOnto:issue></myOnto:issue>
    <j.0:type>Note</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081656421</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Grasselli G., Pesenti A., Cecconi M.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:identifier>10.1001/jama.2020.4031</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081656421&amp;doi=10.1001%2fjama.2020.4031&amp;partnerID=40&amp;md5=c1150cb18829eaaa34dd6f51077e6ab0&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081991340">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081991340&amp;doi=10.1186%2fs13054-020-2828-4&amp;partnerID=40&amp;md5=84108d08d12267e3e955033eb2c43855&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>24</myOnto:volume>
    <j.0:identifier>2-s2.0-85081991340</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:keywords>severe acute respiratory syndrome coronavirus 2; Betacoronavirus; human; influenza; intensive care; pandemic; Betacoronavirus; Critical Care; Humans; Influenza, Human; Pandemics</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>10.1186/s13054-020-2828-4</j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Liew M.F., Siow W.T., Yau Y.W., See K.C.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Critical_care_(London,_England)"/>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Safe patient transport for COVID-19</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081993103">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Nursing_Studies">
        <j.1:name>International Journal of Nursing Studies</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081993103&amp;doi=10.1016%2fj.ijnurstu.2020.103567&amp;partnerID=40&amp;md5=afd9b080eb83cfacaa7292353f709581&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:volume>105</myOnto:volume>
    <j.0:identifier>10.1016/j.ijnurstu.2020.103567</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081993103</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Chughtai A.A., Seale H., Islam M.S., Owais M., Macintyre C.R.</dc:creator>
    <j.0:title>Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19)</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082083362">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates</j.0:title>
    <dc:creator>Chen Y.W., Yiu C.-P.B., Wong K.-Y.</dc:creator>
    <j.0:identifier>2-s2.0-85082083362</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/F1000Research"/>
    <j.0:type>Article</j.0:type>
    <schema:keywords>benzimidazole derivative; carbamic acid derivative; cysteine proteinase; fluorene derivative; fused heterocyclic rings; ledipasvir; severe acute respiratory syndrome coronavirus 2; velpatasvir; viral protein; Betacoronavirus; drug repositioning; Benzimidazoles; Betacoronavirus; Carbamates; Cysteine Endopeptidases; Drug Repositioning; Fluorenes; Heterocyclic Compounds, 4 or More Rings; Viral Nonstructural Proteins; Viral Proteins</schema:keywords>
    <myOnto:volume>9</myOnto:volume>
    <j.0:identifier>10.12688/f1000research.22457.1</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082083362&amp;doi=10.12688%2ff1000research.22457.1&amp;partnerID=40&amp;md5=d98ac7684168e29836b2fb3812dc5524&gt;</schema:url>
    <rdfs:comment>We prepared the three-dimensional model of the SARS-CoV-2 (aka 2019-nCoV) 3C-like protease (3CL pro) using the crystal structure of the highly similar (96% identity) ortholog from the SARS-CoV. All residues involved in the catalysis, substrate binding and dimerisation are 100% conserved. Comparison of the polyprotein PP1AB sequences showed 86% identity. The 3C-like cleavage sites on the coronaviral polyproteins are highly conserved. Based on the near-identical substrate specificities and high sequence identities, we are of the opinion that some of the previous progress of specific inhibitors development for the SARS-CoV enzyme can be conferred on its SARS-CoV-2 counterpart.  With the 3CL pro molecular model, we performed virtual screening for purchasable drugs and proposed 16 candidates for consideration. Among these, the antivirals ledipasvir or velpatasvir are particularly attractive as therapeutics to combat the new coronavirus with minimal side effects, commonly fatigue and headache.  The drugs Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) could be very effective owing to their dual inhibitory actions on two viral enzymes. Copyright: © 2020 Chen YW et al.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082106028">
    <j.0:title>DAZ-SPEZIAL COVID-19: Wenn keiner liefern kann...</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Deutscher Apotheker Verlag</j.0:publisher>
    <j.0:identifier>2-s2.0-85082106028</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Ziegler A.S.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Deutsche_Apotheker_Zeitung"/>
    <j.0:identifier></j.0:identifier>
    <dc:language>German</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <myOnto:issue>10</myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082106028&amp;partnerID=40&amp;md5=d335b7442b5083c1126e7c3d042c94ca&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>160</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082092310">
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082092310&amp;doi=10.1186%2fs12939-020-01162-y&amp;partnerID=40&amp;md5=378ff4dec69a34e3dedfd7e55b2c52ad&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Responding to the COVID-19 pandemic in complex humanitarian crises</j.0:title>
    <myOnto:issue>1</myOnto:issue>
    <j.0:type>Note</j.0:type>
    <j.0:identifier>10.1186/s12939-020-01162-y</j.0:identifier>
    <dc:creator>Poole D.N., Escudero D.J., Gostin L.O., Leblang D., Talbot E.A.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_for_Equity_in_Health">
        <j.1:name>International Journal for Equity in Health</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85082092310</j.0:identifier>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <myOnto:volume>19</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082192973">
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082192973&amp;doi=10.1016%2fS1473-3099%2820%2930175-4&amp;partnerID=40&amp;md5=2a6f9f52de9fbb9e015bb7f95739e1e7&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85082192973</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:creator>Schmid M.B., Fontijn J., Ochsenbein-Kölble N., Berger C., Bassler D.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>COVID-19 in pregnant women</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <j.0:identifier>10.1016/S1473-3099(20)30175-4</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082095408">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Review</j.0:type>
    <j.0:title>What we know so far: COVID-19 current clinical knowledge and research</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Clinical_medicine_(London,_England)">
        <j.1:name>Clinical medicine (London, England)</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082095408&amp;doi=10.7861%2fclinmed.2019-coron&amp;partnerID=40&amp;md5=13fd528f58b3022da933826e4e91502a&gt;</schema:url>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>2-s2.0-85082095408</j.0:identifier>
    <j.0:identifier>10.7861/clinmed.2019-coron</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:volume>20</myOnto:volume>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; epidemic; health survey; human; palliative therapy; public health; severe acute respiratory syndrome; virus pneumonia; Betacoronavirus; Coronavirus Infections; Disease Outbreaks; Humans; Palliative Care; Pneumonia, Viral; Public Health; Public Health Surveillance; Severe Acute Respiratory Syndrome</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Lake M.A.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features. © Royal College of Physicians 2020. All rights reserved.</rdfs:comment>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081266636">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>Nature Research</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081266636&amp;doi=10.1038%2fs41564-020-0695-z&amp;partnerID=40&amp;md5=c3b90b29e9e51014a492edc9b240221e&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85081266636</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Microbiology"/>
    <j.0:title>The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1038/s41564-020-0695-z</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L.M., Samborskiy D.V., Sidorov I.A., Sola I., Ziebuhr J., Coronaviridae Study Group of the International Committee on Taxonomy of Viruses</dc:creator>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081048893">
    <dc:date>2020</dc:date>
    <j.0:title>And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Pulmonology">
        <j.1:name>Pulmonology</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>Froes F.</dc:creator>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081048893&amp;doi=10.1016%2fj.pulmoe.2020.02.010&amp;partnerID=40&amp;md5=881f74272d65fba98928cdfbe77525ba&gt;</schema:url>
    <j.0:publisher>Elsevier Espana S.L.U</j.0:publisher>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords>2019 novel corovirus; behavior change; biomass; civilization; corovirus disease 2019; Editorial; electron microscopy; epidemic; human; immune response; infection control; interpersonal communication; knowledge; life expectancy; mortality; nonhuman; pandemic; SARS coronavirus; vaccination; virus infection; World Health Organization; communicable disease; Coronavirus infection; epidemic; global health; history; social status; virus pneumonia; COVID-19; vaccine; Communicable Diseases, Emerging; Coronavirus Infections; Disease Outbreaks; Global Health; History; Humans; Pneumonia, Viral; Social Conditions; Vaccines</schema:keywords>
    <myOnto:volume>26</myOnto:volume>
    <j.0:identifier>10.1016/j.pulmoe.2020.02.010</j.0:identifier>
    <j.0:identifier>2-s2.0-85081048893</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081240462">
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>9</myOnto:volume>
    <rdfs:comment>Human coronaviruses continue to pose a threat to human health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease-2019 (COVID-19), an acute respiratory disease marked the third introduction of a highly pathogenic coronavirus into the human population in the twenty-first century. This recent emergence of a previously unknown coronavirus in China leads to huge impacts on humans globally. Covid-19 is a challenge to global public health. Here, we discuss the COVID-19 outbreak in a one health context, highlighting the need for the implementation of one health measures and practices to improve human health and reduce the emergence of pandemic viruses. © 2020 The Authors</rdfs:comment>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:creator>El Zowalaty M.E., Järhult J.D.</dc:creator>
    <j.0:identifier>10.1016/j.onehlt.2020.100124</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/One_Health"/>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081240462&amp;doi=10.1016%2fj.onehlt.2020.100124&amp;partnerID=40&amp;md5=92f4f216c0d12917075b6d3b4ff557f8&gt;</schema:url>
    <j.0:title>From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach</j.0:title>
    <schema:keywords>influenza vaccine; 2019 novel coronavirus; adult respiratory distress syndrome; antibiotic resistance; Article; case fatality rate; cause of death; China; comorbidity; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease severity; disease transmission; hospitalization; human; infection control; influenza A; influenza vaccination; mortality; nonhuman; pneumonia; polymerase chain reaction; prevalence; public health; seroconversion; translational research; virus detection</schema:keywords>
    <j.0:identifier>2-s2.0-85081240462</j.0:identifier>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078661544">
    <j.0:identifier>2-s2.0-85078661544</j.0:identifier>
    <j.0:identifier>10.1056/NEJMe2001126</j.0:identifier>
    <j.0:type>Editorial</j.0:type>
    <dc:date>2020</dc:date>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>antivirus agent; virus vaccine; 2019 novel coronavirus; airway epithelium cell; China; Coronavirinae; Coronavirus infection; disease severity; drug synthesis; Editorial; epidemic; gene sequence; human; lower respiratory tract infection; Middle East respiratory syndrome coronavirus; mortality rate; nonhuman; prevalence; priority journal; public health service; SARS coronavirus; sea food; serology; severe acute respiratory syndrome; vaccine production; virus carrier; virus cell interaction; virus detection; virus genome; virus identification; virus mutation; virus pathogenesis; virus replication; virus transmission; virus virulence; Coronavirus infection; pneumonia; China; Coronavirus; Coronavirus Infections; Humans; Pneumonia</schema:keywords>
    <dc:creator>Perlman S.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:volume>382</myOnto:volume>
    <j.0:publisher>Massachussetts Medical Society</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078661544&amp;doi=10.1056%2fNEJMe2001126&amp;partnerID=40&amp;md5=15d1201c9edcd89466abedb60615eaad&gt;</schema:url>
    <j.0:title>Another decade, another coronavirus</j.0:title>
    <myOnto:citeyBy>19</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/New_England_Journal_of_Medicine"/>
    <myOnto:issue>8</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081552285">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <dc:creator>Zhang W.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:title>Imaging changes of severe COVID-19 pneumonia in advanced stage</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Intensive_Care_Medicine"/>
    <j.0:identifier>2-s2.0-85081552285</j.0:identifier>
    <j.0:identifier>10.1007/s00134-020-05990-y</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Springer</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081552285&amp;doi=10.1007%2fs00134-020-05990-y&amp;partnerID=40&amp;md5=2e54f717f03c6b8a0fd120c7abdc4b12&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081150961">
    <j.0:identifier>10.4103/1995-7645.277516</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081150961&amp;doi=10.4103%2f1995-7645.277516&amp;partnerID=40&amp;md5=9d3b4afa2891a773b4e3767a1b927113&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Pacific_Journal_of_Tropical_Medicine"/>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:publisher>Wolters Kluwer Medknow Publications</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081150961</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:creator>Sookaromdee P., Wiwanitkit V.</dc:creator>
    <j.0:title>Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:volume>13</myOnto:volume>
    <schema:keywords>2019 novel coronavirus infection; acceleration; Coronavirinae; Coronavirus infection; disease control; disease duration; epidemic; human; Letter; managed care; mathematical model; priority journal; professional knowledge; public health; Thailand; treatment planning; virus transmission</schema:keywords>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081736693">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1111/pcn.12995</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:publisher>Blackwell Publishing</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Psychiatry_and_Clinical_Neurosciences">
        <j.1:name>Psychiatry and Clinical Neurosciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081736693&amp;doi=10.1111%2fpcn.12995&amp;partnerID=40&amp;md5=aeebda6fcc3edd725efeb7d3e6d4f82f&gt;</schema:url>
    <j.0:title>Trust is a key factor in the willingness of health professionals to work during the COVID-19 outbreak: Experience from the H1N1 pandemic in Japan 2009</j.0:title>
    <j.0:identifier>2-s2.0-85081736693</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Imai H.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078709834">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Science"/>
    <dc:language>English</dc:language>
    <j.0:publisher>American Association for the Advancement of Science</j.0:publisher>
    <j.0:identifier>10.1126/science.367.6477.492</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078709834&amp;doi=10.1126%2fscience.367.6477.492&amp;partnerID=40&amp;md5=82410e8f61977089cd09123e2db35edb&gt;</schema:url>
    <j.0:title>New coronavirus threat galvanizes scientists</j.0:title>
    <j.0:type>Short Survey</j.0:type>
    <schema:keywords>epidemic; global perspective; research work; science and technology; virus; 2019 novel coronavirus; China; Coronavirinae; disease transmission; epidemic; human; infection rate; life threat; population risk; priority journal; risk factor; Short Survey; China; Hubei; Wuhan; Coronavirus</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85078709834</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>6477</myOnto:issue>
    <dc:creator>Cohen J.</dc:creator>
    <myOnto:volume>367</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080919920">
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>BMJ Publishing Group</j.0:publisher>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:creator>Liang W., Feng Z., Rao S., Xiao C., Xue X., Lin Z., Zhang Q., Qi W.</dc:creator>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080919920&amp;doi=10.1136%2fgutjnl-2020-320832&amp;partnerID=40&amp;md5=cfb8eb2025773a0681be8cc90bb27512&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>2-s2.0-85080919920</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Gut"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:title>Diarrhoea may be underestimated: A missing link in 2019 novel coronavirus</j.0:title>
    <j.0:identifier>10.1136/gutjnl-2020-320832</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081527791">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:creator>Iacobucci G.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081527791</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:title>Covid-19: GP surgeries close for two weeks after staff test positive</j.0:title>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m936</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081527791&amp;doi=10.1136%2fbmj.m936&amp;partnerID=40&amp;md5=46244b6e88d9743d1a184825b2a404b3&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081979582">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English</dc:language>
    <dc:creator>Ebrahim S.H., Memish Z.A.</dc:creator>
    <j.0:identifier>10.1016/j.tmaid.2020.101617</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081979582&amp;doi=10.1016%2fj.tmaid.2020.101617&amp;partnerID=40&amp;md5=e036d9427c306a13b2a5ac4d62a2ecd3&gt;</schema:url>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85081979582</j.0:identifier>
    <rdfs:comment>Mass gathering (MG) medicine emerged against the backdrop of the 2009 pandemic H1N1 Public Health Emergency of International Concern (PHEIC) when the Kingdom of Saudi Arabia (KSA) hosted the largest annual mass gathering of over 3 million pilgrims from 180 plus countries. However, the events surrounding the latest threat to global health, the PHEIC COVID-19, may be sufficient to highlight the role of mass gatherings, mass migration, and other forms of dense gatherings of people on the emergence, sustenance, and transmission of novel pathogens. The COVID-19 spread illustrates the role of MGs in exacerbation of the scope of pandemics. Cancellation or suspension of MGs would be critical to pandemic mitigation. It is unlikely that medical countermeasures are available during the early phase of pandemics. Therefore, mitigation of its impact, rather than containment and control becomes a priority during pandemics. As the most systematically studied MG-related respiratory disease data come from KSA, the cancellation of Umrah by the KSA authorities, prior to emergence of cases, provide the best opportunity to develop mathematical models to quantify event cancellations related mitigation of COVID-19 transmission in KSA and to the home countries of pilgrims. COVID-19 has already provided examples of both clearly planned event cancellations such as the Umrah suspension in KSA, and where outbreaks and events were continued. © 2020 Elsevier Ltd</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>COVID-19 – the role of mass gatherings</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081729685">
    <schema:keywords></schema:keywords>
    <j.0:publisher>Blackwell Publishing Ltd</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Care of haematology patients in a COVID-19 epidemic</j.0:title>
    <j.0:type>Letter</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081729685&amp;doi=10.1111%2fbjh.16620&amp;partnerID=40&amp;md5=b007290455c3c00bdc63ebeb6cd07f02&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081729685</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Willan J., King A.J., Hayes S., Collins G.P., Peniket A.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/British_Journal_of_Haematology"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1111/bjh.16620</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082090359">
    <j.0:identifier>10.1016/j.annemergmed.2020.02.006</j.0:identifier>
    <j.0:title>Initial Experience of an Emergency Department in Shenzhen in Responding to the Emerging Wuhan Coronavirus Pneumonia</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85082090359</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <j.0:publisher>Mosby Inc.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Annals_of_Emergency_Medicine">
        <j.1:name>Annals of Emergency Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:date>2020</dc:date>
    <myOnto:volume>75</myOnto:volume>
    <myOnto:issue>4</myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082090359&amp;doi=10.1016%2fj.annemergmed.2020.02.006&amp;partnerID=40&amp;md5=eb1164640c9dcbe219a660860823071c&gt;</schema:url>
    <dc:creator>Lu K.-L., Chen S., Leung L.-P.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079775225">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Novel coronavirus (SARS-CoV-2) is found to cause a large outbreak started from Wuhan since December 2019 in China and SARS-CoV-2 infections have been reported with epidemiological linkage to China in 25 countries until now. We isolated SARS-CoV-2 from the oropharyngeal sample obtained from the patient with the first laboratory-confirmed SARS-CoV-2 infection in Korea. Cytopathic effects of SARS-CoV-2 in the Vero cell cultures were confluent 3 days after the first blind passage of the sample. Coronavirus was confirmed with spherical particle having a fringe reminiscent of crown on transmission electron microscopy. Phylogenetic analyses of whole genome sequences showed that it clustered with other SARS-CoV-2 reported from Wuhan. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:identifier>10.3346/jkms.2020.35.e84</j.0:identifier>
    <j.0:identifier>2-s2.0-85079775225</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>35</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079775225&amp;doi=10.3346%2fjkms.2020.35.e84&amp;partnerID=40&amp;md5=7cd7c19abea81c4263a42615688f0780&gt;</schema:url>
    <dc:creator>Park W.B., Kwon N.-J., Choi S.-J., Kang C.K., Choe P.G., Kim J.Y., Yun J., Lee G.-W., Seong M.-W., Kim N.J., Seo J.-S., Oh M.-D.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Virus isolation from the first patient with SARS-CoV-2 in Korea</j.0:title>
    <myOnto:issue>7</myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; adult; Betacoronavirus; case report; Coronavirus infection; female; genetics; human; isolation and purification; oropharynx; phylogeny; South Korea; transmission electron microscopy; virology; virus pneumonia; whole genome sequencing; Adult; Betacoronavirus; Coronavirus Infections; Female; Humans; Microscopy, Electron, Transmission; Oropharynx; Phylogeny; Pneumonia, Viral; Republic of Korea; Whole Genome Sequencing</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079883412">
    <myOnto:issue>3</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Li J., Li J.J., Xie X., Cai X., Huang J., Tian X., Zhu H.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079883412&amp;doi=10.1016%2fS1473-3099%2820%2930063-3&amp;partnerID=40&amp;md5=bd1f8b0477908c055f411f7ec9f2bd39&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079883412</j.0:identifier>
    <j.0:title>Game consumption and the 2019 novel coronavirus</j.0:title>
    <j.0:identifier>10.1016/S1473-3099(20)30063-3</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <schema:keywords>aphrodisiac agent; 2019 novel coronavirus; brain; circulation; Coronavirinae; Coronavirus infection; disease severity; Ebola hemorrhagic fever; epidemic; fish; food intake; game animal; genotype; Haplorhini; human; internet access; kidney; law; liver disease; meat; microbial diversity; Middle East respiratory syndrome coronavirus; modern times; neurologic disease; Note; penis; Pholidota (animal); pneumonia; prehistoric period; priority journal; public health; respiratory tract disease; rheumatic disease; RNA virus; SARS coronavirus; sea food; severe acute respiratory syndrome; social marketing; therapy effect; tiger; wild animal; zoonosis</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>20</myOnto:volume>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081680616">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081680616&amp;doi=10.1016%2fj.tmaid.2020.101624&amp;partnerID=40&amp;md5=0768d708ebc4fd245a652a24518a7791&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <j.0:identifier>2-s2.0-85081680616</j.0:identifier>
    <dc:language>English</dc:language>
    <rdfs:comment>Background: An ongoing epidemic of respiratory diseases caused by a novel coronavirus (COVID 2019, SARS-CoV2) started in Wuhan, Hubei, in China at the end of December 2019. The French government decided to repatriate the 337 French nationals living in Wuhan and place them in quarantine in their home country. We decided to test them all for SARS-Cov2 twice in order to reduce anxiety among the population and decision-makers. Methods: We investigated the presence of SARS-CoV-19 in asymptomatic carriers by testing all repatriated patients within the first 24 h of their arrival in France and at day 5. Viral RNA was extracted from pooled nasal and oropharyngeal swab fluids or sputum in the absence of nasal/oropharyngeal swabs. Detection of SARS-CoV-2 RNA was then carried out using several real-time reverse transcription (RT)-PCR assays. Results: We tested 337 passengers at day 0 and day 5. All the tests for SARS-CoV2 were negative. By optimising the sampling process, sending samples sequentially and reducing the time-scale for biological analysis, we were able to test the samples within 5 h (including sampling, shipment and biological tests). Conclusion: Optimising our procedures reduces anxiety and reassures the population and decision makers. © 2020</rdfs:comment>
    <dc:creator>Lagier J.C., Colson P., Tissot Dupont H., Salomon J., Doudier B., Aubry C., Gouriet F., Baron S., Dudouet P., Flores R., Ailhaud L., Gautret P., Parola P., La Scola B., Raoult D., Brouqui P.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <j.0:title>Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/j.tmaid.2020.101624</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081963231">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Annals_of_Intensive_Care">
        <j.1:name>Annals of Intensive Care</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:volume>10</myOnto:volume>
    <myOnto:issue>1</myOnto:issue>
    <j.0:title>Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province</j.0:title>
    <dc:date>2020</dc:date>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Letter</j.0:type>
    <j.0:identifier>10.1186/s13613-020-00650-2</j.0:identifier>
    <j.0:identifier>2-s2.0-85081963231</j.0:identifier>
    <dc:creator>Sun Q., Qiu H., Huang M., Yang Y.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081963231&amp;doi=10.1186%2fs13613-020-00650-2&amp;partnerID=40&amp;md5=7d0e59441b9336b99d52de1e278bc2f4&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080917087">
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080917087&amp;doi=10.1002%2fddr.21656&amp;partnerID=40&amp;md5=36491c923e3824fa96fe35453c4a858b&gt;</schema:url>
    <rdfs:comment>At the time of writing this commentary (February 2020), the coronavirus COVID-19 epidemic has already resulted in more fatalities compared with the SARS and MERS coronavirus epidemics combined. Therapeutics that may assist to contain its rapid spread and reduce its high mortality rates are urgently needed. Developing vaccines against the SARS-CoV-2 virus may take many months. Moreover, vaccines based on viral-encoded peptides may not be effective against future coronavirus epidemics, as virus mutations could make them futile. Indeed, new Influenza virus strains emerge every year, requiring new immunizations. A tentative suggestion based on existing therapeutics, which would likely be resistant to new coronavirus mutations, is to use available angiotensin receptor 1 (AT1R) blockers, such as losartan, as therapeutics for reducing the aggressiveness and mortality from SARS-CoV-2 virus infections. This idea is based on observations that the angiotensin-converting enzyme 2 (ACE2) very likely serves as the binding site for SARS-CoV-2, the strain implicated in the current COVID-19 epidemic, similarly to strain SARS-CoV implicated in the 2002–2003 SARS epidemic. This commentary elaborates on the idea of considering AT1R blockers as tentative treatment for SARS-CoV-2 infections, and proposes a research direction based on datamining of clinical patient records for assessing its feasibility. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <dc:creator>Gurwitz D.</dc:creator>
    <j.0:title>Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1002/ddr.21656</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Drug_Development_Research">
        <j.1:name>Drug Development Research</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Note</j.0:type>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85080917087</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:publisher>Wiley-Liss Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082147065">
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/European_review_for_medical_and_pharmacological_sciences"/>
    <schema:keywords></schema:keywords>
    <dc:creator>Buonsenso D., Piano A., Raffaelli F., Bonadia N., de Gaetano Donati K., Franceschi F.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082147065&amp;doi=10.26355%2feurrev_202003_20549&amp;partnerID=40&amp;md5=194037aba22cf55f90250dd222218316&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082147065</j.0:identifier>
    <myOnto:volume>24</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:identifier>10.26355/eurrev_202003_20549</j.0:identifier>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:title>Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak</j.0:title>
    <rdfs:comment>An outbreak of a novel coronavirus disease-19 (nCoV-19) infection began in December 2019 in Wuhan, China, and now involved the whole word. Several health workers have been infected in different countries. We report the case of a young man with documented nCoV-19 infection evaluated with lung ultrasound and discuss potential applications of lung ultrasound in this setting. Lung ultrasound allowed the identification of nCoV-19 infection at bed-side. Moreover, lung ultrasound can have several other advantages, such as reduced health worker exposition to infected patients, repeatability during follow-up, low-costs and easier application in low-resource settings.</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081911507">
    <j.0:identifier>2-s2.0-85081911507</j.0:identifier>
    <myOnto:volume>9</myOnto:volume>
    <j.0:type>Review</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081911507&amp;doi=10.1080%2f22221751.2020.1736644&amp;partnerID=40&amp;md5=1917008e6844d6744e2ac96cbeb70859&gt;</schema:url>
    <dc:language>English</dc:language>
    <myOnto:issue>1</myOnto:issue>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <rdfs:comment>World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1080/22221751.2020.1736644</j.0:identifier>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; animal; Betacoronavirus; Coronavirus infection; disease carrier; host pathogen interaction; human; isolation and purification; physiology; virology; virus pneumonia; Animals; Betacoronavirus; Coronavirus Infections; Disease Vectors; Host-Pathogen Interactions; Humans; Pneumonia, Viral</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Fung S.-Y., Yuen K.-S., Ye Z.-W., Chan C.-P., Jin D.-Y.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:title>A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081140313">
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:identifier>10.1001/jama.2020.2565</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>15</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <dc:creator>Bai Y., Yao L., Wei T., Tian F., Jin D.-Y., Chen L., Wang M.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume></myOnto:volume>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081140313</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081140313&amp;doi=10.1001%2fjama.2020.2565&amp;partnerID=40&amp;md5=5918991d5523f089e390a6ea1590b7a4&gt;</schema:url>
    <j.0:title>Presumed Asymptomatic Carrier Transmission of COVID-19</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079835555">
    <schema:keywords>2019 novel coronavirus; China; Chinese (language); clinical feature; clinical research; Coronavirinae; coronavirus disease 2019; Coronavirus infection; disease control; English (language); epidemic; health care personnel; human; Letter; nonhuman; priority journal; public health; publication; SARS coronavirus; scientific literature; Coronavirus infection; medical research; virus pneumonia; COVID-19; Biomedical Research; China; Coronavirus Infections; Humans; Periodicals as Topic; Pneumonia, Viral; Publications</schema:keywords>
    <dc:creator>Xiang Y.-T., Li W., Zhang Q., Jin Y., Rao W.-W., Zeng L.-N., Lok G.K.I., Chow I.H.I., Cheung T., Hall B.J.</dc:creator>
    <myOnto:volume>395</myOnto:volume>
    <j.0:title>Timely research papers about COVID-19 in China</j.0:title>
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079835555&amp;doi=10.1016%2fS0140-6736%2820%2930375-5&amp;partnerID=40&amp;md5=ae1aa5312f18c7590ee9bb3e45fd5b5f&gt;</schema:url>
    <j.0:identifier>10.1016/S0140-6736(20)30375-5</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:issue>10225</myOnto:issue>
    <j.0:identifier>2-s2.0-85079835555</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082079576">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Zhou P., Huang Z., Xiao Y., Huang X., Fan X.-G.</dc:creator>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082079576&amp;doi=10.1017%2fice.2020.60&amp;partnerID=40&amp;md5=1dda966f60feac7a08e5a66d6f5a22c3&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>Cambridge University Press</j.0:publisher>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection_Control_and_Hospital_Epidemiology"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <j.0:type>Letter</j.0:type>
    <j.0:title>Protecting Chinese Healthcare Workers while Combating the 2019 Novel Coronavirus</j.0:title>
    <j.0:identifier>10.1017/ice.2020.60</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85082079576</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081322505">
    <j.0:identifier>10.1002/jmv.25731</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2</j.0:title>
    <j.0:identifier>2-s2.0-85081322505</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081322505&amp;doi=10.1002%2fjmv.25731&amp;partnerID=40&amp;md5=bf6d6d047205b0528168a818ed0873d8&gt;</schema:url>
    <rdfs:comment>To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS-CoV-2 virus, we reanalyzed virome data sets from pangolins and representative SARS-related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood-mapping, and comparative analyses of the genomes. Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS-CoV-2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 × 10?3 substitutions per site per year, respectively. Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS-CoV-2 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378). We also identified a unique peptide (PRRA) insertion in the human SARS-CoV-2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility. Interestingly, the coronavirus carried by pangolins did not have the RRAR motif. Therefore, we concluded that the human SARS-CoV-2 virus, which is responsible for the recent outbreak of COVID-19, did not come directly from pangolins. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Li X., Zai J., Zhao Q., Nie Q., Li Y., Foley B.T., Chaillon A.</dc:creator>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>2</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079524058">
    <schema:keywords>2019 novel coronavirus; Article; bootstrapping; calibration; China; coronavirus disease 2019; epidemic; forecasting; human; least square analysis; mathematical model; phenomenology; prediction</schema:keywords>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85079524058</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>KeAi Communications Co.</j.0:publisher>
    <j.0:title>Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Roosa K., Lee Y., Luo R., Kirpich A., Rothenberg R., Hyman J.M., Yan P., Chowell G.</dc:creator>
    <rdfs:comment>The initial cluster of severe pneumonia cases that triggered the COVID-19 epidemic was identified in Wuhan, China in December 2019. While early cases of the disease were linked to a wet market, human-to-human transmission has driven the rapid spread of the virus throughout China. The Chinese government has implemented containment strategies of city-wide lockdowns, screening at airports and train stations, and isolation of suspected patients; however, the cumulative case count keeps growing every day. The ongoing outbreak presents a challenge for modelers, as limited data are available on the early growth trajectory, and the epidemiological characteristics of the novel coronavirus are yet to be fully elucidated. We use phenomenological models that have been validated during previous outbreaks to generate and assess short-term forecasts of the cumulative number of confirmed reported cases in Hubei province, the epicenter of the epidemic, and for the overall trajectory in China, excluding the province of Hubei. We collect daily reported cumulative confirmed cases for the 2019-nCoV outbreak for each Chinese province from the National Health Commission of China. Here, we provide 5, 10, and 15 day forecasts for five consecutive days, February 5th through February 9th, with quantified uncertainty based on a generalized logistic growth model, the Richards growth model, and a sub-epidemic wave model. Our most recent forecasts reported here, based on data up until February 9, 2020, largely agree across the three models presented and suggest an average range of 7409–7496 additional confirmed cases in Hubei and 1128–1929 additional cases in other provinces within the next five days. Models also predict an average total cumulative case count between 37,415 and 38,028 in Hubei and 11,588–13,499 in other provinces by February 24, 2020. Mean estimates and uncertainty bounds for both Hubei and other provinces have remained relatively stable in the last three reporting dates (February 7th – 9th). We also observe that each of the models predicts that the epidemic has reached saturation in both Hubei and other provinces. Our findings suggest that the containment strategies implemented in China are successfully reducing transmission and that the epidemic growth has slowed in recent days. © 2020 The Authors</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:language>English</dc:language>
    <myOnto:volume>5</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infectious_Disease_Modelling"/>
    <j.0:identifier>10.1016/j.idm.2020.02.002</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079524058&amp;doi=10.1016%2fj.idm.2020.02.002&amp;partnerID=40&amp;md5=d091f8a6710f260ff73357ce18fcc97e&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080944832">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080944832&amp;doi=10.1016%2fj.ajp.2020.101989&amp;partnerID=40&amp;md5=61f2e844c403e8ae9128a710798cdc83&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85080944832</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <schema:keywords>coronavirus disease 2019; Coronavirus infection; developing country; fear; hanging; human; India; infection sensitivity; internet access; Letter; priority journal; public health; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; social media; social network; suicidal behavior; virus strain</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Asian_Journal_of_Psychiatry"/>
    <myOnto:volume>49</myOnto:volume>
    <j.0:identifier>10.1016/j.ajp.2020.101989</j.0:identifier>
    <dc:creator>Goyal K., Chauhan P., Chhikara K., Gupta P., Singh M.P.</dc:creator>
    <j.0:title>Fear of COVID 2019: First suicidal case in India !</j.0:title>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079885874">
    <j.0:identifier>10.1016/S0140-6736(20)30421-9</j.0:identifier>
    <dc:creator>Chen S., Yang J., Yang W., Wang C., Bärnighausen T.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Note</j.0:type>
    <schema:keywords>asymptomatic infection; China; coronavirus disease 2019; epidemic; hand washing; human; infection control; infection prevention; medical care; migration; morbidity; mortality; nonhuman; Note; priority journal; quarantine; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; social control; social distance; social isolation; social marketing; commercial phenomena; Coronavirus infection; epidemic; government regulation; leisure; management; public health; public policy; social status; travel; virus pneumonia; COVID-19; China; Commerce; Coronavirus Infections; Disease Outbreaks; Government Regulation; Holidays; Humans; Pneumonia, Viral; Policy Making; Public Health; Public Policy; Social Conditions; Travel</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:title>COVID-19 control in China during mass population movements at New Year</j.0:title>
    <j.0:identifier>2-s2.0-85079885874</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079885874&amp;doi=10.1016%2fS0140-6736%2820%2930421-9&amp;partnerID=40&amp;md5=56e7dda3cb18fa4041794af007092f00&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>10226</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <myOnto:volume>395</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078840425">
    <dc:creator>Horton R.</dc:creator>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue>10222</myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078840425&amp;doi=10.1016%2fS0140-6736%2820%2930299-3&amp;partnerID=40&amp;md5=cfc587bf60ebdb525d150cb6edcc8c56&gt;</schema:url>
    <j.0:title>Offline: 2019-nCoV—“A desperate plea”</j.0:title>
    <j.0:identifier>2-s2.0-85078840425</j.0:identifier>
    <j.0:identifier>10.1016/S0140-6736(20)30299-3</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; anxiety; China; Coronavirinae; Coronavirus infection; epidemic; health care policy; human; Note; priority journal; quarantine; stress; viral respiratory tract infection; wellbeing</schema:keywords>
    <myOnto:volume>395</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082134682">
    <dc:date>2020</dc:date>
    <dc:creator>Yuen K.-S., Ye Z.-W., Fung S.-Y., Chan C.-P., Jin D.-Y.</dc:creator>
    <j.0:identifier>10.1186/s13578-020-00404-4</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>10</myOnto:volume>
    <j.0:identifier>2-s2.0-85082134682</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>SARS-CoV-2 and COVID-19: The most important research questions</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Cell_and_Bioscience">
        <j.1:name>Cell and Bioscience</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082134682&amp;doi=10.1186%2fs13578-020-00404-4&amp;partnerID=40&amp;md5=5c27204dfa02b81ee3c909866b8d98ce&gt;</schema:url>
    <schema:keywords></schema:keywords>
    <myOnto:issue>1</myOnto:issue>
    <rdfs:comment>Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. Here we highlight nine most important research questions concerning virus transmission, asymptomatic and presymptomatic virus shedding, diagnosis, treatment, vaccine development, origin of virus and viral pathogenesis. © 2020 The Author(s).</rdfs:comment>
    <j.0:publisher>BioMed Central Ltd.</j.0:publisher>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082069144">
    <myOnto:issue>3</myOnto:issue>
    <schema:keywords>COVID-19; China; colorectal tumor; complication; Coronavirus infection; epidemic; human; virus pneumonia; China; Colorectal Neoplasms; Coronavirus Infections; Disease Outbreaks; Humans; Pneumonia, Viral</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Zhonghua_wei_chang_wai_ke_za_zhi_=_Chinese_journal_of_gastrointestinal_surgery"/>
    <j.0:identifier>10.3760/cma.j.cn.441530-20200217-00057</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>Chinese</dc:language>
    <myOnto:volume>23</myOnto:volume>
    <j.0:identifier>2-s2.0-85082069144</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Standardized diagnosis and treatment of colorectal cancer during the outbreak of corona virus disease 2019 in Renji hospital</j.0:title>
    <rdfs:comment>??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????1????????(MDT)????????????????MDT?????????????????????????2????????????????????????????????????????????????????????????????????????????????????????????????????????3?????????????????????????????????????????????-5 Pa????????????????????????????????????????????????????4??????????????????????????????????????????"????"14 d????????????.Corona virus disease 2019 (COVID-19) is currently raging in China. It has been proven that COVID-19 can be transmitted from human to human and cause hospital infection, which seriously threatens surgical staffs and inpatients. Although colorectal surgery is not a front-line subject in the fight against the epidemic, but in this special situation, it is a difficult task to provide the highest quality medical services and ensure the orderly clinical work, on the premise of maximizing the protection for patients and their families, health of medical staff, and the safety of wards and hospitals, We summarize how to carry out the clinical practice of colorectal surgery under the situation of the prevention and control of the COVID-19 epidemiology, including the procedures of diagnose and treatment for emergency patients with colorectal tumor, and share the experiences of the diagnosis of colorectal tumor, the management of patients with colorectal cancer who are scheduled to be admitted for surgery, the protection of wards, the perioperative management. More importantly, we introduce in detail the operative management and perioperative management of colorectal surgery patients suspected or diagnosed with new coronary pneumonia, including prevention and control measures for medical staff, operating rooms and surgical instruments. The main points are as follows: (1) Multidisciplinary team (MDT) must be run through the diagnosis and treatment of colorectal cancer. The members include not only routine departments, but also respiratory department and infectious department. (2) Colonoscopy examination may cause cross infection of COVID-19 to patients and doctors. Therefore, it is prior to examine the emergency cases and life-threatening patients (bleeding, obstruction, gastrointestinal foreign bodies, etc.). If the emergent patients (intestinal obstruction) with suspected or confirmed COVID-19, the surgeons must perform emergency surgery, and intestinal decompressive tube through colonoscopy is not recommended. (3) The colorectal cancer patients with suspected or confirmed COVID-19 should be placed in the isolated room with separate medical devices, and the operative room with negative pressure (under -5 Pa) must be separated. All disposable medical items, body fluids and feces of the patients in perioperative periods must be unified disposed according to the medical waste standard. (4) The surgical medical workers who process colorectal cancer patients with COVID-19 must be protected by three-level. After operation, the medical workers must receive medical observation and be isolated for 14 days. We hope our "Renji experience" will be beneficial to colleagues.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <dc:creator>Luo Y., Zhong M.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082069144&amp;doi=10.3760%2fcma.j.cn.441530-20200217-00057&amp;partnerID=40&amp;md5=3d8e0f2515484072433e75d5dee9b5a9&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080998230">
    <j.0:identifier>10.1016/j.lfs.2020.117477</j.0:identifier>
    <j.0:publisher>Elsevier Inc.</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>248</myOnto:volume>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Aims: A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today &gt;2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for &gt;8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp). Materials and methods: In this study, sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin. Key findings: The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease. Significance: The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs. Besides, the study presents some drugs that previously proved its efficiency against the newly emerged viral infection. © 2020 Elsevier Inc.</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Life_Sciences">
        <j.1:name>Life Sciences</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:language>English</dc:language>
    <j.0:title>Anti-HCV, nucleotide inhibitors, repurposing against COVID-19</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080998230&amp;doi=10.1016%2fj.lfs.2020.117477&amp;partnerID=40&amp;md5=05ce39491b2be7c5eaf0502aa2add368&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <schema:keywords>antivirus agent; guanosine triphosphate; hepatitis C antibody; idx 184; remidisvir; ribavirin; RNA directed RNA polymerase; sofosbuvir; unclassified drug; Article; binding affinity; China; computer model; controlled study; coronavirus disease 2019; coronavirus disease 2019; Coronavirus infection; drug efficacy; drug repositioning; drug structure; enzyme active site; human; Middle East respiratory syndrome coronavirus; molecular docking; nonhuman; SARS coronavirus; sequence alignment; sequence analysis; structural bioinformatics; virus transmission</schema:keywords>
    <dc:creator>Elfiky A.A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080998230</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082177573">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Surveillance_and_Society">
        <j.1:name>Surveillance and Society</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <dc:creator>French M., Monahan T.</dc:creator>
    <j.0:type>Article</j.0:type>
    <rdfs:comment>We are currently in the midst of a global pandemic with the spread of Coronavirus Disease 2019 (COVID-19). While we do not know how this situation will unfold or resolve, we do have insight into how it fits within existing patterns and relations, particularly those pertaining to sociocultural constructions of (in)security, vulnerability, and risk. We can see evidence of surveillance dynamics at play with how bodies and pathogens are being measured, tracked, predicted, and regulated. We can grasp how threat is being racialized, how and why institutions are flailing, and how social media might be fueling social divisions. There is, in other words, a lot that our scholarly community could add to the conversation. In this rapid-response editorial, we provide an introduction to the framing devices of disease surveillance and discuss how a surveillance studies orientation could help us think critically about the present crisis and its possible aftermath. © The author(s), 2020.</rdfs:comment>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.24908/ss.v18i1.13985</j.0:identifier>
    <myOnto:volume>18</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Surveillance Studies Network</j.0:publisher>
    <j.0:title>Disease surveillance: how might surveillance studies address covid-19?</j.0:title>
    <dc:date>2020</dc:date>
    <myOnto:issue>1</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082177573&amp;doi=10.24908%2fss.v18i1.13985&amp;partnerID=40&amp;md5=fe66b6374d2d42ad88d03a9214aa1890&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082177573</j.0:identifier>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079121719">
    <j.0:identifier>2-s2.0-85079121719</j.0:identifier>
    <myOnto:issue></myOnto:issue>
    <j.0:title>SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis</j.0:title>
    <j.0:publisher>Elsevier USA</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>2019 novel coronavirus; bibliographic database; bibliometrics; Coronavirinae; epidemic; Letter; medical research; Middle East respiratory syndrome coronavirus; nonhuman; priority journal; public health; SARS coronavirus; World Health Organization</schema:keywords>
    <j.0:type>Letter</j.0:type>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Travel_Medicine_and_Infectious_Disease"/>
    <dc:creator>Bonilla-Aldana D.K., Quintero-Rada K., Montoya-Posada J.P., Ramírez-Ocampo S., Paniz-Mondolfi A., Rabaan A.A., Sah R., Rodríguez-Morales A.J.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079121719&amp;doi=10.1016%2fj.tmaid.2020.101566&amp;partnerID=40&amp;md5=2ca16f718bf74b337d230c02f3333d4d&gt;</schema:url>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.tmaid.2020.101566</j.0:identifier>
    <myOnto:volume>33</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082169162">
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>93</myOnto:volume>
    <schema:keywords>article; case report; clinical article; convalescence; human; nonhuman; SARS coronavirus</schema:keywords>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <dc:language>English</dc:language>
    <rdfs:comment>The ongoing outbreak of COVID-19 that began in Wuhan, China, has constituted a Public Health Emergency of International Concern, with cases confirmed in multiple countries. Currently, patients are the primary source of infection. We report a confirmed case of COVID-19 whose oropharyngeal swab test of SARS-CoV-2 RNA turned positive in convalescence. This case highlights the importance of active surveillance of SARS-CoV-2 RNA for infectivity assessment. © 2020 The Author(s)</rdfs:comment>
    <dc:creator>Chen D., Xu W., Lei Z., Huang Z., Liu J., Gao Z., Peng L.</dc:creator>
    <j.0:identifier>10.1016/j.ijid.2020.03.003</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082169162&amp;doi=10.1016%2fj.ijid.2020.03.003&amp;partnerID=40&amp;md5=bcc2fa5d83770331c761d17d1c71f768&gt;</schema:url>
    <j.0:title>Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Infectious_Diseases"/>
    <dc:date>2020</dc:date>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85082169162</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079767277">
    <j.0:identifier>10.1038/s41564-020-0688-y</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079767277&amp;doi=10.1038%2fs41564-020-0688-y&amp;partnerID=40&amp;md5=02b475d9ec4e8dc67a12e3cea35a056e&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079767277</j.0:identifier>
    <j.0:publisher>Nature Research</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <myOnto:citeyBy>3</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature_Microbiology"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Letko M., Marzi A., Munster V.</dc:creator>
    <dc:language>English</dc:language>
    <schema:keywords></schema:keywords>
    <rdfs:comment>Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2. © 2020, The Author(s), under exclusive licence to Springer Nature Limited.</rdfs:comment>
    <j.0:title>Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082181294">
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082181294</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082181294&amp;doi=10.1016%2fS1473-3099%2820%2930180-8&amp;partnerID=40&amp;md5=7bb3f7a255b6325d6d3058133d3f21bd&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:title>COVID-19, a pandemic or not?</j.0:title>
    <j.0:identifier>10.1016/S1473-3099(20)30180-8</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>The Lancet Infectious Diseases</dc:creator>
    <j.0:type>Editorial</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:volume>20</myOnto:volume>
    <myOnto:issue>4</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079904159">
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Medicina_Clinica">
        <j.1:name>Medicina Clinica</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Ediciones Doyma, S.L.</j.0:publisher>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079904159&amp;doi=10.1016%2fj.medcli.2020.02.002&amp;partnerID=40&amp;md5=e6c850b66da09353434ab0151a9a0da6&gt;</schema:url>
    <j.0:identifier>10.1016/j.medcli.2020.02.002</j.0:identifier>
    <j.0:title>One world, one health: The novel coronavirus COVID-19 epidemic [Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19]</j.0:title>
    <j.0:identifier>2-s2.0-85079904159</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords>2019 novel coronavirus; Article; Coronavirinae; coronavirus disease 2019; Coronavirus infection; epidemic; global health; human; nonhuman; Betacoronavirus; China; civil defense; Coronavirus infection; genetics; international cooperation; pathogenicity; public health; virus pneumonia; COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Civil Defense; Coronavirus Infections; Global Health; Humans; Internationality; Pneumonia, Viral; Public Health</schema:keywords>
    <dc:creator>Trilla A.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:language>English; Spanish</dc:language>
    <myOnto:issue>5</myOnto:issue>
    <myOnto:volume>154</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081620476">
    <myOnto:issue>2</myOnto:issue>
    <dc:language>English</dc:language>
    <myOnto:volume>27</myOnto:volume>
    <j.0:type>Review</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_travel_medicine"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1093/jtm/taaa021</j.0:identifier>
    <dc:creator>Liu Y., Gayle A.A., Wilder-Smith A., Rocklöv J.</dc:creator>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; Coronavirus infection; disease transmission; growth, development and aging; human; incubation time; international cooperation; pathogenicity; physiology; SARS coronavirus; travel; virology; virus load; virus pneumonia; virus replication; Betacoronavirus; Coronavirus Infections; Disease Transmission, Infectious; Humans; Infectious Disease Incubation Period; Internationality; Pneumonia, Viral; SARS Virus; Travel; Viral Load; Virus Replication</schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081620476&amp;doi=10.1093%2fjtm%2ftaaa021&amp;partnerID=40&amp;md5=86d5c78105eada22ecb916af275b34db&gt;</schema:url>
    <j.0:identifier>2-s2.0-85081620476</j.0:identifier>
    <j.0:title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</j.0:title>
    <myOnto:citeyBy>3</myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081075101">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue></myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081075101&amp;doi=10.1136%2fbmj.m793&amp;partnerID=40&amp;md5=2326eee0a995354c4f5f68c95bdd73bd&gt;</schema:url>
    <j.0:type>Article</j.0:type>
    <myOnto:volume>368</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:title>Covid-19: Trump says risk to Americans is "very low"</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081075101</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1136/bmj.m793</j.0:identifier>
    <dc:creator>Tanne J.H.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082145854">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082145854&amp;doi=10.1136%2fbmj.m1152&amp;partnerID=40&amp;md5=500f967305c34297df007ca1eb04b7db&gt;</schema:url>
    <j.0:title>Covid-19: 15?000 deregistered doctors are told, "Your NHS needs you"</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Dyer C.</dc:creator>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:identifier>2-s2.0-85082145854</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:volume>368</myOnto:volume>
    <schema:keywords></schema:keywords>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1136/bmj.m1152</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081657223">
    <dc:creator>Yang R., Gui X., Xiong Y.</dc:creator>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <myOnto:volume>165</myOnto:volume>
    <schema:keywords>adult; aged; Article; Coronavirinae; Coronavirus infection; coughing; disease duration; epidemic; female; hand washing; human; major clinical study; male; nasopharynx; patient risk; patient safety; priority journal; quarantine; respiratory tract disease; saliva; virus shedding; virus transmission</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Patients with respiratory symptoms are at greater risk of COVID-19 transmission</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Respiratory_Medicine">
        <j.1:name>Respiratory Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081657223&amp;doi=10.1016%2fj.rmed.2020.105935&amp;partnerID=40&amp;md5=7f7288e298d3df4c5e09f349d4ed1083&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1016/j.rmed.2020.105935</j.0:identifier>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>2-s2.0-85081657223</j.0:identifier>
    <myOnto:issue></myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080092738">
    <j.0:identifier>2-s2.0-85080092738</j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
    <dc:creator>Chen W., Lan Y., Yuan X., Deng X., Li Y., Cai X., Li L., He R., Tan Y., Deng X., Gao M., Tang G., Zhao L., Wang J., Fan Q., Wen C., Tong Y., Tang Y., Hu F., Li F., Tang X.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Emerging_Microbes_and_Infections"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080092738&amp;doi=10.1080%2f22221751.2020.1732837&amp;partnerID=40&amp;md5=141954f22314b2d7d77f049ed1e15651&gt;</schema:url>
    <rdfs:comment>The novel coronavirus (2019-nCoV) infection caused pneumonia. we retrospectively analyzed the virus presence in the pharyngeal swab, blood, and the anal swab detected by real-time PCR in the clinical lab. Unexpectedly, the 2109-nCoV RNA was readily detected in the blood (6 of 57 patients) and the anal swabs (11 of 28 patients). Importantly, all of the 6 patients with detectable viral RNA in the blood cohort progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity (p-value = 0.0001). Meanwhile, 8 of the 11 patients with annal swab virus-positive was in severe clinical stage. However, the concentration of viral RNA in the anal swab (Ct value = 24 + 39) was higher than in the blood (Ct value = 34 + 39) from patient 2, suggesting that the virus might replicate in the digestive tract. Altogether, our results confirmed the presence of virus RNA in extra-pulmonary sites. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd.</rdfs:comment>
    <myOnto:volume>9</myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1080/22221751.2020.1732837</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:publisher>Taylor and Francis Ltd.</j.0:publisher>
    <schema:keywords>angiotensin converting enzyme 2; virus RNA; virus spike protein; COVID-19; severe acute respiratory syndrome coronavirus 2; virus RNA; 2019 novel coronavirus infection; blood sampling; clinical article; clinical laboratory; cohort analysis; consultation; Coronavirus infection; coughing; disease exacerbation; disease severity; endothelium cell; fever; hospital admission; human; intensive care unit; Letter; lung alveolus; lung lavage; lung lobe; medical care; medical history; patient information; pneumonia; practice guideline; priority journal; real time polymerase chain reaction; respiratory system; retrospective study; throat culture; virus detection; virus isolation; virus load; virus replication; virus transmission; Betacoronavirus; blood; Coronavirus infection; genetics; isolation and purification; severity of illness index; virology; virus pneumonia; Betacoronavirus; Coronavirus Infections; Humans; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; Retrospective Studies; RNA, Viral; Severity of Illness Index</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082172766">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <j.0:identifier>2-s2.0-85082172766</j.0:identifier>
    <schema:keywords>erratum</schema:keywords>
    <dc:creator>[No author name available]</dc:creator>
    <rdfs:comment>Peckham R. COVID-19 and the anti-lessons of history. Lancet 2020; 395: 850–52—In this Comment, the dates in references 13 and 14 have been corrected. These corrections have been made to the online version as of March 16, 2020. © 2020 Elsevier Ltd</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:volume>395</myOnto:volume>
    <j.0:identifier>10.1016/S0140-6736(20)30629-2</j.0:identifier>
    <j.0:type>Erratum</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082172766&amp;doi=10.1016%2fS0140-6736%2820%2930629-2&amp;partnerID=40&amp;md5=d8b725e9152a4d7cab309385bd628ac5&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10229</myOnto:issue>
    <j.0:title>Erratum: Department of Error (The Lancet (2020) 395(10227) (850–852), (S0140673620304682), (10.1016/S0140-6736(20)30468-2))</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079131599">
    <j.0:publisher>Elsevier Masson SAS</j.0:publisher>
    <rdfs:comment>On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO). As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries. Therefore, combating this new virus and stopping the epidemic is a matter of urgency. Here, we focus on advances in research and development of fast diagnosis methods, as well as potential prophylactics and therapeutics to prevent or treat 2019-nCoV infection. © 2020 Institut Pasteur</rdfs:comment>
    <myOnto:issue>2</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Microbes_and_Infection"/>
    <j.0:type>Article</j.0:type>
    <j.0:title>Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079131599&amp;doi=10.1016%2fj.micinf.2020.01.003&amp;partnerID=40&amp;md5=4752634686dd0d8363a297bcf81cadcc&gt;</schema:url>
    <j.0:identifier>10.1016/j.micinf.2020.01.003</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Yu F., Du L., Ojcius D.M., Pan C., Jiang S.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:volume>22</myOnto:volume>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>antivirus agent; neutralizing antibody; virus fusion inhibitor; virus vaccine; antivirus agent; coronavirus spike glycoprotein; COVID-19; severe acute respiratory syndrome coronavirus 2; virus antibody; virus RNA; virus vaccine; 2019 novel coronavirus; antibody detection; Article; China; Coronavirus infection; epidemic; human; nonhuman; pneumonia; priority journal; prophylaxis; virus replication; World Health Organization; amino acid sequence; Betacoronavirus; Coronavirus infection; epidemiology; immunology; isolation and purification; nucleic acid amplification; pathogenicity; sequence alignment; virus pneumonia; Amino Acid Sequence; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; Humans; Nucleic Acid Amplification Techniques; Pneumonia, Viral; RNA, Viral; Sequence Alignment; Spike Glycoprotein, Coronavirus; Viral Vaccines</schema:keywords>
    <j.0:identifier>2-s2.0-85079131599</j.0:identifier>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079239232">
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:issue></myOnto:issue>
    <dc:creator>Zhang Z., Li X., Zhang W., Shi Z.-L., Zheng Z., Wang T.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:publisher>Science Press</j.0:publisher>
    <j.0:identifier>10.1007/s12250-020-00203-8</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Virologica_Sinica"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:title>Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases</j.0:title>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079239232&amp;doi=10.1007%2fs12250-020-00203-8&amp;partnerID=40&amp;md5=853bc7249b21e02108eaae75303543ce&gt;</schema:url>
    <j.0:identifier>2-s2.0-85079239232</j.0:identifier>
    <j.0:type>Letter</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081266700">
    <j.0:identifier>10.1001/jama.2020.2648</j.0:identifier>
    <myOnto:volume></myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <myOnto:issue></myOnto:issue>
    <j.0:publisher>American Medical Association</j.0:publisher>
    <j.0:identifier>2-s2.0-85081266700</j.0:identifier>
    <dc:creator>Wu Z., McGoogan J.M.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081266700&amp;doi=10.1001%2fjama.2020.2648&amp;partnerID=40&amp;md5=ab1d59d985f80ac12065a2099d21891e&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:citeyBy>28</myOnto:citeyBy>
    <j.0:title>Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention</j.0:title>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords></schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080072709">
    <myOnto:volume>18</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Integrative_Medicine"/>
    <j.0:identifier>10.1016/j.joim.2020.02.005</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus</j.0:title>
    <myOnto:issue>2</myOnto:issue>
    <j.0:identifier>2-s2.0-85080072709</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080072709&amp;doi=10.1016%2fj.joim.2020.02.005&amp;partnerID=40&amp;md5=5ea97c15c149f96862fed073a11969b5&gt;</schema:url>
    <dc:language>English</dc:language>
    <schema:keywords>herbaceous agent; 2019 novel coronavirus; antiviral activity; Article; Chinese medicine; computer model; Coronavirinae; Coronavirus infection; drug absorption; drug distribution; drug excretion; drug mechanism; drug metabolism; drug screening; drug targeting; human; hypoxia; in vivo study; inflammation; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; molecular docking; nonhuman; priority journal; SARS coronavirus; severe acute respiratory syndrome</schema:keywords>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>Objective: In this study we execute a rational screen to identify Chinese medical herbs that are commonly used in treating viral respiratory infections and also contain compounds that might directly inhibit 2019 novel coronavirus (2019-nCoV), an ongoing novel coronavirus that causes pneumonia. Methods: There were two main steps in the screening process. In the first step we conducted a literature search for natural compounds that had been biologically confirmed as against sever acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus. Resulting compounds were cross-checked for listing in the Traditional Chinese Medicine Systems Pharmacology Database. Compounds meeting both requirements were subjected to absorption, distribution, metabolism and excretion (ADME) evaluation to verify that oral administration would be effective. Next, a docking analysis was used to test whether the compound had the potential for direct 2019-nCoV protein interaction. In the second step we searched Chinese herbal databases to identify plants containing the selected compounds. Plants containing 2 or more of the compounds identified in our screen were then checked against the catalogue for classic herbal usage. Finally, network pharmacology analysis was used to predict the general in vivo effects of each selected herb. Results: Of the natural compounds screened, 13 that exist in traditional Chinese medicines were also found to have potential anti-2019-nCoV activity. Further, 125 Chinese herbs were found to contain 2 or more of these 13 compounds. Of these 125 herbs, 26 are classically catalogued as treating viral respiratory infections. Network pharmacology analysis predicted that the general in vivo roles of these 26 herbal plants were related to regulating viral infection, immune/inflammation reactions and hypoxia response. Conclusion: Chinese herbal treatments classically used for treating viral respiratory infection might contain direct anti-2019-nCoV compounds. © 2020 Shanghai Changhai Hospital</rdfs:comment>
    <j.0:publisher>Elsevier (Singapore) Pte Ltd</j.0:publisher>
    <dc:creator>Zhang D.-H., Wu K.-L., Zhang X., Deng S.-Q., Peng B.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079722627">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1007/s12250-020-00206-5</j.0:identifier>
    <j.0:publisher>Science Press</j.0:publisher>
    <schema:keywords></schema:keywords>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079722627&amp;doi=10.1007%2fs12250-020-00206-5&amp;partnerID=40&amp;md5=74dce354264dc9e9cfdda8fd5276f33b&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>Based on the announcement of the World Health Organization (WHO) in 2018, the Wuhan pneumonia caused by an unknown etiology should be recognized as the first Disease X. Later, the pathogen was identified to be a novel coronavirus denoted 2019-nCoV, which has 79.5% and 96% whole genome sequence identify to SARS-CoV and bat SARS-related coronavirus (SARSr-CoV-RaTG13), respectively, suggesting its potential bat origin. With high human-to-human transmission rate (R0), 2019-nCoV has quickly spread in China and other countries, resulting in 34,953 confirmed cases and 725 deaths as of 8 February 2020, thus calling for urgent development of therapeutics and prophylactics. Here we suggest renaming 2019-nCoV as “transmissible acute respiratory syndrome coronavirus (TARS-CoV)” and briefly review the advancement of research and development of neutralizing antibodies and vaccines targeting the receptor-binding domain (RBD) and viral fusion inhibitors targeting the heptad repeat 1 (HR1) domain in spike protein of 2019-nCoV. © 2020, Wuhan Institute of Virology, CAS.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079722627</j.0:identifier>
    <dc:language>English</dc:language>
    <j.0:title>The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus</j.0:title>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Virologica_Sinica"/>
    <j.0:type>Review</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Jiang S., Shi Z.-L.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082132395">
    <myOnto:volume>21</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082132395&amp;doi=10.3348%2fkjr.2020.0112&amp;partnerID=40&amp;md5=95dfa6f936d4cc0b2af6d55020d21aa1&gt;</schema:url>
    <rdfs:comment>From December 2019, Coronavirus disease 2019 (COVID-19) pneumonia (formerly known as the 2019 novel Coronavirus [2019-nCoV]) broke out in Wuhan, China. In this study, we present serial CT findings in a 40-year-old female patient with COVID-19 pneumonia who presented with the symptoms of fever, chest tightness, and fatigue. She was diagnosed with COVID-19 infection confirmed by real-time reverse-transcriptase-polymerase chain reaction. CT showed rapidly progressing peripheral consolidations and ground-glass opacities in both lungs. After treatment, the lesions were shown to be almost absorbed leaving the fibrous lesions. © 2020 The Korean Society of Radiology.</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Korean_Journal_of_Radiology"/>
    <j.0:identifier>2-s2.0-85082132395</j.0:identifier>
    <j.0:title>2019 novel coronavirus (Covid-19) pneumonia: Serial computed tomography findings</j.0:title>
    <schema:keywords>COVID-19; adult; case report; Coronavirus infection; diagnostic imaging; female; fever; human; lung; virus pneumonia; x-ray computed tomography; Adult; Coronavirus Infections; Female; Fever; Humans; Lung; Pneumonia, Viral; Tomography, X-Ray Computed</schema:keywords>
    <dc:date>2020</dc:date>
    <dc:creator>Wei J., Xu H., Xiong J., Shen Q., Fan B., Ye C., Dong W., Hu F.</dc:creator>
    <j.0:publisher>Korean Radiological Society</j.0:publisher>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.3348/kjr.2020.0112</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082096801">
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <myOnto:volume>18</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:language>English</dc:language>
    <dc:creator>Contreras G.W.</dc:creator>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_emergency_management_(Weston,_Mass.)"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.5055/jem.2020.046</j.0:identifier>
    <j.0:title>Getting ready for the next pandemic COVID-19: Why we need to be more prepared and less scared</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082096801&amp;doi=10.5055%2fjem.2020.046&amp;partnerID=40&amp;md5=6aae8d845d93d46a06052b6ac5ab7b9a&gt;</schema:url>
    <j.0:identifier>2-s2.0-85082096801</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:issue>2</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080064519">
    <j.0:identifier>2-s2.0-85080064519</j.0:identifier>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>10.1016/j.ijantimicag.2020.105924</j.0:identifier>
    <myOnto:volume>55</myOnto:volume>
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <j.0:title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</j.0:title>
    <myOnto:citeyBy>9</myOnto:citeyBy>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080064519&amp;doi=10.1016%2fj.ijantimicag.2020.105924&amp;partnerID=40&amp;md5=bb3f6cc0317f19ae076a02dac83e473c&gt;</schema:url>
    <dc:date>2020</dc:date>
    <dc:creator>Lai C.-C., Shih T.-P., Ko W.-C., Tang H.-J., Hsueh P.-R.</dc:creator>
    <rdfs:comment>The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with &gt;99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24–3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond. © 2020 Elsevier Ltd</rdfs:comment>
    <schema:keywords>3CLpro inhibitor; alcohol; antibiotic agent; antifungal agent; antivirus agent; arbidol; benzalkonium chloride; Chinese drug; chlorhexidine gluconate; chloroquine; corticosteroid; disinfectant agent; ganciclovir; hydrogen peroxide; hypochlorite sodium; immunoglobulin; lamivudine; lianhua qingwen; lopinavir plus ritonavir; nucleoside analog; oseltamivir; peptide derivative; proteinase inhibitor; remdesivir; shufeng jiedu; sialidase inhibitor; steroid; tenofovir disoproxil; unclassified drug; acute heart failure; acute kidney failure; adult respiratory distress syndrome; antiviral activity; artificial ventilation; asymptomatic infection; basic reproduction number; China; clinical feature; computer assisted tomography; continuous renal replacement therapy; Coronavirinae; coronavirus disease 2019; Coronavirus infection; coughing; drug efficacy; drug response; epidemic; extracorporeal oxygenation; fever; human; hypoxemia; incidence; incubation time; infection control; infection prevention; intensive care unit; mixed infection; mortality; nonhuman; priority journal; Review; secondary infection; Severe acute respiratory syndrome coronavirus 2; shock; treatment outcome; virus inactivation; virus pneumonia; virus transmission</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/International_Journal_of_Antimicrobial_Agents"/>
    <myOnto:issue>3</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081275146">
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081275146&amp;partnerID=40&amp;md5=dad29811bb65ff9fe436490ba2e512d4&gt;</schema:url>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/BioPharm_International">
        <j.1:name>BioPharm International</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier></j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:publisher>UBM Medica Periodical Publication</j.0:publisher>
    <schema:keywords>coronavirus vaccine; unclassified drug; virus vaccine; antiviral activity; antiviral therapy; Coronavirinae; Coronavirus infection; covid 19; data base; disease surveillance; drug approval; drug industry; drug research; Editorial; gene sequence; health care personnel; human; jumping; medical research; nonhuman; public health; scientific literature; virus pneumonia</schema:keywords>
    <j.0:type>Editorial</j.0:type>
    <myOnto:issue>2</myOnto:issue>
    <j.0:title>The call for a rapid response</j.0:title>
    <dc:creator>Peters R.</dc:creator>
    <j.0:identifier>2-s2.0-85081275146</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:volume>33</myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078894398">
    <j.0:publisher>American Medical Association</j.0:publisher>
    <myOnto:citeyBy>12</myOnto:citeyBy>
    <j.0:identifier>10.1001/jama.2020.1097</j.0:identifier>
    <dc:creator>Phelan A.L., Katz R., Gostin L.O.</dc:creator>
    <j.0:identifier>2-s2.0-85078894398</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/JAMA_-_Journal_of_the_American_Medical_Association"/>
    <j.0:type>Note</j.0:type>
    <j.0:title>The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078894398&amp;doi=10.1001%2fjama.2020.1097&amp;partnerID=40&amp;md5=a9cb09b4f68d83476697551c87ba87b8&gt;</schema:url>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <schema:keywords>2019 novel coronavirus; awareness; China; Coronavirinae; disease control; disease severity; disease transmission; epidemic; epidemiologist; evidence based medicine; global health; health care delivery; health hazard; human; isolation; nonhuman; Note; prediction; priority journal; public health; World Health Organization</schema:keywords>
    <myOnto:volume>323</myOnto:volume>
    <myOnto:issue>8</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082179531">
    <j.0:identifier>2-s2.0-85082179531</j.0:identifier>
    <j.0:type>Letter</j.0:type>
    <myOnto:issue>4</myOnto:issue>
    <myOnto:volume>20</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:title>The first Vietnamese case of COVID-19 acquired from China</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Van Cuong L., Giang H.T.N., Linh L.K., Shah J., Van Sy L., Hung T.H., Reda A., Truong L.N., Tien D.X., Huy N.T.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082179531&amp;doi=10.1016%2fS1473-3099%2820%2930111-0&amp;partnerID=40&amp;md5=d981ed6cb4d9f79dc57cd657637f2459&gt;</schema:url>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <j.0:identifier>10.1016/S1473-3099(20)30111-0</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079385506">
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:issue>2</myOnto:issue>
    <myOnto:volume>9</myOnto:volume>
    <j.0:title>Wuhan coronavirus (2019-nCoV): The need to maintain regular physical activity while taking precautions</j.0:title>
    <dc:creator>Chen P., Mao L., Nassis G.P., Harmer P., Ainsworth B.E., Li F.</dc:creator>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Sport_and_Health_Science">
        <j.1:name>Journal of Sport and Health Science</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079385506&amp;doi=10.1016%2fj.jshs.2020.02.001&amp;partnerID=40&amp;md5=becffe10724ef239e99dd409b1d18df1&gt;</schema:url>
    <j.0:identifier>10.1016/j.jshs.2020.02.001</j.0:identifier>
    <j.0:identifier>2-s2.0-85079385506</j.0:identifier>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <schema:keywords>Coronavirus infection; covid 19; exercise; home; home environment; human; immune system; mental health; Note; physical activity; priority journal; public health; stretching exercise; World Health Organization</schema:keywords>
    <j.0:type>Note</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079080346">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079080346&amp;doi=10.3346%2fjkms.2020.35.e61&amp;partnerID=40&amp;md5=c4833263d2da0fe48cc636f48088a23c&gt;</schema:url>
    <j.0:identifier>10.3346/jkms.2020.35.e61</j.0:identifier>
    <myOnto:volume>35</myOnto:volume>
    <myOnto:issue>5</myOnto:issue>
    <dc:language>English</dc:language>
    <j.0:type>Article</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:creator>Kim J.Y., Choe P.G., Oh Y., Oh K.J., Kim J., Park S.J., Park J.H., Na H.K., Oh M.-D.</dc:creator>
    <j.0:title>The first case of 2019 novel coronavirus pneumonia imported into korea from wuhan, china: Implication for infection prevention and control measures</j.0:title>
    <j.0:publisher>Korean Academy of Medical Science</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Korean_Medical_Science"/>
    <myOnto:citeyBy>9</myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <rdfs:comment>In December 2019, a viral pneumonia outbreak caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV), began in Wuhan, China. We report the epidemiological and clinical features of the first patient with 2019-nCoV pneumonia imported into Korea from Wuhan. This report suggests that in the early phase of 2019-nCoV pneumonia, chest radiography would miss patients with pneumonia and highlights taking travel history is of paramount importance for early detection and isolation of 2019-nCoV cases. © 2020 The Korean Academy of Medical Sciences.</rdfs:comment>
    <j.0:identifier>2-s2.0-85079080346</j.0:identifier>
    <schema:keywords>COVID-19; adult; anamnesis; case report; China; Coronavirus infection; diagnostic imaging; epidemic; female; human; lung; pathology; South Korea; thorax radiography; travel; virus pneumonia; Adult; China; Coronavirus Infections; Disease Outbreaks; Female; Humans; Lung; Medical History Taking; Pneumonia, Viral; Radiography, Thoracic; Republic of Korea; Travel</schema:keywords>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078850043">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>anthrax; Coronavirinae; Coronavirus infection; disease transmission; Editorial; epidemic; Filovirus; food poisoning; foodborne pathogen; histoplasmosis; human; Lyssavirus; Middle East respiratory syndrome coronavirus; nonhuman; Paramyxoviridae; public health; rabies; Reoviridae; sea food; seroprevalence; severe acute respiratory syndrome; virus transmission; zoonosis; animal; bat; China; Coronavirinae; Coronavirus infection; epidemic; mammal; pathogenicity; virology; virus pneumonia; zoonosis; COVID-19; Animals; China; Chiroptera; Coronavirus; Coronavirus Infections; Disease Outbreaks; Epidemics; Humans; Mammals; Pneumonia, Viral; Zoonoses</schema:keywords>
    <dc:language>English</dc:language>
    <j.0:identifier></j.0:identifier>
    <myOnto:issue>1</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:date>2020</dc:date>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Infezioni_in_Medicina">
        <j.1:name>Infezioni in Medicina</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:type>Editorial</j.0:type>
    <j.0:title>History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel coronavirus epidemic</j.0:title>
    <j.0:publisher>EDIMES Edizioni Medico Scientifiche</j.0:publisher>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078850043&amp;partnerID=40&amp;md5=c7b16da3e136205e71bf3f89b11c9d87&gt;</schema:url>
    <myOnto:volume>28</myOnto:volume>
    <j.0:identifier>2-s2.0-85078850043</j.0:identifier>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <dc:creator>Rodriguez-Morales A.J., Bonilla-Aldana D.K., Balbin-Ramon G.J., Rabaan A.A., Sah R., Paniz-Mondolfi A., Pagliano P., Esposito S.</dc:creator>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079757744">
    <dc:creator>Shu L.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079757744&amp;doi=10.1038%2fd41586-020-00458-x&amp;partnerID=40&amp;md5=4e14c8dac450c02ded2866dcb6f89538&gt;</schema:url>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1038/d41586-020-00458-x</j.0:identifier>
    <schema:keywords></schema:keywords>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Avoid stigmatizing names for 2019 novel coronavirus</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Nature"/>
    <j.0:identifier>2-s2.0-85079757744</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>7795</myOnto:issue>
    <myOnto:volume>578</myOnto:volume>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081694419">
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:identifier>10.1089/bfm.2020.29149.poa</j.0:identifier>
    <myOnto:volume>15</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081694419</j.0:identifier>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081694419&amp;doi=10.1089%2fbfm.2020.29149.poa&amp;partnerID=40&amp;md5=24f70997e771cfd164fc7bcc99aec44e&gt;</schema:url>
    <schema:keywords>amantadine; antivirus agent; baloxavir; oseltamivir; peramivir; remdesivir; rimantadine; zanamivir; 2019 novel coronavirus; breast feeding; Coronavirinae; Coronavirus infection; human; influenza; influenza A; influenza B; Note; phase 3 clinical trial (topic); priority journal; randomized controlled trial (topic)</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Breastfeeding_Medicine">
        <j.1:name>Breastfeeding Medicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:issue>3</myOnto:issue>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:publisher>Mary Ann Liebert Inc.</j.0:publisher>
    <dc:creator>Anderson P.O.</dc:creator>
    <j.0:title>Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079612108">
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <j.0:publisher>Elsevier Ltd</j.0:publisher>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079612108</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:volume>7</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Psychiatry"/>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Xiang Y.-T., Yang Y., Li W., Zhang L., Zhang Q., Cheung T., Ng C.H.</dc:creator>
    <schema:keywords>2019 novel coronavirus; anger; anxiety; boredom; China; clinical psychology; contact examination; Coronavirinae; Coronavirus infection; counseling; crisis intervention; delirium; depression; distress syndrome; epidemic; excitement; fear; frustration; human; loneliness; mental health care; mental health care personnel; mobile application; nonhuman; Note; nurse; panic; posttraumatic stress disorder; priority journal; psychiatrist; psychosis; psychotherapy; quarantine; severe acute respiratory syndrome; suicidal behavior; virus pneumonia; virus transmission; civil defense; Coronavirinae; Coronavirus infection; growth, development and aging; health care personnel; health care planning; interpersonal communication; isolation and purification; legislation and jurisprudence; mental health; procedures; psychology; traffic and transport; virology; China; Civil Defense; Communication; Coronavirus; Coronavirus Infections; Crisis Intervention; Disease Outbreaks; Health Personnel; Health Plan Implementation; Humans; Mental Health; Quarantine; Transportation</schema:keywords>
    <j.0:identifier>10.1016/S2215-0366(20)30046-8</j.0:identifier>
    <j.0:type>Note</j.0:type>
    <myOnto:issue>3</myOnto:issue>
    <j.0:title>Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed</j.0:title>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079612108&amp;doi=10.1016%2fS2215-0366%2820%2930046-8&amp;partnerID=40&amp;md5=0a41b2b7ae3114808f2ee32c7b3dae45&gt;</schema:url>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082003173">
    <dc:language>English</dc:language>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:issue>12</myOnto:issue>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_New_England_journal_of_medicine"/>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <j.0:title>Audio Interview: New Research on Possible Treatments for Covid-19</j.0:title>
    <j.0:identifier>10.1056/NEJMe2005759</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:volume>382</myOnto:volume>
    <j.0:type>Editorial</j.0:type>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082003173&amp;doi=10.1056%2fNEJMe2005759&amp;partnerID=40&amp;md5=9952930287e676c23dedd38f4b80726f&gt;</schema:url>
    <dc:creator>Rubin E.J., Baden L.R., Morrissey S.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85082003173</j.0:identifier>
    <myOnto:citeyBy></myOnto:citeyBy>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079162868">
    <myOnto:issue>4</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079162868&amp;doi=10.1002%2fjmv.25688&amp;partnerID=40&amp;md5=165e9af0d9b5139ca98d32987b977818&gt;</schema:url>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079162868</j.0:identifier>
    <dc:creator>Benvenuto D., Giovanetti M., Ciccozzi A., Spoto S., Angeletti S., Ciccozzi M.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:identifier>10.1002/jmv.25688</j.0:identifier>
    <j.0:type>Article</j.0:type>
    <j.0:title>The 2019-new coronavirus epidemic: Evidence for virus evolution</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:volume>92</myOnto:volume>
    <j.0:publisher>John Wiley and Sons Inc.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>There is a worldwide concern about the new coronavirus 2019-nCoV as a global public health threat. In this article, we provide a preliminary evolutionary and molecular epidemiological analysis of this new virus. A phylogenetic tree has been built using the 15 available whole genome sequences of 2019-nCoV, 12 whole genome sequences of 2019-nCoV, and 12 highly similar whole genome sequences available in gene bank (five from the severe acute respiratory syndrome, two from Middle East respiratory syndrome, and five from bat SARS-like coronavirus). Fast unconstrained Bayesian approximation analysis shows that the nucleocapsid and the spike glycoprotein have some sites under positive pressure, whereas homology modeling revealed some molecular and structural differences between the viruses. The phylogenetic tree showed that 2019-nCoV significantly clustered with bat SARS-like coronavirus sequence isolated in 2015, whereas structural analysis revealed mutation in Spike Glycoprotein and nucleocapsid protein. From these results, the new 2019-nCoV is distinct from SARS virus, probably trasmitted from bats after mutation conferring ability to infect humans. © 2020 Wiley Periodicals, Inc.</rdfs:comment>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <schema:keywords>glycoprotein; spike glycoprotein; unclassified drug; coronavirus spike glycoprotein; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; Article; Bayes theorem; controlled study; Coronavirinae; fast unconstrained Bayesian approximation analysis; Middle East respiratory syndrome coronavirus; molecular evolution; mutational analysis; nonhuman; phylogenetic tree; SARS coronavirus; SARS-related coronavirus; sequence alignment; sequence homology; virus isolation; virus nucleocapsid; virus pathogenesis; whole genome sequencing; animal; bat; Betacoronavirus; Coronavirus infection; genetics; human; phylogeny; SARS coronavirus; Animals; Bayes Theorem; Betacoronavirus; Chiroptera; Coronavirus; Coronavirus Infections; Humans; Phylogeny; SARS Virus; Spike Glycoprotein, Coronavirus</schema:keywords>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Virology"/>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078690988">
    <schema:keywords></schema:keywords>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <myOnto:volume>368</myOnto:volume>
    <j.0:type>Article</j.0:type>
    <dc:creator>Parry J.</dc:creator>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078690988&amp;doi=10.1136%2fbmj.m351&amp;partnerID=40&amp;md5=d88a060efb5c3c56f6271722c3c86a1c&gt;</schema:url>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/BMJ_(Clinical_research_ed.)"/>
    <j.0:title>Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city</j.0:title>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:identifier>10.1136/bmj.m351</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>2-s2.0-85078690988</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081663780">
    <dc:creator>Flahault A.</dc:creator>
    <dc:language>English</dc:language>
    <j.0:identifier>10.1016/S0140-6736(20)30521-3</j.0:identifier>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:date>2020</dc:date>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081663780&amp;doi=10.1016%2fS0140-6736%2820%2930521-3&amp;partnerID=40&amp;md5=8992146065e859084ebb80135f584019&gt;</schema:url>
    <j.0:type>Letter</j.0:type>
    <myOnto:volume>395</myOnto:volume>
    <j.0:title>Has China faced only a herald wave of SARS-CoV-2?</j.0:title>
    <myOnto:citeyBy></myOnto:citeyBy>
    <schema:keywords></schema:keywords>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85081663780</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <myOnto:issue>10228</myOnto:issue>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081733274">
    <j.0:identifier>10.1007/s12630-020-01625-4</j.0:identifier>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081733274&amp;doi=10.1007%2fs12630-020-01625-4&amp;partnerID=40&amp;md5=078f678b0dff74d2dfde20b8ef250973&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>2-s2.0-85081733274</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>Chest computed tomography images of early coronavirus disease (COVID-19)</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:date>2020</dc:date>
    <dc:creator>Chen R., Chen J., Meng Q.-T.</dc:creator>
    <j.0:publisher>Springer</j.0:publisher>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:language>English</dc:language>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Canadian_Journal_of_Anesthesia"/>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078688233">
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.3.2000044</j.0:identifier>
    <myOnto:citeyBy>6</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078688233&amp;doi=10.2807%2f1560-7917.ES.2020.25.3.2000044&amp;partnerID=40&amp;md5=c46d4f706894f33a0978c4ad6f4c5477&gt;</schema:url>
    <j.0:title>Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020</j.0:title>
    <myOnto:volume>25</myOnto:volume>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <dc:creator>Wu P., Hao X., Lau E.H.Y., Wong J.Y., Leung K.S.M., Wu J.T., Cowling B.J., Leung G.M.</dc:creator>
    <dc:language>English</dc:language>
    <myOnto:issue>3</myOnto:issue>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <schema:keywords>China; classification; communicable disease; Coronavirinae; Coronavirus infection; epidemic; hospital mortality; hospitalization; human; isolation and purification; mortality; public health; respiratory tract infection; risk assessment; China; Communicable Diseases, Emerging; Coronavirus; Coronavirus Infections; Disease Outbreaks; Hospital Mortality; Hospitalization; Humans; Public Health; Respiratory Tract Infections; Risk Assessment</schema:keywords>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>A novel coronavirus (2019-nCoV) causing severe acute respiratory disease emerged recently in Wuhan, China. Information on reported cases strongly indicates human-to-human spread, and the most recent information is increasingly indicative of sustained human-to-human transmission. While the overall severity profile among cases may change as more mild cases are identified, we estimate a risk of fatality among hospitalised cases at 14% (95% confidence interval: 3.9-32%).</rdfs:comment>
    <j.0:identifier>2-s2.0-85078688233</j.0:identifier>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <dc:date>2020</dc:date>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079336160">
    <dc:language>English</dc:language>
    <j.0:identifier>10.2807/1560-7917.ES.2020.25.5.2000062</j.0:identifier>
    <dc:creator>Backer J.A., Klinkenberg D., Wallinga J.</dc:creator>
    <dc:date>2020</dc:date>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079336160&amp;doi=10.2807%2f1560-7917.ES.2020.25.5.2000062&amp;partnerID=40&amp;md5=18340f6996d44ad1928b82509e2d2b39&gt;</schema:url>
    <myOnto:volume>25</myOnto:volume>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:publisher>NLM (Medline)</j.0:publisher>
    <rdfs:comment>A novel coronavirus (2019-nCoV) is causing an outbreak of viral pneumonia that started in Wuhan, China. Using the travel history and symptom onset of 88 confirmed cases that were detected outside Wuhan in the early outbreak phase, we estimate the mean incubation period to be 6.4 days (95% credible interval: 5.6-7.7), ranging from 2.1 to 11.1 days (2.5th to 97.5th percentile). These values should help inform 2019-nCoV case definitions and appropriate quarantine durations.</rdfs:comment>
    <myOnto:issue>5</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Euro_surveillance_:_bulletin_Europeen_sur_les_maladies_transmissibles_=_European_communicable_disease_bulletin"/>
    <j.0:title>Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020</j.0:title>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>COVID-19; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus infection; human; incubation time; pathogenicity; severe acute respiratory syndrome; travel; virus pneumonia; Betacoronavirus; China; Coronavirus Infections; Humans; Infectious Disease Incubation Period; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Travel</schema:keywords>
    <myOnto:citeyBy>12</myOnto:citeyBy>
    <j.0:identifier>2-s2.0-85079336160</j.0:identifier>
    <j.0:type>Article</j.0:type>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079827431">
    <myOnto:issue></myOnto:issue>
    <rdfs:comment>There is a current worldwide outbreak of a new type of coronavirus (2019-nCoV), which originated from Wuhan in China and has now spread to 17 other countries. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak sites and from laboratories supporting the investigation. This paper aggregates and consolidates the virology, epidemiology, clinical management strategies from both English and Chinese literature, official news channels, and other official government documents. In addition, by fitting the number of infections with a single-term exponential model, we report that the infection is spreading at an exponential rate, with a doubling period of 1.8 days. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.</rdfs:comment>
    <j.0:type>Review</j.0:type>
    <myOnto:volume></myOnto:volume>
    <schema:keywords>China; Coronavirinae; government; nonhuman; practice guideline; review; virology</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:publisher>Springer</j.0:publisher>
    <dc:language>English</dc:language>
    <j.0:identifier>2-s2.0-85079827431</j.0:identifier>
    <j.0:title>2019 Novel coronavirus: where we are and what we know</j.0:title>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Infection">
        <j.1:name>Infection</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079827431&amp;doi=10.1007%2fs15010-020-01401-y&amp;partnerID=40&amp;md5=91022fcd1d820341d3d2faf7eb5b873a&gt;</schema:url>
    <j.0:identifier>10.1007/s15010-020-01401-y</j.0:identifier>
    <myOnto:citeyBy>2</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Cheng Z.J., Shan J.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079837095">
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079837095&amp;doi=10.1016%2fj.jhin.2020.01.019&amp;partnerID=40&amp;md5=ba2db49c1e6695c1bca3810bb74ee7b1&gt;</schema:url>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Note</j.0:type>
    <j.0:publisher>W.B. Saunders Ltd</j.0:publisher>
    <dc:date>2020</dc:date>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <dc:language>English</dc:language>
    <schema:keywords>adult respiratory distress syndrome; alertness; China; coronavirus disease 2019; Coronavirus infection; disease course; epidemic; health care planning; human; infection control; infection prevention; mass screening; Note; pandemic; pneumonia; quarantine; Betacoronavirus; Coronavirinae; Coronavirus infection; severe acute respiratory syndrome coronavirus 2; Betacoronavirus; China; Coronavirus; Coronavirus Infections; Humans</schema:keywords>
    <myOnto:issue>3</myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Hospital_Infection"/>
    <j.0:title>Novel coronavirus is putting the whole world on alert</j.0:title>
    <j.0:identifier>2-s2.0-85079837095</j.0:identifier>
    <myOnto:volume>104</myOnto:volume>
    <j.0:identifier>10.1016/j.jhin.2020.01.019</j.0:identifier>
    <dc:creator>Khan S., Ali A., Siddique R., Nabi G.</dc:creator>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079228854">
    <dc:date>2020</dc:date>
    <j.0:type>Review</j.0:type>
    <myOnto:volume></myOnto:volume>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <j.0:identifier>10.1007/s12519-020-00345-5</j.0:identifier>
    <j.0:title>Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus</j.0:title>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords></schema:keywords>
    <j.0:identifier>2-s2.0-85079228854</j.0:identifier>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/World_Journal_of_Pediatrics"/>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079228854&amp;doi=10.1007%2fs12519-020-00345-5&amp;partnerID=40&amp;md5=f439921c887d1666adac2719ea16657e&gt;</schema:url>
    <dc:creator>Chen Z.-M., Fu J.-F., Shu Q., Chen Y.-H., Hua C.-Z., Li F.-B., Lin R., Tang L.-F., Wang T.-L., Wang W., Wang Y.-S., Xu W.-Z., Yang Z.-H., Ye S., Yuan T.-M., Zhang C.-M., Zhang Y.-Y.</dc:creator>
    <rdfs:comment>Since December 2019, an epidemic caused by novel coronavirus (2019-nCoV) infection has occurred unexpectedly in China. As of 8 pm, 31 January 2020, more than 20 pediatric cases have been reported in China. Of these cases, ten patients were identified in Zhejiang Province, with an age of onset ranging from 112 days to 17 years. Following the latest National recommendations for diagnosis and treatment of pneumonia caused by 2019-nCoV (the 4th edition) and current status of clinical practice in Zhejiang Province, recommendations for the diagnosis and treatment of respiratory infection caused by 2019-nCoV for children were drafted by the National Clinical Research Center for Child Health, the National Children’s Regional Medical Center, Children’s Hospital, Zhejiang University School of Medicine to further standardize the protocol for diagnosis and treatment of respiratory infection in children caused by 2019-nCoV. © 2020, Children's Hospital, Zhejiang University School of Medicine.</rdfs:comment>
    <myOnto:citeyBy>4</myOnto:citeyBy>
    <j.0:publisher>Institute of Pediatrics of Zhejiang University</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080089137">
    <dc:language>English</dc:language>
    <j.0:type>Review</j.0:type>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:title>The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak</j.0:title>
    <myOnto:issue></myOnto:issue>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080089137&amp;doi=10.1016%2fj.jaut.2020.102433&amp;partnerID=40&amp;md5=3b060ba0dd8e028411c8f35ed85e6db9&gt;</schema:url>
    <j.0:identifier>10.1016/j.jaut.2020.102433</j.0:identifier>
    <j.0:publisher>Academic Press</j.0:publisher>
    <j.0:identifier>2-s2.0-85080089137</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <dc:creator>Rothan H.A., Byrareddy S.N.</dc:creator>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Autoimmunity"/>
    <rdfs:comment>Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19. Person-to-person transmission of COVID-19 infection led to the isolation of patients that were subsequently administered a variety of treatments. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. In this review, we highlights the symptoms, epidemiology, transmission, pathogenesis, phylogenetic analysis and future directions to control the spread of this fatal disease. © 2020 Elsevier Ltd</rdfs:comment>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085080894822">
    <j.0:identifier>10.1016/j.eclinm.2020.100289</j.0:identifier>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/EClinicalMedicine">
        <j.1:name>EClinicalMedicine</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <myOnto:issue></myOnto:issue>
    <myOnto:volume>20</myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080894822&amp;doi=10.1016%2fj.eclinm.2020.100289&amp;partnerID=40&amp;md5=27b5c48752555c70168757ceaf30bb03&gt;</schema:url>
    <schema:keywords>China; coronavirus disease 2010; Coronavirus infection; disease severity; epidemic; geographic distribution; government regulation; health care policy; health service; human; infection control; infection rate; Middle East respiratory syndrome; Note; pandemic; travel; virus transmission; Zika fever</schema:keywords>
    <myOnto:citeyBy></myOnto:citeyBy>
    <j.0:type>Note</j.0:type>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:identifier>2-s2.0-85080894822</j.0:identifier>
    <dc:creator>Malta M., Rimoin A.W., Strathdee S.A.</dc:creator>
    <dc:date>2020</dc:date>
    <j.0:title>The coronavirus 2019-nCoV epidemic: Is hindsight 20/20?</j.0:title>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085082193644">
    <j.0:title>One Health approach and Coronavirus Disease 2019</j.0:title>
    <j.0:identifier>10.1080/21645515.2020.1732168</j.0:identifier>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <myOnto:citeyBy></myOnto:citeyBy>
    <dc:creator>Ahmad T., Hui J.</dc:creator>
    <j.0:publisher>Taylor and Francis Inc.</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <myOnto:issue></myOnto:issue>
    <dc:date>2020</dc:date>
    <j.0:type>Article</j.0:type>
    <j.0:identifier>2-s2.0-85082193644</j.0:identifier>
    <schema:keywords></schema:keywords>
    <myOnto:volume></myOnto:volume>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082193644&amp;doi=10.1080%2f21645515.2020.1732168&amp;partnerID=40&amp;md5=11da4686b4ca6f48cfa9c7e123417d33&gt;</schema:url>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Human_Vaccines_and_Immunotherapeutics"/>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078951179">
    <j.0:identifier>2-s2.0-85078951179</j.0:identifier>
    <myOnto:issue>3</myOnto:issue>
    <dc:creator>Long J.B., Ehrenfeld J.M.</dc:creator>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078951179&amp;doi=10.1007%2fs10916-020-1536-6&amp;partnerID=40&amp;md5=a768614a7c7fc6ec71f1b322564e7f0a&gt;</schema:url>
    <myOnto:volume>44</myOnto:volume>
    <dc:date>2020</dc:date>
    <j.0:type>Editorial</j.0:type>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <schema:keywords>2019 novel coronavirus; augmented intelligence; Coronavirinae; Coronavirus infection; deep learning; diagnostic accuracy; Editorial; epidemic; health care system; human; infection control; information processing; nonhuman; public health; viral respiratory tract infection; virus detection; virus transmission</schema:keywords>
    <j.0:source>
      <fabio:Journal rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/Journal_of_Medical_Systems">
        <j.1:name>Journal of Medical Systems</j.1:name>
      </fabio:Journal>
    </j.0:source>
    <j.0:title>The Role of Augmented Intelligence (AI) in Detecting and Preventing the Spread of Novel Coronavirus</j.0:title>
    <j.0:identifier>10.1007/s10916-020-1536-6</j.0:identifier>
    <j.0:publisher>Springer</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085079841872">
    <rdfs:comment>Background: An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically ill patients with SARS-CoV-2 infection is scarce. We aimed to describe the clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia. Methods: In this single-centered, retrospective, observational study, we enrolled 52 critically ill adult patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) of Wuhan Jin Yin-tan hospital (Wuhan, China) between late December, 2019, and Jan 26, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were all collected. Data were compared between survivors and non-survivors. The primary outcome was 28-day mortality, as of Feb 9, 2020. Secondary outcomes included incidence of SARS-CoV-2-related acute respiratory distress syndrome (ARDS) and the proportion of patients requiring mechanical ventilation. Findings: Of 710 patients with SARS-CoV-2 pneumonia, 52 critically ill adult patients were included. The mean age of the 52 patients was 59·7 (SD 13·3) years, 35 (67%) were men, 21 (40%) had chronic illness, 51 (98%) had fever. 32 (61·5%) patients had died at 28 days, and the median duration from admission to the intensive care unit (ICU) to death was 7 (IQR 3–11) days for non-survivors. Compared with survivors, non-survivors were older (64·6 years [11·2] vs 51·9 years [12·9]), more likely to develop ARDS (26 [81%] patients vs 9 [45%] patients), and more likely to receive mechanical ventilation (30 [94%] patients vs 7 [35%] patients), either invasively or non-invasively. Most patients had organ function damage, including 35 (67%) with ARDS, 15 (29%) with acute kidney injury, 12 (23%) with cardiac injury, 15 (29%) with liver dysfunction, and one (2%) with pneumothorax. 37 (71%) patients required mechanical ventilation. Hospital-acquired infection occurred in seven (13·5%) patients. Interpretation: The mortality of critically ill patients with SARS-CoV-2 pneumonia is considerable. The survival time of the non-survivors is likely to be within 1–2 weeks after ICU admission. Older patients (&gt;65 years) with comorbidities and ARDS are at increased risk of death. The severity of SARS-CoV-2 pneumonia poses great strain on critical care resources in hospitals, especially if they are not adequately staffed or resourced. Funding: None. © 2020 Elsevier Ltd</rdfs:comment>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079841872&amp;doi=10.1016%2fS2213-2600%2820%2930079-5&amp;partnerID=40&amp;md5=45e03f8fcc7bb2ce2b3528a63c11a48c&gt;</schema:url>
    <myOnto:issue></myOnto:issue>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Respiratory_Medicine"/>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:type>Article</j.0:type>
    <myOnto:volume></myOnto:volume>
    <j.0:identifier>10.1016/S2213-2600(20)30079-5</j.0:identifier>
    <j.0:identifier>2-s2.0-85079841872</j.0:identifier>
    <dc:date>2020</dc:date>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <dc:creator>Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., Yu T., Wang Y., Pan S., Zou X., Yuan S., Shang Y.</dc:creator>
    <schema:keywords></schema:keywords>
    <j.0:title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</j.0:title>
    <myOnto:citeyBy>14</myOnto:citeyBy>
    <dc:language>English</dc:language>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078675459">
    <myOnto:volume>79</myOnto:volume>
    <rdfs:comment>Background: A novel coronavirus (2019-nCoV) associated with human to human transmission and severe human infection has been recently reported from the city of Wuhan in China. Our objectives were to characterize the genetic relationships of the 2019-nCoV and to search for putative recombination within the subgenus of sarbecovirus. Methods: Putative recombination was investigated by RDP4 and Simplot v3.5.1 and discordant phylogenetic clustering in individual genomic fragments was confirmed by phylogenetic analysis using maximum likelihood and Bayesian methods. Results: Our analysis suggests that the 2019-nCoV although closely related to BatCoV RaTG13 sequence throughout the genome (sequence similarity 96.3%), shows discordant clustering with the Bat_SARS-like coronavirus sequences. Specifically, in the 5?-part spanning the first 11,498 nucleotides and the last 3?-part spanning 24,341–30,696 positions, 2019-nCoV and RaTG13 formed a single cluster with Bat_SARS-like coronavirus sequences, whereas in the middle region spanning the 3?-end of ORF1a, the ORF1b and almost half of the spike regions, 2019-nCoV and RaTG13 grouped in a separate distant lineage within the sarbecovirus branch. Conclusions: The levels of genetic similarity between the 2019-nCoV and RaTG13 suggest that the latter does not provide the exact variant that caused the outbreak in humans, but the hypothesis that 2019-nCoV has originated from bats is very likely. We show evidence that the novel coronavirus (2019-nCov) is not-mosaic consisting in almost half of its genome of a distinct lineage within the betacoronavirus. These genomic features and their potential association with virus characteristics and virulence in humans need further attention. © 2020 Elsevier B.V.</rdfs:comment>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <dc:creator>Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S.</dc:creator>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078675459&amp;doi=10.1016%2fj.meegid.2020.104212&amp;partnerID=40&amp;md5=4316c28f32bf576206af3f9e38c2875e&gt;</schema:url>
    <j.0:title>Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event</j.0:title>
    <j.0:identifier>2-s2.0-85078675459</j.0:identifier>
    <dc:language>English</dc:language>
    <myOnto:citeyBy>11</myOnto:citeyBy>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/Infection,_Genetics_and_Evolution"/>
    <myOnto:issue></myOnto:issue>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <schema:keywords>nucleotide; severe acute respiratory syndrome coronavirus 2; 2019 novel coronavirus; Article; bat; Bayes theorem; Coronavirinae; gene cluster; gene sequence; genetic recombination; maximum likelihood method; molecular evolution; molecular phylogeny; nonhuman; priority journal; sarbecovirus; SARS-related coronavirus; sequence homology; virus genome; Betacoronavirus; genetics; high throughput sequencing; phylogeny; Betacoronavirus; Genome, Viral; High-Throughput Nucleotide Sequencing; Phylogeny; Recombination, Genetic</schema:keywords>
    <dc:date>2020</dc:date>
    <j.0:publisher>Elsevier B.V.</j.0:publisher>
    <j.0:identifier>10.1016/j.meegid.2020.104212</j.0:identifier>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085081661253">
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <rdfs:comment>[No abstract available]</rdfs:comment>
    <dc:language>English</dc:language>
    <dc:date>2020</dc:date>
    <schema:keywords></schema:keywords>
    <j.0:type>Letter</j.0:type>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet_Infectious_Diseases"/>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <j.0:identifier>10.1016/S1473-3099(20)30113-4</j.0:identifier>
    <j.0:identifier>2-s2.0-85081661253</j.0:identifier>
    <myOnto:citeyBy>1</myOnto:citeyBy>
    <j.0:title>Viral load of SARS-CoV-2 in clinical samples</j.0:title>
    <myOnto:volume>20</myOnto:volume>
    <dc:creator>Pan Y., Zhang D., Yang P., Poon L.L.M., Wang Q.</dc:creator>
    <myOnto:issue>4</myOnto:issue>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081661253&amp;doi=10.1016%2fS1473-3099%2820%2930113-4&amp;partnerID=40&amp;md5=0ede99f9367e4d43debf0558158a7f35&gt;</schema:url>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
  </dc:BibliographicResource>
  <dc:BibliographicResource rdf:about="http://utpl.edu.ec/lod/publicCOVID/data/2s2.085078761741">
    <j.0:identifier>10.1016/S0140-6736(20)30211-7</j.0:identifier>
    <j.0:publisher>Lancet Publishing Group</j.0:publisher>
    <myOnto:fundinText>objeto.getFoundingText()</myOnto:fundinText>
    <j.0:type>Article</j.0:type>
    <j.0:title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</j.0:title>
    <rdfs:comment>Background: In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia. Methods: In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020. Findings: Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market. The average age of the patients was 55·5 years (SD 13·1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT-PCR. 50 (51%) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient). According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneumothorax. 17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure. Interpretation: The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome. In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia. Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection. Funding: National Key R&amp;D Program of China. © 2020 Elsevier Ltd</rdfs:comment>
    <j.0:source rdf:resource="http://utpl.edu.ec/lod/publicCOVID/data/The_Lancet"/>
    <dc:date>2020</dc:date>
    <j.0:identifier>2-s2.0-85078761741</j.0:identifier>
    <myOnto:volume>395</myOnto:volume>
    <myOnto:issue>10223</myOnto:issue>
    <myOnto:citeyBy>132</myOnto:citeyBy>
    <schema:url>&lt;https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078761741&amp;doi=10.1016%2fS0140-6736%2820%2930211-7&amp;partnerID=40&amp;md5=4f69b2ff8156236477a98c94585f393b&gt;</schema:url>
    <dc:creator>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L.</dc:creator>
    <myOnto:fundinDetails>objeto.getFoundinDetails()</myOnto:fundinDetails>
    <dc:language>English</dc:language>
    <schema:keywords>adult; age; Article; China; chronic disease; clinical feature; confusion; Coronavirus disease 2019; Coronavirus infection; coughing; descriptive research; disease exacerbation; dyspnea; epidemiological data; exposure; female; fever; follow up; headache; human; major clinical study; male; marketing; medical history; multiple organ failure; myalgia; nausea and vomiting; pneumothorax; priority journal; real time polymerase chain reaction; respiratory distress; retrospective study; sea food; sore throat; thorax pain; virus detection; virus pneumonia; aged; comorbidity; complication; Coronavirus infection; coughing; dyspnea; epidemic; fever; middle aged; prognosis; severe acute respiratory syndrome; thorax radiography; very elderly; virology; virus pneumonia; x-ray computed tomography; young adult; COVID-19; Adult; Aged; Aged, 80 and over; China; Comorbidity; Coronavirus Infections; Cough; Disease Outbreaks; Dyspnea; Female; Fever; Humans; Male; Middle Aged; Pneumonia, Viral; Prognosis; Radiography, Thoracic; Retrospective Studies; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Young Adult</schema:keywords>
  </dc:BibliographicResource>
</rdf:RDF>
